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Preface 
This thesis is the result of 3½ years research, as part of the Danish program to obtain a Ph.D. degree. The 
work has been carried out at the DTU Chemistry, Technical University of Denmark, under the 
supervision of Professor Mads Hartvig Clausen.  
Chapter two describes the structure of the cell wall with an emphasis on galactan-rich polysaccharides, 
pectin and arabinogalactan protein. Chapter three is an introduction to the structure and function of the 
carbohydrate-binding protein, Galectin-3. Chapter four deals with the extensive studies of 
-(14)-galactan synthesis and the final preparation of a series of -(14)-linked galactans including 
linear and branched structures. Chapter five describes the synthesis of branched and linear 
-(13)-linked galactans by a convergent block strategy. In chapter six, work regarding synthesis of 
branched and linear -(16)-linked galactans is outlined. Chapter seven tells of different biological 
applications of synthesized compounds. In chapter eight the synthesis of Tunicamycin analogues by a 
chemoenzymatic method is discussed. The work described in this chapter was carried out at the 
University of Oxford, UK in collaboration with Professor Benjamin G. Davis. Chapter eight is a 
conclusion and Chapter nine contains experimental protocols and compound data. 
 
Two articles describing the work in chapter three are currently in preparation and will be submitted prior 
to the Ph.D. defense:  
Convenient synthesis of branched and linear -1,4-linked galactans as ligands for galectin-3. 
Mathias C. F. Andersen, Henriette L. Pedersen, Maja G. Rydahl, Gyrithe Lanz, Derek Logan, William G. 
T. Willats and Mads H. Clausen. 
Synthesis of -1,4 and -1,6-linked Rhamnogalacturonan-I galactan side chains 
Mathias C. F. Andersen and Mads H. Clausen. 
 
An article describing the work in chapter four and five is currently in preparation.  
Modular synthesis of oligogalactans related to arabinogalactan protein. 
Mathias C. F. Andersen and Mads H. Clausen. 
 
Articles describing the work in chapter six are included in the appendix B 
Pectin Biosynthesis: GALS1 in Arabidopsis thaliana Is a β-1,4-Galactan β-1,4-Galactosyl-
transferase. 
Liwanag A, Ebert B, Verhertbruggen Y,  Rennie E, Rautengarten C,  Oikawa A,  Andersen M, Clausen, 
M,  Scheller H. Plant Cell, 2012, 12, 5024-36. 
Versatile high resolution oligosaccharide microarrays for plant glycobiology and cell wall research. 
Pedersen HL, Fangel JU, McCleary B, Ruzanski C, Rydahl MG, Ralet MC, Farkas V, von Schantz L, 
Marcus SE, Andersen MC, Field R, Ohlin M, Knox JP, Clausen MH, Willats WG.  
J Biol Chem. 2012, 287, 47, 39429-38 
Distinct substrate specificities of three glycoside hydrolase family 42 β-galactosidases from 
Bifidobacterium longum subsp. infantis ATCC 15697. 
A. H. Viborg, T. Katayama, M. Abou Hachem, M. C. F. Andersen, M. Nishimoto, M. H. Clausen, T. 
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Abstract 
The plant cell walls represent almost 50% of the biomass found in plants and are therefore one of the 
main targets for biotechnological research. Major motivators are their potential as a renewable energy 
source for transport fuels, as functional foods, and as a source of raw materials to generate chemical 
building blocks for industrial processes. To achieve a sustainable development it is necessary to optimize 
plant production and utilization. This will require a better understanding of the cell wall structure and 
function at the molecular level. 
The cell wall is composed by an intricate network of polysaccharides and proteins that changes during the 
different developmental stages of the cell. This makes it very challenging to address the function of 
individual components in living cells. Alternatively, structurally defined oligosaccharides can be used as 
models for the more complex polysaccharide components in order to investigate a range of properties 
such as cell wall biosynthesis and protein-carbohydrate interactions. The oligosaccharides can be obtained 
by chemical or enzymatic degradation of the cell wall. However, although extensive studies have been 
conducted only a limited range of structures is available and the obtained oligosaccharides require 
extensive purification. Chemical synthesis, on the other hand, is capable of producing structurally diverse 
oligosaccharides of excellent purity and in higher quantities.  
This thesis presents the chemical synthesis of fragments of galactans and arabinogalactans that are 
prominent side chains of the pectic polysaccharide rhamnogalacturonan I (RG-I) and the main component 
of arabinogalactan protein (AGP). In the galactan series, 16 linear or branched -(14)-linked 
D-galactosides of four to eight residues were prepared by a convergent block strategy. Using a 
disaccharide donor the number of glycosylations were reduced significantly and late stage regioselective 
deprotection made it possible to introduce various branches. By the same general strategy, seven linear or 
branched -(13)-linked- and three linear -(16)-linked D-galactosides were prepared as part of the 
arabinogalactans series. The fragments were applied in the characterization of a glycosyl transferase, a 
hydrolase and to study the important cancer biomarker galectin-3.  The work done during an external stay 
at University of Oxford is also presented. This concerns isolation and modification of the carbohydrate-
based antibiotic, Tunicamycin. A simple and effective method has been developed for chemo-enzymatic 
synthesis of the partially protected core tunicaminyl lactol. Furthermore, synthesis of several novel 
muramic acid donors and attempts to glycosylate the tunicaminyl lactol are discussed.   
  
  v 
Dansk Resumé 
Plantecellevæggen udgør over 50% af plantens samlede biomasse, hvilket gør den til et interessant 
forskningsområde indenfor bioteknologi. Det skyldes i høj grad biomassens potentiale som en vedvarende 
kilde til brændstoffer, funktionelle fødevarer, og som råstof i fremstillingen af byggeblokke til industrielle 
processer. For at opnå en bæredygtig udvikling er det nødvendigt at optimere produktionen og 
udnyttelsen af planterne. Dette kræver en indgående forståelse af cellevæggens struktur og funktion på et 
molekylært niveau. 
Cellevæggen består af et indviklet netværk af polysakkarider og proteiner, der ændrer sig i løbet af cellens 
forskellige udviklingsstadier. Dette besværliggører bestemmelsen af de enkelte molekylers funktion i 
levende celler. Alternativt kan veldefinerede oligosakkarider anvendes som model-substrater til at 
undersøge en række egenskaber, såsom cellevæggens biosyntese og interaktioner med kulhydratbindende 
proteiner. Kemisk eller enzymatisk nedbrydning af cellevæggen har tidligere været den mest anvendte 
metode til fremstilling af planteoligosakkarider men har kun givet adgang til et begrænset antal strukturer. 
Dette skyldes hovedsageligt, at en omfattende oprensning er nødvendig for at opnå en tilstrækkelig 
renhed. Kemisk syntese gør det derimod muligt at fremstille veldefinerede oligosakkarider af høj renhed 
og i stor mængde. 
Denne afhandling beskriver den kemiske syntese af galaktan- og arabinogalaktanfragmenter, der er 
hyppigt forekomne sidekæder i rhamnogalakturonan I (RG-I), og den vigtigste del af arabinogalaktan 
protein (AGP). De β-(1→4)-forbundne galaktaner blev fremstillet ved at anvende en konvergent 
blokstrategi, der gjorde det muligt at syntetisere 16 forskellige lineære eller forgrenede oligosakkarider 
bestående af fire til otte sukre. Ved at anvende en disakkarid donor kunne antallet af glykosyleringer 
reduceres og ved hjælp af regioselektiv afbeskyttelse var det muligt at introducere forskellige 
forgreninger sent i syntesen. Den samme generelle strategi blev benyttet til at syntetisere 10 
arabinogalaktan fragmenter i form af syv lineære eller forgrenede β-(1→3)-forbundne D-galaktosider 
samt tre lineære β-(1→6)-forbundne D-galaktosider. Oligosakkariderne blev benyttet til at karakterisere 
en glykosyl syntase, en hydrolase og til at studere den vigtige cancer biomarkør galectin-3. Desuden 
beskrives resultaterne fra et eksternt ophold på University of Oxford, der omhandlede isolering og 
modifikation af det kulhydrat-baserede antibiotikum Tunicamycin. En enkel og effektiv metode til 
kemoenzymatisk syntese af grundstrukturen, tunicaminyl laktol blev udviklet. Desuden beskrives 
syntesen af en række nye muraminsyre glykosyldonorer og forsøgene på at glykosylere tunicaminyl 
lactolen. 
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1 Introduction 
Plant science has never been more important. The growing and increasingly prosperous human population 
needs abundant, safe and nutritious food, clothes, fiber, and renewable energy while addressing the 
problems generated by climate change. These global challenges can only be met in the context of a strong 
fundamental understanding of plant biology and translation of this knowledge into applications.  
A unique feature of the plant is the presence of a polysaccharide-rich cell wall. The wall encloses the cell 
but at the same time allows transfer of solutes and signaling molecules between cells via specific pores. 
Similar to the skeleton in animals, the plant cell wall is the key determinant of the plant form, growth and 
development. However, in contrast to the specialized skeleton found in animals the shape and strength of 
plants rely solely on the properties of the wall. Thus, plants would be piles of slime instead of stately trees 
and other greenery if it was not for the cell wall. The plant cell wall also plays a crucial role in plant 
defense and response to environmental stresses. Thus, an improved understanding of the plant cell wall 
will be critical for the development of modified crops. Furthermore, it is generally acknowledged that 
efficient utilization of plant cell wall material as e.g. food additives and a source of both bioenergy and 
biochemicals is hampered by a lack of detailed molecular-level information about polysaccharide 
structure and function. Studies of the structure are complicated by the great complexity of the cell wall. 
Not only does it constitute a range of polysaccharides, it also has significant microheterogeneity, which 
makes it extremely challenging to isolate well-defined structures by degradation of plant material. 
Chemical synthesis, on the other hand, is capable of producing structurally diverse oligosaccharides of 
excellent purity and in large quantities.  
The hypothesis of the research described in this thesis is that we can add to the available information by 
preparing well-defined, structurally resolved oligosaccharides that resemble the more complex 
polysaccharide networks found in the plant cell wall. These can function as ligands in characterization of 
carbohydrate-binding proteins, such as antibodies, lectins and carbohydrate-binding modules that are the 
probes used to study carbohydrate structure in the complex environment of the cell wall. This, in turn, 
will lead to a better understanding of the spatial and temporal distribution of polysaccharides in the plant 
cell wall and their various functions. 
We have chosen to focus on galactans and arabinogalactans that are prominent side chains of the pectic 
polysaccharide, rhamnogalacturonan I (RG-I) (as described in section 2.1) and the main component of 
arabinogalactan protein (AGP), outlined in section 2.2. Furthermore, galactans have attracted our interest 
because they are hypothesized to play important roles in modulating mammalian cell biology, 
exemplified by their role as ligands for the important cancer biomarker galectin-3 (Gal-3), which is 
introduced in section 3.  
Structure of the plant cell wall 
 2 
2 Structure of the plant cell wall 
The primary plant walls are composed mainly of a complex array of polysaccharides (approx. 90%) and 
protein components (approx. 10%). The types of polysaccharides present in the cell wall vary depending 
on plant species, cell type and location, developmental stage and history of responses to external stress.
1
 
All plant cell types are, however, based on a structure of rigid cellulose microfibrils embedded in a 
gel-like matrix of complex non-cellulosic polysaccharides and pectins. 
2,3
 The primary cell wall is divided 
into two categories based on the non-cellulosic polysaccharide composition. Type I walls consist of a 
cellulosic microfibrils cross-linked by hemicelluloses (mostly xyloglucan) and enmeshed in a non-
covalently cross-linked pectic network (Figure 1).
2,3
 Type II walls are organized in essentially the same 
way but in this case the matrix is mainly composed by glucuronoarabinoxylans (GAXs) and 
-D-(13;14)-glucans (mixed-linkage glucans, MLGs).2,3 The organization and interactions of wall 
components is not known with certainty and there is still considerable debate about how wall organization 
is modified to allow cells to expand and grow. A range of models has been published to address this issue 
but it is outside the scope of this section to describe them. Numerous reviews covering plant cell wall 
structure and polysaccharide content have been published and can be consulted for further information.
3–5
  
Plant cells that have ceased to grow and are required to withstand growing compressive forces change 
character by depositing a secondary cell wall.
5
 This serves to increase the strength of the cell and reduce 
flexibility. The secondary cell wall consists of cellulose and matrix-polysaccharides with a lower degree 
of backbone branching, mainly xylan and heteromannans that are deposited in a highly ordered fashion. 
Together with deposition of lignin, a complex polyphenolic polymer, this results in a dehydration of the 
wall, which becomes more hydrophobic and less dynamic.
5
  
 
 
Figure 1. Segment of the primary cell wall. Pectin is shown in blue intertwined in the cellulose network (green cylinders).6 
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The major polysaccharide structures found in the plant cell wall are summarized in Figure 2. Cellulose 
microfibrils consists of approx. 36 linear -(14)-linked D-Glcp chains held tightly together by hydrogen 
bonds.
7
 The diameter, length and crystallinity are highly variable and depend of the age and type of 
tissue. Xyloglucans are similar in structure to cellulose but xylosyl (Xylp) side chains and their extension 
prevent hydrogen bonding along the length of the molecules and thereby make them more flexible.
8
 
MLGs are also similar to cellulose but in this case single -(13)-linked D-Glcp residues are located in 
between blocks of several -(14)-linked D-Glcp units. This results in “kinks” and precludes microfibril 
formation.
9
 Heteroxylans consist of a backbone of -(14)-linked Xylp residues of which approx. 10% 
are C2 or C3 branched with -D-glucuronic acid (GlcpA), -L-arabinofuranosyl (Araf) residues, or a 
combination of both to give glucuronoxylan (GX), arabinoxylans (AX), and glucoron-arabinoxylans 
(GAX). The backbone C2-O and C3-O can furthermore be acetylated.
10
 Heteromannans are a family of 
mannopyranosyl (Manp)-containing polysaccharides that includes mannans, glucomannans, 
galactomannans and glucogalactomannans. Galactomannans are composed of a -(14)-linked D-Manp 
backbone with C6-branching by -D-Galp residues. In glucomannans the -(14)-Manp backbone is 
interrupted by -(14)-Glcp residues.11 
Another class of plant polysaccharides, pectins, are among the most complex families of polysaccharides 
and the focus of our research. In the next section, special attention is therefore given to their structure.  
             
Figure 2. Illustration of the most common plant cell wall polysaccharides. 
2.1 The structure of pectin 
The pectin backbone is primarily made up from two major units: homogalacturonan (HG) and 
rhamnogalacturonan I (RG I). HG is an up to 200 residue long homopolymer of 
(14)-α-D-galactopyranuronic acid (GalpA) with varying proportions of methylesterified carboxyl 
groups and acetylation of the C2-O and/or C3-O hydroxyls (Figure 3). The free carboxyl groups make it 
possible for separate HG chains to condense by cross-linking with Ca
2+
 and thereby form ‘junction 
cellulose 
xyloglucan (XyG) 
(1:3;1:4)--glucan heteroxylan 
heteromannan 
D-glucose 
D-galactose 
L-arabinose 
D-xylose 
D-fucose 
COOH 
= 
= 
D-mannose 
Ferulic acid 
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zones’, linking two anti-parallel polysaccharide chains. It is believed that this property is responsible for 
the porosity of the cell wall, since the pectin chains are condensed in the junction zones, but creates pores 
where the intervening chains are separated. This correlates with the fact that the methyl-esterification 
seems to be tightly regulated by the plant both with regard to developmental stage and in a tissue-specific 
manner.
12–14
  
RG I is a heteropolymer of repeating (12)-α-L-rhamnopyranosyl-(14)-α-D-galactopyranuronic acid 
disaccharide units (Figure 3). The average length has not been determined, since the RG I domains are 
generally flanked by HG domains. However, they are all shorter than the HG domains. The backbone 
GalpA residues may be O-acetylated on C2-O and/or C3-O as seen for HG, but no methyl-esterification 
has been observed.
12
  
 
Figure 3. Structure of the two major constituents of the pectic backbone A) homogalacturonan and B) 
rhamnogalacturonan I. 
Both HG and RG I contain side chains, but the degree of substitution, size and diversity of the 
substituents are very different. HG has a low level of substitution consisting of D-apiose and D-xylose 
monosaccharides. However, short parts of the HG backbone, also referred to as RG II, are substituted by 
very diverse side chains. The side chains contain monosaccharide residues such as D-glucose, 
D-galactose, D-xylose, L-rhamnose, L-arabinose, L-fucose along with many rare sugars.
12,15
  
In RG I, the side chains are exclusively attached to the rhamnose residues of the backbone. They consist 
of four different types of branched oligosaccharides of varying length (1-20 residues): arabinans, 
galactans and type I or type II arabinogalactans (AG) (Figure 4).
12,15
 
Type I arabinogalactan (AG I) is the most abundant neutral pectic structure and is especially abundant in 
citrus fruits and apple. It is characterized by single interspersed α-(15)-linked L-arabinofuranosyl (Araf) 
residues in a β-(14)-linked D-Galp chain. The main chain is furthermore branched by one or more Araf 
and D-Galp residues or single terminal arabinopyranosyl (Arap) residues.
16
 The type II arabinogalactan is 
constituted by much more branched galactan chains. Thus, they are characterized by a backbone of 
β-(13)-linked D-Galp with branch points of 6-linked β-D-Galp of one, two, or three residues in length. 
Some of the β-(13)-galactan chains are capped by single β-Arap residues.17 Galactans are simply 
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β-(14)-linked D-galactan chains and have been observed in up to 40 residues length.18 Finally, the 
arabinans consists of α-(15)-linked L-Araf residues with some degree of (13)-bran-ching.12  
 
Figure 4. Illustration of the different side chains on the RG I backbone.12  
Because of the difference in substitution level of the different pectic backbones, they are often described 
as having alternating “smooth” and “hairy” regions. The “smooth” regions are HG stretches of 25-50 
residues with a low substituent level except for methyl esterified or acetylated galacturonic acid residues. 
This region governs the solubility of the polymer and gives rise to pectin’s ability to cross-link.15 
The “hairy” regions encompass all pectic structures that contain neutral sugars with AG I, AG II and 
galactans being the “bulk” of the hair.15 Studies by molecular modeling of the tertiary structure of pectin 
has implied that AG I’s lateral chains are orthogonal to the rhamnogalactan backbone and therefore create 
plenty of unoccupied space for attachment of other molecules, such as proteins, to the β-galactoside 
region.
19
 The same holds true for AG II, which has an open helical structure. This makes it sterically 
relaxed and available for both efficient packing and exogenous interactions.
19
  
2.2 Arabinogalactan protein 
As described previously, the plant cell wall does not only comprise polysaccharides. Wall glycoproteins, 
which constitute less than 10% of the dry weight of the primary cell wall, are crucial to the structure and 
function of the wall. In addition to serving a structural role the wall proteins contribute to the wall 
assembly and remodeling during growth and development, and in stress responses.
5
 The proteins includes 
hydrolases, proteases, glycosidases, peroxidases, esterases, wall-associated kinases, hydroxyproline-rich 
glycoproteins that includes extensins, arabinogalactan-proteins and proline-rich protein and the glycine 
rich protein.
20
 Detailed description of the wall proteins is beyond the scope of this thesis and readers are 
referred to reviews.
20
 Instead focus will be on arabinogalactan protein, which is very interesting in our 
context since its backbone is covered with complex galactan polysaccharides.  
Arabinogalactan-protein (AGPs) is one of the most complex families of macromolecules found in plants. 
The complexity arises from a great diversity of glycans decorating the protein backbone and constituting 
90-98% of the total mass.
5
 Although this has made it impossible to address the precise function of a single 
AGP, they are known to be involved in several processes in plant growth and development including 
D-glucose 
D-galactose 
L-arabinose 
L-rhamnose 
D-fucose 
COOH 
β-notation 
α-notation 
= 
= 
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differentiation,[67] signaling,
22
 root growth,
23
 embryogenesis,
24
 and programmed cell death
25
. It is outside 
the scope of this section to describe APGs biological role but excellent reviews have been published on 
this subject by Seifert & Roberts
26
 and Nothnagel
27
. 
2.3 The structure of arabinogalactan protein 
2.3.1 Carbohydrate moiety 
Characterization of the glycan structures of AGPs is complicated by difficulties in isolation of single 
AGPs and the micro heterogeneity found in the constituent chains. Knowledge of the structure is based on 
NMR-characterization of fragments or binding of carbohydrate-specific monoclonal antibodies for which 
epitope specificities are partially known.
28
 It should therefore only used as a guideline. 
The AGP glycans are predominantly type II arabinogalactan chains of 30-120 carbohydrate residues that 
are O-glycosidically linked to hydroxyproline (Hyp) residues in the protein backbone.
29
 The type II AGs 
are made up by a -(13)-linked D-Galp backbone substituted at C-6 by side-chains of -(16)-linked 
D-Galp. The side chains are often substituted by a great diversity of sugars including Araf, 
rhamnopyranosyl (Rhap), fucopyranosyl (Fucp) and glucopyranuronic acid (GlcpA) (Figure 5). The AGs 
are generally neutral but GlcpA-rich versions have also been found in gum Arabica.
30
 
Several groups have reported that the AG backbone is susceptible to periodate oxidation resulting in 
fragments of approximately seven -(13) Galp units. This suggests that the backbone contains 
repeating units of seven Galp residues interrupted by periodate-sensitive linkages such as (16)-Galp or 
(15)-Araf.31,32 Besides AG II, single Galp residues linked to serine or threonine and short 
oligoarabinosides linked to Hyp have also been found.
33
 The largest fragment characterized so far is a 
15-residue AG-Hyp section isolated by heterologous AGP expression in tobacco BY2 cells followed by 
alkaline hydrolysis and purification.
34
 This confirmed the general held view of AG structure. However, 
the average chain length is significantly lower than the ones estimated for native AGPs.
29
 Furthermore, 
the “periodate repeats” are much shorter than what was predicted for native AGPs.32 
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Figure 5. Model of the structure of the carbohydrate moiety of AGPs.30 
2.3.2 Protein moiety 
The first studies of the AGP protein backbone required purification of native AGPs, deglycosylation and 
Edman degradation
35
, which is a difficult and time-consuming process.
36
 The emergence of gene 
sequencing has significantly increased the understanding of AGPs. Like the glycans, the protein backbone 
has an incredible diversity. For example, Arabidopsis has more than 100 genes coding for proteins with 
AGP domains.
37
 The genes were categorized in four different classes: classical AGPs, Lys-rich AGPs, 
AG peptides and FLAs (fascilin-like AGPs). The classical AGPs and AG peptides are considered to be 
the basal form of AGPs, since they have no other functional areas that could interfere with their activity. 
Thus, the entire backbone is a scaffold for glycosylation. FLAs are a class of chimeric proteins that in 
addition to an AGP domain, constitutes one or two fasciclin domains. These are believed to be important 
for protein-protein interaction.
38
  
Classical AGPs contain Hyp, alanine, serine, threonine and glycine as the major amino acid constituents 
and have a backbone of approx. 100 amino acids. AG peptides are made up by the same amino acids but 
contain only 10 to 13 residues. The Hyp residues are formed by post-translational modification by prolyl 
4-hydroxylase, where 80-90% of the proline residues are hydroxylated.
39
 There is no well-characterized 
amino acid sequence motif defining O-glycosylation of the AGPs. Instead, it has been hypothesized that 
single noncontiguous Hyp residues are glycosylated with polysaccharide units whereas clusters of Hyp 
residues are glycosylated by oligoarabinosides. Further studies are needed to verify this but, for the time 
being, the prediction correlates with all experimental data.
40
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3 Galectins 
This section gives an introduction to the structure and biological role of the β-galactoside binding protein 
family, galectins. Since there is a remarkable homology between the different galectins most of the 
discussion is general for all galectins. However, special attention will be given to galectin-3’s properties, 
since this is the most abundant galectin in cancer tissues, together with galectin-1. 
3.1 General characteristics of galectins 
Galectins are a subfamily of the lectins, which is a protein family possessing a relatively high affinity to 
certain carbohydrate moieties.
41
 Galectins are defined by their affinity for β-galactosides, and their 
significant sequence similarity in the carbohydrate-binding site.
42
 They appear to be of very old origin, 
since galectin-like structures are found in all kingdoms (animal, plant, fungi, protest and prokaryotes).
43
 
Galectin-1 was the first galectin to be discovered in 1975 in its display of hemagglutinating properties in 
electric eels and is still by far the most studied of the galectins.
44
 Since the discovery, 14 mammalian 
galectins have been characterized and many more have been found in other organisms.
45
 All animal cells 
appear to express one or more galectins with varying expression level from cell to cell depending on the 
activation state. The different types of galectins are generally found in high concentration in specific cell 
types.
46
 
3.2 The structure of galectins 
The galectins have been divided into three groups based on their structure: prototype (galectin-1, 2, 5, 7, 
10, 11, 13 and 14), chimera (Gal-3) and tandem repeat (galectin-4, 6, 8, 9 and 12).
45,47
 The prototype only 
consists of the carbohydrate recognition domain (CRD). Gal-3 is the only mammalian chimera galectin 
and possesses both a CRD and another N- or C-terminal domain mainly observed as a long peptide 
extension with various properties. Tandem repeat galectins have two homologous but distinct CRDs, 
joined either directly or via a linker peptide of variable length.
45,47
 The structure seems to have great 
importance for the galectins’ ability to form oligomers. 
3.2.1 Structure of the CRD 
Even though the different types of galectins vary in their overall structure and amino acid sequence they 
all contain at least one CRD made up from approx. 135 amino acids. Interestingly, the monomer fold of 
all CRDs is remarkably conserved not only between mammalian galectins, but among all galectins. This 
is demonstrated in Figure 6B, where the CRD of all known human galectins have been superimposed 
resulting in a root-mean-square deviation (RMSD) value of only 1.5 Å for the backbone. Similar results 
are given in Figure 6C where the CRD of galectin-1 originating from different species have been super-
imposed.
42,48
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Figure 6. A) Cartoon representation of the monomer fold of galectin-1 B) Superimposition of the CRD from all known 
human galectins C) Superimposition of galectin-1 from different species.48 
The fold is composed by two slightly bend anti-parallel β-sheets, one of which is formed by six (S1-S6) 
and the other formed by five (F1-F5) β-strands (see Figure 6A).42,48 The motif is known as a β-sandwich. 
The folded structure forms a more or less globular shape, where the hydrophobic residues are packed 
within the interior to improve the stability in solution. However, due to the bend of the β-sheets, the CRD 
has a concave and a convex surface. This structural feature is more evident in the crystal structure shown 
in Figure 7a.  Within the concave surface formed by the six-stranded β-sheet, the S3-S6 chains form two 
fingers, which are steeply bent at the ends and thereby form a negatively charged groove. This is where 
the carbohydrate is bound (Figure 7B).
48
 
 
Figure 7. A) Representation of the convex and concave side of Gal-3. B) The carbohydrate binding site C) The five 
subsites of the carbohydrate binding site.48  
Based on the observation that the carbohydrate-binding site is able to accommodate a linear 
tetrasaccharide, it has been proposed to have four subsites (A-D) (Figure 7C).
49
 This hypothesis is 
supported by galectins specificity for small carbohydrates. Using this model, subsite C is the defining 
β-galactoside binding site and together with subsite D constitutes the core disaccharide-binding site. The 
binding of galactose in site C is the most conserved feature of galectin binding activities. Six of the seven 
“motif amino acids” interact with the galactose residue, however, some with weaker binding than others. 
The D binding site is the second most conserved feature, but here structural requirements are much lower 
and hence accommodate many different saccharides. Preference for one or the other is one of the sources 
of variation in the specificity of different galectins. However, the major source of variation in specificity 
of the different galectins seems to be their different ability to accommodate saccharides and other groups 
in subsite A and B. The amino acid composition of this area varies to a much higher extent resulting in 
A) Galectin-1 B) Human galectins C) Galectin-1 of different species 
A) B) C) 
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some of the differences.
49
 Most of the galectins also have an E-site even though it is less defined. This is 
believed to accommodate interactions with moieties linked to the reducing end of the saccharide (site D), 
which are large enough to interact with the CRD outside the groove. Thus, for some glycoproteins it has 
been observed that two proteins with the same glycoconjugate bound Gal-3 with different affinity.
46,50
  
 
Figure 8. Galectin-1 in complex with the disaccharide lactose.49 
Seven conserved amino acids constitute subsite C of which only the position in the overall amino acid 
sequence varies. Hence, the galectins-1 subsite C is composed of H44, N46, R48, H52, N61, W68, and 
E71 whereas galectins-3’s is made up from H158, N164, R162, H169, N174, W181, and E184.50,51 Figure 
8 shows galectin-1 in complex with lactose, the simplest carbohydrate ligand for the galectins. It is seen 
that three hydroxyl groups of lactose (C4-OH and C6-OH of galactose and the C3-OH of glucose) form 
hydrogen bonds with the hydrophilic residues from galectins. The galactose ring, in particular, forms 
several H-bonds between its oxygen atoms C4-O, C5-O and C6-O and H44, E71, and N61, while the 
C3-O of the glucose ring forms H-bonds with the residues R48 and E71.
50
 H52 and W68 are proposed to 
have van der Walls interactions with the non-polar side of the galactose ring, which is almost only 
substituted by hydrogen. This hydrophobically mediated interaction contributes to the binding free energy 
and is important for the discrimination of galactose and glucose. This is due to the fact that glucose has its 
C4-OH group in the equatorial position and therefore decreases the apolar nature of the corresponding 
surface.
52
  
3.2.2 Formation of dimers and oligomers 
Despite the fact that the galectins are remarkably similar in both structure and sequence, they have several 
distinct effects and different cellular positions. This is explained by galectins ability to self-associate. 
Self-association mostly leads to different dimer structures, but also forms higher oligomers depending on 
the galectin concentration. Despite the similarity of the CRD in all galectins they form different types of 
dimers. In Figure 9, three examples are given. Galectin-1 forms a dimer through hydrophobic interactions 
between the N- and C-terminal residues of two monomers with the resulting twofold rotation axis being 
perpendicular to the plane of the β-sheet.50 Galectin-2, on the other hand, forms a “non-symmetric” dimer 
Galectins 
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interface from the convex surfaces of the two monomer stabilized by electrostatic interactions between 
charged residues.
53
 Finally, galectin-7 forms a “symmetric sandwich” dimer also established by 
electrostatic interactions on the convex surface, but here the interface is reduced compared to the other 
two.
54
 The ability to form different multimer states gives the otherwise very similar proteins a broad range 
of possible quarternary structures and hence different binding properties. 
 
Figure 9. X-ray structures of three different types of dimers formed by galectin-1, -2 and -7.50,53,54  
3.2.3 The N-terminus of galectins-3 
As already mentioned galectins-3 differs from the other galectins due to its N-terminal domain (ND), 
which is composed of 110-130 amino acids depending on the species. This relatively flexible structure 
contains 7-14 homologues repeats, which includes the sequence Pro-Gly-Ala-Tyr-Pro-Gly followed by 
three additional amino acids. Although the ND has been shown to lack carbohydrate-binding activity, it is 
essential for full biological function of Gal-3.
51
 Molecular modeling and mutagenesis studies have 
indicated that ND participates together with the CRD in oligosaccharide binding and thereby in 
distinguishing Gal-3 from other galectins. However, the most important property of the ND domain 
seems to be its responsibility for forming multimers and which makes it possible for Gal-3 to act as a 
cross-linker.
55
 Finally the terminal region of the domain has two phosphorylation sites by residues S6 and 
S12. These have been shown to be very important for the cellular location of Gal-3 as described in section 
3.3.4.
56
  
3.3 Gal-3’s function in the progression and metastasis of cancer 
Galectins generally elicit their biological effects by binding and cross-linking different glycan groups of 
glycoproteins and/or glycolipids on the surface of various cells. In contrast to most enzymes the binding 
is not accompanied by a chemical conversion of the ligand. They rather bind them to form non-covalent 
multivalent complexes that bring the ligands together. This either results in structural interactions that 
mediate cell-cell and/or cell-matrix adhesion or migration, or in signal transduction to effect intracellular 
changes necessary for example cell growth and proliferation.
43
  
Due to the variety of different galectins and self-associated oligomer states of these, galectins are able to 
bind a huge array of different ligands and thereby mediate a multitude of effects throughout the body. For 
example Gal-3, which seems to be one of the most promiscuous galectins, display biological activities 
including cell growth,
57
 cell adhesion,
57
 apoptosis,
58
 immune response
59
 as well as gene transcription 
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regulation,
60,61
 Figure 10 gives an idea of the over-whelming array of ligands to which Gal-3 binds and 
these are only the extra-cellular binding partners.
61
 It is outside the scope of this project to go into details 
with all the biological functions. The focus will be on Gal-3’s involvement in the progression and 
metastasis of cancer and the potential therapeutic applications of Gal-3. It should be noted that many 
other galectins are known to be involved in this process with galectin-1 being the most studied together 
with Gal-3.
62
  
 
 
Figure 10. A representation of some of the extracellular receptors and ligands to which Gal-3 has been observed to bind.61 
Metastasis is a major fatal complication associated with malignant tumors.
63,64
 Cancer emerges when a 
single cell is genetically damaged in ways that result in the formation of a cancer stem cell. The cancer 
stem cell may undergo uncontrolled mitosis resulting in a rapid increase in the total number of cancer 
cells. When the area of cancer cells becomes clinically detectable it is called the primary tumor. Cancer 
cells are able to penetrate and infiltrate surrounding tissue thereby forming “daughter” tumors at the 
adjacent site. Some cancer cells are able to penetrate the walls of the lymphatic system and/or blood 
vessels making it possible for them to circulate to other tissues in the body through the lymphatic system 
and/or blood stream. Once the tumor cell comes to rest at another site it repenetrates the vessels or walls 
and start multiplying resulting in a new tumor, a metastatic tumor.
63,64
 The process is depicted in Figure 
11 and can be divided into eight steps 1) growth at the primary site, 2) angiogenesis at the primary site, 3) 
detachment from the primary site, 4) invasion through the extracellular matrix, 5) dissemination of cells 
through the blood flow, 6) tumour embolous formation in capillaries, 7) extravasation, 8) growth at the 
new site.
63
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Figure 11. Illustration of some of the steps involved in cancer metastasis.63 
In several cancer tissues it has been shown, that the expression of Gal-3 correlates with the level of 
differentiation and that metastases express higher levels of galectins-3 as compared to the primary tumor, 
from which they arise.
65
 This indicates that galectins-3 plays a role in the metastasis biology. The 
underlying mechanisms of Gal-3 have therefore been studied with great interest in order to discover 
potential therapeutic targets.
58
 It has been demonstrated that Gal-3 is indeed involved in several steps in 
the metastasis process through various mechanisms, some of which will be described here.  
3.3.1 Angiogenesis and galectins-3 
Angiogenesis is the formation of new blood vessels by a complex multistep process associated with 
inflammation, wound healing, and tumor growth. New vessels are required for the growth at the primary 
and secondary sites and provide gateways to dissemination through the blood flow.
66
 Carbohydrate 
recognition may have an important role in this process, since the angiogenic growth factors responsible 
for starting the process are bound to extracellular proteoglycans. These are probably guided towards the 
growth factor receptors by adhesion molecules such as Gal-3.
67,68
 Thus, it has been demonstrated, that 
over-expression of Gal-3 stimulates in vitro capillary tube formation by human umbilical vein endothelial 
cells (HUVEC) and in vivo neovascularization (formation of functional microvascular networks). It was 
furthermore shown, that capillary tube formation was competitively inhibited by the galectin ligands 
lactose (50mM) and pH-modified citrus pectin (0.1%), which is described in section 3.4.
66
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3.3.2 Anoikis 
After the escape from the primary tumor and intravasation, the first obstacle that blood-borne cancer cells 
encounter is to survive the apoptosis associated with the loss of anchorage (anoikis) and the journey 
through the circulation. Gal-3 has been shown to protect cancer cells from anoikis by regulation of their 
transition through the cell cycle. This is obtained by induction of a cell cycle arrest at an anoikis-
insensitive point (late G1 phase).
69
  
3.3.3 Cell-matrix interaction and homotypic interactions  
A crucial step in cancer metastasis is associated with tumor cell arrest in distant organ microvasculature. 
The cancer cell must attach to the extracellular matrix and then invade the tissue. This takes place by 
adhesion to the basement membrane. The basement membrane is a thin sheet of fibers that underlies the 
epithelium, which lines the organs, or the endothelium, which covers the interior surface of blood vessels. 
This membrane is rich in glycoconjugates such as laminin and fibronectin, and it is therefore believed that 
cross-linking between Gal-3 on the cancer cell surface and laminin promotes adhesion.
70
 For example, 
breast cancer cells ability to adhere to laminin and fibronectin was improved by 60% in cell lines 
expressing Gal-3.
71
 Furthermore, it was shown that over-expression of Gal-3 enhanced in vitro invasion 
of a solubilized basement membrane.
72
 The same results were observed for other Gal-3 ligands such as 
elastin, which is predominantly found in the lungs.
73
 Evidence also exists that Gal-3 interacts with 
cancer-associated Thomsen–Friedenreich glycoantigen and thereby mediate both the initial adhesion of 
cancer cells to the vascular wall and subsequent tumor cell homotypic aggregation at the site of primary 
attachment to the endothelium.
74
 Homotypic aggregation is the crosslinking between the already attached 
cancer cell and circulating cancer cells resulting in accumulation of cells at the point of attachment. This 
is important, since aggregation with other cancer cells improves the chance of invasion and survival of the 
early metastatic tumour.
74
  
3.3.4 Anti-apoptotic effect 
Perhaps the major property that supports the supposed potential for Gal-3 as a therapeutic target is its 
anti-apoptotic ability.
75
 Apoptosis is the process of programmed cell death, which is a natural biological 
mechanism observed during cell differentiation, immune response or tumour cell death after chemo- or 
radiotherapy. The resistance to apoptosis enables tumour cells to escape cell death induced by anti-cancer 
drugs or natural effector cells like natural killer or killer T-cells.  This property is of great importance, 
since the vast majority of cancer cells die due to apoptosis following the arrival to distant organs. Only a 
few of them (<2%) survive and grow into micrometastases. Hence, the survival of early metastatic 
colonies is one of the most important steps determining the efficiency of the metastatic process.
75
 
It is well established that intracellular Gal-3 protects different cell types against apoptosis in response to 
various stimuli. For example, Gal-3-transfected Jurkat cells (T lymphoma cells) are more resistant to 
apoptosis provoked by anti-Fas antibody compared to controls.
76
 Furthermore expression of Gal-3 in 
human breast carcinoma BT549 cells that innately expresses no Gal-3, makes them remarkably more 
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resistant to apoptosis induced by cis-diamminedichloroplatinum(II) (cisplatin).
77
 Likewise Gal-3 has been 
shown to directly regulate sensitivity of cancer cells to various chemotherapeutic agents such a 
staurosporine,
77
 etoposide,
78
 bortezomib,
79
 dexamethasone,
79
 and doxorubicin
80
 in various cancerous 
tissues. 
Although the anti-apoptotic effect of the intracellular Gal-3 is well documented, the precise mechanism of 
this action is still elusive.
81
 It seems as if several regulatory pathways are involved. Two main 
mechanisms of apoptotic regulation have been identified: directly transducing the signal via adaptor 
proteins to the apoptotic mechanisms or targeting mitochondria functionality of which Gal-3 is involved 
in the latter. In the response to a variety of apoptotic stimuli, Gal-3 translocate from the cytosol or the 
nucleus to the perinuclear mitochondrial membrane. Here it prevents mitochondrial damage and inhibits 
cytochrome-c release, thus downregulating caspase activation and ultimately blocking cell death.
81
  
Phosphorylation of Gal-3 at position Ser6 (see section 3.2.3) seems to be essential for its anti-apoptotic 
activity, since the transfection of Gal-3-null human breast carcinoma BT549 cells with the mutant Gal-3 
(S6A and S6E) fails to protect the cells from cisplatin-induced cell death compared to mice transfected 
with the wild type Gal-3.
56
 It has been suggested that post-translational phosphorylation of Gal-3 
functions as a type of molecular trigger for the cellular translocation of Gal-3 from the nucleus to the 
cytoplasm and hinders extracellular release. This is of great importance, since it has been shown, that the 
cytosolic localization of Gal-3 inhibits apoptosis, whereas extracellular Gal-3 has pro-apoptotic effects.
56
  
Another interesting observation is the fact that Gal-3 shares significant sequence similarity (28% identity 
and 48% similarity) with another anti-apoptotic protein, Bcl-2.
76
 Both proteins are rich in proline, glycine, 
and alanine residues in the N-terminal domain and contain the Asp-Trp-Gly-Arg (NWGR) motif in the 
C-terminal domain. In Bcl-2 this motif is designated as the anti-death motif and mutagenesis studies have 
shown that it is critical for the anti-apoptotic function in both proteins. Gal-3 is the only member of the 
galectin family, known by now, that contains the NWGR motif and which have anti-apoptotic properties. 
The receptor or ligand for the motif is yet to be found. However, a better understanding of this 
mechanism would be an important step towards a therapeutic agent, which could be co-administered with 
the classical chemotherapeutics to increase efficiency against cancer.
76
 
3.4 Ligands for inhibition of galectin and their potential therapeutic applications 
Due to Gal-3’s potential as a therapeutic target, extensive research has been focused on the development 
of effective inhibitors and the study of their effect on the various Gal-3 functions. 
Lactose is the simplest carbohydrate to which galectins bind. Affinities for lactose binding range from 
millimolar (weak binding affinity) to micromolar (moderate binding affinity) and vary to a great extent 
depending on the analytical method being used.
42
 For example, the dissociation constant for lactose 
binding to Gal-3 ranges from 26 
. 
10
-6 
M to 1 
. 
10
-3 
M.
82,83
 In general, the Kd values indicate a relatively 
weak binding to Gal-3, which is not surprising, since the lactose unit is the minimal unit required for 
carbohydrate recognition and binding to galectins.  
Galectins 
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Improved carbohydrate-binding affinity was obtained using N-acetyllactosamine (LacNAc), which binds 
about a five fold better to Gal-3 (Kd of 0.2 
. 
10
-3 
M).
83
 Moreover, it was found that Gal-3 binds more 
strongly to larger oligosaccharides, for example the Kd value is reduced to app. 1 
. 
10
-6 
M for a linear 
tri- and pentasaccharide (Gal--(13)-Gal--(14)-GlcNAc and Gal--(13)-Gal--(14)-GlcNAc-
-(13)-Gal--(14)-Glc).53  
These observations has given rise to the analysis of a broad range of galactoside rich carbohydrates. In 
1992 the field had a breakthrough, when D. Platt and A. Raz reported that modified citrus pectin is able to 
remarkably decrease experimental melanoma.
84
 The term modified citrus pectin (MCP) encompasses a 
complex formulation of partially depolymerized and hydrolyzed citrus pectic polysaccharides derived by 
alkaline and acidic treatment of citrus pectin.  
Following the first reports indicating MCP’s anti-metastatic properties the carbohydrate-formulation 
sparked significant attention among cancer researchers. Thus, MCP has been shown to be effective either 
in vitro or in vivo, or both, against prostate carcinoma,
85
 colon carcinoma,
86
 breast carcinoma,
87
 
melanoma,
84,88
 multiple myeloma,
79
 and hemangiosarcoma.
89
 As first postulated the established 
mechanism of action for MCP is by antagonizing Gal-3. This correlates well with the fact, that MCP have 
been shown to affect all of the metastatic steps described in the previous section (Figure 12) 
 
 
Figure 12. MCP has been demonstrated to have an effect of most of the steps involved in the metastasis of cancer. This 
figure shows some of the important steps.75 
The best studied anti-metastatic effect is MCP’s anti-adhesive property. It has been demonstrated, that 
MCP is capable of inhibiting both tumor cell adhesion to the endothelium and homotypic aggregation in 
both mouse B16 melanoma and rat MAT-LyLu prostate cancer cells.
84,88
 Moreover, Nangia-Makker et al. 
established dose-dependent inhibition of the binding of tumor cells (MDA-MB-435 cell line) to human 
endothelial cells in vitro.
86
 The anti-adhesive properties have also been studied in vivo, where MCP was 
demonstrated to inhibit the formation of metastatic deposits of human breast and prostate tumour cells in 
lungs and bones by >90%. Figure 13 shows metastatic deposit formation of prostate carcinoma cells in 
untreated mice and mice treated with 0.25% MCP.
90
 As seen the effect is remarkable with almost zero 
spread in the MCP treated mice. 
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Figure 13. The effect of MCP on in vivo metastatic deposit formation of human metastatic prostate carcinoma cells in 
mice. The cancer cells were fluorescently labeled and injected intravenously.90 
MCP also inhibits in vitro and in vivo carbohydrate-mediated angiogenesis by blocking the association of 
Gal-3 to its receptors in a dose-pendent manner (68% at 0.005% and completely at 0.1%).
66
 Finally, as 
opposed to the observation that over-expression of Gal-3 resulted in increased invasiveness of tumor cells 
in the basement membrane, MCP was shown to inhibit invasion.
86
  
The broad spectrum of targets makes MCP a promising potential anti-metastatic drug for both 
prophylaxis and therapy. However, MCP may be even more important as a drug co-administered with 
various “classical” chemotherapeutic agents due its potential inhibition of Gal-3’s anti-apoptotic function. 
One of the first MCP formulations to reach clinical trials was GCS-100.
79
 This formulation was 
demonstrated to inhibit Gal-3 anti-apoptotic function sufficiently to reverse multiple myeloma cell 
resistance to bortezomib and enhance the response to apoptosis induced by dexamethasone.
79
 Moreover, it 
was demonstrated, that GCS-100 itself could induce apoptosis by activation of the classical extrinsic 
death-signaling pathway, caspase-8/caspase-3/PARP. A major advantage of GCS-100 is that it is much 
less toxic to normal cells as compared to classical chemotherapeutics. Even large doses of MCP only led 
to minor side effects. This is supported by the observation that Gal-3 null mutant mice, corresponding to 
100% inhibition, are relatively healthy.
91
  
Another example is the increase in sensitivity of hemangiosarcoma cells to doxorubicin-induced 
apoptosis, when MCP is co-administered. This causes a 10-fold reduction of doxorubicin IC50 in vitro 
(from 0.0075 μg/ mL to 0.0007 μg/mL). These results suggest that addition of MCP to a therapeutic 
regime for treatment of Gal-3 expressing malignancies would improve the effect of chemotherapy.
89
  
It should be noted that MCP is not the only effective inhibitor of galectin-dependent tumour metastasis. 
Other carbohydrate-based inhibitors encompass larch arabinogalactan (LAG). This polysaccharide 
consists of a β-D-(1→3)-galactan backbone with extensive branching by β-D-(1→6)-galactan chains, 
which are in turn substituted with different arabinose derived residues.
15
 Some fungal polysaccharides 
have also been demonstrated to lower the adhesion and proliferation potential of tumor cells expressing 
Gal-3.
82
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An alternative to sugar based inhibitors is artificial peptide inhibitors. These offer the advantage of ease 
of synthesis along with equally potent immune response. Pentapeptides, based on the common Tyr-X-Tyr 
motif found in glycomimetic peptides, have been found to be effective in millimolar ranges in preventing 
binding of several galectins.
92
 Recent experiments have shown that 15 residues long peptides made by 
phage-display are effective at nanomolar affinity for galectins-3 and inhibit metastasis-associated cell 
adhesion.
93
 One of the most extensive studies of Gal-3 inhibitors has been done by Nilsson and co-
workers. They showed that derivatization at the C-3’ atom in 3’-amino-N-acetyllactosamine by 
N-acylation or N-sulfonylations resulted in up to 50-fold increase of affinity compared to the parent 
LacNAc
94
. Second-generation aromatic 3,3′-diester- and 1,4-disubstituted triazole derivatives of 
thiodigalactoside resulted in affinities down to 29 nM for galectin-3. 
95,96
 These inhibitors has the 
advantage that they are more easily synthesized and are expected to have improved hydrolytic stability 
relative to O-glycosides 
Even though the results are promising, very little is still known about the exact nature of the carbohydrate 
inhibitors and their binding to Gal-3. Thus, no crystallographic studies have been published with MCP or 
defined galactans bound to galectins-3, and the complex MCP has not been separated and characterized. 
3.5 Modified pectin formulations  
It was not until the 90’s that pectin formulations found application as potential anti-metastatic agents. 
However, pectins have been used in the industry for decades as a gelling agent due the HG domains’ 
cross-linking properties.
15
 Both the pectin used for gelling in the food industry, and the pectin that has 
been demonstrated as tumor metastasis inhibitors, are modified extracts of plant pectins. In industry the 
extraction of pectin is done under mild acidic conditions (pH 3-4). This results in hydrolysis of the 
methylated galacturonate carboxylic groups and the neutral carbohydrate side chains as well as some 
degree of depolymerization of the backbone. The increase in galacturonic acid content and the 
fragmentation of polymer leads to enhanced gelling properties since more carboxylic acid are liberated 
for cross-linkage.
15
  
Interestingly, untreated pectin has been tested in most of the Gal-3 inhibition studies described so far 
without any observed activity. This indicates that the bulky pectin structure is either too large to 
bind/reach the galectin or that the target residues are buried within the structure.
15
 The name “modified 
citrus pectins” was given to a therapeutically active formulation of partially depolymerized and 
hydrolyzed citrus pectin.
84
 The starting material had 70-100 kDa molecular weight, high arabinogalactan 
content (35% of the combined Gal + Ara content) and a low degree of methyl esterification. When the 
sample was first treated at pH 10 followed by pH 3 the average molecular weight dropped to 10 kDA 
estimated viscometrically.
84
 Although no detailed analysis was made of the MCP it has been suggested 
that the alkaline treatment will cause β-elimination reactions, which result in depolymerization of the 
polysaccharide backbone.
97
 Alkali treatment will furthermore de-esterify the HG regions and generate 
lower molecular weight oligomers of polygalacturonic acid plus RG I regions attached to 
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polygalacturonic oligomers.
97
 Acid treatment will preferentially cleave neutral sugars and is expected to 
result in release of the hairy regions and preferentially remove the arabinose residues.
98
 Hence, acid 
treatment would be expected to generate RG I regions lacking arabinan side chains and with reduced 
arabinose substitution of the arabinogalactan and galactan chains.
98
 The potential importance of 
arabinogalactans or galactans is supported by the fact that arabinogalactans, just as modified pectin, also 
has anticancer activity.
99
 Moreover, it has been shown that the inhibitory behavior is enhanced in pectic 
polysaccharides with higher arabinose and galactose contents indicating the importance of arabino-
galactans.
100
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4 Synthesis of β-(1→4)-D-galactan oligosaccharides 
This section describes the extensive studies of -(14)-galactan synthesis and the final preparation of a 
series of -(14)-linked galactans including linear and branched structures. 
The preparation or isolation of well-defined β-(1→4)-D-galactans has previously turned out to be 
problematic. Isolation from pectic cell wall material is exceedingly cumbersome and has rarely provided 
well defined products exceptions being mg quantities of galactobiose, -triose, and -tetraose.
101,102
 The 
generation of β-(1→4)-oligogalactosides by β-galactosidase-induced galactosyl transfer has also been 
investigated, but despite its simplicity, it has not passed the β-(1→4)-D-galactobiose stage.103  
The chemical synthesis of β-(1→4)-D-galactans has also proved to be very difficult due to the low 
reactivity of the axially disposed C4-OH of galactosyl acceptors. Not only, are axial hydroxyls less 
accessible towards glycosylation compared to primary and equatorial alcohols, but the acceptor must also 
be protected on the C3-O and C6-O, thereby making the C4-OH even more sterically hindered. Thus, 
only three groups have reported syntheses of β-(1→4)-D-galactooligosaccharides and two of them only 
reached the trisaccharide level (see Table 1).
104–106
 
 
Table 1. Previous studies of  β-(1→4)-D-galactan synthesis. 
Synthetic oligosaccharide fragment Reference 
-D-Galp-(1→4)--D-Galp-(1→4)--D-Galp-OMe Kováč & Taylor
105
 
-D-Galp-(1→4)--D-Galp-(1→4)--D-Galp-OnPr El-Shenawy & Schuerch
104
 
-D-Galp-(1→4)--D-Galp-(1→4)-D-Galp Komba et al.
107
 
-D-Galp-(1→4)--D-Galp-(1→4)--D-Galp-OMe Lichthenthaler et al.
106
 
-D-Galp-(1→4)-{-D-Galp-(1→4)}2--D-Galp-OpMP Lichthenthaler et al.
106
 
-D-Galp-(1→4)-{-D-Galp-(1→4)}3--D-Galp-OpMP 
fully protected 
Lichthenthaler et al.
106
 
-D-Galp-(1→4)-{-D-Galp-(1→4)}4--D-Galp-OpMP Lichthenthaler et al.
106
 
-D-Galp-(1→4)-{-D-Galp-(1→4)}5--D-Galp-SPh 
fully protected 
Oberthür et al.
108
 
 
4.1 Previous studies of β-(1→4)-D-galactan synthesis 
4.1.1 Synthesis of a linear trisaccharide 
The first method used for the synthesis of a trisaccharide, shown in Scheme 1, was developed by Schuerch & 
El-Shenawy.
104
 Their strategy was based on reactivation by exchange of an anomeric protecting group. The 
building block 1 was protected by electron-donating benzyl (Bn) groups at the 3- and 6-positions to increase the 
reactivity. A benzoyl was chosen for the 2-position to ensure neighboring group participation and an allyl group was 
chosen as an exchangeable protecting group at the anomeric position. The acceptor 4 was coupled to glycosyl 
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bromide 3 in a silver tresylate (2,2,2-trifluoroethanesulfonate, OTres) catalyzed glycosylation reaction to give 
the disaccharide 5 in 62% yield (Scheme 1). 
The disaccharide was converted into the corresponding glycosyl chloride 7 in three steps. The allyl ether was 
removed by isomerization with (PPh3)3RhCl and N,N-diisopropylethylamine (DIPEA) followed by hydrolysis with 
HgO/HgCl2 to give the hemiacetal 6. This was converted to the corresponding glycosyl chloride by activation of the 
anomeric hydroxyl with N-phenyl isocyanate followed by treatment with HCl gas. Glycosylation of the acceptor 4 
with the disaccharide donor 7 afforded the trisaccharide 8 in 85% yield. Even though both glycosylations gave good 
yields the strategy has three major drawbacks. First of all, it was not possible to turn the di- and trisaccharide into 
acceptors, since selective deprotection of the C4-O could not be accomplished. Secondly, the reactivation of the 
anomeric group by three steps is both time consuming and results in low overall yield. Finally, glycosyl bromide 3 
had to be synthesized by a laborious ten-step procedure.  
 
Scheme 1. Synthesis of β-(1→4)-D-galactotriose by Schuerch & El-Shenawy.104 
4.1.2 Alternative strategy for synthesis of a linear trisaccharide 
Kováč and co-workers reported an alternative approach, where they sought to shorten the synthesis by employing 
a simpler protecting group strategy (see Scheme 2).105 Hence, methyl glycoside 9 was used as acceptor, which is 
accessible in just one step from commercially available methyl -D-galactopyranoside. This was in turn converted to 
the glycosyl chloride 10 in two steps.  
Coupling of acceptor 9 and donor 10 promoted by silver trifluoromethanesulfonate (AgOTf) gave the desired 
disaccharide 11 in decent yield. The bromoacetyl group was removed with thiourea to give acceptor 12, which was 
once again glycosylated with glycosyl chloride 10. In this case glycosylation was slower and the trisaccharide 13 
could only be obtained in a 35% yield. The low reactivity is attributable to negative electronic effects of the ester 
protecting groups and size of the acceptor. Further elongation was therefore not feasible. 
 
Scheme 2. Synthesis of β-(1→4)-D-trigalactotriose by Kováč.105 
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4.1.3 Synthesis of linear hexagalactoside 
Lichtentaler et al. has published the only strategy by which longer β-(1→4)-linked galactans have been 
made  (Scheme 3).
106
 The method was also based on reactivation by exchange of anomeric protecting 
group, but as opposed to Schuerch and El-Shenawy, they used thioglycosides for the glycosylations and 
p-methoxyphenyl as the anomeric protecting group.104 The C3-O and the C6-O were protected with allyl 
and/or benzyl groups in order to enhance accessibility and to improve the nucleophilicity of the 
notoriously unreactive galactosyl C4-OH. Pivaloyl esters (Piv) were used to protect the C2-O in order to 
ensure -stereoselectivity. Moreover, this made it possible to use an acetyl group as temporary protection 
group for the C4-OH. 
Protection with p-methoxyphenyl is more efficient than allyl groups, since it can be converted to the corresponding 
thioglycoside in a single step by trimethyl(phenylthio)silane (TMSSPh) and BF3
.
OEt2 in good yield.  
 
Scheme 3. Synthesis of β-(1→4)-D-hexagalactoside by Lichtentaler et al.106 
As seen in Scheme 3 the strategy is truly convergent. MeOTf-mediated coupling of thioglycoside 14 and 
acceptor 15 afforded the disaccharide 16 in 79% yield. This could be turned into both disaccharide donor 
17 and a disaccharide acceptor 18 by either glycosylation of TMSSPh or mild deacetylation under 
Zemplén conditions
109
. The building blocks were used in two following glycosylations furnishing the 
hexasaccharide 21 on gram scale.  As an alternative to the toxic MeOTf it was later shown that oxidation 
of the thioglycoside donors to the corresponding glycosyl sulfoxides followed by activation with triflic 
anhydride (Tf2O) gave comparable glycosylation yields.
108
 
The purpose for the study was to turn 21 into the corresponding cyclogalactin, an “inside-out” analog of 
cyclodextrin, by an intramolecular coupling. However, even though several promoters were tried and the 
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heptasaccharide was later prepared to reduce potential strain, the final coupling was never 
accomplished.
108
 It is remarkable that the glycosylation yields are significantly improved compared to the 
two other strategies. This can either result from use of small electron-donating protecting groups at the 
3- and 6-position or application of thioglycosides as donors. The strategy is, however, not without 
problems. Deprotection of the allyl ether groups turned out to be complicated and a five-step procedure 
was necessary to deprotect the linear hexasaccharide. This results in loss of almost 50% of the final 
product. Furthermore, the final product is the unnatural p-methoxyphenyl glycoside and a low yielding 
oxidation (70% for a trisaccharide) is necessary if the reducing sugar is needed. 
4.2 Results & Discussion 
The aim of the project was to synthesize a range of β-D-galactooligosaccharides and test these in binding 
assay with lectins (e.g. Gal-3) or various antibodies for epitope mapping.  
The oligosaccharide should comprise at least four residues in order to exploit the entire CRD of Gal-3 and 
other carbohydrate binding proteins. Secondly, it should be an oligomer of D-Galp and have a 
β-(1→4)-linked backbone with possibly (1→3) or (1→6)-branching to mimic the structure of the 
galactans present in pectin. Finally, the protecting group strategy should allow global deprotection to give 
the fully unprotected oligosaccharide. This would make it possible to conjugate the oligosaccharide to 
proteins and linkers via the reducing end and it would increase the similarity to natural polysaccharides. 
The results and discussion section is divided into two parts. The first part describes the stereoselective 
synthesis of three branched tetragalactans with various α/β binding patterns. The synthesis is done by a 
stepwise approach, since only a few glycosylations are needed. The second part deals with the synthesis 
of the longer oligosaccharides. In order to prepare these a more advanced method was needed to limit the 
number of glycosylations. Different block strategies were investigated towards the synthesis of a 
disaccharide donor and ultimately linear and branched hepta- and octasaccharides. 
4.3 Synthesis of branched and linear tetrasaccharides 
The first aim was to prepare branched- and linear tetrasaccharides with either natural -linkages or 
unnatural -linkages. These would be interesting for epitope mapping of antibodies and test of Gal-3 
specificity. The synthesis was furthermore used to develop a robust protecting group strategy for 
introduction of branching on larger oligosaccharides. 
In order to glycosylate the C4- and C6-OH in a sequential manner, it was necessary to find a protecting 
group strategy that allowed regioselective deprotection of first the 4-position and at a later point the 
6-position. The benzylidene acetal is often used as a temporary protecting group for the 4- and/or 
6-position, since it can be regioselectively opened under reductive conditions.
110–112
 Its use is, however, 
limited by the fact that the resulting benzyl ether is a permanent protecting group in most strategies. 
Several other acetals have been developed that allow selective deprotection of the corresponding ether. 
The most common is the p-methoxybenzylidene acetal.
113–115
 Regioselective cleavage of the 
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p-methoxybenzylidene acetal results in a p-methoxybenzyl (PMB) group, which can be cleaved using 
oxidative conditions without affecting benzyl- and acyl protecting groups. The standard oxidation agents 
are 2,3-dichloro-5,6-di-cyano-1,4-benzoquinone (DDQ)
116
 or ceric ammonium nitrate (CAN)
117
. 
Unfortunately, the p-methoxybenzylidene acetal is much more acid labile than its unsubstituted 
counterpart. Especially the C6-O-PMB is prone to acidic cleavage and therefore could give rise to 
problems in glycosylation reactions.
118,119
 
Instead it was decided to use the less common (2-naphthyl)methylene acetal as a double-acting temporary 
protecting group. This acetal and its corresponding ether are less sensitive to acid, but due to the 
electron-withdrawing second aromatic ring, they still have many of PMB’s advantages.114 Not only has it 
been shown that (2-naphthyl)methyl (NAP) ethers can be hydrogenolysed in the presence of benzyl ethers 
or esters, more interestingly, regioselective opening of the acetal with NaCNBH3/HCl-OEt2 results in the 
C6-O-NAP ether, which can be removed by oxidation with DDQ.
120,121
 This ability would make it 
possible to selectively deprotect first the 4-position and later on selectively cleave the C4-O-NAP.  
 
Scheme 4. Synthesis of monosaccharide building block 22 and 25. 
The fully protected donor 22 was prepared from commercially available -D-galactose pentaacetate in 
four steps. BF3
.
OEt2-promoted glycosylation of thiophenol followed by deacetylation under Zemplén 
conditions afforded known thioglycoside 23.
122
 Treatment with 2-naphtaldehyde and camphor-10-sulfonic 
acid (CSA) gave the diol 24 which was converted to 22 by 4-dimethylaminopyridine (DMAP)-catalyzed 
acetylation (Scheme 4). The acceptor 25 was prepared from -D-galactose pentaacetate in six steps by a 
literature procedure.
123
 BF3
.
OEt2-mediated glycosylation of benzyl alcohol and deacetylation under 
Zemplén conditions afforded tetraol 26. Temporary protection of the 4- and 6-position was achieved by 
treatment with benzaldehyde dimethyl acetal and CSA to give diol 27. This made it possible to protect the 
C2-O and C3-O with benzyl groups by alkylation with benzyl bromide and NaH to give fully protected 
galactoside 28. The benzylidene acetal was hydrolyzed with 1,3-propandiol/CSA to afford 29 followed by 
regioselective acetylation of the C6-OH to give the acceptor 25 in 58% overall yield. 
Condensation of donor 22 and acceptor 25 with N-iodosuccinimide (NIS) and triethylsilyl 
trifluoromethanesulfonate (TESOTf)
124
 as promoter afforded β-glycoside 30 in 77% yield (Scheme 5). 
Use of acetonitrile (MeCN) as co-solvent resulted in shorter reaction time and higher yield. This effect 
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can either be explained by improved solubility of the promoter or by participation of the solvent also 
known as the “nitrile effect”.125 Regioselective reductive opening of the naphthylidene acetal was 
achieved by treatment with NaCNBH3/HCl
.
OEt2
126
 to give the disaccharide acceptor 31 in 83% yield. The 
identity of the product was verified by heteronuclear multiple bond correlation spectroscopy (HMBC). 
 
Scheme 5. Synthesis of disaccharide acceptor. 
NIS/TESOTf-mediated coupling of donor 22 and acceptor 31 afforded the β-linked trisaccharide 32 in 
81% yield (Scheme 6). Compound 31 was furthermore coupled to the perbenzylated thioglycoside donor 
33
127
 to give the α,β-linked trisaccharide 34 in 84% yield. In this case, the use of a 1:1 CH2Cl2/Et2O 
solvent mixture resulted in improved α-selectivity compared to pure CH2Cl2. This is most likely a result 
of the lower reactivity of the donor in CH2Cl2/Et2O, which promotes formation of the thermodynamic 
product. Alternatively, the effect has been explained by formation of an equatorial diethyl-glycosyl-
oxonium ion that blocks the -face.128 
The NAP group on both trisaccharides was selectively removed with DDQ to give ,-linked acceptor 35 
and ,-linked acceptor 36. The oxidation is generally done in wet CH2Cl2 (0.5-10% water).
129,130
 
However, it was observed that addition of 20% methanol was crucial in order to avoid concurrent 
deprotection of the benzyl groups. It is noteworthy, that the naphthylidene acetal is not hydrolyzed under 
these conditions. 
 
Scheme 6. Synthesis of ,- and ,- linked trisaccharide acceptors 32 and 34. 
Coupling of the two trisaccharides to either donor 22 or donor 33 by NIS/TESOTf-mediated 
glycosylations, afforded the three tetrasaccharides 37, 38 and 39 in acceptable yield (Scheme 7). 
Moreover, trisaccharide 32 was regioselectively deprotected followed by glycosylation with thioglycoside 
22 to give the linear tetrasaccharide 41 in 56% yield over two steps.  
 
Synthesis of -(14)-D-galactan oligosaccharides 
 26 
 
Scheme 7. Synthesis of the four tetrasaccharides 37, 38, 39 and 41. 
Transesterification with NaOMe/MeOH followed by hydrogenation over Pd/C provided the four 
unprotected tetrasaccharides 42, 43, 44 and 45 (Scheme 8). A high amount of palladium (20 mol%) and 
addition of acetic acid was necessary to obtain full conversion. This is in agreement with reports by Gaunt 
et al. who have shown that (2-naphthyl)methane formed during the reaction poisons the palladium 
catalyst.
120
 
In summary, we have developed a simple, and efficient strategy for the synthesis of (1→6)-branched 
(1→4)-D-tetragalactosides, where the naphthylidene acetal acts as temporary protecting group for first the 
4-position and later the 6-position. This strategy can potentially be expanded to larger branched 
oligosaccharides, preferably via block synthesis. The four galactosides were conjugated to bovine serum 
albumin (BSA) and printed on a microarray that made it possible to test binding to Gal-3 and various 
monoclonal antibodies (mAb). The conjugation and preliminary results are described in section 7.3. 
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Scheme 8. Global deprotection of four tetrasaccharides. 
4.4 Synthesis of -(14)-galactans by block-wise approach 
Larger oligosaccharides were needed if the full binding site of Gal-3 and other carbohydrate binding 
proteins were to be studied. The tetrasaccharides discussed in section 4.3, were synthesized by a stepwise 
strategy. The synthesis only consists of 19 steps, of which most are high yielding and can be done on 
large scale. However, synthesis of longer oligosaccharides by this approach is untenable. The high 
number of steps will result in very low overall yields and a laborious synthesis.  Instead, a block strategy 
should be used where di- or trisaccharide donors are coupled. This reduces the total number of steps and 
in particular the number of glycosylations that are usually the critical steps in oligosaccharide synthesis. 
This section describes the work leading up to development of a strategy for synthesis of -(14)-linked 
galactans. 
4.4.1 Armed-disarmed strategy 
The first strategy was based on previous work done by Madsen and Clausen.
131
 Their method relies on the 
armed-disarmed concept first described by Fraser-Reid.
132,133
 As opposed to most other block strategies, 
this method does not rely on the use of orthogonal anomeric leaving groups. Instead, it is based on the 
observation that the substituents on the carbohydrate ring, mostly protecting groups, influence the 
reactivity in glycosylation reactions. Electron-withdrawing protecting groups, such as esters, deactivate 
(disarm) the glycosylating capability, because they decrease the nucleophilicity of the anomeric leaving 
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group and destabilize the carbocationic transition state. Electron donating substituents, such as ethers, 
activates (arm) the donor.
134
 This makes it possible to couple an armed donor with a disarmed donor 
without activating the latter. Fraser-Reid and co-workers introduced the concept by showing that the 
acetylated “disarmed” n-pentenyl glycoside 46 could be selectively glycosylated with a perbenzylated 
“armed” n-pentenyl glycoside 47 using iodonium di-sym-collidine perchlorate (IDCP) as promoter 
(Scheme 9). The disaccharide 48 could afterwards be used as a donor to give the trisaccharide 49 after 
glycosylation with isopropylidene-protected acceptor 50.
132
 It was later discovered by van Boom and 
co-workers that IDCP could also selectively activate armed ethyl thiorhamnosides in presence of 
disarmed thioglycosides and soon after the armed-disarmed concept found application for other 
thioglycosides.
135
  
 
Scheme 9. Example of an armed-disarmed glycosylation.132 
The first armed/disarmed strategies were usually between a perbenzylated- and a peracylated glycosides 
resulting in a limited scope of protecting groups. Madsen and Clausen showed that sufficient difference in 
reactivity could be obtained by a minimal difference in protecting group pattern between donor and 
acceptor. Based on screening of several acyl groups, it was found that the 2,3,4,5,6-pentafluorobenzoyl 
(PFBz) was sufficiently electron-withdrawing to allow armed/disarmed coupling of acceptor 51 and 
donor 52 to give the disaccharide 53 in 52% yield (Scheme 10).
132
 The scope of the method was later 
expanded to also include thioglycosides.
136
 
 
Scheme 10. Armed-disarmed strategy based on deactivation by 2,3,4,5,6-pentafluorobenzoyl.124 
Our target structures only differ from Madsen and Clausen by the configuration of the anomeric center. 
For synthesis of -(14)-linked galactans, the 2- and 3-position should also be permanently blocked, but 
as opposed to disaccharide 53, it is necessary to have a 2-O-acyl group for anchimeric assistance during 
the glycosylation. 
The donor 54 and acceptor 55 were both synthesized starting from thioglycoside 23 (Scheme 11). The 
4- and 6-position were protected by a benzylidene acetal by treatment with PhCH(OMe)2 and CSA to 
give diol 56. This was converted to donor 54 by acetylation of the C2- and C3-OH. 
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Scheme 11. Synthesis of donor 54 and acceptor 55 for use in armed-disarmed coupling. 
The acceptor was prepared from donor 54 in two additional steps. First, the benzylidene acetal was 
hydrolyzed. Standard conditions such aq. AcOH
137
 and MeOH/para-toluenesulfonic acid (p-TSA)
138
 
resulted in moderate yields and long reaction time, but propane-1,3-diol and p-TSA
131
 gave diol 57 in 
82% yield after 12 h. It was observed that a longer reaction time (48 h) resulted in almost complete 
hydrolysis of the C3-O-acetyl group, but not the C2-O-acetyl. The 6-position was regioselectively 
protected by treatment of diol 57 with 2,3,4,5,6-pentafluorobenzoyl chloride and Et3N to afford acceptor 
55. Coupling of donor 54 and acceptor 55 with NIS/TESOTf as promoter resulted in a complex mixture 
of products. The expected product could be isolated in less than 5% yield and only in an impure form. 
The reaction was repeated at various temperatures without significant change in outcome. Increased 
reactivity of the donor and acceptor could be achieved by exchanging one or more of the electron-
withdrawing groups with ether functionalities. Hence, the C3-O-acetyl group was exchanged for a NAP 
ether in both acceptor and donor. Moreover, Jensen et al. has reported that the benzylidene acetal is 
disarming due to torsional strain.
139
 It was therefore opened regioselectively and a triethylsilyl group was 
introduced as a temporary protecting group of the C4-OH. The synthesis of donor 63 and acceptor 61 is 
shown in Scheme 12. 
 
Scheme 12. Synthesis of more reactive acceptor/donor pair 61 and 63 for armed/disarmed coupling. 
The armed-disarmed glycosylation of 63 and 61 was carried out with the same conditions as the first 
coupling (Scheme 13). The reactivity seemed to be improved since full conversion of the donor was 
observed after less than one hour. However, the reaction resulted in several products. Separation and 
characterization of the most prominent products showed that a disaccharide donor was indeed formed in 
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approx. 10% yield, but that the TES group had been cleaved during the glycosylation. The homologation 
product of 63 was also observed, which is consistent with the formation of a more reactive acceptor after 
the TES group is cleaved.     
 
Scheme 13. Coupling of donor 63/64 and acceptor 61. 
The C4-OH was instead protected with a chloroacetyl (ClAc) group. Coupling of 64 and 61 using the 
general coupling conditions again resulted in a complex mixture of products with the unchanged acceptor 
and hydrolyzed donor as the most prominent. The 4-position exerts the greatest influence on the reactivity 
in galactose
140
 and since the chloroacetyl is very electron withdrawing, the overall reactivity of donor 64 
is probably not much higher than for thioglycoside 61. One of the major problems in the chemoselective 
synthesis seemed to be low reactivity of the disarmed acceptors. The very electron-withdrawing 
protecting group at the 6-position appears to make the C4-OH such a poor nucleophile that reaction is not 
possible.  
Another way to alter the reactivity of a donor/acceptor pair is by using different anomeric thiofunctions. 
For example electron-withdrawing substituents will lower the nucleophilicity of the sulfur. One of the 
advantages of this approach is that the disarming effect is manifested far from the nucleophilic C4-OH. 
Lahmann and Oscarson have prepared a range of oligosaccharides by chemoselective couplings between 
p-bromophenyl thioglycosides and phenyl thioglycosides with great success.
141
 In order to obtain even 
greater difference in reactivity the more deactivated p-fluorophenyl (PhpF) thioglycosides were used. 
This also has the advantage that the products have characteristic 
19
F-NMR signals. Syntheses of 
C6-O-NAP acceptor 65 and C6-O-acetyl acceptor 66 are shown in Scheme 14.  
 
Scheme 14. Synthesis of p-fluorophenyl thioglycosides 65 and 66. 
The two acceptors 65 and 66 were glycosylated with donor 22 with NIS/TESOTF as promoter (Scheme 
15). Both reactions resulted in similar outcome, but the glycosylation of acceptor 65 was four times faster. 
The acceptor was fully consumed and the major product co-eluted with the donor. To our surprise, it was 
neither disaccharide nor excess donor, but instead thioglycoside 69. This could either have been formed 
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by activation of the acceptor followed by glycosylation of 22 with the liberated p-fluorothiophenol or via 
direct attack by from the p-fluorothiophenol on the activated thioglycoside 22 resulting in aglycon 
transfer.  
 
Scheme 15. Formation of aglycon-transfer product in armed-disarmed glycosylation. 
This result made us question whether the reactivity of the acceptor was sufficiently decreased by the 
p-fluorophenyl. In order to test this, a competition experiment was conducted, where a 1:1 mixture of 22 
and 69 was used to glycosylate acceptor 25 (Scheme 16). It was not possible to separate the mixture of 
donors due to structural similarity, but based on NMR it consisted of approx. 5:1 mixture of 69/22. This 
confirms, that 69 is indeed deactivated by the electron withdrawing fluorine.  
 
Scheme 16. Competition experiment between donor 69 and 22. 
In both chemoselective strategies, the low reactivity of the electron-poor C4-OH and/or insufficient 
reactivity difference seems to be the problem. One way to improve the glycosylation outcome would be to 
use a more reactive donor. Thus, a stable, orthogonal arming protecting group should be found for the 
4-position. Alternatively, another thiofunction could be used to lower the reactivity of the acceptor even 
further. For example, 2,4- or 3,4-difluorothiophenol are more electron withdrawing and are not much 
more expensive than 4-fluorothiophenol.  
4.4.2 Orthogonal strategy 
It had not been possible to find protecting group pattern that gave a sufficient difference in reactivity of 
the donor/acceptor pair, while retaining the nucleophilicity of the acceptor. Another approach was 
therefore undertaken. The orthogonal strategy is based on the use of two different anomeric 
functionalities that can be activated by orthogonal promoter systems. This has the advantage that the 
anomeric center of the acceptor is unreactive under the glycosylation conditions and it is therefore 
possible to couple a electron-poor donor with an electro-rich acceptor.
142
 
Thioglycosides can be converted into almost all other donors directly or by a two-step procedure. The 
new donor can then be coupled to the thioglycoside under orthogonal conditions. This feature makes 
thioglycosides ideal for orthogonal couplings since it is possible to start from a single building block.
142
 
Five different donors were synthesized from thioglycoside 22 or 54: A glycosyl sulfoxide 71, glycosyl 
fluoride 72, glycosyl bromide 73, glycosyl trichloroacetimidate (TCA) 74 and glycosyl N-phenyl 
trifluoroacetimidate (PTFAI) 75. The synthesis and outcome of glycosylation of acceptor 76 are compiled 
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in Table 2. The first orthogonal donor to be examined was a glycosyl sulfoxide which had been used by 
Lichtentaler et al. to synthesize a β-D-(14)-disaccharide thioglycosides (section 4.1).106 Donor 71 was 
prepared in one step by titration with m-CPBA (meta-chloroperbenzoic acid).
143
 The reaction had to be 
carefully monitored in order to avoid over-oxidation to the sulfone. The couplings were carried out by the 
Kahne procedure using triflic anhydride as promoter and a hindered base to keep the reaction from 
becoming too acidic. Both 2,6-lutidine and 2,6-di-tert-butyl-4-methylpyridine (DTBMP) were tested as 
bases.
144,145
 Lutidine is much cheaper than DTBMP, but is less sterically hindered. This seems to be 
critical, since the outcome of the reaction was degradation of the donor, whereas most of the acceptor 
could be recovered. In the next experiment, DTBMP was used as base. In this case full conversion of the 
acceptor was achieved but the expected product was not observed. 
Glycosyl fluoride 72 was prepared in one step from the corresponding thioglycoside by treatment with 
diethylaminosulfur trifluoride (DAST) and N-bromosuccinimide (NBS).
146
 Against expectations 72 was 
obtained as a 2:3 α/β mixture (72a = α-fluoride and 72b = β-fluoride) even though the α-glycosyl fluoride 
is favored as a result of stabilization by the anomeric effect. The stereochemical outcome is probably a 
result of neighboring-group participation of the acetyl group. It was possible to increase the selectivity 
(95:5 β/) by changing the solvent to acetonitrile but this also resulted in lowered yield (60%).  
The first choice of promoter, BF3
.
OEt2
147
 afforded disaccharide 77 in 28% yield. It was observed that the 
β-glycosyl fluoride 72b was fully consumed within one hour, whereas the α-glycosyl fluoride 72a 
remained unchanged. Increasing the temperature or amount of promoter only increased the yield to 32%. 
Even though the turnover of 72a was improved, the harsher conditions gave rise to formation of the 
thioglycoside 22 as the major product (Scheme 17). This result is very similar to the observations for the 
p-fluorothiophenol aglycon and strongly suggests that aglycon transfer causes the problem. 
 
Scheme 17. Aglycon transfer in glycosylation with glycosyl fluorides. 
A reaction was performed with only the β-glycosyl fluoride 72b. This resulted in higher yield (42%) but 
the effect was not as pronounced as expected due to concurrent conversion of 72b into the unreactive -
fluoride 72a. BF4
-
 probably acts as fluoride source and converts the activated species into the 
thermodynamically favored 72a. 
Three other promoter systems were investigated. Both SnCl2-AgOTf
148
 and Cp2ZrCl2-AgClO4
149
 resulted 
in degradation of the acceptor leading to a complex product mixture. Cp2ZrCl2-AgClO4 is the most 
reactive group IVB metallocenes and the reaction with both acceptor and donor was almost instantaneous. 
Unfortunately, the milder promoters Cp2HfCl2
150
 and Cp2TiCl2
150
 were not available. Activation with 
SnCl2-AgClO4 gave results similar to BF3
.
OEt2 with regard to difference in reactivity of the α- and β-
glycosyl fluoride, but the yields were generally lower.
151
 
Synthesis of -(14)-D-galactan oligosaccharides 
 33 
The major problem with the glycosyl fluorides was their low reactivity. An obvious alternative was to use 
the more reactive glycosyl bromides. Glycosyl bromide 73 was prepared in situ by titration with bromine. 
The glycosylation was carried out at -50 °C with AgOTf as promoter. 4Å molecular sieves (MS) were 
added to reduce the acidity and thereby avoid decomposition of the acceptor. Even though these are rather 
mild conditions, the acceptor was degraded and formation of thioglycoside 22 was again observed among 
many other by-products. 
 
Table 2. Synthesis and glycosylation with orthogonal donors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Donor synthesis Glycosylation cond. Temp. Yield 
 
 
 
m-CPBA, CH2Cl2, 
-78 °C 
Tf2O, 2,6-lutidine 
CH2Cl2 
-78 °C 
Donor degraded, 
no product 
Tf2O, DTBMP 
CH2Cl2 
-78 °C 
Acceptor 
degraded, 
no product 
 
 
NBS, DAST, 
CH2Cl2,                     
2:3  α/β-mix 
 
BF3
.OEt2, 
4Å MS, CH2Cl2 
-150 °C 22-28 % 
BF3
.OEt2, 
4Å MS, CH2Cl2 
5 °C 32% 
SnCl4, AgClO4, 
4Å MS, CH2Cl2 
-15 °C 19-24% 
Cp2ZrCl2-AgClO4, 
4Å MS, CH2Cl2 
-20 °C 0% 
NBS, DAST, 
MeCN 
BF3
.OEt2, 
4Å MS, CH2Cl2 
-150 °C 42% 
SnCl2-AgClO4, 
4Å MS, CH2Cl2 
-15 °C 31-34% 
 
 
 
Br2, CH2Cl2,          
0 °C, quant. 
AgOTf, 
4Å MS, CH2Cl2 
-50 °C 
Acceptor 
degraded 
 
 
 
1) NBS, 
H2O, CH2Cl2 
2) Cl3CCN, DBU, 
CH2Cl2 
TESOTf, 
CH2Cl2 
-20 °C 
Only formation of 
the corresponding 
trichloro-
acetamide 
 
1) NBS, 
H2O, CH2Cl2 
2) CF3CClNPh, 
Cs2CO3, CH2Cl2 
TESOTf, 
CH2Cl2 
-40 °C 12% 
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The final donor-types investigated were glycosyl imidates. The general significance of O-glycosyl 
trichloroacetimidates lies in their ability to act as strong glycosyl donors in presence of only catalytic 
amounts of Brønsted or Lewis acids. The mild conditions were anticipated to limit the risk of acceptor 
activation and the high reactivity of the donor should make both the α- and β-glycoside reactive. 
Compared to glycosyl bromides, glycosyl imidates have the advantage that they are more compatible with 
chromatographic purification.
152
  
Thioglycoside 22 was converted to the corresponding trichloroacetimidate (TCA) 73 by hydrolysis with 
NBS and H2O followed by treatment with trichloroacetonitrile and a base. In this case, 
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) was used since it favors formation of the more stable 
α-glycosyl trichloroacetimidate.153 Instead of the frequently used TMSOTf, the more easily handled 
TESOTf was employed for the coupling. Full conversion of the donor was observed after only 20 min, 
while the acceptor remained unchanged. The trichloroacetimidate had instead rearranged into the 
unreactive glycosyl trichloroacetamide due to the low reactivity of the acceptor.
154
 
In an effort to solve this problem the corresponding glycosyl N-phenyl trifluoroacetimidate was prepared. 
This rather new donor has the advantage that the leaving group is not nucleophilic and the rearrangement 
product is therefore not observed.
155
 Nonetheless, it still has reactivity similar to TCAs and can be 
activated under mild condition (e.g. TMSOTf or BF3
.
OEt2
156,157
, TBSOTf
158
, Bi(OTf)3
159
, Yb(OTf)3
160
).  
Donor 75 was prepared by treating the lactol with N-phenyl trifluoroacetimidoyl chloride and Cs2CO3.
161
 
The imidoyl chloride can be prepared by refluxing aniline with trifluoroacetic acid (TFA) in CCl4 in the 
presence of Ph3P and Et3N followed by distillation.
162
 However, PTFAICl was purchased from 
commercial suppliers for the remainder of the reported reactions due to the toxicity of the reagents. 
TMSOTf-catalyzed glycosylation at -40 °C resulted in full conversion of donor and acceptor. The 
expected product 70 was formed, but only in 12% yield. Instead, 54 was isolated as the major product, 
just as it was the case for glycosyl fluorides and p-fluorophenyl thioglycosides. As opposed to the 
previous examples, 0.1 equiv. TESOTf was unlikely to activate the acceptor. Instead it was hypothesized 
that degradation of the acceptor was effected by attack of the acceptors’ sulfur atom onto the activated 
glycosyl donor (Scheme 18). Pathway b is only favored because of the very low reactivity of the axial 
C4-OH. 
 
Scheme 18. Proposed mechanism for aglycon transfer.163 
A similar mechanism has previously been described by Li et al., who named the phenomenon ”aglycon 
transfer”.163 They described that aglycon transfer could be prevented by decreasing the nucleophilicity of 
the acceptor aglycon by steric hindrance or with electron withdrawing substituents.  Screening of a wide 
range of donors showed that electron withdrawing substituents only had a minor effect whereas better 
results were obtained when 2,6-dimethylthiophenol.
163
 Based on these results, 2,6-dimethylthiophenyl 
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acceptor was prepared in five steps from β-D-galactose pentaacetate to test if this would prevent aglycon 
transfer (Scheme 19). 
 
Scheme 19. Synthesis and 2,5-dimethylthiophenyl disaccharide 80. 
Coupling of PTFAI donor 75 and acceptor 79 in a TMSOTf-catalyzed glycosylation still resulted in 
formation of several products, but the disaccharide 80 could be isolated in 57% yield. This result strongly 
suggests that aglycon transfer is the reason for the poor yield in both the chemoselective- and orthogonal 
glycosylations. Even though the yield was remarkably improved, it was still evident that the choice of 
thiofunctionalities as aglycons for unreactive acceptors is unfavorable. Furthermore, the 
2,5-dimethylthioglycosides has been shown to be poor donors, which could be problematic in couplings 
to the unreactive C4-OH.  
4.5 Study of 1,6-anhydro sugars as precursors for thioglycosides  
One of the major issue in the synthesis of a -(14)-digalactoside is the low reactivity of the axial C4-
OH. This gives rise to degradation and aglycon transfer of the more reactive anomeric functionalities. 
One way to increase the reactivity would be to use less bulky and/or less electron withdrawing protecting 
groups. Alternatively, a drastic change was expected if the ring was flipped from a 
4
C1- towards a 
1
C4- conformation. In this way the C4-OH would be the only equatorial hydroxyl group, thus, a much 
better nucleophile. Unfortunately, the 
1
C4- conformation is strongly disfavored due to 1,3-diaxial 
interactions between the -CH2OR and two -OR groups and therefore has to be forced to change 
conformation. 
The preliminary studies were based on work by Pedersen et al.
164
 They had shown that a ring flip could 
be achieved by introduction of two or more bulky silyl groups (tert-butyldimethylsilyl (TBDMS) or 
triisoproylsilyl (TIPS)). These cannot be accommodated in a 
4
C1 conformation, thus, force the pyranose 
ring into an axial-rich conformation. Instead of the expected 
1
C4 conformation they obtained a twisted 
boat conformation but this would still be a remarkable improvement.
164
 It was decided to introduce 
TBDMS groups at the 2- and 3-position followed by selective protection of the 6-position. Hydrolysis of 
a benzylidene acetal resulted in concurrent deprotection of the silyl ethers. Instead, the more acid labile 
3,4-dimethoxybenzylidene acetal was introduced followed by protection of the diol with TBDMSOTf and 
DMAP in pyridine (Scheme 20).
165
, 
164
 The more common reagent combination, TBDMSCl and 
Synthesis of -(14)-D-galactan oligosaccharides 
 36 
imidazole in N,N-dimethylformamide (DMF), only resulted in monosilylation.
166
 Next the 2,4-methoxy-
benzylidene was hydrolyzed under almost neutral conditions with pyridinium p-toluenesulfonate (PPTS) 
in methanol to give diol 82. At this point, the 
1
C4 should be favored over the 
4
C1, but judging from the 
coupling constants in 
1
H-NMR, the ring was still in the 
4
C1 conformation. Regioselective acetylation 
afforded 83 but did not change the conformation. The approach was therefore abandoned. 
 
Scheme 20. Preliminary attempts to force D-galactose into a 1C4-like conformation. 
Another way to force D-galactose into a 
1
C4 conformation is by converting it into the 1,6-anhydro 
derivative. 1,6-anhydrides can either be formed by selective tosylation followed by intramolecular attack 
by the anomeric hydroxyl or via displacement of an anomeric leaving group by the C6-OH under basic 
conditions.
167,168
 In this case the peracetylated thioglycoside 84 was treated with aq. NaOH resulting in 
both deacetylation and formation of the 1,6-anhydride 85 (Scheme 21). Ring flip to the 
1
C4-conformation 
was evident from the changes in coupling constants (J) in 
1
H-NMR. For example, the J2,3 changes from 
10.5 to 1.4 Hz whereas the J3,4 goes from 3.4 to 5.5 Hz. Regioselective protection of the 3- and 4-position 
with triethylorthoacetate and p-TSA afforded the ethyl orthoester 86. The free C2-OH was acetylated and 
finally the orthoester was hydrolyzed with aq. acetic acid to give the 2,3-diacetylanhydro sugar 88 in four 
steps (Scheme 21). 
 
Scheme 21. Synthesis of 1,6-anhydro building block 88. 
This is an improvement to previously published procedures with regard to both overall yield and length of 
synthesis.
169
 The 1,6-anhydride 88 was glycosylated with thioglycoside 54 to give the disaccharide 89 
(Scheme 22). As expected the reaction was fast and gave a high yield even though both acceptor and 
donor were electron-deficient.  
 
Scheme 22. Glycosylation of 1,6-anhydride 88 followed by acetolysis. 
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The 1,6-anhydro acetal had to be opened and converted to a donor. One of the classical ways to cleave the 
acetal is by acetolysis. In this reaction the anhydro sugar is treated with acetic anhydride and a Lewis- or 
Brønsted acid, which breaks the 1,6-anhydro ring and acetylates the 1- and 6-position.
170–172
 A catalytic 
amount of scandium(III) triflate was chosen as Lewis acid, since it had previously been used to open 
anhydro sugars on complex oligosaccharides.
173
 Acetolysis of 89 did not give rise to the desired product. 
Instead, peracetylated galactobiose 90 was formed as a result of concurrent acetolysis of the benzylidene 
acetal. This result is apprehensible, since the 1,6-anhydro acetal is generally more stable towards 
hydrolysis than the benzylidene acetal.  To solve the issue, the benzylidene acetal was regioselectively 
opened with NaCNBH3/HCl
.
OEt2 to give 91 followed by protection of the C4-OH with a chloroacetyl 
group to afford disaccharide 92 in 76% yield over two steps (Scheme 23). Acetolysis of 92 with Ac2O and 
Sc(OTf)3 again resulted in formation of a single product, but also in this case not the expected. The harsh 
conditions give rise to concurrent acetolysis of the primary benzyl ether resulting in formation of 
disaccharide 93. Several attempts to avoid cleavage of the benzyl ether were made. TFA, TMSOTf, and 
AcOH were used as acid catalysts without any significant difference. The best result was obtained when 
the reaction was performed with only 1% Sc(OTf)3 at -30 °C. In this case, an approx. 1:1 mixture of the 
desired product and the C6’-OAc was observed by NMR (the two compound were not separable by flash 
chromatography). This is still far from acceptable and the approach was abandoned.   
 
Scheme 23. Introduction of chloroacetyl and acetolysis of 1,6-anhydride 92. 
Disaccharide 93 could be converted to a thioglycoside or glycosyl imidate, but the many acetyl groups 
would make it a poor donor and acceptor. Wang et al. have reported that 1,6-anhydro sugars can be 
turned directly into the corresponding thioglycoside with zinc(II) iodide and trimethyl(phenylthio)silane, 
also known as Hanessian conditions.
174,175
 Treatment of the disaccharide 89 with TMSSPh/ZnI2 resulted 
in concurrent hydrolysis of the benzylidene acetal to give triol 94 (Scheme 24). Opening of the 
chloroacetyl-protected disaccharide 92 resulted in a complex mixture of products with compound 95 as 
the major product. The iodoacetyl must arise from substitution of the primary chloride. Moreover, it was 
found that one of the other by-products was the triol, which derives from cleavage of the benzyl group.  
 
Scheme 24. Opening of 1,6-anhydride under Hanessian conditions. 
In the final experiment, the C4’-OTBDMS analogue 96 was applied. The silyl ether was stable under the 
reaction conditions, but significant deprotection of the benzyl was still observed. A range of conditions 
was screened in order to optimize the reaction. Some of the results are shown in Table 3. 
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Table 3. Optimization of 1,6-anhydride opening under Hanessian conditions. 
Entry 
ZnI2 
(equiv.) 
TMSSPh 
(equiv.) 
Solvent 
Time 
(h) 
Recovered 
st. mat 
Yield 
(%) 
1 3 3 DCE 48 0 0 
2 3 3 DCE 8 4 50 
3 1.1 3 DCE 48 61 28 
4 3 1.1 DCE 48 95 0 
5 1.75 3 DCE 14 16 58 
6 1.75 3 1,4-dioxane 8 20 40 
 
In the first entry, the original conditions published by Hanessian and Guindon were used.
175
 This resulted 
in complete deprotection of the benzyl ether. If the reaction was stopped after 8h the product could be 
isolated in 50% yield (entry 2). Next, the reagent loading was changed (entry 3-5). The results indicate 
that 3 equiv. of TMSSPh is necessary, but that it is possible to lower the amount of ZnI2. The best result 
was obtained with 1.75 equiv., where 97 was isolated in 58% yield together with 16% of the starting 
material. It was tested whether the thioglycoside could be used as a donor. The C6-OH was acetylated to 
give the fully protected disaccharide 98, which was used as donor in a NIS/TESOTf-promoted 
glycosylation reaction with disaccharide acceptor 91 (Scheme 25). No coupling product was observed and 
the acceptor could be fully recovered. This can be explained by the observation that the TBDMS group 
was too acid labile to be used under these glycosylation conditions. 
 
Scheme 25. Attempts to glycosylate with donor 98. 
None of the applied protecting groups had been stable to both 1,6-anhydride opening and the subsequent 
glycosylation. Instead, it was decided not to protect the 4-position until after the acetal opening. Using the 
optimized conditions, the disaccharide 91 could be converted to the corresponding thioglycoside 99 in 
41% yield (Scheme 26). This is unacceptable for large-scale synthesis, but sufficient to study the 
subsequent coupling. The C6-OH was selectively protected with a benzoyl group followed by protection 
of the C4’-OH by a chloroacetyl to give the fully protected thioglycoside 100 in 75% yield over two 
steps. 
 
Scheme 26. Synthesis of fully protected thioglycoside 100. 
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NIS/TESOTf-catalyzed condensation of 100 and 91 afforded the tetrasaccharide 101 in 41% yield 
(Scheme 27). The poor yield may be caused by the low reactivity of donor and acceptor. This shows that 
even though the strategy solves the first coupling, the subsequent glycosylations remain challenging.  
 
Scheme 27. Synthesis of fully protected tetrasaccharide 101. 
In conclusion, it was shown, that 1,6-anhydro acceptor 88 is indeed more reactive than the other acceptors 
studied so far. It was, however, not possible to convert the 1,6-anhydro disaccharide into a donor in 
acceptable yield. Both acetolysis and Hanessian conditions resulted in deprotection of one or more 
protecting groups. The major challenge is that the opening conditions are not compatible with primary 
benzyl ethers. Another issue in this strategy is that the use of 1,6-anhydrosugars only solves the problem 
in the first coupling. Subsequent glycosylations will still be to an axial hydroxyl group and will be further 
complicated by the steric hindrance manifested by the second ring in the disaccharide. An alternative 
would be to synthesize the oligosaccharide from the reducing end by sequential couplings to 1,6-anhydro 
monosaccharides. This would, however, result in a large number of glycosylations and 1,6-anhydro acetal 
openings. 
A recent report by Van der Marel and co-workers described the chemo- and regioselective 
2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPO)/bis(acetoxy)iodobenzene (BAIB)-mediated oxidation of 
3,6-dihydroxy 1-thio glycopyranosides to the corresponding 1-thio uronic acid lactones.
176
 Based on these 
results, it may be possible to prepare donor 102 and use it for the consecutive coupling (Scheme 28). In 
that case, all of the glycosylation would be to an equatorial hydroxyl group and the conformation would 
favor formation of the -product due to neighboring group participation. In the final step, reduction, 
hydrolysis or transesterification would either give the C6-hydroxyl, C6-acid or C6-ester.  
 
Scheme 28. Alternative strategy based on 1-thio uronic acid lactones. 
Interestingly, the original paper by Van der Marel shows that excellent 1,2-cis glycosylation are obtained 
when the 2-position is protected with a benzyl group and the donor is pre-activated with Ph2SO and Tf2O. 
The -selectivity can be explained by formation of the axial triflate followed by a “SN2”-like attack 
similar Crich’s -mannosylation approach.176,177 
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4.6 Synthesis of -(14)-linked pentenyl disaccharide and its use in oligosaccharide 
synthesis. 
As described in section 4.4.2, aglycon transfer was the major problem in glycosylation of unreactive 
thioglycoside acceptors. The simplest way to eliminate this side-reaction would be to use an acceptor 
without a nucleophilic aglycon. One way to accomplish this is by using an aglycon with a very electron 
withdrawing functionality that makes the sulfur less nucleophilic. This approach was applied in the 
active/latent strategy described by Roy and co-workers.
178
 They used p-nitrothiophenol as aglycon, which 
makes the thiofunctionality virtually unreactive. After the glycosylation, the aglycon can be turned into a 
better leaving group by reduction and acetylation and used in the following coupling. However, the two 
steps after every glycosylation make the strategy less favorable. 
Alternatively, the thioglycoside could be exchanged for an O-glycoside, either in the form of a potential 
donor or a protecting group. The oxygen is significantly less nucleophilic than sulfur and the 
O-glycosides are therefore not expected to undergo aglycon transfer. Typical examples of anomeric 
protecting groups are allyl ether
179
, silyl ethers
180
 and p-methoxyphenyl ethers
181
. These all serve as 
temporary protecting group and can be turned into a donor in one or two steps in the presence of most 
common protecting groups. A more elegant strategy would be to use an orthogonal O-glycoside donor. 
This makes it possible to use the product directly in the following glycosylation and thereby avoid 
low-yielding protecting group manipulations. Glycosyl imidates
182
 and glycosyl phosphates
183
 are too 
reactive to act as acceptors, but n-pentenyl glycosides
132
 and ortho-alkenyl benzoates
184
 have been applied 
with great success.  
It was decided to use pentenyl glycosides, since they allow many of the same manipulations as 
thioglycosides. The strategy was to make a single building block 103 that could be converted to an 
orthogonal donor 104 and an acceptor 105 (Scheme 29). These could be coupled to give a disaccharide 
donor 106, which could be used in the following glycosylations in the synthesis of hexasaccharide 107. 
Glycosyl imidates were chosen as orthogonal donors because of their high reactivity and ease of 
synthesis. In some of the preliminary experiments, extensive migration during hydrolysis formation was 
observed with an acetyl in the 2-position. Instead, it was decided to protect the C2-OH with a benzoyl. 
The 3-position, on the other hand, was protected with an acetyl to avoid steric hindrance of the 4-position 
from the larger benzoyl ester. 
 
Scheme 29. Retrosynthetic analysis of n-pentenyl glycoside-based strategy. 
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The fully protected pentenyl glycoside 103 was prepared in five steps from D-galactose pentaacetate 
(Scheme 30). BF-3
.
OEt2-mediated glycosylation of 4-penten-1-ol with -D-galactose pentaacetate 
followed by Zemplén deacetylation afforded the unprotected pentenyl glycoside 108 as a 6:1 /-mixture. 
Treatment of 108 with benzaldehyde dimethylacetal and CSA gave the diol 109. Activation of diol 109 
with dibutyltinoxide followed by treatment with acetyl chloride in presence of 4Å MS gave the partially 
protected glycoside 110 in excellent yield. The molecular sieves both removed residual water but also 
acted as acid-scavenger. Finally, benzoylation of the 2-position with BzCl in pyridine afforded building 
block 103. The acceptor 105 was prepared by regioselective ring opening of the benzylidene acetal with 
NaCNBH3/ HCl
.
OEt2.
126
  
 
Scheme 30. Synthesis of building block 103 and 105. 
Next, the pentenyl glycoside 103 had to be hydrolyzed in order to prepare the glycosyl imidate. This 
turned out to be challenging due to the low reactivity of the donor and instability of the benzylidene 
acetal. The optimization results are shown in Table 4. Activation with NIS/TESOTf and NBS/TESOTf in 
presence of water resulted in concomitant hydrolysis of the benzylidene acetal (entry 1-2). The higher 
yield observed for NBS can be explained by a shorter reaction time. Hydrolysis with NBS/H2O
132
 (entry 
3) also resulted in low yield, due to hydrolysis of the benzylidene acetal and formation of the halohydrin. 
The electron-poor ring makes the intramolecular attack on the bromonium ion slow and competing 
intermolecular attack by water therefore takes place.  
 
Table 4. Hydrolysis of disarmed pentenyl glycoside 103. 
Entry Reagents Yield 
1 NIS, TESOTf, H2O 0% 
2 NBS, TESOTf, H2O 21% 
3 NBS, H2O 35% 
4 Br2, TBAB, H2O 29% 
5 Br2, TBAB, Et3N, H2O 82% 
 
Instead we developed a method based on Lemieux conditions (entry 5). Lemieux and coworkers observed 
that glycosyl bromides could anomerize in presence of a bromide source (e.g. tetrabutylammonium 
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bromide (TBAB)) and that the -glycosyl bromide was more reactive than the -glycosyl bromide.185 
Thus, in the absence of promoters, -glycosyl bromide could slowly react with an alcohol by “SN2-like” 
displacement to give the -glycosides with high stereoselectivity. In this case, mutarotation would lead to 
an /-mixture, but the reaction would be a mild alternative to the use of NBS or NIS. The pentenyl 
glycoside was titrated with bromine followed by treatment with TBAB and water in a one-pot reaction. A 
temperature of 55 C was necessary to obtain full conversion. The yield was significantly improved, but 
hydrolysis of the benzylidene acetal was still observed. This was solved by addition of Et3N, which 
resulted in excellent yields of hemiacetal 111. Even though the reaction is a two-step conversion, the fact 
that it can be made one-pot makes it a simple and efficient alternative to the known methods.  
The hemiacetal 111 was converted to glycosyl trichloroacetimidate 104 by treatment with 
trichloroacetonitrile and DBU
186
 which was used in a TMSOTf-promoted glycosylation of pentenyl 
acceptor 105 (Table 5, entry 1). Just as for the coupling to the thioglycoside acceptor 76, only little 
conversion of the acceptor was observed, since most of the donor rearranged to the trichloroacetamide. A 
range of conditions was tested in order to optimize the reaction.  
 
Table 5. Optimization of orthogonal coupling between TCA donor 104 and pentenyl acceptor 105. 
Entry Method Promoter Temp. Yield 
1 Classic TMSOTf 0 °C 13% 
2 Inverse TMSOTf 0 °C 35% 
3 Inverse TMSOTf -15 °C 57% 
4 Inverse TMSOTf -40 °C 0% 
5 Classic BF3OEt2 -15 °C 25% 
6 Inverse BF3OEt2 -15 °C 37% 
7 Classic Bi(OTf)3 0 °C 21% 
8 Classic HClO4/silica 0 °C 0% 
9 Inverse TBSOTf -15 °C 56% 
 
Rearrangement of imidates is most frequently observed when unreactive acceptors are used. Schmidt and 
Weingart showed that the reaction outcome could often be improved by an “inverted” addition 
procedure.
187
 Instead of mixing acceptor and donor prior to activation, the acceptor and promoter were 
first mixed followed by slow addition of donor. In this way the acceptor concentration will be 
significantly higher than the donor concentration and glycosylation is therefore favored over 
rearrangement.   
The inverted procedure was tested at three different temperatures (entry 2-4) with variable success. The 
best result was obtained at -15 °C, where disaccharide 106 could be isolated in 57% yield. Use of the 
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second-most common catalyst, BF3
.
OEt2,
188
 did not give rise to better results even though the yield for the 
classic procedure was improved (entry 5-6). Yb(OTf)3 and H2SO4-silica have both been described to be 
milder alternatives to TMSOTf but procedures resulted in low yield (entry 7-8).
189,190
 It has previously 
been reported that TMSOTf-catalyzed glycosylations of hindered acceptors can give rise to concurrent 
TMS silylation.
158
 This can be avoided if the more bulky TBSOTf is used. In this case the yield was 
similar, which suggests that silylation of the acceptor is not the issue (entry 9). 
In most of the reactions, a by-product was isolated in 5-15% yield. This was first believed to be the 
-anomer, but further characterization proved that it was instead the orthoester. Orthoesters can be 
avoided if the glycosylation is sufficiently acidic (>0.25 equiv. TMSOTf).
191
 Unfortunately, this would 
also result in faster rearrangement of the imidate. Alternatively, additional promoter could be added after 
the glycosylation was finished. The conditions from entry 3 were used and after finished reaction an extra 
0.25 equiv. was added. This afforded the disaccharide 106 in 62% yield.  
The major problem with the TCA donor was rearrangement to the glycosyl trichloroacetamide prior to 
attack from the acceptor. The PTFAI donor is not affected by this problem, since the leaving group is a 
poor nucleophile. The PTFAI donor 104 was used to glycosylate acceptor 105 with TMSOTf as promoter 
by both the classic and “inverse” procedure affording disaccharide 105 in 78% and 74% yield, 
respectively (Scheme 31).  
 
Scheme 31. Orthogonal coupling between pentenyl glycoside 105 and PTFAI donor 112. 
Glycosylation of monosaccharide 113 with disaccharide 106 using NIS/TESOTf as promoter afforded the 
trisaccharide 114 in excellent yield (Scheme 32). Trisaccharide 114 was converted to acceptor 115 by 
regioselective ring opening of the benzylidene acetal using NaCNBH3/ HCl
.
OEt2.
126
 Coupling of the 
trisaccharide 115 and the pentenyl disaccharide 106 only resulted in hydrolysis of the donor and almost 
no conversion of the acceptor. The reaction was repeated at -40 °C, -20 °C, and 0 °C without a significant 
change in outcome. The low reactivity of trisaccharide acceptor 115 compared to monosaccharide 113 
can be explained by the disarming protecting groups and steric hindrance manifested by the disaccharide 
unit.  
 
Scheme 32. Introduction of reducing end residue by 2+1-coupling. 
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The reactivity of the acceptor could not be changed without significant modifications to the strategy. 
Instead, we focused on changing the reactivity of the donor. Thioglycosides and glycosyl imidates are 
known to be more reactive than pentenyl glycosides.
192
 The pentenyl glycoside 106 was therefore 
converted to the PTFAI donor 116 in two steps. Hydrolysis by the conditions described in Table 4 turned 
out to be much slower than for the monosaccharide and migration of the C2-O-benzoyl was observed. 
Nonetheless, the hemiacetal was isolated in 51% yield. Treatment of the hemiacetal with PTFAICl and 
Cs2CO3 afforded the PTFAI donor. Coupling of PTFAI donor 116 and trisaccharide acceptor 115 resulted 
in almost complete conversion of the acceptor and formation of a single product. Unfortunately, this 
turned out to be the orthoester and not the desired product.  
 
Scheme 33. Synthesis of PTFAI donor 106 and condensation with trisaccharide 115. 
Changing the temperature and promoter did not change the outcome and attempts to rearrange the 
orthoester into the product were also unsuccessful. The low yields for the two-step conversion to the 
PTFAI donor made this strategy unfavorable no matter what and it was therefore decided to change the 
strategy for synthesis of the disaccharide donor. 
4.7 Use of TBDPS as anomeric protecting group in synthesis of -(14)-linked tri-, tetra- 
and pentasaccharides 
Very reactive donors e.g. N-phenyl trifluoroacetimidates, are essential for couplings to acceptors with low 
reactivity. Unfortunately, it had not been possible to find an efficient method for conversion of pentenyl 
glycosides to PTFAI donors. All the same, it is not favorable to install a pentenyl moiety via a 
low-yielding two-step procedure, just to use it as a protecting group. Instead it was decided to introduce a 
more common protecting group that would allow simple conversion to the PTFAI donor. 
An obvious choice would be to use an allyl group. The ease of formation, mild methods for its cleavage in 
the presence of other protecting groups and its stability to various glycosylation conditions has made it 
mainstay in many protecting group strategies.
192
 However, deprotection of allyl groups had previously 
been shown to be challenging in several projects in the group. The isomerization is often incomplete and 
concurrent reduction of the alkene is often observed.
193
 The problematic isomerization is evident from the 
range of catalysts that have been developed including PdCl2, (PPh3)3RuCl/BuLi
124
, (1,5-cyclooctadiene)-
bis(methyldiphenylphosphine)-iridium(I) hexafluorophosphate Ir(COD)(Ph2MeP)2PF6
194
 and 
(Ph3P)4Pd
195196
. Instead, we decided to use silyl ethers as anomeric protecting groups. Silyl ethers can be 
deprotected under acidic conditions or with fluoride ion sources such as TBAF or hydrogen fluoride.
197,198
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This is attributed to the fluoride ions’ high affinity for silicon with the Si-F bond strength being 
approximately 30 kcal/mol higher than the Si-O bond.
199
 Since the first reports by Schmidt and 
co-workers, anomeric TBDMS ethers have often been used as a precursor for TCAI donors.
196,200,201
 Their 
application is, however, limited to the synthesis of 2-amino-2-deoxy sugars because the TBDMS group is 
prone to migrate if the 2-position is not protected. Schmidt and co-workers showed that the tendency to 
migrate could be significantly reduced by using the sterically hindered thexyldimethylsilyl (TDS) ether.
202
 
This made it possible to remove acyl groups under Zemplén conditions. We expected that a tert-butyl-
diphenylsilyl (TBDPS)-ether would be even more stable and therefore set out to make a building block 
with an anomeric TBDPS group. The synthesis is shown in Scheme 34.  
 
Scheme 34. Synthesis of donor 122 and acceptor 120 from C1-O-TBDPS building block. 
Selective anomeric deacetylation of galactose pentaacetate with hydrazine acetate in DMF afforded the 
hemiacetal 117.
203
 This was treated with TBDPSCl and imidazole in DMF at 0 C to give only the kinetic 
product, the -anomer 118. The acetyl groups were removed with the Zemplén procedure but in this case 
the reaction was performed in only 0.01 M NaOMe in MeOH at -20 °C to avoid migration. The 4- and 
6-position were protected with a benzylidene acetal followed by acetylation of the diol to give 119. The 
low yield is caused by migration of the TBDPS group during the acetal formation. This could possibly be 
avoided if a lower temperature and milder acids were used. The benzylidene acetal was opened 
regioselectively with NaCNBH3/TfOH
204
 to give the free C4-OH 120. The use of triflic acid instead of 
HCl/Et2O improved the reaction outcome, because the stoichiometry was more easily controlled.
204
  
Next, an allyloxycarbonyl (Alloc) group was introduced at the C4-OH by treatment with AllocCl and 
N,N,N′,N′-tetramethylethylenediamine (TMEDA) to give 121.205 The TBDPS group was removed in 
excellent yield with TBAF and AcOH to give the hemiacetal.
206
 Addition of acetic acid was crucial to 
avoid simultaneous migration and/or deprotection of the acetyl groups. Finally, the hemiacetal was 
converted to the PTFAI donor 122 with PTFAICl and Cs2CO3.
207
 The coupling of donor 122 and acceptor 
120 with 0.1 equiv TMSOTf as promoter resulted in a 3:2 mixture of disaccharide 123 and the 
corresponding orthoester (Scheme 35). The reaction was repeated using 0.25 equiv. of TMSOTf. In this 
case, the orthoester was not observed and the disaccharide 123 could be isolated in 81% yield.  
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Scheme 35. Condensation of donor 122 and acceptor 120. 
The disaccharide was converted into acceptor 124 by deprotection of allyloxycarbonyl. This was 
accomplished by Pd(0)-catalyzed transfer of allyl to the weak base morpholine. Instead of the 
air-sensitive PdPPh34, it was possible to use the cheaper and more stable Pd(OAc)2, which is reduced in 
situ with PPh3 (Scheme 36).
208
 Dimedone was also tested as scavenger but this resulted in slower 
conversion and similar yield.
209
  
 
Scheme 36. Transformation of disaccharide 123 into a donor 125 and acceptor 124. 
Disaccharide 123 was also turned into the corresponding PTFAI donor 125 by deprotection of the TBDPS 
group followed by treatment with PTFAICl and Cs2CO3. As opposed to deprotection of the 
monosaccharide, no reaction was observed with TBAF and acetic acid at 22 C. Even with a large excess 
of the reagents in refluxing tetrahydrofuran (THF), it was not possible to get more than 10% conversion. 
HF-pyridine in THF, on the contrary, afforded the hemiacetal in 88% yield after 10 h at 22 C.198  
Glycosylation of acceptor 124 with either donor 122 or donor 125 using 0.25 equiv. TMSOTf as promoter 
afforded trisaccharide 126 and tetrasaccharide 127 in excellent yield (Scheme 37). No orthoester by-
products were observed in any of the reactions. The Alloc group was removed with Pd(OAc)2, PPh3 and 
morpholine to give the acceptor 128, which only needed to be glycosylated once more in order to obtain 
the target hexasaccharide. 
 
Scheme 37. Glycosylation of disaccharide 124 with mono- and disaccharide donors. 
TMSOTf-promoted coupling of the tetrasaccharide 128 and disaccharide 125 only resulted in degradation 
of the donor (Scheme 38). The reaction was repeated at different temperatures (-40 °C, -20 °C and 0 °C), 
with 4 Å MS and with two other promoters (BF3
.
OEt2
188
 and TBSOTf
158
) without any significant change 
in outcome. Attempts to glycosylate 128 with monosaccharide donor 122 also resulted in degradation of 
the donor (Scheme 38). This indicates that it is not the donor but rather the acceptor that caused the 
problems. 
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Scheme 38. Unsuccessful attempts to glycosylate tetrasaccharide 128. 
It had been confirmed by NMR that the Alloc group had been removed, but the poor glycosylation results 
made us question whether a free hydroxy group was present. The tetrasaccharide was treated with BzCl 
and Et3N resulting in formation of a single product. NMR and LC-MS confirmed that it was the 
monobenzoylated tetrasaccharide. Based on this result, there must be a free C4-OH on the tetrasaccharide, 
but it is simply too unreactive. Hence, the donor is degraded, before it has a chance to react with the 
acceptor. This is in agreement with work by Kováč et al. (section 4.1), who observed a remarkable drop 
in yield in glycosylations to a disaccharide acceptor compared to a monosaccharide acceptor.
105
   
It was investigated if a different type of donor would be a better match. To our surprise, we found that 
NIS/TESOTf-promoted glycosylation of the tetrasaccharide 128 with thioglycoside 54 afforded the 
pentasaccharide 129 in 69% yield with 18% of recovery of the acceptor (Scheme 39). The activation of 
the thioglycoside was much slower than for the PTFAI donors, which may have been the reason for the 
improvement.  
 
Scheme 39. Successful glycosylation of tetrasaccharide 128 using thioglycoside donor 54. 
It had not been possible to prepare the target hexasaccharide by this strategy, but the tri, tetra- and 
pentasaccharide were still in high demand from our collaborators. Global deprotection of the three 
oligosaccharides was accomplished in three steps (Scheme 40). First, the TBDPS group was removed 
with HF-pyridine, followed by Zemplén deacetylation and hydrogenation over Pd/C to give the fully 
unprotected oligosaccharides in 68-75% yield.
198
 
In summary, it was demonstrated that the TBDPS group is an interesting alternative to the common 
anomeric protecting groups, allyl ether and p-methoxyphenyl. The high yield in the selective desilylation 
shows that the strategy can be used to prepare tri-, tetra- and pentasaccharide donors that could have been 
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used as building blocks in larger oligosaccharides. It was possible to make a fully protected 
tetrasaccharide from galactose pentaacetate in just 14 steps based on the C1-O-TBDPS strategy.  
Unfortunately, the reactivity of the C4-OH decreases with increasing size of the acceptor, which prec-
luded the final 2+4 glycosylation with PTFAI donor 125. One way to increase reactivity of the C4-OH 
would be to use small electron-donating protecting groups (e.g. benzyl or allyl). However, these 
protecting groups are not compatible with TBDPS protection of the anomeric center, since it has a 
tendency to migrate under typical alkylation conditions. 
 
Scheme 40. Global deprotection of tri-, tetra- and pentasaccharide. 
4.8 Synthesis of unnatural tetrasaccharides for co-crystallization studies with GALS1 
from Arabidopsis thaliana 
In a study by Scheller and co-workers, the galactotriose, -tetraose and -pentaose described in the previous 
section were used as substrates in the identification of a novel -(14)-galactosyl-transferase, GALS1. 
The results are summarized in section 7.1. The functional properties of proteins depend upon their three-
dimensional structure. It is therefore essential to understand the folding in order to understand the 
protein’s specificity and mode of action. In spite of considerable efforts over the last 40 years, it is still 
not possible to predict the folding of individual proteins in sufficient detail. The three-dimensional 
structure is instead determined experimentally by X-ray crystallography, electron crystallography or 
nuclear magnetic resonance. Even though the crystal structure is only a static representation of the protein 
fold, it still gives valuable information about the protein structure.
210
 The next step in the study of GALS1 
was to obtain a high-resolution crystal structure of the enzyme. Thus, members of H. Scheller’s group 
have been performing extensive crystallization studies, but so far without success. Without a ligand the 
enzyme seemed to be too flexible and when natural substrate was used it was modified by the enzyme to 
give a mixture of ligands. 
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In an attempt to solve this issue, we decided to make competitive inhibitors, which maintain the binding 
affinity but does not act as substrates. This was done by modification of the axial C4-OH in the 
non-reducing end of a natural ligand. The new substituent should be very similar to the natural hydroxy 
group in order to maintain the ligands binding properties. It was therefore decided to make three different 
analogs: A C4-F (133), C4-OMe (134), and C4-epimer (135) (Scheme 41). This would not only make us 
more likely to find a good inhibitor, but also give information about the promiscuity of the active site. 
 
Scheme 41. Structures of the potential GALS1 inhibitors. 
As described in section 4.4.2, it was possible to make a β-(14)-linked trisaccharide acceptor by 
orthogonal coupling of pentenyl glycosides and PTFAI donors. The synthesis was, however, complicated 
by formation of orthoesters during glycosylation and migration during hydrolysis of the pentenyl moiety. 
One way to solve this is by using the more hindered pivaloyl ester, which only migrates under harsh 
conditions. The only drawback is that pivaloyl groups must be removed under strong alkaline conditions 
(e.g. LiOH in refluxing MeOH), which could result in elimination of the axial fluorine under the global 
deprotection. It was therefore decided to exchange the pivaloyl groups with benzyl groups after synthesis 
of the trisaccharide followed by glycosylation with three different monosaccharide donors. We 
furthermore sought to improve the reactivity of the donor and acceptor by introducing a benzyl group at 
the 3-position. The retrosynthetic analysis for synthesis of the three inhibitors is shown in Scheme 42. 
Starting from pentenyl glycoside 136 and acceptor 113 it was possible to make perbenzylated 
trisaccharide acceptor 137. This was coupled to three different donors 138a,b,c followed by global 
deprotection to give the three inhibitors 139a,b,c. 
 
Scheme 42. Retrosynthetic analysis of tetrasaccharide synthesis. 
4.8.1 Synthesis of trisaccharide acceptor 
Starting from pentenyl glycoside 109, regioselective benzylation of the C3-OH via a stannylene acetal 
afforded 140 in 79% yield (Scheme 43). The use of CsF
211
 as activator resulted in approx. 10% higher 
yield than TBAB
212
 and TBAI
212
. Next, the 2-position was protected with a pivaloyl group to give the 
fully protected donor 136. It was necessary to use rather forceful conditions for the protection due to the 
steric bulk of the tert-butyl group and the low reactivity of the C2-OH. Pentenyl glycoside 136 was 
Synthesis of -(14)-D-galactan oligosaccharides 
 50 
converted to the PTFAI donor 141 in two steps by the method described in section 4.6. The benzylidene 
acetal had to be opened to form the acceptor 142. Against expectations, very little conversion was 
observed with NaCNBH3/HCl
.
OEt2.
126
 Opening was instead achieved by treatment of 136 with 
Et3SiH/TFA to give 142 in 76% yield.
213
 It should be mentioned, that the original paper states that 
reductive opening of benzylidene-protected galactose derivatives does not take place under these 
conditions. Since our result suggests otherwise, it was decided to validate the finding by acetylating the 
liberated C4-OH. This resulted in a characteristic downfield shift of the H-4 proton, whereas the H-6 
proton remained unchanged. The method has the advantage that it is easily scaled up compared to the 
NaCNBH3/HCl
.
OEt2-procedure.
213
 
 
Scheme 43. Synthesis of donor 141 and acceptor 142 from common building block 109. 
TMSOTf-catalyzed coupling of donor 141 and acceptor 142 afforded disaccharide 143 in excellent yield 
(Scheme 44). No orthoester by-products were observed and the reaction was significantly faster than the 
glycosylation described in section 4.7. The disaccharide was used as donor in the following glycosylation 
of the monosaccharide acceptor 113 to give the fully protected trisaccharide 144. The reaction turned out 
to be very fast compared to the similar coupling of 105 and 113 (section 4.6). It was therefore possible to 
perform the reaction at -40 C, which resulted in less by-products and an impressive 86% yield.  
The pivaloyl groups were deprotected using KOH in dimethylsulfoxide (DMSO) to give diol 145. In 
DMSO the hydroxide ion is not solvated to the same extent as in water or methanol and therefore 
becomes a better nucleophile (and base).
214
 The conditions made it possible to cleave both pivaloyl 
groups in less than 12 h at 22 C which makes it a promising alternative to known methods e.g. 48 h with 
LiOH in refluxing MeOH.
106
 The liberated hydroxyl groups were benzylated to give 146 in 82% yield 
over two steps. 
 
Scheme 44. Synthesis of disaccharide donor 143 followed by coupling to acceptor 113. 
The regioselective opening of the benzylidene acetal to give a trisaccharide acceptor 137 turned out to be 
problematic. No reaction was observed for NaCNBH3/HCl
126
 or NaCNBH3/I2,
215
 whereas Et3SiH/TFA
213
 
and Et3SiH/Cu(OTf)2
216
 only resulted in slow hydrolysis of the benzylidene. Instead, the benzylidene was 
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hydrolyzed by treatment with EtSH and p-TSA to give 147 in 94% yield (Scheme 45).
217
 These 
conditions gave significantly better results than 1,3-propanediol/ p-TSA and aq. AcOH, that had been 
used previously.
124,218
 Regioselective acetylation of the 6-position afforded the acceptor 148 in 88% yield.  
 
Scheme 45. Synthesis of trisaccharide acceptor 148 by hydrolysis and regioselective acetylation.  
4.8.2 Synthesis of 4-deoxy-4-fluoro-, 4-O-methyl- and glucose donor 
With access to the acceptor, the next step was to prepare the three donors. It was decided to use pentenyl 
glycosides, since they are stable under methylation and fluorination conditions. 
The common way to prepare fluorine analogues is with DAST.
219
 Starting from the free alcohol, DAST 
both activates the hydroxyl group and displaces it via an SN2 mechanism. Unfortunately, this method is 
not applicable for the C4-F galactose analogues because axial attack is hampered by steric hindrance.
220
 
Instead, the fluorine analogue 149 was prepared in four steps from the known pentenyl glucoside 150 
(Scheme 46).
221,222
 Benzoylation of the diol followed by regioselective opening of the benzylidene acetal 
afforded 152. Next the C4-OH was converted to the corresponding triflate with Tf2O and pyridine.
220
 The 
more hindered base, 2,6-lutidine resulted in slightly cleaner reactions, but was harder to remove during 
work-up. The triflate is a better leaving group than the DAST-species and made it possible to introduce 
the fluorine by SN2 substitution with TBAF to give the donor 149 in 85% yield over two steps. It was 
critical that the TBAF solution was completely anhydrous since concurrent hydrolysis, elimination and 
deacylation was otherwise observed.  
 
Scheme 46. Synthesis of 4-deoxy-4-fluoro donor 149. 
The methyl analogue 153 was prepared in two steps from the known pentenyl galactoside 154 (Scheme 
47). Regioselective ring opening of the benzylidene acetal was achieved with Et3SiH/TFA to give 155. 
The methylation of the C4-OH turned out to be challenging due to the low reactivity and since only 
neutral conditions could be used in order to avoid migration or deprotection of the benzoyl groups. 
Methyl iodide and silver(I) oxide should meet these criteria but resulted in almost 40% of the migration 
product.
223
 On the contrary, no conversion was observed with MeOTf and DTBMP
224
 even after 24 h at 
reflux. The methylation was finally accomplished with Meerweins’ salt and Proton-sponge, which 
afforded 153 in 84% yield after just 6 h at 22 C.225 To the best our knowledge, this is the first time that 
this combination of reagent has been used for methylation of carbohydrates.  
The perbenzoylated PTFAI glucoside 156 was used for the glucose analogue. This was synthesized in 
three steps from D-glucose based on a literature procedure.
226
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Scheme 47. Synthesis of 4-O-methyl donor 153.  
4.8.3 Final glycosylation and deprotection of tetrasaccharide inhibitors 
Glycosylation of trisaccharide 148 with the pentenyl glycoside 149 using NIS/TESOTf as promoter only 
resulted in degradation of the donor. The poor result was most likely attributable to the electron-poor 
nature of the donors. The pentenyl glycosides were instead converted to the more reactive PTFAI donors 
(157 and 158) by hydrolysis with NBS/H2O followed by treatment with PTFAICl and Cs2CO3. 
TMSOTf-catalyzed glycosylation of acceptor 148 with the three PTFAI donors gave the corresponding 
tetrasaccharides 159, 160 and 161 in excellent yield (Scheme 48). The three reactions had to be 
performed at 0 ºC, since no conversion was observed at lower temperatures. The reactivity of the different 
donors followed the expected trends. Thus, methyl analogue 157 reacted much faster than electron-poor 
fluorine donor 158 and glucose donor 156 had intermediate reactivity. 
 
Scheme 48. Glycosylation of trisaccharide acceptor 148 with three PTFAI donors. 
Global deprotection of the three tetrasaccharides was achieved by transesterification with NaOMe in 
MeOH followed by Pd(OH)2-catalyzed hydrogenolysis to give the target molecules: 133, 134, and 135 
(Scheme 49). A final purification by reverse-phase chromatography was necessary in order to remove 
Pd(OH)2/C traces. The three analogues were sent to University of California, Berkley, USA and we are 
currently waiting for results of the crystallization studies. 
 
Scheme 49. Global deprotection of the three tetrasaccharides 159, 160 and 161. 
In conclusion, it was possible to prepare three tetrasaccharide analogues by glycosylation of a mutual 
trisaccharide acceptor with various PTFAI donors. The very effective coupling of 143 and 113 suggests 
that the acceptor reactivity is more influenced by the C3-O protecting group than first anticipated. The 
final couplings showed that careful choice of donors and glycosylation conditions are necessary to 
achieve successful couplings to the C4-OH of galactose. 
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4.9 Block-synthesis of β-(14)-linked linear penta- and heptagalactans  
The coupling of the disaccharide donor 143 and monosaccharide acceptor 113 was very promising but the 
following conversion to an acceptor by hydrolysis and regioselective acetylation was problematic. Not 
only was it a two-step procedure, but previous results also showed that a C6-O-acetyl significantly 
lowered the reactivity of the C4-OH.
227
 This observation was confirmed by the low reactivity of 
trisaccharide 148 in couplings to pentenyl glycosides. Instead, it was decided to open the benzylidene 
acetal on the monosaccharide stage and protect the C4-OH with a temporary protecting group. The 
chloroacetyl was chosen, since it can be easily removed either with thiourea or under mild basic 
conditions.
228
  
4.9.1 Synthesis of disaccharide donor 
For large-scale synthesis of the disaccharide donor, it was favorable to make the PTFAI donor 165 from 
the corresponding thioglycoside, since the first steps of the pentenyl glycoside synthesis result in 
mediocre yields (Scheme 50). Regioselective benzylation of diol 56 afforded 166 in excellent yield. As 
opposed to the synthesis of pentenyl glycoside 140, the best results were obtained with TBAB rather than 
CsF. The C2-OH was acylated to give thioglycoside 167 followed by regioselective reductive opening of 
the benzylidene acetal with Et3SiH/TFA. The opening resulted in higher yields for thioglycosides, since 
by-product formation from hydrosilylation or reduction of the double bond was avoided. Treatment of the 
free C4-OH of 168 with ClAc2O and Et3N afforded the fully protected thioglycoside 169. Finally, 
hydrolysis with NBS/H2O followed by treatment with PTFAICl and Cs2CO3 gave the PTFAI donor 165 
in 40% total yield over six steps. TMSOTf-catalyzed glycosylation of pentenyl acceptor 142 with PTFAI 
glycoside 165 afforded disaccharide donor 170 in 83% yield. Careful control of the temperature was 
necessary, since formation of the α-anomer was observed at higher temperatures (-10 °C). All of the 
reactions were easily performed at large scale and it was possible to prepare disaccharide 170 in 30 g. 
 
Scheme 50. Large-scale synthesis of disaccharide 170. 
4.9.2 Block-synthesis of penta- and heptasaccharide 
NIS/TESOTf-promoted glycosylation of acceptor 113 with disaccharide donor 170 afforded trisaccharide 
171 (Scheme 51). Just like the coupling of 143 and 113 the 3-O-benzyl seemed to improve the reactivity 
of the donor remarkably. The chloroacetyl group was removed with thiourea, NaHCO3 and TBAI to give 
172 in 88% yield.
228
 This was acceptable but it was found that the cumbersome work-up to remove 
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thiourea could be avoided, if 0.02M NaOMe in MeOH at 0 ºC was used instead. The pivaloyl group is 
stable under mild basic conditions and the C3-O-benzyl group prevents migration. 
 
Scheme 51. Block-synthesis of pentasaccharide 173. 
The trisaccharide acceptor 172 was glycosylated with the disaccharide donor 170 to give the 
pentasaccharide 174 in 83% yield. As opposed to all previous efforts to synthesize longer β-(14)-linked 
galactans, the reaction was fast and almost no by-products were observed. Deprotection with 
NaOMe/MeOH followed by glycosylation with donor 170 gave the fully protected heptasaccharide 175 
(Scheme 52). The reaction was slower than the two previous glycosylations (3 h vs. 1 h) but resulted in a 
similar yield.  
 
Scheme 52. [2+5]-glycosylation to give the fully protected heptasaccharide 175. 
Cleavage of the pivaloyl groups with KOH/DMSO resulted in complete deprotection but also in 
significant degradation of the heptasaccharide. The product was isolated in only 46% yield. A range of 
conditions was investigated in an effort to improve the yield. Deprotection with NaOMe in refluxing 
MeOH,
229
 aq. MeNH2,
230
 LiOH in refluxing MeOH
106
 and aq. Bu4NOH/H2O
193
 resulted in incomplete 
deprotection after 72 h. MeLi/Et2O
231
 and i-Bu2AlH/CH2Cl2
232
 gave rise to pronounced degradation. 
Global deprotection was possible by Birch reduction but it was necessary to acetylate the product in order 
to purify it.
233
 Attempts to remove the benzyl ethers first followed by depivaloation under Zemplén 
conditions also resulted in degradation, most likely due to reaction with the hemiacetal. The best result 
was achieved with aq. Bu4NOH, but poor solubility seemed to be a problem. The deprotection was 
instead done with Et4NOH in MeOH/THF at 60 °C, which resulted in full conversion and a minimum of 
by-products (Scheme 53). The benzyl groups were cleaved by Pd(OH)2-catalyzed hydrogenolysis to give 
the fully unprotected oligosaccharides 132 and 176 in 78 and 72% yield over two steps, respectively.  
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Scheme 53. Global deprotection of penta- and heptasaccharide. 
Judging from the high glycosylation yields, the 3-O- and 6-O-benzyl protection made the acceptors more 
reactive. The increased nucleophilicity can be ascribed to both electronic and steric effects. Not only are 
benzyl groups electron donating, but their flexibility also allow them to adopt conformations, where the 
C4-OH is significantly less hindered. It would be interesting to make even longer linear oligosaccharides 
by this method to investigate if the reactivity will decrease at some point, as it was the case for the 
2,3-O-diacetylated oligosaccharides. This is, however, outside the scope of this project.  
The method is similar to the report by Oberthür et al. (section 4.1.3), but has several advantages.
108
 In this 
case the disaccharide can be used directly as donor in the next coupling. Furthermore, allyl groups were 
avoided which resulted in a more effective global deprotection and enabled us to use iodonium-based 
promoters instead of toxic MeOTf. Finally, the two-step deprotection gives direct access to the natural 
reducing oligosaccharide instead of the p-methoxyphenyl glycoside. 
4.10 Branched β-(14)-linked galactans 
As described in section 2.1, the structure of RG-I is highly complex and includes several branchings. The 
linear galactans are therefore not necessarily the best ligands for the carbohydrate-binding proteins (e.g. 
Gal-3) and antibodies. This is exemplified in section 7.3, where the antibody LM16 was shown to bind a 
branched tetrasaccharide but not a linear. In order to study how branching would influence the binding, it 
was decided to prepare a linear -(14)-linked hexasaccharide core with branchings at the 4th residue. 
The synthetic strategy was based on results from section 4.3, where it was shown that a C6-O-NAP could 
be selectively removed in the presence of benzyl ethers and acyl groups. This made it possible to design a 
convergent strategy where the linear hexasaccharide 178 with only one free hydroxyl was glycosylated 
with various glycosyl donors. The NAP group has the advantage that it is sterically and electronically 
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similar to the benzyl groups. The glycosylations were therefore likely to follow the same trend as the 
previous examples. It was decided to use the NAP-protected monosaccharide 180 for introduction of the 
branching point and disaccharide donor 170 for the remaining glycosylations. The retrosynthetic analysis 
of the hexasaccharide backbone is shown in Scheme 54.  
 
Scheme 54. Retrosynthetic analysis of the hexasaccharide acceptor 178. 
4.10.1 Synthesis of hexasaccharide acceptor 
The NAP-protected building block 180 was prepared by the same route as thioglycoside 169, but in this 
case a naphthylidene acetal was used (Scheme 55). Stannylene-promoted regioselective benzylation of 
diol 24 gave thioglycoside 181 followed by acylation of the C2-OH to afford the fully protected 
thioglycoside 182. Regioselective opening of the naphthylidene acetal was achieved by treatment with 
Et3SiH/TFA to give 183. It is remarkable that the NAP group is stable under the Et3SiH/TFA conditions, 
since 10% TFA in CH2Cl2 has previously been used to deprotect NAP ethers.
234
 Finally, the chloroacetyl 
group was introduced with (ClAc)2O, Et3N and DMAP to afford 180 in 55% yield over four steps.  
 
Scheme 55. Synthesis of NAP-protected building block. 
The branching point was installed at the 4
th
 sugar by glycosylation of trisaccharide acceptor 172 
(described in section 4.9.2) with thioglycoside 180 to give tetrasaccharide 184 in 73% yield (Scheme 56). 
The low yield compared to glycosylations with the disaccharide donor is most likely attributable to the 
C4-O-chloroacetyl. In the monosaccharide, it is much closer to the aglycon, which results in a rather 
electron poor system. The effect is further enhanced since the 4-position on galactose has been shown to 
have the largest effect on the donor reactivity.
140
 Deprotection of the chloroacetyl group with 
NaOMe/MeOH gave the tetrasaccharide acceptor 185 in 94% yield.  
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Scheme 56. NIS/TESOTf-promoted glycosylation of trisaccharide 172 with NAP-protected donor 180. 
A second glycosylation with disaccharide donor 170 gave the fully protected hexasaccharide 179 in 84% 
yield (Scheme 57). As expected the NAP ether did not negatively impact the glycosylation outcome.  
The first attempt to cleave the NAP ether with DDQ in a 4:1:0.2 CH2Cl2/MeOH/H2O-mixture resulted in 
a slow conversion and several by-products. Much better results were obtained without methanol, where 
the product 178 could be isolated in 75% yield after a special work-up described by Boltje et al..
235
 
Characterization of the byproducts showed that they were a mixture of hexasaccharides where one or 
more of the benzyl groups had been cleaved.  
 
Scheme 57. Glycosylation and NAP-cleavage to give target hexasaccharide 178. 
4.10.2 Synthesis and introduction of branchings 
The hexasaccharide acceptor could now be glycosylated with a range of donors. It was decided to 
introduce three disaccharides and two monosaccharides: β-(14)-linked D-digalactan 170, β-(16)-
linked D-digalactan 186, α-(15)-linked L-diarabinan 187, D-galactose 188 and L-arabinose 189, since 
they are all found in nature.
12
 The structures of the five donors are shown in Scheme 58. 
 
Scheme 58. Structure of the five donors used for branching. 
L-Arabinofuranosyl donors 
The perbenzoylated PTFAI donor 189 was chosen as donor for the L-arabinose branch. It could be 
prepared from commercially available L-arabinose in four steps (Scheme 59). First, L-arabinose was 
transformed into the methyl glycoside by a Fischer glycosylation of methanol under kinetic control.
236
 
This ensures formation of the furanoside. Benzoylation with benzoyl chloride in pyridine afforded 190 as 
the -isomer in 45% yield over two steps.237 The methyl glycoside 190 was hydrolyzed with 90% 
aqueous TFA to give the hemiacetal 191 in 68% yield and finally the PTFAI donor 189 was formed after 
treatment with PTFAICl and Cs2CO3.
207
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Scheme 59. Synthesis of L-arabinose PTFAI donor 189. 
Donor 189 was not only used in the glycosylation of the hexasaccharide but also acted as donor in the 
synthesis of diarabinan donor 187. Thioglycoside acceptor 192 was prepared in five steps from methyl 
glycoside 190 based on literature procedure for the corresponding D-arabinofuranosyl thioglycoside 
(Scheme 60).
238
 Compound 190 was treated with thiophenol and BF3OEt2 followed by debenzoylation 
under Zemplén conditions to give the phenyl thioglycoside 193 in 72% yield over two steps. Next, the 
primary C5-OH was selectively protected with the bulky TBDPS group using TBDPSCl and imidazole 
followed by benzoylation of the diol to afford 194 in 77% yield over two steps. Finally, the TBDPS group 
was removed with TBAF/AcOH to give the acceptor 192 in 88% yield. It was necessary to add AcOH to 
avoid concurrent deprotection or migration of the benzoyl esters. TMSOTf-mediated glycosylation of 
thioglycoside acceptor 192 with PTFAI donor 189 afforded disaccharide 187 in an excellent yield 
(Scheme 60). 
 
Scheme 60. Synthesis of diarabinan thioglycoside 187. 
D-Galactose donors 
Synthesis of the β-(16)-linked D-digalactan donor 186 is described in section 6.2 and the 
β-D-(14)-digalactan was introduced with disaccharide donor 170, discussed in section 4.9.1.  
The galactose monomer was introduced using the perbenzoylated PTFAI donor 188 which was prepared 
in four steps from commercially available D-galactose according to a literature procedure (Scheme 61).
239
 
D-Galactose was treated with benzoyl chloride in pyridine to give the perbenzoylated sugar 195 in 85% 
yield. The anomeric center was brominated with HBr/AcOH and the crude glycosyl bromide was 
subjected to silver(I) carbonate in the mixture of acetone and water to afford hemiacetal 196 in 71% yield 
over two steps. Hemiacetal 196 was converted to the PTFAI donor 188 with PTFAICl and Cs2CO3.
207
  
 
Scheme 61. Synthesis of PTFAI donor 188.  
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4.10.3 Glycosylations of hexasaccharide acceptor 178 
With all the donors at hand, it was possible to make the branched oligosaccharides. The glycosylations 
with pentenyl and thioglycosides were promoted by NIS/TESOTf in a 1:1 acetonitrile (MeCN)/CH2Cl2 
mixture, whereas the glycosyl imidates were activated with TMSOTf in CH2Cl2 (Scheme 62). All of the 
reactions were performed at -40 ºC to enhance the stereoselectivity. All of oligosaccharides 197-201 were 
isolated in over 70% yield. Against expectations, the disaccharide donors gave the best results. This can 
perhaps be explained by their lower reactivity, which often results in better α/β-selectivity. It is 
remarkable that couplings to the primary C6-OH gives lower yields than glycosylations to the hindered 
C4-OH. The low reactivity of the C6-OH is probably attributable to its position in the middle of the 
oligosaccharide chain and is further reduced by -(14)-D-galactans tendency to fold into helical 
structures.
240
 The knowledge of the 3-dimensional structure of protected carbohydrates is, however, 
limited. 
 
Scheme 62. Glycosylation of hexasaccharide 178 with various donors. 
Structural studies of RG-I have shown that linear galactans are often capped by a single L-arabinose 
residue. We were interested to see how this affects binding and decided to prepare a heptasaccharide with 
a L-arabinofuranosyl in the non-reducing end. The compound was synthesized from hexasaccharide 179. 
Instead of deprotecting the NAP-ether, the chloroacetyl group was removed with NaOMe/MeOH to give 
the hexasaccharide acceptor 202 in 94% yield (Scheme 63). This was glycosylated with perbenzoylated 
PTFAI donor 189 with TMSOTf as promoter to afford the heptasaccharide 203 in 74% yield. 
Synthesis of -(14)-D-galactan oligosaccharides 
 60 
 
Scheme 63. Synthesis of L-arabinofuranosyl-capped heptasaccharide. 
The final type of branched oligogalactans that we were interested in were C3-branched oligogalactans. As 
described in section 2.1, this class includes a range of sugars with L-arabinose being the most common. 
The strategy was based on the same approach as for the C6-branched oligosaccharides. A C3-O-NAP-
protected monosaccharide was introduced at the branching point and once the hexasaccharide core had 
been prepared the NAP group was selectively deprotected. 
The synthesis of the monosaccharide donor 204 is shown in Scheme 64. Acylation of thioglycoside 56 
with PivCl, Et3N and DMAP afforded 205 in 93% yield. The benzylidene acetal was regioselectively 
opened with Et3SiH/TFA to give 206 followed by protection of the liberated C4-OH with ClAc2O and 
Et3N to give the fully protected thioglycoside 204 in 94% yield. 
 
Scheme 64. Synthesis of C3-O-NAP building block. 
NIS/TESOTf-mediated glycosylation of trisaccharide acceptor 172 with the monosaccharide donor 204 
afforded the tetraasaccharide 207 in 79% yield (Scheme 65). As expected, the reactivity was similar to 
thioglycoside 180. The chloroacetyl group was deprotected with NaOMe/MeOH to afford 208 followed 
by glycosylation with disaccharide donor 170 to give the fully protected hexasaccharide 209 in 83% 
yield.  
 
Scheme 65. Synthesis of C3-O-NAP protected hexasaccharide 209. 
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The final step in the synthesis of the hexasaccharide acceptor was selective removal of the NAP group. 
Unfortunately, treatment of 209 with DDQ in CH2Cl2/H2O
234
 gave a complex mixture of products. Lower 
temperature or addition of methanol resulted in a slower reaction but not a change in reaction outcome. 
Fuwa et al. have reported that NAP ethers are selectively cleaved by 9:1 CH2Cl2/TFA, but in our hands 
the reaction was slow and only resulted in degradation.
234
 Selective hydrogenolysis of a NAP-ether in 
presence of benzyl groups has been reported but in this case no selectivity was observed.
120
 In hindsight, 
the problems in the final deprotection should have been anticipated. Deprotection of C6-O-NAP gave rise 
to notable cleavage of the benzyl ethers and since the C3-O-NAP is considerably more sterically 
hindered, this problem was likely to be increased. Other methods for selective NAP deprotection have to 
be screened in order to solve the problem. Alternatively, the NAP-group should have been exchanged for 
another protecting group e.g. an acetyl or silyl group.  
Global deprotection of the linear hexasaccharide (179), three branched heptasaccharides (200, 201 and 
203) and three octasaccharides (197, 198 and 199) was accomplished with the conditions described in 
section 4.9.2 to give the fully unprotected oligosaccharides 210-216 in yields ranging between 65% and 
75% (Scheme 66). This was acceptable considering the difficult deprotection of the pivaloyl groups.  
In conclusion, a convergent strategy for (16)-branched -(14)-D-galactans was developed and a small 
library of hepta- and octasaccharides was prepared. The late-stage introduction of the branchings 
significantly reduces the overall number of steps and makes it possible to introduce different donors. The 
use of pivaloyl groups is favorable throughout the synthesis but results in reduced yields in the final 
deprotection. It would be interesting to study if the pivaloyl groups could be exchanged for an alternative 
protecting group. One possibility is the 2-chloro-2-methyl-propanoyl group developed by Carreira and 
Szpilman.
241
 This reduces formation of orthoesters and can be cleaved under mild Zemplén conditions 
due to the electron withdrawing chloro substituent. Unfortunately, it was not possible to apply the same 
strategy to synthesis of (13)-branched galactans. In this case, a different orthogonal protecting group is 
needed. The problem will be addressed in future studies in the group. 
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Scheme 66. Global deprotection of the branched -(14)-linked ligogalactans.
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5 Synthesis of -(13)-D-galactan oligosaccharides 
The equatorial C3-OH of D-galactose is significantly less sterically hindered than the axial C4-OH. 
Problems such as aglycon transfer and unreactive acceptors are therefore less common and it is possible 
to make glycosylations between electron-deficient acceptors and -donors in high yields. However, the 
higher reactivity is not without its challenges. The increased nucleophilicity makes the glycosylation 
reactions faster and more difficult to control which typically results in poorer stereoselectivity.
192
 
Electron-withdrawing substituents reduce electron density of the neighboring hydroxyl group and thereby 
lower its nucleophilicity. This may improve the stereoselectivity as the reaction can be carried out in a 
more controlled manner.
242
 
As described in section 2.2, the -(13)-linked galactans are widespread in nature in the form of AG-II. 
Nevertheless, very little work has been done regarding synthesis of defined oligosaccharide fragments.  
Table 6 summarizes the published work.  
Table 6. Published work on synthesis of -(13)-linked galactans. 
Synthetic oligosaccharide fragment Reference 
Trisaccharides  
-D-Galp-(1→3)--D-Galp-(1→3)--D-Galp Komba et al.107 
-D-Galp-(1→3)--D-Galp-(1→3)--D-Galp-HMBA Komba & Machida
243
 
-D-Galp-(1→3)--D-Galp-(1→6)--D-Galp-HMBA Komba & Machida
243
 
-D-Galp-(1→3)--D-Galp-(1→3)--D-Galp 
fully protected 
Ziegler et al.
244
 
-D-Galp-(1→3)--D-Galp-(1→3)--D-Galp-OMe 
partially protected 
Fenger & Madsen
245
 
-D-Galp-(1→3)--D-Galp-(1→3)--D-Galp-OMe Kováč et al.
246
 
-D-Galp-(1→3)--D-Galp-(1→3)--D-Galp-O(CH2)8N3 McGill & Williams
247
 
-D-Galp-(1→3)--D-Galp-(1→3)-D-Galp Chowdhary et al.
248
 
 
Tetrasaccharides and larger oligomers 
 
-D-Galp-(1→3)-{-D-Galp-(1→3)}2--D-Galp-OMe Kováč et al.
246
 
-D-Galp-(1→3)-{-D-Galp-(1→3)}3--D-Galp-OMe Kováč et al.
246
 
-D-Galp-(1→3)-{-D-Galp-(1→3)}5--D-Galp-OMe Kováč et al.
246
 
5.1 Previous studies of β-(1→3)-D-galactan synthesis 
5.1.1 Synthesis of linear -(13)-linked tri, tetra, penta and heptagalactans  
The elegant work by Kováč and co-workers is so far the only published strategy for synthesis of higher 
members of the -(13)-D-galactan series.246 They showed that it was possible to prepare the entire 
series of linear methyl -glycosides of DP 2-7 from a single building block, namely methyl 2,4,6-tri-O-
benzoyl-3-O-benzyl--D-galactopyranoside. This could either be converted to the corresponding glycosyl 
chloride 217 by treatment with 1,1-dichloromethyl methyl ether (DCMME) or turned into acceptor 218 
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by hydrogenolysis of the 3-O-benzyl group. Glycosyl chlorides were chosen over glycosyl bromides, 
since they are easier to purify and have longer shelf life. Syntheses of the disaccharide and tetrasaccharide 
building blocks 219, 220, 221 and 222 are outlined in Scheme 67. AgOTf-mediated glycosylation of 
acceptor 223 with glycosyl chloride 217 afforded disaccharide 224 in 56% yield. Like the 
monosaccharide, this was converted to either a disaccharide donor 220 with DCMME or a disaccharide 
acceptor 219 by hydrogenolysis. Disaccharide building block 221 was prepared by AgOTf-mediated 
glycosylation of 225 with perbenzoylated glycosyl bromide 226 to give disaccharide 227 followed by 
activation with DCMME. Condensation of donor 221 and acceptor 219 with AgOTf as activator afforded 
fully protected D-galactotetraose 228 in 54% yield. By careful control of the amount of Lewis acid it was 
possible to convert acetate 228 into the corresponding glycosyl chloride 222 in 82% yield. 
 
 
Scheme 67. Synthesis of -(13)-linked disaccharide and tetrasaccharide building blocks.246 
It was now possible to prepare all the methyl glycosides (Scheme 68). Condensation of glycosyl halide 
217 and acceptor 218 followed by hydrogenolysis gave disaccharide acceptor 229. This was coupled to 
donor 221 to give fully protected tetrasaccharide 230. Alternatively, glycosylation with donor 217 
followed by deprotection of the 3-O-benzyl group afforded trisaccharide acceptor 231. Coupling to either 
donor 221 or 222 gave the fully protected pentose 232 and heptaose 233. Debenzoylation was achieved 
by transesterification under Zemplén conditions to give the fully unprotected methyl glycosides.  
Kováč’s synthesis excels by its simplicity, but suffers from low glycosylation yields and cumbersome 
purifications. This is mainly explained by poor stereoselectivity resulting in formation of -glycoside 
by-products even though the 2-O-benzoyl group should facilitate formation of the -product. 
Furthermore, the mediocre glycosylation yields are caused by formation of orthoesters, transesterification 
of the 2-O-acyl group or acyl migration on the acceptor.  
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Scheme 68. Assembly of the methyl -D-(13)-galactose series.246 
5.1.2 2,6-Disubstitued benzoates as neighboring groups in galactosylation reactions 
In a more recent work by McGill and Williams, it was studied whether more bulky 2,6-substituted 
benzoates could overcome the issue of poor stereoselectivity.
247
 Glycosylation of 8-azidooctanol with a 
range of thioglycosides showed that 2,4,6-trimethylbenzoyl (Mez) protected donor 234 gave significantly 
higher yield than the corresponding benzoate donor 235 (Scheme 69). In order to test the applicability of 
the new protecting group, 237 was converted to acceptor 238 in three steps and glycosylated with donor 
234. However, in this case none of the expected product 239 was observed. The failed glycosylation was 
explained by steric hindrance manifested by the 2-O-mesitoyl of the acceptor. 
  
Scheme 69. Comparison of the glycosylation with 2-O-mesitoyl and a 2-O-benzoyl donor.247 
To solve the problem, the target trisaccharide was instead prepared by a 2+1-strategy. Tetramesitoate 
240 was coupled to methoxyphenyl glycoside 241 in a NIS/TfOH-promoted glycosylation to give 
disaccharide 242 in 80% yield. This was converted to the heptamesiotate thioglycoside 243 by 
deacetylation, acylation and exchange of the anomeric protecting group. Glycosylation of acceptor 244 
with donor 243 afforded the trisaccharide 245 in just 28% yield. Deprotection of the hindered mesitoyl 
ester was achieved by saponification with LiOH for five days to give 246 in 88% yield.  
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Even though the mesitoyl ester lowers the amount of - and orthoester byproducts, its use in 
oligosaccharide synthesis seems to be limited by the additional steric hindrance induced by the three 
methyl groups. 
 
Scheme 70. Synthesis of (13)-linked trisaccharides with Mez-protected glycosyl donors.247 
5.1.3 One-pot synthesis of -(13)-galactans by transient protecting group strategy 
Significant progress has been made in oligosaccharide synthesis over the last two decades but the 
fundamental principle remains the same.
192
 A fully protected glycosyl donor is activated by a promoter 
and reacts with a partially protected acceptor with only one or two free hydroxy groups. Most common 
methods therefore involve far more protective group manipulations than glycosylations, resulting in poor 
atom-economy and a time-consuming synthesis. In an effort to address this problem Madsen & Fenger 
developed a simple method for synthesis of -(13)-linked di- and trisaccharides.245 They were able 
perform regioselective glycosylations of unprotected glycosyl acceptors by transient protection of the 
4- and 6-position with phenyl boronic acid. The method also works for unprotected thioglycoside 
acceptors and, thus, gives access to valuable disaccharide building blocks for oligosaccharide synthesis. 
Alternatively, the thioglycosides could be used directly in a second regioselective glycosylation to give 
gluco- or galactotrioses. An example is shown in Scheme 71, where the perbenzoylated glycosyl bromide 
247 was first coupled to thioglycoside 248 under Koenigs-Knorr conditions. Next, the pre-formed 
4,6-O-phenylboronate 249 was added followed by activation of the thioglycoside with NIS/TESOTf. The 
boronates were removed by weakly basic ion-exchange resin IRA 743 and after purification trisaccharide 
250 was isolated in 66% yield. 
 
 
Scheme 71. One-pot glycosylation of unprotected glycosyl acceptors.245 
 
Synthesis of -(13)-D-galactan oligosaccharides 
 67 
5.2 Synthesis of β-(13)-linked linear hexa- and tetragalactans  
Because of the lack of defined substrates, knowledge of the AGP glycan backbones’ biological functions 
is very limited. It was therefore decided to make a range of linear and branched β-13)-linked galactans 
and test binding of lectins and antibodies with the microarray technology described in section 4.3. 
Novozymes was furthermore interested in β-(13)-linked oligo-saccharides for characterization of new 
glycosidases. 
The strategy for synthesis of β-(13)-linked galactans was very similar to the block strategy described in 
section 4.4. We aimed to prepare a single building block, which could be converted to a disaccharide 
donor. This would lower the number of critical glycosylations in the rest of the synthesis. As described in 
the previous section it is possible to glycosylate the 3-position of galactose even though the 2-position is 
unprotected. The yields were, however, mediocre and it was necessary to protect the 2-position after 
every glycosylation.
245
 Instead, we decided to protect the 2-, 4- and 6-position with permanent protecting 
groups and the 3-position with a temporary protecting group. A pivaloyl group was chosen for the 
2-position since neighboring group participation was necessary to ensure β-selectivity. The pivaloyl 
group furthermore has the advantage that it reduces the risk of orthoester formation, which had been a 
problem in the synthesis by Kováč.244 The 4- and 6-position was protected with a benzylidene acetal, 
which is easily introduced and is sterically small. An acetyl group was chosen for temporary protection of 
the 3-position, since it had previously been selectively removed in presence of the more bulky pivaloyl 
esters.
106
 A retrosynthetic analysis of the synthesis of a linear hexasaccharide is shown in Scheme 72. 
Starting from building block 251, it was possible to make a disaccharide donor 252 by coupling to an 
orthogonal PTFAI donor. The disaccharide could then be used to build the hexasaccharide 253 by three 
glycosylations. 
 
 
Scheme 72. Retrosynthetic analysis of the synthesis of fully protected hexasaccharide 253. 
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5.2.1 Synthesis of disaccharide donor 252 
Thioglycoside 56 was regioselectively acetylated via formation of the stannylene acetal with Bu2SnO 
followed by treatment with AcCl and 4Å molecular sieves (Scheme 73).
249
 The molecular sieves removed 
residual water, but also helped to quench the HCl formed during the reaction. Treatment of 254 with 
PivCl, Et3N and DMAP afforded the fully protected thioglycoside 251 in 88% yield. 
   
Scheme 73. Synthesis of the common building block 251. 
In order to make the PTFAI donor the thioglycoside had to be hydrolyzed. This turned out to be very 
challenging and several reagent combinations were tested before a suitable set was found. The results are 
compiled in Table 7. NBS in acetone/H2O (entry 1) gave rise to hydrolysis of the benzylidene acetal and 
no product was observed. Instead, the glycosyl bromide was formed by titration with bromine followed 
by hydrolysis under basic conditions as described in section 4.4.2 (entry 2). This gave the expected 
product 255, but the reaction was slow and gave rise to several by-products. The corresponding glycosyl 
iodide was expected to be more reactive. However, it was not possible to obtain full conversion of the 
thioglycoside (entry 3). A similar compound had been hydrolyzed with chloramine-T (entry 4) as 
activator but in this case only low conversion was observed.
250
  
There had to be acid present in order for the benzylidene acetal to be hydrolyzed. This could either derive 
from HBr already present in the NBS or it could be formed during the hydrolysis by reaction between 
NBS and water. In entries 5-7 different bases were screened as acid-scavengers. No hydrolysis of the 
benzylidene was observed with triethylamine but instead migration of the pivaloyl resulted in low yields. 
The milder bases, pyridine and 2,6-lutidine, afforded 255 in high yields. The better results observed with 
2,6-lutidine may be explained by its lower tendency to react with the bromonium ion or act as a com-
peting nucleophile. 
 
Table 7. Hydrolysis of benzylidene-protected thioglycoside 251. 
Entry Conditions  Yield (%) 
1 NBS, H2O/MeCN                - 
2 Br2 then TBAB/H2O/MeCN, Et3N  55 
3 I2 then H2O/MeCN  20 
4 Chloramine-T, H2O/MeCN  35 
5 NBS, Et3N, H2O/MeCN  41 
6 NBS, pyridine, H2O/MeCN  75 
7 NBS, 2,6-lutidine, H2O/MeCN 84 
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The selective deacetylation to give acceptor 257 also turned out to be far from simple. The results of the 
experiments are shown in Table 8. It was expected that the acetyl could be removed by Zemplén 
condition without affecting the pivaloyl group just as it had been the case for the chloroacetyl group in 
section 4.9. However, this resulted in extensive migration as well as deprotection of the pivaloyl (entry 1). 
Most likely, the pivaloyl group first migrates to the 3-position, where it is more accessible and is therefore 
cleaved. Lowering the temperature only made the reaction slower but gave a similar outcome (entry 2). 
Decreasing both NaOMe concentration and temperature improved the yield to 59% but this was still far 
from acceptable. Xu et al. had reported that Mg(OMe)2 can be used as a milder alternative to NaOMe 
(entry 4).
251
 In this case no deprotection of the pivaloyl was observed but it did not solve the migration 
problem. The same was the case for the even milder conditions with ammonia in methanol (entry 5).
252
 
All the methods described in entries 1-5 follow the same mechanism. In order to change the conditions 
more drastically, it was attempted to remove the acetal by reduction (entries 6 and 7). DIBAL-H did not 
give rise to migration but deprotection of the pivaloyl was still observed, which had also been reported by 
Nicolaou and co-workers.
232
 On the contrary, the more bulky reducing agent, LiEt3BH (superhydride) 
solved the problem and the product 257 was obtained in excellent yield.
253
 
 
 
Table 8. Optimization of conditions for selective deacetylation. 
Entry Conditions 257 (%*) 258 (%*) 259 (%*) 
1 NaOMe/MeOH (0.1 M), rt 37 35 20 
2 NaOMe/MeOH (0.1 M), 0 °C 40 37 10 
3 NaOMe/MeOH (0.01 M), 0 °C 59 25 11 
4 Mg(OMe)2 (0.1 M), 0 °C 61 32 0 
5 NH3/MeOH 74 15 0 
6 1M DIBAL-H in toluene, CH2Cl2, 0 °C 70 0 22 
7 1M superhydride in THF, CH2Cl2, 0 °C 94 0 0 
*isolated yields 
With access to both donor 256 and acceptor 257, the disaccharide donor 252 was prepared in 92% by a 
TMSOTf-mediated glycosylation (Scheme 74). The disaccharide was converted to an acceptor in two 
steps. NIS/TESOTf-promoted glycosylation of benzyl alcohol with disaccharide 252 gave the β-benzyl 
glycoside 260 in 75% yield. It was crucial to use only a small surplus of benzyl alcohol and to carry out 
the reaction at low temperature, since significant amounts of the α-glycoside were otherwise formed. 
Selective deacetylation with superhydride afforded acceptor 261 in 90% yield. Scale up of the reaction 
resulted in a minor explosion, since triethylborane formed during workup reacted with oxygen and 
ignited. To avoid accidents superhydride was substituted for the more bulky reducing agent, 
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Li(sec-Bu)3BH (L-selectride). This did not affect the yields and the corresponding borane is less volatile 
and therefore less likely to react with oxygen. However, the reductions were generally slower due to the 
increased bulk of the sec-butyl groups. 
 
Scheme 74. Synthesis of disaccharide donor and disaccharide acceptor. 
Condensation of disaccharide acceptor 261 and disaccharide donor 252, promoted by NIS/TESOTf, 
afforded tetrasaccharide 262 in 88% yield. Tetrasaccharide 262 was converted to acceptor 263 by 
reduction with L-selectride. Finally, this was glycosylated with disaccharide donor 252 to give the fully 
protected hexasaccharide in 79% yield.  
 
Scheme 75. Synthesis of -(13)-linked hexasaccharide. 
5.3 Synthesis of branched β-(13)-linked galactans 
As described earlier, the glycan backbone of AGP is decorated by a wide variety of branchings. It is 
therefore likely that proteins bind motifs that include both the backbone and part of the branching. 
Nonetheless, only one group has reported synthesis of well-defined oligosaccharides with both backbone 
and branching.
254
  
We decided to prepare a small library of (16)-branched β-(13)-linked oligosaccharides. In order to 
have a sufficient size for proteins to recognize the oligosaccharide, it was decided to make octa- and 
nonasaccharides. We furthermore aimed to introduce branching at either the third or fifth sugar residue to 
test how the position would affect protein binding and enzymatic degradation. 
The strategy was the same as for the branched β-(14)-linked galactans. Monosaccharide donor 265 with 
a temporary C6-O protecting group was introduced at the branching point and the rest of the backbone 
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was constructed using disaccharide donor 264. After preparation of the linear heptasaccharide 266, the 
temporary protecting was to be removed to give an acceptor, which could be glycosylated with different 
donors. The retrosynthetic strategy is shown in Scheme 76. 
 
Scheme 76. Retrosynthetic analysis for synthesis of heptasaccharide acceptor. R and R’ are orthogonal protecting groups 
5.3.1 Synthesis of donor for introduction of C6-branching 
The monosaccharide donor 265 could be prepared in two steps from thioglycoside 251 (Scheme 77). The 
benzylidene acetal was regioselectively opened with borane-tetrahydrofuran complex and copper(II) 
triflate to afford the free C6-OH 266.
216
 Next, a temporary protecting group had to be found which was 
stable under the glycosylation conditions and during reductive deacetylation. The first choice of 
temporary protecting group was a TIPS ether, which could be introduced with TIPSCl and imidazole in 
DMF to give 267 in 93%.
255
 
 
Scheme 77. Synthesis of potential donors for introduction of branching point. 
Glycosylation of the disaccharide 261 with TIPS donor 267 resulted in several by-products and the 
trisaccharide 268 was only isolated in 38% yield (Scheme 78). The degradation of the donor is most 
likely caused by formation of the corresponding 1,6-anhydrosugar as a result of intramolecular attack 
from the 6-position. Bols and co-workers have previously reported this issue when TBDMS protected 
donors were used.
164
 Deprotection of the acetyl group with L-selectride was effective and the acceptor 
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269 could be isolated in 91% yield but the low glycosylation yield made us look for an alternative 
protective group.  
 
Scheme 78. Glycosylation of disaccharide acceptor 261 with C6-O protected donors. 
Carbonates, like esters, can be cleaved by basic hydrolysis but are normally far less susceptible due to 
resonance stabilization by the second oxygen.
199
 The same trend was expected with regard to reduction. 
The C6-OH of 266 was therefore protected with an Alloc group by reaction with allyl chloroformate and 
TMEDA (Scheme 77).
205
 Coupling of 270 to disaccharide acceptor 261 afforded the trisaccharide 271 in 
74% yield even though minor by-products were observed from reaction between NIS and the Alloc 
alkene. This is problematic since these by-products could also be formed in the following glycosylations. 
Against expectations the reduction with L-selectride was not selective even at low temperatures. The 
difference in lability is probably evened out by the greater accessibility of the 6-position. It was possible 
to obtain selectivity with Mg(OMe)2, but as described in the previous section, this gave rise to migration 
of the pivaloyl group. 
Instead, the TIPS ether was replaced with the less acid-labile TBDPS group to prevent it from acting as an 
internal acceptor. In this case glycosylation of disaccharide 261 with donor 272 gave trisaccharide 273 in 
71% yield. The acetyl group was deprotected with L-selectride to give 274, which was used as acceptor in 
a NIS/TESOTf-mediated glycosylation with donor 252 (Scheme 79). Unfortunately, no conversion of the 
acceptor was observed. The low reactivity is presumably caused by the bulky TBDPS ether that blocks 
the 3-position. 
 
Scheme 79. Unsuccessful glycosylation of TBDPS-protected acceptor 274. 
The final choice of protecting group was an allyl ether. Due to the acyl groups, it was not possible to 
introduce the allyl ether by Williamson ether synthesis. Instead, a method developed by Sinou and 
co-workers was used where allyl groups can be introduced under neutral conditions with ethyl allyl 
carbonate and bis(dibenzylidene-acetone)palladium(0) (Scheme 77).
256
 This made it possible to prepare 
donor 275 in 83% yield. The glycosylation of acceptor 261 with donor 275 turned out to be very slow and 
several by-products were formed. This is probably due to competing reaction of iodonium with the allylic 
alkene. Since iodonium ions seemed to be the problem, different pre-activation methods were instead 
tested. However, glycosylation promoted by 1-benzenesulfinyl piperidine (BSP)/Tf2O,
257
 Ph2SO/Tf2O
258
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or Me2S2/Tf2O
259
 (with or without DTBMP) did not give significantly higher yields (33-65%). 
Me2S2/Tf2O was the most successful. 
5.3.2 Synthesis of chloroacetyl protected building blocks  
Since no suitable orthogonal protecting group could be found, we decided to change the strategy. The 
3-position was instead protected with a chloroacetyl group. This made it possible to use an acetyl group 
for the 6-position, which could be removed by L-selectride reduction at the end of the synthesis.  
The synthesis of the disaccharide donor was very similar to what was previously described. First, the 
chloroacetyl group was regioselectively introduced at the 3-position via the stannylene acetal. The 
preliminary experiments were done with ClAc2O but the liberated ClAcOH seemed to disrupt the 
stannylene acetal and resulted in poor selectivity. When chloroacetyl chloride was used instead, the 
product 278 was obtained in excellent yield (Scheme 80). The 2-position was protected with a pivaloyl 
ester by treatment with PivCl, Et3N, and DMAP to give the fully protected thioglycoside 279. Hydrolysis 
with NBS/H2O/2,6-lutidine followed by treatment with PTFAICl and Cs2CO3 afforded PTFAI donor 280. 
The thioglycoside 279 could furthermore be transformed to the acceptor 281 by deprotection of the 
chloroacetyl group with L-selectride.  
 
Scheme 80. Synthesis of orthogonal PTFA donor and thioglycoside acceptor.  
TMSOTf-catalyzed coupling of donor 280 and acceptor 281 afforded disaccharide donor 283 in 84% 
yield (Scheme 81). It would be unfavorable to have a chloroacetyl in the non-reducing end of the 
heptasaccharide, since it would be removed during reduction of the C6-O-acetyl. Hence, the chloroacetyl 
was exchanged with a pivaloyl to give disaccharide 284 by reduction with L-selectride followed by 
treatment with PivCl, Et3N, and DMAP. Furthermore, the disaccharide donor 283 was converted to 
acceptor 261 by glycosylation of benzyl alcohol to give 285 followed by deprotection of the chloroacetyl 
group with L-selectride.  
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Scheme 81. Synthesis of the three disaccharide building blocks 261, 283 and 284. 
The final building block 286 was prepared by regioselective opening of the benzylidene acetal of 279 
with borane-THF complex and copper(II) triflate followed by acetylation (Scheme 82). 
 
Scheme 82. Synthesis of C6-O-acetyl donor 286. 
5.3.3 Synthesis of heptasaccharides acceptors 
With all the building blocks at hand it was now possible to syntheize the two heptasaccharides. 
Trisaccharide 287 was prepared by NIS/TESOTf-promoted coupling of donor 286 and acceptor 261 
(Scheme 83). The new protecting group combination resulted in decent yields, but it was necessary to use 
1.5 equiv. of donor in order to obtain full conversion of the acceptor. This can be ascribed to degradation 
of the donor because of the primary acetyl or simply that the donor was rather unreactive due to the three 
acyl groups.  
 
Scheme 83. Introduction of branching point. 
Trisaccharide 287 was converted to trisaccharide acceptor 288 by deprotection of the chloroacetyl group 
with thiourea, NaHCO3 and TBAI.
228
 A second NIS/TESOTf-mediated glycosylation of 288 with 
disaccharide donor 283 afforded the pentasaccharide 289 in 80% yield. We were pleased to find that the 
reaction gave fewer by-products and that only 1.2 equiv. of donor was necessary. This confirms that it 
was the donor rather than degradation of the product that caused the problems in the first glycosylation. 
The chloroacetyl group was again removed with thiourea, NaHCO3 and TBAI to give acceptor 290, 
which could be glycosylated with the tripivaloyl donor 284 to give the fully protected heptasaccharide 
291. Finally, the C6-O-acetyl was removed selectively with L-selectride to give the acceptor 292.  
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Scheme 84. Synthesis of heptasaccharide with branching point at 3rd residue. 
The second heptasaccharide was synthesized in the same way. NIS/TESOTf-promoted coupling of 
disaccharide donor 283 and acceptor 261 afforded tetrasaccharide 293 in 79% yield. Deprotection of the 
chloroacetyl group with L-selectride afforded tetrasaccharide acceptor 294, which was coupled to 
monosaccharide donor 286 by a NIS/TESOTf-mediated glycosylation reaction to give the 
pentasaccharide 295 in 69% yield. The chloroacetyl group was removed with thiourea, NaHCO3 and 
TBAI to give pentasaccharide acceptor 296, which could be glycosylated with tripivaloyl donor 284 to 
give the fully protected heptasaccharide 297. Finally, selective deprotection of the acetyl with L-selectride 
afforded the second heptasaccharide acceptor 298. 
 
Scheme 85. Synthesis of heptasaccharide with C6-O-acetyl on the 5th residue. 
5.3.4 Introduction of branchings and global deprotection 
Three different side chains were introduced on each heptasaccharide by glycosylation with the 
thioglycoside donors 186, 299 and 284 shown in Scheme 86. Their synthesis has already been described 
in previous sections. 
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Scheme 86. Thioglycosides used for introduction of branchings. 
All of the glycosylations were promoted by NIS/TESOTf in a 1:1 mixture of CH2Cl2 and MeCN at -30 ºC 
(Scheme 87). The low temperature and use of MeCN was necessary to increase the stereoselectivity. The 
reactions were slow compared to the couplings to the 3-position and full conversion of the acceptor was 
not achieved even with 2 equiv. of donor. Just as for the branched -(14)-linked galactans, the 
reactivity of the C6-OH seems to be reduced due to its position in the middle of the oligosaccharide chain. 
Nonetheless, the two octaasaccharides 300 and 301 and four nonasaccharides 302-305 were all isolated in 
yields above 70%. Unfortunately, compound 302 was lost prior to full characterization and needs to be 
resynthesized. 
 
Scheme 87. Introduction of three different branchings. 
Global deprotection of the linear penta- and heptasaccharide (289 and 291), two branched octasaccharides 
(300 and 301) and three nonasaccharides (303, 304 and 305) was accomplished with the conditions 
described in section 4.9.2 (Scheme 88). Compared to the -(14)-linked galactans, the deprotection of 
the pivaloyl group with Et4NOH was faster and resulted in less by-products. This may be explained by the 
1,2-trans diaxial relationship between -(14)-linked sugars and neighboring hydrogen atoms, which 
makes them more susceptible to -elimination. Unfortunately, the solubility of the partially protected 
(13)-linked galactans in common organic solvents is very low. This resulted in loss of material during 
purification and made the following hydrogenolysis over Pd(OH)2/C very slow (48 h). Even though the 
yields are still acceptable they could have been significantly higher if alternative conditions were found 
for the purification.  
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In conclusion, a strategy for linear and branched -(13)-linked sugars has been developed and applied 
in the synthesis of a small library of AGP glycan fragments. The strategy makes it possible to introduce 
the branching point at different positions in the backbone. This could lead to interesting studies of various 
glycosyl hydrolases’ ability to degrade branched sugars. The glycosylations of the heptasaccharide 
acceptors resulted in high yields and it is likely that larger and less reactive donors could also be used. An 
obvious choice would be to introduce -(16)-linked tetra- and hexagalactans to make structures that 
mimic the AGP glycan to an even higher extent. 
 
Scheme 88. Deprotection of -(13)-oligosaccharid
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6 Synthesis of -(16)-D-galactan oligosaccharides 
The final class of oligosaccharides that we were interested in were the β-(16)-linked galactans. As 
opposed to the other -galactans, linear and branched (16)-linked galactans have been prepared via a 
wide range of strategies. The primary hydroxy group of the 6-position is much more reactive than both 
the 3- and 4-position. The glycosylation reactions are therefore generally more efficient and the protecting 
group manipulations are easier. However, the higher reactivity also exacerbates the stereoselectivity issue 
described in section 5. Thus, careful choice of protecting groups and reaction conditions is critical. Most 
of the published work describes synthesis of fragments AGP-glycan side chains. The references are 
compiled in Table 9. 
Table 9. Published work on synthesis of -(16)-linked galactans. 
Synthetic oligosaccharide fragment Reference 
Trisaccharides  
α-L-Araf-1→3--D-Galp-(1→6)--D-Galp-OMe Valdor & Mackie
260
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-OSE 
fully protected 
Ravindranathan et al.
261
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-OMe 
fully protected 
Kováč262 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-OMe Kováč
263
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-OMe Ziegler et al.
264
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-OMe Srivastava et al.
265
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-OCH2CHOCH2 Nashed & Glaudemans
266
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-OMe Kováč
267
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-OC4H6pNO2 Ekborg et al.
268
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp Bhattacharjee et al.
269
 
Tetrasaccharides  
-D-Galp-(1→6)-[α-L-Araf-1→3]--D-Galp-(1→6)--D-Galp-O(CH2)3NH2 Liang et al.
270
  
-D-Galp-(1→6)--D-Galp-(1→3)--D-Galp-(1→6)-D-Galp              Ning et al.
271
  
-D-Galp-(1→6)--D-Galp-(1→3)--D-Galp-(1→6)--D-Galp-Ser 
fully protected 
Du et al.
272
 
-D-Galp-(1→6)-[α-L-Araf-1→3]--D-Galp-(1→6)--D-Galp-
O(CH2)3NH2 
Fekete et al. 
273
                                                   
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp 
fully protected 
Yang et al.
274
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp 
fully protected 
Huang et al.
275
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-OMe 
fully protected 
Zhu & Kong
276
 
-D-Galp-(1→6)--D-Galp-(1→6)-[α-L-Araf-1→2]--D-Galp-
O(CH2)11CH3 
 
Du et al.
277
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Synthetic oligosaccharide fragment Reference 
[α-L-Araf-1→2]--D-Galp-(1→6)- -D-Galp-(1→6)--D-Galp-
O(CH2)11CO2Me 
Timmers et al.
278
 
-D-Galp-(1→6)-[α-L-Araf-1→2]--D-Galp-(1→6)--D-Galp- 
O(CH2)11CO2Me 
Timmers et al. 
278
 
-D-Galp-(1→6)--D-Galp-(1→6)-[α-L-Araf-1→2]--D-Galp- 
O(CH2)11CO2Me 
Timmers et al. 
278
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-OMe Ziegler et al.
279
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-OMe Nashed & Glaudemans
280
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp- 
OCH2CHOCH2 
Nashed & Glaudemans
266
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-OMe Kováč
267
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-OMe 
fully protected 
Kováč262 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-OPr Srivastava & Schuerch
281
 
α-L-Araf-(1→3)--D-Galp-(1→6)--D-Galp-(1→6)-D-Galp Pan et al.
282
 
-D-Galp-(1→6)--D-Galp-(1→6)-α-L-Araf-(1→3)-D-Galp Pan et al.
282
 
Pentasaccharides  
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)-D-Galp  
fully protected 
Huang et  al.
275
 
-D-Galp-(1→6)-α-L-Araf-(1→5)-α-L-Araf-(1→2)--D-Galp-(1→6)--D-
Galp-OMp 
Zeng et al.
283
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)-D-
Galp 
Miura et al.
284
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6) --D-Galp-(1→6)--D-
Galp-OMe 
Kováč267 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-
Galp-OMe 
fully protected 
Kováč262 
Hexasaccharides  
[α-L-Araf-1→3]--D-Galp-(1→6)- -D-Galp-(1→6)-[α-L-Araf-1→3]--D-
Galp-(1→6)--D-Galp-O(CH2)3NH2 
Fekete et al. 
273
                                                   
-D-Galp-(1→6)-[α-L-Araf-1→3]--D-Galp-(1→6)--D-Galp-(1→6)-[α-L-
Araf-1→2]--D-Galp-OMp 
Li & Kong 
285
 
-D-Galp-(1→6)-[α-L-Araf-1→3]--D-Galp-(1→6)--D-Galp-(1→6)-[α-L-
Araf-1→3]--D-Galp-OMe 
Gu et al.
286
 
-D-Galp-(1→6)-[α-L-Araf-1→3]--D-Galp-(1→6)--D-Galp-(1→6)-[α-L-
Araf-1→2]-D-Galp 
Ning et al.
271
 
-D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-(1→6)--D-
Galp-(1→6)--D-Galp-OMe 
fully protected 
Kováč262 
Heptasaccharides  
-D-Galp-(1→3)-{-D-Galp-(1→6)}4-(1→6)--D-Galp-(1→3)--D-Galp-
OMp 
Li & Kong
254
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Synthetic oligosaccharide fragment Reference 
-D-Galp-(1→3)--D-Galp-(1→3)--D-Galp-(1→3)--D-Galp-(1→6)--D-
Galp-(1→6)--D-Galp-(1→6)--D-Galp-OMe 
Ziegler et al.
279
 
Octasaccharides  
-D-Galp-(1→6)-α-L-Araf-(1→5)-α-L-Araf-(1→2)--D-Galp-(1→6)- -D-
Galp-(1→6)-α-L-Araf-(1→5)-α-L-Araf-(1→2)--D-Galp-OpMP 
Zeng et al.
283
 
-D-Galp-(1→3)-{-D-Galp-(1→6)}5-(1→6)--D-Galp-(1→3)-D-Galp-
OpMP 
Li & Kong 
254
 
-D-Galp-(1→6)-[α-L-Araf-1→2]--D-Galp-(1→6)--D-Galp-(1→6)--D-
Galp-(1→6)-[α-L-Araf-1→3]--D-Galp-(1→6)--D-Galp-OpMP 
Li & Kong 
285
 
-D-Galp-(1→6)-[α-L-Araf-1→2]--D-Galp-(1→6)--D-Galp-(1→6)--D-
Galp-(1→6)-[α-L-Araf-1→2]--D-Galp-(1→6)-D-Galp 
Csávás et al.
287
 
-D-Galp-(1→6)-[α-L-Araf-1→2]--D-Galp-(1→6)--D-Galp-(1→6)-[α-L-
Araf-(1→5)-α-L-Araf-(1→2)]--D-Galp-(1→6)--D-Galp-OpMP 
Li & Kong 
288
 
Nonasaccharides  
-D-Galp-(1→3)-{-D-Galp-(1→6)}6-(1→6)--D-Galp-(1→3)-D-Galp- 
OpMP 
Li & Kong 
254
 
-D-Galp-(1→6)-[α-L-Araf-1→2]--D-Galp-(1→6)--D-Galp-(1→6)--D-
Galp-(1→6)-α-L-Araf-(1→5)-α-L-Araf-(1→2)--D-Galp-(1→6)-D-Galp 
Csávás et al.
287
 
-D-Galp-(1→6)-α-L-Araf-(1→5)-α-L-Araf-(1→2)--D-Galp-(1→6)--D-
Galp-(1→6)--D-Galp-(1→6)-[α-L-Araf-1→2]--D-Galp-(1→6)-D-Galp 
Csávás et al.
287
 
-D-Galp-(1→6)-[α-L-Araf-1→3]--D-Galp-(1→6)--D-Galp-(1→6)--D-
Galp-(1→6)-[α-L-Araf-(1→5)-α-L-Araf-(1→3)]--D-Galp-(1→6)--D-
Galp-OpMP 
Li & Kong 
289
 
-D-Galp-(1→6)-[α-L-Araf-(1→5)-α-L-Araf-(1→3)]--D-Galp-(1→6)--D-
Galp-(1→6)--D-Galp-(1→6)-[α-L-Araf-(1→3)]--D-Galp-(1→6)--D-
Galp-OpMP 
Li & Kong 
289
 
Decasaccharides and larger oligomers  
-D-Galp-(1→3)-{-D-Galp-(1→6)}7-(1→6)--D-Galp-(1→3)-D-Galp- 
OpMP 
Li & Kong 
254
 
-D-Galp-(1→6)-[α-L-Araf-1→3]--D-Galp-(1→6)--D-Galp-(1→6)--D-
Galp-(1→6)-[α-L-Araf-1→3]--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-
(1→6)-[α-L-Araf-1→3]--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-
(1→6)-[α-L-Araf-1→3]--D-Galp-(1→6)--D-Galp-OpMP 
Li & Kong
290
 
-D-Galp-(1→6)-[α-L-Araf-1→3]--D-Galp-(1→6)--D-Galp-(1→6)--D-
Galp-(1→6)-[α-L-Araf-1→2]--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-
(1→6)-[α-L-Araf-1→3]--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-
(1→6)-[α-L-Araf-1→2]--D-Galp-(1→6)--D-Galp-(1→6)--D-Galp-
(1→6)-[α-L-Araf-1→3]--D-Galp-(1→6)--D-Galp-OpMP 
Li & Kong 
285
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6.1 Previous studies of -(16)-linked galactans 
6.1.1 Synthesis of branched icosaose arabinogalactan by block synthesis 
By means of a general synthetic strategy, Kong and co-workers have prepared a range of linear and 
branched arabinogalactans ranging from DP 4-20.
254,283,288–291
 The largest structure is an icosaose 
consisting of a -(16)-linked pentadecasaccharide backbone with arabinofuranose side chains attached 
at C-2 or C-3 of the middle galactose residue of each consecutive -(16)-linked galactotriose unit. The 
strategy was based on synthesis block, which allowed for the consecutive couplings of two 
tetrasaccharide units. Acetyl groups were used as temporary protecting groups of the 6-position whereas 
allyl groups served as orthogonal protecting groups at the branching points.
285
  
The C-3 branched tetrasaccharide building block was prepared starting from thioglycoside 313 (Scheme 
89). Coupling to TCA donor 314 in a TMSOTf-catalyzed glycosylation reaction afforded disaccharide 
donor 315. This was condensed with 4-methoxyphenyl acceptor 316 using NIS/TMSOTf as promoter to 
give trisaccharide 317 in an excellent yield. Subsequent, deallylation and coupling to the perbenzoylated 
TCA donor 319 gave the fully protected tetrasaccharide 320. This could either be converted to donor 321 
via oxidative cleavage of the p-methoxyphenyl group followed by trichloroacetimidate formation or 
turned into acceptor 322 by selective deacetylation under acidic conditions. 
 
Scheme 89. Synthesis of 3-branched tetrasaccharide building block.  
The C2’-branched tetrasaccharide was prepared by a similar method (Scheme 90). TMSOTf-catalyzed 
glycosylation of 4-methoxyphenyl acceptor 323 with diacetyl-protected donor 324 afforded disaccharide 
325 in 89% yield. Deacetylation under acidic conditions gave the diol 326, which after regioselective 
glycosylation of the 6-postion with donor 314 afforded trisaccharide 327. It is remarkable that none of the 
(12)-linked trisaccharide was observed. Now the C2-OH was the only nucleophile and it was possible 
to couple 327 with TCA donor 319 to give tetrasaccharide 328. Finally, oxidative cleavage of the 
methoxyphenyl group followed by trichloroacetimidation gave the tetrasaccharide donor 329. 
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Scheme 90. Synthesis of 2-O-branched tetrasaccharide building block. 
TMSOTf-catalyzed coupling of the two tetrasaccharides followed by selective deacetylation gave the 
octasaccharide acceptor 330 (Scheme 91). This sequence was repeated three times with either donor 321 
or donor 329 to give the icosaose 331. The yields of the glycosylations decrease with the growing size of 
the acceptor but remain over 65% for all coupling. 
 
Scheme 91. Synthesis of 2- and 3-branched icosaose 331.285 
6.1.2 Synthesis of arabinogalactan-type octa- and nonasaccharide 
Lipták and co-workers reported the synthesis of double-branched octa- and nonasaccharides.
287
 The key 
reaction in the strategy was the treatment of -D-galactopyranosyl-(16)-galacto-pyranose with 
2,2-dimethoxypropane in the presence of an acid catalyst. This made it possible to access disaccharide 
332 and 333 in just three steps. The C2’-OH was protected with either a benzyl- or NAP-ether that served 
as acid and base stable orthogonal protective groups. Both can be removed by hydrogenolysis but the 
NAP group can also be cleaved under oxidative conditions with DDQ or CAN. The two disaccharides 
were coupled to glycosyl bromide 334 in a Hg(CN)-2-catalyzed Helferich glycosylation to afford 
trisaccharides 335 and 336 in 58% and 56% yield, respectively (Scheme 92).
292
 The NAP-protected 
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trisaccharide 335 was converted to the corresponding trichloroacetimidate donor 337 in four steps 
whereas protecting group manipulations on 336 gave acceptor 338. TMSOTf-catalyzed coupling of the 
two trisaccharides gave the fully protected hexasaccharide 339 in 59% yield. The orthogonal protecting 
groups at the 2-positions made it possible to prepare all of the three oligosaccharides from this building 
block.  
First, the NAP-ether was removed with DDQ to afford 340, followed by glycosylation with the 
peracetylated TCA donor 341 to give heptasaccharide 342 in 56% yield. Next, hydrogenolysis liberated 
the C2’-OH, which was glycosylated with donor 344 to give nonasaccharide 345. Global deprotection 
was accomplished in two steps by deacetylation under Zemplén conditions followed by mild hydrolysis 
of the isopropylidenes with TFA. The low yield in the final glycosylation results in a low overall yield 
(approx. 1%). It is nonetheless remarkable that molecules of this complexity can be made in just 13 steps 
for the longest linear sequence.  
 
 
Scheme 92. Strategy for synthesis of C2-branched arabinogalactans.287 
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6.1.3 One-pot synthesis of arabinogalactan fragments  
The two routes discussed so far required multiple protection/deprotection steps for elongation of the sugar 
chain, which makes them time consuming. One way to address this problem is to perform several 
glycosylation in a single vessel without intermediate purification also known as one-pot synthesis. This 
approach has received growing attention due to its efficiency in rapid preparation of oligosaccharides. 
Recently, Yang and co-workers reported a one-pot synthesis of a (13)-branched -(16)-linked 
tetrasaccharide 346 (Scheme 93).
270
 The strategy relies on the reactivity difference of the primary and 
secondary hydroxy groups. Starting from the 3,6-dihydroxy thioglycoside 347, it was possible to perform 
a regio- and chemoselective glycosylation of the primary alcohol with TCA donor 348. 
Next, another regioselective coupling of the resulting disaccharide with acceptor 349 gave the 
trisaccharide. Finally, the remaining secondary hydroxy group was glycosylated with thioglycoside 299 to 
give the perbenzoylated tetrasaccharide 346 in 52% yield for three steps. The entire sequence takes less 
than 5 h, which makes it an interesting alternative to existing methods. It should however be mentioned 
that only relatively small oligosaccharides have been made by one-pot strategies so far. The major reason 
being that all glycosylations must be very effective in order to avoid too many deletion sequences.   
 
 
Scheme 93. One-pot four-component synthesis of 3,6-branched arabinogalactosyl glycoside 346.270 
Another problem in one-pot synthesis is the purification of the final product. Due to the many 
manipulations done in a single step, this is often a challenging process that requires time- and solvent-
consuming flash chromatography. Huang and co-workers developed a new methodology to solve this 
problem.
274
 After the one-pot synthesis is done a fluorous tag is used to selectively “catch” the desired 
oligosaccharide. This makes it possible to purify the conjugate by a simple fluorous solid-phase extraction 
(F-SPE). Subsequently, the oligosaccharide is “released” from the fluorous tag that can be removed by a 
second F-SPE purification.   
The methodology was applied in the one-pot synthesis of the linear -(16)-linked tetragalactoside 347 
(Scheme 94). The tetrasaccharide was made by sequential preactivation-based glycosylation of three 
thioglycoside donors using AgOTf/pTolSCl as promoter. After the glycosylations, the reaction mixture 
was treated with the fluorous hydrazide 351 under mild acidic conditions resulting in formation of 
corresponding hydrazone. This made it possible to remove all non-fluorous compounds by F-SPE. 
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Finally, acidic hydrolysis of the hydrazone and another F-SPE column gave the pure tetrasaccharide 347 
in 62% yield over five steps. The 4-hydroxy-2-butanone “handle”, furthermore, has the advantage that it 
can be removed by a retro-Michael reaction under Zemplén conditions to produce the free sugar. The 
entire synthesis and purification took less than three hours. 
 
Scheme 94. Synthesis of linear tetrasaccharide by a fluorous-assisted one-pot strategy.274 
6.2 β-(16)-Linked linear tetra, hexa- and octagalactans  
As described in the previous section, excellent methods already exist for synthesis of -(16)-galactans 
and there is no point in re-inventing the wheel. Nevertheless, we were interested in studying if it would be 
possible to apply the same concept that had been used for the (13)- and (14)-linked galactans. A 
single monosaccharide building block 351 was converted to orthogonal donor 352 and acceptor 353 and 
coupled (Scheme 95). The resulting disaccharide 354 could be turned into an acceptor but was also used 
as donor in the consecutive glycosylations. In this way the synthesis was kept short and was easily scaled 
up. It was decided to use a thioglycoside building block, since aglycon transfer should not be a problem. 
Good results had previously been obtained in the regioselective opening of benzylidene acetals with 
borane-THF complex and copper(II) triflate.[196] A benzylidene acetal was therefore chosen as the 
temporary protecting group. The 2- and 3-positions were protected with pivaloyl esters to get anchimeric 
assistance while avoiding migration and orthoester formation.  
 
Scheme 95. Retrosynthetic analysis of the synthesis of -(16)-linked galactans. 
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6.2.1 Synthesis of tetrasaccharide based on benzylidene protected donor 
The synthesis of the disaccharide donor 354 is outlined in Scheme 96. Starting from the known 
thioglycoside 56, the C2- and C3-OH was protected with pivaloyl esters to give 351. Interestingly, only 
the 3-position was protected, if the reaction was carried out at 22 C with 0.1 equiv. of DMAP. This is 
consistent with reports by Jiang and co-workers, who isolated the same compound after treatment with 
pivaloyl chloride and pyridine.
293
 Complete protection was achieved when the reaction was heated to 
reflux and 0.5 equiv. DMAP was used. Thioglycoside 351 was hydrolyzed with NBS/H2O/2,6-lutidine 
followed by treatment with PTFAICl and Cs2CO3 to give the corresponding PTFAI glycoside 352.
207
 
Thioglycoside 351 was converted to acceptor 353 by regioselective opening of the benzylidene acetal 
with BH3
.
THF and Cu(OTf)2.
216
 Coupling of PTFAI donor 352 and acceptor 353 by TMSOTf-promoted 
glycosylation afforded disaccharide 354 in 91% yield. It was critical to perform the reaction at low 
temperature since formation of the -product was otherwise observed. 
 
Scheme 96. Synthesis of disaccharide donor 354. 
Thioglycoside 354 was converted to an acceptor in two steps (Scheme 97). First, the anomeric center was 
protected with a benzyl group by glycosylation of benzyl alcohol to give 355 in 86% yield. The following 
regioselective opening of the benzylidene acetal turned out to be problematic. The Cu(OTf)2/BH3
.
THF 
combination resulted in significant hydrolysis of the glycosidic linkage and 355 was isolated in only 35% 
yield. Similar results were obtained after treatment with PhBCl2/Et3SiH at -78 ºC.
294
. The best method 
proved to be Bu2BOTf/BH3
.
THF, which afforded disaccharide acceptor 356 in 79% yield.
295,296
 However, 
the reaction still gave rise to hydrolysis and the problem was believed to increase in the following 
benzylidene openings due to the increasing number of glycosidic linkages. It was therefore decided to 
change the strategy. 
 
Scheme 97. Conversion of thioglycoside 354 into disaccharide acceptor 356. 
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The C6-OH of thioglycoside 353 was instead protected with a chloroacetyl group to give thioglycoside 
358 (Scheme 98). Hydrolysis with NBS in wet acetone afforded hemiacetal 359. In this case it was not 
necessary to add a base, which resulted in a faster reaction. The hemiacetal was converted to the PTFAI 
donor 360 by treatment with PTFAICl and Cs2CO3 and coupled to thioglycoside 353 in a 
TMSOTf-promoted glycosylation. The reaction was slow compared to the benzylidene acetal-protected 
PTFAI donor 352, but disaccharide 361 was isolated in similar yield. The reducing end building block 
356 could now be prepared without problems by NIS/TESOTf-mediated glycosylation of benzyl alcohol 
to give 362 followed by deprotection of the chloroacetyl with thiourea, NaHCO3 and TBAI.    
 
Scheme 98. Synthesis of chloroacetyl-protected disaccharide donor 361. 
NIS/TESOTf-promoted glycosylation of disaccharide acceptor 363 with disaccharide donor 361 gave the 
tetrasaccharide 363 in excellent yield (Scheme 99). The chloroacetyl group was removed with thiourea, 
NaHCO3 and TBAI to give acceptor 364 followed by a second NIS/TESOTf-promoted glycosylation with 
donor 361 to give the hexasaccharide 365. A final deprotection and glycosylation afforded the fully 
protected octasaccharide 367. The yield and reaction time were very similar in the three glycosylations. It 
is therefore likely that much longer oligosaccharides can be made with this protecting group combination. 
 
Scheme 99. Synthesis of tetra-, hexa- and octasaccharide 363, 365 and 367.
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In conclusion, we have shown that it is possible to use a general strategy for synthesis of -(13), 
-(14) and -(16)-galactans. As expected, the glycosylations of the primary hydroxy group gave 
significantly higher yields compared to the 3- and 4-position and problems such as aglycon transfer and 
poor stereoselectivity were not observed. One of the advantages in this strategy is that the C4-O-benzyl 
blocks potential acyl migration. This is a problem in many of the published strategies since acyl groups 
have a tendency to migrate towards the 6-position under both acidic and basic conditions.
142
 Branching 
could be easily introduced with the 3-O-NAP protected monosaccharide 204 and since no primary benzyl 
groups are present the selective deprotection should be straightforward. This was, however, outside the 
scope of this project. Likewise, deprotection of the -(16)-linked oligosaccharides was not performed 
before the deadline. 
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7 Applications of synthetic D-galactan oligosaccharides 
A major obstacle in the study of pectin’s glycobiology is the lack of pure and structurally well-defined 
carbohydrates. The complexity of the degradation products and the micro heterogeneity of poly-
saccharides greatly complicate their isolation and characterization from natural sources. The 
oligosaccharides prepared throughout this work can therefore be used to get new, valuable information 
about the pectic structure, biosynthesis and degradation. The synthesis of the complex oligosaccharides 
was not completed until the end of the PhD and therefore only a limited number of substrates have been 
available for the collaborators. Nevertheless, some of the smaller oligosaccharides have already found 
application in three different studies. This section gives a short introduction to some of the results. 
7.1 Pectin Biosynthesis: GALS1 in Arabidopsis thaliana is a -1,4-Galactan -1,4-
Galactosyltransferase 
The first application of the oligosaccharides was performed by H. Scheller and co-workers at Lawrence 
Berkeley National Laboratory, Berkeley, California. They were interested in studying the biosynthesis of 
pectin that involves a range of enzymes (e.g. glycosyl transferases), of which only a few have been 
identified.
297 
The investigation was based on recent finding of a new family of glycosyltranferases, GT92, which acts 
as -(14)-galactosyltransferases in animals. The GT92 protein was reported from pigeons, where they 
catalyze the transfer of -(14)-linked Gal onto -(14)-linked Gal in N-glycan structures.298 All plants 
that have had their genome sequenced contain members of the GT92 family but since plants do not have 
-(14)-linked N-glycans, they are likely to have another role. Tension wood is known to be rich in 
-(14)-galactan and it was therefore decided to study the function of three members of the GT92 family 
in Arabidopsis thaliana. The proteins were designated GALS1, GALS2 and GALS3. Loss-of-function 
mutants in the corresponding genes resulted in decreased -(14)-galactan content, and overexpression 
of GALS1 resulted in plants with 50% higher -(14)-galactan content. These results strongly suggest 
that GALS1 acts as -(14)-synthase.  
For further characterization of the galactosyltransferase activity, it was necessary to determine the 
substrate. It was not possible to isolate pure -(14)-linked galactans from plant sources. Instead, 
galactotriose, -tetraose and –pentaose (130-132) synthesized by the strategy described in section 4.7 were 
studied as acceptors. The protein was heterologously expressed and incubated with the acceptor and 
14
C-labeled uridine diphosphate galactose (UDP-[
14
C]Gal). Purification and analysis by liquid scintillation 
counting showed substantial transfer of Gal onto the galactopentaose but not the other acceptors. The 
activity obtained with FLAG-GALS1 corresponds to more than 50 nmol Gal h
-1
 mg protein
-1
 with 0.34 
mM UDP-Gal (Figure 14A). The specific activity is substantially higher than what has been reported for 
other cell wall–related glycosyltransferases after heterologous expression. TLC analysis demonstrated a 
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ladder of products, with longer incubation times and higher UDP-Gal/acceptor ratios leading to 
increasingly large products (Figure 14B). Interestingly, TLC indicates that the incorporation speed was 
higher for the products than the pentaose acceptor. This suggests that the hexaose, heptaose and octaose 
may be even better substrates for the enzyme.  
It is not clear if the GALS1 enzyme will add the first Gal residues onto the RG-I backbone, but it is 
unlikely due to the very different properties of the acceptor polysaccharide. Most likely, one or two as yet 
unidentified galactosyltransferases are required to initiate the -(14)-galactan side chains. This is 
agreement with GALS1’s lack of activity towards short acceptors. Further studies with the larger 
oligosaccharides discussed in section 4.10 will possibly give more insight to the enzyme specificity and 
potentially lead to activity for the GALS2 and GALS3 enzymes.  
 
Figure 14. A) Activity of GALS1 as a function of acceptor concentration. B) TLC analysis showing the formation of the 
more polar hexa, hepta, octa and nonasaccharide products 
7.2 Distinct substrate specificities of three glycoside hydrolase family 42 β-galactosidases 
from Bifidobacterium longum subsp. infantis ATCC 15697 
Over the last decade, genome sequencing and homology modeling has resulted in discovery of several 
new glycosyl hydrolase families. However, insight into the specificity of individual enzymes with respect 
to substrate monosaccharide composition, glycosidic linkage, and degree of polymerization is lagging. 
Not only is enzyme isolation difficult but in many cases the studies are also precluded by a lack of 
well-defined substrates. The simple oligosaccharides -(14)-galactotriose and -tetraose (section 4.7) 
and -(16)-galactotetraose (see section 6.2) were therefore included in a study performed by A. Viborg 
at the Department of Systems Biology, DTU, Lyngby, Denmark.
299 
Viborg and co-workers were interested in studying glycoside hydrolase family 42 (GH42), which 
includes β-galactosidases catalyzing the release of galactose from the non-reducing end of different β-D-
galactosides. Health-promoting probiotic bifidobacteria, which are important members of the human 
gastrointestinal tract microbiota, produce GH42 enzymes enabling utilization of β-galactosides exerting 
prebiotic effects.
299
 
A) B) 
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Kinetic analysis of natural and synthetic substrates resembling various milk and plant 
galactooligosaccharides made it possible to distinguish the three GH42 members, Bga42A, Bga42B and 
Bga42C, encoded by the probiotic B. longum subsp. infantis ATCC 15697. The results revealed the 
glycosyl residue at subsite +1 and its linkage to the terminal Gal at subsite -1 to be key specificity 
determinants. Bga42A thus prefers the β-(13)-galactosidic linkage from human milk oligosaccharides 
(HMOs) and other β-(13)- and β-(16)-galactosides with glucose or Gal situated at subsite +1. In 
contrast, Bga42B very efficiently hydrolyses (14)-galacto-syllactose (Galβ14Galβ14 Glc) as well 
as 4-galactobiose (Galβ14Gal) and 4-galactotriose (Galβ14Galβ1Gal). The specificity of Bga42C 
resembles that of Bga42B, but the activity was one order of magnitude lower. Based on enzyme kinetics, 
gene organization and phylogenetic analyses, Bga42C is proposed to act in the metabolism of 
arabinogalactan-derived oligosaccharides. Overall, the data illustrate the metabolic adaptation of 
bifidobacteria to the β-galactoside-rich gut niche and emphasize the importance and diversity of 
β-galactoside metabolism in probiotic bifidobacteria.299 
7.3 Determination of LM16-specificity by microarray screening 
One of the main objectives in the project was to prepare a microarray with a range of defined pectic 
oligosaccharide fragments in collaboration with Willats and co-workers. Oligosaccharide fragments of the 
homogalacturonan- and rhamnogalactorunan backbone had previously been prepared and current work in 
the Clausen group also includes synthesis of arabinans.
300,301
 Microarrays make it possible to assess 
hundreds or thousands of molecular interactions simultaneously using minimal amounts of analytes. 
Thus, the arrayed samples could be interrogated by a number of different glycan-binding proteins, ligands 
or enzymes including Gal-3 and monoclonal antibodies. The preliminary studies of the oligogalactans 
were performed on the unprotected oligosaccharides 42-45.  
The system developed by Willats and co-workers was based on probe capture where the oligosaccharides 
are immobilized on a surface and then exposed to probes in solution.
302,303
 Binding of the probes to 
arrayed oligosaccharides is detected by means of a fluorescent or colorimetric tag, usually coupled to an 
antibody. This is analogous to antibody-capture enzyme-linked immunosorbent assays (ELISAs) and 
contrasts with most nucleotide microarrays and some protein microarrays in which the probes are 
immobilized and the substrates added in solution.
302
  
The method relies on non-covalent immobilization on nitrocellulose membranes, which is advantageous 
since the samples can be spotted directly onto the membrane. Unfortunately, non-covalent immobilization 
is generally not effective for oligosaccharides of less than ten sugar residues. In order to overcome this, 
the oligosaccharides were coupled to bovine serum albumin (BSA).
302
 The use of BSA as a carrier 
molecule has the advantage that BSA-based neoglycoproteins are a multifunctional resource that can be 
used not just for microarray production but also as immunogens and as components of other assays, for 
which immobilization is required. However, any coupling procedure that involves modification of 
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reducing ends is likely to interfere with the activity of reducing end-acting probes or enzymes, and this 
may be exacerbated by the large size of the BSA molecule.
304
 
The conjugation of tetrasaccharide 42-45 to BSA was carried out by reductive amination between the 
sugars reducing end residue and the -amino functionality of lysine in BSA. The best results were 
obtained with a procedure by Knox and co-workers, where NaCNBH3 is used as reducing agent in a 
borane/sulphate buffer.
305
 The work-up was done by filtration through centrifugal filter with a cut-off of 
10 kDA. This made it possible to remove unreacted sugar residues and the buffer leaving only the protein 
behind. Based on the starting material, 40-60% of the BSA-conjugate was recovered from the four 
experiments. The products were analyzed by Matrix-Assisted Laser Desorption/Ionization 
Time-Of-Flight (MALDI-TOF), which indicated 7 to 12 sugar residues/BSA molecule.  
 
Figure 15. Binding of mAb LM16 to linear- and branched tetragalactoside-BSA conjugates.  
Microarray printing and binding analysis was performed by Willats and co-workers. The branched 
oligosaccharides 42, 43 and 44 are not known to occur on any plant cell wall polysaccharide and it was 
therefore surprising that mAb LM16 bound strongly to 6’-β-D-galactosyl-(1→4)-β-D-galacto-triose 42 
(Figure 15). LM16 has previously been described to bind an epitope occurring on sugar beet RG-I that is 
generated by arabinofuranosidase treatment and is galactosidase labile.
306
 Sugar beet arabinan side chains 
can in some cases be attached to RG-I backbones via short galactosyl motifs and it is possible that LM16 
recognizes this structure once exposed by arabinofuranosidase.
306
 It has been shown that such short 
galactan stubs can be substituted with ferulic acid at the C6 position but substitution with another sugar 
has not been reported
307
. LM16 does not bind to galactosyl residues per se since it does not bind to linear 
galactan, galactomannan or galactoxyloglucans. The strong binding of LM16 to both structure 42 and 
native sugar beet pectin therefore raises the intriguing possibility of a novel RG I epitope. It will be very 
interesting to test the affinity of LM16 and other mAbs for the larger oligosaccharides fragments.
304
 
The results suggest that the microarray technology is a promising tool for studying protein-glycan 
interactions. It has not been possible to set up a rigid system for screening of Gal-3 affinity due to limited 
access to pure Gal-3. However, we hope that this issue will soon be solved so that the binding affinity of 
defined oligogalactans to Gal-3 can be tested in the near future.
304
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7.4 Co-crystallization of Gal-3 and -(14)-pentagalactoside 
As described in section 3.2, it has been hypothesized that the CRD of Gal-3 is able to accommodate a 
linear tetrasaccharide. If this is the case, oligosaccharides of four or more residues are likely to have 
higher binding affinity than N-acetyllactosamine (LacNAc), which has previously been used as scaffold 
for development of Gal-3 inhibitors. No crystal structures have been published of Gal-3 in complex with 
carbohydrates larger than disaccharides. Since RG-I fragments are believed to be ligands for Gal-3, it was 
decided to crystallize Gal-3 in complex with the linear pentasaccharide 132. This could give valuable 
information about the binding site and guide us in the design of better ligands.  
The protein crystallization and crystallography was performed in collaboration with the Nilsson group 
and SARomics Biostructures in Lund. They had previously solved high-resolution X-ray crystal 
structures of human Gal-3 in complex with a series of LacNAc-conjugates and, consequently, had a great 
expertise in Gal-3 expression and crystallization.  
The co-crystallization turned out to be challenging. Lactose contaminants in the first protein sample 
occupied the binding site and thereby precluded co-crystallization with the ligand. However, use of a 
lactose-free batch of protein and a higher ligand concentration made it possible to obtain a crystal 
structure of Gal-3 in complex with pentasaccharide 132 at 1.4 Å resolution. A cartoon- and surface model 
of the structure is shown in Figure 16A-C. Contrary to expectations, Gal-3 only binds two of the five 
galactose residues. The remaining residues are too flexible to be observed. Moreover, the second residue 
appears to have a lower occupancy than the first one. Since the first residue has full occupancy and there 
is presumably no hydrolysis of the ligand, this means that the second residue has other conformations. 
Given that the binding site has really evolved to bind glucose in the second site, it is perhaps not 
surprising that galactose binds with lower affinity. Important interactions observed between the C3-O of 
glucose and Arg162/Glu184 seem to be lost, and a water molecule binds there instead (Figure 16D). 
Nonetheless, it is surprising that the pentasaccharide does not occupy subsite A and B. 
The results suggest, that the general view of Gal-3’s carbohydrate recognition domain as a multi-sugar 
binding site should be subject to revision. Even though the binding of the -(14)-linked galactan seems 
to be poor it does not exclude it as a potential ligand of Gal-3. As described in section 3.2 Gal-3 is able to 
form oligomers and binding to several digalactan motifs could therefore result in a significantly higher 
total binding affinity.
308
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Figure 16. A) and B) Cartoon representations of Galectin-3 in complex with -(14)-linked pentagalactoside 132             
C) Surface model of Galectin-3 showing binding pocket D) Close-up of the binding pocket showing the polar connections 
to the ligand.
 
  
A) B) 
C) D) 
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8 Tunicamycin analogues as glycosyltransferase inhibitors 
8.1 Project background 
Disease-causing microbes that have become resistant to drug therapy are an increasing public health 
problem. Until recently, research and development efforts have provided new drugs in time to treat 
bacteria that became resistant to older antibiotics. However, the development of new antimicrobial agents 
has slowed dramatically and we may face the prospect of a future, where we have far fewer options in the 
treatment of infectious diseases. This may lead to a scenario, where simple surgeries may be life 
threatening due to routine infections.  
One of the reasons for the decline in new antibiotics is the challenge of developing new drug scaffolds. 
This requires huge libraries of compounds with great diversity and a reliable screening setup. A much 
simpler approach would be to alter a naturally occurring antibiotic and thereby change its activity or 
selectivity. In this way it may be possible to develop new, potent drugs with a minimum of resources. 
Tunicamycin was first isolated in 1971 by Takatsuki et al. from Streptomyces lysosuperificus following 
the screening of over 4000 Actinomycetes strains for antibiotic activity.
309
 Its structure was subsequently 
solved and it emerged that Tunicamycin was present as a mixture of closely related nucleoside antibiotics 
(Figure 17).
310
 The core structure of the Tunicamycin family members is highly unusual. It comprises a 
unique eleven-carbon dialdose termed tunicamine that resembles ribose and 6-deoxy-galactosamine 
residues linked tail-to-tail through a C-C bond. At one end of the pseudo disaccharide is an 
N-glycosidically linked uracil group and at the other an N-acetyl-D-glucosamine (GlcNAc) residue 
attached through a non-reducing α,β-1,1 glycosidic bond – also referred to as an α,β-trehalose linkage.311 
The diversity of the Tunicamycin family derives from the nature of the acyl chain attached to the core 
through the tunicamine nitrogen.
312
 
 
Figure 17. Structure of Tunicamycin. 
The Tunicamycins act as non-hydrolysable analogues of UDP-GlcNAc, and together with their fatty acyl 
chains they most likely functions as bi-substrate transition-state mimics. This make them exhibit 
extraordinary properties as tightly binding and highly specific glycosyltransferase inhibitors. Their 
antibiotic activity arises from their ability to block the biosynthesis of peptidoglycan. They do so by 
inhibition of the membrane protein MraY, which is responsible for the formation of the key 
peptidoglycan precursor undecaprenyl-pyrophosphoryl-N-acetyl-muramoyl pentapeptide (lipid I) (Figure 
18).
313
 Even though Tunicamycins have great antibiotic properties, they have never been used clinically. 
This is due to cytotoxicity against mammalian cells associated with their inhibition of eukaryotic 
UDP-GlcNAc:dolichol-P GlcNAc-1-P transferase (GPT), which is involved in the first step of protein 
N-glycosylation.
314
 By tailoring the terminal GlcNAc moiety of Tunicamycin to more closely resemble 
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the native muramic acid (MurNAc) substrate of MraY, a greater selectivity for MraY over GPT might be 
achieved. This has the potential to provide a novel therapeutic antibiotic with a mode of action orthogonal 
to those of existing drugs and thus helping to combat emerging antibiotic-resistance in bacteria.  Based on 
the structure of the peptidoglycan precursor the compound shown in Figure 18 would be the best inhibitor 
and is therefore the main focus of this project. A broader range of Tunicamycin analogues was, however, 
also pursued, since this could give rise to compounds with other interesting properties. For example 
replacement of the GlcNAc residue with other carbohydrates could change the analogues specificity into 
targeting a range of physiologically important glycosyl transferase enzymes. 
 
Figure 18. Lipid I biosynthesis and the target Tunicamycin analogue.  
8.2 Synthetic strategy 
The essential substrate in the synthesis of analogues is the tunicaminyl uracil 368 (Scheme 100). It 
possesses the core of the parent natural product and can be functionalized with a variety of subunits. A 
number of synthetic routes to tunicaminyl uracil derivatives have been developed, but they are all lengthy 
and result in low yields.
311,315,316,317
 A far more economical route to this intermediate is through 
degradation of native Tunicamycins 369 followed by protection and glycosylation. It has previously been 
shown in the Davis group that tunicamycins can be isolated in preparative quantities in pure form from 
fermentation broths of S. chartreusis.
313
 This is in contrast to other natural products, which are often 
produced by organisms that are extremely difficult to culture or grow very slowly. Acidic hydrolysis of 
the N-acyl chain and GlcNAc followed by acetylation and selective anomeric deprotection should give 
the glycosyl acceptor 368. Finally, glycosylation, selective deprotection, peptide coupling and global 
deprotection should give the target compound 370. As seen in Scheme 100, the N-acyl chain is not re-
installed in order to simplify the synthesis. This may result in lowered permeability of the cell membrane 
resulting in lower activity. 
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Scheme 100. Retrosynthetic analysis of the target structure. 
8.3 Preparative scale isolation of Tunicamycin 
Preparative scale isolation of tunicamycins was based on a procedure described by Wyszyński but several 
factors were varied to improve the yield. The results are compiled in Table 10.
313
 In the original procedure 
the S. chartreusis culture was grown for 6-8 days at 28 °C. However, it was shown that a growth period 
of eight days is essential. On the contrary, higher temperature, higher glucose concentration, or lower 
oxygen levels only stunted the bacterial growth.  
Table 10. Preparative scale isolation of Tunicamycins. 
Entry 
Modification to the 
original procedure 
Crude yield 
(mg) 
Purity 
(%) 
mg/L 
media 
1 6 day growth 618 24 12.4 
2 8 day growth 1080 38 34.2 
3 
Temperatures up to 
42 °C during period 
820 34 23.2 
4 Additional glucose 1011 33 27.8 
5 
1.5L media/2 L 
conical flask 
880 30 14.7 
6 
Same as entry 2 but 
16 L culture 
1408-1730 35-41 36.1-38 
 
The tunicamycins are found both in the supernatant and inside the cells, but by taking advantage of their 
hydrophobicity, a rather short work-up allows high recovery. The tunicamycins were extracted from the 
supernatant using Amberlite XAD-16 resin, which has a high affinity for lipids. Liberation from the resin 
followed by precipitation from 1 M HCl gave rise to highly enriched samples. The mycelium cake was 
treated with 1 M HCl in order to break the cells and remove cellular debris and then extracted with 
MeOH. The combined tunicamycin extracts were finally purified by recrystallization. The purity was 
determined by high-pressure liquid chromatography (HPLC) using a standard curve based on a 
commercial tunicamycin sample (Figure 19).  
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Figure 19. Example of HPLC chromatograms of a range of tunicamycin concentrations. 
8.4 Degradation of tunicamycins 
The degradation of tunicamycins was carried out according to a procedure by Myers et al.
315
 They 
reported that a sample of tunicamycins could be heated to reflux in 3 M HCl followed by acetylation of 
the crude mixture to give heptaacetyl-tunicaminyl uracil in 30% yield. A similar method for cleaving of 
the tunicamycins’ N-acyl and terminal GlcNAc moieties was described by Tamura, although no yields 
were reported.
318
 As such, tunicamycins isolated from S. chartreusis cultures were refluxed in 3 M HCl, 
concentrated, and acetylated with Ac2O in pyridine to give heptaacetyl-tunicaminyl uracil 371 as an 
α/β-mixture (Scheme 101). The yields ranged between 31% and 37%. Interestingly, the compound has a 
distinct red color when visualized with H2SO4-stain compared to the brown color of GlcNAc and other 
sugars.  
 
Scheme 101. Degradation of tunicamycins. 
The relatively low yield in this reaction makes it a bottleneck in the synthesis of tunicamycin analogues. 
The harsh conditions gave rise to a range of by-products and the reaction was hard to monitor. It has been 
reported that 2 M TFA at 120 °C results in cleaner degradation of polysaccharides.
319
 After acetylation 
and purification these conditions resulted in a product with the same Rf in much higher yields (59%). 
However, NMR of the product did not match the product of the HCl treatment. This may be explained by 
opening of the uracil ring.  
8.4.1 Selective deprotection of the anomeric acetyl group   
The final step in the synthesis of the acceptor was selective deprotection of the anomeric acetyl group. To 
avoid wasting tunicaminyl uracil 371, a series of test reactions were performed using peracetylated 
GlcNAc 372 as a model substrate. The synthesis of tetraacetate 372 and the results of the deprotection are 
shown in Table 11. 
 
10: 0 μg/mL 
9: 2,5 μg/mL 
8: 5 μg/mL 
7: 10 μg/mL 
6: 25 μg/mL 
5: 50 μg/mL 
4: 100 μg/mL 
3: 250 μg/mL 
2: 500 μg/mL 
1: 1250 μg/mL 
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Table 11. Synthesis and anomeric deprotection of GlcNAc. 
Entry Reagents Reaction time Yield 
1 Hydrazine acetate (55 °C)
 
4 h 75% 
2 MeOH over 4 Å MS 2 h 82% 
3 Ethylenediamine, AcOH 24 h 80% 
4 Benzyl amine 12 h 64% 
 
Hydrazine acetate,
320
 MeOH over 4 Å MS,
321
 and ethylenediamine acetate
322
 all gave very similar results, 
whereas benzyl amine
323
 was less attractive. MeOH over 4 Å MS was by far the fastest reaction (2 h), but 
also gave rise to substantial deacetylation of the 6-postion. It had previously been reported in the group 
that prolonged treatment of heptaacetyl-tunicaminyl uracil with hydrazine acetate had resulted in almost 
complete degradation. The milder conditions used in the deprotection with ethylenediamine therefore 
seemed more appealing. When the reaction was performed with heptaacetyl-tunicaminyl uracil as 
substrate, only 50% conversion was observed (Scheme 102). NMR analysis showed that almost only the 
β-anomer had reacted. The hexaacetate could be isolated in 39% yield together with 46% of the starting 
material. 
 
Scheme 102. Selective anomeric deprotection of heptaacetyl tuncaminyl uracil. 
The hexaacetate 374 exist as a single stereoisomer and judging from the coupling constant of H-1, it is the 
-anomer (Figure 20). This may be problematic in the following glycosylations, since the glycosidic 
linkage has to be ,-linked. The strong preference for the -conformation is most likely attributed to the 
solvent polarity of CDCl3. A more polar solvent such as MeCN is likely to favor the -conformation.
324
 
 
Figure 20. 1H-NMR spectra of compound 374. 
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8.5 Synthesis of MurNac and Gal glycosyl donors 
With the acceptor in hand a suitable donor had to be synthesized. As discussed in the introduction, the 
peptidoglycan layer in the bacterial cell wall is made up by linear chains of two alternating amino sugars, 
namely N-acetyl glucosamine and N-acetyl muramic acid (MurNAc).
325
 Since the muramic acid residue is 
not found in mammalian cells as opposed to GlcNAc, it was hypothesized that exchanging the GlcNAc in 
tunicamycin for a MurNAc or MurNAc pentapeptide could result in tunicamycin analogues specific 
towards bacterial cells. We also wanted to introduce a simple carbohydrate to see which effects this 
would have on activity and specificity. This would furthermore make the glycosylation simpler compared 
to the rather complex MurNAc donor. D-Galactose was chosen and α- and β-selective donors were 
synthesized.  
The glycosylation of hexaacetyl-tunicaminyl uracil is very challenging. Not only is the acceptor very 
electron-poor due to the many acetyl groups. The glycosidic linkage formed is also a trehalose bond, 
giving rise to four possible isomers.  Hence, only two groups have managed to prepare it and only in low 
yields (21%) using a glycosyl chloride and glycosyl bromide as donors.
316
 It is therefore crucial to choose 
the right set of protecting- and leaving groups.  
Thioglycoside donors were chosen, since they are stable, often crystalline solids that can be activated 
under selective and mild conditions. Furthermore, thioglycosides can be converted into other glycosyl 
donors such as glycosyl halides and imidates, which is useful in case the coupling reaction proves to be 
prohibitively slow. Based on good results using N-phenyl trifluoroacetimidates for difficult couplings, it 
was decided to make the corresponding imidate in the D-galactose series. This would make it possible to 
compare thioglycosides and glycosyl imidates performance in the glycosylation of a model substrate. 
 
Figure 21. Target MurNAc donor. 
The amino functionality was protected as a phthalimide (NPhth), since 2-acetylamino-2-deoxy sugars are 
known to be poor donors due to formation of a stable oxazoline.
142
 The phthalimide also has the 
advantage that it gives rise to β-selective glycosylations due to neighboring group participation142. In 
order to avoid interference from the carboxylic acid, this was also protected with a benzyl group. The 4- 
and 6-position were protected with either acetyl- or benzyl groups. This gives rise to a disarmed and an 
armed donor. The target donors 375 and 376 are shown in Figure 21. The D-galactose donors were also 
protected with benzyl groups as permanent protecting groups and both a -direting and -directing set of 
donors (33, 377, 378, 379) were prepared (Figure 22).  
 
Figure 22. Target D-galactose donors. 
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8.5.1 -Directing muramic acid donor 
The synthesis of the MurNAc building block is shown in Scheme 103. Thioglycoside 382 was prepared 
according to work by Hernandez-Torres et al.
326
 Commercially available glucosamine hydrochloride was 
neutralized with NaOMe and then treated with phthalic anhydride and Et3N in a one-pot procedure to 
form the phthalamate intermediate. The crude product was acetylated with Ac2O/pyridine, which also 
closed the phthalimide ring to give the tetraacetate 380 in 77% yield as an 8:1 mixture of anomers after 
recrystallization.    
 
Scheme 103. First synthesis of the MurNAc donor. 
The anomeric mixture of glycosyl tetraacetates 380 was most efficiently converted to thiophenyl 
glycoside 381 using PhSH and TMSOTf. The less expensive BF3
.
OEt2 resulted in longer reaction times 
and partial decomposition. The acetyl groups were removed via transesterification under Zemplén 
conditions. Careful control of the temperature was important, since the reaction did not proceed at an 
appreciable rate under -20 °C and partial cleavage of the phthalimide was observed at temperatures above 
0 °C. The crude product was treated with p-anisaldehyde dimethylacetal and a catalytic amount of CSA in 
refluxing MeCN to afford the 4-methoxybenzylidene protected carbohydrate 382. Next, the lactic acid 
moiety was introduced via an alkylation. This proved difficult and optimization had to be done. The 
results are shown in Table 12.  
 
 
Table 12. Optimization of alkylation of compound 383. 
Entry Electrophile 
Equiv. of 
electrophile 
Solvent 
Temp. 
(°C) 
Yield 
(%) 
1 385 2 DMF 25 20 
2 385 5 DMF 25 35 
3 385 5 THF 25 42 
4 385 5 THF 0 >10 
5 386 5 DMF 25 >10 
6 386 5 THF 0 86 
7 386 2 THF 0 88 
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The lactyl side chain is usually introduced as the free carboxylic acid followed by protection (most 
commonly as the methyl ester).
327,328,329
 In order to make the synthesis more convergent, the commercially 
available (S)-2-bromopropanoic acid was first esterified with benzyl alcohol to give 385 (Scheme 104).  
 
Scheme 104. Synthesis of benzyl (S)-2-bromolactate. 
Alkylation of thioglycoside 382 using 385 as electrophile and NaH as base gave rise to a range of 
by-products and muramic acid analogue 383 was only obtained in 35% yield. Changing reaction 
temperature, amount of reagent and solvent did not improve the yield to a great extent. The low yields 
were caused by competing transesterification and phthalimide opening. Furthermore, the undesired 
diastereoisomer could be formed if the reaction did not follow the SN2 mechanism. It was postulated that 
a better electrophile could solve the problem. The corresponding triflate 386 was prepared in two steps 
from the cheap starting material ethyl L-lactate via a iron(III)acetylacetone-catalyzed (Fe(acac)3) 
transesterification to give 387 followed by formation of the triflate 386 using Tf2O in pyridine/CH2Cl2 
(Scheme 105).
330,331
 At first 2,6-lutidine was used, but it was later avoided due to problems in the 
purification. The first experiment with 386 as electrophile was done in DMF and once again gave poor 
results. However, it was found that excellent yield (entry 6) could be obtained in THF at 0 °C and that the 
amount of electrophile could be reduced to 2 equivalents (entry 7).  
 
Scheme 105. Synthesis of benzyl (S)-2-triflatelactate 386. 
Judging from the NMR, thioglycoside 383 was not a single compound but rather a 3:1 mixture of two 
compounds. It was first believed, that this was two diastereoisomers resulting from an SN1 attack that 
were just inseparable. The acetal was hydrolyzed with MeOH/CSA in order to see, if they could be 
separated at this point. Interestingly, this gave the diol 384 in 92% yield as a single compound based on 
NMR. The 3:1 mixture is therefore most likely due to a rotamer system rather than two diastereoisomers. 
Acetylation of diol 384 with Ac2O, Et3N and DMAP afforded target donor 376 in 96% yield. The final 
benzylation on the other hand gave rise to problems. Under basic conditions the benzyl lactate was 
attacked by the C4-OH to form a cyclic intermediate, which render alkylation under basic conditions 
impossible. Instead, alkylation with BnBr, Ag2O and KI was done.
332
 This gave the product 375, but only 
in 40% yield and with an inseparable by-product present. 
Based on literature reports, cyclization could also be a problem after deprotection of the amine.
329
 This 
would be necessary in order to prepare the azide. Hence, it was decided to modify the strategy to allow 
introduction of the lactate as the final step (Scheme 106). An allyl group was introduced at the 3-position 
using allyl bromide and NaH to give 388 in 79% yield. The acetal was hydrolyzed with MeOH/CSA to 
give the diol 389 in 94% yield followed by benzylation to give 390 in 97% yield. THF again turned out to 
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be the solvent of choice, since use of DMF resulted in almost complete opening and benzylation of the 
phthalimide.  
 
Scheme 106. Synthesis of armed -directing MurNAc donor. 
The common reagent for allyl deprotection is PdCl2, but this was avoided, since sulfur has been reported 
to poison palladium catalysts. Instead, a procedure using n-BuLi and Wilkinson’s catalyst (RhCl(PPh3)3) 
was used to isomerize the allyl group.
301,333
 The isomerization product was observed, however, the 
reaction did not go to completion, even when 20 mol% of the catalyst was used. Instead, the iridium 
catalyst, Ir(COD)[PCH3(C6H5)2]PF6 and H2, was used.
334
 This resulted in complete isomerization with 
only 6 mol% catalyst after 2 h. The resulting 1-propenyl ether was cleaved with methanol in the presence 
of Amberlite-120 H
+
 resin to give 391 in excellent yield. 
The final alkylation was done using the optimal conditions developed in the synthesis of 383 (Scheme 
107). Unfortunately, no reaction was observed at 0 °C and when the reaction mixture was heated to 22 °C 
several by-products were formed. Hence, the MurNAc donor 375 was only obtained in 21% yield with 
several inseparable impurities. The benzyl groups seem to be more bulky than the acetal, which makes the 
alkylation slow. The competing opening of the phthalimide therefore becomes the dominant pathway. In 
the future, the phthalimide should be substituted with a less base-labile alternative.  
 
Scheme 107. Problems in the alkylation of the hindered 3-position. 
8.5.2 -Directing MurNAc donors 
The UDP-MurNAc pentapeptide is -linked. It was therefore decided to make a set of donors with a 
non-participating protecting group in the 2-position. An azide functionality was chosen, since it is stable 
towards most protecting group manipulations and glycosylations. Moreover, it can be cleaved under mild 
conditions by hydrogenolysis or reduction with phosphines.
335,336
 
As opposed to the phthalimide protecting group, the azide is stable towards basic conditions. It was 
therefore decided to follow the same strategy as described in Scheme 106, where the lactate is introduced 
as the final step. The first part of the synthesis is shown in Scheme 108. The triol was protected by 
treatment with benzaldehyde dimethyl acetal and CSA to afford benzylidene acetal-protected 
thioglycoside 392. Next, the phthalimide was deprotected with ethylenediamine to give the free amine 
393. This was selectively protected via diazotransfer with triflic azide and DMAP according to a 
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procedure developed by Konradsson and co-workers to afford the azide 394.
337
 An alternative procedure 
by Zhang and Ye was tested in an effort to reduce the amount of the toxic reagents NaN3 and Tf2O.
338
 
However, this resulted in lower yields and a troublesome purification. 
 
Scheme 108. Introduction of azide protecting group. 
It is not possible to selectively remove benzyl ethers in the presence of an azide. This precluded the use of 
the triflate 386 for introduction of the lactate moiety. Moreover, the base-labile uracil ring in the target 
molecule rules out simple alkyl esters. It was therefore decided to protect the carboxylic acid with an allyl 
group. Compound 394 was treated with (S)-(−)-2-bromopropionic acid and NaH to give the free carboxyl 
acid 395 (Scheme 109). This was converted to the corresponding allyl ester 396 by treatment with allyl 
bromide and DBU.  
The allyl ester turned out to be a poor choice of protecting group, since it precluded conversion of 396 to 
the corresponding PTFAI donor. Hydrolysis of the thioglycoside with NBS/H2O or NIS/H2O resulted in 
conversion of the alkene to a halohydrin. As an alternative, preactivation with Me2S2/Tf2O, followed by 
hydrolysis was tried, but this only resulted in decomposition.  
 
Scheme 109. Synthesis of thioglycoside 396 and failed attempt of hydrolysis. 
Benzylidene acetals have been shown to significantly lower the reactivity of glycosyl donors due to 
torsional strain. It was therefore decided to replace the benzylidene acetal for two benzyl ethers (Scheme 
110). The C3-OH was protected with an allyl group followed by hydrolysis of the benzylidene acetal with 
ethanethiol and p-TSA to give 398. The use of ethanethiol resulted in significantly higher yields 
compared to other classic methods such as 60% aq. AcOH or 1,3-propandiol/p-TSA.
217
 Benzylation of the 
diol 398 resulted in formation of thioglycoside 399 in an excellent yield.  
 
Scheme 110. Towards synthesis of armed -directing MurNAc donor. 
The two final steps were to removed the allyl ether and introduce a lactate moiety. However, no 
isomerization was observed when 399 was treated with Ir(COD)[PCH3(C6H5)2]PF6 and H2. Several other 
conditions were tried including tert-BuOK/DMSO,
339
 H2Ru(PPh3)4,
229
 and RhCl(PPh3)3,
340
 but they only 
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resulted in decomposition of the starting material or no reaction. It had been possible to remove allyl 
ethers in presence of a phthalimide group, but not an azide. This could indicate that concomitant 
reduction of the azide or coordination to the catalyst causes the problem. Instead, it was decided to 
introduce the azide as one of the final steps, after the allyl group had been removed. This is also 
advantageous since both the - and -directing donors can be made from one synthetic sequence (Scheme 
111).  
Starting from the thioglycoside 392, the 3-position was protected by an allyl group to give the fully 
protected thioglycoside 400. The benzylidene acetal was hydrolyzed with ethanethiol and p-TSA and the 
resulting diol 389 was benzylated to afford 390. Finally, the allyl ether was cleaved via isomerization 
catalyzed by iridium complex followed by acidic hydrolysis to give 391.  
 
Scheme 111. Alternative synthesis of MurNAc building block. 
Deprotection of the phthalimide followed by diazotransfer afforded the azide 402 (Scheme 112). Next, 
the lactate moiety was introduced as the carboxylic acid by alkylation with (S)-(−)-2-bromopropionic acid 
and NaH to give 403. As a consequence of the many problems with allyl ethers, it was decided to use a 
different protecting group. A range of protecting groups has been developed for carboxylic acids but the 
selection is limited by the many different functionalities in the final molecule. Thus, the protecting group 
should be orthogonal to acetyl groups, benzyl ethers, azides, alkenes and glycosylation conditions. The 
trimethylsilylethyl (TMSE) group was found to meet all these criteria, since it can be removed with a 
fluoride source such as TBAF or tris(dimethylamino)sulfonium difluorotrimethylsilicate (TAS-F) under 
neutral conditions.
341,342
 The protecting group was introduced using with 2-trimethylsilylethanol, 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCl) and DMAP to afford 404. As opposed to the 
allyl ester this was easily converted to PTFAI donor 406 by hydrolysis with NBS/H2O followed by 
treatment with PTFAICl and Cs2CO3. 
 
Scheme 112. Final steps in the synthesis of an armed MurNAc donor.  
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8.5.3 D-Galactose donors 
Synthesis of the α-selective pair of galactose donors is shown in Scheme 113. The perbenzylated 
thioglycoside 33 was prepared according to the procedure described in section 4.3.
343
 Thiogly-coside 33 
could be converted into the corresponding N-phenyl trifluoroacetimidate over two steps.
344
 Hydrolysis 
with NBS/H2O afforded the lactol 407 and next the imidate functionality was introduced with PTFAICl in 
presence of Cs2CO3 to give the imidate 408.  
 
Scheme 113. α-Selective galactose donors. 
The β-directing galactose donors had an acetyl group in the 2-position that provides anchimeric 
assistance. The rest of the hydroxyl-groups were protected with arming benzyl groups. The synthesis is 
outlined in and is based on literature procedures (Scheme 114).
345,346
  
 
Scheme 114. β-Selective galactose donors. 
Galactose pentaacetate was treated with 33% HBr/AcOH to give the glycosyl bromide which upon reflux 
in collidine in presence of TBAB and ethanol gave the ethyl orthoester 409. The acetyl groups were 
exchanged with benzyl groups to afford 410 after which the orthoester was opened and acetylated to give 
411 in 82% yield over six steps. The acetate 411 could be turned into both thioglycoside 412 in 71% yield 
by treatment with thiophenol and BF3
.
OEt2 or into the free hemiacetal 413 in 66% yield via reaction with 
benzyl amine. This could be converted to PTFAI donor 414 by treatment with PTFAICl and Cs2CO3. 
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8.6 Glycosylation experiments 
8.6.1 Test glycosylations to GlcNAc hemiacetal 
The next step was to perform the final glycosylation. Since the amount of tunicaminyl uracil was limited, 
it was decided to screen different donors and reaction conditions against a test substrate (Scheme 115). 
The hemiacetal 373 was chosen due to its high similarity to the tunicaminyl uracil. Furthermore, it had the 
advantage that Dragendorff TLC stain could be used to selectively visualize any products containing a 
N-acetyl due to its preference for amides. 
 
Scheme 115. Test glycosylations for synthesis of trehalose linkage. 
Glycosylation with thioglycoside 33 using NIS/TESOTf as promoter only resulted in slow degradation of 
the thioglycoside. The temperature was raised from -30 ºC to 0 ºC to increase the reactivity of the 
acceptor, but this just resulted in faster hydrolysis of the donor. Furthermore, a by-product was formed 
which appeared to be (11)-digalactan formed by glycosylation of the hydrolyzed donor. A similar 
outcome was obtained when the “super armed” thioglycoside 412 was used.347 In this case, a second 
by-product appeared due to hydrolysis, migration of the acetyl, followed by glycosylation to give the 
(12)-linked digalactan. It was postulated that the high reactivity of the electron-rich donors 33 and 412 
made them degrade, before the unreactive acceptor had a chance to react. A less reactive donor could 
therefore be a better match.  However, AgOTf-promoted glycosylation with the electron-poor glycosyl 
bromide 334 once again only resulted in decomposition of the donor. 
 
Scheme 116. Successful formation of the mixed trehalose 415. 
PTFAI donors have previously been used for couplings to very unreactive acceptors. When the imidate 
408 was used as donor with TMSOTf as promoter, the product 415 was formed in 25% yield (Scheme 
116). Further optimization increased the yield to 61%. It was found to be crucial to add 4 Å MS and to 
conduct the reaction at 0 ºC. At lower temperatures no product was formed and the donor slowly 
degraded. The “super armed” imidate 414, on the other hand, only resulted in by-product formation even 
with the optimized conditions. The conversion of the donor was much faster, which can be explained by 
rapid formation of the acetoxonium ion. Finally, the perbenzoylated imidate donor 188 was tested to see 
if lowered reactivity would be beneficial (Scheme 117). This did not result in the expected product, but 
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instead the orthoester was formed in 64% yield. This was still a promising result, since it should be 
possible to rearrange the orthoester into the product under acid conditions. 
 
Scheme 117. Orthoester formation under coupling of 188 and 373. 
8.6.2 Glycosylations to tunicaminyl uracil hemiacetal 
Having shown that it was possible to glycosylate the unreactive hemiacetal 373, we turned the focus 
towards couplings to the tunicaminyl acceptor 374. Based on the results from the test experiments, it was 
decided to use PTFAI donors and to conduct the reactions at the optimized conditions used for acceptor 
373. Four different donors were chosen: An - and -directing galactose donor and an - and -directing 
muramic acid donor (Scheme 118). 
 
Scheme 118. Glycosylation of tunicaminyl uracil 374 with various donors. 
Coupling with perbenzoylated imidate 188 with 0.3 equiv. TMSOTf to avoid orthoester formation only 
resulted in slow degradation of the donor. The amount of promoter was lowered to 0.1 equiv. in an 
attempt to form the orthoester, but the outcome was the same. 
Glycosylation between imidate 405 and the tunicaminyl acceptor 374, on the other hand, resulted in full 
conversion of the acceptor and formation of a product in 65% yield. Preliminary characterization by 
NMR and LC-MS showed that the compound had the correct mass and characteristic signals. It was 
therefore decided to perform the last two couplings. The -directing muramic acid imidate 376 did also 
give rise to a single product, but the reaction was slower, and it was not possible to get full conversion of 
the acceptor. Nonetheless, the product could be isolated in 45% yield with 30% recovery of the acceptor. 
The difference in yield may be caused by the fact that donor 376 is less electron rich than donor 408. This 
is consistent with the last coupling of imidate 406 and acceptor 374, which was faster and gave the 
product in 59% yield. 
It was believed that global deprotection would give the target compounds. However, careful analysis by 
NMR showed that the anomeric signal of the muramic acid or galactose moiety was found unexpectedly 
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far downfield. HMBC correlations between the anomeric center and the uracil carbonyls confirmed that 
the glycosylation had taken place on the imide-nitrogen instead of the hemiacetal. This resulted in the 
three molecules 416-418 shown in Scheme 119 rather than the target molecules.  
 
Scheme 119. The structure of the actual product after full assignment by NMR. 
Couplings to imides have previously been reported as by-products in glycosylations promoted by NIS. 
However, the hydroxy groups are normally much stronger nucleophiles and it was therefore surprising 
that the imide gave rise to problems. The result shows that the hemiacetal must be very unreactive and 
that all other nucleophiles must be protected. Hence, it was decided to protect the imide with a benzyl 
group. Treatment of hexaacetyl tunicaminyl uracil 374 with benzyl bromide and Cs2CO3 gave the fully 
protected tunicaminyl 419 (Scheme 120). Next, the anomeric acetyl group was removed with 
ethylenediamine and acetic acid to give the acceptor 420. 
 
Scheme 120. Protection of the imide. 
Glycosylation of acceptor 420 with the muramic acid donor 406 using the optimized conditions did not 
result in formation of the expected product (Scheme 121). The only conversion observed resulted from 
TMS-protection of the hemiacetal. Similar results were obtained when the galactose donor 408 was used. 
Due to time constraints no additional glycosylation experiments were performed. 
 
Scheme 121. Attempts to glycosylate the benzyl-protected tunicaminyl acceptor 420. 
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In conclusion, a novel synthetic route to the tunicaminyl uracil hemiacetal 374 has been developed. This 
gives access to a potential glycosyl acceptor in only three steps from tunicamycins isolated from S. 
chartreusis cultures. Due to the short route and the use of bacterial cultures, it would be possible to scale 
the synthesis to multi-gram quantities. This is in stark contrast to the published total syntheses, where 
analogues of 374 have only been prepared on milligram scale. The degradation and selective 
deacetylation are still major bottlenecks due to mediocre yields. Further optimization, such as degradation 
with milder acids, is therefore desirable.  
A range of donors was prepared including - and -selective MurNAc and galactose donors. In the 
synthesis of MurNAc donors, the introduction of the lactate turned out to be very challenging. The 
secondary bromide was too unreactive resulting in concomitant transesterification and phthalimide 
opening.  This problem was partially solved by using the corresponding triflate. However, it was still not 
possible to alkylate sterically hindered hydroxyl groups as in the case of 391. In the future, a less base-
labile amino protecting group should be chosen instead of a phthalimide. 
A series of glycosylations of a model substrate made it possible to find the best donor match and 
glycosylation conditions before the final couplings. The hemiacetal 373 turned out to be very unreactive, 
but with N-phenyl trifluoroacetimidates it was possible to synthesize a novel ,-linked mixed trehalose 
sugar 415. PTFAI donors were therefore used for the final glycosylations. They all resulted in formation 
of a major product with the correct mass and characteristic signals. However, full characterization showed 
that the glycosylation had taken place on the uracil ring instead of the hemiacetal. The imide must be 
more nucleophilic than the lactol. It was therefore protected with a benzyl group in an attempt to solve the 
problem. Unfortunately, glycosylations of the acceptor 420 did not give rise to any product. More 
experiments are needed to see if different temperatures and/or promoter will give better results. 
The major challenge is the low reactivity of the tunicaminyl acceptor. The many electron-withdrawing 
acetyl groups and steric hindrance from the second ring seems to make the lactol virtually unreactive. One 
way to address this would be to exchange the acetyl with benzyl ethers, which would make the ring more 
electron-rich. Alternatively, another amine protecting group should be used since this has a great effect 
due to its proximity to the anomeric center. This would furthermore allow late stage introduction of fatty 
acid chains, which have been shown to be important for binding. This could for example be done by 
phthalimide or azide protection of the tunicaminyl uracil after the degradation (Scheme 122).    
 
 
Scheme 122. Possible strategies for protection of amine functionality of tunicaminyl uracil 
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9 Conclusion 
The aim of the project was to develop reliable and efficient methods for synthesizing defined fragments 
of plant cell wall galactans and arabinogalactans. A general method for preparation of both linear and 
branched -(14)-linked and -(13)-linked D-galactosides were the major outcome of the project. The 
strategy utilizes a convergent block strategy where a disaccharide donor could be prepared from a single 
building block and used in the remaining glycosylations. This resulted in a significant reduction of the 
number of glycosylation reactions required. Furthermore, late stage regioselective deprotection made it 
possible to introduce branches on the backbone.  
A broad range of routes towards a -(14)-linked digalactoside donor was studied (chapter 4). As a 
result of the low reactivity of the C4-OH in galactose, aglycon transfer was observed when common 
thioglycoside acceptors were applied.  The problem was solved either by applying hindered 
2,6-dimethylthiophenyl acceptors or via use of the less nucleophilic aglycons -O-TBPDS 
and -O-n-pentenyl. A novel, mild procedure for hydrolysis of n-pentenyl glycosides, which reduces 
formation of halohydrin byproducts, was developed. This made it possible to obtain the corresponding 
PTFAI donors in high yields. The PTFAI donors were exceptional donors for glycosylation of pentenyl 
glycoside acceptors and gave access to fully protected pentenyl disaccharide donors.  
Decreasing reactivity of the acceptors with growing degree of polymerization turned out to be a major 
obstacle to the synthesis of longer oligosaccharides. It was therefore crucial to increase the reactivity of 
the acceptor by using small, electron donating protecting groups for the neighboring hydroxy groups. The 
3,6-O-benzyl protected disaccharide donor 170 made it possible to prepare a small library of 
oligogalactans including linear tetra-, penta-, hexa-, and heptasaccharides (131, 132, 210 and 176) and six 
(16)-branched hepta- or octasaccharides (211-216). The assembly of the oligosaccharides went 
smoothly with good to excellent yields and high selectivity for the desired -linked products. This 
constitutes the first reported synthesis of branched -(14)-linked galactans.  
Potential inhibitors of the -14-galactosyltransferase, GALS1 were prepared by late stage introduction 
of C4-F, C4-OMe or C4-epimer galactose residues. Meerwein’s salt and Proton sponge® were used for 
methylation of D-galactose. This is the first application of this method in carbohydrate chemistry and it 
serves as a mild alternative to other known methods. The hindered fluorine analogue was prepared high 
yields by TBAF-mediated displacement of a C4-triflate. 
The 3-position of galactose is significantly more reactive compared to the 4-position. Thus, aglycon 
transfer was not a problem and the more stable and readily available thioglycosides were used for the 
assembly of -(13)-linked galactans. Due to significant migration of the 2-O-acyl group under basic 
conditions, a novel method for selective deacetylation of carbohydrates was developed, where the acetyl 
group is removed by treatment with the bulky reducing agents, L-selectride or superhydride. Using an 
orthogonally protected monosaccharide building block, it was possible to introduce branching at two 
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different positions in a heptasaccharide backbone. This resulted in five different -(13)-linked octa- and 
nonasaccharides (308-312). Furthermore, the strategy gave access to the linear penta- and heptasaccharide 
(306 and 307), which have previously only been prepared as the methyl glycosides. Finally, a series of 
linear -(16)-linked D-galactosides (363, 365, and 367) was prepared. The increased reactivity of the 
6-position resulted in very high glycosylation yields and it is likely that even longer oligosaccharides can 
be prepared by the same strategy. 
Proof of concept for the utility of the synthetic cell wall fragments was obtained by researchers at 
Lawrence Berkeley National Laboratory, Berkeley, California. They used compound 130-132 as 
substrates in the characterization of a novel -14-galactosyltransferase from Arabidopsis thaliana, 
which is believed to take part in pectin biosynthesis. Researchers at DTU Systems Biology in Lyngby 
used some smaller oligosaccharides to study the substrate specificities of three β-galactosidases from 
Bifidobacterium. Moreover, researchers at University of Copenhagen were able to study the binding of 
oligosaccharides 42-45 with a novel microarray technology. This gave interesting new information about 
the epitope of antibody LM16, which had higher affinity for branched structures than linear. Finally, 
co-crystallization of pentasaccharide 132 with the important cancer biomarker Galectin-3 gave new 
insight to the size and specificity of the carbohydrate binding site. Further studies are currently being 
undertaken concerning the oligosaccharides’ potential as Galectin-3 inhibitors in collaboration with 
University of Copenhagen and the German Cancer Research Center, Heidelberg, Germany. 
In conclusion, the project has been very rewarding. Methods for synthesizing branched- and linear 
oligogalactosides have been developed and exemplified by the preparation of three small libraries of 
oligosaccharides. The work is a typical example of the challenges faced in oligosaccharide synthesis. 
Each position in the pyranose ring has different reactivity which is furthermore affected by the nature of 
the surrounding protecting groups. This makes it hard to predict the outcome of glycosylation reactions 
and often makes extensive method development necessary. A systematic analysis of acceptor 
conformation and reactivity could result in a better understanding of chemical glyco-sylation reactions.  
The project has shown the value of synthetically prepared, well-defined oligosaccharides for various 
aspects of plant research. Hopefully, the larger oligosaccharides will give further insight to the structure 
and function of the plant cell wall in the future. 
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10 Experimental  
10.1 General Considerations 
Starting materials, reagents and solvents were purchased from commercial suppliers and have been used 
without further purification.  All solvents are HPLC-grade. The dry solvents were obtained from 
Innovative Technology PS-MD-7 Pure-solv solvent purification system. All of the reactions were carried 
out in flame-dried glassware under inert atmosphere. Thin-layer chromatography (TLC) was performed 
on Merck Aluminium Sheets pre-coated with silica, C-60 F254 plates. Compounds were visualized by 
charring after dipping in CAM stain (Ce(SO4)2 (1.6 g) and (NH4)6Mo7O24 (4 g) in 10 % sulphuric acid 
(200 mL). Eluent systems are specified for each Rf-value, and ratios are given as volume ratios. 
Evaporation of solvents was performed with a VWR International Laborota 400 under reduced pressure 
(in vacuo) at temperatures ranging between 35-55°C. Trace solvent was removed by under reduced 
pressure by means of an oil pump. Flash chromatography was performed using Matrex 60 Å silica gel 
(35-70 µm) as the stationary phase by the general procedure developed by Still et al.
348
 The eluent system 
is specified under the protocol for each synthesis. Eluent ratios are given as volume ratios. NMR-spectras 
were recorded on a Bruker Ascend 400, Varian Mercury 300 B, Bruker DQX 400 and Bruker AC 500 
spectrometer. Chemical shifts () are reported in ppm and coupling constants in Hz. Solvents were 
CDCl3, CD3OD, D2O or d6-DMSO and their resonances were used as internal standards. IR analysis was 
done on a Bruker Alpha-P FT-IR instrument where solid compound is applied directly onto the 
instrument. Optical rotation was measured on a Perkin Elmer Model 241 Polarimeter. Solvents used were 
either CHCl3 or H2O. Melting points were measured on a Stuart melting point SMP30 and reported in ° C 
uncorrected. UPLC/MS analysis was performed on a Waters AQUITY UPLC system equipped with PDA 
and SQD MS detector. Column: AQUITY UPLC BEH C18 1.7µm, 2.1 x 50mm. Column temp: 65 º C. 
Flowrate: 0.6 ml/min. Solvent A: 0.1% formic acid in water, Solvent B: 0.1% formic in MeCN. Gradient: 
5% B to 100% B in 2.4 min, hold 0.1 min, total run time – 2.6 min. High-resolution LC-DAD-MS was 
performed in an Agilent 1100 system equipped with a photodiode array detector (DAD) and coupled to a 
LCT orthogonal time-of-flight mass spectrometer (Waters-Micromass, Manchester, UK) with Z-spray 
electrospray ionization (ESI) source and a LockSpray probe and controlled MassLynx 4.0 software. LC-
MS calibration from m/z 100-900 was done with a PEG mixture. Standard separation involved a LUNA 2 
column with a MeCN (50 ppm TFA) in water gradient starting from 15% to 100% over 25 minutes with a 
flow rate of 0.3 mL/min.  
Most of the compounds have been characterized by NMR and/or HRMS. However, N-phenyl 
trifluoroacetimidates are generally not characterized due to low stability. 
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Phenyl 2,3-di-O-acetyl-4,6-O-(2-naphthyl)methylene-1-thio-β-D-galactopyranoside (22)  
24 (12 g ; 29.23 mmol) was dissolved in CH2Cl2 (250 mL). Et3N (12.2 mL; 87.7 mmol), DMAP 
(71 mg; 0.58 mmol) and acetic anhydride (6.9 mL; 73.1 mmol) were added to the solution and the 
reaction mixture was stirred until TLC revealed full conversion (2 h). The reaction was quenched 
with MeOH (5 mL), washed with water (2x200 mL), dried over MgSO4 and concentrated. The 
product was purified by flash chromatography (CH2Cl2/MeOH 19:1) to afford 22 as a white 
crystalline powder. Rf 0.71 (1:1 EtOAc/Tol). Yield: 13.59 g (95%) 
mp: 165.4 - 167 °C.     
  = +36.0° (c 1.0, CDCl3). IR (neat, cm
-1
): 3059.39, 2974.36, 2906.11, 2863.98, 2803.27, 
1751.73, 1243.25, 1216.57, 1097.35, 1031.81, 993.68. 
1
H NMR (300 MHz, CDCl3) δ 7.86 – 7.74 (m, 4H, Ar-H), 
7.60 – 7.52 (m, 2H, Ar-H), 7.50 – 7.38 (m, 3H, Ar-H), 7.28 – 7.17 (m, 3H, Ar-H), 5.56 (s, 1H, CHNapth), 5.31 (t, 1H, 
J1,2 = J2,3 =  9.9 Hz, H-2), 4.96 (dd, 1H, J2,3 = 9.9, J3,4 = 3.5 Hz, H-3), 4.66 (d, 1H, J1,2 = 9.9 Hz, H-1), 4.36 (d, 1H, 
J3,4 = 3.5 Hz, H-4), 4.36 (dd, 1H, J6a,6b = 12.5, J5,6b = 1.7 Hz, H-6b), 4.02 (dd, 1H, J6a,6b = 12.5, J5,6a =1.7 Hz, H-6a), 
3.56 (t, 1H, J5,6a = J5,6b = 1.7 Hz, H-5), 2.03 (s, 3H, CH3), 1.96 (s, 3H, CH3). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 170.96, 
169.32, 135.05, 134.01, 133.83 (2C), 133.02, 131.52, 129.05, 128.62, 128.38, 128.30, 127.96, 126.63, 126.30, 
126.11, 124.38, 101.62, 85.45, 73.80, 73.41, 69.99, 69.41, 67.03, 21.16 (2C, COCH3). HRMS: calc. [M+NH4]
+
: 
512.1743 found [M+ NH4]
+
: 512.1755 
 
Phenyl 1-thio-β-D-galactopyranoside (23)349 
A solution of galactose pentaacetate (25.0 g; 64.0 mmol), thiophenol (7.3 mL; 70.4 mmol) and 
BF3
.
OEt2 (7.9 mL; 64.0 mmol) in CH2Cl2 (200 mL) was stirred at 22 °C for 16 h. The mixture was 
diluted with CH2Cl2 (100 mL) and washed with sat. aq. NaHCO3 (300 mL). The organic phase was 
dried over MgSO4, filtered and concentrated. Without further purification, the peracetylated thioglycoside was 
deacetylated. Na (1.03 g; 44.8 mmol) was dissolved in MeOH (100 mL) and the NaOMe/MeOH solution was slowly 
added to a solution of the peracetylated sugar in MeOH (100 mL). The reaction mixture was stirred at 22 °C until 
TLC showed full conversion (12 h). The reaction was quenched with Amberlite IR-120 H
+
 (50 mL) and stirred for 1 
h. The ion-exchange resin was filtered off, washed with MeOH and the filtrate was concentrated. The product was 
recrystallized from EtOAc to give 23 as colorless crystals. Rf 0.48 (1:1 EtOAc/Acetone). Yield (over two steps) 
15.87 g (91%)    
mp: 97-100 °C (litt.
350
 98-100 °C).     
  = -53.4° (c 1.0, EtOH) (litt
350
-55°). IR (neat, cm
-1
): 3500-3000, 2884.8, 
1074.72, 1045.53, 1024.75. 
1
H NMR (300 MHz, DMSO) δ 7.42 (d, J = 7.4 Hz, 2H), 7.27 (t, J = 7.4 Hz, 2H), 7.17 
(d, J = 7.4 Hz, 1H), 5.12 (d, J = 6.0 Hz, 1H), 4.87 (dd, J = 6.0, 3.1 Hz, 1H), 4.62 (t, J = 6.0 Hz, 1H), 4.56 (d, J = 
9.3Hz, 1H), 4.47 (d, J = 3.1 Hz, 1H), 3.68 (s, 1H), 3.57 – 3.26 (m, 7H). 13C NMR   (300 MHz, DMSO) δ 136.25, 
129.80 (2C), 129.47 (2C), 126.72, 88.36, 79.81, 75.33, 69.86, 68.98, 61.20, 49.91. HRMS: calc. [M+Na]
+
: 295.0616 
found [M+ Na]
+
: 295.0608 
 
Phenyl 4,6-O-(2-naphthyl)methylene-1-thio-β-D-galactopyranoside (24) 
To a solution of 2-naphthaldehyde (7.7 g, 49.3 mmol) and camphorsulphonic acid (255 mg, 1.1 
mmol) in MeCN (200 mL) was added 23 (10 g, 36.5 mmol). The flask was equipped with a 
distillation unit and the mixture was heated to 95 °C for 1.5 h. During the period app. 100 mL of 
MeCN-MeOH was distilled off. The distillation unit was replaced with a condenser and the reaction 
mixture was heated to reflux until TLC showed completion (1 h). The reaction mixture was 
concentrated and purified by flash chromatography (19:1 CH2Cl2/MeOH) to afford 24 as a white crystalline powder. 
Rf 0.14 (1:1 EtOAc/toluene). Yield: 13.8 g (92%) 
mp: 129.5 - 132 °C.     
  = -21.3° (c 1.0, CDCl3). IR (neat, cm
-1
): 3600-3000, 3057.04, 2976.16, 2904.45, 2857.50, 
1402.74, 1354.27, 1094.07, 1068.42, 1041.28. 
1
H NMR (300 MHz, CDCl3) δ 7.87 – 7.73 (m, 4H, Ar-H), 7.69 – 
7.58 (m, 2H, Ar-H), 7.50 – 7.39 (m, 3H, Ar-H), 7.30 – 7.17 (m, 3H, Ar-H), 5.60 (s, 1H, -CHNapth), 4.45 (d, 1H, J1,2 = 
9.2 Hz, H-1), 4.36 (dd, 1H, J6a,6b = 12.5, J5,6a = 1.2 Hz, H-6b), 4.19 (d, 1H, J3,4 = 3.4 Hz, H-4), 4.01 (dd, 1H, J = 
12.5, 1.2 Hz, H-6a), 3.71 – 3.61 (m, 2H, H-2, H-3), 3.51 (dd, 1H, J5,6a = 1.2, J5,6a = 1.5 Hz, H-5). 
13
C NMR 
 
 (75 
MHz, CDCl3) δ 135.20, 134.01, 133.82 (2C), 133.02, 131.12, 129.16 (2C), 128.54, 128.36, 127.97, 126.79, 126.50, 
126.16, 124.28, 101.66, 87.15, 75.69, 73.87, 70.19, 69.52, 68.84. HRMS: calc. [M+H]
+
: 411.1266 found [M+ H]
+
: 
411.1249 
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Benzyl 6-O-acetyl-2,3-di-O-benzyl-β-D-galactopyranoside (25)123 
The diol 29 (5 g; 11.2 mmol) was dissolved in CH2Cl2 (35 mL). Et3N (2.3 mL; 16.8 mmol) and 
acetic anhydride (1.2 mL; 12.3 mmol) was added and the reaction mixture was stirred until TLC 
revealed full conversion (1-2h). The reaction was quenched by addition of MeOH, diluted with 
CH2Cl2 (50 mL) and washed with H2O (50 mL). The organic phase was dried over MgSO4 and 
concentrated to a white crystalline powder. The product was purified by flash chromatography (1:2 EtOAc/ 
Heptane) to give 25 as a white crystalline powder. Rf 0.4 (EtOAc/Heptane 1:1). Yield: 5.3g (97%) 
mp: 97-100 °C (litt.
123
 99-103 °C).     
  = -16.3° (c 1.0, CHCl3) C (litt.
123
 -17.7). IR (neat, cm
-1
): 3500-3400, 
3028.7, 2917.8, 1710.6, 1271.5, 1088.7. 
1
H NMR (300 MHz, CDCl3) δ 7.34 – 7.19 (m, 15H), 4.87 (d, J = 11.5 Hz, 
1H), 4.88 (d, J = 11.5 Hz, 1H), 4.71 – 4.56 (m, 4H), 4.37 (d, J = 7.8 Hz, 1H), 4.29 (dd, J = 6.3, 2.5 Hz, 2H), 3.86 (d, 
J = 3.4 Hz, 1H), 3.64 (dd, J = 9.4, 7.8 Hz, 1H), 3.51 (t, J = 6.7 Hz, 1H), 3.43 (dd, J = 9.4, 3.4 Hz, 1H), 2.03 (s, 3H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 171.07, 138.65, 137.95, 137.52, 128.76-127.91 (15C), 102.50, 80.59, 79.16, 75.50, 
72.92, 72.05, 71.08, 66.94, 63.32, 21.19. HRMS: calc. [M+ Na]
+
: 515.2046 found [M+ Na]
+
: 515.2067 
 
Benzyl β-D-galactopyranoside (26)351 
A solution of galactose pentaacetate (25 g; 64 mmol), BnOH (12.0 mL; 116 mmol) and BF3
.
OEt2 
(10.0 mL; 79 mmol) in CH2Cl2 (200 mL) was stirred at 22 °C for 12 h. The mixture was diluted with 
CH2Cl2 (150 mL) and washed with sat. aq. NaHCO3 (300 mL). The organic phase was dried over 
MgSO4, filtered and concentrated. Without further purification the fully protected monosaccharide was deacetylated. 
Na (1.03 g; 44.8 mmol) was dissolved in MeOH (100 mL) and the NaOMe/MeOH solution was slowly added to a 
solution of the fully protected monosaccharide in MeOH (100 mL). The reaction was stirred at 22 °C until TLC 
showed full conversion (14 h), quenched with Amberlite IR-120 H
+
 (50 mL) and stirred for 1 h. The ion-exchange 
resin was filtered off, washed with MeOH and the filtrate was concentrated. Purified by flash chromatography 
(acetone:EtOAc 1:1) to give 26 as a white colorless solid. Rf 0.15 (1:1 EtOAc/Acetone). Yield (over two steps): 
14.20 g (81%) 
mp: 96-98 °C (litt.
351
 100-101 °C).     
  = -25.2° (c 1.0, CHCl3) C (litt.
351
 -27.2). 
1
H NMR (300 MHz, DMSO) δ 
7.41 – 7.22 (m, 5H), 4.97 (d, J = 4.7 Hz, 1H), 4.78 (d, J = 12.4 Hz, 1H), 4.68 (d, J = 5.6 Hz, 1H) 4.61 (1H, d, J = 5.8 
Hz, 1H), 4.55 (d, J = 12.4 Hz, 1H), 4.35 (d, J = 4.7 Hz, 1H), 4.17 (d, J = 7.5 Hz, 1H), 3.64 (t, J = 4.7 Hz, 1H), 3.53 
(ddd, 12.5, 5.8, 3.0 Hz, 1H), 3.38 – 3.30 (m, 4H). 13C NMR   (75 MHz, DMSO) δ 138.85, 128.77, 128.26, 127.97, 
103.39, 75.97, 74.10, 71.30, 70.07, 68.85, 61.16. HRMS: calc. [M+NH4]
+
: 288.1447 found [M+ NH4]
+
: 288.1453  
 
Benzyl 4,6-O-benzylidene-β-D-galactopyranoside (27)351 
To a solution of PhCH(OMe)2 (7.7 mL, 50.0 mmol) and camphorsulphonic acid (258 mg, 1.1 mmol) 
in MeCN (200 mL) was added 26 (10 g, 37.0 mmol). The flask was equipped with a distillation unit 
and the mixture was heated to reflux for 2 h during which time approximately 100 mL of MeCN-
MeOH was distilled off. The distillation unit was then replaced with a condenser and the reaction 
mixture was heated to reflux until TLC showed completion (1 h). The reaction mixture was 
concentrated and recrystallized from EtOAc to afford 27 as a white crystalline powder. Rf 0.56 (9:1 CH2Cl2/MeOH). 
Yield: 12.73 g (96%) 
mp: 198-201 °C (litt.
351
 209-210 °C).     
  = -61.8° (c 1.0, CHCl3) (litt.
351
 -62.4). 
1
H NMR (300 MHz, DMS) δ 7.50 
– 7.23 (m, 10H), 5.55 (s, 1H), 5.08 (d, J = 4.3 Hz, 1H), 4.90 (d, J = 5.5 Hz, 1H), 4.82 (d, J = 12.3 Hz, 1H), 4.58 (d, J 
= 12.3 Hz, 1H), 4.31 (d, J = 6.4 Hz, 1H), 4.06 (s, 3H), 3.49 (s, 1H), 3.48 – 3.41 (m, 2H). 13C NMR   (75 MHz, 
DMSO) δ 139.31, 138.74, 129.25, 128.80 (2C), 128.56 (2C), 128.24 (2C), 128.03, 126.93 (2C), 103.21, 100.42, 
76.68, 72.56, 70.78, 70.33, 69.29, 66.69. HRMS: calc. [M+ H]
+
: 359.1459 found [M+ NH4]
+
: 359.1498 
 
Benzyl 4,6-O-benzylidene-2,3-di-O-benzyl-β-D-galactopyranoside (28)351 
27 (10.0 g; 27.9 mmol) was dissolved in DMF (150 mL). NaH (5.1 g; of ~50% oil dispersion, 106.3 
mmol) was added and the mixture was stirred until gas evolution ceased (10 min). The reaction 
mixture was cooled to 0 °C followed by addition of BnBr (10.0 mL; 17.41 84.3 mmol) and Bu4NI 
(0.72 g; 2.0 mmol)  and the solution was stirred at 22 °C overnight. Quenched with MeOH, diluted 
with CH2Cl2 (500 mL) and washed with H2O (3x400 mL). The organic phase was dried over 
MgSO4, concentrated and recrystallized from EtOAc to yield 28 as colorless crystals. Rf 0.59 (1:1 EtOAc/Heptane). 
Yield: 13.53 g (90%)   
mp: 168-169 °C (litt. 
351
 169.5-170.5 °C).     
  = -4.1° (c 1.0, CHCl3) (litt.
351
 -2.3). IR (neat, cm
-1
): 3064.58, 
3027.05, 2886.78, 2861.33,1495.81, 1365.55, 1098.97, 1060.26, 1023.43. 
1
H NMR (400 MHz, CDCl3) δ 7.57 – 
7.08 (m, 20H, -CH2
Bn,a
), 5.43 (s, 1H, -CH
benzylidene
), 4.93 (d, J = 12.1 Hz, 1H, -CH2
Bn,a
), 4.87 (d, J = 10.8 Hz, 1H, -
CH2
Bn,b
), 4.72 (d, J = 10.8 Hz, 1H, -CH2
Bn,b
), 4.68 (d, J = 4.7 Hz, 2H, -CH2
Bn,c
), 4.59 (d, J = 12.1 Hz, 1H, -CH2
Bn,a
), 
4.43 (d, J1,2 = 7.8 Hz, 1H, H-1), 4.26 (dd, J6a,6b = 12.3, J5,6a = 1.5 Hz, 1H, H-6a), 4.04 (dd, J3,4 = 3.7, J4,5 = 1.0 Hz, 
Experimental 
 116 
1H, H-4), 3.95 (dd, J6a,6b = 12.3, J5,6b = 1.8 Hz, 1H, H-6b), 3.85 (dd, J2,3 = 9.7, J1,2 = 7.7 Hz, 1H, H-2), 3.48 (dd, J2,3 
= 9.7, J3,4 = 3.7 Hz, 1H, H-3), 3.24 (m, 1H, H-5). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 138.80, 138.42, 137.84, 137.63, 
128.97, 128.36 (4C), 128.26 (2C), 128.16 (2C), 128.11 (2C), 127.92 (2C), 127.77 (2C), 127.69, 127.68, 127.53,  
126.52 (2C), 102.55, 101.36, 79.28, 78.50, 75.33, 73.99, 72.07, 70.91, 69.26, 66.46. HRMS: [M+ NH4]
+
: calc. for 
C34H34NaO6: 558.2314 found [M+ NH4]
+
: 558.2307 
 
Benzyl 2,3-di-O-benzyl-β-D-galactopyranoside (29)351 
28 (10 g; 18.6 mmol) was dissolved in CH2Cl2 (100 mL) and MeOH (100 mL). Propan-1,3-diol 
(6.7 mL; 92.82 mmol) and p-toluene sulphonic acid  (80 mg; 0.46 mmol) was added and the 
reaction mixture was immersed in an oil bath and heated to reflux. After 72 hours the reaction 
mixture was cooled, diluted by 100 mL CH2Cl2, washed with 200 mL sat. aq. NaHCO3, dried with 
MgSO4 and concentrated. The product was recrystallized from EtOAc-heptane to afford 29 as a white crystalline 
solid. Rf 0.15 (1:1 EtOAc/Heptane). Yield: 7.70 g (92%)   
mp: 115-116 °C (litt.
351
 116-117 °C).     
  = -16.8° (c 1.0, CHCl3) C (litt.
351
 -17.0). IR (neat, cm
-1
): 3500-3000, 
3088.8, 3030.7, 2899.3, 1713.5, 1451.9, 1026.8. 
1
H NMR (300 MHz, CDCl3) δ 7.42 – 7.11 (m, 15H), 4.88 (d, J = 
8.9 Hz, 1H), 4.89 (d, J = 8.9 Hz, 1H),  4.73 – 4.58 (m, 4H), 4.42 (d, J = 7.8 Hz, 1H), 3.91 (dd, J = 11.7, 6.8 Hz, 1H), 
3.91 (dd, J = 3.5, 1.1 Hz, 1H), 3.75 (dd, J = 11.7, 4.5 Hz, 1H), 3.65 (dd, J = 9.4, 7.8 Hz, 1H), 3.44 (dd, J = 9.4, 3.5 
Hz, 1H), 3.38 (ddd, J = 6.8, 4.5, 1.1 Hz, 1H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 138.68, 137.96, 137.67, 128.95 – 
127.77 (15C), 103.02, 80.67, 79.12, 75.52, 74.22, 72.82, 71.51, 67.68, 62.72. HRMS: calc. [M+NH4]
+
: 468.2386 
found [M+ NH4]
+
: 468.2405 
 
Benzyl 2,3-di-O-acetyl-4,6-O-(2-naphthyl)methylene-β-D-galactopyranosyl-(1→4)-6-O-acetyl-2,3-di-O-benzyl-
β-D-galactopyranoside (30) 
A mixture of 25 (2.0 g; 4.01 mmol) and 22 (2.58 g; 5.21 mmol) was dried azeotropically 
with benzene (2x30 mL) and subjected to vacuum overnight. The mixture was dissolved in 
dry CH2Cl2 (25 mL) and dry MeCN (25 mL), cooled to -20 °C, followed by addition of NIS 
(1.20 g; 5.33 mmol) and TESOTf (212 mg; 0.80 mmol). The reaction mixture was stirred at -
20 °C until TLC revealed full conversion of the donor (2 h). The solution was diluted with 
CH2Cl2 (150 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic phase was 
dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography (5:1 
toluene/EtOAc) to afford 30 as a white crystalline material. Rf 0.58 (1:2 EtOAc/toluene). Yield: 2.70 g (77%) 
mp: 152.3-154.1 °C.     
  = +47.1° (c 1.0, CDCl3). IR (neat, cm
-1
): 3062.68, 3030.40, 2868.79, 1737.93, 1222.87, 
1057.46. 
1
H NMR (300 MHz, CDCl3) δ 7.88 – 7.72 (m, 4H, Ar-H), 7.56 (dd, 1H, J = 8.5, 1.6 Hz, Ar-H), 7.44 – 
7.35 (m, 2H, Ar-H), 7.33 – 7.17 (m, 15H, Ar-H), 5.53 (s, 1H, CHNapth), 5.33 (dd, 1H, J2,3 = 10.4, J1,2 = 7.8 Hz, H-2’), 
4.90 (d, 1H, JCH2 = 2.0 Hz, 0.5xCH2
Bn
), 4.87 (d, 1H, JCH2 = 1.5 Hz, 0.5xCH2
Bn
), 4.85 (d, 1H, J2,3 = 9.0 Hz, H-3’), 
4.74 – 4.54 (m, 5H, CH2
Bn
, H-1’), 4.50 (dd, 1H, J6a,6b = 11.9, J5,6b = 4.5 Hz, H-6b), 4.33 (d, 1H, J1,2 = 7.6 Hz, H-1), 
4.30 – 4.13 (m, 2H, H-4’, H-6b’), 4.03 – 3.91 (m, 2H, H-6a, H6a’), 3.70 – 3.62 (m, 1H, H-5’), 3.58 (dd, 1H, J2,3 = 
9.7, J1,2 = 7.6 Hz, H-2), 3.47 (dd, 1H, J5,6a = 7.0, J5,6b = 4.5 Hz, H-5), 3.39 (dd, 1H, J2,3 = 9.7, J3,4 = 2.9 Hz, H-3), 
3.29 (s, 1H, H-4), 1.98 (s, 6H, 2xCH3
Ac
), 1.82 (s, 3H, CH3
Ac
). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 171.23, 171.18, 
169.64, 138.82, 138.52, 137.71, 135.16, 134.08, 133.10, 128.72-127.81 (15C), 126.58, 126.26, 126.19, 124.40, 
102.47, 101.93, 101.73, 81.55, 79.49, 75.53, 74.64, 73.73, 73.53, 72.39, 72.16, 70.88, 69.18, 68.22, 66.38, 64.42, 
21.26, 21.23, 21.11. HRMS: calc. [M+NH4]
+
: 894.3701 found [M+ NH4]
+
: 894.3695 
 
Benzyl 2,3-di-O-acetyl-6-O-(2-naphthyl)methyl-β-D-galactopyranosyl-(1→4)-6-O-acetyl-2,3-di-O-benzyl-β-D-
galactopyranoside (31) 
To a solution of 30 (2.6 g; 2.96 mmol) in dry THF (60 mL), NaCNBH3 (3.73 g; 59.30 mmol) 
was added. The mixture was stirred at 22 °C and a 2M solution of HCl in dry ether was 
added drop wise until gas development ceased and the mixture remained acidic (pH 3-4). 
The reaction mixture was concentrated to 4 ml, diluted with CH2Cl2 (150 mL) and 
neutralized with sat. aq. NaHCO3 (80 mL). The aqueous phase was extracted with CH2Cl2 (3x100 mL). The 
combined organic phases were washed with water (500 mL), dried over MgSO4, filtered and evaporated. The 
product was purified by flash chromatography (3:1 toluene/EtOAc) to afford 31 as a colorless crystalline powder. Rf 
0.49 (1:2 EtOAc/toluene). Yield: 2.16 g (83%) 
mp: 133.5-134.8 °C.     
  = +46.4° (c 1.0, CHCl3). IR (neat, cm
-1
): 3600-3400, 3030.61, 2916.50, 2868.86, 
1738.02, 1366.16, 1226.88, 1063.52. 
1
H NMR (300 MHz, CDCl3) δ 7.78 – 7.71 (m, 3H, Ar-H), 7.69 (s, 1H, Ar-H), 
7.43 – 7.33 (m, 3H, Ar-H), 7.33 – 7.15 (m, 15H, Ar-H), 5.20 (dd, 1H, J2,3 = 10.3, J1,2 = 7.8 Hz, H-2’), 4.90 – 4.78 
(m, 3H, H-1’, CH2
Bn
), 4.67 – 4.51 (m, 7H, H-6b, 3xCH2
Bn
), 4.37 – 4.29 (m, 2H, H-1, H-6b’), 4.19 (dd, 1H, J2,3 = 
10.8, J2,3 = 3.2 Hz, H-3’), 4.05 (d, 1H, J = 2.7 Hz, H-6a), 3.87 (d, 1H, J = 2.4 Hz, H-6a’), 3.68 (m,  2H, H-4’, H-5’), 
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3.59 – 3.49 (m, 2H, H-2, H-4), 3.43 (dd, 1H, J5,6a = 6.7, J5,6b = 5.0 Hz, H-5), 3.34 (dd, 1H, J2,3 = 9.7, J3,4 = 2.9 Hz, 
H-3), 2.01 (s, 3H, CH3
Ac
), 1.91 (s, 3H, CH3
Ac
), 1.78 (s, 3H, CH3
Ac
). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 171.04 170.64, 
169.89, 138.76, 138.33, 137.66, 135.46, 133.45, 133.26, 128.66 (2C), 128.57 (2C), 128.52 (3C), 128.28 (2C), 
128.23 (2C), 128.12, 128.04, 127.93 (2C), 127.85 (2C), 126.85, 126.42, 126.23, 125.91, 102.48, 102.15, 81.39, 
79.45, 75.53, 74.56, 74.10, 73.61, 73.57, 73.33, 72.17, 70.88, 69.70, 69.46, 68.03, 64.36, 21.19, 21.12, 21.00. 
HRMS: calc. [M+NH4]
+
: 896.3858 found [M+ NH4]
+
: 896.3824 
 
Benzyl 2,3-di-O-acetyl-4,6-O-(2-naphthyl)methylene-β-D-galactopyranosyl)-(1→4)-(2,3-di-O-acetyl-6-O-(2-
naphthyl)methyl-β-D-galactopyranosyl)-(1→4)-6-O-acetyl-2,3-di-O-benzyl-β-D-galactopyranoside (32) 
A mixture of 31 (1.9 g; 2.16 mmol) and 22 (1.50 g; 3.02 mmol) was dried 
azeotropically with benzene (2x30 mL) and subjected to vacuum overnight. The 
mixture was dissolved in dry CH2Cl2 (20 mL) and dry MeCN (20 mL), cooled to -20 
°C, followed by addition of NIS (0.69 g; 3.09 mmol) and TESOTf (114 mg; 0.43 
mmol). The reaction mixture was stirred at -20 °C until TLC revealed full conversion 
of the donor (3 h). The solution was diluted with CH2Cl2 (100 mL) and washed with 
sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic phase was 
dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography (3:1 
toluene/EtOAc) to afford 31 as a white crystalline material Rf 0.41 (2:1 toluene/EtOAc). Yield: 2.21 g (81%)  
mp: 87.4 – 88.3 °C.     
  = -18.7° (c 1.0, CDCl3). IR (neat, cm
-1
): 3062.10, 3030.30, 2919.45, 2865.48, 1744.70, 
1368.26, 1241.72, 1222.54, 1060.61. 
1
H NMR (300 MHz, CDCl3) δ 7.93 (s, 1H, Ar-H), 7.88 – 7.78 (m, 3H, Ar-H), 
7.71 – 7.57 (m, 4H, Ar-H), 7.51 (d, J = 6.7 Hz, 1H, Ar-H), 7.47 – 7.41 (m, 2H, Ar-H), 7.35 – 7.17 (m, 18H, Ar-H), 
5.60 (s, 1H, CH
Napth
), 5.33 (dd, 1H, J2,3 = 10.5, J1,2 = 7.9 Hz, H-2’’), 4.92 (m, 5H, H-1’’, H-2’, H-3’’, CH2
Bn
), 4.75 – 
4.51 (m, 8H, H-1’, H-6b, 3xCH2
Bn
), 4.38 – 4.15 (m, 5H, H-1, H-3’, H-4’’, H-6b’, H-6b’’), 4.06 (d, 1H, J6a,6b = 12.2 
Hz, H-6a), 3.97 – 3.76 (m, 3H, H-4’, H-6a’, H6a’’), 3.62 – 3.45 (m, 3H, H-2, H-5’, H-5’’), 3.46 – 3.38 (m, 1H, H-5), 
3.36 (s, 1H, H-4), 3.33 (dd, 1H, J2,3 = 9.8, J3,4 = 2.9 Hz, H-3), 2.14 (s, 3H, CH3
Ac
), 2.04 (s, 3H, CH3
Ac
), 2.02 (s, 3H, 
CH3
Ac
), 1.84 (s, 3H, CH3
Ac
), 1.81 (s, 3H, CH3
Ac
). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 170.89, 170.762, 170.16, 169.52, 
169.33, 138.49, 138.14, 137.42, 135.80, 135.07, 133.73, 133.13, 132.78, 128.93, 128.41-125.62 (m, 29C), 102.13, 
101.13, 100.98, 81.27, 79.13, 75.09, 73.47, 73.29, 73.11, 72.47, 71.92, 71.77, 70.50, 69.81, 68.95, 68.45, 66.26, 
63.80   
 
Phenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-galactopyranoside (33)352 
23 (3.0 g; 11.0 mmol) was dissolved in DMF (40 mL) and cooled to 0 °C. NaH (2.53 g of ~50% oil 
dispersion, 52.80 mmol) was added and the mixture was stirred until gas evolution ceased (20 min). 
BnBr (6.28 mL; 52.80 mmol) was added and the reaction was stirred at 22 °C overnight. Quenched 
with MeOH, diluted with CH2Cl2 (150 mL) and washed with H2O (3x400 mL). The organic phase 
was dried over MgSO4, concentrated and purified by flash chromatography (Heptane:EtOAc 9:1) to yield 33 as 
colorless crystals. Rf 0.6 (EtOAc/Heptane 1:3). Yield: 6.01 g (87%) 
mp: 69-71 °C (lit. 70-71 °C).     
  = +15.1° (c 1.0, CHCl3) (lit. +16.5). IR (neat, cm
-1
): 3060.01, 3029.96, 2916.62, 
2883.94, 2863.99, 1452.95, 1369.33, 1080.33, 1049.58, 1014.86. 
1
H NMR (300 MHz, CDCl3) δ 7.54 – 7.45 (m, 
2H), 7.35 – 7.14 (m, 20H), 7.14 – 7.05 (m, 3H), 4.89 (d, J = 11.5 Hz, 1H), 4.74 – 4.62 (m, 3H), 4.56 (d, J = 9.5 Hz, 
1H), 4.54 – 4.48 (m, 2H), 4.40 (d, J = 11.7 Hz, 1H), 4.34 (d, J = 11.7 Hz, 1H), 3.90 (d, J = 2.7 Hz, 1H), 3.86 (t, J = 
9.5 Hz, 1H), 3.55 (m, 4H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 138.98, 138.54, 138.48, 138.09, 134.37, 131.73-127.27 
(25C), 87.95, 84.41, 77.52 (2C), 75.89, 74.69, 73.82 (2C), 72.96, 68.99. HRMS: calc. [M+ Na]
+
: 655.2495 found 
[M+ Na]
+
: 655.2498  
 
Benzyl 2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl-(1→4)-(2,3-di-O-acetyl-6-O-(2-naphthyl)methyl-β-D-
galactopyranosyl)-(1→4)-6-O-acetyl-2,3-di-O-benzyl-β-D-galactopyranoside (34) 
A mixture of 31 (1.2 g; 1.37 mmol) and 33 (1.21 g; 1.91 mmol) was dried 
azeotropically with benzene (2x30 mL) and subjected to vacuum overnight. The 
mixture was dissolved in dry CH2Cl2 (10 mL) and dry Et2O (10 mL), cooled to -20 °C, 
followed by addition of NIS (0.44 g; 1.95 mmol) and TESOTf (72 mg; 0.27 mmol). 
The reaction mixture was stirred at -20 °C until TLC revealed full conversion of the 
donor (4 h). The solution was diluted with CH2Cl2 (100 mL) and washed with sat. aq. 
NaS2O3 (80 mL) and sat. aq. NaHCO3 (80 mL). The organic phase was dried over 
MgSO4, filtered and concentrated. The product was purified by flash chromatography (4:1 toluene/EtOAc) to afford 
34 as a white crystalline material Rf 0.62 (2:1 toluene/EtOAc). Yield: 1.61 g (84%)  
mp: 54.2 – 55.1 °C.     
  = -27.2° (c 1. 0, CHCl3). IR (neat, cm
-1
): 3062.57, 3030.41, 2925.39, 2866.92, 1742.01, 
1365.91, 1236.91, 1065.61. 
1
H NMR (300 MHz, CDCl3) δ 7.75 – 7.64 (m, 3H, Ar-H), 7.47 (s, 1H, Ar-H), 7.37 (m, 
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4H, Ar-H), 7.32 – 7.09 (m, 34H, Ar-H), 5.21 (dd, 1H, J2,3 = 10.6, J1,2 = 7.7 Hz, H-2’), 4.95 – 4.72 (m, 8H, 4xCH2
Bn
), 
4.65 – 4.45 (m, 7H, H-1’, H-6b, 2.5xCH2
Bn
), 4.39 – 4.17 (m, 8H, H-1, H-1’’, H-3’, H-6b’, H-6b’’, 0.5xCH2
Bn
), 4.08 
(m, 3H, H-4’’, H-6a, H-6a’’), 3.97 (dd, 1H, J2,3 = 9.5, J3,4 = 3.3 Hz, H-3), 3.81 (m, 2H, H-3’’, H-4’), 3.56 (m, 3H, H-
2, H-5’, H-5’’), 3.47 – 3.28 (m, 4H, H-2’’, H-6a’, H-4, H-5), 1.85 (s, 3H, CH3
Ac
), 1.79 (s, 3H, CH3
Ac
), 1.74 (s, 3H, 
CH3
Ac
). 
13
C NMR 
 
 (75 MHz, CDCl3) 170.78 (2C), 169.51, 139.10, 138.94, 138.80, 138.25, 138.10, 137.60, 135.56, 
133.32, 133.10, 128.46-127.84 (m, 38C), 127.55, 126.54, 126.22, 126.01, 125.79, 102.52 (2C), 100.35(1C), 81.26, 
79.51, 79.03, 75.47, 75.12, 74.43, 74.19, 73.73, 73.57, 73.40, 73.12, 72.70, 72.05, 70.94, 69.88, 69.59, 68.22, 67.63, 
63.87, 20.89 (2C), 20.74. 
 
Benzyl 2,3-di-O-acetyl-4,6-O-(2-naphthyl)methylene-β-D-galactopyranosyl)-(1→4)-(2,3-di-O-acetyl-β-D-
galactopyranosyl)-(1→4)-6-O-acetyl-2,3-di-O-benzyl-β-D-galactopyranoside (35) 
To a solution of 32 (1.1 g; 0.87 mmol) in CH2Cl2 (8 mL) and MeOH (2 mL), DDQ 
(0.27 g; 1.18 mmol) and three drops of water were added and the reaction was stirred 
at 22 °C. After complete conversion (2 h), the mixture was concentrated and the 
residue was purified by flash chromatography (19:1 CH2Cl2/MeOH followed by 
another column with the eluent system 3:1 toluene/EtOAc). Rf 0.31 (2:1 
toluene/EtOAc). Yield: 0.77 g (79%) 
mp: 114.3 – 115.4 °C.     
  = 31.5° (c 1.0, CHCl3). IR (neat, cm
-1
): 3600-3400, 
3063.06, 3030.43, 2869.65, 1742.52, 1367.26, 1220.37, 1055.46. 
1
H NMR (300 MHz, CDCl3) δ 7.90 – 7.74 (m, 4H, 
Ar-H), 7.56 (m, 1H, Ar-H), 7.46 – 7.39 (m, 2H, Ar-H), 7.34 – 7.16 (m, 15H, Ar-H), 5.57 (s, 1H, CHNapth), 5.31 (dd, 
1H, J2,3 = 10.5, J3,4 = 7.9 Hz, H-2’’), 5.08 – 4.77 (m, 5H, H-1’’, H-3’’, 1.5xCH2
Bn
), 4.69 (d, 1H, J6a,6b = 11.3 Hz, H-
6b), 4.63 – 4.49 (m, 5H, H-1’, H-2’, 1.5xCH2
Bn
), 4.40 – 4.26 (m, 3H, H-1, H-4’’, H-6b’’), 4.21 – 4.11 (m, 2H, H-3’, 
H-6b’), 4.03 (d, 1H, J6a,6b = 11.3 Hz, H-6a), 3.86 (d, 1H, J = 2.6 Hz, H-6a’), 3.82 – 3.67 (m, 2H, H-4’, H-6a’’), 3.58 
– 3.46 (m, 3H, H-2, H-4, H-5,), 3.42 (t, 1H, J5,6a = J5,6b = 5.8 Hz, H-5’), 3.36 (dd, 1H, J2,3 = 9.7, J3,4 = 2.9 Hz, H-3), 
3.18 (t, 1H, J5,6a = J5,6b = 7.3 Hz, H-5’’), 2.12 (s, 3H, CH3
Ac
), 2.05 (s, 3H, CH3
 Ac
), 2.02 (s, 3H, CH3
 Ac
), 2.00 (s, 3H, 
CH3
 Ac
), 1.80 (s, 3H, CH3
 Ac
). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 170.97, 170.83, 170.24, 169.351 (2C), 138.47, 138.13, 
137.37, 134.61, 133.75, 132.74, 128.34-127.47 (m, 18C), 126.30, 125.96, 125.77, 123.82, 102.22, 101.56 (2C), 
101.36, 81.09, 79.15, 75.16, 74.51, 73.81 (2C), 73.26, 73.14, 72.56, 71.74, 71.48, 70.64, 69.46, 68.63 (2C), 66.50, 
63.81, 60.36, 20.83-20.59 (5C) 
 
Benzyl 2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl-(1→4)-(2,3-di-O-acetyl-β-D-galactopyranosyl)-(1→4)-6-O-
acetyl-2,3-di-O-benzyl-β-D-galactopyranoside (36) 
To a solution of 34 (0.92 g; 0.66 mmol) in CH2Cl2 (8 mL) and methanol (2 mL), DDQ 
(0.18 g; 0.79 mmol) and three drops of water were added and the reaction was stirred at 
22 °C. After complete conversion (2 h) the mixture was concentrated and the residue 
was purified by flash chromatography (19:1 CH2Cl2/MeOH followed by another 
column with the eluent system 4:1 toluene/EtOAc). Rf 0.47 (2:1 toluene/EtOAc). Yield: 
0.72 g (87%). 
mp: 61.2 – 63.5 °C.     
  = -15.7° (c 1.0, CHCl3). IR (neat, cm
-1
): 3600-3400, 3063.13, 
3030.31, 2917.56, 2868.89, 1746.19, 1365.82, 1221.71,1052.50. 
1
H NMR (300 MHz, CDCl3) δ 7.41 – 7.12 (m, 
35H, Ar-H), 5.16 (dd, 1H, J2,3 = 10.7, J1,2 = 7.7 Hz, H-2’), 4.93 – 4.70 (m, 7H, 3.5xCH2
Bn
), 4.70 – 4.46 (m, 7H, 
3.5xCH2
Bn
), 4.43 (d, 1H, J1,2 = 7.7 Hz, H-1’), 4.39 – 4.30 (m, 2H, H-1, H-1’’), 4.27 (d, 1H, J3,4 = 3.6 Hz, H-4’, H-
6b), 4.26 (d, 1H, J6a,6b = 6.1, H-6b), 4.21 (dd, 1H, J2,3 = 9.3, J3,4 = 3.6 Hz, H-3’), 4.08 (s, 1H, H-6b’’), 4.02 (s, 1H, 
H-6a), 3.98 (dd, 2H, J = 6.2, 2.6 Hz, H-4’’, H-5’’), 3.77 (d, 1H, J = 2.5 Hz, H-6a’’), 3.70 – 3.29 (m, 9H, H-2, H-2’’, 
H-3, H-3’’, H-4, H-5, H-5’, H-6a’, H-6b’), 1.99 (s, 3H, CH3
Ac
), 1.85 (s, 3H, CH3
Ac
), 1.76 (s, 3H, CH3
Ac
). 
13
C NMR 
 
 
(75 MHz, CDCl3) δ 170.78, 170.61, 169.15, 138.75, 138.52, 138.42, 138.21, 138.03, 137.48, 137.36, 128.21-127.42 
(m, 45), 102.44 (2C), 101.26, 81.01, 79.22, 78.76, 75.65, 75.29, 74.96, 74.68, 74.56, 74.40, 73.32, 72.78, 72.20, 
71.56, 70.83, 69.61, 69.28, 67.93, 63.53, 60.13, 20.85-20.69 (3C) 
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Benzyl 2,3-di-O-acetyl-4,6-O-(2-naphthyl)methylene-β-D-galactopyranosyl-(1→4)-[2,3-di-O-acetyl-4,6-O-(2-
naphthyl)methylene-β-D-galactopyranosyl-(1→6)]-(2,3-di-O-acetyl-β-D-galactopyranosyl)-(1→4)-6-O-acetyl-
2,3-di-O-benzyl-β-D-galactopyranoside (37) 
A mixture of 35 (450 mg; 0.40 mmol) and 22 (277 mg; 0.56 mmol) was dried 
azeotropically with benzene (2 x 5 mL) and subjected to vacuum overnight. The 
mixture was dissolved in dry CH2Cl2 (2.5 mL) and dry MeCN (2.5 mL), cooled to -20 
°C, followed by addition of NIS (130 mg; 0.58 mmol) and TESOTf (21 mg; 0.08 
mmol). The reaction mixture was stirred at -20 °C until TLC revealed full conversion 
of the donor (2 h). The solution was diluted with CH2Cl2 (40 mL) and washed with 
sat. aq. NaS2O3 (40 mL) and sat. aq. NaHCO3 (40 mL). The organic phase was dried 
over MgSO4, filtered and concentrated. The product was purified by flash 
chromatography (3:1 toluene/EtOAc) to afford a white crystalline material. Rf 0.25 (2:1 toluene/EtOAc). Yield: 452 
mg (75%) 
mp: 143.4 – 144.2 °C.     
  = -42.5° (c 1.0, CHCl3). IR (neat, cm
-1
): 3062.41, 3030.38, 2867.75, 1742.18, 1367.70, 
1242.11, 1220.49, 1061.20. 
1
H NMR (300 MHz, CDCl3) δ 8.00 – 7.67 (m, 9H, Ar-H), 7.59 (dd, 1H, J = 8.4, 1.5 Hz, 
Ar-H), 7.51 – 7.14 (m, 19H, Ar-H), 5.51 (s, 1H, CHNapth), 5.40 (s, 1H, CHNapth), 5.28 (m, 2H, H-2’’, Gal-1,6 H-2), 
5.05 – 4.52 (m, 11H, H-1’’, Gal-1,6 H-1, H-2’, H-3’’, Gal-1,6 H-3, 3xCH2
Bn
), 4.44 (d, 1H, J1,2 = 7.8 Hz, H-1), 4.40 
– 3.90 (m, 11H, H-3’, H-4’’, Gal-1,6 H-4, H-6a, H-6a’, H-6a’’, Gal-1,6 H-6a, H-6b, H-6b’, H-6b’’, H-4’), 3.84 (dd, 
1H, J6a,6b = 12.0, J5,6b = 7.9 Hz, Gal-1,6 H-6b), 3.51 (m, 6H, H-2, H-4, H-5, H-5’, H-5’’, Gal-1,6 H-5), 3.36 (dd, 1H, 
J2,3 = 9.7, J3,4 = 2.8 Hz, H-3), 3.12 (s, 1H, H-4), 2.12 (s, 3H, CH3
Ac
), 2.09 (s, 3H, CH3
Ac
), 2.02 (s, 3H, CH3
Ac
), 2.00 
(s, 3H, CH3
Ac
), 1.95 (s, 3H, CH3
Ac
), 1.87 (s, 3H, CH3
Ac
), 1.82 (s, 3H, CH3
Ac
). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 171.09 
(2C), 170.66, 170.44, 169.67, 169.54, 169.23, 138.74, 138.39, 137.65, 135.49, 135.19, 133.93, 133.76, 132.98, 
128.53-127.633 (m, 14C), 126.60, 126.33, 126.05, 125.80, 124.35, 124.17, 102.22, 101.49, 101.30 (2C), 101.04 
(2C), 81.48, 79.44, 75.25, 73.78, 73.39, 72.44, 72.06, 71.87, 70.66, 69.77, 69.57, 69.11, 68.84, 66.36, 66.24, 65.28, 
21.17-20.85 (7C). 
 
Benzyl 2,3-di-O-acetyl-4,6-O-(2-naphthyl)methylene-β-D-galactopyranosyl)-(1→4)-[ 2,3,4,6-tetra-O-benzyl-α-
D-galactopyranosyl)-(1→6)]-(2,3-di-O-acetyl-β-D-galactopyranosyl)-(1→4)-6-O-acetyl-2,3-di-O-benzyl-β-D-
galactopyranoside (38) 
A mixture of 35 (450 mg; 0.40 mmol) and 33 (355 mg; 0.56 mmol) was dried 
azeotropically with benzene (2 x 5 mL) and subjected to vacuum overnight. The 
mixture was dissolved in dry CH2Cl2 (2.5 mL) and dry Et2O (2.5 mL), cooled to -20 
°C, followed by addition of NIS (130 mg; 0.58 mmol) and TESOTf (21 mg; 0.08 
mmol). The reaction mixture was stirred at -20 °C until TLC revealed full conversion 
of the donor (4 h). The solution was diluted with CH2Cl2 (40 mL) and washed with 
sat. aq. NaS2O3 (40 mL) and sat. aq. NaHCO3 (40 mL). The organic phase was dried 
over MgSO4, filtered and concentrated. The product was purified by flash chromatography (4:1 toluene/EtOAc) to 
afford a white crystalline material. Rf 0.44 (2:1 toluene/EtOAc). Yield: 514 mg (78%) 
mp: 85.8 – 86.4 °C.     
  = 31.2° (c 1.0, CHCl3). IR (neat, cm
-1
): 3062.96, 3030.63, 2868.58, 1746.69, 1367.42, 
1220.78, 1058.26. 
1
H NMR (300 MHz, CDCl3) δ 7.88 – 7.65 (m, 4H, Ar-H), 7.54 (dd, 1H, J = 8.5, 1.6 Hz, Ar-H), 
7.42 – 7.05 (m, 37H, Ar-H), 5.48 (s, 1H, -CHNapth), 5.27 (dd, 1H, J = 10.5, 7.9 Hz, H-2’’), 5.03 (dd, 1H, J2,3 = 10.3, 
J1,2 = 7.7 Hz, H-2’), 4.93 – 4.74 (m, 7H, H-1’’, 3xCH2
Bn
), 4.70 (d, 1H, J1,2 = 7.7 Hz, H-1’), 4.63 – 4.39 (m, 9H, H-1, 
H-3’’, H-6b, 3xCH2
Bn
), 4.37 – 4.03 (m, 8H, Gal-1,6 H-1, H-3’, H-4’’, H-6a, H-6b’’, Gal-1,6 H-6b, CH2
Bn
), 4.00 – 
3.65 (m, 9H, H-2, Gal-1,6 H-2, Gal-1,6 H-3, H-4’, Gal-1,6 H-4, Gal-1,6 H-5, H-6a’, H-6a’’), 3.61 (t, 1H, J5,6a = J5,6b 
=5.4 Hz, H-5’’), 3.55 – 3.33 (m, 4H, H-4, H-5, H-5’, Gal-1,6 H-6a), 3.28 (dd, H1, J2,3 = 9.8, J3,4 = 2.8 Hz, H-3), 2.12 
(s, 3H, CH3
Ac
), 2.07 (s, 3H, CH3
Ac
), 2.00 (s, 3H, CH3
Ac
), 1.90 (s, 3H, CH3
Ac
), 1.79 (s, 3H, CH3
Ac
), 1.60 (s, 3H, 
CH3
Ac
). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 171.078 (2C), 170.38, 169.56 (2C), 139.24, 138.96, 138.79, 138.44, 138.22, 
137.69, 135.15, 133.90, 132.97, 128.41-127.53 (m, 39C), 126.35, 126.04, 125.91, 124.28, 102.22, 101.40 (3C), 
98.58, 81.45, 79.40, 75.29, 74.90, 73.84, 73.49, 73.24, 72.58, 72.28, 72.02, 70.62, 69.97, 69.39, 69.00, 68.74, 67.43, 
66.49, 64.36, 21.06-20.86 (m, 5C) 
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Benzyl 2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-(1→4)-[2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-
(1→6)]-(2,3-di-O-acetyl-β-D-galactopyranosyl)-(1→4)-6-O-acetyl-2,3-di-O-benzyl-β-D-galactopyranoside (39) 
A mixture of 36 (310 mg; 0.25 mmol) and 33 (218 mg; 0.34 mmol) was dried 
azeotropically with benzene (2 x 5 mL) and subjected to vacuum overnight. The 
mixture was dissolved in dry CH2Cl2 (2.5 mL) and dry Et2O (2.5 mL), cooled to -20 
°C, followed by addition of NIS (79 mg; 0.35 mmol) and TESOTf (13 mg; 0.05 
mmol). The reaction mixture was stirred at -20 °C until TLC revealed full conversion 
of the donor (2 h). The solution was diluted with CH2Cl2 (40 mL) and washed with sat. 
aq. NaS2O3 (40 mL) and sat. aq. NaHCO3 (40 mL). The organic phase was dried over 
MgSO4, filtered and concentrated. The product was purified by flash chromatography (4:1 toluene/EtOAc) to afford 
a white crystalline material. Rf 0.55 (2:1 toluene/EtOAc) Based on 
1
H NMR and 
13
C NMR 
 
 the product is a mixture 
of the α- and β-product and is therefore deprotected prior to characterization. Separated mass: 355 mg (81%) 
mp: 44.7-45.9 °C. IR (neat, cm
-1
): 3062.83, 3029.99, 2919.27, 2868.25, 1750.43, 1453.96, 1365.76, 1237.76, 
1094.02, 1054.77. 
1
H NMR (300 MHz, CDCl3) δ 7.40 – 6.90 (m, 55H, Ar-H), 5.19 (dd, 1H, J = 10.7, 7.7 Hz, H-2’), 
5.00 – 3.21 (m, 49H, H-1, H-1’, H-1’’, Gal-1,6 H-1, H-2, H-2’’, Gal-1,6 H-2, H-3, H-3’, H-3’’, Gal-1,6 H-3, H-4, 
H-4’, H-4’’, Gal-1,6 H-4, H-5, H-5’, H-5’’, Gal-1,6 H-5, H-6a, H-6a’, H-6a’’, Gal-1,6 H-6a, H-6b, H-6b’, H-6b’’, 
Gal-1,6 H-6b, 11xCH2
Bn
), 1.90 (s, 3H, CH3
Ac
), 1.86 (s, 3H, CH3
Ac
), 1.72 (s, 3H, CH3
Ac
). 
13
C NMR 
 
 (75 MHz, 
CDCl3) δ 170.67 (2C), 169.53, 139.27, 139.03, 138.86, 138.68, 138.25, 138.14, 137.61, 128.44-127.21 (m, 59C), 
102.60, 102.43, 99.97, 98.73, 81.22, 79.53, 78.86, 76.20, 75.47, 75.12, 74.85, 73.62, 73.52, 73.33, 72.94, 72.73, 
72.41, 72.03, 70.89, 69.92, 69.54, 69.12, 68.28, 63.88, 21.07, 20.77, 20.67. 
 
Benzyl 2,3-di-O-acetyl-6-O-(2-naphthyl)methyl-β-D-galactopyranosyl-(1→4)-(2,3-di-O-acetyl-6-O-(2-
naphthyl)methyl-β-D-galactopyranosyl)-(1→4)-6-O-acetyl-2,3-di-O-benzyl-β-D-galactopyranoside (40) 
To a solution of 32 (1.0 g; 0.79 mmol) in dry THF (20 mL), NaCNBH3 (1.0 g; 15.81 
mmol) was added. The mixture was stirred at 22 °C and a 2M solution of HCl in dry 
ether was added drop wise until gas development ceased and the mixture remained 
acidic (pH 3-4). The mixture was concentrated to 2 ml, diluted with CH2Cl2 (50 ml) 
and the mixture was neutralized with sat. aq. NaHCO3 (50 mL). The aqueous phase 
was extracted with CH2Cl2 (3 x 50 ml). The combined organic phases were washed 
with water (200 mL), dried over MgSO4, filtered and evaporated. The product was purified by flash chromatography 
(4:1 toluene/EtOAc) to afford a colorless crystalline powder. 40 was used for the following reaction without 
characterization. Rf 0.35 (2:1 toluene/EtOAc) 
Yield: 290 mg (74%) 
 
Benzyl 2,3-di-O-acetyl-4,6-O-(2-naphthyl)methylene-β-D-galactopyranosyl-(1→4)-(2,3-di-O-acetyl-6-O-(2-
naphthyl)methyl-β-D-galactopyranosyl)-(1→4)-(2,3-di-O-acetyl-6-O-(2-naphthyl)methyl-β-D-
galactopyranosyl)-(1→4)-6-O-acetyl-2,3-di-O-benzyl-β-D-galactopyranoside (41) 
A mixture of 40 (760 mg; 0.60 mmol) and 22 (416 mg; 0.84 mmol) was dried 
azeotropically with benzene (2 x 5 mL) and subjected to vacuum overnight. 
The mixture was dissolved in dry CH2Cl2 (5 mL) and dry MeCN (5 mL), 
cooled to -20 °C, followed by addition of NIS (196 mg; 0.87 mmol) and 
TESOTf (32 mg; 0.12 mmol). The reaction mixture was stirred at -20 °C until 
TLC revealed full conversion of the donor (2 h). The solution was diluted with 
CH2Cl2 (40 mL) and washed with sat. aq. NaS2O3 (40 mL) and sat. aq. 
NaHCO3 (40 mL). The organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash chromatography (4:1 toluene/EtOAc) to afford a white crystalline 
material. 41 was deprotected prior to characterization. Rf 0.44 (1:1 toluene/EtOAc) 
Mass: 749 mg (76%)  
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β-D-galactopyranosyl-(1→4)-[β-D-galactopyranosyl-(1→6)]-β-D-galactopyranosyl-(1→4)-D-galactopyranose 
(42)  
37 (465 mg; 0.28 mmol) was dissolved in MeOH (6 mL) and THF (2 mL) and 6 drops 
of freshly prepared 1M NaOMe in MeOH was added. The reaction mixture was stirred 
at 22 °C until full conversion was observed by TLC (24 hours). The reaction was 
quenched with Amberlite IR-120 (H
+
), filtered and concentrated. The product was 
purified by flash chromatography (9:1 CH2Cl2/MeOH) to yield colorless crystals. The 
product was next dissolved in MeOH (6 mL), THF (2 mL) and AcOH (0.5 mL). 10% 
Pd/C (223 mg; 0.18 mmol) was added and an atmosphere of H2 (1 atm.) was installed. 
The reaction was stirred for 2 h, and then water (2 mL) was added. The reaction was stirred until TLC indicated full 
conversion (72 h), filtered through celite, and concentrated to give a white solid. Rf 0.72 (3:1 MeOH/H2O). Yield: 
92 mg (79%). 
1
H NMR (400 MHz, D2O) δ 5.21 (d, J1,2 = 3.8 Hz, 1H, H-1
1), 4.60 (d, J1,2 = 8.0 Hz, 1H, H-1), 4.59 (d, J = 8.0 Hz, 
1H, H-1), 4.55 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.52 (d, J1,2 = 7.8 Hz, 2H, H-1, H-1), 4.39 (d, J1,2 = 8.0, 2H, H-1, 
H-1), 4.20 (d, J3,4 = 3.4 Hz, 1H, H-4
1
a), 4.14 (d, J3,4 = 3.4 Hz, 1H, H-4, H-4), 4.12 (d, J3,4 = 3.3 Hz, 3H, H-4, 
2xH-4), 4.10 – 4.02 (m, 3H, H-4, H-4, H-6), 3.99 – 3.41 (m, 39H). 13C NMR   (75 MHz, D2O) δ 107.46, 
106.99, 106.28, 101.11, 99.11, 95.06, 82.47, 81.55, 80.41, 80.20, 77.99, 77.84, 77.26, 76.51, 76.01, 75.75, 75.49, 
75.09, 74.72, 74.43, 74.21, 73.62, 72.83, 72.44, 72.23, 71.92, 71.66, 71.41, 70.96, 69.83, 63.87 HRMS: calc. 
[M+H]
+
: 667.2297 found [M+ H]
+
: 667.2267 
 
β-D-galactopyranosyl-(1→4)-[α-D-galactopyranosyl-(1→6)]-β-D-galactopyranosyl-(1→4)-D-galactopyranose 
(43)  
38 (323 mg; 0.21 mmol) was dissolved in MeOH (6 mL) and THF (2 mL) and 5 drops 
of freshly prepared 1M NaOMe in MeOH was added. The reaction mixture was stirred 
at 22 °C until full conversion was observed by TLC (24 hours). The reaction was 
quenched with Amberlite IR-120 (H
+
), filtered and concentrated. The product was 
purified by flash chromatography (9:1 EtOAc/MeOH) to yield colorless crystals. The 
product was next dissolved in MeOH (6 mL), THF (2 mL) and AcOH (0.5 mL). 10% 
Pd/C (132 mg; 0.18 mmol) was added and an atmosphere of H2 (1 atm.) was installed. 
The reaction was stirred for 2 h, then water (2 mL) was added. The reaction was stirred until TLC indicated full 
conversion (72 h), filtered through celite, and concentrated to give a white solid. Rf 0.68 (3:1 MeOH/H2O)  
Yield: 67 mg (81%) 
1
H NMR (400 MHz, D2O) δ 5.30 (d, J1,2 = 3.8 Hz, 1H, H-1
1), 5.03 (d, J1,2 = 3.5 Hz, 2H, H-1,, H-1,), 4.71 – 
4.56 (m, 4H, 4xH-1), 4.48 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.32 – 4.11 (m, 4H, 4xH-4), 4.04 – 3.52 (m, 40H). 
13
C NMR 
 
 
(75 MHz, D2O) δ 106.85, 106.62, 106.06, 98.88, 81.24, 80.26, 79.94, 77.61, 76.67, 76.27, 75.76, 75.26, 74.77, 74.22, 
73.97, 73.24, 72.64, 72.21, 71.34, 71.14, 63.47, 63.16 HRMS: calc. [M+H]
+
: 667.2297 found [M+ H]
+
: 667.2275. 
 
α-D-galactopyranosyl-(1→4)-[α-D-galactopyranosyl)-(1→6)]-β-D-galactopyranosyl-(1→4)-D-galactopyranose 
(44)  
39 (200 mg; 0.11 mmol) was dissolved in MeOH (6 mL), THF (2 mL) and AcOH (0.5 
mL). 10% Pd/C (223 mg; 0.18 mmol) was added and an atmosphere of H2 (1 atm.) was 
installed. The reaction was stirred for 2 h, then water (2 mL) was added. The reaction 
was stirred until TLC indicated full conversion (48 h), filtered through celite, and 
concentrated to give a white solid. The product was next dissolved in MeOH (6 mL) and 
THF (2 mL) and 6 drops of freshly prepared 1M NaOMe in MeOH was added. The 
reaction mixture was stirred at 22 °C until full conversion was observed by TLC (24 
hours). The reaction was quenched with Amberlite IR-120 (H
+
), filtered and concentrated. The product was purified 
by flash chromatography (2:1 toluene/EtOAc) to yield colorless crystals. Rf 0.31 (1:1 toluene/EtOAc). Yield 269 mg 
(90%). 
1
H NMR (400 MHz, D2O) δ 5.22 (d, J1,2 = 3.9 Hz, 1H, H-1
1), 4.92 (d, J1,2 = 3.8 Hz, 4H, H-1,, H-1,, H-1,, 
H-1,), 4.55 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.49 (d, J = 7.8 Hz, 1H, H-1), 4.40 – 4.30 (m, 8H, 8xH-4), 4.21 – 3.42 
(m, 40H). 
13
C NMR 
 
 (75 MHz, D2O) δ   107.69, 107.43, 106.58, 105.95, 102.89, 101.40, 99.08, 95.03, 84.49, 
82.71, 81.83, 81.30, 79.59, 79.42, 77.86, 77.33, 76.76, 76.33, 76.04, 75.41, 75.06, 74.80, 74.31, 73.76, 73.37, 72.91, 
72.248, 72.10, 71.87, 71.72, 71.46, 70.89, 68.66, 66.06, 64.09, 63.81, 63.22 HRMS: calc. [M+Na]
+
: 689.2117 found 
[M+ Na]
+
: 689.2095 
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β-D-galactopyranosyl-(1→4)-(β-D-galactopyranosyl)-(1→4)-(β-D-galactopyranosyl)-(1→4)-D-galactopyranose 
(45) 
41(260 mg; 0.16 mmol) was dissolved in MeOH (6 mL) and THF (2 mL) and 5 
drops of freshly prepared 1M NaOMe in MeOH was added. The reaction 
mixture was stirred at 22 °C until full conversion was observed by TLC (24 
hours). The reaction was quenched with Amberlite IR-120 (H
+
), filtered and 
concentrated. The product was purified by flash chromatography (4:1 
EtOAc/MeOH) to yield colorless crystals. The product was next dissolved in 
MeOH (6 mL), THF (2 mL) and AcOH (0.5 mL). 10% Pd/C (223 mg; 0.18 
mmol) was added and an atmosphere of H2 (1 atm.) was installed. The reaction was stirred for 2 h, then water (2 
mL) was added. The reaction was stirred until TLC indicated full conversion (48 h), filtered through celite, and 
concentrated to give a white solid. Rf 0.74 (3:1 MeOH/H2O). Yield: 72 mg (83%). 
1
H NMR (400 MHz, D2O) δ 5.17 (d, J1,2 = 3.7 Hz, 1H, H-1), 4.58 – 4.47 (m, 7H, 7xH-1), 4.13 (d, J3,4 = 3.1 Hz, 
1H, H-4), 4.08 (m, 7H, 7xH-4), 4.03 (dd, J = 7.2, 5.7 Hz, 1H, H-5), 3.89 – 3.42 (m, 39H). 13C NMR (101 MHz, 
D2O) δ 104.38, 104.34, 104.29, 104.24, 96.35, 92.27, 78.80, 77.83, 77.55, 77.51, 77.07, 75.11, 74.47, 74.41, 74.27, 
73.33, 73.28, 73.24, 73.19, 72.70, 72.19, 71.85, 71.79, 71.75, 71.32, 69.81, 69.66, 68.77, 68.57, 60.95, 60.85, 60.69, 
60.67, 60.50. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C24H42NaO21 689.2116 Found 689.2111. 
 
Phenyl 2,3-di-O-acetyl-4,6-O-benzylidene-1-thio-β-D-galactopyranoside (54)353 
56 (7 g; 19.3mmol) was dissolved in CH2Cl2 (150 mL). Et3N (8.1 mL; 58.0 mmol), DMAP (0.05 g; 
0.39 mmol) and acetic anhydride (4.6 mL; 48.4 mmol) was added to the solution and the reaction 
mixture was stirred until TLC revealed full conversion (1.5 h). The reaction was quenched with 
MeOH (5 mL), washed with water (2x100 mL), dried over MgSO4 and concentrated. The product 
was purified by flash chromatography (CH2Cl2/MeOH 19:1) to afford 54 as a white crystalline 
powder Rf 0.71 (19:1 CH2Cl2/MeOH). Yield: 8.5 g (98%). 
mp: 158-160 °C.     
  = +12.3° (c 1.0, CDCl3) (litt.
137
 + 5.8). IR (neat, cm
-1
): 3031.90, 2886.39, 1729.88, 1243.25, 
1046.47, 995.65, 933.67. 
1
H NMR (300 MHz, CDCl3) δ 7.58 – 7.50 (m, 2H), 7.36 – 7.14 (m, 8H), 5.40 (s, 1H), 5.28 
(t, J = 9.8 Hz, 1H), 4.93 (dd, J = 9.8, 3.4 Hz, 1H), 4.64 (d, J = 9.8 Hz, 1H), 4.31 (dd, J = 12.5, 1.6 Hz, 2H), 4.30 (d, 
J = 3.4 Hz, 1H), 3.96 (dd, J = 12.5, 1.6 Hz, 1H), 3.53 (d, J = 1.6 Hz, 1H), 2.02 (s, 3H), 1.96 (s, 3H). 
13
C NMR 
 
 (75 
MHz, CDCl3) δ 170.95, 169.31, 137.68, 133.82 (2C), 131.47, 129.39, 129.03 (2C), 128.39 (2C), 128.34, 126.75 
(2C), 101.34, 85.37, 73.65, 73.41, 69.93, 69.29, 66.96, 21.15 (2C). HRMS: calc. [M+ NH4]
+
: 462.1587 found [M+ 
NH4]
+
: 462.1566 
 
Phenyl 2,3-di-O-acetyl-6-O-(2,3,4,5,6-pentafluorobenzoyl)-1-thio-β-D-galactopyranoside (55) 
57 (280 mg; 0.79 mmol) was dissolved in CH2Cl2 (5 mL) and cooled to 0 °C. 2,3,4,5,6-
pentafluorobenzoyl chloride (0.11 mL; 0.81 mmol) and Et3N (0.16 mL; 1.18 mmol) was added 
and the reaction was stirred at 0 °C for 1½ h. The reaction mixture was quenched with MeOH, 
diluted with 35 mL CH2Cl2 and washed with H2O (40 mL). The organic phase was dried over MgSO4, concentrated 
and purified by flash chromatography (1:1 EtOAc/Heptane) to afford 55 as a white crystalline powder. Rf 0.71 (3:1 
EtOAc/Heptane). Yield: 375 mg (87%)  
mp: 160-161 °C.     
  = +9.9° (c 1.0, CDCl3). IR (neat, cm
-1
): 3600-3400, 3063.14, 2964.84, 1740.89, 1736.41, 
1732.71, 1494.50, 1222.64, 1054.20. 
1
H NMR (300 MHz, CDCl3) δ 7.48 – 7.35 (m, 2H), 7.26 – 7.13 (m, 3H), 5.22 
(t, J = 9.9 Hz, 1H), 4.96 (dd, J = 9.9, 3.2 Hz, 1H), 4.67 (d, J = 9.9 Hz, 1H), 4.61 (dd, J = 11.6, 7.3 Hz, 1H), 4.49 (dd, 
J = 11.6, 5.0 Hz, 1H), 4.08 (dd, J = 4.6, 3.2 Hz, 1H), 3.86 (ddd, J = 7.3, 5.0, 4.6 Hz, 1H), 2.03 (s, 3H), 2.03 (s, 3H).. 
13
C NMR 
 
 (75 MHz, CDCl3) δ 170.27, 169.87, 158.87, 132.68 (2C), 132.57, 129.08 (2C), 128.30, 86.77, 75.90, 
74.31, 67.63 (2C), 65.10, 21.05 (2C). 
19
F NMR (282 MHz, CDCl3) δ -137.69 – (-137.91) (m), -147.97 (tt, J = 21.0, 
4.9 Hz), -160.32  – (-160.79) (m). HRMS: calc. [M+ NH4]
+
: 568.1065 found [M+ NH4]
+
: 568.1071 
 
Phenyl 4,6-O-benzylidene-1-thio-β-D-galactopyranoside (56)354 
To a solution of PhCH(OMe)2 (7.6 mL, 49.3 mmol) and camphor sulphonic acid (255 mg, 1.1 mmol) 
in MeCN (200 mL) was added 23 (10 g, 36.5 mmol). The flask was equipped with a distillation unit 
and the mixture was heated to reflux for 1.5 h. During this period app. 100 mL of MeCN-MeOH was 
distilled off. The distillation unit was replaced with a condenser and the reaction mixture was heated 
to reflux until TLC showed full conversion (1 h). The reaction mixture was concentrated and purified 
by flash chromatography (CH2Cl2/MeOH 19:1) to afford 56 as a white crystalline powder. Rf 0.25 (CH2Cl2/MeOH 
19:1) Yield: 13.1 g (99%) 
mp: 148-150 °C (litt. 
184
 149-151 °C).     
  = -27.2° (c 1.0, CDCl3) (litt. 
184
 -24). IR (neat, cm
-1
): 3500-3100, 
3070.9, 2916.85, 2873.10, 1096.39, 1066.36, 1039.24. 
1
H NMR (300 MHz, CDCl3) δ 7.76 – 7.65 (m, 2H), 7.45 – 
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7.23 (m, 8H), 5.51 (s, 1H), 4.51 (d, J = 8.0 Hz, 1H), 4.38 (d, J = 12.5 Hz, 1H), 4.21 (d, J = 1.3 Hz, 1H), 4.03 (d, J = 
12.5 Hz, 1H), 3.76 – 3.63 (m, 2H), 3.56 (s, 1H), 2.30 (s, 2H). 13C NMR   (75 MHz, CDCl3) δ 137.82, 133.88 (2C), 
131.03, 129.58, 129.15 (2C), 128.48 (2C), 128.39, 126.75 (2C), 101.58, 87.14, 75.59, 73.95, 70.22, 69.48, 68.92.  
HRMS: calc. [M+ NH4]
+
: 378.1375 found [M+ NH4]
+
: 378.1362. 
 
Phenyl 2,3-di-O-acetyl-1-thio-β-D-galactopyranoside (57)137 
54 (1.5g; 3.37mmol) was dissolved in CH2Cl2 (30 mL) and MeOH (30 mL). Propan-1,3- diol (1.22 
mL; 16.83 mmol) and p-toluenesulphonic acid  (14 mg; 0.084 mmol) was added and the reaction 
mixture was heated to reflux. After 12 hours the reaction mixture was allowed to cool, diluted by 
CH2Cl2 (100 mL), washed with sat. aq. NaHCO3 (200 mL), dried over MgSO4 and concentrated to 
afford a white crystalline solid. The product was purified by flash chromatography (19:1 CH2Cl2/MeOH) to give 57 
as a colorless crystalline material. Rf 0.63 (9:1 CH2Cl2/MeOH). Yield: 0.98 g (82%).    
mp: 166.3-167.5 °C.     
  = +13.7° (c 1.0, CDCl3) (litt.
355
 +13.3). 
1
H NMR (300 MHz, CDCl3) δ 7.46 – 7.39 (m, 
2H), 7.30 – 7.21 (m, 3H), 5.26 (t, J = 9.9 Hz, 1H), 4.92 (dd, J = 9.9, 3.1 Hz, 1H), 4.68 (d, J = 9.9 Hz, 1H), 4.12 (dd, 
J = 3.1, 0.9 Hz, 1H), 3.90 (dd, J = 12.0, 5.8 Hz, 1H), 3.80 (dd, J = 12.0, 4.3 Hz, 1H), 3.58 (ddd, J = 5.5, 4.3, 0.9 Hz, 
1H), 2.02 (s, 3H), 2.02 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 170.48, 169.91, 132.37 (2C), 129.28 (2C), 129.20, 
128.26, 86.62, 78.09, 74.65, 68.58, 67.84, 62.85, 21.13, 21.11. HRMS: calc. [M+ NH4]
+
: 374.1274 found [M+ 
NH4]
+
: 374.1282. 
Phenyl 4,6-O-benzylidene-3-O-(2-naphthyl)methyl-1-thio-β-D-galactopyranoside (58) 
Di-n-butyl tin oxide (4.48g; 19.42 mmol) was added to a solution of compound 56 (5.00 g, 13.87 
mmol) in dry toluene (130 mL) and stirred under refluxing temperature for 12 h. The temperature 
was adjusted to 75-80 °C, and then n-Bu4NI (7.69 g, 20.81 mmol) and naphthylmethyl bromide 
(4.6 g, 20.81 mmol) were added in one portion; stirring was maintained at this temperature for 24 
h. The mixture was concentrated and purified by flash chromatography (4:1 Tol/EtOAc) to give 58 
as white crystals. Rf 0.60 (2:1 Tol/EtOAc). Yield: 4.72 g (68%). 
mp: 181.3 – 182.4 °C.     
  = -18.0° (c 1.0, CDCl3). IR (neat, cm
-1
): 3500-3100, 3053.72, 2981.81, 2871.51, 
1071.98, 1044.72, 995.03, 734.37. 
1
H NMR (300 MHz, CDCl3) δ 7.81 – 7.63 (m, 6H), 7.63 – 7.53 (m, 2H), 7.48 – 
7.23 (m, 9H), 7.23 – 7.09 (m, 4H), 5.32 (s, 1H), 4.80 (s, 2H), 4.74 (s, 2H), 4.42 (d, J = 9.5 Hz, 1H), 4.24 (dd, J = 
12.4, 1.5 Hz, 1H), 4.05 (d, J = 3.3 Hz, 1H), 3.91 (t, J = 9.5, 1H), 3.84 (dd, J = 12.4, 1.5 Hz, 2H), 3.46 (dd, J = 9.5, 
3.3 Hz, 1H), 3.30 (d, J = 1.1 Hz, 1H), 2.46 (d, J = 2.0 Hz, 1H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 138.05, 135.70, 
134.01 (2C), 130.86, 129.31-125.41 (18C), 101.40, 87.29, 80.41, 73.60, 72.07, 70.28, 67.49, 65.68. HRMS: calc. 
[M+ NH4]
+
: 518.2001 found [M+ NH4]
+
: 518.1995 
 
Phenyl 2-O-acetyl-4,6-O-benzylidene-3-O-(2-naphthyl)methyl-1-thio-β-D-galactopyranoside (59)  
58 (4.2 g ; 8.39 mmol) was dissolved in CH2Cl2 (30 mL). Et3N (2.0 mL; 14.68 mmol), DMAP (20 
mg; 0.17 mmol) and acetic anhydride (1.2 mL; 12.6 mmol) was added to the solution and the 
reaction mixture was stirred until TLC revealed full conversion (2 h). The reaction was quenched 
with MeOH (2 mL), washed with water (2x30 mL), dried over MgSO4 and concentrated. The 
product was purified by flash chromatography (2:1 toluene/EtOAc) to afford 59 as a white 
crystalline powder. Rf 0.67 (1:2 EtOAc/toluene). Yield: 4.19 g (92%)  
mp: 190.4 – 191.8 °C.     
  = -14.3° (c 1.0, CDCl3). IR (neat, cm
-1
): 3059.50, 2991.18, 2969.61, 2874.91, 1736.20, 
1368.60, 1232.25, 1052.34. 
1
H NMR (300 MHz, CDCl3) δ 7.79 – 7.62 (m, 4H), 7.56 – 7.48 (m, 2H), 7.44 – 7.11 
(m, 11H), 5.35 (s, 1H), 5.28 (t, J = 9.7 Hz, 1H), 4.74 (d, J = 12.9 Hz, 1H), 4.68 (d, J = 12.9 Hz, 1H), 4.53 (d, J = 9.7 
Hz, 1H), 4.24 (dd, J = 12.4, 1.5 Hz, 1H), 4.11 (d, J = 3.4 Hz, 1H), 3.87 (dd, J = 12.4, 1.5 Hz, 1H), 3.57 (dd, J = 9.7, 
3.4 Hz, 1H), 3.32 (t, J = 1.5 Hz, 1H), 2.01 (s, 3H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 169.44, 137.83, 135.67, 133.63 
(2C), 133.34, 133.25, 131.95, 129.30-125.83 (15C), 101.53, 85.58, 78.70, 73.42, 71.52, 70.19, 69.46, 68.56, 21.37. 
HRMS: calc. [M+ NH4]
+
: 560.2107 found [M+ NH4]
+
: 560.2105. 
 
Phenyl 2-O-acetyl-3-O-(2-naphthyl)methyl-1-thio-β-D-galactopyranoside (60) 
59 (500 mg; 0.92 mmol) was dissolved in CH2Cl2 (15 mL) and MeOH (15 mL). Propan-1,3- diol 
(0.33 mL; 4.61 mmol) and p-toluenesulphonic acid  (4 mg; 0.023 mmol) was added and the 
reaction mixture was heated to reflux. After 14 hours the reaction mixture was allowed to cool, 
diluted with CH2Cl2 (50 mL), washed with sat. aq. NaHCO3 (100 mL), dried over MgSO4 and concentrated. The 
product was purified by flash chromatography (19:1 CH2Cl2/MeOH) resulting in 60 as a white crystalline solid. Rf 
0.15 (1:1 EtOAc/Heptane). Yield: 390 mg (93%) 
mp: 138.1 – 138.6 °C.     
  = 11.5° (c 1.0, CDCl3). IR (neat, cm
-1
) 3600-3100, 3056.93, 2932.17, 2879.93, 1742.58, 
1369.11, 1229.72, 1048.29. 
1
H NMR (300 MHz, CDCl3) δ 7.80 – 7.69 (m, 3H), 7.63 (s, 1H), 7.49 – 7.28 (m, 5H), 
7.27 – 7.12 (m, 3H), 5.18 (dd, J = 10.5, 9.5 Hz, 1H), 4.76 (d, J = 12.4 Hz, 1H), 4.60 (d, J = 12.4 Hz, 1H), 4.52 (d, J 
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= 10.5 Hz, 1H), 4.06 (d, J = 3.1 Hz, 1H), 3.97 – 3.83 (m, 1H), 3.81 – 3.64 (m, 1H), 3.50 (dd, J = 9.5, 3.1 Hz, 1H), 
3.44 (t, J = 5.8 Hz, 1H), 1.97 (s, 3H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 169.88, 134.83, 133.33 (2C), 132.10 (2C), 
129.16 (2C), 128.70, 128.09, 127.97 (2C), 127.94, 127.02, 126.63, 126.48, 125.81, 86.59, 79.56, 78.54, 71.82, 
69.21, 66.93, 62.65, 21.30. HRMS: calc. [M+NH4]
+
: 472.1794 found [M+ NH4]
+
: 472.1804. 
 
Phenyl 2-O-acetyl-3-O-(2-naphthyl)methyl-6-O-(2,3,4,5,6-pentafluorobenzoyl)-1-thio-β-D-galactopyranoside 
(61) 
60 (350 mg; 0.77 mmol) was dissolved in CH2Cl2 (5 mL) and cooled to 0 °C. 2,3,4,5,6-
pentafluorobenzoyl chloride (0.11 mL; 0.79 mmol) and Et3N (0.16 mL; 1.16 mmol) was added 
and the reaction was stirred at 0 °C for 1½ h. The reaction mixture was quenched with MeOH, 
diluted with CH2Cl2 (35 mL) and washed with water (40 mL). The organic phase was dried over MgSO4, 
concentrated and purified by flash chromatography (3:1 Tol/EtOAc) to afford 61 as a white crystalline powder. Rf 
0.72 (2:1 Tol/EtOAc). Yield: 460 mg (93%)  
mp: 174 – 175.3 °C.     
  = +9.4° (c 1.0, CDCl3). IR (neat, cm
-1
): 3545.59, 3069.09, 2976.76, 2884.34, 1737.78, 
1524.10, 1495.93, 1220.96, 1094.86. 
1
H NMR (300 MHz, CDCl3) δ 7.79 – 7.67 (m, 3H), 7.63 (s, 1H), 7.44 – 7.27 
(m, 5H), 7.18 – 7.07 (m, 3H), 5.19  (t, J =9.6 Hz 1H), 4.76 (d, J = 12.4 Hz, 1H), 4.63 (d, J = 12.4 Hz, 1H), 4.62 (d, J 
= 11.7 Hz, 1H), 4.56 (d, J = 9.6 Hz, 1H), 4.51 (d, J = 11.7 Hz, 1H), 4.02 (d, 3.3 Hz, 1H), 3.74 – 3.64 (m, 1H), 3.53 
(dd, J = 9.3, 3.3 Hz, 1H), 1.98 (s, 3H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 169.89, 158.90, 134.70, 133.35, 133.32, 
133.30, 132.28 (2C), 128.97 (2C), 128.77, 128.06, 127.96 (2C), 127.06, 126.67, 126.54, 125.76, 86.83, 79.26, 75.84, 
72.15, 68.99, 66.60, 65.71, 21.29. 
19
F NMR (282 MHz, cdcl3) δ -136.99 – -138.72 (m), -148.23 (tt, J = 20.9, 4.8 
Hz), -159.81 – -161.54 (m). HRMS: calc. [M+NH4]
+
: 666.1585 found [M+ NH4]
+
: 666.1586 
 
Phenyl 2-O-acetyl-6-O-benzyl-3-O-(2-naphthyl)methyl-1-thio-β-D-galactopyranoside (62) 
To a solution of 59 (1.5 g; 2.76 mmol) in dry THF (45 mL), NaCNBH3 (2.61 g; 41.46 mmol) was 
added. The mixture was stirred at 22 °C and a 2M solution of HCl in dry ether was added drop 
wise until gas development ceased and the mixture remained acidic (pH 3-4). The mixture was 
concentrated to 2 ml, diluted with CH2Cl2 (150 ml) and the mixture was neutralized with sat. aq. 
NaHCO3 (100 mL). The aqueous phase was extracted with CH2Cl2 (3 x 100 ml). The combined organic phases were 
washed with water (500 mL), dried over MgSO4, filtered and evaporated. The product was purified by flash 
chromatography (2:1 toluene/EtOAc) to afford 62 a colorless crystalline powder. Rf 0.39 (1:2 EtOAc/toluene). 
Yield: 1.31 g (87%). 
mp: 141.3 – 142.2 °C.     
  = +3.9° (c 1.0, CDCl3). IR(neat, cm
-1
): 3565.71, 3055.31, 2868.77, 1736.40, 
1362.21, 1230.57, 1065.77. 
1
H NMR (300 MHz, CDCl3) δ 7.80 – 7.69 (m, 3H), 7.64 (s, 1H), 7.45 – 7.37 
(m, 4H), 7.32 (dd, J = 8.5, 1.6 Hz, 1H), 7.29 – 7.11 (m, 8H), 5.19 (t, J = 9.7 Hz, 1H), 4.77 (d, J = 12.3 Hz, 
1H), 4.60 (d, J = 12.3 Hz, 1H), 4.51 (d, J = 9.7 Hz, 3H), 4.49 (s, 2H), 4.08 (s, 1H), 3.72 (dd, J = 5.9, 2.8 
Hz, 2H), 3.56 (t, J = 5.9, 1H), 3.48 (dd, J = 9.7, 3.2 Hz, 1H), 2.51 (s, 1H), 1.96 (s, 3H). 
13
C NMR (75 
MHz, CDCl3) δ 169.83, 138.15, 134.93, 133.34, 133.32 (3C), 132.17-125.83 (17C), 86.67, 79.68, 77.60, 
73.96, 71.74, 69.47, 69.20, 66.58, 21.32. 
HRMS: calc. [M+ NH4]
+
: 562.2264 found [M+ NH4]
+
: 562.2277 
 
Phenyl 2-O-acetyl-6-O-benzyl-4-O-triethylsilyl-3-O-(2-naphthyl)methyl-1-thio-β-D-galactopyranoside (63) 
62 (650 mg; 1.19 mmol) was dissolved in DMF (10 mL) and cooled to 0 °C. To the solution were 
added triethylsilyl chloride (0.30 mL; 1.79 mmol) and imidazole (162 mg; 2.39 mmol). The 
reaction mixture was stirred at 0 °C in 1h and then at 22 °C for 12h. The mixture was diluted with 
Et2O (100 mL) and washed with water (4 x 25 mL). The organic phase was dried over MgSO4, 
filtered, concentrated and purified by flash chromatography (5:1 toluene/EtOAc). Rf 0.69 (1:2 EtOAc/Tol) 
Yield: 708 mg (99%). 
mp: 89.3 – 91.2 °C.     
  = -8.1° (c 1.0, CDCl3). IR (neat, cm
-1
): 3060.03, 2953.41, 2874.51, 1747.77, 1227.91, 
1070.90, 906.55, 725.83. 
1
H NMR (300 MHz, CDCl3) δ 7.92 – 7.83 (m, 3H), 7.78 (s, 1H), 7.64 – 7.26 (m, 13H), 
5.45 (t, J = 9.7 Hz, 1H), 4.89 (d, J = 12.2 Hz, 1H), 4.69 (d, J = 12.2 Hz, 1H), 4.64 (d, J = 9.7 Hz, 1H), 4.62 (d, J = 
11.5 Hz, 2H), 4.57 (d, J = 11.5 Hz, 1H), 4.30 (d, J = 2.5 Hz, 1H), 3.83 – 3.65 (m, 3H), 3.51 (dd, J = 9.6, 2.5 Hz, 
1H), 2.03 (s, 3H), 0.98 (t, J = 8.0 Hz, 9H), 0.65 (q, J = 8.0, 3.1 Hz, 6H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 169.66, 
138.16, 135.56, 133.51, 133.46, 133.25, 132.28 (2C), 128.97-125.95 (15C), 86.44, 81.41, 78.41, 73.98, 72.97, 69.48, 
69.20 , 68.51 , 21.39, 7.26 (3C), 5.49 (3C). HRMS: calc. [M+ NH4]
+
: 676.3128 found [M+ NH4]
+
: 676.3141 
 
 
 
Experimental 
 125 
Phenyl 2-O-acetyl-6-O-benzyl-4-O-chloroacetyl-3-O-(2-naphthyl)methyl-1-thio-β-D-galactopyranoside (64) 
156 (470 mg; 0.86 mmol) was dissolved in CH2Cl2 (10 mL) and cooled to 0 °C. (ClAc)2O (251 
mg; 1.47 mmol), Et3N (0.21 mL; 1.51 mmol) and DMAP (4 mg; 0.03 mmol) was added and the 
reaction was stirred at 0 °C for 2 h. The reaction mixture was concentrated and purified by flash 
chromatography (4:1 Tol/EtOAc) to afford a white crystalline powder. Rf 0.76 (1:2 EtOAc/Tol). 
Yield: 487 mg (91%). 
mp: 113.6 – 116-1 °C.     
  = -6.1° (c 1.0, CDCl3). IR (neat, cm
-1
): 3058.34, 2869.99, 1747.58, 1227.39, 1169.72, 
1094.82, 1060.35. 
1
H NMR (300 MHz, CDCl3) δ 7.80 – 7.69 (m, 3H), 7.63 (s, 1H), 7.45 – 7.35 (m, 4H), 7.34 – 7.12 
(m, 9H), 5.66 (d, J = 3.2 Hz, 1H), 5.04 (t, J = 9.8 Hz, 1H), 4.77 (d, J = 12.6 Hz, 1H),  4.52 (d, J = 9.8 Hz, 1H),  4.50 
(d, J = 12.6 Hz, 1H), 4.49 (d, J = 11.7 Hz, 1H), 4.37 (d, J = 11.7 Hz, 1H), 4.04 (d, J = 15.1 Hz, 1H), 3.91 (d, J = 
15.1 Hz, 1H), 3.72 (t, J = 6.6 Hz, 1H), 3.61 – 3.49 (m, 2H), 3.45 (dd, J = 9.8, 3.2 Hz, 1H), 1.95 (s, 3H). 13C NMR   
(75 MHz, CDCl3) δ 169.63, 167.16, 137.52, 134.82, 133.33, 133.30, 133.01, 132.50 (2C), 129.06 (2C), 128.76 (2C), 
128.47, 128.43 (2C), 128.28, 128.09 (2C), 127.93, 127.28, 126.50, 126.36, 126.12, 86.89, 77.42, 75.87, 73.97, 
71.56, 68.97, 68.40, 67.60, 41.05, 21.23. 
HRMS:  calc. [M+Na]
+
: 643.1534 found [M+ Na]
+
: 643.1553 
 
4-fluorophenyl 2,3-di-O-acetyl-6-O-(2-naphthyl)methyl-1-thio-β-D-galactopyranoside (65) 
To a solution of 69 (1.0 g; 1.95 mmol) in dry THF (20 mL), NaCNBH3 (2.45 g; 39.02 mmol) was 
added. The mixture was stirred at 22 °C and a 2M solution of HCl in dry ether was added drop 
wise until gas development ceased and the mixture remained acidic (pH 3-4). The mixture was 
concentrated to 2 ml, diluted with CH2Cl2 (50 ml) and the mixture was neutralized with sat. aq. NaHCO3 (50 mL). 
The aqueous phase was extracted with CH2Cl2 (3 x 50 ml). The combined organic phases were washed with water 
(200 mL), dried over MgSO4, filtered and evaporated. The product was purified by flash chromatography (4:1 
toluene/EtOAc) to afford a colorless crystalline powder. Rf 0.48 (1:2 EtOAc/toluene). Yield: 843 mg (84%). 
mp: 148.7 – 151.1 °C.     
  = +6.8° (c 1.0, CDCl3). IR (neat, cm
-1
) 3577.97, 3061.31, 2959.52, 2911.52, 2869.03, 
1747.80, 1490.32, 1367.87, 1234.70, 1216.60, 1052.55. 
1
H NMR (300 MHz, CDCl3) δ 7.90 – 7.79 (m, 4H), 7.76 (s, 
1H), 7.56 – 7.45 (m, 4H), 6.92 (t, J = 8.7 Hz, 2H), 5.26 (t, J = 9.7 Hz, 1H), 4.97 (dd, J = 9.7, 3.0 Hz, 1H), 4.73 (s, 
2H), 4.60 (d, J = 9.7 Hz, 1H), 4.19 (d, J = 3.0 Hz, 1H), 3.82 (dd, J = 5.0, 2.0 Hz, 2H), 3.73 (dd, J = 5.0, 2.0 Hz, 1H), 
2.09 (s, 3H), 2.08 (s, 3H). 
13
C NMR 
 
 (75 MHz, CDCl3): 170.26, 169.58, 135.89 (2), 135.73 (2), 135.04, 133.35, 
128.51, 128.02, 127.86, 126.79, 126.40, 126.23(2C), 125.72, 116.30, 115.86, 86.20, 76.52, 74.62, 74.07, 69.66, 
68.38, 67.71, 20.99 (2C). 
19
F NMR (282 MHz, CDCl3) δ -112.99. HRMS: calc. [M+Na]
+
: 537.1360 found [M+ 
Na]
+
: 537.1360 
 
4-fluorophenyl 2,3,6-tri-O-acetyl-1-thio-β-D-galactopyranoside (66) 
70 (1.3 g; 3.62 mmol) was dissolved in CH2Cl2 (20 mL) and cooled to 0 °C. acetic anhydride 
(0.38 mL; 3.98 mmol) and Et3N (0.76 mL; 5.43 mmol) was added and the reaction was stirred at 0 
°C for 3 h. The reaction mixture was quenched with MeOH, diluted with CH2Cl2 (100 mL) and 
washed with water (100 mL). The organic phase was dried over MgSO4, concentrated and purified by flash 
chromatography (4:1 toluene/EtOAc) to afford a white crystalline powder. Rf 0.51 (1:2 EtOAc/toluene). Yield: 1.07 
g (71%)  
mp: 190 - 191 °C.     
  = +39.7° (c 1.0, CDCl3). IR (neat, cm
-1
): 3600-3400, 3077.36, 2939.18, 2881.31, 1732.78, 
1726.81, 1490.09, 1366.38, 1215.13, 1037.66. 
1
H NMR (300 MHz, CDCl3) δ 7.45 (dd, J = 8.7, 5.3 Hz, 2H), 6.95 (t, 
J = 8.7 Hz, 2H), 5.14 (t, J = 9.9 Hz, 1H), 4.91 (dd, J = 9.9, 3.1 Hz, 1H), 4.52 (d, J = 9.9 Hz, 1H), 4.24 (d, J = 6.4 Hz, 
2H), 3.99 (s, 1H), 3.70 (td, J = 6.4, 0.9 Hz, 1H), 2.03 (s, 3H), 2.02 (s, 3H), 2.01 (s, 3H). 
13
C NMR 
 
 (75 MHz, 
CDCl3) δ 171.07, 170.31, 169.76, 136.03, 135.92, 126.83 (2C), 116.33, 116.04, 86.29, 76.08, 74.39, 67.57, 67.43, 
62.77, 21.09, 21.06 (2C). 
19
F NMR (282 MHz, CDCl3) δ -113.11. HRMS: calc. [M+NH4]
+
: 434.1285 found [M+ 
NH4]
+
: 434.1299. 
 
4-fluorophenyl 1-thio-β-D-galactopyranoside (67)356 
A solution of galactose pentaacetate (20.0 g; 51.24 mmol), 4-fluorothiophenol (6.6 mL; 61.48 
mmol) and BF3
.
OEt2 (7.8 mL; 61.48 mmol) in CH2Cl2 (200 mL) was stirred at 22 °C for 24 h. The 
mixture was diluted with CH2Cl2 (100 mL) and washed with sat. aq. NaHCO3 (300 mL). The 
organic phase was dried over MgSO4, filtered and concentrated. Without further purification it was deacetylated. Na 
(1.03 g; 44.8 mmol) was dissolved in MeOH (100 mL) and the NaOMe/MeOH solution was slowly added to a 
solution of 157 in MeOH (100 mL). The reaction mixture was stirred at 22 °C until TLC showed full conversion (12 
h). The reaction was quenched with Amberlite IR-120 H
+
 (50 mL) and stirred for 1 h. The ion-exchange resin was 
filtered off, washed with MeOH and the filtrate was concentrated. The product was recrystallized from EtOAc to 
give 67 as colorless crystals. Rf 0.32 (3:2 Heptane/EtOAc). Yield (over two steps) 12.18 g (83%)    
Experimental 
 126 
mp: 140.6 – 141.7 °C.     
  = -51.2° (c 1.0, CDCl3). IR (neat, cm
-1
): 3600-3100, 3061.53, 2885.85, 2865.08, 
1491.75, 1073.19, 1037.98, 980.84. 
1
H NMR (300 MHz, D2O) δ 7.42 (dd, J = 8.9, 5.3 Hz, 2H), 6.97 (t, J = 8.9 Hz, 
2H), 4.50 (d, J = 9.5 Hz, 1H), 3.80 (d, J = 2.8 Hz, 1H), 3.67 – 3.32 (m, 5H). 13C NMR   (75 MHz, D2O) δ 134.36, 
134.25, 127.56, 127.51, 116.41, 116.12, 88.65, 79.08, 74.07, 69.25, 68.76, 61.03. 
19
F NMR (282 MHz, D2O) δ -
114.68 (ddd, J = 14.1, 9.5, 4.8 Hz). HRMS: calc. [M+NH4]
+
: 308.0968 found [M+ NH4]
+
: 308.0957. 
 
4-fluorophenyl 4,6-O-(2-naphthyl)methylene-1-thio-β-D-galactopyranoside (68) 
To a solution of 2-naphthaldehyde (6.54 g, 41.85 mmol) and camphorsulphonic acid (216 mg, 0.93 
mmol) in MeCN (200 mL) was added 67 (9.0 g, 31.0 mmol). The flask was equipped with a 
distillation unit and the mixture was heated to 95 °C for 1.5 h. During the period app. 100 mL of 
MeCN-MeOH was distilled off. The distillation unit was replaced with a condenser and the 
reaction mixture was heated to reflux until TLC showed completion (1 h). The reaction mixture 
was concentrated and purified by flash chromatography (19:1 CH2Cl2/MeOH) to afford 68 as a white crystalline 
powder. Rf 0.18 (1:1 EtOAc/toluene). Yield: 12.5 g (94%) 
mp: 153.5 – 154.3 °C.     
  = -13.9° (c 1.0, CDCl3). IR (neat, cm
-1
): 3600-3100, 3060.82, 2861.77, 1489.72, 
1098.55, 1069.52, 1046.65. 
1
H NMR (300 MHz, CDCl3) δ 7.77 (m, 4H), 7.63 (dd, J = 8.8, 5.3 Hz, 2H), 7.44 (dd, J 
= 6.2, 3.2 Hz, 2H), 7.34 (d, J = 9.9 Hz, 1H), 6.94 (t, J = 8.8 Hz, 2H), 5.58 (s, 1H), 4.39 (d, J = 9.0 Hz, 1H), 4.33 (dd, 
J = 12.5, 1.6 Hz, 1H), 4.17 (d, J = 3.1 Hz, 1H), 4.00 (dd, J = 12.5, 1.6 Hz, 1H), 3.63 (dd, J = 9.0, 3.1 Hz, 1H), 3.56 
(t, J = 9.0 Hz, 1H), 3.49 (t, J = 1.6 Hz, 1H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 136.84, 136.73, 135.10, 134.04, 132.99, 
128.50, 128.41, 126.87, 126.59, 124.13, 116.41, 116.13, 101.68, 86.82, 75.62, 73.92, 70.17, 69.50, 68.78. 
19
F NMR 
(282 MHz, CDCl3) δ -112.90 (s). HRMS: calc. [M+H]
+
: 429.1172 found [M+ H]
+
: 429.1193  
 
4-fluorophenyl 2,3-di-O-acetyl-4,6-O-(2-naphthyl)methylene-1-thio-β-D-galactopyranoside (69) 
68 (10.0 g; 23.34 mmol) was dissolved in CH2Cl2 (150 mL). Et3N (9.7mL; 70.02 mmol), DMAP 
(57 mg; 0.47 mmol) and acetic anhydride (5.5 mL; 58.35 mmol) was added to the solution and the 
reaction mixture was stirred until TLC revealed full conversion (3 h). The reaction was quenched 
with MeOH (10 mL), washed with water (2x200 mL), dried over MgSO4 and concentrated. The 
product was recrystallized with EtOAc/Heptane to afford 69 as a white crystalline powder Rf 0.73 
(1:1 EtOAc/toluene). Yield: 11.15 g (93%).  
mp: 156.5 – 157.4 °C.     
  = -12.4° (c 1.0, CDCl3). IR (neat, cm
-1
): 3064.79, 2901.98, 2863.27, 2845.97, 1750.90, 
1244.26, 1216.43, 1098.16, 1037.73, 995.08. 
1
H NMR (300 MHz, CDCl3) δ 7.84 (d, J = 8.8 Hz, 4H), 7.65 (dd, J = 
8.6, 5.4 Hz, 2H), 7.51 (dd, J = 6.3, 3.2 Hz, 2H), 7.36 (dd, J = 8.4, 1.7 Hz, 1H), 6.97 (t, J = 8.6 Hz, 2H), 5.61 (s, 1H), 
5.29 (t, J = 9.9 Hz, 1H), 5.01 (dd, J = 9.9, 3.4 Hz, 1H), 4.63 (d, J = 9.9 Hz, 1H), 4.40 (dd, J = 12.4, 1.5 Hz, 2H), 
4.41 (d, J = 3.4 Hz, 1H)., 4.07 (dd, J = 12.4, 1.5 Hz, 1H), 3.62 (d, J = 1.5 Hz, 1H), 2.11 (s, 3H), 2.02 (s, 3H).
13
C 
NMR 
 
 (75 MHz, CDCl3) δ 170.94, 169.33, 137.27, 137.16, 134.95, 134.05, 132.97, 128.56, 128.36, 126.69, 126.38, 
124.20, 116.24, 115.95, 101.63, 84.68, 73.70, 73.37, 69.94, 69.39, 66.86, 21.18, 21.14. 
19
F NMR (282 MHz, 
CDCl3) δ -112.89 (s). HRMS: calc. [M+NH4]
+
: 530.1649 found [M+ NH4]
+
: 530.1642 
 
4-fluorophenyl 2,3-di-O-acetyl-1-thio-β-D-galactopyranoside (70) 
69 (3 g; 6.05 mmol) was dissolved in CH2Cl2 (50 mL) and MeOH (50 mL). Propan-1,3-diol (2.2 
mL; 30.27 mmol) and p-toluenesulphonic acid  (26 mg; 0.15 mmol) was added and the reaction 
mixture was heated to reflux. After 10 h the reaction mixture was allowed to cool, diluted with 
CH2Cl2 (50 mL), washed with sat. aq. NaHCO3 (100 mL), dried over MgSO4 and concentrated to 
afford a white crystalline solid. The product was purified by flash chromatography (19:1 CH2Cl2/MeOH). Rf 0.44 
(9:1 CH2Cl2/MeOH). Yield: 1.96 g (86%) 
mp: 109.4 – 110.7 °C.     
  = +6.4° (c 1.0, CDCl3). IR (neat, cm
-1
): 3500-3100, 3068.15, 2932.95, 2897.06, 
1740.80, 1490.07, 1368.35, 1222.86, 1044.28. 
1
H NMR (300 MHz, CDCl3) δ 7.51 (dd, J = 8.9, 5.3 Hz, 2H), 7.05 – 
6.98 (t, J = 8.9 Hz, 2H), 5.25 (t, J = 9.9 Hz, 1H), 4.97 (dd, J = 9.9, 3.1 Hz, 1H), 4.63 (d, J = 9.9 Hz, 1H), 4.17 (dd, J 
= 3.1, 1.0 Hz, 1H), 3.91 (ddd, J = 11.9, 5.5, 4.4 Hz, 2H), 3.63 (ddd, J = 5.5, 4.4, 1.0 Hz, 1H), 2.09 (s, 3H), 2.08 (s, 
3H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 170.44, 169.88, 135.74, 135.63, 126.96, 126.99, 116.47, 116.18, 86.49, 78.02, 
74.62, 68.55, 67.74, 62.82, 21.11 (2C). 
19
F NMR (282 MHz, CDCl3) δ -113.10 (s). HRMS: calc. [M+NH4]
+
: 
392.1180 found [M+ NH4]
+
: 392.1186 
 
 
 
 
 
 
Experimental 
 127 
Phenyl 2,3-di-O-acetyl-4,6-O-benzylidene-1-thio-β-D-galactopyranosyl sulfoxide (71)357 
54 (1.0 g, 2.24 mmol) was dissolved in CH2Cl2 (10 mL) and cooled to -78 °C. The solution was 
treated drop wise with a solution of 3-chloroperbenzoic acid (0.78 g, 4.50 mmol) in CH2Cl2 (5 mL). 
After 15 min at this temperature, the mixture was poured into sat. aq. NaHCO3 (200 mL). The 
organic layer was separated, washed with sat. aq. NaHCO3 (100 mL), dried over MgSO4, and 
concentrated. This resulted in a syrup which was purified by flash chromatography (toluene/EtOAc, 1:1) to give 71 
as a colorless powder. Rf 0.14, 0.24 (1:1 EtOAc/Tol). Yield: 787 mg (76%) 
mp: 89.3-91.3 °C.     
  = -47.2° (c 1.0, CDCl3). IR (neat, cm
-1
): 3600-3100, 3060.13, 2987.07, 2866.11, 1726.19, 
1236.39, 1217.94, 1087.57, 1050.58, 1025.55, 993.99. 
1
H NMR (300 MHz, CDCl3) δ 8.05 – 7.66 (m, 2H), 7.53 – 
7.43 (m, 2H), 7.36 – 7.07 (m, 4H), 6.99 – 6.90 (m, 2H), 5.30 (t, J = 9.9 Hz, 1H), 5.24 (s, 1H), 4.94 (dd, J = 9.9, 3.3 
Hz, 1H), 4.51 (d, J = 9.9 Hz, 1H), 4.22 (d, J = 3.3 Hz, 1H), 4.18 (dd, J = 12.6, 1.6 Hz, 1H), 3.84 (dd, J = 12.6, 1.6 
Hz, 1H), 3.51 (d, J = 1.6 Hz, 1H), 2.05 (s, 3H), 1.96 (s, 2H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 171.36, 170.77(1C), 
137.36(1C), 132.00(1C), 129.51, 128.94 (2C), 128.30 (2C), 127.28 (2C), 126.73 (2C), 101.36, 92.65, 77.72, 77.30, 
76.87, 73.10, 72.82, 70.19, 68.57, 65.20, 21.08 (2C). 
 
Phenyl 2,3-di-O-acetyl-4,6-O-(2-naphthyl)methylene-D-galactopyranosyl fluoride (72) 
22 (1.5 g; 3.03 mmol) was dried azeotropically with benzene (2x10 mL) and subjected to vacuum for 
2h. It was then dissolved in CH2Cl2 (10 mL) and cooled to -15 °C. The stirred solution was treated 
with DAST (0.73 g; 4.45 mmol) and allowed to stir for 2 min before NBS (0.70 g, 3.94 mmol) was 
added. After 1h the reaction mixture heated to 22 °C and was monitored by TLC until full conversion 
was observed (2h). The reaction mixture was diluted with CH2Cl2 (25 mL) and washed with sat. aq. NaHCO3 (6 
mL) and brine (6 mL).  Finally the organic phase was dried over MgSO4 and concentrated. The oily product so was 
subjected to flash column chromatography (2:1 heptane/EtOAc) to afford the two diastereoisomers 72a and 72b. 
Rf(72a) 0.49 (1:2 EtOAc/Tol), Rf(72b) 0.29 (1:2 EtOAc/Tol). Yield (total of diastereoisomers): 419  mg (77%) 
α-glycosyl fluoride (72a) 
mp: 191.3-192.6 °C.     
  = 102.1° (c 1.0, CDCl3). IR (neat, cm
-1
): 3063.51, 2971.58, 2906.60, 1755.99, 1738.21, 
1370.53, 1238.96, 1221.96, 1095.80, 1040.72, 976.45. 
1
H NMR (300 MHz, CDCl3) δ 7.90 (s, 1H), 7.85 – 7.74 (m, 
3H), 7.53 (dd, J = 8.6, 1.6 Hz, 1H), 7.46 – 7.39 (m, 2H), 5.87 (dd, J = 53.9, 1.9 Hz, 1H), 5.62 (s, 1H), 5.34 (qd, J = 
10.9, 2.4 Hz, 2H), 5.30 (d, J = 1.9 Hz, 1H), 4.53 (d, J = 2.4 Hz, 1H), 4.31 (dd, J = 12.7, 1.6 Hz, 1H), 4.06 (dd, J = 
12.7, 1.6 Hz, 1H), 3.97 (t, J = 1.6 Hz, 1H), 2.05 (s, 3H), 2.05 (s, 3H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 170.83, 
170.34, 134.77, 133.97, 133.07, 128.66, 128.40, 127.93, 126.71, 126.40, 125.91, 123.94, 105.46 (d, J = 225.9 Hz, 
1C), 101.37, 73.58, 68.95, 68.17, 67.64 (d, J = 24 Hz, 1C), 64.69 (d, J = 2.4 Hz, 1C), 21.19, 20.95. 
19
F NMR (282 
MHz, CDCl3) δ -150.09 (dd, J = 53.5, 23.2 Hz). HRMS: calc. [M+H]
+
: 405.1349 found [M+ H]
+
: 405.1368 
β-glycosyl fluoride (72b) 
mp: 183.4 – 183.8 °C.     
  = 121.2° (c 1.0, CDCl3). IR (neat, cm
-1
): 3063.51, 2971.58, 2906.60, 1755.99, 1738.21, 
1370.53, 1238.96, 1221.96, 1095.80, 1040.72, 976.45. 
1
H NMR (300 MHz, CDCl3) δ 7.91 (s, 1H), 7.85 – 7.75 (m, 
3H), 7.57 (dd, J = 8.5, 1.7 Hz, 1H), 7.47 – 7.38 (m, 2H), 5.61 (s, 1H), 5.47 (ddd, J = 12.1, 10.4, 7.2 Hz, 1H), 5.24 
(dd, J = 52.6, 7.2 Hz, 1H), 4.94 (ddd, J = 10.4, 3.4, 1.0 Hz, 1H), 4.40 (d, J = 3.4 Hz, 1H), 4.37 (dd, J = 12.6, 1.6 Hz, 
1H), 4.08 (dt, J = 12.7, 1.7 Hz, 1H), 3.62 (s, 1H), 2.04 (s, 3H), 2.02 (s, 3H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 170.90, 
169.42, 134.75, 134.02, 133.04, 128.67, 128.41, 127.95, 126.71, 126.37, 126.11, 124.14, 107.65 (d, J = 217.2 Hz, 
1C), 101.64, 72.99, 71.27 (d, J = 10.9 Hz, 1C), 69.12, 68.80, 66.94 (d, J = 4.9 Hz, 1C), 21.09, 20.97. 
19
F NMR (282 
MHz, CDCl3) δ -142.25 (dd, J = 52.6, 12.1 Hz). HRMS: calc. [M+H]
+
: 405.1349 found [M+ H]
+
: 405.1331 
 
2,3-di-O-acetyl-4,6-O-(2-naphthyl)methylene-α-D-galactopyranosyl trichloroacetimidate (74) 
22 (490 mg; 1.22 mmol) was dried under vacuum for 12h and dissolved in anhydrous CH2Cl2 
(50 mL). CCl3CN (0.49 mL; 4.87 mmol) was added followed by DBU (20 μL; 0.13 mmol). The 
reaction was stirred for 1 h, concentrated and purified by flash chromatography (4:1 Tol/EtOAc) 
to afford only the α-trichloroacetimidate as a white powder. Rf 0.55 (1:1:0.005 
EtOAc/heptane/Et3N). Yield: 570 mg (85%)   
mp: 183.3 – 184.8 °C.     
  = +148° (c 1.0, CDCl3). IR (neat, cm
-1
): 3352.98, 3062.60, 2956.30, 2917.99, 2870.05, 
1743.18, 1669.09, 1371.45, 1235.55, 1218.17, 1075.35, 1053.86, 1032.68
1 
H NMR (300 MHz, CDCl3) δ 8.58 (s, 
1H), 7.91 (s, 1H), 7.86 – 7.69 (m, 3H), 7.55 (dd, J = 8.6, 1.6 Hz, 1H), 7.47 – 7.37 (m, 2H), 6.67 (d, J = 3.4 Hz, 1H), 
5.62 (s, 1H), 5.52 (dd, J = 10.8, 3.4 Hz, 1H), 5.36 (dd, J = 10.8, 3.4 Hz, 1H), 4.58 (d, J = 3.4 Hz, 1H), 4.31 (dd, J = 
12.7, 1.5 Hz, 1H), 4.04 (dd, J = 12.7, 1.7 Hz, 1H), 3.98 (dd, J = 1.7, 1.5 Hz, 1H), 2.04 (s, 3H), 1.96 (s, 3H). 
13
C 
NMR 
 
 (75 MHz, CDCl3) δ 170.95, 170.17, 161.16, 134.90, 133.98, 133.08, 128.67, 128.39, 127.93, 126.67, 126.36, 
125.97, 124.04, 101.44, 94.73, 73.65, 69.11, 68.79, 67.21, 64.94, 21.27, 20.83. 
HRMS: hydrolyzed on column 
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2,3-di-O-acetyl-4,6-O-benzylidene-D-galactopyranose N-phenyl trifluoroacetimidate (74) 
22 (420 mg; 1.19 mmol) was dissolved in anhydrous CH2Cl2 (10 mL) at 0 C. PTFAICl (495 
mg; 2.38 mmol) and Cs2CO3 (777 mg; 2.38 mmol). The reaction mixture was stirred for 6 h at 
22 C after which it was filtered through a plug of celite, concentrated and purified by flash 
chromatography (9:1 Tol/EtOAc) to afford 75 as a white foam. The product was used directly in 
the following glycosylation reaction without characterization to avoid degradation. Rf 0.43 (9:1 
Tol/EtOAc)). Yield: 474 mg (76%)   
 
Phenyl 2,3-di-O-acetyl-6-O-(2-naphthyl)methyl-1-thio-β-D-galactopyranoside (76) 
To a solution of 22 (2.0 g; 4.04 mmol) in dry THF (30 mL), NaCNBH3 (5.1 g; 80.88 mmol) was 
added. The mixture was stirred at 22 °C and a 2M solution of HCl in dry ether was added drop 
wise until gas development ceased and the mixture remained acidic (pH 3-4). The reaction 
mixture was concentrated to 5 ml, diluted with CH2Cl2 (100 ml) and neutralized with sat. aq. 
NaHCO3 (100 mL). The aqueous phase was extracted with CH2Cl2 (3x100 ml). The combined organic phases were 
washed with water (400 mL), dried over MgSO4, filtered and evaporated. The product was purified by flash 
chromatography (2:1 Tol/EtOAc) to afford 76 as colorless crystalline powder. Rf 0.39 (1:2 EtOAc/Tol). Yield: 1.70 
g (85%) 
mp: 68.3 – 71.5 °C.     
  = +5.5° (c 1.0, CDCl3). IR(neat, cm
-1
): 3500-3000, 3058.70, 2945.74, 2916.68, 
2820.42, 1741.63, 1725.79, 1367.73, 1242.88, 1218.38, 1033.12. 
1
H NMR (300 MHz, CDCl3) δ 7.86 – 
7.64 (m, 4H), 7.54 – 7.32 (m, 5H), 7.27 – 7.13 (m, 3H), 5.26 (t, J = 9.9 Hz, 1H), 4.92 (dd, J = 9.9, 3.1 Hz, 
1H), 4.67 (s, 2H), 4.65 (d, J = 9.9 Hz, 1H), 4.14 (d, J = 3.1 Hz, 1H), 3.80 – 3.65 (m, 3H), 2.01 (s, 3H). 13C 
NMR (75 MHz, CDCl3) δ 170.45, 169.78, 135.18, 133.43, 133.27, 132.82 (2C), 132.61, 129.17 (2C), 
128.58, 128.19, 128.14, 127.94, 126.88, 126.44, 126.27, 125.87, 86.59, 77.27, 74.71, 74.13, 69.74, 68.49,  
67.86, 21.17, 21.12. HRMS: calc. [M+Na]
+
: 519.1454 found [M+ Na]
+
: 519.1445 
 
Phenyl 2,3-di-O-acetyl-4,6-O-(2-naphthyl)methylene-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-6-O-(2-
naphthyl)methyl-1-thio-β-D-galactopyranoside (77) 
A mixture of 72b (270 mg; 0.54 mmol) and 76 (330 mg; 0.81 mmol) was dried 
azeotropically with benzene (2 x 10 mL) and subjected to vacuum overnight. The mixture 
was dissolved in dry CH2Cl2 (12 mL) and freshly activated 4Å molecular sieves (250 mg) 
were added. The slurry was cooled to -15 °C, followed by addition of BF3
.
OEt2 (8 drops (~39 
mg); 0.27 mmol). The reaction mixture was stirred at -15 °C for 1h and then at 5 °C for 3h. 
The reaction mixture was filtered through celite, diluted with CH2Cl2 (40 mL) and washed 
with sat. aq. NaHCO3 (50 mL). The organic phase was dried over MgSO4, filtered and concentrated. The product 
was purified by flash chromatography (2:1 Tol/EtOAc) to afford 77 as a colorless crystalline material. Rf 0.18 (2:1 
Tol/EtOAc). Yield: 201 mg (42%) 
mp: 89.5–91.8 °C.     
  = -8.3° (c 1.0, CDCl3). 
1
H NMR (300 MHz, cdcl3) δ 8.15 – 6.99 (m, 19H), 5.67 (s, 1H), 
5.43 (dd, J = 10.4, 7.9 Hz, 1H), 5.20 (t, J = 9.9 Hz, 1H), 5.07 – 4.97 (m, 2H), 4.76 (s, 1H), 4.71 (d, J = 10.0 Hz, 1H), 
4.62 (d, J = 7.9 Hz, 1H), 4.39 (d, J = 3.6 Hz, 1H), 4.32 (d, J = 2.9 Hz, 1H), 4.14 (d, J = 12.3 Hz, 1H), 3.99 (d, J = 
8.1 Hz, 1H), 3.96 (d, J = 8.2 Hz, H), 3.85 – 3.74 (m, 2H), 3.45 (s, 1H), 2.13 (s, 3H), 2.12 (s, 3H), 2.10 (s, 3H), 2.07 
(s, 3H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 171.06, 170.23, 169.57, 169.34, 135.87, 135.22, 133.94, 133.31, 132.96 
(2C), 131.99 (2C), 129.08-125.77 (m, 18C), 124.19, 101.49 (2C), 86.47, 74.662, 73.47, 73.30, 71.98, 69.10, 68.92, 
68.65, 68.03, 66.35, 20.99-20.71(4C). HRMS: calc. [M+NH4]
+
: 898.3109 found [M+ NH4]
+
: 898.3082 
 
2,6-dimethylphenyl 1-thio-β-D-galactopyranoside (78)163 
A solution of galactose pentaacetate (25.0 g; 64.0 mmol), 2,6-dimethylbenzenethiol (11.1 mL; 
83.3 mmol) and BF3
.
OEt2 (8.7 mL; 70.5 mmol) in CH2Cl2 (300 mL) was stirred at 22 °C for 16 h. 
The mixture was diluted with CH2Cl2 (100 mL) and washed with sat. aq. NaHCO3 (300 mL). The 
organic phase was dried over MgSO4, filtered and concentrated. Without further purification the 
peracetylated thioglycoside was deacetylated. Na (1.03 g; 44.8 mmol) was dissolved in MeOH (200 mL) and the 
NaOMe/MeOH solution was slowly added to a solution of the thioglycoside in MeOH (200 mL). The reaction 
mixture was stirred at 22 °C until TLC showed full conversion (12 h). The reaction was quenched with Amberlite 
IR-120 H
+
 (50 mL) and stirred for 1 h. The ion-exchange resin was filtered off, washed with MeOH and the filtrate 
was concentrated. The product was recrystallized from EtOAc to give 78 as colorless crystals. Rf  0.53 (1:1 
EtOAc/Acetone). Yield (over two steps) 7.4 g (69%)    
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2,6-dimethylphenyl 2,3-di-O-acetyl-4,6-O-benzylidene-1-thio-β-D-galactopyranoside (79)163 
To a solution of PhCH(OMe)2 (5.1 mL, 33.3 mmol) and camphor sulphonic acid (172 mg, 0.7 
mmol) in MeCN (150 mL) was added 78 (7.4 g, 24.6 mmol). The flask was equipped with a 
distillation unit and the mixture was heated to reflux for 2 h. During this period app. 100 mL of 
MeCN-MeOH was distilled off. The distillation unit was replaced with a condenser and the 
reaction mixture was heated to reflux until TLC showed completion (1 h). The reaction mixture 
was concentrated. The crude was dissolved in CH2Cl2 (150 mL). Et3N (10.4 mL; 74.8 mmol), 
DMAP (138 mg; 1.1 mmol) and acetic anhydride (6.4 mL; 67.9 mmol) was added to the solution and the reaction 
mixture was stirred until TLC revealed full conversion (2 h). The reaction was quenched with MeOH (10 mL), 
washed with water (2x200 mL), dried over MgSO4 and concentrated. Rf 0.70 (2:1 EtOAc/toluene). Yield (over two 
steps): 10.4 g (94%) 
1
H NMR (400 MHz, CDCl3) δ 7.51 – 7.39 (m, 2H, Ar-H), 7.37 – 7.23 (m, 3H, Ar-H), 7.14 – 6.97 (m, 3H, Ar-H), 
5.40 (t, J1,2 = J2,3 = 10.0 Hz, 1H, H-2), 4.88 (dd, J2,3 =  10.0, J3,4 = 3.6 Hz, 1H, H-3), 4.40 (d, J1,2 =  10.0 Hz, 1H, H-
1), 4.27 (dd, J3,4 =  3.6, J4,5 = 1.1 Hz, 1H, H-4), 4.10 (dd, J6a,6b =  12.4, J5,6a = 1.5 Hz, 1H, H-6a), 3.87 (dd, J6a,6b =  
12.4, J5,6b = 1.8 Hz, 1H, H-6b), 3.25 (m, 1H, H-5), 2.50 (s, 6H,  CH3
dSPh
), 2.06 (s, 3H, CH3
Ac
), 2.00 (s, 3H, CH3
Ac
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 170.84, 169.57, 144.41, 137.72, 131.52-126.54 (10C), 101.12, 88.61, 73.61, 73.22, 
69.47, 69.28, 67.92, 22.60(2C), 21.04, 20.98. HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for C25H28O7S: 495.1453; 
Found 495.1456. 
 
2,6-dimethylphenyl 2,3-di-O-acetyl-4,6-O-benzylidene-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-6-O-
benzyl-1-thio-β-D-galactopyranoside (80) 
To a 10 mL flame-dried flask was added 79b (200 mg, 0.42 mmol) and 75 (286 mg, 0.55 
mmol). The mixture was co-evaporated with toluene (2x5 mL) and subjected to vacuum 
overnight. The mixture dissolved in DCM (5 mL) and cooled to -30 °C. TMSOTf (10 
mg; 0.04 mmol) was added and the reaction mixture was stirred at -30 °C for 1h. Et3N 
(0.5 mL) was added and the reaction mixture was concentrated. The crude compound 
was purified by flash chromatography. Yield: 177 mg (52%) 
1
H NMR (400 MHz, CDCl3) δ 7.51 – 7.43 (m, 2H, Ar-H), 7.34 (m, 2H, Ar-H), 7.21 – 7.10 (m, 6H, Ar-H), 7.10 – 
6.97 (m, 3H, Ar-H), 5.41 (s, 1H, CH
benzylidene
), 5.34 (dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-2'), 5.12 (dd, J = 9.8 Hz, J1,2 
= 10.2, 1H, H-2), 4.89 (dd, J2,3 = 10.5, J3,4 = 3.6 Hz, 1H, H-3'), 4.85 (dd, J2,3 = 9.8, J3,4 = 3.1 Hz, 1H, H-3), 4.49 (d, 
J1,2 = 7.9 Hz, 1H, H-1'), 4.45 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2), 4.38 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2), 4.30 (d, J = 
10.2 Hz, 1H, H-1), 4.26 (d, J3,4 = 3.6 Hz, 1H, H-4'), 4.13 (dd, J3,4 =  3.1, J4,5 = 1.0 Hz, 1H, H-4), 4.01 (dd, J6a,6b =  
12.5, J5,6a = 1.6 Hz, 1H, J-6a,), 3.87 (dd, J6a,6b =  12.5, J5,6b = 1.7 Hz, 1H, H-6b'), 3.78 (dd, J6a,6b = 9.8, J5,6a = 6.1 Hz, 
1H, H-6a), 3.55 (dd, J6a,6b =  9.8, J5,6b = 5.4 Hz, 1H, H-6b), 3.51 – 3.42 (m, 1H, H-5), 3.33 (t, J5,6a = J5,6b = 1.3 Hz, 
1H, H-5'), 2.46 (s, 6H, 2xCH3
dSPh
), 2.13 (s, 3H, CH3
Ac
), 2.03 (s, 3H, CH3
Ac
), 2.02 (s, 6H, 2xCH3
Ac
). 
13
C NMR 
 
 (101 
MHz, CDCl3) δ 171.12, 170.26, 169.67, 169.44, 144.25, 138.49, 137.81, 131.74, 129.28, 129.23, 128.37, 128.37, 
128.34, 128.33, 127.61, 127.61, 127.48, 126.60, 126.59, 101.67, 101.26, 88.81, 77.39, 74.80, 73.60, 73.38, 73.33, 
72.11, 69.21, 68.97, 68.79, 68.65, 66.38, 22.69, 22.69, 21.10, 20.97, 20.96, 20.87. HRMS (ESI-TOF) m/z: [M + 
Na]
+ 
Calcd for C42H48NaO14S: 831.2663; Found 831.2668. 
 
Phenyl 6-O-acetyl-2,3-di-O-(tert-butyldimethylsilyl)-1-thio--D-glucopyranoside (81, 82, 83) 
To a solution of 3,4-dimethoxybenzaldehyde (1.65 g, 9.9 mmol) and camphor 
sulphonic acid (51 mg, 0.22 mmol) in MeCN (100 mL) was added 56 (2.0 g, 7.34 
mmol). The flask was equipped with a distillation unit and the mixture was heated to 
reflux for 2 h. During this period approx. 50 mL of MeCN-MeOH was distilled off. The distillation unit 
was replaced with a condenser and the reaction mixture was heated to reflux until TLC showed 
completion (1 h). The reaction mixture was concentrated, re-dissolved in toluene and filtered through a 
plug of silica to afford 81. To a solution of the crude acetal and DMAP (100 mg) in pyridine (15 mL) was 
slowly added TBSOTf (6.7 mL, 29.38 mmol) at 0 C. The mixture was heated to 60 C. After 14 h the 
reaction was quenched with MeOH, diluted with EtOAc, and washed with water and brine. The organic 
phase was dried over MgSO4 and concentrated to give an yellow oil. The crude oil was dissolved in 
MeOH (50 mL) followed by addition of PPTS (0.18 g; 0.73 mmol). The reaction was stirred at 22 °C 
until TLC showed full conversion (4h). The solution was concentrated and co-evaporated with toluene 
(50 mL) purified by flash chromatography (9:1 Tol/EtOAc) to give 82 as a colorless solid (2.6 g; 71% 
over three steps). The diol was dissolved in CH2Cl2 (50 mL) and cooled to 0 C. Et3N (0.76 mL; 7.79 
mmol) and Ac2O (0.38 mL; 5.71 mmol) were added and the reaction was stirred at 5 C for 10 h. The 
Experimental 
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reaction was quenched with MeOH (0.5 mL), diluted with CH2Cl2 (50 mL) and washed with H2O (100 
mL). The organic phase was dried over MgSO4, filtered and concentrated. The residue was purified by 
flash chromatography (19:1 Tol/EtOAc) to give 83. Yield 2.54 g (91%). Rf 0.28 (19:1 Tol/EtOAc)   
1
H NMR (400 MHz, CDCl3) δ 7.41 – 7.28 (m, 2H, Ar-H), 7.16 – 7.00 (m, 3H, Ar-H), 4.37 (d, J1,2 = 8.6 Hz, 1H, H-
1), 4.26 – 4.12 (m, 2H, H-6), 3.68 (dd, J3,4 = 3.2, J4,5 = 1.4 Hz, 1H, H-4), 3.67 (t, J1,2= J2,3 = 8.6 Hz, 1H, H-2), 3.53 
(ddd, J5,6a = 7.7, J5,6b = 4.8, J4,5 = 1.4 Hz, 1H, H-5), 3.49 (dd, J2,3 = 8.1, J3,4 = 3.2 Hz, 1H, H-3), 1.88 (s, 3H, CH3
Ac
), 
0.78 (s, 18H, CH3
TBDMS
), 0.09 (s, 3H, CH3
TBDMS
), 0.00 (s, 3H, CH3
TBDMS
), -0.03 (s, 3H, CH3
TBDMS
), -0.05 (s, 3H, 
CH3
TBDMS
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 170.90, 135.52, 131.43(2C), 128.83(2C), 127.25, 90.15, 77.28, 75.58, 
71.31, 70.17, 63.84, 26.48(3C), 26.44(3C), 20.97, 18.45, 18.35, -2.03, -3.21, -3.36, -3.95. HRMS (ESI-TOF) m/z: 
[M + Na]
+
 Calcd for : C26H46NaO6SSi2 565.2451; Found 565.2453. 
 
1,6-anhydro-β-D-galactopyranoside (84, 85)358 
A solution of galactose pentaacetate (25.0 g; 64.0 mmol), thiophenol (7.3 mL; 70.4 mmol) and 
BF3
.
OEt2 (7.9 mL; 64.0 mmol) in CH2Cl2 (200 mL) was stirred at 22 °C for 16 h. The mixture was 
diluted with CH2Cl2 (100 mL) and washed with sat. aq. NaHCO3 (300 mL). The organic phase was 
dried over MgSO4, filtered and concentrated. Without further purification phenyl 2,3,4,6-tetra-O-
acetyl-1-thio-β-D-galactopyranoside (84) (35 g) was added a solution of sodium hydroxide (53 g) in water (1 L). 
After the sugar was fully dissolved, the reaction mixture was heated to reflux for 12 h. The solution was cooled and 
12 M HCl (100 ml) was slowly added. 3 M HCl was then added slowly in portions until pH 3 was observed. The 
solution was concentrated to ~200 mL and washed with EtOAc (2 x 200 mL). The aqueous phase was evaporated to 
dryness and the residue was extracted with 1:1 DCM/MeOH (600 mL) using a Soxhlet extractor for 6-12 h. The 
mixture was finally concentrated to give a yellowish solid, which was purified by flash chromatography (9:1 
DCM/MeOH) to afford 85. Yield: 7.78 g (75%). Rf 0.38 (DCM/MeOH 6:1).  
mp. 220-222 °C,     
  = -21.3 (c 1.1, H2O) 
1
H NMR (300 MHz, D2O);  5.28 (s, 1H), 4.38 (t, J = 4.7 Hz, 1H), 4.19 
(d, J = 7.7 Hz, 1H), 3.93 (t, J = 4.3 Hz, 1H), 3.84 – 3.78 (m, 1H), 3.70 – 3.65 (m, 1H), 3.57 – 3.49 (m, 1H). 13C 
NMR 
 
 (75 MHz, D2O) δ 100.73, 74.37, 71.33, 70.22, 64.32, 63.61. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for: 
C6H10NaO5 185.0426; Found 185.0423. 
 
1,6-anhydro-3,4-O-(1-ethoxyethylidene)-β-D-galactopyranoside (86) 
85 (7.7 g; 47.5 mmol) was added to a mixture of triethyl orthoacetate (40 mL) and MeCN (40 mL). To 
the mixture was added p-toluene sulphonic acid monohydrate (90 mg; 0.475 mmol), a condenser was 
installed and the reaction mixture was heated to 60 °C on an oil bath. The reaction was monitored by 
TLC until full conversion of the starting material was observed (approx. 24 h). The reaction was 
quenched with Et3N (4 ml), and the solution was poured into ice-water (100 mL) and extracted with DCM (3 x 100 
mL). The combined organic phases were dried over MgSO4 and concentrated. The compound was purified by flash 
chromatography (2:1 Tol/EtOAc). Yield: 9.70 g (88%) Rf 0.28 (2:1Tol/EtOAc). 
    
  = -3.4° (c 0.5, CDCl3) 
1
H NMR (300 MHz, CDCl3) δ 5.37 (t, J = 1.2 Hz, 1H), 4.54-4.50(m, 2H), 4.36 – 4.27 
(m, 1H), 3.96 (d, J = 7.7 Hz, 1H), 3.87 (dd, J = 8.4, 1.2 Hz, 1H), 3.64 – 3.57 (m, 1H), 3.52 (qd, J = 7.1, 0.8 Hz, 2H), 
1.63 (s, 3H), 1.18 (t, J = 7.1 Hz, 3H) 
13
C NMR (75 MHz, CDCl3) δ 120.44, 101.36, 76.09, 71.90, 69.80, 63.88, 
58.68, 54.58, 19.80, 14.61. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for: C10H16NaO6 255.0845; Found 255.0848. 
 
2-O-acetyl-1,6-anhydro-3,4-O-(1-ethoxyethylidene)-β-D-galactopyranoside (87)169 
Compound 86 (10 g; 43.1 mmol) was dissolved in CH2Cl2 (200 mL). Et3N (10.5 mL; 75.4 mmol), 
DMAP (53 mg; 0.43 mmol) and acetic anhydride (6.1 mL; 64.6 mmol) was added to the solution and 
the reaction mixture was stirred for 3 hours. The reaction mixture was quenched with MeOH (5 mL), 
washed with water (200 mL), dried over MgSO4 and concentrated. The product was purified by flash 
chromatography (Tol/EtOAc 2:1) to afford the product as a white crystalline powder. Rf 0.27 (4:1 Toluene/EtOAc) 
Yield: 11.1 g (94%) 
mp.: 60 °C,     
  = -25.7° (c 1.0, CDCl3). 
1
H NMR (300 MHz, CDCl3) δ 5.38 (s, 1H), 4.91 (d, J = 0.7 Hz, 1H), 
4.62-4.50 (m, 2H), 4.24 (d, J = 6.9 Hz, 1H), 4.00 (d, J = 7.7 Hz, 1H), 3.63 (ddd, J = 7.7, 4.9, 1.2 Hz, 1H), 3.54 (qd, J 
= 7.0, 0.7 Hz, 2H), 2.13 (s, 3H), 1.66 (s, 3H), 1.19 (t, J = 7.1 Hz, 3H). 
13
C NMR 
 
 (75 MHz, CDCl3) δ 169.72, 
120.81, 99.09, 73.69, 72.07, 70.99, 69.62, 63.54, 59.36, 21.11, 19.92, 15.63. HRMS (ESI-TOF) m/z: [M + Na]
+
 
Calcd for: C12H18NaO7 297.0950; Found 297.0945 
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2,3-di-O-acetyl-1,6-anhydro-β-D-galactopyranoside (88)359 
To 87 (6.48 g; 23.6 mmol) was added a 4:1 H2O/AcOH mixture (90 mL) and the reaction was stirred 
for 30 min. The solution was concentrated and co-evaporated with toluene (3x100 mL) and heptane 
(100 mL). This resulted in a white crystalline material that did not need further purification. Rf 0.20 
(2:1 Tol/EtOAc). Yield: 5.67 g (97 %) 
mp.: 105-110 °C (litt.108-112 °C),     
  = +6.5° (c 1.0, CDCl3) (+1.2 °, c 1.6, CDCl3) 
1
H NMR (300 MHz, CDCl3) δ 5.38 (t, J = 1.4 Hz, 1H), 5.06 (dq, J = 5.5, 1.4 Hz, 1H), 4.76 (t, J = 1.5 Hz, 1H), 4.42 
(dd, J = 4.7, J=0.9 Hz, 1H), 4.25 (d, J = 7.6 Hz, 1H), 4.20 (t, J = 5.5 Hz, 1H), 3.68 (ddd, J = 7.5, 5.1, 0.9 Hz, 1H), 
2.15 (s, 3H), 2.10 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 171.57, 169.69, 98.81, 74.18, 71.18, 70.19, 64.75, 64.04, 
21.17, 21.04. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for: C10H14NaO7 269.0637; Found 269.0632. 
 
2,3-di-O-acetyl-4,6-O-benzylidene-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-1,6-anhydro-β-D-
galactopyranoside (89) 
A mixture of acceptor 88 (209 mg; 0.845 mmol) and donor 54 (501 mg; 1.12 mmol) was 
dried azeotropically with toluene (2x10 mL) and left under vacuum over night. The mixture 
was dissolved in dry CH2Cl2 (10 mL) and dry MeCN (10 mL) and cooled to -30 °C on an 
acetone/dry ice bath. Then NIS (260 mg; 1.2 mmol) and TESOTf (20 μL; 0.087 mmol) 
were added and the reaction mixture was stirred at -30 °C until TLC showed full 
conversion of the acceptor (30 min). The solution was diluted with CH2Cl2 (50 mL) and 
washed with sat. aq. NaS2O3 (15 mL) and sat. aq. NaHCO3 (15 mL), dried over MgSO4 and concentrated. The 
yellow crystalline product was purified by flash chromatography (2:1 toluene/EtOAc) to yield a white crystalline 
solid. Rf 0.14 (2:1 Toluene/EtOAc). Yield: 420 mg (85 %) 
mp. 90 C.     
  = +47.8 °(c 1.0, CHCl3), 
1
H NMR (300 MHz, CDCl3) δ 8.10 – 6.98 (m, 5H), 5.51 (d, J = 6.9 Hz, 
1H), 5.37 (t, J = 1.5 Hz, 1H), 5.35 – 5.25 (m, 2H), 4.90 (dd, J = 10.4, 3.7 Hz, 1H), 4.76 (dd, J = 10.0, 5.5 Hz, 1H), 
4.70 (t, J = 1.6 Hz, 1H), 4.62 (d, J = 7.9 Hz, 1H), 4.41 (t, J = 5.1 Hz, 1H), 4.38 (d, J = 3.7 Hz, 1H), 4.29 (dd, J = 
12.5, 1.4 Hz, 1H), 4.14 – 3.98 (m, 2H), 3.78 – 3.66 (m, 1H), 3.54 (d, J = 1.0 Hz, 1H), 2.10 (s, 3H), 2.09 (s, 3H), 2.08 
(s, 3H), 2.07 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 170.94, 170.14, 169.83, 169.52, 129.37, 129.26, 128.57, 128.45, 
126.40, 125.52, 102.40, 101.05, 98.76, 74.51, 73.24, 72.69, 72.06, 71.94, 69.08, 68.25, 67.30, 66.70, 54.66, 22.92, 
21.14, 21.05, 20.98. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for: C27H32NaO14 603.1690; Found 603.1691. 
 
Acetyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl-(1→4)-2,3,6-di-O-acetyl-D-galactopyranoside (90)360 
Sc(OTf)3 (2 mg; 0.004 mmol) was added to a solution of 89 (500 mg, 0.86 mol) in 
Ac2O (5 mL) and the mixture was stirred at 0 C for 1 h. The reaction was quenched 
by the addition of MeOH. The reaction mixture was concentrated and the product 
was purified by silica gel chromatography (4:1 Tol/EtOAc) to afford 90. Yield: 555 
mg (95%). The NMR correlates with literature data.
360
 
 
2,3-di-O-acetyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-1,6-anhydro-β-D-galactopyranoside 
(91) 
To a solution of the disaccharide 89 (0.99 g; 1.71 mmol) in dry THF (30 mL) was added 
NaCNBH3 (1.61 g; 25.6 mmol). The mixture was stirred at 22 °C, and a 2M solution of HCl 
in dry ether was added drop-wise until gas development ceased. The mixture was 
concentrated to approximately 5 mL and then diluted with CH2Cl2 (100 mL). The mixture 
was neutralized with sat. aq. NaHCO3 (100 mL). The aqueous phase was extracted with CH2Cl2 (3x30 mL) and the 
combined organic phases were washed with water (100 mL), dried over MgSO4, filtered, and concentrated. The 
product was purified by flash chromatography (3:2 Tol/EtOAc) to yield a white crystalline solid. Rf 0.31 (3:2 
toluene/EtOAc). Yield: 777 mg (78%) 
Mp. 69 °C,     
  = +7.88° (c 0.7, CDCl3) 
1
H NMR (300 MHz, CDCl3) δ 7.50 – 7.21 (m, 5H, Ar-H), 5.37 (d, J = 1.4 
Hz, 1H), 5.33 – 5.27 (m, 1H), 5.21 (dd, J2,3 = 10.3, J1,2 = 7.9 Hz, 1H, H-2’), 4.89 (dd, J2,3 = 10.3, J3,4 = 3.2 Hz, 1H, 
H-3), 4.74 – 4.65 (m, 2H), 4.62 – 4.47 (m, 3H), 4.38 (d, J1,2 = 7.9 Hz, 1H, H-1’), 4.14 (d, J3,4 = 3.2 Hz, 1H, H-4), 
4.02 (t, J = 4.7 Hz, 1H), 3.80 – 3.61 (m, 5H), 2.10 (s, 3H, CH3
Ac
), 2.08 (s, 3H, CH3
Ac
), 2.06 (s, 3H, CH3
Ac
), 2.05 (s, 
3H, CH3
Ac
) 
13
C NMR 
 
 (75 MHz, CDCl3) δ 170.30, 170.02(2C), 169.54, 129.25-128.02(6C), 102.69, 98.73, 74.45, 
73.92, 73.46, 73.33, 72.94, 71.94, 69.13, 68.76, 67.91, 67.17, 64.84, 21.07-20.87(m, 4C). HRMS (ESI-TOF) m/z: 
[M + Na]
+
 Calcd for: C27H34NaO14 605.1846; Found 605.1844. 
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2,3-di-O-acetyl-6-O-benzyl-4-O-chloroacetyl-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-1,6-anhydro-β-D-
galactopyranoside (92) 
Compound 91 (1.3 g; 2.2 mmol) was dissolved in CH2Cl2 (40 mL) and cooled to 0 °C. 
(ClAc)2O (0.65 g; 3.8 mmol), Et3N (0.54 mL; 3.9 mmol) and DMAP (5 mg; 0.4 mmol) was 
added and the reaction was stirred at 0 °C for 3 h. The reaction mixture was concentrated and 
purified by flash chromatography (9:1 Tol/EtOAc) to afford 92 as a white crystalline powder. 
Yield 1.42 g (98%) 
1
H NMR (400 MHz, CDCl3) δ 7.34 – 7.15 (m, 5H, Ar-H), 5.43 (dd, J3,4 = 3.3, J4,5 = 1.2 Hz, 1H, H-4'), 5.31 (d, J1,2 = 
1.5 Hz, 1H, H-1), 5.23 (dd, J3,4 = 5.0,  J2,3 = 1.5 Hz, 1H, H-3), 4.99 (dd, J2,3 = 10.5, J1,2 = 7.6 Hz, 1H, H-2'), 4.92 (dd, 
J2,3 = 10.5, J3,4 = 3.3 Hz, 1H, H-3'), 4.62 (dd, J1,2 = J2,3 = 1.5 Hz, 1H, H-2), 4.59 – 4.54 (m, 1H, H-5), 4.50 (d, J1,2 = 
7.6 Hz, 1H, H-1'), 4.46 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2
Bn
), 4.35 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2
Bn
), 4.30 (dd, J6a,6b 
= 7.6, J5,6a = 0.8 Hz, 1H, H-6a), 3.99 (d, JCH2 = 14.8 Hz, 1H, 0.5xCH2
AcCl
), 3.94 (td, J3,4 = 5.0, J4,5 = 1.0 Hz, 1H, H-
4), 3.87 (d, JCH2 = 14.8 Hz, 1H, 0.5xCH2
AcCl
), 3.81 (ddd, J5,6b = 7.1, J5,6a = 5.9, J4,5 = 1.2 Hz, 1H, H-5'), 3.63 (dd, J6a,6b 
= 7.6, J5,6b = 5.2, 1H, H-6b), 3.45 (dd, J6a,6b = 9.2, J5,6b = 5.9 Hz, 1H, H-6a'), 3.37 (dd, J6a,6b = 9.2, J5,6b =7.1 Hz, 1H, 
H-6b'), 2.04 (s, 3H, CH3
Ac
), 2.00 (s, 3H, CH3
Ac
), 1.99 (s, 3H, CH3
Ac
), 1.91 (s, 3H, CH3
Ac
). 
13
C NMR (101 MHz, 
CDCl3) δ 170.02, 169.87(2C), 169.40, 166.91, 137.30, 128.70(2C), 128.23, 128.19(2C), 102.50, 98.67, 74.31, 
73.64, 72.98, 71.95, 71.82, 70.75, 69.28, 68.30, 67.04, 66.84, 64.67, 40.66, 20.95(2C), 20.80, 20.64.  HRMS (ESI-
TOF) m/z: [M + Na]
+
 Calcd for: C29H36ClNaO15 682.1640; Found 682.1641. 
 
Acetyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl-(1→4)-2,3,6-di-O-acetyl-D-galactopyranoside (93) 
Sc(OTf)3 (1.8 mg; 0.004 mmol) was added to a solution of 92 (478 mg, 0.72 mol) in 
Ac2O (5 mL) at 0 C and the mixture was stirred at 0 C for 1 h. The reaction was 
quenched by the addition of MeOH. The reaction mixture was concentrated and the 
product was purified by silica gel chromatography (4:1 Tol/EtOAc) to afford 90. 
Yield: 470 mg (91%).  
2,3-di-O-acetyl-6-O-benzyl-4-O-(tert-butyldimethylsilyl)-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-1,6-
anhydro-β-D-galactopyranoside (96) 
Compound 91 (1 g; 1.72 mmol) was dissolved in pyridine (8 mL), and DMAP 
(100 mg) was added. The reaction mixture was stirred 0 C, and tert-
butyldimethylsilyl trifluoromethanesulphonate (0.68 g; 2.57 mmol) was added 
slowly. The reaction was heated to 50 C and stirred over night. After cooling to 0 
C, the reaction was quenched by addition of MeOH. The mixture was diluted with EtOAc, washed with 
water, HCl (1 M), sat. aq. NaHCO3 and brine. The organic phase was concentrated and purified by flash 
chromatography (4:1 Tol/EtOAc) to give 96 as a colorless glassy solid (1.1 g, 92%). 
Phenyl 2,3-di-O-acetyl-6-O-benzyl-4-O-(tert-butyldimethylsilyl)-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-
1-thio-β-D-galactopyranoside (97) 
The disaccharide 96 (1.0 g; 1.43 mmol) was mixed with (phenylthio) trimethylsilane (0.95 
mL; 5.02 mmol) and ZnI2 (801 mg; 2.51 mmol) in C2H4Cl2 (30 mL) and stirred at 22 °C 
for 8 h. The mixture was then diluted with Et2O (200 mL) and washed with 1 M HCl (100 
mL). The organic layer was dried with MgSO4, filtered and concentrated. Purified by flash 
chromatography (2:1 Tol/EtOAc) to give 97 as a yellow crystalline material. Yield: 671 
mg (58%) 
1
H NMR (400 MHz, CDCl3) δ 7.53 – 6.98 (m, 5H, Ar-H), 5.20 (dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-2'), 5.04 (t, J1,2 
= J2,3 = 9.9 Hz, 1H, H-2), 4.92 (dd, J2,3 = 9.9, J3,4 = 3.0 Hz, 1H, H-3), 4.85 (dd, J2,3 = 10.4, J3,4 = 2.7 Hz, 1H, H-3'), 
4.63 (d, J1,2 =  9.9 Hz, 1H, H-1), 4.50 (d, J1,2 =  7.9 Hz, 1H, H-1'), 4.28 (d, J3,4 =  3.0 Hz, 1H, H-4), 3.99 – 3.85 (m, 
1H, H-6a), 3.91 (d, J3,4 =  2.7 Hz, 1H, H-4'), 3.81 – 3.60 (m, 5H, 2xH-5, 1.5xH-6,), 2.02 (s, 3H, CH3
Ac
), 1.98 (s, 6H, 
2xCH3
Ac
), 1.95 (s, 3H, CH3
Ac
), 0.85 (s, 9H, 3xCH3
TBDMS
), 0.00 (s, 3H, CH3
TBDMS
), -0.07 (s, 3H, CH3
TBDMS
). 
13
C 
NMR 
 
 (101 MHz, CDCl3) δ 171.13, 170.56, 169.91, 169.52, 132.53, 131.81(2C), 129.19(2C), 127.94, 102.05, 
86.15, 76.64, 75.14, 74.25, 73.81, 73.41, 69.09, 68.59, 67.68, 63.11, 59.76, 25.93(3C), 21.36, 21.26, 20.98, 20.69, 
18.41, -4.20, -4.48. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for: C39H54NaO14SSi 829.2901; Found 829.2899. 
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Phenyl 2,3-di-O-acetyl-6-O-benzyl-4-O-(tert-butyldimethylsilyl)-β-d-galactopyranosyl-(1→4)-2,3,6-tri-O-
acetyl-1-thio-β-d-galactopyranoside (98) 
The disaccharide 97 (200 mg; 0.25 mmol) was dissolved in CH2Cl2 (10 mL). Et3N (55 
L; 0.40 mmol), DMAP (1 mg; 0.005 mmol) and Ac2O (35 L; 0.37 mmol) were added 
and the reaction mixture was stirred at 22 °C until TLC revealed full conversion (2 h). The 
reaction was quenched with MeOH (0.5 mL), diluted with CH2Cl2 (50 mL), washed with 
water (2x25 mL), dried over MgSO4 and concentrated. The product was purified by flash 
chromatography (2:1 Tol/EtOAc). Yield: 206 mg (98%) 
 
Phenyl 2,3-di-O-acetyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-1-thio-β-D-galactopyranoside 
(99) 
The disaccharide 91 (490 mg; 0.841 mmol) was mixed with (phenylthio) trimethylsilane (0.7 
mL; 3.7 mmol) and ZnI2 (678 mg; 2.12 mmol) in C2H4Cl2 (10 mL) and stirred at 22 °C for 
14 h. The mixture was diluted with Et2O (100 mL) and washed with 1 M HCl (50 mL). The 
organic layer was dried with MgSO4, filtered and concentrated. Purified by flash 
chromatography (3:2 Tol/EtOAc). Rf 0.32 (1:1 Tol/EtOAc). Yield: 243 mg (41 %) 
Mp. 85 °C,     
  = -3.96 ° (c 0.5, CDCl3) 
1
H NMR (300 MHz, CDCl3) δ 7.51 – 6.90 (m, 10H), 5.29 – 5.15 (m, 2H), 
5.03 (t, J1,2 = J2,3 = 9.8 Hz, 1H, H-2), 4.91 (dd, J2,3 = 9.8, J3,4 =  3.2 Hz, 1H, H-3), 4.84 (dd, J2,3 = 10.3, J3,4 = 2.9 Hz, 
1H, H-3), 4.57 (dd, J = 10.9, 6.0 Hz, 2H), 4.43 – 4.29 (m, 2H), 4.18 (d, J3,4 = 2.9 Hz, 1H), 3.97 – 3.83 (m, 2H), 3.78 
– 3.44 (m, 4H), 2.03 (s, 3H, CH3
Ac
), 2.01 (s, 3H, CH3
Ac
), 1.99 (s, 3H, CH3
Ac
), 1.97 (s, 3H, CH3
Ac
) 
13
C NMR 
 
 (75 
MHz, CDCl3) δ 170.48, 170.30, 169.87, 169.40, 137.23-128.02(12C), 102.69, 86.28-59.25(12C), 21.10, 21.06, 
21.01, 20.69. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for: C33H40NaO14S 71520365; Found 715.2031. 
 
Phenyl 2,3-di-O-acetyl-6-O-benzyl-4-O-chloroacetyl-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-6-O-
benzoyl-1-thio-β-D-galactopyranoside (100) 
To a solution of 99 (205 mg; 0.296 mmol) in CH2Cl2 (10 mL) at 0 °C was added BzCl 
(0.04 mL; 0.311 mmol) and Et3N (0.06 mL; 0.444 mmol) and the reaction was stirred for 
10h at 5 °C. The reaction mixture was quenched with MeOH (1 mL), diluted with CH2Cl2 
(100 mL), and washed with H2O (60 mL). The water phase was washed with CH2Cl2 (60 
mL) and the combined organic phases were dried over MgSO4, filtered, and concentrated yielding a syrupy residue. 
The crude product was dissolved in CH2Cl2 (10 mL) and cooled to 0 °C. Chloroacetic anhydride (76 mg; 0.45 
mmol), Et3N (78 L; 0.55 mmol) and DMAP (5 mg; 0.045 mmol) was added and the reaction was stirred at 22 °C 
for 8 h. The reaction was quenched with MeOH (0.5 mL) and concentrated. The product was purified by flash 
chromatography (3:1 Tol/EtOAc). Rf 0.40 (2:1 Tol/EtOAc). Yield over two steps: 193 mg (75 %). 
Mp. 76 °C,     
  = -8.0 °(c 0.5, CHCl3). 
1
H NMR (300 MHz, CDCl3) δ 8.27 – 6.74 (m, 15H), 5.42 (d, J3,4 = 3.1 Hz, 
1H, H-4’), 5.20 – 5.02 (m, 2H), 5.02 – 4.82 (m, 2H), 4.61 (d, J = 10.0 Hz, 1H), 4.53 (dd, J = 11.9, 4.6 Hz, 1H), 4.47 
– 4.29 (m, 3H), 4.26 – 4.10 (m, 2H), 4.00 (d, JCH2 = 15.1 Hz, 1H), 3.93 – 3.79 (m, 2H), 3.70 (d, J = 6.6 Hz, 1H), 
3.38 – 3.19 (m, 2H), 2.04 (s, 3H), 2.03 (s, 3H), 2.00 (s, 3H), 1.93 (s, 3H). 13C NMR   (75 MHz, CDCl3) δ 170.41, 
170.30, 169.64, 169.47, 167.14, 166.31, 137.47-127.95(18C), 102.07, 86.76, 75.93-66.95(11C), 40.81, 21.04, 21.03, 
20.85, 20.78. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for: C42H46ClNaO16S 896.2093; Found 896,2088. 
 
2,3-di-O-acetyl-6-O-benzyl-4-O-chloroacetyl-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-6-O-benzoyl-β-D-
galactopyranosyl-(1→4)-2,3-O-acetyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3-O-acetyl-1,6-anhydro-β-D-
galactopyranoside (101) 
A mixture of acceptor 91 (40 mg; 0.069 mmol) and donor 100 (50 mg; 0.057 
mmol) was dried azeotropically with toluene (2x2 mL) and subjected to 
vacuum over night. The mixture was then dissolved in dry CH2Cl2 (1 mL) and 
dry MeCN (1 mL) and cooled to -30 °C. NIS (13 mg; 0.059 mmol) and one 
drop of TESOTf was added and the mixture was stirred at -30 °C until TLC 
showed full conversion of the donor 1 h. The solution was diluted with CH2Cl2 
(15 mL) and washed with 10 mL of sat. aq. NaS2O3 and 10 mL of sat. aq. NaHCO3. The organic phase was dried 
over MgSO4, filtered and concentrated, yielding a syrupy residue. The product was purified by flash 
chromatography (3:2 Tol/EtOAc). Rf 0.24 (1:1 Tol/EtOAc). Yield: 31 mg (41 %) 
Mp.: 95 °C,     
  = -6.6 °(c 1.0, CHCl3) 
1
H NMR (300 MHz, CDCl3) δ 8.13 – 6.74 (m, 15H), 5.42 (d, J = 3.0 Hz, 
1H), 5.35 – 3.10 (m, 33H), 2.06 (s, 3H), 2.06 (s, 3H), 2.04 (s, 3H), 2.03 (s, 3H), 1.98 (s, 3H), 1.97 (s, 3H), 1.97 (s, 
3H), 1.94 (s, 3H) 
13
C NMR 
 
(50 MHz, CDCl3) δ 170.24-166.01(m, 10 C), 138.14-128.07(m, 18C), 102.19(1C), 
101.93(1C), 101.64(1C), 98.60(1C), 74.14-63.53(m, 22C), 40.62(1C), 20.93-20.81(8C) 
Experimental 
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Pent-4-enyl 3-O-acetyl-2-O-benzoyl-4,6-O-benzylidene-β-D-galactopyranoside (103) 
110 (4.6 g; 12.15 mmol) was dissolved in pyridine (80 mL). DMAP (45 mg; 0.36 mmol) and 
benzoyl chloride (2.11 mL; 18.23 mmol) was added to the solution and the reaction mixture was 
stirred at 22 °C for 12 h. The reaction was quenched with MeOH (2 mL), concentrated and 
purified by flash chromatography (9:1 Tol/EtOAc) to afford 103 as a white crystalline solid. 
Yield 5.4 g (92%). Rf 0.31 (9:1 Tol/EtOAc). 
1
H NMR (400 MHz, CDCl3) δ 8.02 – 7.88 (m, 2H, Ar-H
Bz
), 7.60 – 7.22 (m, 8H, Ar-H), 5.64 – 5.48 (m, 1H, -
CH=CH2), 5.59 (dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-2), 5.46 (s, 1H, CH
benzylidene
), 5.10 (dd, J2,3 = 10.4, J3,4 = 3.6 Hz, 
1H, H-3), 4.77 – 4.67 (m, 2H, -CH=CH2), 4.56 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.34 (dd, J3,4 = 3.6, J4,5 = 1.5 Hz, 1H, H-
4), 4.28 (dd, J6a,6b = 12.4, J5,6a = 1.5 Hz, 1H, H-6a), 4.02 (dd, J6a,6b = 12.4, J5,6b = 1.5 Hz, 1H, H-6b), 3.86 (dt, J = 9.5, 
6.0 Hz, 1H, -OCH2
pentenyl
), 3.49 (t, J5,6a = J5,6b = 1.5 Hz, 1H, H-5), 3.41 (ddd, J = 9.6, 7.4, 6.1 Hz, 1H, -OCH2
pentenyl
), 
1.91 (s, 3H, CH3
Ac
), 1.91 (s, 2H, -CH2
pentenyl
), 1.64 – 1.40 (m, 2H,-CH2
pentenyl
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 
170.96, 165.20, 138.05, 137.62, 133.23, 129.87, 129.80(2C), 129.16, 128.51(2C), 128.27(2C), 126.51(2C), 114.78, 
101.34, 101.14, 73.70, 72.05, 69.30, 69.07, 68.84, 66.52, 29.92, 28.62, 20.97. HRMS (ESI-TOF) m/z: [M + Na]
+
 
Calcd for: C27H30NaO8, 505.1838; Found 505.1840. 
 
3-O-acetyl-2-O-benzyl-4,6-O-benzylidene-α-D-galactopyranosyl trichloroacetimidate (104) 
Compound 103 (3.53 g; 7.32 mmol) was dissolved in dry CH2Cl2 (30 mL) and cooled to 0 C. 
Br2 (1.29 g; 8.05 mmol) was added drop-wise and the resulting reaction mixture was stirred at 0 
C for 2 h. The reaction mixture poured into a solution of TBAB (4.72 g; 14.63 mmol), H2O 
(1.32 g; 73.16 mmol) and Et3N (0.51 mL; 3.66 mmol) in MeCN (100 mL). The reaction mixture 
was heated to 55 C and stirred for 4 h. The reaction mixture was diluted with CH2Cl2 (200 mL) 
and washed with water (200 mL). The organic phase was dried over MgSO4, filtered and concentrated. The product 
was purified by flash chromatography (2:1 Tol/EtOAc) to give 111. Yield: 2.55 g. Small impurities from TBAB are 
present in the compound. Compound 111 was applied directly in the following step. 111 (2.55 g; 6.15 mmol) was 
dissolved in CH2Cl2 (50 mL) and cooled to 0 °C. DBU (0.10 mL; 0.68 mmol) was added followed by 
trichloroacetonitrile (1.78 g; 12.31 mmol). The reaction was tirred at 0 C  for 3h. It was then filtered, concentrated 
and purified by flash chromatography (9:1) to give 104 as an /-mixture. 
Yield:  2.86 g (70%) over two steps  
 
Pent-4-enyl 3-O-acetyl-2-O-benzoyl-6-O-benzyl-β-D-galactopyranoside (105) 
NaCNBH3 (3.44 g; 54.75 mmol) was added to a solution of 103 (1.76 g; 3.65 mmol) in dry THF 
(30 mL). The mixture was stirred at 22 °C while HCl
 
in Et2O (2M) was added drop wise until gas 
development ceased and the mixture remained acidic (pH 3-4). The reaction mixture was 
concentrated to app. 10 ml, diluted with CH2Cl2 (100 mL) and neutralized with sat. aq. NaHCO3 (100 mL). The 
aqueous phase was extracted with CH2Cl2 (3x50 mL). The combined organic phases were washed with water (100 
mL), dried over MgSO4, filtered and evaporated. The product was purified by flash chromatography (4:1 
Tol/EtOAc) to afford 105 as a colorless crystalline powder. Yield: 1.38 g (78%) Rf 0.38 (4:1 Tol/EtOAc) 
1
H NMR (400 MHz, CDCl3) δ 8.00 – 7.84 (m, 2H, Ar-H
Bz
), 7.58 – 7.15 (m, 8H, Ar-HBz), 5.64 – 5.51 (m, 1H, -
CH=CH2), 5.47 (dd, J2,3 = 10.3, J1,2 = 7.9 Hz, 1H, H-2), 5.07 (dd, J2,3 = 10.3, J3,4 = 3.1 Hz, 1H, H-3), 4.79 – 4.64 (m, 
2H, -CH=CH2), 4.55 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2
Bn
), 4.51 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2
Bn
), 4.51 (d, J1,2 = 7.9 
Hz, 1H, H-1), 4.14 (dd, J4,OH = 4.7, J3,4 = 3.1 Hz, 1H, H-4), 3.83 (dt, J = 9.7, 6.1 Hz, 1H, -OCH2
pentenyl
), 3.78 – 3.67 
(m, 3H, H-5, H-6), 3.42 (ddd, J = 9.7, 7.2, 6.1 Hz, 1H,  -OCH2
pentenyl
), 2.59 (d, J = 4.5 Hz, 1H, 4-OH), 1.94 (s, 3H, 
CH3
Ac
), 1.93 – 1.81 (m, 2H, CH2
pentenyl
), 1.62 – 1.44 (m, 2H, CH2
pentenyl
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 170.44, 
165.37, 138.01(2C), 137.72, 133.31, 129.87(2C), 128.66(2C), 128.56(2C), 128.06, 127.93(2C), 114.91, 101.72, 
73.96, 73.48, 73.35, 70.05, 69.30, 68.40, 29.94, 28.71, 21.01. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for: 
C27H32NaO8, 507.1995; Found 507.1998. 
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Pent-4-enyl 3-O-acetyl-2-O-benzoyl-4,6-O-benzylidene-β-D-galactopyranosyl-(1→4)-3-O-acetyl-2-O-benzoyl-
6-O-benzyl-β-D-galactopyranoside (106)  
To a 50 mL flame-dried flask was added 105 (1.45 g, 2.99 mmol) and 112 (2.28 g, 3.89 
mmol). The mixture was co-evaporated with toluene (2x30 mL) and subjected to vacuum 
overnight. The mixture dissolved in DCM (20 mL) and cooled to -40 °C. TESOTf (43 mg; 
0.30 mmol) was added and the reaction mixture was stirred at -20 °C for 4h. Et3N (0.5 mL) 
was added and the reaction mixture was concentrated. The crude compound was purified 
by flash chromatography (9:1 Tol/EtOAc) to give 106. Yield: 5.13 g (82%) Rf 0.29 (9:1 
Tol/EtOAc) 
1
H NMR (400 MHz, CDCl3) δ 8.12 – 7.90 (m, 2H, Ar-H
Bz
), 7.92 – 7.69 (m, 2H, Ar-HBz), 7.63 – 6.96 (m, 16H, Ar-
H), 5.58 – 5.53 (m, 1H, -CH=CH2) 5.55 (dd, J2,3 = 10.5, J1,2 = 7.6 Hz, 1H, H-2), 5.45 (s, 1H, CH
benzylidene
), 5.22 (dd, 
J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-2), 5.17 (dd, J2,3 = 10.5, J3,4 = 3.5 Hz, 1H, H-3), 5.08 (dd, J2,3 = 10.4, J3,4 = 3.1 Hz, 
1H, H-3), 4.75 – 4.64 (m, 2H, -CH=CH2), 4.71 (d, J1,2 = 7.8 Hz, 1H), 4.53 (s, 2H, CH2
Bn
), 4.45 (d, J1,2 = 7.9 Hz, 1H, 
H-1), 4.29 (d, J3,4 = 3.5 Hz, 1H, H-4), 4.19 (d, J3,4 = 3.1 Hz, 1H, H-4), 4.07 (dd, J6a,6b = 12.3, J5,6a=1.6 Hz, 1H, H-6a), 
3.92-3.90 (m, 2H, H-6b, H-6a), 3.76 (dt, J = 9.7, 6.1 Hz, 1H, -OCH2
pentenyl
), 3.72 – 3.65 (m, 2H, H-6b, H-5), 3.42 
(dd, J5,6a = J5,6b =1.3 Hz, 1H, H-5), 3.35 (ddd, J = 9.7, 7.2, 6.2 Hz, 1H, -OCH2
pentenyl
), 1.94 (s, 3H, CH3
Ac
), 1.90 – 1.75 
(m, 2H, CH2
pentenyl
), 1.64 (s, 3H, CH3
Ac
), 1.54 – 1.36 (m, 2H, CH2
pentenyl
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 171.11, 
170.43, 165.32, 164.24, 138.51, 138.21, 137.82, 132.97, 132.82, 130.23, 130.15(2C), 129.95, 129.66(2C), 129.32, 
128.43(2C), 128.39(3C), 128.24(2C), 127.79(2C), 127.58, 126.64(2C), 114.66, 101.71, 101.40, 101.29, 74.07, 
73.90, 73.57, 73.45, 73.23, 71.85, 70.06, 70.03, 69.10, 68.68, 68.57, 66.37, 29.93, 28.62, 21.05, 20.60. HRMS (ESI-
TOF) m/z: [M + Na]
+
 Calcd for: C49H52NaO15, 903.3204; Found 903.3204. 
 
Pent-4-enyl β-D-galactopyranoside (108)349 
To a solution of galactose pentaacetate (35 g; 89.7 mmol) and pent-4-en-1-ol (20 mL, 194 mmol) 
in CH2Cl2 (250 mL) was added BF3∙OEt2 (14 mL, 110 mmol). The mixture was stirred at 22 °C 
under an atmosphere of nitrogen for 10 h, and then diluted with CH2Cl2 (100 mL) and washed with 
sat. aq. NaHCO3 (350 mL). The organic layer was dried over MgSO4 and concentrated. The syrupy 
residue was dissolved in 0.04 M NaOMe in MeOH (300 mL) and stirred for 4 h. The mixture was quenched with 
Amberlite IR-120 (H
+
) (15 mL) and stirred for an additional 30 min. The resin was removed by filtration and the 
filtrate concentrated and purified by flash chromatography (6:1 CH2Cl2/MeOH) to give 17.5 g of a greasy solid. 
Recrystallization from EtOAc afforded 108 (12.5 g, 56%) as white crystals. Rf 0.30 (6:1 CH2Cl2/MeOH) 
mp 88-90 °C (EtOAc).     
  = –10.0 (c 1.6, H2O). (lit.
 
–9.02 (c 1.23, H2O). 
1
H NMR (D2O, 300 MHz) δ 5.82 (m, 
1H), 5.01 (d, J = 17.4 Hz, 1H), 4.94 (d, J = 10.2 Hz, 1H), 4.30 (d, J = 8.0 Hz, 1H), 3.87-3.82 (m, 2H), 3.72-3.51 (m, 
5H), 3.42 (t, J = 8.9 Hz, 1H), 2.07 (m, 2H), 1.65 (m, 2H). 
13
C NMR (D2O, 75 MHz) δ 139.1, 115.0, 103.0, 75.3, 
73.1, 71.0, 70.1, 68.9, 61.1, 29.6, 28.3 
 
Pent-4-enyl 4,6-O-benzylidene-β-D-galactopyranoside (109)361 
To a solution of PhCH(OMe)2 (33 mL, 220 mmol) and CSA (450 mg) in CHCl3 (980 mL) was 
added 108 (38.5 g, 155 mmol). The flask was equipped with a distillation unit and the mixture 
heated at reflux for 1.5 h during which time about 250 mL of a CHCl3-MeOH mixture distilled 
off. The reaction mixture was quenched with Et3N (0.7 mL) and concentrated to a solid which was 
recrystal-lized from EtOAc to give 109 (51.7 g, 99%). Rf 0.53 (EtOAc). 
Mp. 158-160 °C (EtOAc).     
  = -36.5 (c 1.5, CHCl3). 
1
H NMR (CDCl3, 300 MHz) 7.49 (m, 2H, Ar-H), 7.35 (m, 
3H, Ar-H), 5.81 (m, 1H, CH=CH2), 5.54 (s, 1H, CH
benzylidene
), 5.04 (dq, Jtrans = 17.1, JCH2 =1.7 Hz, 1H, CH=CH2), 
4.97 (dq, Jcis = 10.4, JCH2 =1.7 Hz, 1H, CH=CH2), 4.32 (dd, J6a,6b = 12.5, J5,6a= 1.5 Hz, 1H, H-6a), 4.26 (d, J1,2 = 7.3 
Hz, 1H, H-1), 4.20 (dd, J3,4 = 3.6, J4,5 =1.5 Hz, 1H), 4.07 (dd, J6a,6b = 12.5, J5,6b= 1.5 Hz 1.9 Hz, 1H, H-6b), 3.98 
(dt, J = 9.7, 6.6 Hz, 1H, -OCH2), 3.74 (dd, J2,3 = 9.6, J1,2 = 7.3 Hz, 1H, H-2), 3.69 (dd, J2,3 = 9.6, J3,4 = 3.6 Hz, 1H), 
3.52 (dt, J = 9.4, J = 7.0 Hz, 1H, -OCH2), 3.46 (m, 1H, H-5), 2.24-2.06 (m, 4H), 1.76 (m, 2H). 
13
C NMR (CDCl3, 
75 MHz) 138.4, 137.8, 129.4, 128.4 (2C), 126.7 (2C), 115.1, 103.1, 101.6, 75.7, 73.0, 72.0, 69.6, 69.4, 66.9, 30.4, 
28.9. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for: C18H24NaO6 359.1471; Found 359.1464. 
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Pent-4-enyl 3-O-acetyl-4,6-O-benzylidene-β-D-galactopyranoside (110) 
Di-n-butyl tin oxide (7.77 g; 31.21 mmol) was added to a solution of compound 109 (10.0 g, 
29.73 mmol) in dry toluene (300 mL) and stirred under refluxing temperature for 12 h while water 
was removed with a Dean-Stark apparatus. The reaction mixture was cooled to 0 °C, and freshly 
activated 4Å MS (10g) were added. After 30 min acetyl chloride (2.18 mL, 30.62 mmol) was 
added drop-wise and the reaction mixture was stirred at 0 C for 1h. The reaction was quenched 
by addition of MeOH, filtered through a pad of celite and concentrated. The crude product was purified by flash 
chromatography (2:1 Tol/EtOAc) to give 110 as white crystals. Rf 0.23 (2:1 Tol/EtOAc). Yield: 9.91 g (88%) 
1
H NMR (400 MHz, CDCl3) δ 7.49 – 7.36 (m, 2H, Ar-H), 7.35 – 7.23 (m, 3H, Ar-H), 5.75 (ddt, Jtrans = 16.9,  
Jcis=10.2,  JCH2=6.7 Hz, 1H, -CH=CH2), 5.42 (s, 1H, CH
benzylidene
), 4.96 (dq, Jtrans = 17.2, Jgem = 1.7 Hz, 1H, 
CH2=CHtrans), 4.90 (dq, Jcis = 10.2,  Jgem = 1.7 Hz, 1H, CH2=CHcis), 4.78 (dd, J2,3 = 10.2, J3,4 = 3.7 Hz, 1H, H-3), 4.31 
(d, J3,4 = 3.7, 1H, H-4), 4.26 (d, J1,2 = 7.7 Hz, 1H, H-1), 4.24 (dd, J6a,6b = 12.4, J5,6a = 1.4  Hz, 1H, H-6a), 3.98 (dd, 
J6a,6b = 12.4, J5,6b = 1.8 Hz, 1H, H-6b), 3.95 – 3.87 (m, 2H, -OCH2
pentenyl
, H-2), 3.46 (dt, J = 9.5, 6.9 Hz, 1H, -
OCH2
pentenyl
), 3.41 (m, 1H, H-5), 2.16 – 2.07 (m, 2H, CH2
pentenyl
), 2.06 (s, 3H, CH3
Ac
), 1.76 – 1.61 (m, 2H, 
CH2
pentenyl
). 
13
C NMR (101 MHz, CDCl3) δ 171.16, 138.24, 137.76, 129.06, 128.22(2C), 126.36(2C), 115.04, 
103.13, 101.02, 73.84, 73.50, 69.50, 69.15, 68.60, 66.55, 30.30, 28.68, 21.19. HRMS (ESI-TOF) m/z: [M + Na]
+
 
Calcd for: C20H26NaO7 401.1576; Found 401.1579. 
 
3-O-acetyl-2-O-benzoyl-4,6-O-benzylidene-D-galactopyranose (111) 
 110 (3.5 g; 7.32 mmol) was dissolved in CH2Cl2 (30 mL) and the solution was cooled to 0 °C. Br2 
(1.29 g; 8.05 mmol) was added drop wise to the solution until the solution remained red. The 
reaction mixture was transferred to a flask containing a solution of TBAB (4.7 g; 14.65 mmol) and 
H2O (1.3 g; 73.20 mmol) in MeCN (50 mL). The reaction mixture was heated to 55 C and stirred at 
this temperature for 4 h. The reaction mixture was poured into water (100 mL) and extracted with CH2Cl2 (2x100 
mL). The combined organic phases were dried over MgSO4, concentrated and purified by flash chromatography (4:1 
Tol/EtOAc) to afford 111. Yield: 2.48 g (82%) 
 
3-O-acetyl-2-O-benzoyl-4,6-O-benzylidene-β-D-galactopyranose N-phenyl trifluoroacetimidate (112) 
112 (2 g; 4.82 mmol) was dissolved in CH2Cl2 (40 mL) and cooled to 0 °C. Cs2CO3 (3.1 g; 9.65 
mmol) and PTFAICl (2.0 g; 9.65 mmol) were added. The ice bath was removed and the reaction 
mixture was stirred at 22 °C for 14 h. The reaction mixture was filtered through a plug of celite, 
concentrated and purified by flash chromatography (9:1) to afford 112 Yield: 2.3 g (81%)  
 
Benzyl 2,3,6-tri-O-benzyl-β-D-galactopyranoside (113)362  
To 28 (5 g; 9.28 mmol) was added DIBAL-H (27.84 mL, 27.84 mmol) in CH2Cl2 (1 M) drop wise 
at 0 °C, and the reaction mixture was stirred for 1.5 h. The reaction mixture was diluted by CHCl3, 
and quenched by addition of MeOH at 0 °C. The mixture was poured into 10% aq. KOH (50 mL) 
and was extracted with CHCl3. The extract was dried over MgSO4 and concentrated in vacuo. The product 113 was 
isolated by flash chromatography (9:1 Tol/EtOAc). Rf 0.27 (9:1 Tol/EtOAc) 
    
  = -14.2° (c 1.0, CDCl3) IR(neat): 3474.44, 3087.73, 3062.46, 3030.10, 2913.33, 2868.67, 1496.31, 1453.67, 
1364.03, 1209.14, 1094.25, 1071.25, 735.70, 696.81. 
1
H NMR (400 MHz, CDCl3) δ 7.37 – 7.12 (m, 20H, Ar-H), 4.89 
(d, J = 12.0 Hz, 1H, -CH2
Bn,a
), 4.84 (d, J = 10.9 Hz, 1H, -CH2
Bn,b
), 4.66 (d, J = 10.9 Hz, 1H, -CH2
Bn,b
), 4.63 (s, 2H, -
CH2
Bn,c
), 4.58 (d, J = 12.0 Hz, 1H, -CH2
Bn,a
), 4.53 (s, 2H, -CH2
Bn,d
), 4.39 (d, J = 7.7 Hz, 1H, H-1), 3.94 (dd, J3,4 = 
3.4, J4,5 = 1.0 Hz, 1H, H-4), 3.80 – 3.60 (m, 3H, H-2, H-6a, H-6b), 3.49 (td, J5,6a = J5,6b = 5.9, J4,5 = 1.1 Hz, 1H, H-5), 
3.41 (dd, J2,3 = 9.4, J3,4 = 3.4 Hz, 1H, H-3). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 138.54, 138.03, 137.89, 137.51, 128.50 
(2C), 128.48 (2C), 128.38 (2C), 128.33 (2C), 128.31 (2C), 128.18 (2C), 127.96 (2C), 127.93, 127.87 (2C), 127.81 
(3C), 127.72, 127.64, 102.58, 80.66, 79.00, 75.28, 73.76, 73.26, 72.49, 70.93, 69.26, 66.95. HRMS (ESI-TOF) 
m/z:  [M + Na]+ Calcd for C34H36O6Na: 563.2410; Found 563.2415. 
 
Benzyl 3-O-acetyl-2-O-benzoyl-4,6-O-benzylidene-β-D-galactopyranosyl-(1→4)-3-O-acetyl-2-O-benzoyl-6-O-
benzyl-β-D-galactopyranosyl-(1→4)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (114)  
A mixture of 113 (300 mg; 0.55 mmol) and 106 (635 mg; 0.72 mmol) was dried 
azeotropically with toluene (2x10 mL) and subjected to vacuum over night. The 
mixture was then dissolved in dry CH2Cl2 (2.5 mL) and dry MeCN (2.5 mL) and 
cooled to -30 °C. NIS (165 mg; 0.74 mmol) and TESOTf (29 mg; 0.11 mmol) was 
added and the mixture was stirred at -30 °C until TLC showed full conversion of the 
donor (1 h). The solution was diluted with CH2Cl2 (100 mL) and washed with sat. aq. 
NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The organic phase was dried over 
Experimental 
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MgSO4, filtered and concentrated, yielding a syrupy residue. The product was purified by flash chromatography (9:1 
Tol/EtOAc). Yield: 529 mg (79 %) Rf 0.26 (9:1 TOl/EtOAc) 
1
H NMR (400 MHz, CDCl3) δ 8.13 – 7.91 (m, 2H, Ar-H
Bz
), 7.76 (s, 2H, Ar-H
Bz
), 7.61 – 6.75 (m, 36H, Ar-H), 5.58 
(dd, J2,3 = 10.4, J1,2 = 7.8 Hz, 1H, H-2), 5.49 (s, 1H, H
benzylidene
),5.24 – 5.13 (m, 1H, H-2, H-3), 5.08 (dd, J2,3 = 10.4, 
J3,4 = 3.0 Hz, 1H, H-3) 4.89 (d, J1,2 = 7.8 Hz, 1H), 4.77 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.76 (d, J1,2 = 8.0 Hz, 
1H, H-1), 4.57 – 4.40 (m, 7H, 3.5xCH2
Bn
), 4.35 (d, JCH2 = 12.1 Hz, 1H, 0.5xCH2
Bn
), 4.34 (d, J3,4 = 3.7 Hz, 1H, H-
1),4.24 (d, J3,4 = 3.0 Hz, 1H, H-4), 4.22 (d, J1,2 = 7.5 Hz, 1H, H-1), 4.21 (d, JCH2 = 10.7 Hz, 1H, 0.5xCH2
Bn
), 4.09 
(dd, J6a,6b = 12.5, J5,6a = 1.6 Hz, 1H, H-6a), 3.99 – 3.91 (m, 2H, H-6b, H-4), 3.83 (dd, J6a,6b = 9.4, J5,6a = 6.6 Hz, 1H, 
H-6a), 3.67 (dd, J6a,6b = 10.1, J5,6b = 5.7 Hz, 1H), 3.64 – 3.53 (m, 3H, H-4, H-6), 3.59 (s, 1H, H-5), 3.46 (dd, J6a,6b = 
9.4, J5,6b = 5.2 Hz, 1H, H-6b), 3.43 (s, 1H, H-5), 3.37 (t, J5,6a = J5,6b = 5.8 Hz, 1H, H-5), 3.28 – 3.14 (m, 3H, H-2, H-
3, H-6a), 1.98 (s, 3H, CH3
Ac
), 1.72 (s, 3H, CH3
Ac
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 171.12, 170.39, 165.66, 164.21, 
138.85, 138.72, 138.59, 138.57, 138.01, 137.84, 132.90, 132.66, 130.25-126.47(40C), 102.42, 101.67, 101.45, 
101.13, 81.65, 79.45, 74.75, 73.77, 73.71, 73.68, 73.44, 73.32, 73.30, 73.19, 72.01, 70.51, 70.41, 70.02, 69.70, 
68.85, 68.75, 66.57, 21.07, 20.75. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for: C20H26NaO7 1357.4984; Found 
1357.4984. 
 
Benzyl 3-O-acetyl-2-O-benzoyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)-3-O-acetyl-2-O-benzoyl-6-O-benzyl-
β-D-galactopyranosyl-(1→4)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (115) 
NaCNBH3 (705 mg; 11.2 mmol) was added to a solution of 114 (500 mg; 0.37 
mmol) in dry THF (15 mL). The mixture was stirred at 22 °C while HCl
 
in Et2O 
(2M) was added drop wise until gas development ceased and the mixture remained 
acidic (pH 3-4). The reaction mixture was concentrated to approx. 5 ml, diluted with 
CH2Cl2 (50 mL) and neutralized with sat. aq. NaHCO3 (50 mL). The combined 
aqueous phase was extracted with CH2Cl2 (3x50 mL). The combined organic phases 
were washed with water (100 mL), dried over MgSO4, filtered and evaporated. The product was purified by flash 
chromatography (6:1 Tol/EtOAc) to afford 115 as a colorless crystalline powder. Yield: 389 mg (78%) Rf 0.30 (6:1 
Tol/EtOAc) 
1
H NMR (400 MHz, CDCl3) δ 8.19 – 7.97 (m, 2H, Ar-H
Bz
), 7.91 – 7.70 (m, 2H, Ar-HBz), 7.44 – 7.01 (m, 36H, Ar-
H), 5.48 (dd, J2,3 = 9.5, J1,2 = 7.4 Hz, 1H, H-1), 5.28 (dd, J2,3 = 10.4, J1,2 = 7.8 Hz, 1H, H-1), 5.13 (dd, J2,3 = 9.5, J3,4 
= 3.5 Hz, 1H), 5.07 (dd, J2,3 = 10.4, J3,4 = 3.0 Hz, 1H, H-3), 4.89 (d, J1,2 = 7.8 Hz, 1H, H-1), 4.77 (d, JCH2 = 12.3 Hz, 
1H, 0.5xCH2
Bn
), 4.74 (d, J1,2 = 7.4 Hz, 1H, H-1), 4.55 – 4.31 (m, 9H, 4.5xCH2
Bn
), 4.25 – 4.11 (m, 4H, H-11, 2xH-4, 
0.5xCH2
Bn
), 3.94 (d, J3,4 = 2.2 Hz, 1H, H-4), 3.79 – 3.45 (m, 9H, 0.5xCH2
Bn
, 2xH-5, 3xH-6), 3.37 (t, J5,6a = J5,6b = 
5.8 Hz, 1H, H-5), 3.24 (dd, J2,3 = 9.7, J3,4 = 2.6 Hz, 1H, H-3
1
), 3.19 (dd, J2,3 = 9.7, J1,2 = 7.1 Hz, 1H, H-2
1
), 2.67 (d, 
J4,OH = 4.9 Hz, 1H, OH), 2.01 (s, 3H, CH3
Ac
), 1.66 (s, 3H, CH3
Ac
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 170.53, 170.45, 
165.75, 164.38, 138.87, 138.82, 138.56, 138.45, 137.97, 137.62, 133.01, 132.73, 130.17-127.40(40C), 102.39, 
101.73, 101.54, 81.61, 79.49, 74.76, 74.24, 73.84, 73.69, 73.68, 73.60, 73.42, 73.33, 73.33, 73.31, 73.10, 70.59, 
70.40, 70.38, 69.70, 69.26, 69.10, 67.80, 21.04, 20.65. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for: C78H80NaO20 
1359.51406; Found 1359.51406. 
 
3-O-acetyl-2-O-benzoyl-4,6-O-benzylidene-D-galactopyranose (116) 
 106 (1.2 g; 1.36 mmol) was dissolved in CH2Cl2 (10 mL) and the solution was cooled to 
0 °C. Br2 (0.26 g; 1.63 mmol) was added drop wise to the solution until the solution 
remained red. The reaction mixture was transferred to a flask containing a solution of 
TBAB (0.88 g; 2.72 mmol) and H2O (0.37 g; 20.43 mmol) in MeCN (30 mL). The 
reaction mixture was heated to 55 C and stirred at this temperature for 4 h. The reaction 
mixture was poured into water (100 mL) and extracted with CH2Cl2 (2x100 mL). The 
combined organic phases were dried over MgSO4, concentrated and filtered through a plug of silica. The resulting 
yellow oil was dissolved in CH2Cl2 (20 mL) and cooled to 0 °C. Cs2CO3 (0.89 g; 2.72 mmol) and PTFAICl (0.56 g; 
2.72 mmol) were added. The ice bath was removed and the reaction mixture was stirred at 22 °C for 14 h. The 
reaction mixture was filtered through a plug of celite, concentrated and purified by flash chromatography (9:1) to 
afford 111 Yield: 508 mg (38%)  
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2,3,4,6-O-tetraacetyl-D-galactopyranose (117)
363
 
Galactose pentaacetate (70.0 g, 179.36 mmol) was dissolved in anhydrous DMF (300 mL) 
at 55°C, hydrazine acetate (18.5 g, 200.91 mmol) was added and the mixture was stirred at 
55°C for 20 min. After cooling, 50% sat. aq. NaHCO3 (1000 mL) was added and the 
suspension was extracted with EtOAc (4 x 200 mL). The combined organic phase was washed with sat. 
aq. NaHCO3 (400 mL) and H2O (400 mL), evaporated on celite and purified by dry column vacuum 
chromatography (4.5 x 5.5 cm) on silica gel eluting with a gradient of 0-100% EtOAc in hexane (v/v) to 
give the hemiacetal 117. Yield 57.7 g (92%) as a white foam. 
1
H NMR (400 MHz, CDCl3): δ 5.50 (d, J1,2 = 3.6 Hz, 1H, H-1), 5.47 (d, J2,3 =10.7 Hz, J1,2 =3.6 Hz, 1H, H-2), 5.40 
(d, J3,4 =3.3 Hz,1H, H-4),5.15 (dd, J2,3 =10.7 Hz, J3,4 =3.3Hz, 1H, H-3), 4.48 (t, J5,6a = 6.6 Hz, 1H, H-5), 4.38 (s, 1H, 
-OH), 4.11 (dd, J5,6b = 1.8 Hz, 1H, Gal H-6b), 4.09 (m, 1H, H-6a), 2.15 (s, 3H, CH3
Ac
), 2.10 (s, 3H, CH3
Ac
), 2.05 (s, 
3H, CH3
Ac
), 1.99 (s, 3H, CH3
Ac
); 
13
C NMR (101 MHz, CDCl3): δ 170.5, 170.4, 170.2, 170.0, 90.5, 68.4, 68.2, 67.2, 
65.9, 61.7, 20.7, 20.54, 20.54, 20.54. 
 
tert-butyldiphenylsilyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside (118a) 
117 (55.0 g; 157.9 mmol) was dissolved in DMF (250 mL) and cooled to 0 °C. To the solution 
were added tert-butyl diphenylsilyl chloride (51.3 mL; 197.4 mmol) and imidazole (26.9 g; 
394.8 mmol). The reaction mixture was stirred at 0 °C in 1h and then at 22 °C for 18h. The 
mixture was diluted with Et2O (500 mL) and washed with water (4 x 500 mL). The organic phase was dried over 
MgSO4, filtered, concentrated and purified by flash chromatography (9:1 Tol/EtOAc) to give 118a as a white solid. 
Rf 0.65 (2:1 Tol/EtOAc). Yield: 85.3 g (92%).  
    
  = 2.1° (c 1.0, CDCl3) IR (neat, cm
-1
): 3073.45, 3048.95, 2958.82, 2934.48, 2892.20, 2859.91, 1749.51, 1473.24, 
1428.33, 1368.22, 1219.93, 1180.92, 1159.52, 1113.61, 1080.42, 1056.83, 813.78 
1
H NMR (400 MHz, CDCl3) δ 7.67 – 7.59 (m, 2H, Ar-H), 7.59 – 7.53 (m, 2H, Ar-H), 7.41 – 7.25 (m, 6H, Ar-H), 
5.29 – 5.19 (m, 2H, H-3, H-4), 4.79 (dd, J2,3 = 10.5, J3,4 = 3.5 Hz, 1H, H-3), 4.55 (d, J1,2 = 7.7 Hz, 1H, H-1), 3.93 
(m, 2H, H-6a, H-6b), 3.55 (dt, J5,6a = J5,6b = 6.6, J4,5 = 1.2 Hz, 1H, H-5), 2.10 (s, 3H, CH3
Ac
), 1.89 (s, 3H, CH3
Ac
), 
1.88 – 1.85 (m, 6H, 2xCH3
Ac
), 1.00 (s, 9H, 3xCH3
TBDPS
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 170.49, 170.45, 170.30, 
169.61, 136.03 (2C), 135.81 (2C), 132.77, 132.76, 130.10, 130.06, 127.78 (2C), 127.60 (2C), 96.14, 71.07, 70.82, 
70.74, 67.37, 61.50, 26.76 (3C), 20.94, 20.87, 20.71 (2C), 19.21. HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for 
C30H38NaO10Si 609.2132; Found 609.2101. 
 
tert-butyldiphenylsilyl β-D-galactopyranoside (118) 
To a solution of 118a (80.0 g; 136.35 mmol) in MeOH (200 mL) at -20 °C was added a freshly 
prepared 0.02M NaOMe solution in methanol (200 mL). The reaction mixture was stirred at -20 
°C for 12h, quenched with Amberlite 120-H
+
 ion-exchange resin, filtered and concentrated. The 
residue was purified by flash chromatography (1:1 Tol/EtOAc) to give 118 as an oil. Rf 0.06 (2:1 Tol/EtOAc). 
Yield: 50.7 g (79%) 
    
  = 12.9° (c 1.0, CDCl3) IR (neat, cm
-1
): 3384.00, 3072.66, 3049.46, 2955.08, 2931.95, 2892.28, 2858.60, 
1472.39, 1427.48, 1392.47, 1363.05, 1172.10, 1112.17, 1074.35, 909.86, 823.43 
1
H NMR (400 MHz, CDCl3) δ 
7.62 (m, 4H, Ar-H), 7.41 – 7.20 (m, 6H, Ar-H), 4.37 (d, J1,2 = 7.4 Hz, 1H, H-1), 4.17 (d, J3,OH = 5.6 Hz, 1H, 3-OH), 
3.85 (d, J4,OH = 4.5 Hz, 1H, 4-OH), 3.79 – 3.72 (m, 1H, H-4), 3.62 (ddd, J2,3 = 9.4, J1,2 = 7.4, J2,OH = 3.4 Hz, 1H, H-
2), 3.56 – 3.40 (m, 3H, H-6a, H-6b, 2-OH), 3.31 (ddd, J2,3 = 9.4, J3,OH = 5.6, J3,4 = 3.4 Hz, 1H, H-3), 3.01 (t, J5,6a = 
J5,6b = 6.0 Hz, 1H), 2.43 – 2.34 (m, 1H, 6-OH), 0.99 (s, 9H, 3xCH3
TBDPS
). 
13
C NMR (101 MHz, CDCl3) δ 135.85 
(2C), 135.80 (2C), 133.36, 132.92, 129.97, 129.94, 127.73 (2C), 127.55 (2C), 97.98, 74.19, 73.44, 73.38, 69.03, 
61.53, 26.89 (3C), 19.18. 
 
tert-butyldiphenylsilyl 4,6-O-benzylidene-β-D-galactopyranoside (119a) 
To a solution of PhCH(OMe)2 (15 mL, 96.76 mmol) and camphorsulphonic acid (500 mg, 2.15 
mmol) in MeCN (500 mL) was added 118 (30 g, 71.67 mmol). The flask was equipped with a 
distillation unit and the mixture was heated to reflux for 1h. In this period approximately 200 
mL of MeCN-MeOH was distilled off. The distillation unit was then replaced with a condenser 
and the reaction mixture was heated to reflux until TLC showed completion (2h). The reaction 
mixture was concentrated and the product was purified by flash chromatography (4:1 Tol/EtOAc) to afford 119a as 
a white crystalline powder. Rf 0.10 (9:1 Tol/EtOAc). Yield: 25.5 g (70%). 
    
  = -23.5° (c 1.0, CDCl3). IR (neat, cm
-1
): 3424.80, 3070.70, 3048.23, 2958.52, 2931.20, 2892.56, 2857.98, 
1472.60, 1458.97, 1427.57, 1400.27, 1364.62, 1213.19, 1168.51, 1088.75, 1049.80, 997.59, 907.80, 822.55, 803.59. 
1
H 
NMR (400 MHz, CDCl3) δ 7.76 – 7.68 (m, 2H, Ar-H), 7.68 – 7.63 (m, 2H, Ar-H), 7.47 – 7.40 (m, 2H, Ar-H), 7.39 
Experimental 
 139 
– 7.24 (m, 9H, Ar-H), 5.40 (s, 1H, CHbenzylidene), 4.40 (d, J1,2 = 7.4 Hz, 1H, H-1), 3.99 (dd, J3,4 = 3.9, J4,5 = 1.1 Hz, 
1H, H-4), 3.96 (dd, J6a,6b = 12.3, J5,6a =1.5 Hz, 1H, H-6a), 3.81 (dd, J6a,6b = 12.3, J5,6b = 1.9 Hz, 1H, H-6b), 3.74 (dd, 
J2,3 = 9.7, J3,4 = 7.4 Hz, 1H, H-2), 3.51 – 3.39 (m, 1H, H-3), 2.63 – 2.31 (m, 2H, 2xOH), 1.05 (s, 9H, 3xCH3
TBDPS
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 137.79, 136.02 (2C), 135.78 (2C), 133.33, 133.31, 129.81, 129.72, 129.28, 128.32 
(2C), 127.62 (2C), 127.40 (2C), 126.47 (2C), 101.30, 97.60, 75.29, 73.86, 72.58, 68.95, 66.46, 27.01, 19.34 (3C).  
HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C29H34NaO6Si 529.2022; Found 529.2017. 
 
tert-butyldiphenylsilyl 2,3-di-O-acetyl-4,6-O-benzylidene-β-D-galactopyranoside (119) 
119a (20 g ; 39.47 mmol) was dissolved in CH2Cl2 (400 mL). Et3N (16.5 mL; 118.42 mmol), 
DMAP (96 mg; 0.79 mmol) and acetic anhydride (9.31 mL; 98.69 mmol) was added to the 
solution and the reaction mixture was stirred until TLC revealed full conversion (3 h). The 
reaction was quenched with MeOH (10 mL), diluted with DCM (200 mL), washed with water 
(2x200 mL), dried over MgSO4 and concentrated. The product was purified by flash 
chromatography (15:1 Tol/EtOAc). Rf 0.44 (9:1 Tol/EtOAc). Yield: 21.89 g (94%) 
    
  = 40.0° (c 1.0, CDCl3). IR(neat, cm
-1
): 3071.67, 3047.62, 2959.11, 2932.86, 2893.38, 2858.91, 1745.50, 
1459.30, 1428.07, 1404.12, 1368.68, 1242.29, 1221.57, 1174.02, 1096.33, 1063.57, 1044.37, 1004.22, 917.75, 
823.00, 802.10, 738.23, 700.78. 
1
H NMR (400 MHz, CDCl3) δ 7.88 – 7.65 (m, 2H, H
TBDPS
), 7.63 – 7.55 (m, 2H, 
H
TBDPS
), 7.53 – 7.43 (m, 2H, HTBDPS), 7.42 – 7.21 (m, 9H, HTBDPS, Ar-H), 5.43 (dd, J2,3 = 10.5, J1,2 = 7.6 Hz, 1H, H-
2), 5.36 (s, 1H, -CH
benzylidene
), 4.72 (dd, J2,3 = 10.5, J3,4 = 3.7 Hz, 1H, H-3), 4.57 (d, J1,2 = 7.6 Hz, 1H, H-1), 4.18 (dd, 
J3,4 = 3.8, J4,5 = 1.1 Hz, 1H, H-4), 3.97 (dd, J6a,6b = 12.3, J5,6a = 1.5 Hz, 1H, H-6a), 3.82 (dd, J6a,6b = 12.3, J5,6b =1.8 
Hz, 1H), 3.05 (m, 1H, H-5), 1.97 (s, 3H, -CH3
Ac
), 1.91 (s, 3H, -CH3
Ac
), 1.01 (s, 9H, 3xCH3
TBDPS
). 
13
C NMR 
 
 (101 
MHz, CDCl3) δ 170.87, 169.34, 137.73, 136.07 (2C), 135.77 (2C), 133.10, 132.97, 129.82, 129.76, 129.10, 128.24 
(2C), 127.55 (2C), 127.37 (2C), 126.48 (2C), 101.01, 95.93, 73.39, 72.09, 70.59, 68.76, 66.19, 26.74 (3C), 20.93, 
20.91, 19.16. HRMS (ESI-TOF) m/z:[M + Na]
+ 
Calcd for C33H38NaO8Si: 613.2234; Found 613.2244. 
 
tert-butyldiphenylsilyl 2,3-di-O-acetyl-6-O-benzyl-β-D-galactopyranoside (120) 
NaCNBH3 (5.4 g; 86.33 mmol) and 3Å MS (3 g) were added to a solution of 119 (6.0 g; 10.15 
mmol) in dry THF (100 mL). The mixture was stirred at 22 °C while TfOH (7.7 mL; 87.35 
mmol) was added drop wise until gas development ceased and the mixture remained acidic (pH 
3-4). The reaction mixture was concentrated to app. 10 ml, diluted with CH2Cl2 (200 mL) and 
neutralized with sat. aq. NaHCO3 (200 mL). The aqueous phase was extracted with CH2Cl2 (3x100 mL). The 
combined organic phases were washed with water (500 mL), dried over MgSO4, filtered and evaporated. The 
product was purified by flash chromatography (8:1 Tol/EtOAc) to afford 120 as a colorless crystalline powder. Rf 
0.13 (9:1 Tol/EtOAc). Yield: 4.8 (79%) 
    
  = 6.1° (c 1.0, CDCl3). IR (neat, cm
-1
): 3469.06, 3071.41, 2932.65, 2858.98, 1748.28, 1453.65, 1367.94, 
1243.32, 1223.88, 1178.04, 1112.32, 1060.21. 
1
H NMR (400 MHz, CDCl3) δ 7.67 – 7.60 (m, 2H, Ar-H), 7.60 – 
7.54 (m, 2H, Ar-H), 7.38 – 7.10 (m, 11H, Ar-H), 5.31 (dd, J2,3 = 10.3, J1,2 = 7.7 Hz, 1H, H-2), 4.71 (dd, J2,3 = 10.3, 
J3,4 = 3.2 Hz, 1H, H-3), 4.54 (d, J1,2 = 7.7 Hz, 1H, H-1), 4.40 (d, JCH2 = 11.9 Hz, 1H, CH2
Bn
), 4.35 (d, JCH2 = 11.9 Hz, 
1H, CH2
Bn
), 3.98 (d, J3,4 = 3.2 Hz, 1H, H-4), 3.56 (dd, J6a,6b = 10.2, J5,6a =5.4 Hz, 1H, H-6a), 3.48 (dd, J6a,6b = 10.2, 
J5,6b =5.0 Hz, 1H, H-6b), 3.29 (dd, J5,6a = 5.4, J5,6b = 5.0 Hz, 1H, H-5), 2.00 (s, 3H, CH3
Ac
), 1.87 (s, 3H, CH3
Ac
), 0.99 
(s, 9H, 3xCH3
TBDPS
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 170.46, 169.73, 137.74, 136.10 (2C), 135.91 (2C), 133.01, 
132.86, 130.02, 129.94, 128.55 (2C), 127.91, 127.80 (2C), 127.72 (2C), 127.54 (2C), 96.29, 73.88, 73.60, 73.09, 
71.43, 69.28, 68.38, 26.78 (3C), 21.03, 20.93, 19.19. HRMS (ESI-TOF) m/z: [M + NH4]+ Calcd for C33H36NaO8 
583.2308 Found 583.2303 
 
tert-butyldiphenylsilyl 2,3-di-O-acetyl-4-O-allyloxycarbonyl-6-O-benzyl-β-D-galactopyranoside 
(121) 
TMEDA (1.21 mL; 8.1 mmol) and allyl chloroformate (1.57 mL; 14.8 mmol) were added to a 
solution of 120 (8.0 g; 13.5 mmol) in anhydrous CH2Cl2 (135 mL) at 0 °C. After 1h the mixture 
was diluted with CH2Cl2 (150 mL), washed with water (300 mL), dried over MgSO4 and 
concentrated. The product 121 was purified by flash chromatography (19:1 Tol/EtOAc). Rf 0.47 
(9:1 Tol/EtOAc). Yield: 8.3 g (91%) 
    
  = -7.2° (c 1.0, CDCl3). IR (neat, cm
-1
):3072.10, 3033.21, 2933.81, 2859.80, 1752.16, 1428.03, 1367.05, 
1273.67, 1258.93, 1226.53, 1179.40, 1112.13, 1079.58, 1060.21. 
1
H NMR (400 MHz, CDCl3) δ 7.66 – 7.48 (m, 4H, 
Ar-H), 7.40 – 7.07 (m, 11H, Ar-H), 5.86 (ddt, Jtrans = 17.2, Jcis = 10.5, JCH2 = 5.7 Hz, 1H, -CH=CH2), 5.29 (dd, J2,3 = 
10.5, J1,2 = 7.7 Hz, 1H, H-2), 5.32 (dd, Jtrans = 17.2, Jgem = 1.5 Hz, 1H, trans-CH2=CH-), 5.21 (dd, J = 10.5, 1.3 Hz, 
1H, cis-CH2=CH-), 5.12 (dd, J3,4 = 3.4, J4,5 = 0.9 Hz, 1H, H-4), 4.81 (dd, J2,3 = 10.5, J3,4 = 3.4 Hz, 1H, H-3), 4.61 – 
Experimental 
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4.54 (m, 1H, 0.5xCH2
Alloc
), 4.57 – 4.46 (m, 1H, 0.5xCH2
Alloc
), 4.51 (d, J1,2 = 7.7 Hz, 1H, H-1), 4.33 (d, JCH2 = 11.8 
Hz, 1H, 0.5xCH2
Bn
), 4.28 (d, JCH2 = 11.8 Hz, 1H, 0.5xCH2
Bn
), 3.48 – 3.42 (m, 2H, H-5, H-6a), 3.39 – 3.32 (m, 1H, 
H-6b), 1.90 (s, 3H, -CH3
Ac
), 1.86 (s, 3H, -CH3
Ac
), 0.98 (s, 9H, -3xCH3
TBDPS
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 
170.33, 169.54, 154.87, 137.82, 136.13 (2C), 135.90 (2C), 132.83, 132.75, 131.48, 130.06, 129.97, 128.49 (2C), 
127.83, 127.81 (2C), 127.75 (2C), 127.54 (2C), 119.18, 96.15, 73.67, 71.98, 71.82, 71.32, 70.99, 68.91, 67.66, 26.76 
(3C), 20.96, 20.82, 19.20. HRMS (ESI-TOF) m/z: [M + NH4]
+
 Calcd for C37H48NO10Si 694.3048 Found 694.3044 
 
2,3-di-O-acetyl-4-O-allyloxycarbonyl-6-O-benzyl-D-galactopyranose (122a) 
To a solution of 121 (7.8 g; 11.5 mmol) in THF (100 mL) was added AcOH (3.3 ml; 28.81 mmol) 
and TBAF (1M in THF; 25.4 mL; 25.4 mmol). The reaction mixture was stirred at 22 °C until 
TLC showed full conversion (8 h). The reaction mixture was diluted with EtOAc and washed with 
sat. aq. NaHCO3. The organic phase was dried over MgSO4, filtered and concentrated. The crude was purified by 
flash chromatography (4:1 Tol/EtOAc) to give 122a as a white crystalline solid. Rf 0.42 (2:1 Tol /EtOAc). Yield: 
4.6g (91%) 
    
  = -5.9° (c 1.0, CDCl3). IR (neat, cm
-1
): 3072.05, 3052.10, 3031.28, 2934.27, 2860.02, 1752.87, 1472.98, 1454.24, 
1428.02, 1367.20, 1274.26,1259.02, 1227.33, 1179.31, 1112.52, 1079.65, 1060.18, 998.37, 955.10. 
1
H NMR (400 MHz, 
CDCl3) δ 7.39 – 7.12 (m, 10H, Ar-H), 5.92 – 5.77 (m, 2H, CH=CH2, CH=CH2), 5.42 (d, J3,4 = 3.6 Hz, 1H, H-1), 
5.35 (d, J3,4 = 3.3 Hz, 1H, H-4), 5.33 – 5.07 (m, 8H, CH2=CH, CH2=CH, H-2, H-2, H-3, H-4), 5.12 (dd, 
J2,3 = 10.8, J1,2 = 3.6 Hz, 1H, H-3), 4.63 – 4.30 (m, 6H, H-1, CH2
Bn
, CH2
AcCl
, H-5), 3.86 – 3.76 (m, 1H, H-5), 
3.67 – 3.37 (m, 4H, H-6, H-6), 2.10 (s, 3H, CH3
Ac), 2.02 (s, 3H, CH3
Ac), 2.01 (s, 3H, CH3
Ac), 1.94 (s, 1H), 
1.93 (s, 3H, CH3
Ac). 13C NMR   (101 MHz, CDCl3) δ 171.28, 170.40, 170.20, 170.18, 154.82, 154.73, 137.59, 
137.55, 131.42, 131.37, 128.60, 128.01, 127.97, 119.18, 119.11, 96.13, 90.72, 73.76, 73.68, 72.90, 72.26, 71.59, 
71.30, 70.68, 68.97, 68.89, 68.41, 68.37, 67.67, 67.57, 67.35, 31.07, 20.96, 20.88, 20.79. HRMS (ESI-TOF) m/z: 
[M + Na]
+
 Calcd for C21H26NaO10 461.1424 Found 461.1425. 
 
2,3-O-diacetyl-4-O-allyloxycarbonyl-6-O-benzyl-β-D-galactopyranose N-phenyl trifluoroacetimidate 
(122) 
122a (4.4 g; 10.03 mmol) was dissolved in CH2Cl2 (50 mL) and cooled to 0 °C. Cs2CO3 (6.5 g; 
20.07 mmol) was added followed by N-phenyl trifluoroacetimidoyl chloride (4.2 g; 20.07 
mmol). The ice bath was removed and the reaction mixture was stirred at 22 °C until TLC 
showed full conversion (8 h). The reaction mixture was filtered through a plug of celite, concentrated and purified 
by flash chromatography (9:1) to afford 122 as a white crystalline product. Rf 0.51 (9:1 Tol/EtOAc). Yield: 4.64 g 
(76%)  
 
tert-butyldiphenylsilyl 2,3-di-O-acetyl-4-O-allyloxycarbonyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3-di-
O-acetyl-6-O-benzyl-β-D-galactopyranoside (123) 
To a 250 mL flame-dried flask was added 120 (3.66 g, 6.17 mmol) and the 122 (5.46 g, 
8.95 mmol). The mixture was co-evaporated with toluene (2x100 mL) and subjected to 
vacuum overnight. The mixture dissolved in DCM (100 mL) and cooled to -40 °C. 
TMSOTf (0.23 mL; 1.54 mmol) was added and the reaction mixture was stirred at -40 
°C for 4h. Et3N (2 mL) was added and the reaction mixture was concentrated. The crude 
compound was purified by flash chromatography (9:1 Tol/EtOAc) to give 123. Rf 0.17 (9:1 Tol/EtOAc) Yield: 5.13 
g (82%) 
    
  = -6.2° (c 1.0, CDCl3) IR (neat, cm
-1
):3070.55, 3030.83, 2933.04, 2859.78, 1747.93, 1427.83, 1367.61, 
1219.07, 1175.33, 1104.45, 1063.84, 911.40 
1
H NMR (400 MHz, CDCl3) δ 7.62 (dd, J = 7.9, 1.4 Hz, 2H, Ar-H), 
7.55 (dd, J = 7.9, 1.2 Hz, 2H, Ar-H), 7.40 – 7.00 (m, 16H, Ar-H), 5.88 (ddd, Jtrans = 16.2, Jcis = 10.9, JCH2 = 5.7 Hz, 
1H, CH=CH2), 5.33 (dd, Jtrans = 17.2, JCH2 = 1.3 Hz, 1H, CH2=CHtrans), 5.26 (dd, J2,3 = 10.5, J1,2 = 7.9 Hz, 1H, H-2
2
), 
5.23 (dd, Jcis = 10.5, JCH2 = 1.1 Hz, 1H, CH2=CHcis), 5.21 (d, J3,4 = 3.4 Hz, 1H, H-4
2
), 5.11 (dd, J2,3 = 10.3, J2,3 = 7.6 
Hz, 1H, H-2
1
), 4.94 (dd, J2,3 = 10.5, J3,4 = 3.4 Hz, 1H, H-3
2
), 4.71 (dd, J2,3 = 10.4, J3,4 = 3.1 Hz, 1H, H-3
1
), 4.48 (d, 
J1,2 = 7.6 Hz, 1H, H-1
1
), 4.41 (d, J1,2 = 7.9 Hz, 1H, H-1
2
), 4.34 – 4.21 (m, 4H), 3.95 (d, J = 3.1 Hz, 1H, H-41), 3.65 
(t, J5,6a = J5,6b = 6.7 Hz, 1H, H-5
2
), 3.60 (dd, J6a,6b = 10.2, J5,6a =5.2 Hz, 1H, H-6
1
), 3.46 – 3.29 (m, 4H, H-51, 1.5xH-
6), 2.15 (s, 3H, CH3
Ac
), 1.99 (s, 3H, CH3
Ac
), 1.95 (s, 3H, CH3
Ac
), 1.83 (s, 3H, CH3
Ac
), 0.98 (s, 9H, 3xCH3
TBDPS
). 
13
C 
NMR 
 
 (101 MHz, CDCl3) δ 170.45, 170.27, 169.76, 169.54, 154.84, 138.54, 137.61, 136.15 (2C), 135.90 (2C), 
132.99, 132.91, 131.44, 129.90, 129.84, 128.56 (2C), 128.36 (2C), 127.94, 127.74 (2C), 127.68 (2C), 127.52, 
119.26, 101.74, 95.87, 73.98, 73.65, 73.60, 73.39, 71.81, 71.67, 71.32, 71.28, 69.38, 68.94, 68.89, 67.27, 26.78 
(3C), 20.93, 20.91, 20.85, 20.81, 19.18. HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for C54H64NaO17Si 1035.3811; 
Found 1035.3830. 
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tert-butyldiphenylsilyl 2,3-di-O-acetyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-6-O-benzyl-β-
D-galactopyranoside (124) 
To a solution of 123 (2.0 g; 1.97 mmol) in THF (100 mL) at 0 °C was added morpholine 
(208 mg; 1.21 mmol), PPh3 (818 mg; 1.58 mmol) and Pd(OAc)2 (22 mg; 0.10 mmol). The 
solution was stirred at 22 °C for 2 h and then concentrated. The product was purified by 
flash chromatography (3:1 Tol/EtOAc) to give 124 as a white crystal-line solid. Rf 0.45 
(2:1 Tol/EtOAc). Yield: 1.6 g (87%)  
    
  = -5.3° (c 1.0, CDCl3) IR (neat, cm
-1
):3486.42, 3031.65, 2932.77, 2859.46, 1746.03, 1367.54, 1242.00, 
1220.52, 1104.60, 1054.24. 
1
H NMR (400 MHz, CDCl3) δ 7.62 (dd, J = 7.9, 1.3 Hz, 2H, Ar-H), 7.55 (dd, J = 8.0, 
1.2 Hz, 2H, Ar-H), 7.35 – 7.03 (m, 16H), 5.27 (dd, J2,3 = 10.2, J1,2 = 7.9 Hz, 1H, H-2
2
), 5.13 (dd, J2,3 = 10.3, J1,2 = 
7.6 Hz, 1H, H-2
1
), 4.85 (dd, J2,3 = 10.2, J3,4 = 3.1 Hz, 1H, H-3
2
), 4.71 (dd, J2,3 = 10.3, J3,4 = 3.1 Hz, 1H, H-3
1
), 4.49 
(d, J1,2 = 7.6 Hz, 1H, H-1
1
), 4.41 (d, J1,2 = 7.9 Hz, 1H, H-1
2
), 4.35 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.31 (d, JCH2 
= 11.9 Hz, 1H, CH2
Bn
), 4.25 (s, 2H, CH2
Bn
), 4.06 (d, J3,4 = 3.1 Hz, 1H, H-4
2
), 3.99 (d, J3,4 = 3.1 Hz, 1H, H-4
1
), 3.64 
(dd, J6a,6b = 10.2, J5,6a = 5.2 Hz, 1H, H-6a), 3.60 (dd, J6a,6b = 8.8, J5,6a = 5.1 Hz, 1H), 3.53 – 3.39 (m, 3H, H-6b, H-
6b, H-5), 3.34 (t, J5,6a = J5,6b = 5.6 Hz, 1H, H-5), 2.14 (s, 3H, CH3
Ac
), 2.05 (s, 3H, CH3
Ac
), 2.00 (s, 3H, CH3
Ac
), 1.84 
(s, 3H, CH3
Ac
), 0.97 (s, 9H, 3xCH3
TBDPS
). 
13
C NMR (101 MHz, CDCl3) δ 170.51, 170.35, 170.01, 169.52, 138.52, 
137.56, 136.14 (2C), 135.89 (2C), 132.97, 132.93, 129.90, 129.83, 128.62 (2C), 128.36 (2C), 128.03, 127.73 (2C), 
127.67 (2C), 127.53, 127.50 (4C), 101.83, 95.89, 73.99, 73.78, 73.69, 73.60, 73.50, 73.35, 72.95, 71.64, 69.42, 
69.34, 69.01, 67.88, 26.77 (3C), 21.06, 20.94, 20.91, 20.81, 19.18. HRMS (ESI-TOF) m/z: [M + NH4]
+
 Calcd for 
C50H64NO15Si 946.4045 Found 946.4039 
 
(2,3-di-O-acetyl-4-O-allyloxycarbonyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-6-O-benzyl-β-
D-galactopyranose N-phenyl trifluoroacetimidate (125)  
In a plastic container, compound 123 (2.1 g; 2.07 mmol) was dissolved in THF (20 mL) 
and the solution was cooled to 0 C. HF.pyridine complex (5 mL) was added slowly 
while the temperature was maintained below 5 C. The reaction was slowly heated to 22 
°C and stirred at this temperature for 10 h. The solution was poured into sat. aq. NaHCO3 
(200 mL) and extracted with EtOAc (3x100 mL). The combined organic phases were 
dried over MgSO4, filtered and concentrated. The product was purified with a plug of silica to give a syrupy residue. 
Without further purification the hemiacetal was dissolved in CH2Cl2 (25 mL). Cs2CO3 (1.4 g; 4.14 mmol) was added 
followed by N-phenyl trifluoroacetimidoyl chloride (0.86 g; 4.14 mmol). The ice bath was removed and the reaction 
mixture was stirred at 22 °C until TLC showed full conversion (6 h). The reaction mixture was filtered through a 
plug of celite, concentrated and purified by flash chromatography (9:1) to afford 125 as a white crystalline product. 
Yield 1.33 g (68% over two steps). 
 
tert-butyldiphenylsilyl 2,3-di-O-acetyl-4-O-allyloxycarbonyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)- 2,3-di-
O-acetyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-6-O-benzyl-β-D-galactopyranoside (126)  
To a 50 mL flame-dried flask was added 124 (800 mg, 0.86 mmol) and 122 (709 
mg, 1.16 mmol). The mixture was co-evaporated with toluene (2x25 mL) and 
subjected to vacuum overnight. The mixture dissolved in DCM (20 mL) and 
cooled to -30 °C. TMSOTf (48 mg; 0.22 mmol) was added and the reaction 
mixture was stirred at -30 °C for 1h. Et3N (0.5 mL) was added and the reaction 
mixture was concentrated. The crude compound 126 was purified by flash 
chromatography (3:1 Tol/EtOAc) to give 126. Rf 0.44 (2:1 Tol/EtOAc). Yield: 928 g (80%). 
    
  = -22.5° (c 1.0, CDCl3). IR (neat, cm
-1
):3030.77, 2933.30, 2860.01, 1747.84, 1367.65, 1218.43, 1095.87, 
1058.26. 
1
H NMR (400 MHz, CDCl3) δ 7.70 – 7.58 (m, 2H, Ar-H), 7.58 – 7.50 (m, 2H, Ar-H), 7.39 – 6.97 (m, 
21H), 5.85 (ddd, Jtrans = 17.2, Jcis =10.9, JCH2 = 5.3 Hz, 1H, CH=CH2), 5.31 (dd, Jtrans = 17.2, JCH2 = 1.2 Hz, 1H, 
CH2=CHtrans), 5.28 – 5.23 (m, 2H, H-2, H-4
3
), 5.21 (dd, Jcis = 10.8, JCH2 = 0.5 Hz, 1H, CH2=CHcis), 5.12 (dd, J2,3 = 
10.3, J1,2 = 7.5 Hz, 1H, H-2), 5.06 (dd, J2,3 = 10.4, J1,2 = 7.8 Hz, 1H, H-2), 4.98 (dd, J2,3 = 10.6, J3,4 = 3.3 Hz, 1H, H-
3), 4.85 (dd, J2,3 = 10.4, J3,4 = 2.8 Hz, 1H, H-3), 4.71 (dd, J2,3 = 10.4, J3,4 = 3.0 Hz, 1H, H-3), 4.59 (dd, JCH2 = 13.0, 
JCH=CH2 = 5.8 Hz, 1H, CH2
Alloc
), 4.55 – 4.50 (m, 2H, CH2
Alloc
), 4.48 (d, J1,2 = 7.9 Hz, 2H, H-1
1
, H-1), 4.39 (d, J1,2 = 
7.8 Hz, 1H, H-1), 4.36 – 4.19 (m, 6H, 3xCH2
Bn
), 4.05 (d, J3,4 = 3.0 Hz, 1H, H-4), 3.95 (d, J3,4 = 2.8 Hz, 1H, H-4), 
3.68 (t, J = 6.7 Hz, 1H, H-5), 3.64 – 3.26 (m, 8H, 2xH-5, 3xH-6), 2.19 (s, 3H, CH3
Ac
), 2.13 (s, 3H, CH3
Ac
), 2.04 (s, 
3H, CH3
Ac
), 1.97 (s, 3H, CH3
Ac
), 1.96 (s, 3H, CH3
Ac
), 1.83 (s, 3H, CH3
Ac
), 0.98 (s, 9H, 3xCH3
TBDPS
). 
13
C NMR 
 
 
(101 MHz, CDCl3) δ 170.41, 170.32, 170.16, 169.83, 169.80, 169.61, 154.84, 138.77, 138.33, 137.58, 136.16 (2C), 
135.88 (2C), 133.11, 132.94, 131.38, 129.84, 129.82, 128.57 (2C), 128.46 (2C), 128.30 (2C), 127.96, 127.88 (2C), 
127.74 (2C), 127.65 (2C), 127.49 (2C), 127.44 (2C), 127.37, 119.35, 101.50, 101.08, 95.76, 73.77, 73.61 (2C), 
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73.57 (2C), 73.50 (2C), 73.32 (2C), 73.17 (2C), 71.85, 71.77, 71.33, 71.14, 69.63, 69.51, 68.97 (2C), 68.82, 67.20, 
26.80 (3C), 20.97, 20.90 (2C), 20.87, 20.84, 20.75, 19.19. 
 
tert-butyldiphenylsilyl 2,3-di-O-acetyl-4-O-allyloxycarbonyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3- di-
O-acetyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)-
2,3-di-O-acetyl-6-O-benzyl-β-D-galactopyranoside (127) 
To a 50 mL flame-dried flask was added 124 (1.0 g, 1.08 mmol) and 125 
(1.37 g, 1.45 mmol). The mixture was co-evaporated with toluene (2x25 
mL) and subjected to vacuum overnight. The mixture dissolved in DCM 
(25 mL) and cooled to -30 °C. TMSOTf (59 mg; 0.27 mmol) was added 
and the reaction mixture was stirred at -30 °C for 2 h. Et3N (0.5 mL) was 
added and the reaction mixture was concentrated. The crude compound 
was purified by flash chromatography (4:1 Tol/EtOAc) to give compound 
127. Rf 0.45 (2:1 Tol/EtOAc). Yield: 1.43 g (85%) 
    
  = 11.7° (c 1.0, CDCl3). IR (neat, cm
-1
):3031.51, 2934.00, 2860.72, 1747.88, 1367.93, 1218.36, 1174.03, 
1095.54, 1057.94. 
1
H NMR (400 MHz, CDCl3) δ 7.63 (m, 2H, Ar-H), 7.59 – 7.50 (m, 2H, Ar-H), 7.39 – 7.07 (m, 
26H, Ar-H), 5.83 (ddd, Jtrans = 17.2, Jcis = 10.9, JCH2 = 5.3 Hz, 1H, CH=CH2), 5.29 (dd, Jtrans = 17.2, JCH2 = 1.4 Hz, 
1H), 5.26 – 5.21 (m, 2H, H-4, H-2), 5.20 (dd, Jcis = 10.5, JCH2 = 1.1 Hz, 1H), 5.15 – 5.08 (m, 2H, H-2, H-2), 5.05 
(dd, J2,3 = 10.4, J1,2 = 7.8 Hz, 1H, H-2), 4.97 (dd, J2,3 = 10.5, J3,4 = 3.4 Hz, 1H, H-3) 4.87 (dd, J2,3 = 10.2, J3,4 = 3.2 
Hz, 1H, H-3), 4.86 (dd, J2,3 = 10.3, J3,4 = 3.0 Hz, 1H, H-3), 4.70 (dd, J2,3 = 10.4, J3,4 = 3.1 Hz, 1H), 4.61 – 4.50 (m, 
2H, CH2
Alloc
), 4.51 (d, J1,2 = 7.7 Hz, 1H, H-1), 4.48 (d, J1,2 = 7.6 Hz, 1H, H-1
1
), 4.44 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.41 
– 4.15 (m, 9H, H-1, 4xCH2
Bn
), 4.08 (d, J3,4 = 3.0 Hz, 1H, H-4), 4.07 (d, J3,4 = 3.2 Hz, 1H, H-4), 3.93 (d, J3,4 = 3.4 
Hz, 1H, H-4), 3.72 – 3.52 (m, 4H, H-5, 1.5xH-6), 3.52 – 3.28 (m, 8H, 3xH-5, 2.5xH-6), 2.17 (s, 3H, CH3
Ac
), 2.12 (s, 
3H, CH3
Ac
), 2.11 (s, 3H, CH3
Ac
), 2.05 (s, 3H, CH3
Ac
), 2.00 (s, 3H, CH3
Ac
), 1.97 (s, 3H, CH3
Ac
), 1.93 (s, 3H, CH3
Ac
), 
1.82 (s, 3H, CH3
Ac
), 0.98 (s, 9H, CH3
TBDPS
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 170.40, 170.33, 170.19 (2C), 169.89, 
169.83, 169.60, 169.58, 154.85, 138.85, 138.61, 138.36, 137.59, 136.17 (2C), 135.89 (2C), 133.11, 132.94, 131.39, 
129.84, 129.79-127.35 (24C), 119.28, 101.71, 101.26, 100.61, 95.77, 73.90, 73.66, 73.61 (4C), 73.56 (2C), 73.50, 
73.45 (2C), 73.39 (2C), 73.33 (2C), 71.95, 71.82 (2C), 71.31, 71.10, 69.71, 69.62, 69.57, 69.11, 68.95 (2C), 68.75, 
67.18, 26.81 (3C), 20.99, 20.96, 20.91 (2C), 20.86, 20.84, 20.81, 20.76, 19.20. 
 
tert-butyl diphenylsilyl 2,3-di-O-acetyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-6-O-benzyl-β-
D-galactopyranosyl-(1→4)- 2,3-di-O-acetyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3-di-O-acetyl-6-O-
benzyl -β-D-galactopyranoside (128)  
To a solution of 127 (1.4 g; 0.83 mmol) in THF (50 mL) at 0 °C was added 
morpholine (87 mg; 1.0 mmol), PPh3 (344 mg;  1.31 mmol) and Pd(OAc)2 
(9 mg; 0.04 mmol). The solution was stirred at 22 °C for 2 h and then 
concentrated. The product was purified by flash chromatography (2:1 
Tol/EtOAc) to give 128 as a white crystalline solid. Rf 0.24 (2:1 
Tol/EtOAc). Yield: 1.17 g (88%)  
 
tert-butyl diphenylsilyl 2,3-O-diacetyl-4,6-O-benzylidene-6-O-benzyl-β-D-galactopyranosyl-(1→4)- 2,3-O-
diacetyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)- 2,3-O-diacetyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)- 
2,3-O-diacetyl-6-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3-O-diacetyl-6-O-benzyl -β-D-galactopyranoside 
(129)  
To a 10 mL flame-dried flask was added 128 (474 mg, 0.30 mmol) 
and 54 (197 mg, 0.44 mmol). The mixture was dried azeotropically 
with toluene (2x5 mL) and subjected to vacuum overnight. It was 
then dissolved in dry CH2Cl2 (2.5 mL) and MeCN (2.5 mL), 
cooled to -30 °C, followed by addition of NIS (103 mg; 0.46 
mmol) and TMSOTf (8 mg; 0.03 mmol). The reaction mixture was 
stirred at -20 °C until TLC revealed full conversion of the donor 
(3h). The solution was diluted with CH2Cl2 (100 mL) and washed 
with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The 
organic phase was dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography 
(2:1 toluene/EtOAc) to afford 129 as a white powder. Rf 0.17 (2:1 Tol/EtOAc). Yield: 396 mg (69%) 
    
  = 3.3° (c 1.0, CDCl3). IR (neat, cm
-1
):3032.49, 2933.74, 2860.33, 1750.36, 1368.78, 1242.17, 1220.25, 
1097.88, 1057.48. 
1
H NMR (400 MHz, CDCl3) δ 7.67 – 7.59 (m, 2H, Ar-H), 7.55 (m, 2H, Ar-H), 7.45 (m, 2H, Ar-
H), 7.39 – 7.08 (m, 29H), 5.44 (s, 1H, CHbenzylidene), 5.35 (dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-2
5
), 5.15 – 5.02 (m, 
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4H, 4xH-2), 4.92 – 4.81 (m, 4H, 4xH-3), 4.70 (dd, J2,3 = 10.4, J3,4 = 3.0 Hz, 1H, H-3
5
), 4.50 – 4.41 (m, 4H, 4xH-1), 
4.39 – 4.24 (m, 9H, H-1, 4xCH2
Bn
), 4.16 (d, J3,4 = 2.9 Hz, 1H, H-4), 4.09 (d, J3,4 = 2.7 Hz, 1H, H-4), 4.04 (d, J3,4 = 
3.2 Hz, 1H, H-4), 4.03 (d, J6a,6b = 11.3 Hz, 1H, H-6a), 3.92 (d, J3,4 = 2.7 Hz, 1H, H-4), 3.89 (d, J6a,6b = 11.3 Hz, 1H, 
H-6b), 3.72 (dd, J6a,6b = 9.3, J5,6a = 6.9 Hz, 1H, H-6a), 3.66 – 3.26 (m, 13H, H-4, 5xH-5, 3.5xH-6), 2.16 (s, 3H, 
CH3
Ac
), 2.11 (s, 3H, CH3
Ac
), 2.11 (s, 3H, CH3
Ac
), 2.04 (s, 3H, CH3
Ac
), 2.03 (s, 6H, 2xCH3
Ac
), 2.015 (s, 3H, CH3
Ac
), 
2.01 (s, 3H, CH3
Ac
), 1.97 (s, 3H, CH3
Ac
), 1.81 (s, 3H, CH3
Ac
), 0.98 (s, 9H, 3xCH3).. 
13
C NMR 
 
 (101 MHz, CDCl3) δ 
170.94, 170.33, 170.14, 170.09, 170.07, 169.80, 169.77, 169.53, 169.48, 169.36, 138.72, 138.55, 138.30, 138.27, 
137.69, 136.07 (2C), 135.80 (2C), 133.00, 132.86, 129.72, 129.67, 129.04-126.25 (29C), 101.65, 101.16, 100.95, 
100.82, 100.78, 95.66, 73.87, 73.67, 73.56, 73.45, 73.36, 73.29, 73.10, 73.00, 72.51, 72.00, 71.87, 71.70, 69.74, 
69.54, 69.45, 69.19, 68.81, 68.59, 68.30, 66.37, 26.70 (3C), 20.95, 20.86 (3C), 20.80 (2C), 20.74, 20.70, 20.65 (2C), 
19.08. 
 
β-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-galactopyranose (130)  
In a plastic container, compound 126 (900 mg; 0.67 mmol) was dissolved in THF (10 
mL) and the solution was cooled to 0 C followed by slow addition of HF.pyridine 
complex (2 mL) while maintaining a temperature below 5 C. The reaction was slowly 
heated to 22 °C and stirred at this temperature for 10 h. The solution was poured into 
sat. aq. NaHCO3 (100 mL) and extracted with EtOAc (3x50 mL). The combined 
organic phases were dried over MgSO4, filtered and concentrated. The product was purified by flash 
chromatography (4:1 Tol/EtOAc). The product was dissolved in MeOH (12 mL) and THF (4 mL) and 10 drops of 
freshly prepared 1M NaOMe in MeOH was added. The reaction mixture was stirred at 22 °C until full conversion 
was observed by TLC (24 hours). The reaction was quenched with Amberlite IR-120 (H
+
), filtered and concentrated. 
The product was purified by flash chromatography (9:1 CH2Cl2/MeOH) to yield colorless crystals. The product was 
next dissolved in MeOH (4 mL), THF (1 mL). 10% Pd/C (46 mg; 0.07 mmol) was added and an atmosphere of H2 
(1 atm.) was installed. The reaction was stirred for 2 h, and then water (1 mL) was added. The reaction was stirred 
for 12 h, filtered through celite, and concentrated to give a white solid. Yield: 252 mg (75%) 
1
H NMR (400 MHz, D2O) δ 5.27 (d, J1,2 = 3.7 Hz, 1H, H-1
1), 4.64 (d, J1,2 = 8.0 Hz, 2H, H-1, H-1), 4.61 (d, J1,2 
= 7.9 Hz, 2H, H-1, H-1), 4.60 (d, J1,2 = 7.6 Hz, H-1), 4.23 (d, J3,4 = 3.0 Hz, 1H, H-4
1), 4.17 (m, 5H, 5xH-4), 
4.13 (dd, J = 7.2, 5.6 Hz, 1H), 3.99 – 3.53 (m, 29H). 13C NMR (101 MHz, D2O) δ 104.39, 104.35, 104.24, 96.35, 
92.27, 78.77, 77.80, 77.09, 77.07, 75.11, 74.40, 74.28, 73.25, 73.21, 72.70, 72.18, 71.84, 71.79, 71.33, 69.83, 69.67, 
68.77, 68.58, 60.94, 60.87, 60.69, 60.50. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C18H32NaO16 527.1588 Found 
527.1587 
 
β-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-galactopyranose 
(131)  
In a plastic container, compound 127 (600 mg; 0.36 mmol) was dissolved in 
THF (10 mL) and the solution was cooled to 0 C followed by slow addition of 
HF
.
pyridine complex (2 mL) while maintaining a temperature below 5 C. The 
reaction was slowly heated to 22 °C and stirred at this temperature for 10 h. The 
solution was poured into sat. aq. NaHCO3 (100 mL) and extracted with EtOAc 
(3x50 mL). The combined organic phases were dried over MgSO4, filtered and 
concentrated. The product was purified by flash chromatography (4:1 Tol/EtOAc). The product was dissolved in 
MeOH (8 mL) and THF (2 mL) and 8 drops of freshly prepared 1M NaOMe in MeOH was added. The reaction 
mixture was stirred at 22 °C until full conversion was observed by TLC (24 hours). The reaction was quenched with 
Amberlite IR-120 (H
+
), filtered and concentrated. The product was purified by flash chromatography (9:1 
CH2Cl2/MeOH) to yield colorless crystals. The product was next dissolved in MeOH (4 mL), THF (1 mL). 10% 
Pd/C (25 mg; 0.04 mmol) was added and an atmosphere of H2 (1 atm.) was installed. The reaction was stirred for 2 
h, and then water (1 mL) was added. The reaction was stirred 12 h, filtered through celite, and concentrated to give a 
white solid. Yield: 165 mg (70%) 
1
H NMR (400 MHz, D2O) δ 5.17 (d, J1,2 = 3.7 Hz, 1H, H-1), 4.58 – 4.47 (m, 7H, 7xH-1), 4.13 (d, J3,4 = 3.1 Hz, 
1H, H-4), 4.08 (m, 7H, 7xH-4), 4.03 (dd, J = 7.2, 5.7 Hz, 1H, H-5), 3.89 – 3.42 (m, 39H). 13C NMR (101 MHz, 
D2O) δ 104.38, 104.34, 104.29, 104.24, 96.35, 92.27, 78.80, 77.83, 77.55, 77.51, 77.07, 75.11, 74.47, 74.41, 74.27, 
73.33, 73.28, 73.24, 73.19, 72.70, 72.19, 71.85, 71.79, 71.75, 71.32, 69.81, 69.66, 68.77, 68.57, 60.95, 60.85, 60.69, 
60.67, 60.50. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C24H42NaO21 689.2116 Found 689.2111 
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β-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-
(1→4)-β-D-galactopyranose (132) 
In a plastic container, compound 127 (400 mg; 0.36 mmol) was 
dissolved in THF (10 mL) and the solution was cooled to 0 C followed 
by slow addition of HF
.
pyridine complex (2 mL) while maintaining a 
temperature below 5 C. The reaction was slowly heated to 22 °C and 
stirred at this temperature for 10 h. The solution was poured into sat. 
aq. NaHCO3 (100 mL) and extracted with EtOAc (3x50 mL). The 
combined organic phases were dried over MgSO4, filtered and 
concentrated. The product was purified by flash chromatography (4:1 
Tol/EtOAc). The product was dissolved in MeOH (4 mL) and THF (1 mL) and 4 drops of freshly prepared 1M 
NaOMe in MeOH was added. The reaction mixture was stirred at 22 °C until full conversion was observed by TLC 
(24 hours). The reaction was quenched with Amberlite IR-120 (H
+
), filtered and concentrated. The product was 
purified by flash chromatography (9:1 CH2Cl2/MeOH) to yield colorless crystals. The product was dissolved in 
MeOH (4 mL), THF (1 mL). 10% Pd/C (25 mg; 0.04 mmol) was added and an atmosphere of H2 (1 atm.) was 
installed. The reaction was stirred for 2 h, and then water (1 mL) was added. The reaction was stirred for 12 h, 
filtered through celite, and concentrated to give a white solid. Yield: 117 mg (68%)  
1
H NMR (400 MHz, D2O) δ 5.18 (d, J1,2 = 3.7 Hz, 1H, H-1), 4.58 – 4.48 (m, 14H, H-1
1-H-15, H-12-H-15), 
4.14 (d, J3,4 = 3.1 Hz, 1H, H-4), 4.08 (m, 12H, 9xH-4), 4.04 (t, J = 6.5 Hz, 1H, H-5), 3.90 – 3.43 (m, 49H). 
13
C 
NMR (101 MHz, D2O) δ 104.34, 104.30, 104.24, 96.35, 92.27, 78.80, 77.82, 77.56, 77.53, 77.07, 75.12, 74.48, 
74.46, 74.41, 74.28, 73.27, 73.24, 73.19, 72.71, 72.19, 71.80, 71.75, 71.32, 69.82, 69.66, 68.78, 68.58, 60.95, 60.86, 
60.67, 60.50. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C30H52NaO26 851.2645Found 851.2642 
 
4-O-methyl-β-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-
galactopyranose (133) 
159 (640 mg; 0.35 mmol) was dissolved in MeOH (10 mL) and THF (5 mL) 
and 10 drops of freshly prepared 1M NaOMe in MeOH was added. The reaction 
mixture was stirred at 22 °C until full conversion was observed by TLC (24 
hours). The reaction was quenched with Amberlite IR-120 (H
+
), filtered and 
concentrated. The product was purified by flash chromatography (2:1 
Toluene/EtOAc) to yield colorless crystals. The product was dissolved in 
MeOH (10 mL), THF (2 mL). 20% Pd(OH)2/C (122 mg; 0.17 mmol) was added 
and an atmosphere of H2 (1 atm.) was installed. The reaction was stirred at 22 °C for 24h and then filtered through 
celite, and concentrated to give a white solid. Purified by reverse phase chromatography to give 133 as a white solid. 
Yield: 211 mg (89%) 
1
H NMR (400 MHz, D2O) δ 5.18 (d, J1,2 = 3.7 Hz, 1H, H-1a), 4.55 (d, J1,2 = 8.0 Hz, 1H, H-1b), 4.54 (d, 
J1,2 = 7.7 Hz, 2H), 4.52 (d, J1,2 = 8.3 Hz, 2H), 4.47 (d, J1,2 = 7.9 Hz, 2H), 4.42 (d, J1,2 = 7.9 Hz, 1H), 4.21 
– 3.99 (m, 4H), 3.92 – 3.43 (m, 25H), 3.42 (s, 3H, CH3). 
13
C NMR (101 MHz, D2O) δ 104.38, 104.34, 
104.29, 104.16, 103.20, 96.35, 92.27, 78.99, 78.80, 77.83, 77.63, 77.57, 77.53, 77.08, 77.01, 75.24, 74.46, 
74.42, 74.27, 74.23, 73.33, 73.29, 73.24, 73.20, 73.11, 72.19, 71.85, 71.79, 71.74, 71.59, 71.19, 70.46, 
70.13, 69.81, 69.66, 69.39, 68.77, 62.44, 61.37, 60.85, 60.76, 60.69, 60.67, 60.49, 60.49, 60.47, 52.75. 
HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for C25H44NaO21: 703.2273; Found 703.2268. 
 
4-deoxy-4-fluoro-β-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-
galactopyranose (134) 
160 (550 mg; 0.30 mmol) was dissolved in MeOH (10 mL) and THF (5 mL) 
and 10 drops of freshly prepared 1M NaOMe in MeOH was added. The reaction 
mixture was stirred at 22 °C until full conversion was observed by TLC (24 
hours). The reaction was quenched with Amberlite IR-120 (H
+
), filtered and 
concentrated. The product was purified by flash chromatography (2:1 
Toluene/EtOAc) to yield colorless crystals. The product was dissolved in 
MeOH (10 mL), THF (2 mL). 20% Pd(OH)2/C (105 mg; 0.15 mmol) was added 
and an atmosphere of H2 (1 atm.) was installed. The reaction was stirred at 22 °C for 24h and then filtered through 
celite, and concentrated to give a white solid. Purified by reverse phase chromatography to give 134 as a white solid. 
Yield: 165 mg (82%) 
1
H NMR (400 MHz, D2O) δ 5.28 (d, J1,2 = 3.7 Hz, 1H, H-1a), 4.90 (d, J3,4 = 2.7 Hz, 1H, H-4
F
), 4.72 (d, J1,2 = 7.9 
Hz, 1H, H-1b), 4.64 (d, J1,2 = 8.1 Hz, 1H, H-1), 4.64 (d, J1,2 = 8.1 Hz, 1H, H-1), 4.61 (d, J1,2 = 7.9 Hz, 1H, H-1), 
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4.23 (d, J = 3.1 Hz, 1H), 4.21 – 4.16 (m, 9H), 4.13 (t, J = 6.4 Hz, 1H), 3.95 (dd, J = 10.3, 3.0 Hz, 1H), 3.90 (d, J = 
3.8 Hz, 1H), 3.88 – 3.62 (m, 55H), 3.57 (dd, J = 10.0, 7.8 Hz, 2H). 13C NMR (101 MHz, D2O) δ 102.93, 102.89, 
102.83, 102.39, 94.89, 90.81, 88.85, 87.08, 77.35, 76.38, 76.09, 76.06, 75.96, 73.04, 72.99, 72.82, 72.27, 72.10, 
71.84, 71.78, 70.73, 70.40, 70.34, 70.25, 70.12, 69.94, 69.84, 68.36, 68.21, 67.32, 59.40, 59.32, 59.21, 59.20, 58.34, 
58.29, 57.10. HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for C24H41FNaO20: 691.2073; Found 691.2068. 
 
β-D-glucopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-galactopyranose 
(135) 
161 (615 mg; 0.32 mmol) was dissolved in MeOH (10 mL) and THF (5 mL) 
and 10 drops of freshly prepared 1M NaOMe in MeOH was added. The 
reaction mixture was stirred at 22 °C until TLC showed full conversion (24 
hours). The reaction was quenched with Amberlite IR-120 (H
+
), filtered and 
concentrated. The product was purified by flash chromatography (2:1 
Toluene/EtOAc) to yield colorless crystals. The product was dissolved in 
MeOH (10 mL), THF (2 mL). 20% Pd(OH)2/C (111 mg; 0.15 mmol) was added and an atmosphere of H2 (1 atm.) 
was installed. The reaction was stirred at 22 °C for 24h and then filtered through celite, and concentrated to give a 
white solid. Purified by reverse phase chromatography to give 135 as a white solid. Yield: 184 mg (87%). 
1
H NMR (400 MHz, D2O) δ 5.27 (d, J1,2 = 3.7 Hz, 1H, H-1
1), 4.67 (d, J1,2 = 7.9 Hz, 2H, H-1, H-1), 4.64 (d, J1,2 
= 7.8 Hz, 4H, 2xH-1, 2xH-1), 4.61 (d, J1,2 = 8.0 Hz, 1H, H-1), 4.23 (d, J3,4 = 3.1 Hz, 1H, H-4
1), 4.17 (m, 7H, 
7xH-4), 4.13 (t, J = 6.6 Hz, 1H), 4.00 – 3.30 (m, 39H). 13C NMR (101 MHz, D2O) δ 104.39, 104.35, 104.28, 
103.64, 96.35, 92.27, 78.81, 77.84, 77.51, 77.48, 77.23, 75.81, 75.67, 74.45, 74.28, 73.54, 73.31, 73.26, 73.24, 
73.15, 72.19, 71.86, 71.80, 71.74, 69.82, 69.67, 69.52, 68.78, 60.86, 60.70, 60.66. HRMS (ESI-TOF) m/z: [M + 
Na]
+ 
Calcd for C24H42NaO21: 689.2116; Found 689.2111. 
 
Pent-4-enyl 3-O-benzyl-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside (136) 
140 (10 g; 23.44 mmol) was dissolved in CH2Cl2 (150 mL). Et3N (5.7 mL; 41.0 mmol), DMAP 
(1.43 g; 11.7 mmol) and pivaloyl chloride (4.3 mL; 35.2 mmol) was added to the solution and 
the reaction mixture was heated to 45 °C for 4 h. The reaction mixture was cooled to 0 °C, 
quenched with MeOH (10 mL), washed with water (2x150 mL), dried over MgSO4 and 
concentrated. The product was purified by flash chromatography (15:1 Tol/EtOAc) to afford 
136 as a white crystalline powder. Rf 0.40 (9:1 Tol/EtOAc). Yield 11.04 g (92%) 
    
  = 30.0° (c 1.0, CDCl3). IR (neat, cm
-1
): 3066.29, 3032.92, 2973.51, 2934.24, 2907.31, 2871.73, 1732.08, 1479.12, 
1454.26, 1397.47, 1367.41, 1279.10, 1175.00, 1145.56, 1103.67, 1081.36, 1061.30, 1027.14, 1002.40, 910.86, 734.44, 
697.85 
1
H NMR (400 MHz, CDCl3) δ 7.47 (m, 2H, Ar-H), 7.35 – 7.13 (m, 8H, Ar-H), 5.71 (ddt, Jtrans = 16.9, Jcis 
=10.2, JCH2 = 6.6 Hz, 1H, -CH=CH2), 5.39 (s, 1H, CH
benzylidene
), 5.32 (dd, J2,3 = 10.1, J1,2 = 8.0 Hz, 1H, H-2), 4.92 
(ddd, Jtrans = 17.1, JCH2 = 3.5, Jgem =1.6 Hz, 1H, CH2=CH
trans
), 4.86 (ddt, Jcis = 10.2, JCH2 = 2.1, Jgem =1.6 Hz, 1H, 
CH2=CH
cis
), 4.60 (d, JCH2 = 12.6 Hz, 1H, 0.5xCH2
Bn
), 4.57 (d, JCH2 = 12.6 Hz, 1H, 0.5xCH2
Bn
), 4.37 (d, J1,2 = 8.0 
Hz, 1H, H-1), 4.23 (dd, J6a,6b = 12.3, J5,6a =1.4 Hz, 1H, H-6a), 4.05 (d, J3,4 = 3.1 Hz, 1H, H-4), 3.95 (dd, J6a,6b = 12.3, 
J5,6b =1.7 Hz, 1H), 3.82 (dt, JCH2 = 9.4, JCH=CH2 = 6.6 Hz, 1H, -OCH2
pentenyl
), 3.56 (dd, J2,3 = 10.2, J3,4 = 3.1 Hz, 1H, 
H-3), 3.38 (dt, JCH2 = 9.4, JCH=CH2 =6.6 Hz, 1H, -OCH2
pentenyl
), 3.28 (m, 1H, H-5), 2.09 – 1.93 (m, 2H, CH2
pentenyl
), 
1.68 – 1.45 (m, 2H, CH2
pentenyl
), 1.15 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.93, 138.35, 138.20, 
137.80, 129.04, 128.46 (2C), 128.24 (2C), 127.86, 127.73 (2C), 126.56 (2C), 114.82, 101.36, 101.21, 77.67, 73.49, 
71.37, 69.93, 69.32, 68.50, 66.69, 38.93, 30.23, 28.91, 27.36 (3C). HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for 
C30H38O7Na: 533.2515; Found 533.2516. 
 
Pent-4-enyl 3-O-benzyl-4,6-O-benzylidene-β-D-galactopyranoside (140) 
To a solution of 109 (18.5 g, 55.0 mmol) in toluene (400 mL) was added Bu2SnO (20.5 g, 82.50 
mmol). The flask was fitted with a Dean-Stark apparatus and the mixture was stirred under 
reflux for 12 h. The reaction mixture was cooled to 22 °C and CsF (16.7 g, 110.00 mmol) and 
BnBr (19.6 mL, 165.00 mmol) were added. The reaction mixture was stirred at reflux for 24 h, 
and then cooled to 22 °C, diluted with EtOAc, and quenched with sat. aq. NaHCO3. The water 
phase was extracted with EtOAc (2x300 mL). The combined organic layers were dried over MgSO4, filtered, and 
concentrated. Purification by column chromatography (9:1 Tol/EtOAc) to give 140. Rf 0.19 (9:1 Tol/EtOAc). Yield: 
18.5 g (79%). 
    
  = 18.7° (c 1.0, CDCl3), IR(neat): 3449.34, 3059.64, 3030.08, 2958.09, 2924.67, 2869.46, 1496.29, 1454.07, 
1440.48, 1362.53, 1247.35, 1168.81, 1100.66, 1082.24, 1045.84, 1027.47, 994.84, 859.11, 831.63, 746.56, 697.69. 
1
H 
NMR (400 MHz, CDCl3) δ 7.52 – 7.41 (m, 2H, Ar-H), 7.38 – 7.16 (m, 8H, Ar-H), 5.74 (ddt, Jtrans = 16.9, , Jcis = 
10.1, JCH2 = 6.6 Hz, 1H, -CH=CH2), 5.38 (s, 1H, -CH
benzylidene
), 4.95 (dt, Jtrans = 17.1, Jgem =1.8 Hz, 1H, -CH2=CHcis), 
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4.89 (ddd, Jcis = 9.9, JCH2 = 3.2, Jgem = 1.8 Hz, 1H, -CH2=CHcis), 4.68 (s, 2H, -CH2
Bn
), 4.22 (dd, J6a,6b = 12.4, J5,6a= 
1.6 Hz, 1H, H-6a), 4.20 (d, J1,2 = 7.8 Hz, 1H, H-1), 4.04 (dd, J3,4 = 3.6, J4,5 = 1.1 Hz, 1H, H-4), 3.96 – 3.83 (m, 3H, -
OCH2
pentenyl
, H-6b, H-2), 3.49 – 3.38 (m, 2H, -OCH2
pentenyl
, H-3), 3.26 (m, 1H, H-5), 2.17 – 1.98 (m, 2H, -CH2
pentenyl
), 
1.75 – 1.61 (m, 2H, -CH2
pentenyl
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 138.32, 138.24, 137.87, 129.00, 128.54 (2C), 
128.20 (2C), 127.95 (2C), 127.93, 126.48 (2C), 114.95, 103.05, 101.21, 79.21, 73.32, 71.61, 70.17, 69.39, 69.22, 
66.75, 30.30, 28.74. HRMS (ESI-TOF) m/z:[M + Na]
+ 
Calcd for C25H30O6Na: 449.1940; Found 567.1948. 
 
4,6-O-benzylidene-3-O-benzyl-2-O-pivaloyl-D-galactopyranose (141a) 
136 (12.0 g; 22.4 mmol) was dissolved in acetone (180 mL) and water (20 mL). NBS (16.0 g; 89.8 
mmol) and 2,6-lutidine (13.0 mL; 112.2 mmol) were added and the reaction was stirred at 50 °C 
until TLC showed full conversion (3h). The solution was diluted with CH2Cl2 (400 mL) and washed 
with sat. aq. NaS2O3 (200 mL) and sat. aq. NaHCO3 (200 mL). The organic phase was dried over 
MgSO4, filtered and concentrated. The product was purified by flash chromatography (4:1 
Tol/EtOAc) to afford 141a as a 3:5 α/β mixture. Rf 0.44 (2:1 Tol/EtOAc) . Yield: 8.0 g (81%) 
    
  = 75.0° (c 1.0, CDCl3) IR (neat, cm
-1
):3429.32, 3033.96, 2906.34, 1725.45, 1601.00, 1581.49, 1479.42, 
1398.30, 1363.72, 1283.48, 1168.13, 1098.74, 1082.09, 1026.87, 997.43 
1
H NMR (400 MHz, CDCl3) δ 7.53 – 7.16 
(m, 20H, Ar-H), 5.51 (d, J1,2 = 3.6 Hz, 1H, H-1), 5.41 (s, 1H, CH
benzylidene), 5.39 (s, 1H, CHbenzylidene), 5.19 (dd, 
J2,3 = 10.4, J1,2 = 3.6 Hz, 1H, H-2), 5.13 (dd, J2,3 = 10.0, J1,2 = 8.1 Hz, 1H, H-2), 4.68 (d, JCH2 = 12.4 Hz, 1H, 
0.5xCH2
Bn
), 4.61 (m, 1H, 0.5xCH2
Bn
), 4.60 (d, JCH2 = 12.1 Hz, 2H, CH2
Bn
), 4.50 (d, J1,2 = 8.1 Hz, 1H, H-1), 4.25 
(dd, J6a,6b = 12.4, J5,6a = 1.4 Hz, 1H, H-6a), 4.13 (dd, J6a,6b = 12.5, J5,6a = 1.4 Hz, 1H, H-6a), 4.09 (d, J3,4 = 3.1 Hz, 
1H, H-4), 4.06 (d, J3,4 = 3.2 Hz, 1H, H-4), 4.01 (dd, J2,3 = 10.4, J3,4 = 3.1 Hz, 1H, H-3), 3.97 – 3.88 (m, 2H, H-
6b, H-6b), 3.79 (s, 1H, H-5), 3.58 (dd, J2,3 = 10.1, J3,4 = 3.6 Hz, 1H, H-3), 3.33 (d, J5,6a = 0.9 Hz, 1H, , H-5), 
1.16 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 179.47, 178.06, 157.22, 138.50, 137.92, 137.85, 137.64, 
129.14, 129.07, 128.97, 128.53, 128.45, 128.33, 128.27, 128.24, 128.03, 127.81, 127.77, 127.71, 126.44, 126.37, 
120.96, 101.08, 101.02, 96.48, 91.00, 76.96, 74.49, 73.39, 73.35, 72.96, 72.01, 71.69, 70.48, 69.55, 69.29, 66.96, 
62.43, 39.08, 38.89, 27.27, 27.22. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C25H30NaO7 465.1889 Found 
465.1893 
 
4,6-O-benzylidene-3-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranose N-phenyl trifluoroacetimidate (141) 
141a (8 g; 18.3 mmol) was dissolved in DCM (100 mL) and cooled to 0 °C. Cs2CO3 (11.9 g; 
36.7 mmol) was added followed by N-phenyl trifluoroacetimidoyl chloride (7.6 g; 36.7 mmol). 
The ice bath was removed and the reaction mixture was stirred until TLC showed full 
conversion (12 h). It was then filtered, concentrated and purified by flash chromatography (20/1 
Tol/EtOAc) to give a white crystalline product. Yield:  8.8 g (79%)  
 
Pent-4-enyl 3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranoside (142) 
Trifluoroacetic acid (11.8 mL, 154 mmol) was added drop wise to a solution of 136 (10.4 g, 20.31 
mmol ) and triethylsilane (24.5 mL, 153.3 mmol ) in CH2Cl2 (75 mL) at 0 °C. When the addition 
was complete (10 min), the reaction was warmed to 22 °C and stirred for 3 hr. The mixture was 
diluted with ethyl acetate and washed with sat. aq. NaHCO3 and brine, dried over MgSO4, filtered and concentrated. 
The product was purified by flash chromatography (4:1 Tol/EtOAc) to afford 142. Rf 0.65 (2:1 Tol/EtOAc). Yield: 
9.0 g (86%) 
    
  = -0.9° (c 1.0, CDCl3). IR(neat, cm
-1
): 3468.65, 3064.96, 3030.82, 2972.43, 2932.64, 2872.00, 1731.35, 1479.41, 
1454.20, 1368.34, 1278.83, 1176.44, 1154.93, 1136.93, 1096.12, 1069.27, 911.64, 737.68, 698.36. 
1
H NMR (400 MHz, 
CDCl3) δ 7.31 – 7.16 (m, 10H, Ar-H), 5.70 (ddt, Jtrans = 16.9, Jcis = 10.2, JCH2 = 6.6 Hz, 1H, -CH=CH2), 5.14 (dd, J = 
9.8, 8.0 Hz, 1H, H-2), 4.91 (dq, Jtrans = 17.2, Jgem = 1.7 Hz, 1H, CH2=CHtrans), 4.86 (ddd, Jcis = 10.0, JCH2 = 3.3, Jgem = 
1.7 Hz, 1H, CH2=CHcis), 4.58 (d, J = 12.0 Hz, 1H, CH2
a
), 4.52 (s, 2H, CH2
b
), 4.49 (d, J = 12.0 Hz, 1H, CH2
a
), 4.28 
(d, J1,2 = 8.0 Hz, 1H, H-1), 3.98 (dd, J3,4 = 3.4, J4,5 = 1.1 Hz, 1H, H-4), 3.82 – 3.70 (m, 2H, -OCH2
pentenyl
, H-6a), 3.67 
(dd, J6a,6b = 9.9, J5,6b = 6.0 Hz, 1H, H-6b), 3.53 (td, J5,6a = J5,6b = 6.0, J4,5 = 1.1 Hz, 1H, H-5), 3.46 (dd, J2,3 = 9.8, J3,4 
= 3.4 Hz, 1H, H-3), 3.37 (dt, Jgem = 9.6, JCH2pent = 6.8 Hz, 1H, -CH2
pentenyl
), 2.09 – 1.91 (m, 2H, -CH2
pentenyl
), 1.66 – 
1.46 (m, 2H, -CH2
pentenyl
) 1.13 (s, 9H, 3xCH3
pivaloyl
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.94, 138.12, 137.98, 
137.32, 128.51 (2C), 128.44 (2C), 128.00, 127.81 (2C), 127.78, 127.66 (2C), 114.75, 101.29, 79.03, 73.74, 73.47, 
71.67, 70.48, 69.01, 68.83, 66.25, 38.80, 30.05, 28.81, 27.20 (3C). HRMS (ESI-TOF) m/z:  [M + Na]+ Calcd for 
C30H40O7Na: 535.2672; Found 535.2688. 
 
 
 
Experimental 
 147 
Pent-4-enyl 4,6-O-benzylidene-3-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→4)- 3,6-di-O-benzyl-2-O-
pivaloyl-β-D-galactopyranoside (143) 
To a 250 mL flame-dried flask was added 142 (5 g, 9.75 mmol) and the 141 (8.4 g, 13.7 
mmol). The mixture was co-evaporated with toluene (2x100 mL) and subjected to 
vacuum overnight. The mixture dissolved in DCM (100 mL) and cooled to -40 °C. 
TMSOTf (0.15 mL; 1.0 mmol) was added and the reaction mixture was stirred at -40 °C 
for 2h. Et3N (1 mL) was added and the reaction mixture was concentrated. The crude 
compound was purified by flash chromatography (12:1 Tol/EtOAc) to give 143. Rf 0.37 
(9:1 Tol/EtOAc). Yield: 6.0 g (81%) 
    
  = 21.4° (c 1.0, CDCl3). IR(neat, cm
-1
): 3067.69, 3036.01, 2949.02, 2877.10, 1725.57, 1602.02, 1451.44, 
1373.43, 1314.59, 1269.67, 1179.07, 1092.28, 1069.92, 1026.97, 999.28, 914.33. 
1
H NMR (400 MHz, CDCl3) δ 
7.55 – 7.37 (m, 2H), 7.37 – 7.07 (m, 18H), 5.70 (ddt, Jtrans = 16.9, Jcis =10.2, JCH2 = 6.6 Hz, 1H, -
CH=CH2), 5.31 (s, 1H, -CH
benzylidene
), 5.26 (dd, J2,3 = 10.2, J1,2 = 7.9 Hz, 1H, H-2’), 5.11 (dd, J2,3 = 10.3, 
J1,2 = 7.8 Hz, 1H, H-2), 4.97 (d, J = 7.9 Hz, 1H, H-1’), 4.91 (dq, Jtrans = 17.1, JCH2 = 1.7 Hz, 1H, 
CH2=CHtrans), 4.86 (dt, Jcis = 10.3, JCH2 = 1.6 Hz, 1H, CH2=CHcis), 4.62 – 4.44 (m, 6H, 3xCH2
Bn
), 4.42 
(dd, J3,4 = 2.8, J4,5 = 1.1 Hz, 1H, H-4), 4.27 (d, J1,2 = 7.8 Hz, 1H, H-1), 3.97 (dd, J6a,6b = 12.3, J5,6a = 1.6 
Hz, 1H, H-6a’), 3.89 (d, J3,4 = 3.2 Hz, 1H, H-4’), 3.81 – 3.66 (m, 3H, H-6b’, H-6a 0.5xOCH2
pentenyl
), 3.61 
(dd, J6a,6b = 9.9, J5,6b = 5.6 Hz, 1H, H-6b), 3.55 – 3.43 (m, 3H, H-3, H-3’, H-5), 3.33 (dt, JCH2 = 9.6, JCH2 = 
6.6 Hz, 1H, 0.5xOCH2
pentenyl
), 2.89 – 2.79 (m, 1H, H-5’), 1.98 (m, 2H, -CH2
pentenyl
), 1.53 (m, 2H, -
CH2
pentenyl
), 1.19 (s, 9H, 3xCH3
Piv
), 1.11 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.31, 
176.85, 138.60, 138.40, 138.32, 138.11, 137.93, 129.42-126.32 (15C), 114.72, 101.52, 101.03, 99.10, 
81.07, 77.61, 74.09, 73.92, 73.63, 72.23, 71.61, 70.98, 70.62, 69.39, 68.91, 68.46, 68.20, 66.60, 38.99, 
38.88, 30.19, 29.01, 27.46 (3C), 27.31 (3C). HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C55H68NaO13 
959.4558; Found 959.4551. 
 
Benzyl 4,6-O-benzylidene-3-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→4)- 3,6-di-O-benzyl-2-O-
pivaloyl-β-D-galactopyranosyl-(1→4)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (144) 
To a 25 mL flame-dried flask was added acceptor 113 (400 mg, 0.74 mmol) and the 
donor 143 (901 mg, 0.96 mmol). The mixture was dried azeotropically with toluene 
(2x10 mL) and subjected to vacuum overnight. It was then dissolved in dry CH2Cl2 
(10 mL) and cooled to -30 °C, followed by addition of NIS (221 mg; 0.98 mmol) and 
TMSOTf (33 mg; 0.15 mmol). The reaction mixture was stirred at -30 °C until TLC 
revealed full conversion of the donor (2h). The solution was diluted with CH2Cl2 
(100 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). 
The organic phase was dried over MgSO4, filtered and concentrated. The product was purified by flash 
chromatography (12:1 Tol/EtOAc) to afford 144 as a white crystalline material. Rf  0.36 (9:1 Tol/EtOAc). Yield: 885 
mg (86%) 
    
  = 2.5° (c 1.0, CDCl3). IR(neat, cm
-1
): 3447.32, 3087.92, 2970.89, 2870.33, 1737.68, 1496.74, 1479.31, 
1454.22, 1365.17, 1278.22, 1154.61, 1090.21, 1073.58, 1055.80. 
1
H NMR (400 MHz, CDCl3) δ 7.37 – 7.05 (m, 
40H), 5.33 (s, 1H, -CH
benzylidene
), 5.30 (dd, J2,3 = 10.1, J2,3 = 7.8 Hz, 1H, H-2
2/3
), 5.08 (dd, J2,3 = 10.1, J2,3 = 7.9 Hz, 
1H, H-2
2/3
), 4.92 (d, J = 7.9 Hz, 1H, H-1
2/3
), 4.90 – 4.81 (m, 2H, -CH2
Bn
), 4.80 (d, J = 7.8 Hz, 1H, H-1
2/3
), 4.66 – 
4.43 (m, 11H, 5.5xCH2
Bn
), 4.40 (d, J3,4 = 2.7 Hz, 1H, H-4
2/3
), 4.33 (d, J = 7.8 Hz, 1H, H-1
1
), 4.31 (d, J = 12.0 Hz, 
1H, 0.5x-CH2
Bn
), 4.08 (d, J3,4 = 2.5 Hz, 1H, H-4
1
), 4.01 (dd, J6a,6b = 12.4, J5,6a = 1.5 Hz, 1H, H-6a
1
), 3.89 (d, J3,4 = 
3.6 Hz, 1H, H-4
2/3
), 3.74 (dd, J6a,6b = 12.4, J5,6a = 1.8 Hz, 1H, H-6b
1
), 3.71 – 3.56 (m, 4H, H-21, H-6a2/3, H-62/3), 3.47 
– 3.29 (m, 3H, H-32/3, H-32/3, H-52/3, H-52/3, H-6a2/3), 2.82 (m, 1H, H-51), 1.24 (s, 9H, 3xCH3
Piv
), 1.08 (s, 9H, 
3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.13, 176.64, 138.82, 138.69, 138.60, 138.53, 138.20, 138.10, 137.89 
(2C), 128.80-126.28 (45C), 102.61, 100.80, 100.51, 99.24, 81.92, 81.40, 79.44, 77.63, 77.25, 75.08, 73.98, 73.71, 
73.58, 73.46, 72.87, 72.19, 71.54, 71.37, 70.77, 70.51, 70.29, 70.12, 68.92, 68.85, 67.66, 66.48, 38.95, 38.75, 27.54, 
27.37. HRMS (ESI-TOF) m/z:[M + Na]
+ 
Calcd for C84H94NaO18: 1413.6338; Found 1413.6356. 
 
 
 
 
 
 
 
Experimental 
 148 
Benzyl 4,6-O-benzylidene-2,3-O-dibenzyl-β-D-galactopyranosyl-(1→4)- 2,3,6-O-tribenzyl-β-D-
galactopyranosyl-(1→4)- 2,3,6-O-tribenzyl-β-D-galactopyranoside (146) 
To a solution of 144 (6.4 g; 4.58 mmol) in DMSO (40 mL) was added KOH (5.1 g; 
91.6 mmol) and the reaction mixture was stirred at 22 °C for 16 h. The solution was 
poured into sat. aq. NH4Cl (300 mL) and extracted with CH2Cl2 (3x100 mL). The 
organic phase was dried over MgSO4, filtered and concentrated. The crude compound  
145 was dissolved in DMF (50 mL) and cooled to 0 °C. NaH (60% oil dispension; 
730 mg; 18.31 mmol) was added and the reaction mixture was stirred at 0 °C until 
gas development ceased. Next BnBr (1.9 mL; 16.02 mmol) and TBAI (169 mg; 0.46 
mmol) were added and the reaction mixture was stirred at 22 °C for 12h. The reaction mixture was quenched with 
MeOH, diluted with CH2Cl2 (500 mL) and washed with NH4Cl (400 mL). The organic phase was dried over 
MgSO4, filtered and concentrated. The crude product was purified by flash chromatography (14:1 Tol/EtOAc) to 
give 146 as a white crystalline powder. Rf 0.36 (9:1 Tol/EtOAc). Yield: 5.2 g (82%) 
    
  = 4.0° (c 1.0, CDCl3). IR(neat, cm
-1
): 3454.35, 3087.60, 2919.41, 1701.05, 1604.54, 1585.34, 1496.44, 
1453.61, 1396.15, 1362.75, 1308.61, 1207.48, 1154.03, 1098.98, 1071.83.      
1
H NMR (400 MHz, CDCl3) δ 7.54 – 
7.41 (m, 4H, Ar-H), 7.36 – 7.00 (m, 46H, Ar-H, HBn), 5.44 (s, 1H, -CHbenzylidene), 5.03 (d, JCH2 = 10.8 Hz, 1H, 
0.5xCH2
Bn
), 4.95 (d, J1,2 = 7.6 Hz, 1H, H-1
2/3
), 4.89 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2
Bn
), 4.85 (d, J1,2 = 7.0 Hz, 1H, 
H-1
2/3
), 4.84 (d, JCH2 = 11.8 Hz, 1H, 0.5xCH2
Bn
), 4.79 – 4.50 (m, 12H, 6xCH2
Bn
), 4.46 – 4.30 (m, 3H, H-11, CH2
Bn
), 
4.27 (d, J3,4 = 2.7 Hz, 1H, H-4
1/2/3
), 4.24 (d, JCH2 = 10.9 Hz, 1H, 0.5xCH2
Bn
), 4.18 (d, J = 2.8 Hz, 1H, H-4
1/2/3
), 4.10 
(d, J = 12.1 Hz, 1H, H-6a
1/2/3
), 4.01 (d, J = 3.7 Hz, 1H, H-4
1/2/3
), 3.87 (dd, J = 12.4, 1.7 Hz, 1H, H-6b
1/2/3
), 3.81 – 
3.36 (m, 6H, H-2
1
-H-2
3
, H-3
1 
-H-3
3
, H-5
1
-H-5
3
, H-6
1/2/3
, H-6
1/2/3
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 139.15, 138.99 
(2C), 138.81, 138.73, 138.59, 138.57, 138.28 (2C), 137.84, 128.92-126.49 (50C), 102.89, 102.81, 102.39, 101.20, 
81.88, 81.83, 80.33, 80.02, 78.87, 78.83, 75.31, 74.91, 74.83, 74.37, 74.03, 73.73, 73.53, 73.36, 72.98, 72.76, 72.30, 
71.02, 70.89, 70.31, 70.26, 69.19, 69.06, 66.24. HRMS (ESI-TOF) m/z:[M + Na]
+ 
Calcd for C88H90NaO16: 
1425.6127; Found 1425.6151. 
 
Benzyl 2,3-di-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3,6-tri-O-benzyl-β-D-galactopyranosyl-(1→4)- 2,3,6-tri-
O-benzyl-β-D-galactopyranoside (147) 
146 (6.2 g; 4.4 mmol) was dissolved in CH2Cl2 (100 mL). To the solution was added 
EtSH (1.6 mL; 22.1 mmol) and p-TSA (84 mg; 0.44 mmol) and the reaction mixture 
was stirred at 22 °C for 4 h. The reaction was quenched with Et3N (2 mL) and 
concentrated. The product 147 was purified by flash chromatography (3:1 
Tol/EtOAc). Rf 0.4 (2:1 Tol/EtOAc). Yield 5.4 g (94%) 
    
  = 2.0° (c 1.0, CDCl3). IR(neat, cm
-1
): 3442.71, 3087.68, 3062.40, 3029.77, 
2918.61, 2867.53, 1496.39, 1453.57, 1362.63, 1096.13, 1069.22, 735.98, 697.01. 
1
H NMR (400 MHz, CDCl3) δ 
7.59 – 6.76 (m, 35H), 5.06 (d, JCH2 = 10.9 Hz, 1H, 0.5xCH2
Bn
), 4.89 (d, JCH2 = 11.5 Hz, 2H, CH2
Bn
), 4.81 (d, J = 7.6 
Hz, 1H, H-1
2/3
), 4.74 (d, J = 7.7 Hz, 1H, H-1
2/3
), 4.72  – 4.28 (m, 7H, H-11, 7.5xCH2
Bn
), 4.15 (d, J = 2.8 Hz, 1H, H-
4
2/3
), 4.11 (d, J = 2.9 Hz, 1H, H-4
2/3
), 3.94 (dd, J6a,6b = 9.7, J5,6a =7.3 Hz, 1H, H-6a
1/2/3
), 3.85 (dd, J6a,6b = 11.8, J5,6a 
=7.8 Hz, H-6a
1/2/3
), 3.82 (d, J = 3.7 Hz, 1H, H-4
2/3
), 3.76 - 3.24 (m, 6H, H-2
1
-H-2
3
, H-3
1 
- H-3
3
, H-5
1
-H-5
3
, H-6
1/2/3
, 
H-6
1/2/3
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 139.01, 138.73 (2C), 138.70, 138.58, 138.38, 138.03, 137.97, 137.72, 
128.51-127.35 (45), 103.44, 103.02, 102.81, 81.81, 81.33, 80.32, 80.20, 79.97, 79.00, 75.30, 74.98, 74.81, 74.21, 
73.94, 73.66, 73.41, 73.02, 72.97, 72.78, 72.22, 72.09, 71.28, 70.98, 70.21, 68.56, 67.68, 62.41. HRMS (ESI-TOF) 
m/z: [M + Na]
+ 
Calcd for C81H86NaO16: 1337.5814; Found 1337.5828. 
 
Benzyl 6-O-acetyl-2,3-di-O-benzyl-β-D-galactopyranosyl-(1→4)- 2,3,6-tri-O-benzyl-β-D-galactopyranosyl-
(1→4)- 2,3,6-tri-O-benzyl-β-D-galactopyranoside (148) 
147 (5.8 g; 4.41 mmol) was dissolved in DCM (44 mL) and cooled to 0 °C. Et3N 
(1.23 mL; 8.82 mmol) and acetic anhydride (0.66 mL; 6.6 mmol) was added and the 
reaction mixture was stirred until TLC revealed full conversion (36 h). The reaction 
was quenched with MeOH (2 mL), diluted with CH2Cl2 (50 mL), washed with water 
(2x100 mL), dried over MgSO4 and concentrated. The product was purified by flash 
chromatography to afford the product as a white crystalline powder. Yield: 5.3 g 
(88%) 
    
  = 4.6° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.53 – 6.93 (m, 45H, Ar-H), 4.99 (d, JCH2 = 10.8 Hz, 1H, 
CH2
Bn
), 4.95 (d, J1,2 = 7.7 Hz, 1H, H-1), 4.89 (d, JCH2 = 12.1 Hz, 1H, CH2
Bn
), 4.89 (d, JCH2 = 10.8 Hz, 1H, CH2
Bn
), 
4.84 (d, J1,2 = 7.5 Hz, 1H, H-1), 4.74 – 4.27 (m, 16H, H-1, 7.5xCH2
Bn
), 4.26 (dd, J6a,6b =  11.3, J5,6b = 5.7 Hz, 1H, H-
6a
3
), 4.21 (d, J3,4 = 3.0 Hz, 1H, H-4), 4.20 (dd, J6a,6b = 11.3, J5,6b = 5.3 Hz, 1H, H-6b
3
), 4.17 (d, J3,4 = 2.0 Hz, 1H, H-
4), 3.83 (d, J3,4 = 3.3 Hz, 1H, H-4), 3.78 – 3.36 (m, 13H, 3xH-2, 3xH-3, 3xH-5, H-6
1
, H-6
2
), 1.95 (s, 3H, CH3
Ac
). 
Experimental 
 149 
13
C NMR 
 
 (101 MHz, CDCl3) δ 170.86, 139.16, 138.87, 138.81, 138.64, 138.59, 138.53, 138.46, 138.06, 137.88, 
130.22-127.26 (45C), 103.11, 102.87, 102.34, 82.02, 81.88, 80.17, 80.12, 79.03, 77.36, 75.40, 74.99, 74.22, 73.70, 
73.68, 73.62, 73.16, 73.10, 72.83, 71.85, 71.54, 71.00, 70.82, 70.65, 70.05, 67.11, 63.28, 21.02. HRMS (ESI-TOF) 
m/z: [M + Na]
+ 
Calcd for C83H88NaO17 1379.5919; Found 1379.5922. 
 
Pent-4-enyl 2,3-di-O-benzoyl-6-O-benzyl-4-deoxy-4-fluoro-β-D-glucopyranoside (149) 
Trifluoromethanesulfonic anhydride (2.46 mL; 14.63 mmol) was added dropwise to a solution of 
152 (4 g; 7.31 mmol) in dry CH2Cl2 and dry pyridine (1.37mL) at -15 C, and stirred for 15 min 
before the reaction mixture was allowed to reach 22 °C and stirred for one hour. The reaction 
mixture was then concentrated in vacuo and cooled on ice as tetrabutylammonium fluoride (TBAF, 1 M in THF, 
73.2 mL) was added drop wise. The mixture was stirred at 22 °C for 3 h, diluted with CH2Cl2 (100 mL) and washed 
with 1M HCl (3x50 mL). The combined aqueous phases were washed once with CH2Cl2 (100 mL) and the 
combined organic phases were washed with sat. aq. NaHCO3 (2x50 mL), H2O (50 mL), dried over MgSO4 and 
concentrated. The residue was purified by flash chromatography. (Heptane/EtOAc 2:1) to give 149 as a yellow 
syrup. Rf 0.58 (9:1 Tol/EtOAc). Yield 3.4 g (85%)   
    
  = 52.0° (c 1.0, CDCl3) IR(neat, cm
-1
): 3065.54, 3033.26, 2938.88, 2875.27, 1726.24, 1640.67, 1601.97, 
1584.63, 1493.68, 1451.99, 1314.64, 1276.22, 1177.62, 1106.20, 1070.51, 1028.16, 709.86 
1
H NMR (400 MHz, 
CDCl3) δ 8.05 – 7.79 (m, 4H, H
Bz
), 7.54 – 7.35 (m, 2H, HBz), 7.37 – 7.18 (m, 9H, HBz, HBn), 5.66 (dd, J = 10.5, 7.9 
Hz, 1H, H-2), 5.57 (ddt, Jtrans = 17.1, Jcis =10.6, JCH2 =6.7 Hz, 1H, -CH=CH2), 5.28 (ddd, J3,F = 27.4, J2,3 = 10.5, J3,4 
= 2.7 Hz, 1H, H-3), 5.03 (dd, J4,F = 50.1, J3,4 = 2.7 Hz, 1H, H-4), 4.77-4.73 (m, 2H, CH2=CHtrans, CH2=CHcis), 4.62 
(dd, J1,2 = 7.9, 0.9 Hz, 1H, H-1), 4.52 (s, 2H, -CH2
Bn
), 3.96 – 3.77 (m, 2H, -OCH2
pentenyl
, H-5), 3.76 – 3.62 (m, 2H, H-
6a, H-6b), 3.45 (ddd, J = 9.7, 7.2, 6.2 Hz, 1H, -OCH2
pentenyl
), 2.01 – 1.76 (m, 2H, , -CH2
pentenyl
), 1.72 – 1.35 (m, 2H, , 
-CH2
pentenyl
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 166.03, 165.27, 137.94, 137.76, 133.63, 133.27, 130.10 (2C), 129.83 
(2C), 129.63, 129.01, 128.62 (2C), 128.58 (2C), 128.53 (2C), 128.47 (2C), 128.02, 127.90 (2C), 114.95, 101.38, 
87.30 (0.5C), 85.45 (0.5C), 73.85, 72.65 (0.25C), 72.56 (0.25C), 72.46 (0.25C), 72.38 (0.25C), 69.58, 69.37, 67.60 
(0.5C), 67.55 (0.5C), 29.92, 28.69. HRMS (ESI-TOF) m/z:[M + Na]
+ 
Calcd for C32H33FNaO7: 571.2108; Found 
571.2111. 
 
Pent-4-enyl 4,6-O-benzylidene-β-D-glucopyranoside (150)221 
To a solution of PhCH(OMe)2 (4.2 mL, 27.2 mmol) and camphorsulphonic acid (140 mg, 0.6 
mmol) in MeCN (150 mL) was added pent-4-enyl β-D-glucopyranoside (5 g, 20.15 mmol). 
The flask was equipped with a distillation unit and the mixture was heated to reflux for 2 h 
during which time approximately 75 mL of MeCN-MeOH was distilled off. The distillation unit was replaced with a 
condenser and the reaction mixture was heated to reflux until TLC showed completion (2.5h). The reaction mixture 
was concentrated and the product was purified by flash chromatography (2:1 Tol/EtOAc) to afford 150 as an oil. Rf 
0.31 (2:1 Tol/EtOAc). Yield: 6.5 g (98%) 
    
  = -33.1° (c 1.0, CDCl3) 
1
H NMR (400 MHz, CDCl3) δ 7.49 – 7.37 (m, 2H, Ar-H), 7.29 (m, 3H, Ar-H), 5.74 
(ddt, Jtrans = 16.9, Jcis = 10.2, JCH2 = 6.6 Hz, 1H), 5.44 (s, 1H, -CH
benzylidene
), 4.97 (dd, Jtrans = 17.2, Jgem = 1.8 Hz, 1H, 
-CH2=CHtrans), 4.92 (dd, Jcis = 10.2, Jgem = 1.8 Hz, 1H, -CH2=CHcis), 4.29 (dd, J1,2 = 7.7, 1.1 Hz, 1H, H-1), 4.25 (dd, 
J6a,6b = 10.8, J5,6a = 5.3 Hz, 1H, H-6a), 3.87 – 3.79 (m, 1H, -OCH2
pentenyl
), 3.75 – 3.64 (m, 2H, H-6b, H-3), 3.56 – 
3.27 (m, 4H, H-2, H-4, H-5, -OCH2
pentenyl
), 3.10 – 2.93 (m, 1H, -OH), 2.88 – 2.73 (m, 1H, -OH), 2.13 – 2.02 (m, 2H, 
-CH2
pentenyl
), 1.75 – 1.62 (m, 2H, -CH2
pentenyl
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 137.97, 136.97, 129.28, 128.35 (2C), 
126.30 (2C), 115.07, 103.18, 101.91, 80.58, 74.55, 73.11, 69.87, 68.68, 66.38, 30.12, 28.72. HRMS (ESI-TOF) m/z: 
[M + H]+ Calcd for C18H25O6 337.1651 Found 337.1659 
 
Pent-4-enyl 2,3-di-O-benzoyl-4,6-O-benzylidene-β-D-glucopyranoside (151) 
150 (3.0 g; 8.92 mmol) was dissolved in CH2Cl2 (50 mL). Et3N (4.3 mL; 31.21 mmol), 
DMAP (11 mg; 0.09 mmol) and benzoyl chloride (3.1 mL; 26.76 mmol) was added to the 
solution and the reaction mixture was stirred until TLC revealed full conversion (3 h). The 
reaction was quenched with MeOH (5 mL), diluted with CH2Cl2 (100 mL), washed with water (2x100 mL), dried 
over MgSO4 and concentrated. The product was purified by flash chromatography (Tol/EtOAc 19:1) to afford 151 
as an oil. Rf 0.57 (9:1 Tol/EtOAc). Yield 4.4 g (89%) 
    
  = -5.0° (c 1.0, CDCl3) 
1
H NMR (400 MHz, CDCl3) δ 7.89 (m, 4H, Ar-H), 7.55 – 7.10 (m, 11H, Ar-H), 5.71 (t, 
J2,3 = J3,4 = 9.6 Hz, 1H, H-3), 5.56 (ddt, Jtrans = 17.0, Jcis = 10.4, JCH2 = 6.6 Hz, 1H), 5.47 (s, 1H, CH
benzylidene
), 5.40 
(dd, J2,3 = 9.5, J1,2 = 7.8 Hz, 1H, H-2), 4.76 (m, 2H, CH2=CH-), 4.71 (d, J1,2 = 7.8 Hz, 1H, H-1), 4.36 (dd, J4,5 = 10.5, 
J5,6 = 4.9 Hz, 1H, H-5), 3.90 – 3.79 (m, 3H, H-4, 0.5xOCH2
pentenyl
, H-6a), 3.62 (td, J6a,6b = 9.7, J5,6b = 4.9 Hz, 1H, H-
6b), 3.46 (dt, JCH2 = 9.7, JCH2 = 6.7 Hz, 1H, 0.5xOCH2
pentenyl
), 2.08-1.72 (m, 2H, CH2
pentenyl
), 1.72 – 1.30 (m, 2H, 
CH2
pentenyl
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 165.65, 165.20, 137.71, 136.81, 133.19, 133.10, 129.83 (2C), 129.77 
Experimental 
 150 
(2C), 129.44, 129.37, 129.04, 128.37 (2C), 128.31 (2C), 128.21 (2C), 126.13 (2C), 114.92, 101.79, 101.48, 78.88, 
72.53, 72.12, 69.68, 68.71, 66.63, 29.77, 28.60. HRMS (ESI-TOF) m/z: [M + Na]+ Calcd for C32H32NaO8 
567.1995; Found 567.1996. 
 
Pent-4-enyl 2,3-di-O-benzoyl-6-O-benzyl-β-D-glucopyranoside (152) 
Trifluoroacetic acid (3.7 mL, 48.96 mmol) was added drop wise to a solution of 151 (5 g, 9.79 
mmol) and triethylsilane (7.8 mL, 48.96 mmol) in CH2Cl2 (100 mL) at 0 °C. When the addition 
was complete (10 min), the reaction was warmed to 22 °C and stirred for 2 h. The mixture was 
diluted with CH2Cl2 (100 mL) and washed with sat. aq. NaHCO3 and brine. The organic phase 
was dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography (9:1 
Tol/EtOAc) to afford 152. Rf 0.28 (9:1 Tol/EtOAc). Yield: 3.72 g (74%) 
    
  = 45.9° (c 1.0, CDCl3) IR (neat, cm
-1
): 3489.05, 3065.46, 3032.96, 2939.13, 2871.25, 1728.28, 1451.65, 
1315.18, 1276.66, 1177.56, 1096.00, 1068.93, 1027.24, 709.90 
1
H NMR (400 MHz, CDCl3) δ 7.89 (m, 4H, Ar-H), 
7.50 – 7.37 (m, 2H, Ar-H), 7.35 – 7.24 (m, 9H, Ar-H), 5.58 (ddt, Jtrans = 17.1, Jcis = 10.7, JCH2 = 6.7 Hz, 1H, 
CH=CH2), 5.43 – 5.28 (m, 2H, H-2, H-3), 4.77 (s, 1H, CH2=CH), 4.74 (m, 1H, CH2=CH), 4.60 (d, J1,2 = 7.3 Hz, 1H, 
H-1), 4.58 (d, JCH2 = 11.9 Hz, 1H, CH2
Bn
), 4.53 (d, JCH2 = 11.9 Hz, 1H, CH2
Bn
), 3.89 (dt, J3,4 = J4,5 = 9.3, J4,OH = 3.2 
Hz, 1H, H-4), 3.94 – 3.75 (m, 3H, 0.5xOCH2
pentenyl
, H-6a, H-6b), 3.62 (dt, J4,5 = J5,6a = 9.3, J5,6b =4.6 Hz, 1H, H-5), 
3.44 (dt, JCH2 = 9.7, JCH2 =  6.7 Hz, 1H, 0.5xOCH2
pentenyl
), 3.19 (d, J4,OH = 3.3 Hz, 1H, -OH), 2.02 – 1.78 (m, 2H, -
CH2
pentenyl
), 1.66 – 1.44 (m, 2H, -CH2
pentenyl
).
13
C NMR 
 
 (101 MHz, CDCl3) δ 167.23, 165.26, 137.84, 137.67, 
133.42, 133.12, 129.98 (2C), 129.72 (2C), 129.50, 129.07, 128.50 (2C), 128.40 (2C), 128.33 (2C), 127.88, 127.78 
(2C), 114.82, 101.07, 76.68, 74.58, 73.82, 71.51, 71.20, 70.12, 69.29, 29.82, 28.60. 
 
Pent-4-enyl 2,3-di-O-benzoyl-6-O-benzyl-4-O-methyl-β-D-galactopyranoside (153) 
To a solution of 155 (2.0 g, 3.67 mmol) in CH2Cl2 (80 mL) at 0 C was added Proton Sponge (7.9 
g, 36.72 mmol) and Me3OBF4 (7.0 g, 36.72 mmol). The reaction mixture was warmed to 22 °C 
and stirred for 6 h. The reaction mixture was concentrated and quenched with sat. aq. NH4Cl (50 
mL). The reaction mixture was diluted with Et2O (100 mL), and the aqueous layer was extracted with Et2O (2 × 100 
mL). The combined organic layers were washed with 1N aq. HCl solution (100 mL), sat. aq. NaHCO3 (80 mL), H2O 
(100 mL), dried over MgSO4, filtered and concentrated. The residue was purified by flash chromatography (19:1 
Tol/EtOAc) to afford the methyl ether 153 as a white crystalline material. Rf 0.50 (9:1 Tol/EtOAc). Yield: 1.7 g (84 
%) 
    
  = 25.8° (c 1.0, CDCl3).  IR(neat, cm
-1
): 3065.11, 2934.57, 2871.06, 1726.80, 1640.62, 1601.97, 1584.48, 
1493.98, 1451.80, 1314.38, 1277.24, 1177.38, 1107.81, 1071.77, 1028.09.  
1
H NMR (400 MHz, CDCl3) δ 8.22 – 7.63 (m, 4H, Ar-H), 7.53 – 7.08 (m, 11H, Ar-H), 5.67 (dd, J2,3 = 10.5, J1,2 = 
7.9 Hz, 1H, H-2), 5.63 – 5.51 (m, 1H, CH=CH2), 5.25 (dd, J2,3 = 10.5, J3,4 = 3.0 Hz, 1H, H-3), 4.76 (t, Jgem = 1.2 Hz, 
1H, CH2=CH), 4.74 – 4.70 (m, 1H, CH2=CH), 4.56 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.54 (d, JCH2 = 11.8 Hz, 1H, 
0.5xCH2
Bn
), 4.48 (d, JCH2 = 11.8 Hz, 1H, 0.5xCH2
Bn
), 3.87 (d, J3,4 = 3.0 Hz, 1H, H-4), 3.86 – 3.75 (m, 2H, H-5,  -
OCH2
pentenyl
), 3.71 (dd, J6a,6b = 9.0, J5,6a =7.3 Hz, 1H, H-6a), 3.64 (dd, J6a,6b = 9.0, J5,6b = 5.7 Hz, 1H), 3.48 – 3.40 (m, 
1H,  -OCH2
pentenyl
), 3.39 (s, 3H, CH3
OMe
), 1.97 – 1.81 (m, 2H, CH2
pentenyl
), 1.63 – 1.42 (m, 2H, CH2
pentenyl
). 
13
C NMR 
 
 
(101 MHz, CDCl3) δ 166.15, 165.41, 138.12, 137.98, 133.50, 133.08, 130.00 (2C), 129.92, 129.79 (2C), 129.27, 
128.62 (2C), 128.60 (2C), 128.40 (2C), 127.96 (2C), 114.81, 101.48, 76.45, 74.96, 73.74, 73.53, 70.29, 69.09, 
68.20, 61.50, 29.96, 28.71. HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for C32H33FNaO7: 583.2308; Found 583.2312. 
 
Pent-4-enyl 2,3-di-O-benzoyl-4,6-O-benzylidene -β-D-galactopyranoside (154) 
109 (4 g ; 11.90 mmol) was dissolved in CH2Cl2 (100 mL). Et3N (5.0 mL; 35.70 mmol), DMAP 
(9 mg; 0.39 mmol) and benzoyl chloride (3.5 mL; 29.75 mmol) was added to the solution and the 
reaction mixture was stirred until TLC revealed full conversion (3 h). The reaction was quenched 
with MeOH (10 mL), washed with water (2x100 mL), dried over MgSO4 and concentrated. The 
product was purified by flash chromatography (Tol/EtOAc 19:1) to afford 154 as a white 
crystalline powder. Rf 0.44 (9:1 Tol/EtOAc). Yield 6.0 g (94%) 
    
  = 105.9° (c 1.0, CDCl3). IR(neat, cm
-1
): 3068.38, 3035.61, 2939.64, 1720.19, 1602.03, 1451.33, 1315.13, 
1273.67, 1178.58, 1108.97, 1093.98, 1059.31, 1026.80, 909.62. 
1
H NMR (400 MHz, CDCl3) δ 7.91 (m, 4H, Ar-H), 
7.54 – 7.36 (m, 4H, HBz), 7.35 – 7.24 (m, 7H, Ar-H), 5.79 (dd, J2,3 = 10.4, J1,2 = 8.0 Hz, 1H, H-2), 5.58 (ddt, Jtrans = 
16.2, Jcis =10.9, JCH2 =6.7 Hz, 1H, CH=CH2), 5.47 (s, 1H, -CH
benzylidene
), 5.29 (dd, J2,3 = 10.4, J3,4 = 3.6 Hz, 1H, H-3), 
4.76 – 4.69 (m, 2H, -CH2=CHtrans, -CH2=CHcis), 4.66 (d, J1,2 = 8.0 Hz, 1H, H-1), 4.51 (dd, J3,4 = 3.6,  J4,5 = 1.0 Hz, 
1H, H-4), 4.32 (dd, J6a,6b = 12.4, J5,6a = 1.6 Hz, 1H, H-6a), 4.06 (dd, J6a,6b = 12.4, J5,6b = 1.8 Hz, 1H, H-6b), 3.89 (dt, 
Jgem = 9.6, JCH2pent =6.1 Hz, 1H,  -OCH2
pentenyl
), 3.59 (m, 1H, H-5), 3.46 (ddd, Jgem = 9.6, JCH2pent =7.3, JCH2pent = 6.2 
Hz, 1H, -OCH2
pentenyl
), 1.99 – 1.79 (m, 2H, -CH2
pentenyl
), 1.68 – 1.42 (m, 2H, -CH2
pentenyl
). 
13
C NMR 
 
 (101 MHz, 
Experimental 
 151 
CDCl3) δ 166.38, 165.35, 138.09, 137.64, 133.47, 133.15, 130.07 (2C), 129.88, 129.80 (2C), 129.29, 129.05, 128.52 
(2C), 128.43 (2C), 128.22 (2C), 126.42 (2C), 114.82, 101.35, 101.01, 73.76, 72.95, 69.27, 69.12, 68.90, 66.63, 
29.97, 28.67. HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for C32H32O8Na: 567.1995; Found 567.1998. 
 
Pent-4-enyl 2,3-di-O-benzoyl-6-O-benzyl-β-D-galactopyranoside (155) 
Trifluoroacetic acid (7.0 mL, 91.88 mmol) was added drop wise to a solution of 154 (10.0 g, 
18.37 mmol) and triethylsilane (14.7 mL, 91.88 mmol) in CH2Cl2 (75 mL) at 0 °C. When the 
addition was complete (10 min), the reaction was heated to 22 °C and stirred for 5 h. The mixture 
was diluted with EtOAc and washed with sat. aq. NaHCO3 and brine, dried over MgSO4, filtered and concentrated. 
The product was purified by flash chromatography (19:1 Tol/EtOAc) to afford 155. Rf  0.38 (9:1 Tol/EtOAc). Yield: 
7.1 (72%) 
    
  = 37.9° (c 1.0, CDCl3). IR(neat): 3483.76, 3066.25, 3032.49, 2937.28, 2874.13 ,1719.34, 1601.94, 1451.65, 
1315.18, 1265.13, 1177.72, 1106.62, 1069.16, 1027.79, 709.34. 
1
H NMR (400 MHz, CDCl3) δ 7.95 – 7.85 (m, 4H, 
H
Bz
), 7.47 – 7.38 (m, 2H, HSPh), 7.33 – 7.19 (m, 9H, HSPh, HBz), 5.75 – 5.65 (dd, J1,2 = J2,3 = 9.5, H-2), 5.57 (ddt, 
Jtrans = 15.7, Jcis = 11.2, JCH2 = 6.6 Hz, 1H, -CH=CH2), 5.21 (dt, J2,3 = 9.5, J3,4 =1.6 Hz, 1H, H-3), 4.76-4.73 (m, 2H, 
CH2=CHtrans, CH2=CHcis), 4.60 (d, J1,2 = 9.5, 1H, H-1), 4.52 (m, 2H, , CH2
Bn
), 4.31 – 4.28 (m, 1H, H-4), 3.85 (dt, 
Jgem = 9.7, JCH2pent = 6.2 Hz, 1H, -OCH2
pentenyl
), 3.80 – 3.69 (m, 3H, H-5, H-6a, H-6b), 3.51 – 3.39 (m, 1H, -
OCH2
pentenyl
), 1.98 – 1.81 (m, 2H, -CH2
pentenyl
), 1.62 – 1.45 (m, 2H, -CH2
pentenyl
).
13
C NMR 
 
 (101 MHz, CDCl3) δ 
165.95, 165.35, 137.90, 137.65, 137.64, 133.37, 133.06, 129.89 (2C), 129.69 (2C), 129.18, 128.51 (3C), 128.44 
(2C), 128.32 (2C) , 127.89, 127.81 (2C), 114.78, 101.55, 74.45, 74.43, 73.80, 73.32, 69.75, 69.28, 69.17, 68.12, 
29.84, 28.62. HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for C32H34O8Na: 569.2151; Found 569.2150 
 
2,3,4,6-tetra-O-benzoyl-D-glucopyranose N-phenyl trifluoroacetimidate (156) 
 To a solution of perbenzoylated glucopyranoside (2 g; 2.85 mmol) was dissolved in CH2Cl2 
(10 mL) followed by addition of 30% HBr/AcOH (1.33 mL). The reaction mixture was stirred 
for 3 h and then poured into ice water (100 mL). The aqueous phase was extracted with CH2Cl2 
(2x50 mL). The combined organic phases were dried over MgSO4, filtered and concentrated. Without further 
purification the off-white solid was dissolved in acetone (10 mL) and H2O (0.5 mL). Ag2CO3 (0.4 g; 1.46 mmol) 
was added and the reaction mixture was stirred for 2 h at 22 °C. The solution dispension was filtered through a plug 
of celite and concentrated to give the product in quantitative yield. Rf 0.36 (2:1 heptane/EtOAc). The residue was 
dissolved in CH2Cl2 (20 mL). The solution was cooled to 0 °C followed by addition of PTFAICl (1.2 g; 5.70 mmol) 
and Cs2CO3 (1.9 g; 5.7 mmol). The reaction was stirred at 0 °C for 5 h. The reaction was filtered, concentrated and 
the crude was purified by flash chromatography (9:1 Tol/EtOAc) to give the product 156 as a white powder. Yield: 
1.7 g (79% over two steps) 
1
H NMR (400 MHz, CDCl3) δ 7.95 (dd, J = 8.3, 1.4 Hz, 2H, Ar-H
Bz
), 7.93 – 7.88 (m, 2H, Ar-HBz), 7.83 (dd, J = 8.3, 
1.4 Hz, 2H, Ar-H
Bz
), 7.81 – 7.76 (m, 2H, Ar-HBz), 7.53 – 6.98 (m, 17H, Ar-H), 6.69 – 6.62 (m, 2H, Ar-HNPh), 6.29 – 
5.98 (m, 1H), 5.89 (t, J = 9.2 Hz, 1H), 5.79 – 5.61 (m, 2H), 4.57 (dd, J6a,6b = 12.3, J5,6b= 2.9 Hz, 1H, H-6a), 4.43 (dd, 
J6a,6b = 12.3, J5,6b= 5.5 Hz, 1H, H-6b). 
13
C NMR (101 MHz, CDCl3) δ 166.08, 165.67, 165.10, 164.82, 142.95, 
133.60, 133.54, 133.43, 133.19, 129.88-119.23 (25C), 94.70, 73.30, 72.54, 70.80, 68.97, 62.79. 
 
2,3-di-O-benzoyl-6-O-benzyl-4-O-methyl-D-galactopyranose N-phenyl trifluoroacetimidate (157) 
157 (1.6 g; 2.94 mmol) was dissolved in MeCN (20 mL) and water (1 mL). NBS (1.3 g; 5.89 
mmol) was added and the reaction was stirred at 22 °C for 3 h. The solution was diluted with 
CH2Cl2 (100 mL) and washed with sat. aq. NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The 
organic phase was dried over MgSO4, filtered and concentrated. The product was filtered through a plug of silica 
(2:1 Tol/EtOAc) and the resulting yellow oil was used directly in the next step. The residue was dissolved in CH2Cl2 
(30 mL). The solution was cooled to 0 °C followed by addition of PTFAICl (1.2 g; 5.89 mmol) and Cs2CO3 (1.9 g; 
5.89 mmol). The reaction was stirred at 0 °C until TLC showed full conversion (6 h). The reaction was filtered, 
concentrated and the crude was purified by flash chromatography (9:1 Tol/EtOAc) to give the product 157 as an oil. 
Yield: 1.44 g (74% over two steps) 
1
H NMR (400 MHz, CDCl3) δ 7.97 – 7.92 (m, 2H), 7.91 – 7.86 (m, 2H), 7.61 – 6.89 (m, 14H), 6.63 (d, J = 7.7 Hz, 
2H, Ar-H
NPh
), 5.90 (d, J = 9.6 Hz, 1H), 5.41 – 5.23 (m, 1H), 4.62 – 4.37 (m, 2H), 3.91 (d, J = 2.8 Hz, 1H), 3.69 (m, 
2H), 3.41 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 165.86, 164.97, 143.15, 137.65, 133.55, 133.31, 129.90, 129.75, 
129.23, 128.90, 128.73, 128.58, 128.49, 128.43, 127.91, 127.90, 124.42, 119.26, 95.23, 75.95, 74.54, 74.28, 73.61, 
69.25, 67.50, 61.55. 
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2,3-di-O-benzoyl-6-O-benzyl-4-deoxy-4-fluoro-D-galactopyranose N-phenyl trifluoroacetimidate (158) 
149 (2.0 g; 3.64 mmol) was dissolved in MeCN (20 mL) and water (1 mL). NBS (1.6 g; 7.29 
mmol) was added and the reaction was stirred at 22 °C for 6 h. The solution was diluted with 
CH2Cl2 (100 mL) and washed with sat. aq. NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The 
organic phase was dried over MgSO4, filtered and concentrated. The product was filtered through a plug of silica 
(3:1 Tol/EtOAc) and the resulting yellow oil was used directly in the next step. The residue was dissolved in CH2Cl2 
(30 mL). The solution was cooled to 0 °C followed by addition of PTFAICl (1.5 g; 7.28 mmol) and Cs2CO3 (2.4 g; 
7.28 mmol). The reaction was stirred at 5 °C for 12 h. The reaction was filtered, concentrated and the crude was 
purified by flash chromatography (6:1 Tol/EtOAc) to give the product 158 as a sticky oil. Yield: 1.40 g (59% over 
two steps) 
1
H NMR (400 MHz, CDCl3) δ 7.93 (dd, J = 8.4, 1.4 Hz, 2H), 7.92 – 7.87 (m, 2H), 7.52 – 6.94 (m, 14H, Ar-H), 6.64 
(d, J = 7.7 Hz, 2H, Ar-H
NPh
), 5.95 – 5.82 (m, 1H), 5.37 (m, 1H), 5.18 – 4.96 (m, 1H), 4.52 (m, 2H, CH2
Bn
), 3.73 (m, 
2H, H-6a, H-6b). 
13
C NMR (101 MHz, CDCl3) δ 165.73, 164.83, 142.96, 137.45, 133.67, 133.47, 130.01-
119.22(20C), 94.92, 86.77, 84.91, 73.71, 73.49 (d, J = 18.1 Hz), 71.94 (d, J = 17.7 Hz), 68.56. 
 
Benzyl 2,3-di-O-benzoyl-6-O-benzyl-4-O-methyl-β-D-galactopyranosyl-(1→4)-6-O-acetyl-2,3-di-O-benzyl-β-D-
galactopyranosyl-(1→4)-2,3,6-tri-O-benzyl-β-D-galactopyranosyl-(1→4)- 2,3,6-tri-O-benzyl-β-D-
galactopyranoside (159) 
To a 50 mL flame-dried flask was added 148 (1000 mg, 0.74 mmol) and 157 
(978 mg, 1.47 mmol). The mixture was co-evaporated with toluene (2x20 
mL) and subjected to vacuum overnight. The mixture dissolved in DCM (20 
mL) and cooled to -20 °C. TMSOTf (16 L; 0.07 mmol) was added and the 
reaction mixture was stirred at 0 °C for 2.5h. Et3N (1 mL) was added and the 
reaction mixture was concentrated. The crude compound was purified by flash 
chromatography (12:1 Tol/EtOAc) to afford 159. Rf 0.25 (9:1 Tol/EtOAc). 
Yield: 1046 mg (78%) 
    
  = 15.0° (c 1.0, CDCl3). IR(neat, cm
-1
): 3062.51, 3030.28, 2920.72, 2866.91, 1730.42, 1602.22, 1496.29, 
1452.97, 1364.06, 1276.54, 1105.38, 1070.11, 737.05, 697.93 
1
H NMR (400 MHz, CDCl3) δ 8.05 – 7.82 (m, 4H, 
H
Bz
), 7.58 – 6.87 (m, 38H, HBz, HBn), 5.71 (dd, J2,3 = 10.5, J1,2 = 7.9 Hz, 1H, H-2
4
), 5.25 (dd, J2,3 = 10.5, J3,4 = 3.1 
Hz, 1H, H-3
4
), 4.93 (d, J = 7.9 Hz, 1H, H-1
4
), 4.90 (d, JCH2 = 4.6 Hz, 1H, -CH2
Bn
), 4.87 (d, JCH2 = 5.7 Hz, 1H, -
CH2
Bn
), 4.84 (d, J1,2 = 7.2 Hz, 1H, H-1
2/3
), 4.78 (d, J1,2 = 7.6 Hz, 1H, H-1
2/3
), 4.65 – 4.46 (m, 14H, 7xCH2
Bn
), 4.40 
(d, J1,2 = 7.6 Hz, 1H, H-1
1
), 4.38 – 4.24 (m, 6H, H-41/2/3, H-6a3, 2xCH2
Bn
), 4.12 (d, J = 2.8 Hz, 1H, H-4
1/2/3
), 4.02 
(dd, J6a,6b = 11.8, J5,6b = 6.8 Hz, 1H, H-6b
3
), 3.88 (d, J = 3.1 Hz, 2H, H-4
2/3
,
 
H-4
4
), 3.81 – 3.26 (m, 17H, H-21, H-22/3, 
H-3
1
, H-3
2/3
, H-5
1
-H-5
4
, H-6
1
-H-6
3
, -OCH3), 3.25 (dd, J2,3 = 9.7, J3,4 = 2.7 Hz, 1H, H-3
2/3
), 3.20 (dd, J2,3 =  9.7, J1,2 = 
7.2 Hz, 1H, H-2
2/3
), 1.86 (s, 3H, -CH3
Ac
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 170.63, 166.04, 165.12, 139.21, 138.81, 
138.76, 138.72, 138.70, 138.59, 138.56, 138.55, 137.94, 137.83, 133.34, 132.74, 130.05-127.06 (60C), 103.22, 
102.75, 101.83, 101.76, 82.04, 81.77, 80.83, 80.14, 80.04, 79.92, 77.25, 76.34, 75.26, 74.87, 74.65, 74.61, 74.25, 
74.21, 73.87, 73.69, 73.59, 73.55, 73.47, 73.23, 72.73, 72.71, 71.95, 70.79, 70.65, 70.06, 69.77, 69.28, 68.15, 64.37, 
61.40, 20.94. 
 
Benzyl 2,3-di-O-benzoyl-6-O-benzyl-4-deoxy-4-fluoro-β-D-galactopyranosyl-(1→4)-6-O-acetyl-2,3-di-O-
benzyl-β-D-galactopyranosyl-(1→4)-2,3,6-tri-O-benzyl-β-D-galactopyranosyl-(1→4)- 2,3,6-tri-O-benzyl-β-D-
galactopyranoside (160) 
To a 25 mL flame-dried flask was added 148 (600 mg, 0.44 mmol) and 158 
(575 mg, 0.88 mmol). The mixture was co-evaporated with toluene (2x10 mL) 
and subjected to vacuum overnight. The mixture dissolved in DCM (10 mL) 
and cooled to -20 °C. TMSOTf (8 L; 0.04 mmol) was added and the reaction 
mixture was stirred at 0 °C for 4h. Et3N (0.5 mL) was added and the reaction 
mixture was concentrated. The crude compound was purified by flash 
chromatography (12:1 Tol/EtOAc) to afford 160. Rf 0.38 (9:1 Tol/EtOAc). 
Yield: 589 mg (74%) 
    
  = 28.24° (c 1.0, CDCl3) IR(neat, cm
-1
): 3088.39, 3063.00, 2922.52, 1733.08, 1602.25, 1584.91, 1496.35, 
1363.55, 1313.81, 1276.07, 1261.75, 1104.44, 1069.34, 1028.39. 
1
H NMR (400 MHz, CDCl3) δ 8.15 – 7.73 (m, 4H), 7.59 – 6.90 (m, 40H), 5.69 (dd, J2,3 = 10.5, J1,2 = 7.9 Hz, 1H, H-
2
4
), 5.27 (ddd, J3,F = 27.3, J2,3 = 10.5, J3,4 =2.7 Hz, 1H, H-3
3
), 5.04 (dd, J4,F = 50.1, J3,4 = 2.7 Hz, 1H, H-4
4
), 5.01 (d, 
J = 7.9 Hz, 1H, H-1
4
), 4.92 – 4.83 (m, 3H, H-12/3, -CH2
Bn
), 4.78 (d, J1,2 = 7.6 Hz, 1H, H-1
2/3
), 4.66 – 4.47 (m, 14H, -
7xCH2
Bn
), 4.40 (d, J = 7.6 Hz, 1H, H-1
1
), 4.38 – 4.23 (m, 6H, H-42/3 H-6a3, 2xCH2
Bn
), 4.12 (d, J3,4 = 2.8 Hz, 1H, H-
Experimental 
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4
2/3
), 4.00 (dd, J6a,6b = 11.7, J5,6b = 6.8 Hz, 1H, H-6b
3
), 3.90 (d, J3,4 = 2.8 Hz, 1H, H-4
1
), 3.78 – 3.31 (m, 16H, H-21, 
H-2
2/3
, H-3
1
, H-3
2/3
 H-5
1
-H-5
4
, H-6
1
-H-6
4
), 3.27 (dd, J2,3 = 9.7, J3,4 = 2.8 Hz, 1H, H-3
2/3
), 3.18 (dd, J2,3 = 9.7, J1,2 = 
7.4 Hz, 1H, H-2
2/3
), 1.87 (s, 3H, CH3
Ac
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 170.57, 165.92, 164.94, 139.18, 138.80, 
138.71 (2C), 138.64, 138.54 (2C), 138.51, 137.82, 137.70, 133.48, 132.95, 130.06-127.07 (60C), 103.27, 102.75, 
101.74, 101.50, 82.04, 81.75, 80.77, 80.19, 80.04, 79.92, 77.24, 75.26, 74.87, 74.58, 74.26, 74.18, 73.86, 73.83, 
73.73 (2C), 73.50, 73.45 (2C), 72.77, 72.73, 72.28, 72.06, 71.80, 70.80, 70.63, 69.69, 69.45, 69.30, 67.48, 64.16, 
20.90. 
 
Benzyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl-(1→4)-6-O-acetyl-2,3-di-O-benzyl-β-D-galactopyranosyl-
(1→4)-2,3,6-tri-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (161) 
To a 25 mL flame-dried flask was added 148 (620 mg, 0.46 mmol) and 156 
(699 mg, 0.91 mmol). The mixture was co-evaporated with toluene (2x10 
mL) and subjected to vacuum overnight. The mixture dissolved in DCM (10 
mL) and cooled to -20 °C. TMSOTf (8 L; 0.04 mmol) was added and the 
reaction mixture was stirred at 0 °C for 4h. Et3N (0.5 mL) was added and the 
reaction mixture was concentrated. The crude compound was purified by flash 
chromatography (12:1 Tol/EtOAc) to afford 161. Rf 0.32 (9:1 Tol/EtOAc). 
Yield: 627 mg (74%) 
    
  = 13.8° (c 1.0, CDCl3). IR(neat, cm
-1
): 3088.42, 3062.89, 3030.58, 2918.98, 2868.34, 1733.36, 1601.76, 
1584.39, 1496.02, 1452.52, 1364.00, 1314.43, 1262.07, 1091.21, 1067.85, 1027.25, 735.31, 709.52, 697.82. 
1
H 
NMR (400 MHz, CDCl3) δ 7.97 – 7.88 (m, 4H, H
Bz
), 7.80 (m, 5H, H
Bz
), 7.49 – 6.96 (m, 56H), 5.83 (t, J2,3 = J3,4 = 
9.8 Hz, 1H, H-3
4
), 5.58 (t, J3,4 = J4,5 =  9.8 Hz, 1H, H-4
4
), 5.46 (dd, J2,3 = 9.8, J1,2 = 8.1 Hz, 1H, H-2
4
), 5.17 (d, J1,2 = 
8.1 Hz, 1H, H-1
4
), 4.93 – 4.81 (m, 3H, H-12/3, CH2
Bn
), 4.78 (d, J1,2 = 7.6 Hz, 1H, H-1
2/3
), 4.67 – 4.21 (m, 21H, H-11, 
H-4
2/3
, H-6a
3
, H-6a
4
, H-6b
4
, 8xCH2
Bn
), 4.16 – 4.11 (m, 1H, H-41), 4.07 (dd, J6a,6b = 11.6, J5,6b = 6.6 Hz, 1H, H-6b
3
), 
3.96 (dt, J4,5 = 9.8, J5,6 = 4.2 Hz, 1H, H-5
4
), 3.93 – 3.89 (m, 1H, H-42/3), 3.83 – 3.10 (m, 13H, H-21-H-23, H-31-H-33, 
H-5
1
-H-5
3
, H-6
1
, H-6
2
), 1.87 (s, 3H, -CH3
Ac
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 170.52, 166.14, 165.81, 165.27, 
164.90, 139.18, 138.82, 138.74, 138.69 (2C), 138.55, 138.53 (2C), 137.82, 133.44, 133.23, 133.17, 133.07, 130.10 -
127.10 (65C), 103.30, 102.78, 101.86, 101.49, 82.02, 81.78, 80.66, 80.24, 80.05, 79.93, 77.28, 75.28, 74.89, 74.69, 
74.41, 74.21, 73.86, 73.78, 73.55, 73.47, 72.83, 72.77, 72.75, 72.10, 72.01 (2C), 71.71, 70.83, 70.65, 70.05, 69.79, 
69.62, 63.88, 63.18, 20.86. 
 
3,6-O-dibenzyl-4-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranose (165a) 
169 (29.5 g; 48.27 mmol) was dissolved in acetone (360 mL) and water (40 mL). NBS (34.4 g; 
193.07 mmol) was added and the reaction was stirred at 22 °C for 3 h. The solution was diluted with 
CH2Cl2 (500 mL) and washed with sat. aq. NaS2O3 (250 mL) and sat. aq. NaHCO3 (250 mL). The 
organic phase was dried over MgSO4, filtered and concentrated. The product 165a was purified by flash 
chromatography (12:1 Tol/EtOAc). Rf 0.23 (9:1 Tol/EtOAc). Yield:  21.8 g (88%)  
    
  = 45.0° (c 1.0, CDCl3). IR(neat, cm
-1
): 3447.69, 3064.18, 3031.62, 2971.66, 2932.75, 2909.68, 2872.70, 1763.56, 
1730.54, 1496.83, 1479.89, 1454.78, 1398.86, 1366.02, 1283.02, 1156.41, 1095.43, 1064.77, 738.54, 698.63. 
1
H NMR 
(400 MHz, CDCl3) δ 7.34 – 7.15 (m, 10H, H
Bn
), 5.61 (td, J3,4 = 3.8, J4,5 = 1.1 Hz, 1H, H-4a, H-4b), 5.39 (d, J = 3.7 
Hz, 1H, H-1a), 4.89 (dd, J2,3 = 10.4, J1,2 =3.7 Hz, 1H, H-2a), 4.84 (dd, J2,3 = 10.1, J1,2 = 8.1 Hz, 1H, H-2b), 4.66 (d, J 
= 4.4 Hz, 1H, -CH2
Bn
), 4.63 (d, J = 4.2 Hz, 1H, -CH2
Bn
), 4.52 – 4.48 (m, 1H, -CH2
Bn
), 4.48 (d, J1,2 = 8.1 Hz, 1H, H-
1b), 4.42 – 4.34 (m, 2H, -CH2
Bn
), 4.32 – 4.26 (m, 1H, H-5a), 4.05 – 3.88 (m, 3H, H-3a, -CH2
AcCl
), 3.73 (ddd, J5,6a = 
7.0, J5,6b = 5.6, J4,5 = 1.2 Hz, 1H, H-5b), 3.59 (dd, J = 10.1, 3.3 Hz, 1H, H-3b), 3.53 (dd, J6a,6b = 9.3, J5b,6a = 5.6 Hz, 
1H, H-6a
b
), 3.49 – 3.36 (m, 3H, H-6bb, H-6aa, H-6ba), 1.13 (s, 9H, 3xCH3
Piv
), 1.12 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 
(101 MHz, CDCl3) δ 179.43, 177.99, 166.99, 166.85, 137.26, 137.24, 137.16, 136.85, 129.01, 128.56, 128.54, 
128.52, 128.49, 128.44, 128.39, 128.36, 128.30, 128.27, 128.23, 128.20, 128.11, 128.08, 128.05, 128.01, 127.90, 
96.32, 90.64, 77.24, 76.46, 73.76, 73.73, 72.98, 72.89, 72.12, 72.07, 71.97, 70.10, 69.87, 69.29, 68.22, 68.10, 68.02, 
67.69, 67.31, 67.14, 40.82, 40.76, 38.95, 38.78, 27.10, 27.07, 27.04. HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for 
C27H33ClO8Na: 543.1762; Found 543.1766. 
 
4,6-O-benzylidene-3-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranose N-phenyl trifluoroacetimidate (165)  
141a (21.3 g; 40.86 mmol) was dissolved in DCM (100 mL) and cooled to 0 °C. Cs2CO3 (26.6 
g; 81.74 mmol) was added followed by N-phenyl trifluoroacetimidoyl chloride (17.0 g; 81.73 
mmol). The ice bath was removed and the reaction mixture was stirred until TLC showed full 
conversion (6 h). It was then filtered, concentrated and purified by flash chromatography (20:1 
Tol/EtOAc) to give a white crystalline product. Yield: 22.3 g (80%)  
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Phenyl 4,6-O-benzylidene-3-O-benzyl-1-thio-β-D-galactopyranoside (166)364 
A mixture of 56 (10.0 g, 27.7 mmol), n-Bu2SnO (7.6 g, 30.5 mmol), and 200 mL of dry benzene 
was stirred at reflux for 12 h. The reaction mixture was concentrated and the stannylidene 
derivative was redissolved in toluene (100 mL). Then n-Bu4NBr (13.4 g, 41.6 mmol) and benzyl 
bromide (5.0 mL, 41.9 mmol) were added and the reaction mixture was stirred for 5 h at 60 °C. 
The reaction mixture was then concentrated and the product was purified by flash chromatography (9:1 Tol/EtOAc) 
to give 166 as an amorphous solid. Rf 0.19 (9:1 Tol/EtOAc). Yield: 10.5 g (84%)  
    
  = 6.4° (c 1.0, CDCl3). IR (neat, cm
-1
): 3454.08, 3061.88, 2971.92, 1583.10, 1496.37, 1453.87, 1363.13, 
1339.19, 1286.57, 1212.72, 1167.31, 1078.73, 1042.32, 1026.56, 994.77. 
1
H NMR (400 MHz, CDCl3) δ 7.64 – 7.55 
(m, 2H), 7.41 – 7.08 (m, 13H), 5.35 (s, 1H, CHbenzylidene), 4.66 (d, JCH2 = 12.3 Hz, 1H, CH2
Bn
), 4.62 (d, JCH2 = 12.3 
Hz, 1H, CH2
Bn
), 4.44 (d, J1,2 = 9.3 Hz, 1H, H-1), 4.27 (dd, J6a,6b = 12.5, J5,6a = 1.6 Hz, 1H, H-6a), 4.06 (d, J3,4 = 3.3 
Hz, 1H, H-4), 3.89 (dd, J6a,6b = 12.5, J5,6b = 1.7 Hz, 1H, H-6b), 3.87 (t, J2,3 = J3,4 = 9.3 Hz, 1H, H-2), 3.43 (dd, J2,3 = 
9.3, J3,4 = 3.3 Hz, 1H, H-3), 3.36 (m, 1H, H-5), 2.42 (m, 1H, -OH). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 137.97, 137.84, 
133.76 (2C), 130.70, 129.06, 128.90 (2C), 128.49 (2C), 128.13 (2C), 128.10, 127.94, 127.92 (2C), 126.54 (2C), 
101.14, 87.08, 80.28, 73.26, 71.65, 70.09, 69.41, 67.21. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C26H26NaO5S 
473.1399; Found 473.1392. 
 
Phenyl 4,6-O-benzylidene-3-O-benzyl-2-O-pivaloyl-1-thio-β-D-galactopyranoside (167)365 
166 (40 g; 88.78 mmol) was dissolved in CH2Cl2 (500 mL). Et3N (21.7 mL; 21.65 mmol), DMAP 
(5.4 g; 44.39 mmol) and pivaloyl chloride (16.4 mL; 133.17 mmol) was added to the solution and 
the reaction mixture was heated to 45 °C for 6 h. The reaction mixture was cooled to 0 °C, 
quenched with MeOH (10 mL), washed with water (2x150 mL), dried over MgSO4 and 
concentrated. The product was purified by flash chromatography (9:1 Tol/EtOAc) to afford 167 as 
a white crystalline powder. Rf 0.47 (9:1 Tol/EtOAc). Yield 43.7 g (92%). 
1
H NMR (400 MHz, CDCl3) δ 7.51 (m, 2H, H
SPh
), 7.41 – 7.06 (m, 13H, HSPh, H
Bn
, Ar-H), 5.36 (s, 1H, -CH
benzylidene
), 
5.27 (t, J1,2 = J2,3 = 9.7 Hz, 1H, H-2), 4.62 (d, J1,2 = 9.7 Hz, 1H, H-1), 4.55 (d, JCH2 = 1.8 Hz, 2H, -CH2
Bn
), 4.27 (dd, 
J6a,6b = 12.4, J5,6a =1.6 Hz, 1H, H-6a), 4.08 (dd, J3,4 = 3.4, J4,5 = 1.0 Hz, 1H, H-4), 3.90 (dd, J6a,6b = 12.4, J5,6b = 1.7 
Hz, 1H), 3.61 (dd, J2,3 = 9.7, J3,4 = 3.4 Hz, 1H, H-3), 3.35 (m, 1H, H-5), 1.17 (s, 9H, 3x-CH3
Piv
). 
13
C NMR 
 
 (101 
MHz, CDCl3) δ 176.56, 138.05, 137.77, 133.39 (2C), 132.25, 129.09, 128.83 (2C), 128.44 (2C), 128.20 (2C), 
127.95, 127.86, 127.66 (2C), 126.65 (2C), 101.22, 85.87, 78.85, 73.47, 71.42, 70.07, 69.43, 68.05, 38.88, 27.35, 
27.33 (3C). HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C31H34NaO6S 557.1974; Found 557.1975. 
 
Phenyl 3,6-di-O-benzyl-2-O-pivaloyl-1-thio-β-D-galactopyranoside (168) 
Trifluoroacetic acid (23.7 mL, 309.46 mmol) was added drop wise to a solution of 167 (32.97 g, 
61.89 mmol) and triethylsilane (49.4 mL, 309.46 mmol) in CH2Cl2 (400 mL) at 0 °C. When the 
addition was complete (10 min), the reaction was warmed to 22 °C and stirred for 3 hr. The 
mixture was diluted with ethyl acetate and washed with sat. aq. NaHCO3 and brine. The organic 
phase was dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography (12:1 
Tol/EtOAc) to afford 168. Rf 0.31 (9:1 Tol/EtOAc). Yield: 26.8 g (81%). 
    
  = -54.3° (c 1.0, CDCl3). IR(neat, cm
-1
): 3468.17, 3062.04, 2904.62, 1731.80, 1583.86, 1496.63, 1478.63, 
1454.44, 1396.64, 1366.07, 1277.93, 1229.95, 1207.26, 1151.67, 1095.40, 1063.86. 
1
H NMR (400 MHz, CDCl3) δ 
7.48 – 7.36 (m, 2H, HSPh), 7.30 – 7.13 (m, 13H, , HBn, HSPh),), 5.20 (dd, J1,2 = 10.1, J2,3 = 9.3 Hz, 1H, H-2), 4.60 – 
4.54 (m, 2H, H-1, -CH2
Bn
), 4.54 – 4.48 (m, 3H, 3x-CH2
Bn
), 4.02 (dd, J3,4 = 3.3, J4,5 =1.1 Hz, 1H, H-4), 3.73 (dd, J5,6a 
= J5,6b = 5.9, J6a,6b = 1.5 Hz, 2H, H-6a, H-6b), 3.59 (td, J5,6a = J5,6b = 5.9, J4,5 = 1.1 Hz, 1H, H-5), 3.51 (dd, J2,3 =9.3, 
J3,4 = 3.3 Hz, 1H, H-3), 1.17 (s, 9H, 3x-CH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.97, 138.12, 137.35, 133.91, 
132.03 (2C), 128.96 (2C), 128.65 (2C), 128.54 (2C), 128.17, 127.89 (2C), 127.87, 127.76 (2C), 127.71, 87.14, 
80.18, 77.53, 73.84, 71.97, 69.43, 68.74, 66.66, 38.91, 27.32. HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for 
C31H36ClNaO6S: 559.2130; Found 559.2140. 
 
Phenyl 3,6-di-O-benzyl-4-O-chloroacetyl-2-O-pivaloyl-1-thio-β-D-galactopyranoside (169) 
168 (30 g; 56.11 mmol) was dissolved in CH2Cl2 (350 mL) and cooled to 0 °C. (ClAc)2O (16.3 g; 
95.38 mmol), Et3N (15.6 mL; 112.21 mmol) and DMAP (137 mg; 1.12 mmol) was added and the 
reaction was stirred at 0 °C for 3 h. The reaction mixture was concentrated and purified by flash 
chromatography (30:1 Tol/EtOAc) to afford 169 as a yellowish crystalline powder. Rf 0.59 (9:1 
Tol/EtOAc). Yield 31.8 g (93%) 
    
  = 14.7° (c 1.0, CDCl3). IR(neat, cm
-1
): 3087.86, 3061.83, 3030.97, 2969.93, 2932.50, 2906.70, 2870.91, 1763.39, 
1738.73, 1478.57, 1454.85, 1366.32, 1277.76, 1145.59, 1098.56, 1064.02, 743.79, 697.64. 
1
H NMR (400 MHz, CDCl3) 
δ 7.48 – 7.35 (m, 2H, HSPh), 7.34 – 7.05 (m, 13H, HBn, HSPh), 5.64 (dd, J3,4 = 3.3, J4,5 = 1.0 Hz, 1H, H-4), 5.06 (t, J1,2 
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= J2,3 =9.8 Hz, 1H, H-2), 4.64 (d, JCH2 =11.4 Hz, 1H, -CH2
Bn
), 4.61 (d, J1,2 = 9.8 Hz, 1H, H-1), 4.49 (d, JCH2 =11.7 
Hz, 1H, -CH2
Bn
), 4.37 (d, JCH2 =11.7 Hz, 1H, -CH2
Bn
), 4.33 (d, JCH2 = 11.4 Hz, 1H, -CH2
Bn
), 3.99 (d, JCH2 = 15.2 Hz, 
1H, -CH2
AcCl
), 3.89 (d, JCH2 = 15.2 Hz, 1H, -CH2
AcCl
), 3.76 (ddd, J5,6a = 7.1, J5,6b = 5.9, J4,5 =1.1 Hz, 1H, H-5), 3.57 
(m, 2H, H-3, H-6b), 3.46 (dd, J6a,6b = 9.4, J5,6a = 7.1 Hz, 1H, H-6a), 1.14 (s, 9H, 3x-CH3
Piv
). 
13
C NMR 
 
 (101 MHz, 
CDCl3) δ 176.87, 167.01, 137.46, 137.04, 133.30, 132.39 (2C), 129.00 (2C), 128.64 (2C), 128.51 (2C), 128.30 (2C), 
128.17 (2C), 128.15, 128.05, 128.02, 87.35, 78.20, 75.81, 73.86, 71.90, 68.50, 68.47, 67.61, 40.90, 38.87, 27.28 
(3C). HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for C33H37ClNaO7: 635.1846; Found 635.1844. 
 
Pent-4-enyl 3,6-di-O-benzyl-4-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-
pivaloyl-β-D-galactopyranoside (170) 
To a 500 mL flame-dried flask was added 142 (20 g, 39.01 mmol) and the 165 (35.1 g, 
50.72 mmol). The mixture was co-evaporated with toluene (2x200 mL) and subjected to 
vacuum overnight. The mixture dissolved in DCM (250 mL) and cooled to -40 °C. 
TMSOTf (0.7 mL; 3.9 mmol) was added and the reaction mixture was stirred at -40 °C for 
2h. Et3N (4 mL) was added and the reaction mixture was concentrated. The crude compound was purified by flash 
chromatography (20:1 Tol/EtOAc) to give disaccharide 170. Rf 0.49 (9:1 Tol/EtOAc). Yield: 32.8 g (83%) 
    
  = 3.3° (c 1.0, CDCl3). IR(neat, cm
-1
): 3064.08, 2973.10, 2871.20, 1738.29, 1497.01, 1479.43, 1454.62, 
1366.91, 1278.31, 1149.83, 1135.46, 1089.27, 1066.29, 912.64, 738.48, 698.59. 
1
H NMR (400 MHz, CDCl3) δ 7.36 
– 7.00 (m, 20H, HBn), 5.70 (dddd, Jtrans = 15.5, Jcis =10.1, JCH2 =7.3, JCH2 = 5.9 Hz, 1H), 5.50 (dd, J3’,4’ = 3.2, J4’,5’ = 
1.3 Hz, 1H, H-4’), 5.07 (dd, J2,3 = 9.9, J1,2 = 7.7, 1H, H-2), 5.01 – 4.96 (m, 2H, H-1’, H-2’), 4.91 (dd, J = 17.4, 1.7 
Hz, 1H, CH2=CHtrans), 4.84 (m, 1H, CH2=CHcis), 4.62 – 4.54 (m, 2H, -CH2
Bn
), 4.52 – 4.35 (m, 5H, 3x-CH2
Bn
), 4.35 – 
4.21 (m, 3H, H-1, H-4, -CH2
Bn
), 3.92 (d, J = 15.1 Hz, 1H, -CH2
AcCl
), 3.77 (d, J = 15.1 Hz, 1H, -CH2
AcCl
), 3.73 – 3.56 
(m, 3H, -OCH2
pentenyl
, H-6’), 3.56 – 3.49 (m, 1H, H-5), 3.45 (m, 3H, H-3, H-3’, H-5’), 3.39 – 3.25 (m, 3H, H-6, -
OCH2
pentenyl
), 2.08 – 1.87 (m, 2H, -CH2
pentenyl
), 1.62 – 1.44 (m, 2H, -CH2
pentenyl
), 1.16 (s, 9H, 3xCH3
Piv
), 1.10 (s, 9H, 
3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.37, 176.70, 166.84, 138.54, 138.24, 137.77, 137.38, 137.15, 129.04, 
128.54 (2C), 128.39 (2C), 128.34 (2C), 128.31 (2C), 128.23, 128.06 (2C), 128.02, 127.96 (2C), 127.80, 127.70 
(3C), 127.61, 127.01, 114.65, 101.43, 99.03, 80.65, 76.94, 73.80, 73.64, 73.55, 71.97, 71.91, 71.81, 70.75, 69.25, 
68.54, 68.46, 67.83, 67.28, 40.76, 38.88, 38.76, 30.07, 28.91, 27.31 (3C), 27.21 (3C). HRMS (ESI-TOF) m/z: [M + 
Na]
+ 
Calcd for C57H71ClNaO14: 1037.4430; Found 1037.4437. 
 
Benzyl 3,6-di-O-benzyl-4-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)- 3,6-di-O-benzyl-2-O-
pivaloyl-β-D-galactopyranosyl-(14)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (171) 
To a 100 mL flame-dried flask was added acceptor 113 (2.8 g, 5.17 mmol) and 
donor 170 (6.8 g, 6.73 mmol). The mixture was dried azeotropically with toluene 
(2x50 mL) and subjected to vacuum overnight. It was then dissolved in dry 
CH2Cl2 (30 mL) and dry MeCN (30 mL), cooled to -40 °C, followed by addition 
of NIS (1.6 g; 6.99 mmol) and TESOTf (273 mg; 1.03 mmol). The reaction 
mixture was stirred at -40 °C until TLC revealed full conversion of the donor (2h). 
The solution was diluted with CH2Cl2 (200 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 
(100 mL). The organic phase was dried over MgSO4, filtered and concentrated. The product was purified by flash 
chromatography (9:1 Tol/EtOAc) to afford a white crystalline material. Rf 0.48 (9:1 Tol/EtOAc). Yield: 6.5 g (85%)  
    
  = -1.4° (c 1.0, CDCl3). IR(neat, cm
-1
): 3088.25, 3063.40, 3030.60, 2970.63, 2929.85, 2869.72, 1737.84, 
1603.01, 1585.50, 1496.62, 1479.30, 1453.95, 1364.45, 1277.23, 1134.25, 1098.69, 1064.19, 910.75. 
1
H NMR (400 
MHz, CDCl3) δ 7.60 – 7.01 (m, 40H), 5.49 (d, J3,4 = 3.3 Hz, 1H, H-4
3
), 5.11 – 4.92 (m, 3H, H-22, H-23, H-12/3), 4.88 
– 4.75 (m, 3H, H-12/3, -CH2
Bn
), 4.70 – 4.24 (m, 16H, H-11, H-41, 7x-CH2
Bn
), 4.05 (d, J3,4 = 2.6 Hz, 1H, H-4
2
), 3.87 
(d, J CH2 = 15.0 Hz, 1H, -CH2
AcCl
), 3.73 (d, JCH2 = 15.0 Hz, 1H, -CH2
AcCl
), 3.70 – 3.55 (m, 13H, H-21, H-31 – H-33, H-
5
1
-H-5
3
, H-6
1
-H-6
3
), 3.50 – 3.23 (m, 9H, 3xCH3
Piv
), 1.20 (s, 9H, 3xCH3
Piv
), 1.08 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 
MHz, CDCl3) δ 177.34, 176.68, 166.82, 138.80 (2C), 138.60, 138.50, 137.84, 137.81, 137.42, 137.08, 128.56-
126.87 (40C), 102.62, 100.62, 99.16, 81.85, 81.24, 79.45, 75.08, 73.95, 73.68, 73.66, 73.53, 73.30, 72.91, 72.02, 
71.99, 71.81, 71.06 (2C), 70.68, 70.52, 70.13, 68.94, 68.49, 67.31, 67.29, 40.74, 38.95, 38.77, 27.51(3C), 27.39(3C). 
HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for C86H97ClNaO19: 1491.6210; Found 1491.6223. 
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Benzyl 3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-
galactopyranosyl-(14)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (172) 
To a solution of 171 (4.35 g; 2.96 mmol) in THF (50 mL) at 0 °C was added a 
0.02M NaOCH3 solution in CH3OH (100 mL). The reaction mixture was stirred at 0 
°C for 1h, quenched with amberlite 120-H
+
 resin, filtered and concentrated. The 
residue was purified by flash chromatography (9:1 Tol/EtOAc) to give 172 as a 
white crystalline material. Rf 0.19 (Tol/EtOAc). Yield: 3.7 g (91%)  
    
  = -1.7° (c 1.0, CDCl3). IR(neat, cm
-1
): 3441.58, 3063.04, 3030.23, 2969.23, 
2929.93, 2870.10, 1737.07, 1496.64, 1479.39, 1454.15, 1365.69, 1278.01, 1154.12, 1100.98, 1070.66, 737.48, 
697.65. 
1
H NMR (400 MHz, CDCl3) δ 7.30 – 7.08 (m, 40H, H
Bn
), 5.16 – 5.04 (m, 2H, H-22/3, H-22/3), 4.92 (d, J1,2 = 
7.8 Hz, 1H, H-1
2/3
), 4.84 (d, JCH2 = 12.1 Hz, 1H, 0.5xCH2
Bn
), 4.79 (d, J CH2 = 10.7 Hz, 1H, 0.5xCH2
Bn
), 4.75 (d, J1,2 = 
7.8 Hz, 1H, H-1
2/3
), 4.65 – 4.43 (m, 12H, 5.5xCH2
Bn
), 4.43 – 4.26 (m, H-11, H-41/2/3, 1.5xCH2
Bn
), 4.10 – 4.03 (d, J = 
3.1 Hz,1H, H-4
1/2/3
), 3.85 (d, J = 3.3 Hz, 1H, H-4
1/2/3
), 3.71 – 3.55 (m, 5H, H-21, H-61/2/3, H-61/2/3), 3.55 – 3.23 (m, 
8H, H-3
1
-H-3
3
, H-5
1
-H-5
3
, H-6
1/2/3
), 1.23 (s, 9H, 3xCH3
Piv
), 1.07 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 
177.52, 176.77, 138.81, 138.80, 138.60, 138.52, 138.06, 137.87 (2C), 137.33, 129.78-127.00 (40C), 102.61, 100.60, 
98.96, 81.83, 81.14, 79.44, 79.00, 77.27, 75.08, 74.03, 73.70, 73.65, 73.60, 73.52, 73.36, 72.83, 72.06, 71.63, 71.13, 
71.04, 70.80, 70.52, 70.26, 69.47, 68.97, 67.12, 66.40, 38.99, 38.76, 27.54(3C), 27.40(3C). HRMS (ESI-TOF) m/z: 
[M + Na]
+ 
Calcd for C84H96NaO18: 1415.6494; Found 1415.6498. 
 
Benzyl 3,6-di-O-benzyl-4-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-
pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)- 3,6-di-O-
benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (173) 
To a 100 mL flame-dried flask was added acceptor 172 (4 g, 2.87 
mmol) and donor 170 (3.8 g, 3.73 mmol). The mixture was dried 
azeotropically with toluene (2x50 mL) and subjected to vacuum 
overnight. It was then dissolved in dry CH2Cl2 (30 mL) and dry 
MeCN (30 mL), cooled to -40 °C, followed by addition of NIS (870 
mg; 3.87 mmol) and TESOTf (151 mg; 0.57 mmol). The reaction 
mixture was stirred at -40 °C until TLC revealed full conversion of 
the donor (1h). The solution was diluted with CH2Cl2 (200 mL) and 
washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic phase was dried over MgSO4, 
filtered and concentrated. The product was purified by flash chromatography (9:1 Tol/EtOAc) to afford compound 
173 as  white crystalline material. Rf 0.58 (2:1 Tol/EtOAc). Yield: 5.4 g (83%) 
    
  = 4.3° (c 1.0, CDCl3). IR(neat, cm
-1
): 3088.59, 2930.71, 2870.06, 1738.23, 1496.61, 1479.31, 1454.21, 
1365.07, 1277.37, 1150.19, 1132.87, 1098.81, 1059.86, 910.25, 734.25, 697.19. 
1
H NMR (400 MHz, CDCl3) δ 7.49 
– 6.96 (m, 60H, HBn), 5.50 (d, J3,4 = 3.8 Hz, 1H, H-4
5
), 5.10 – 4.91 (m, 4H, H-22 – H-25), 4.89 – 4.67 (m, 7H, H-12 – 
H-1
5
, CH2
Bn
), 4.66 – 4.22 (m, 24H, H-11, H-41, 11xCH2
Bn
), 4.20 – 4.00 (m, 4H, H-42-H-44), 3.86 (d, J = 14.9 Hz, 
1H, CH2
AcCl
), 3.76 (d, J = 14.9 Hz, 1H, CH2
AcCl
), 3.72 – 3.10 (m, 21H, H-21, H-31 – H-35, H-51-H-55, H-6
1
-H-6
5
), 
1.17 (s, 9H, 3xCH3
Piv
), 1.12 (s, 9H, 3xCH3
Piv
), 1.09 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, 
CDCl3) δ 177.14, 176.73, 176.62, 176.57, 166.81, 138.93, 138.87, 138.83, 138.60, 138.55 (2C), 138.04, 137.95, 
137.91, 137.90, 137.41, 137.04, 129.07-125.34 (60C), 102.55, 100.63, 99.96 (2C), 99.70, 81.75, 80.90, 80.62, 79.43, 
77.28, 75.07, 74.33, 74.08, 73.89, 73.68, 73.64, 73.60, 73.55, 73.52, 73.50, 72.75, 72.65, 72.02, 71.99, 71.69, 71.64, 
71.37, 71.20, 71.09, 71.05, 70.69, 70.48, 70.43, 70.13, 69.64, 69.40, 69.24, 68.37, 68.29, 67.85, 67.27, 40.78, 38.87, 
38.83, 38.78, 38.74, 27.56(3C), 27.49(3C), 27.42(3C), 27.38(3C) 
 
Benzyl 3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)- 3,6-di-O-benzyl-2-O-pivaloyl-β-D-
galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)- 3,6-di-O-benzyl-2-O-
pivaloyl-β-D-galactopyranosyl-(14)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (174) 
To a solution of 173 (4.0 g; 1.76 mmol) in THF (25 mL) at 0 C was 
added a 0.02M NaOMe solution in CH3OH (75 mL). The reaction 
mixture was stirred at 0 C for 1h, quenched with amberlite 120-H+ 
resin, filtered and concentrated. The residue was purified by flash 
chromatography (9:1 Tol/EtOAc) to afford 174 as a white crystalline 
material. Rf 0.30 (9:1 Tol/EtOAc). Yield: 3.6 g (93%) 
    
  = -2.14° (c 1.0, CDCl3). IR(neat, cm
-1
): 3088.36, 3063.23, 
3030.39, 2969.66, 2930.24, 2869.29, 1737.79, 1496.65, 1479.28, 
1454.16, 1365.24, 1277.26, 1152.03, 1099.26, 1069.52, 910.28, 735.06, 697.07. 
1
H NMR (400 MHz, CDCl3) δ 7.44 
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– 7.03 (m, 60H, HBn), 5.09 (dd, J2,3 = 9.8, J1,2 = 8.0 Hz, 1H, H
2/3/4/5
), 5.02 (m, 3H, H-2
2
-H-2
4/5
), 4.86 – 4.69 (m, 6H, 
H-1
2
-H-1
5
, CH2
Bn
), 4.64 – 4.26 (m, 24H, H-11, H-41/2/3/4/5 11xCH2
Bn
), 4.17 (dd, J3,4 = 3.0, J4,5 = 1.2 Hz, 1H, H-
4
1/2/3/4/5
), 4.15 (dd, J3,4 = 3.0, J4,5 = 1.0 Hz, 1H, H-4
1/2/3/4/5
), 4.03 (dd, J3,4 = 3.1, J4,5 = 1.1 Hz, 1H, H-4
1/2/3/4/5
), 3.86 
(dd, J3,4 = 3.3, J4,5 = 1.1 Hz, 1H, H-4
1/2/3/4/5
), 3.73 – 3.44 (m, 10H, H-21, H-61-H-6a5), 3.43 – 3.20 (m, 11H, H-31-H-
3
5
, H-5
1
-H-5
5
, H-6b
1/2/3/4/5
), 1.17 (s, 9H, 3xCH3
Piv
), 1.12 (s, 18H, 6xCH3
Piv
), 1.06 (s, 8H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 
MHz, CDCl3) δ 177.27, 176.70, 176.65, 176.56, 138.94, 138.88, 138.87, 138.85, 138.64, 138.60, 138.04 (2C), 
137.97, 137.92, 137.91, 137.32, 128.53-127.16 (60C), 102.54, 100.61, 99.95, 99.71, 99.65, 81.75, 80.89, 80.54, 
79.43, 79.17, 77.28, 75.07, 74.33, 74.12, 74.00, 73.93, 73.60, 73.53, 73.50, 73.22, 72.73, 72.27, 71.97, 71.94, 71.57, 
71.35, 71.16, 71.07, 70.68, 70.60, 70.41, 70.20, 69.75, 69.05, 68.87, 68.33, 67.73, 66.23, 38.86, 38.82, 38.73, 
27.57(3C), 27.50(3C), 27.42 (6C). 
 
Benzyl 3,6-di-O-benzyl-4-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-
pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)- 3,6-di-O-
benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)- 
3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (175) 
To a 100 mL flame-dried flask was added acceptor 174 
(2.5 g, 1.11 mmol) and donor 170 (1.6 g, 1.55 mmol). 
The mixture was dried azeotropically with toluene 
(2x50 mL) and subjected to vacuum overnight. It was 
then dissolved in dry CH2Cl2 (20 mL) and dry MeCN 
(20 mL), cooled to -40 °C, followed by addition of NIS 
(360 mg; 1.60 mmol) and TESOTf (59 mg; 0.22 
mmol). The reaction mixture was stirred at -40 °C until 
TLC revealed full conversion of the donor (2h). The 
solution was diluted with CH2Cl2 (200 mL) and washed 
with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic phase was dried over MgSO4, filtered 
and concentrated. The product was purified by flash chromatography (19:1 Tol/EtOAc) to afford 175 as a white 
crystalline material. Rf 0.48 (9:1 Tol/EtOAc). Yield: 2.8 g (80%) 
    
  = 6.9° (c 1.0, CDCl3). IR(neat, cm
-1
): 3088.61, 3063.52, 3030.46, 2971.54, 2930.92, 2869.87, 1738.32, 
1496.70, 1479.31, 1454.28, 1365.19, 1277.24, 1071.43, 910.17, 734.27, 697.12 
1
H NMR (400 MHz, CDCl3) δ 7.40 
– 7.01 (m, 80H), 5.50 (d, J = 3.3 Hz, 1H, H-47), 4.99 (m, 6H, H-22 – H-27), 4.89 – 4.75 (m, 6H, H-12 – H-17), 4.73– 
4.22 (m, 34H, H-1
1
, H-4
1
, 16xCH2
Bn
), 4.21 – 3.99 (m, 5H, H-42-H-46), 3.86 (d, J = 14.9 Hz, 1H, CH2
AcCl
), 3.76 (d, J 
= 14.8 Hz, 1H, CH2
AcCl
), 3.72 – 3.19 (m, 29H, H-21, H-31 – H-37, H-51-H-57, H-6
1
-H-6
7
), 1.17 (s, 9H, 3xCH3
Piv
), 
1.11 (s, 9H, 3xCH3
Piv
), 1.10 (s, 9H, 3xCH3
Piv
), 1.09 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
), 1.05 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.12, 176.65 (2C), 176.60, 176.56, 176.54, 138.98, 138.92, 138.87 (2C), 138.85, 
138.60, 138.52, 138.02, 137.96 (2C), 137.94, 137.92, 137.90, 137.40, 137.02, 129.07-127.15 (80C), 102.54, 100.59, 
100.26, 100.10, 99.99, 99.88, 99.47, 81.75, 80.87, 80.68, 80.57, 80.46, 79.43, 77.40, 77.28, 77.08, 76.76, 75.06, 
74.45, 74.31, 74.09, 73.76, 73.68, 73.57, 73.49, 73.40, 72.71, 72.64, 72.23, 72.05, 71.99, 71.92, 71.69, 71.30, 71.12, 
70.93, 70.64, 70.47, 70.41, 70.19, 69.50, 69.44, 69.23, 68.81, 68.35, 68.05, 67.28, 40.77, 38.86, 38.84, 38.80 (2C), 
38.76, 38.73, 27.58(3C), 27.48(3C), 27.47(3C), 27.44(3C), 27.41(3C), 27.38(3C). 
 
β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-
(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranoside (132) 
173 (1.0 g; 0.43 mmol) was dissolved in THF (20 mL) and a 1M 
Et4NOH in MeOH solution (10.8 mL; 10.8 mmol) was added. The 
reaction mixture was stirred stirred at 65 C until TLC showed full 
conversion (24 hours). The reaction mixture was poured into sat. aq. 
NH4Cl (100 mL) and extracted with CH2Cl2 (3x50 mL). The combined 
organic phases were dried over MgSO4, filtered and concentrated. The 
product was purified by flash chromatography (2:1 Tol/EtOAc) to yield 
colorless crystals. The product was dissolved in MeOH (20 mL), THF (5 mL). 20% Pd(OH)2/C (302 mg; 0.43 
mmol) was added and an atmosphere of H2 (1 atm.) was installed. The reaction was stirred at 22 °C for 48h, filtered 
through celite, and concentrated to give a grey solid. Purified by reverse phase chromatography to afford 132 as a 
white solid. Yield: 278 mg (78% over two steps) 
1
H NMR (400 MHz, D2O) δ 5.18 (d, J1,2 = 3.7 Hz, 1H, H-1), 4.58 – 4.48 (m, 14H, H-1
1-H-15, H-12-H-15), 
4.14 (d, J3,4 = 3.1 Hz, 1H, H-4), 4.08 (m, 12H, 9xH-4), 4.04 (t, J = 6.5 Hz, 1H, H-5), 3.90 – 3.43 (m, 49H). 
13
C 
NMR (101 MHz, D2O) δ 104.34, 104.30, 104.24, 96.35, 92.27, 78.80, 77.82, 77.56, 77.53, 77.07, 75.12, 74.48, 
Experimental 
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74.46, 74.41, 74.28, 73.27, 73.24, 73.19, 72.71, 72.19, 71.80, 71.75, 71.32, 69.82, 69.66, 68.78, 68.58, 60.95, 60.86, 
60.67, 60.50. 
 
β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-
(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranoside (176) 
173 (890 mg; 0.28 mmol) was dissolved in THF (20 mL) 
and a 1M Et4NOH in MeOH solution (9.8 mL; 9.81 
mmol)  was added. The reaction mixture was stirred at 
65 C until TLC showed full conversion (24 hours). The 
reaction mixture was poured into sat. aq. NH4Cl (100 
mL) and extracted with CH2Cl2 (3x50 mL). The 
combined organic phases were dried over MgSO4, 
filtered and concentrated. The product was purified by 
flash chromatography (1:1 Toluene/EtOAc) to yield 
colorless crystals. The product was dissolved in MeOH 
(20 mL), THF (5 mL). 20% Pd(OH)2/C (196 mg; 0.28 mmol) was added and an atmosphere of H2 (1 atm.) was 
installed. The reaction was stirred at 22 °C for 48h, filtered through celite, and concentrated to give a grey solid. 
Purified by reverse phase chromatography to afford 176 as a white solid. Yield: 242 mg (75% over two steps). 
1
H NMR (400 MHz, D2O) δ 5.18 (d, J = 3.7 Hz, 1H, H-1), 4.60 – 4.48 (m, 13H, H-1
1-H-17, H-12-H-17), 4.14 
(d, J = 3.0 Hz, 1H, H-4), 4.08 (m, 19H, 13xH-4), 4.04 (t, J = 6.5 Hz, 1H), 3.86 (dd, J = 10.3, 3.0 Hz, 1H), 3.83 – 
3.43 (m, 68H)
. 13
C NMR (101 MHz, D2O) δ 104.33, 104.30, 104.25, 96.35, 92.27, 78.80, 77.82, 77.58, 77.56, 
77.07, 75.12, 74.46, 74.41, 74.28, 73.25, 73.19, 72.71, 72.19, 71.80, 71.75, 71.32, 68.58, 60.95, 60.68, 60.50. Full 
characterization will be performed in collaboration with the Carlsberg Laboratories
 
 
Benzyl 3,6-di-O-benzyl-4-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-
pivaloyl-β-D-galactopyranosyl-(14)-3-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-
2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-2,3,6-tri-
O-benzyl-β-D-galactopyranoside (178) 
To a solution of 179 (3.75 g, 1.34 mmol) in CH2Cl2 (35 mL) 
and water (3.5 mL) was added DDQ (0.46 g, 2.01 mmol). The 
mixture was stirred for 90 min at 22 °C in the dark. The 
mixture was diluted with CH2Cl2 (30 mL) and washed with an 
aqueous solution of ascorbic acid (0.7%), citric acid (1.5%) 
and NaOH (0.9%). The organic layer was dried (MgSO4), 
filtered and the filtrate was concentrated in vacuo. Purification 
of the residue by flash chromatography (9:1 Tol/EtOAc) 
afforded 178 as a white solid. Rf 0.21 (9:1 Tol/EtOAc).Yield: 
2.63g (75%) 
    
  = -1.9° (c 1.0, CDCl3). IR(neat, cm
-1
): 3517.23, 3063.61, 3030.38, 2970.41, 2930.60, 2869.68, 1739.44, 
1496.83, 1479.49, 1454.46, 1365.36, 1277.43, 1134.73, 1100.35, 1071.60. 
1
H NMR (400 MHz, CDCl3) δ 7.43 – 
7.10 (m, 65H), 5.45 (d, J3,4 = 3.3 Hz, 1H, H-4
6
), 5.11 – 4.89 (m, 5H, H-22-H-26), 4.86 (d, JCH2 = 12.8 Hz, 1H, 
0.5xCH2), 4.82 – 4.76 (m, 3H, H-1
2/3/4/5/6
, H-1
2/3/4/5/6
, 0.5xCH2), 4.72 (d, J1,2 = 7.9 Hz, 1H, H-1
2/3/4/5/6
), 4.62 (d, J = 
7.9 Hz, 1H, H-1
2/3/4/5/6
), 4.60 – 4.20 (m, 27H, H-11, H-12/3/4/5/6, H-41, 12xCH2
Bn
), 4.10 – 4.06 (m, 1H, H-42/3/4/5/6), 4.06 
– 4.02 (m, 2H, H-42/3/4/5/6, H-42/3/4/5/6), 3.98 (m, 1H, H-42/3/4/5/6), 3.96 (d, JCH2 = 15.0 Hz, 1H, 0.5xCH2
AcCl
), 3.86 (d, 
JCH2 = 15.0 Hz, 1H, 0.5xCH2
AcCl
), 3.78 – 3.52 (m, 8H, H-21, 3.5xH-6), 3.50 – 3.05 (m, 17H, H-31 – H-36, H-51-H-56, 
2.5xH-6), 1.19 (s, 9H, 3xCH3
Piv
), 1.12 (s, 9H, 3xCH3
Piv
), 1.09 (s, 9H, 3xCH3
Piv
), 1.05 (s, 9H, 3xCH3
Piv
), 1.00 (s, 9H, 
3xCH3
Piv
). 
13
C NMR (101 MHz, CDCl3) δ 177.27, 176.73, 176.59 (2C), 176.25, 166.84, 138.95, 138.91, 138.86, 
138.78, 138.60, 138.07, 137.99, 137.95, 137.91, 137.85, 137.63, 137.40, 137.05, 128.55-127.08 (65C), 102.54, 
101.79, 100.65, 100.52, 99.44, 81.73, 80.95, 80.66, 80.30, 80.05, 79.43, 77.26, 76.97, 75.06, 74.28, 74.18, 74.03, 
73.89, 73.63, 73.57, 73.53, 73.48, 73.04, 72.76, 72.59, 71.97, 71.79, 71.33, 71.23, 71.10, 70.57 (2C), 70.39, 70.28, 
69.86, 69.80, 69.44, 69.39, 68.92, 68.41, 67.33, 67.06, 40.81, 38.86, 38.82, 38.77, 38.75, 38.71, 27.57 (3C), 27.46 
(3C), 27.40 (3C), 27.25 (6C). 
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Benzyl 3,6-di-O-benzyl-4-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-
2-O-pivaloyl-β-D-galactopyranosyl-(14)-3-O-benzyl-6-O-(2-naphthyl)methyl-2-O-pivaloyl-β-D-
galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)- 3,6-di-O-
benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (179) 
To a 100 mL flame-dried flask was added acceptor 185 
(3.95 g, 2.11 mmol) and the donor 170 (3.00 g, 2.96 mmol). 
The mixture was dried azeotropically with toluene (2x50 
mL) and subjected to vacuum overnight. It was then 
dissolved in dry CH2Cl2 (30 mL) and dry MeCN (30 mL), 
cooled to -40 °C, followed by addition of NIS (683 mg; 
3.04 mmol) and TESOTf (112 mg; 0.42 mmol). The 
reaction mixture was stirred at -40 °C until TLC revealed 
full conversion of the donor (2h). The solution was diluted 
with CH2Cl2 (200 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic 
phase was dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography (19:1 
Tol/EtOAc) to afford 179 as white crystalline material. Rf 0.48 (9:1 Tol/EtOAc).  Yield: 4.9 g (84%) 
    
  = -2.1° (c 1.0, CDCl3). IR(neat, cm
-1
): 3088.09, 3063.03, 2970.86, 2930.82, 2869.91, 1738.33, 1496.77, 
1454.35, 1365.07, 1277.30, 1151.02, 1099.14, 1072.34, 1060.16. 
1
H NMR (400 MHz, CDCl3) δ 7.86 – 7.75 (m, 2H, 
H
NAP
), 7.71 (m, 2H, H
NAP
), 7.44 (m, 1H, H
NAP
), 7.39 – 6.95 (m, 80H), 5.52 (d, J = 3.4 Hz, 1H, H-46), 5.01 (ddt, J = 
11.5, 8.1, 5.8 Hz, 5H, H-2
2-6
), 4.86 – 4.75 (m, 4H, H-12/3/4/5/6, H-12/3/4/5/6, -CH2
Bn
), 4.73 (d, J1,2 = 7.8 Hz, 1H, H-
1
2/3/4/5/6
), 4.71 (d, J1,2 = 8.0 Hz, 1H, H-1
2/3/4/5/6
), 4.65 (d, J1,2 = 7.9 Hz, 1H, H-1
2/3/4/5/6
), 4.62 – 4.26 (m, 26H, H-11, H-
4
1
, 12xCH2
Bn
), 4.19 – 4.15 (m, 1H, H-42/3/4/5), 4.11 (m, 2H, H-42/3/4/5, H-42/3/4/5), 4.09 (d, JCH2 = 12.4 Hz, 1H, 
0.5xCH2
Bn
), 4.04 – 4.02 (m, 1H, H-42/3/4/5), 3.98 (d, JCH2 = 11.8 Hz, 1H, 0.5xCH2
Bn
), 3.74 (d, J = 15.0 Hz, 1H, 
0.5xCH2
AcCl
), 3.69 – 3.47 (m, 8H, H-21, 4.5xH-6), 3.46 – 3.18 (m, 15H, H-31 – H-36, H-51-H-56, 1.5xH-6), 1.17 (s, 
9H, 3xCH3
Piv
), 1.12 (s, 9H, 3xCH3
Piv
), 1.09 (s, 18H, 6xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, 
CDCl3) δ 177.18, 176.62, 176.58, 176.57, 176.54, 166.87, 138.94 (2C), 138.88, 138.87, 138.60, 138.47, 138.03, 
137.97, 137.95, 137.93, 137.89, 137.39, 137.00, 136.44, 133.38, 132.97, 129.07-125.69 (71C), 102.54, 100.58, 
100.31, 100.17, 99.90, 99.50, 81.75, 80.91, 80.62, 80.58, 80.35, 79.43, 77.39, 77.27, 77.07, 76.75, 75.06, 74.37, 
74.29, 74.11, 73.73, 73.67 (2C), 73.58, 73.56 (2C), 73.52, 73.41, 73.21, 72.71, 72.67, 72.23, 72.05, 71.99, 71.72, 
71.37, 71.27, 71.23, 71.11, 70.92, 70.61, 70.43, 70.39, 70.24, 69.65, 69.40, 69.27, 69.17, 68.37, 68.13, 67.31, 67.15, 
40.72, 38.87, 38.85, 38.79 (2C), 38.72, 27.58(3C), 27.47(3C), 27.45(3C), 27.42 (6C). 
 
Phenyl 3-O-benzyl-4-O-chloroacetyl-6-O-(2-naphthyl)methyl-2-O-pivaloyl-1-thio-β-D-galactopyranoside (180) 
183 (8 g; 13.68 mmol) was dissolved in CH2Cl2 (100 mL) and cooled to 0 °C. (ClAc)2O (3.98 g; 
23.26 mmol), Et3N (3.8 mL; 27.36 mmol) and DMAP (33 mg; 0.27 mmol) was added and the 
reaction was stirred at 0 °C for 3 h. The reaction mixture was concentrated and purified by flash 
chromatography (30:1 Tol/ EtOAc) to afford 180 as a yellowish crystalline powder. Rf 0.60 (19:1 
Tol/EtOAc). Yield 8.6 g (95%) 
    
  = 6.0° (c 1.0, CDCl3). IR(neat, cm
-1
): 3058.81, 3031.83, 2970.28, 2932.03, 2907.12, 2870.85, 1762.73, 
1738.25, 1478.31, 1366.63, 1277.06, 1145.62, 1097.91, 1063.23, 1026.74. 
1
H NMR (400 MHz, CDCl3) δ 7.83 – 
7.71 (m, 3H, Ar-H), 7.67 (s, 1H, Ar-H), 7.50 – 7.09 (m, 13H, Ar-H), 5.65 (d, J3,4 = 3.1 Hz, 1H, H-4), 5.06 (t, J1,2 
=J2,3 = 9.8 Hz, 1H, H-2), 4.65 (d, JCH2 = 11.8 Hz, 1H, 0.5xCH2
Bn
), 4.63 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2
Bn
), 4.62 (d, 
J1,2 = 9.8 Hz, 1H, H-1), 4.54 (d, JCH2 = 11.8 Hz, 1H, 0.5xCH2
Bn
), 4.32 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2
Bn
), 3.95 (d, 
JCH2 = 15.1 Hz, 1H, CH2
AcCl
), 3.84 (d, JCH2 = 15.1 Hz, 1H, CH2
AcCl
), 3.77 (t, J5,6a = J5,6b = 6.3 Hz, 1H, H-5), 3.63 – 
3.54 (m, 2H, H-3, H-6a), 3.49 (dd, J6a,6b = 9.4, J5,6b = 6.3 Hz, 1H, H-6b), 1.13 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 
MHz, CDCl3) δ 176.86, 167.03, 137.04, 134.91, 133.29, 133.21, 132.38 (2C), 129.00 (2C), 128.51 (2C), 128.16 
(2C), 128.05 (2C), 128.01, 127.85, 127.18, 126.37, 126.23, 126.07, 87.32, 78.20, 75.86, 73.98, 71.89, 68.52, 68.46, 
67.67, 40.90, 38.87, 27.28 (3C). HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for C37H39ClNaO7S: 685.2003; Found 
685.2007. 
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Phenyl 3-O-benzyl-4,6-O-(2-naphthyl)methylene-1-thio-β-D-galactopyranoside (181) 
A mixture of 24 (10.0 g, 24.36 mmol) and n-Bu2SnO (6.67 g, 26.80 mmol) in 250 mL of dry 
toluene was stirred at reflux for 12 h. Then n-Bu4NBr (11.78 g, 36.54 mmol) and benzyl bromide 
(4.4 mL, 36.78 mmol) were added and the reaction mixture was stirred for 5 h at 60 °C. The 
reaction mixture was concentrated and the product 181 was purified by flash chromatography (9:1 
Tol/EtOAc). Rf 0.19 (9:1 Tol/EtOAc).  Yield: 10.0 g (82%, TBAB impurities have been 
accounted for based on NMR)  
    
  = 34.4° (c 1.0, CDCl3). IR(neat, cm
-1
): 3455.75, 3059.89, 3029.46, 2955.09, 1690.50, 1626.83, 1581.91, 
1477.54, 1454.00, 1440.08, 1404.30, 1363.52, , 1271.45, , 1170.33, 1118.18, 1099.63, 1078.25, 1045.28, 881.95. 
1
H 
NMR (400 MHz, CDCl3) δ 7.87 – 7.70 (m, 4H, Hnapth), 7.69 – 7.55 (m, 2H, HSPh), 7.50 – 7.36 (m, 3H, Hnapth,), 7.35 
– 7.08 (m, 8H, HBn, HSPh), 5.51 (s, 1H, CHnapth), 4.66 (d, J = 3.8 Hz, 2H, -CH2
Bn
), 4.46 (d, J1,2 = 9.5 Hz, 1H, H-1), 
4.32 (dd, J6a,6b = 12.3, J5,6a = 1.6 Hz, 1H, H-6a), 4.13 (dd, J3,4= 3.3, J4,5 =1.0 Hz, 1H, H-4), 4.02 – 3.84 (m, 2H, H-2, 
H-6b), 3.46 (dd, J2,3 = 9.3, J3,4 =3.3 Hz, 1H, H-3), 3.40 (dd, J5,6a = 5,6b = 1.6 Hz, 1H, H-5) 
13
C NMR 
 
 (101 MHz, 
CDCl3) δ 138.06, 135.31, 133.86 (2C), 133.01, 130.81, 129.04 (2C), 128.60 (2C), 128.47, 128.24, 128.09, 128.04 
(2C), 127.82, 126.42, 126.15, 125.93, 124.32, 101.37, 87.24, 80.40, 73.45, 71.76, 70.24, 69.63, 67.33. HRMS (ESI-
TOF) m/z: [M + Na]
+ 
Calcd for C30H28NaO5S: 523.1555; Found 523.1559. 
 
Phenyl 3-O-benzyl-4,6-O-(2-naphthyl)methylene-2-O-pivaloyl-1-thio-β-D-galactopyranoside (182) 
181 (11 g; 21.93 mmol) was dissolved in CH2Cl2 (200 mL). Et3N (5.4 mL; 38.45 mmol), DMAP 
(1.34 g; 10.99 mmol) and pivaloyl chloride (4.1 mL; 32.96 mmol) was added to the solution and the 
reaction mixture was heated to 45 °C for 8 h. The reaction mixture was cooled to 0 °C, quenched 
with MeOH (10 mL), washed with water (2x100 mL), dried over MgSO4 and concentrated. The 
product was purified by flash chromatography (19:1 Tol/EtOAc). Rf 0.47 (9:1 Tol/EtOAc). Yield 11.69 g (91%). 
    
  = 11.3° (c 1.0, CDCl3)  IR(neat, cm
-1
): 3477.69, 3060.53, 2903.49, 1731.71, 1691.98, 1627.05, 1478.12, 
1455.97, 1365.18, 1275.90, 1152.13, 1098.34, 1042.34, 994.28. 
1
H NMR (400 MHz, CDCl3) δ 7.81 – 7.60 (m, 4H, 
H
napth
), 7.56 – 7.48 (m, 2H, Hnapth), 7.44 – 7.33 (m, 5H, HSPh, Hnapth), 7.28 (m, 3H, HSPh, Ar-H), 7.22 – 7.10 (m, 3H, 
H
SPh
, Ar-H), 5.50 (s, 1H, -CH
benzylidene
), 5.29 (t, J1,2 = J2,3 = 9.8 Hz, 1H, H-2), 4.63 (d, J1,2 = 9.8 Hz, 1H, H-1), 4.56 
(s, 2H, CH2
Bn
), 4.30 (d, J6a,6b = 12.3, J5,6a = 1.2 Hz, 1H, H-6a), 4.12 (d, J3,4 = 3.2 Hz, 1H, H-4), 3.95 (dd, J6a,6b = 
12.3, J5,6a = 1.4 Hz, 1H, H-6b), 3.63 (dd, J2,3 = 9.8, J34 = 3.2 Hz, 1H, H-3), 3.36 (m, 1H, H-5), 1.19 (s, 9H, 3x-
CH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.61, 138.05, 135.17, 133.85, 133.38 (2C), 132.99, 132.31, 128.85 (2C), 
128.57, 128.46 (2C), 128.07, 127.98, 127.88, 127.80, 127.69 (2C), 126.35, 126.05, 125.91, 124.36, 101.41, 85.93, 
78.83, 73.60, 71.43, 70.11, 69.54, 68.14, 38.88, 27.35. HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for C35H36NaO6S: 
607.2130; Found 607.2137. 
 
Phenyl 3-O-benzyl-6-O-(2-naphthyl)methyl-2-O-pivaloyl-1-thio-β-D-galactopyranoside (183) 
Trifluoroacetic acid (6.54 mL, 85.5 mmol) was added drop wise to a solution of 182 (10.0 g, 17.1 
mmol) and triethylsilane (13.65 mL, 85.5 mmol ) in CH2Cl2 (100 mL) at 0 °C. When the addition 
was complete (10 min), the reaction was warmed to 22 °C and stirred for 3 hr. The mixture was 
diluted with ethyl acetate and washed with sat. aq. NaHCO3 and brine. The organic phase was dried over MgSO4, 
filtered and concentrated. The product was purified by flash chromatography (9:1 Tol/EtOAc) to afford 183. Rf 0.27 
(9:1 Tol/EtOAc). Yield: 7.8 g (78%). 
    
  = -6.2° (c 1.0, CDCl3) IR(neat, cm
-1
): 3493.70, 3058.30, 3030.44, 2970.76, 2930.47, 2904.90, 2871.41, 
1732.46, 1583.84, 1497.18, 1366.80, 1277.92, 1153.31, 1097.56, 1064.57, 818.28, 742.73, 695.56 
1
H NMR (400 
MHz, CDCl3) δ =  7.79 – 7.65 (m, 4H, H
NAP
), 7.47 – 7.31 (m, 5H, HNAP, HSPh), 7.29 – 7.07 (m, 8H, HBn, HSPh), 5.21 
(dd, J1,2 = 10.1, J2,3 =9.3 Hz, 1H, H-2), 4.65 (s, 2H, -CH2
bn
), 4.58 (d, J1,2 = 10.1 Hz, 1H, H-1), 4.56 (d, JCH2 = 11.8 
Hz, 1H, -CH2
NAP
), 4.49 (d, JCH2 = 11.8 Hz, 1H, -CH2
NAP
), 4.03 (dd, J3,4  = 3.3, J4,5 = 1.1 Hz, 1H, H-4), 3.82 – 3.73 
(m, 2H, H-6a, H-6b), 3.61 (td, J5,6a = J5,6b = 5.9, J4,5 = 1.1 Hz, 1H, H-5), 3.51 (dd, J2,3 = 9.3, J3,4 = 3.3 Hz, 1H, H-3), 
1.16 (s, 9H, 3x-CH3
Piv
). 13C NMR   (101 MHz, CDCl3) δ = 176.95, 137.34, 135.59, 133.92, 133.38, 133.14, 131.99 
(2C), 128.97 (2C), 128.65 (2C), 128.32, 128.17, 128.03, 127.81, 127.76 (2C), 127.70, 126.68, 126.24, 126.04, 
125.89, 87.13, 80.15, 77.58, 73.95, 71.97, 69.51, 68.73, 66.69, 38.90, 27.32. HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for C35H38NaO6S: 609.2287; Found 607.2290. 
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Benzyl 3-O-benzyl-4-O-chloroacetyl-6-O-(2-naphthyl)methyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-
di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)- 3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-
(14)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (184) 
To a 100 mL flame-dried flask was added acceptor 172 (2.6 g, 1.87 mmol) 
and donor 180 (1.7 g, 2.61 mmol). The mixture was dried azeotropically with 
toluene (2x50 mL) and subjected to vacuum overnight. It was then dissolved 
in dry CH2Cl2 (20 mL) and dry MeCN (20 mL), cooled to -40 °C, followed 
by addition of NIS (603 mg; 2.69 mmol) and TESOTf (98 mg; 0.37 mmol). 
The reaction mixture was stirred at -40 °C until TLC revealed full conversion 
of the donor (2h). The solution was diluted with CH2Cl2 (200 mL) and 
washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic phase was dried over MgSO4, 
filtered and concentrated. The product was purified by flash chromatography (20:1 Tol/EtOAc) to afford 184 as a 
white crystalline material. Rf 0.45 (9:1 Tol/EtOAc). Yield: 2.7 g (76%). 
    
  = 1.1° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.75 (m, 3H, H
NAP
), 7.62 (s, 1H, H
NAP
), 7.41 (m, 2H, 
H
NAP
), 7.37 – 6.99 (m, 45H), 5.55 – 5.50 (m, 1H, H-44), 5.10 – 4.91 (m, 3H, H-22-H-24), 4.88 – 4.77 (m, 3H, H-
1
2/3/4
, -CH2
Bn
), 4.76 (d, J1,2 = 7.9 Hz, 1H, H-1
2/3/4
), 4.72 (d, J1,2 = 7.9 Hz, 1H, H-1
2/3/4
), 4.66 – 4.20 (m, 20H, H-11, H-
4
1
, 9xCH2
Bn
), 4.13 – 4.06 (m, 1H, H-42/3), 4.06 – 3.99 (m, 1H, H-42/3), 3.82 (dd, JCH2 = 14.8, 1.3 Hz, 1H, -CH2
AcCl
), 
3.73 (dd, J CH2 = 14.8, 1.3 Hz, 1H), 3.69 – 3.16 (m, 17H, H-2
1
, H-3
1 – H-34, H-51-H-54, H-6
1
-H-6
4
), 1.19 (s, 9H, 
3xCH3
Piv
), 1.11 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.12, 176.64 (2C), 
166.84, 138.90, 138.85, 138.81, 138.59, 138.49, 138.00, 137.92, 137.89, 137.02, 134.90, 133.21, 133.15, 128.47-
125.84 (51C), 102.59, 100.79, 100.12, 99.43, 81.71, 81.12, 80.45, 79.46, 77.32, 77.28, 75.06, 74.20, 73.79, 73.73, 
73.64, 73.55, 73.49 (2C), 72.86, 72.70, 71.99, 71.70, 71.48, 71.45, 71.23, 71.18, 70.45 (2C), 70.41, 69.79, 69.43, 
69.32, 68.37, 67.27, 66.91, 40.80, 38.89, 38.85, 38.74, 27.57(3C), 27.41(3C), 27.39(3C). 
 
Benzyl 3-O-benzyl-6-O-(2-naphthyl)methyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-
pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-2,3,6-tri-O-
benzyl-β-D-galactopyranoside (185) 
To a solution of 184 (4.0 g; 1.76 mmol) in THF (25 mL) at 0 °C was added a 
0.02M NaOMe solution in MeOH (75 mL). The reaction mixture was stirred 
at 0 °C for 1h, quenched with amberlite 120-H
+
 resin, filtered and 
concentrated. The residue was purified by flash chromatography (9:1 
Tol/EtOAc) to afford 185 as a white crystalline material. Rf 0.21 (9:1 
Tol/EtOAc). Yield: 4.91 g (94%) 
    
  = -3.0° (c 1.0, CDCl3). IR(neat, cm
-1
): 3088.25, 3062.66, 3030.44, 
2970.17, 2930.30, 2869.44, 1738.21, 1496.78, 1479.22, 1454.24, 1364.74, 1277.39, 1150.54, 1133.50, 1061.69.      
1
H NMR (400 MHz, CDCl3) δ 7.78 – 7.68 (m, 3H, H
NAP
), 7.64 (m, 1H, H
NAP
), 7.42 – 7.04 (m, 49H), , 5.09 (dd, J = 
9.8, 8.0 Hz, 1H, H-2
2/3/4
), 5.03 (m, 2H, H-2
2/3/4
), 4.83 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2
Bn
), 4.81 (d, J1,2 = 7.8 Hz, 1H, 
H-1
2/3/4
), 4.79 (d, JCH2 = 10.6 Hz, 1H, 0.5xCH2
Bn
), 4.73 (d, J1,2 = 8.0 Hz, 1H, H-1
2/3/4
), 4.72 (d, J1,2 = 7.8 Hz, 1H, H-
1
2/3/4
), 4.65 – 4.23 (m, 20H, , H-11, H-41, 9xCH2
Bn
), 4.15 – 4.09 (m, 1H, H-42/3/4), 4.06 – 4.00 (m, 1H, H-42/3/4), 3.89 
– 3.85 (m, 1H, H-42/3/4), 3.73 – 3.48 (m, 7H, H-21, 3.5xH-6), 3.46 – 3.20 (m, 9H, H-31 – H-34, H-51-H-54, 0.5xH-6), 
1.18 (s, 9H), 1.14 (s, 9H), 1.06 (s, 9H). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.28, 176.67, 176.64, 138.91, 138.86, 
138.81, 138.63, 138.59, 138.02, 137.93, 137.90, 137.30, 135.52, 133.26, 133.03, 129.07-125.71 (51C), 102.58, 
100.75, 99.87, 99.42, 81.73, 81.05, 80.36, 79.45, 79.20, 77.27, 75.06, 74.24, 74.00, 73.72, 73.68, 73.66, 73.51 (2C) , 
73.24, 72.83, 72.33, 71.96, 71.39, 71.34, 71.21, 70.53, 70.51, 70.43, 69.85, 69.56, 69.46, 68.94, 66.88, 66.26, 38.88 
(2C), 38.73, 27.58(3C), 27.44(3C), 27.41(3C). 
 
Phenyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-1-thio-
β-D-galactopyranoside (186) 
To a 250 mL flame-dried flask was added 353 (6.2 g, 11.68 mmol) and the 352 (8.52 g, 
14.02 mmol). The mixture was co-evaporated with toluene (2x100 mL) and subjected to 
vacuum overnight. The mixture dissolved in DCM (100 mL) and cooled to -40 °C. 
TMSOTf (0.26 mL; 1.17 mmol) was added and the reaction mixture was stirred at -40 °C 
for 1.5h. Et3N (2 mL) was added and the reaction mixture was concentrated. The crude 
compound was purified by flash chromatography (19:1 Tol/EtOAc) to afford 186. Rf 0.52 
(9:1 Tol/EtOAc). Yield: 10.1 g (91%) 
    
  = 11.4° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.44 – 7.34 (m, 4H, H
SPh
), 7.29 – 7.13 (m, 11H, HSPh. 
Ar-H), 5.43 (s, 1H, -CH
benzylidene
), 5.38 (t, J1,2 = J2,3 =9.8 Hz, 1H, H-2), 5.33 (dd, J2,3 = 9.7, J1,2 =8.0 Hz, 1H, H-2’), 
Experimental 
 162 
5.02 (dd, J2,3 = 9.8, J3,4 = 2.9 Hz, 1H, H-3), 4.79 (dd, J2,3 = 9.7, J3,4 = 3.7 Hz, 1H, H-3’), 4.68 (d, JCH2 = 11.2 Hz, 1H, 
-CH2
Bn
), 4.59 (d, J = 9.8 Hz, 1H, H-1), 4.55 (d, JCH2 = 11.2 Hz, 1H, -CH2
Bn
), 4.45 (d, J = 8.0 Hz, 1H, H-1’), 4.33 – 
4.28 (m, 1H, H-4’), 4.22 – 4.15 (m, 1H, H-6a’), 3.95 (dd, J = 12.5, 1.9 Hz, 1H, H-6b’), 3.86 (m, 2H, H-4, H-6a), 
3.75 – 3.63 (m, 2H, H-6b, H-5), 3.39 – 3.35 (m, 1H, H-5’), 1.13 (s, 9H, 3xCH3
Piv
), 1.09 (s, 9H, 3xCH3
Piv
), 1.07 (s, 
9H, 3xCH3
Piv
), 1.07 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 178.13, 177.46, 176.53, 176.44, 138.12, 
137.59, 132.82, 132.11 (2C), 128.91 (2C), 128.80, 128.24 (2C), 128.08 (2C), 127.77, 127.59 (2C), 127.48, 125.98 
(2C), 100.73, 100.51, 86.43, 77.65, 74.93, 74.68, 74.56, 73.09, 71.86, 68.77, 68.14, 67.37, 66.95, 66.43, 38.92, 
38.89, 38.74, 27.22, 27.21 (3C), 27.16 (3C), 27.12 (3C), 27.04 (3C). HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for 
C52H58NaO14S: 971.4228; Found 971.4229. 
 
Phenyl 2,3,5-tri-O-benzoyl--L-arabinofuranosyl-(15)-2,3-di-O-benzoyl-1-thio--L-arabinofuranoside (187) 
To a 100 mL flame-dried flask was added 192 (1.5 g, 3.33 mmol) and the 189 (3.0 g, 4.66 
mmol). The mixture was co-evaporated with toluene (2x50 mL) and subjected to vacuum 
overnight. The mixture dissolved in DCM (50 mL) and cooled to -40 °C. TMSOTf (60L; 0.33 
mmol) was added and the reaction mixture was stirred at -40 °C for 2h. Et3N (1 mL) was added 
and the reaction mixture was concentrated. The crude compound was purified by flash 
chromatography (20:1 Tol/EtOAc) to afford 187. Rf 0.56 (9:1 Tol/EtOAc). Yield: 2.54 g (86%) 
    
  = -38.0° (c 1.0, CDCl3). IR(neat , cm
-1
): 3062.91, 3034.46, 2946.99, 2884.40, 1718.36, 1601.47, 1584.22, 
1491.44, 1451.53, 1315.29, 1261.51, 1177.39, 1096.15, 1069.01, 1026.22, 707.83. 
1
H NMR (400 MHz, CDCl3) δ 
8.02 – 7.82 (m, 10H, HBz), 7.54 – 7.44 (m, 4H, HBz), 7.43 – 7.33 (m, 5H, HBz), 7.30 (m, 4H, HBz, HSPh), 7.23 – 7.09 
(m, 7H, , H
Bz
, H
SPh
), 5.73 (d, J1,2 = 1.1 Hz, 1H, H-1’), 5.68 (dd, J3,4 = 4.8, 1.5 Hz, 1H, H-3), 5.65 (s, 1H, H-2), 5.55 
(d, J1,2 = 1.1 Hz, 1H, H-2’), 5.50 (d, J3,4 = 4.9 Hz, 1H, H-3’), 5.37 (s, 1H, H-1’), 4.74 (dd, J5a,5b = 11.8, J4,5b = 3.2 Hz, 
1H, H-5a), 4.71 – 4.62 (m, 2H, H-4, H-4’), 4.57 (dd, J5a,5b = 11.8, J4,5b = 4.8 Hz, 1H, H-5b), 4.20 (dd, J5a,5b = 11.3, 
J4,5a =4.3 Hz, 1H, H-5a’), 3.93 (dd, J5a,5b = 11.3, J4,5b =3.1 Hz, 1H, H-5b’). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 166.21, 
165.74, 165.52, 165.30, 165.25, 133.77, 133.60, 133.58, 133.49, 133.35, 133.03, 131.92 (2C), 130.00 (2C), 129.90 
(2C), 129.83 (3C), 129.78 (2C), 129.72, 129.06 (2C), 128.92, 128.87, 128.56 (3C), 128.52 (2C), 128.36 (2C), 
128.31 (2C), 127.64, 105.97, 91.29, 82.15, 82.09, 81.96, 81.28, 77.80 (2C), 65.98, 63.68. HRMS (ESI-TOF) m/z: 
[M + Na]
+ 
Calcd for C51H42NaO13S: 917.2244; Found 917.2252. 
 
2,3,4,6-tetra-O-benzoyl-D-galactopyranosyl N-phenyl trifluoroacetimidate (188) 
196 (0.50 g; 0.84 mmol) was dissolved in CH2Cl2 (10 mL) and cooled to 0 °C. Cs2CO3 (0.55 g; 
1.68 mmol) was added followed by N-phenyl trifluoro-acetimidoyl chloride (0.24 mL; 1.68 
mmol). The ice bath was removed and the reaction mixture was stirred for 12 h. It was then 
filtered, concentrated and purified by flash chromatography (9:1) to give a white crystalline 
product. Rf 0.37 (9:1 Tol/EtOAc) Yield: 522 mg (81%). 
1
H NMR (400 MHz, CDCl3) δ 8.06 (m, 2H, Ar-H
Bz
), 8.02 (m, 2H, Ar-H
Bz
), 8.02 (m, 2H, Ar-H
Bz
), 7.78 
(m, 2H, Ar-H
Bz
), 7.62–7.34 (m, 12H, Ar-H), 7.26 (m, 2H, Ar-H), 7.10 (m, 2H, Ar-H), 7.02 (m, 1H, Ar-
H), 6.86 (m, 1H, bs), 6.43 (d, J = 6.6 Hz, 2H), 6.17 (d, J = 2.2 Hz, 1H), 6.04 (dd, J = 10.5, 3.0 Hz, 1H), 
5.92(dd, J = 10.5, 3.3 Hz, 1H), 4.81 (m, 1H), 4.63 (dd, J = 11.2, 6.9 Hz, 1H), 4.40 (m, 1H). 
13
C NMR 
(101 MHz, CDCl3) δ 165.9, 165.4, 165.5, 164.9, 142.94, 133.7, 133.5, 133.4, 133.2, 130.0-119.1(20C), 
95.1, 72.6, 71.3, 68.7, 67.8, 62.1. 
 
2,3,5-tri-O-benzoyl-L-arabinofuranosyl N-phenyl trifluoroacetimidate (189) 
191 (5 g; 10.8 mmol) was dissolved in DCM (150 mL) and cooled to 0 °C. Cs2CO3 (7.1 g; 21.6 
mmol) was added followed by N-phenyl trifluoroacet-imidoyl chloride (3.1 mL; 21.6 mmol). 
The ice bath was removed and the reaction mixture was stirred until TLC showed full 
conversion (8 h). the solution was filtered, concentrated and purified by flash chromatography to 
give a white crystalline product. Yield:  5.8 g (85%)  
13
C NMR 
 
 (101 MHz, CDCl3) δ 166.0, 165.9, 165.6, 165.4, 165.3, 164.9, 143.2, 143.1, 133.7, 133.7, 133.6, 133.0, 
129.8, 129.8, 129.7, 129.6, 129.4, 129.4, 129.1, 128.6, 128.5, 128.4, 128.4, 128.2, 124.4, 124.1, 120.4, 119.4, 119.1, 
102.1, 96.7, 84.1, 80.6, 80.4, 76.9, 76.0, 75.4, 64.7, 63.4. 
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Methyl 2,3,5-tri-O-benzoyl-α-L-arabinofuranoside (190) 
To a suspension of L-arabinose (15 g, 100 mmol) in MeOH (150 ml) was added acetyl chloride (2.1 
ml, 30.0 mmol) in a dropwise fashion and the mixture was stirred overnight at 22 °C. The mixture 
was neutralized with pyridine (50 ml) and concentrated under reduced pressure. The residue was 
coevaporated with pyridine (50 ml). Pyridine (110 ml) was added and the solution cooled to 0 °C. 
Benzoyl chloride (46 ml, 400 mmol) was added, the mixture was slowly allowed to warm to 22 °C and stirred for 4 
hours. The reraction was quenched with water (4.5 ml) The mixture was taken up in DCM and washed with water, 1 
M aq. HCl, sat. aq. NaHCO3 and brine. The mixture was dried over anhydrous MgSO4, filtered and concentrated 
under reduced pressure. The crude product was crystallized from ethanol yielding 190 as white crystals. Rf 0.54 (9:1 
Tol/EtOAc). Yield: 23.0 g (47 %). 
    
  = 22.1° (c 1.0, CDCl3). IR (neat, cm
-1
): 3063.81, 2996.07, 2938.30, 2836.07, 1718.38, 1601.65, 1451.40, 
1263.34, 1106.44, 1068.93, 1026.56. 
1
H NMR (400 MHz, CDCl3) δ 8.06 – 7.88 (m, 6H, Ar-H), 7.58 – 7.16 (m, 9H, 
Ar-H), 5.51 (d, J = 4.9 Hz, 1H, H-3), 5.44 (s, 1H, H-2), 5.11 (s, 1H, H-1), 4.77 (dd, J5a,5b = 12.0, J4,5a = 3.4 Hz, 1H), 
4.62 (dd, J5a,5b = 12.0, J4,5b =4.9 Hz, 1H), 4.50 (td, J4,5b = J3,4 = 4.9, J4,5a = 3.6 Hz, 1H, H-4), 3.42 (s, 1H, CH3
OMe
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 166.25, 165.85, 165.51, 133.55, 133.53, 133.08, 129.99 (2C), 129.89 (2C), 129.78 
(2C), 129.76, 129.12, 129.07, 128.53 (2C), 128.50 (2C), 128.34 (2C), 106.90, 82.23, 80.89, 77.96, 63.74, 55.03. 
 
2,3,5-tri-O-benzoyl-L-arabinofuranose (191) 
190 (5 g, 10.5 mmol) was dissolved in a mixture of acetone (2.5 mL) and 90% aq trifluoacetic acid 
(15 mL). The mixture was stirred at 50 °C for 6 h. The reaction mixture was directly concentrated to 
dryness in vacuo and then purified by flash chromatography (2:1 Heptane/EtOAc) to give 191 as a 
sticky oil. Yield: 3.7 (76%). 
    
  = 24.7° (c 1.0, CDCl3). IR(neat, cm
-1
): 3485.15, 3087.54, 3062.46, 3029.88, 2918.20, 2866.56, 1496.41, 
1453.53, 1362.30, 1096.57, 1058.07, 909.54. 
1
H NMR (400 MHz, CDCl3) δ 8.06 – 7.83 (m, 6H, Ar-H), 7.55 – 7.10 
(m, 9H, Ar-H), 5.83 (dd, J3,4 = 5.8, J2,3 = 5.3 Hz, 1H, H-3), 5.77 (d, J = 4.4 Hz, 1H, H-1), 5.68 (s, 1H), 5.61 (s, 
1H, H-1), 5.50 (d, J3,4 = 4.7 Hz, 1H, H-3), 5.47 (s, 1H, H-2), 5.45 (dd, J1,2 = 4.4 J2,3 = 5.3 Hz, 1H), 4.74 (dd, 
J5a,5b = 11.5, J4,5a = 3.4 Hz, 1H, H-5a), 4.70 – 4.65 (m, 2H, H-4, H-5), 4.58 (dd, J5a,5b = 11.6, J4,5b = 5.1 Hz, 1H, 
H-5b), 4.37 (dt, J4,5a = 6.9, J3,4 = J4,5b = 4.5 Hz, 1H, H-4). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 166.65, 166.43, 
166.03, 165.97, 165.96, 165.71, 133.74, 133.71, 133.68 (2C), 133.25, 133.21, 130.09-128.43 (30C), 101.09, 95.61, 
82.69, 81.49, 79.11, 78.05, 77.75, 76.67, 65.96, 64.03. HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for C26H22NaO8: 
485.1212; Found 485.1218. 
 
Phenyl 2,3-di-O-benzoyl-1-thio--L-arabinofuranoside (192) 
To a solution of 194 (2 g, 2.90 mmol) in THF (40 mL) was added TBAF (11.61 mL, 1.0 M in THF) 
and AcOH (1.46 mL; 12.77 mmol) at 0 °C. The resulting mixture was warmed gradually to 22 °C and 
was stirred for 3 h. The reaction was diluted with CH2Cl2 (200 mL), washed with sat. aq. NaHCO3 
(100 mL) and brine (100 mL). The organic layer was dried over MgSO4, filtered, and concentrated. 
The resulting residue was purified by flash chromatography (9:1 Tol/EtOAc) to afford 192 as colorless syrup. Rf 
0.24 (9:1 Tol/EtOAc). Yield: 1.15 g (88%) 
    
  = -38.2° (c 1.0, CDCl3). IR(neat, cm
-1
): 3536.60, 3061.70, 2928.61, 1722.59, 1601.41, 1584.05, 1451.88, 
1266.22, 1108.93, 1069.37, 1026.67. 
1
H NMR (400 MHz, CDCl3) δ 8.13 – 8.00 (m, 2H), 8.01 – 7.94 (m, 2H), 7.74 
– 7.11 (m, 11H), 5.72 (s, 1H, H-1), 5.67 (t, J2,3 = 1.8 Hz, 1H, H-2), 5.48 (dd, J3,4 = 3.9, J2,3 = 1.8 Hz, 1H, H-3), 4.52 
(ddd, J4,5a = J4,5b = J3,4 = 3.9 Hz, 1H, H-4), 3.96 (d, J3,4 = 3.9 Hz, 2H, H-5a, H-5b). 
13
C NMR (101 MHz, CDCl3) δ 
165.98, 165.24, 133.72, 133.69, 133.66, 132.22 (2C), 130.04 (2C), 129.89 (2C), 129.11 (2C), 128.98, 128.91, 
128.60 (2C), 128.58 (2C), 127.84, 91.49, 83.73, 82.23, 77.83, 61.99. HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for 
C25H22NaO6: 473.1035; Found 473.1039. 
 
Phenyl 1-thio--L-arabinofuranoside (193) 
To a solution of 190
 
(19.5 g, 41 mmol) in   CH2Cl2 (28.5 mL) at 0 C was added thiophenol (6 mL, 
58 mmol). The reaction mixture was stirred at 0 C for 15 min, then BF3
.
Et2O (34 mL, 268 mmol) 
was added and the resulting mixture was warmed gradually to 22 C. The reaction was stirred for 
8 h at the same temperature. The reaction was quenched with Et3N and the mixture was 
concentrated. The resulting residue was purified by column chromatography (7:1, Heptane/EtOAc) to give a 
colorless syrup. The syrup was dissolved in MeOH and CH2Cl2 (7:1, 400 mL) followed by addition of NaOMe 
(320 mg) at 22 C. The mixture was stirred at the same temperature for 2 h. The solution was concentrated to 
dryness, and the resulting residue was purified by column chromatography (15:1, CH2Cl2–MeOH) to afford 193 as a 
colorless syrup. Yield: 7.6 g, 64%)  
Experimental 
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1
H NMR (400 MHz, CD3OD): δ 7.52–7.49 (m, 2H, Ar-H),7.31–7.21(m, 3H, Ar-H), 5.26 (d, 1H, J1,2 = 4.6 Hz, H-1), 
3.98 (dd, 1H, J2,3= 4.8 Hz, H-2), 3.97–3.93 (m, 1H, H-4), 3.91 (dd, 1H, J3,4 = 7.2 Hz, H-3), 3.77 (dd, 1H, J5a,5b= 12.1 
Hz, J4,5a = 2.6 Hz, H-5a), 3.64 (dd, 1H, J5a,5b = 12.1 Hz, J4,5b = 4.6 Hz, H-5b); 
13
C NMR (101 MHz, CD3OD): δ 
136.4, 132.6, 129.9, 128.2, 93.1, 84.3, 83.4, 77.6, 62.4. 
 
Phenyl 2,3-di-O-benzoyl-5-O-(tert-butyldiphenylsilyl)-1-thio--L-arabinofuranoside (194) 
To a solution of 193 (3.7 g, 15.3 mmol) in dry DMF (40 mL) was added imidazole (3.5 g) 
followed by t-BuPh2SiCl (6 mL) at 0 C and the resulting mixture was warmed gradually to 22 °C. 
The mixture was stirred overnight at the same temperature. The mixture was diluted with EtOAc 
(500 mL), and then the reaction mixture was washed with water and brine. The organic layer was 
separated and dried over anhydrous Na2SO4, filtered, and concentrated. The resulting residue was purified by 
column chromatography (3:1 Heptane/EtOAc) to afford C5-O-TBDPS analogue. This was used directly in the next 
step. The TBDPS-protected thioglycoside (3.4 g, 7.2 mmol) was dissolved in pyridine (70 mL) after which BzCl (6 
mL) was slowly added at 0 C. The resulting mixture was heated gradually to 22 C. The reaction was stirred for 5 h 
at the same temperature. The reaction was quenched with methanol (1.5 mL), diluted with CH2Cl2 (300 mL), and 
then the mixture was washed with water and brine. The organic layer was separated and dried over anhydrous 
Na2SO4, filtered, and concentrated. The resulting residue was purified by column chromatography (20:1 Tol/EtOAc) 
to afford 194 (4.4 g, 77% over two steps) as a pale yellow syrup. Rf 0.72 (9:1 Tol/EtOAc). 
    
  = -35.7° (c 1.0, CDCl3)  
IR (neat, cm
-1
): 3070.50, 2957.78, 2931.11, 2857.66, 1724.55, 1601.78, 1451.68, 1427.88, 1258.52, 1106.43, 
1068.24, 1025.07 
1
H NMR (400 MHz, CDCl3) δ 8.09 - 7.13 (m, 25H, Ar-H), 5.69 (d, J1,2 = 2.1 Hz, 1H, H-1), 5.67 – 
5.61 (m, 1H, H-3), 5.59 (t, J1,2 = 2.1 Hz, 1H, H-2), 4.55 (ddd, J3,4 =J4,5a = J4,5b = 4.6 Hz, 1H, H-4), 3.97 (d, J4,5 = 4.9 
Hz, 2H, H-5), 0.97 (s, 9H, 3xCH3
TBDPS
). 
13
C NMR (101 MHz, CDCl3) δ 165.60, 165.46, 135.82, 135.78, 134.09, 
133.59, 133.32, 133.19, 132.22, 130.14, 130.08, 129.85, 129.83, 129.42, 129.16, 129.11, 128.62, 128.55, 127.84, 
127.83, 127.73, 91.19, 83.40, 82.55, 77.69, 63.64, 26.91 (3C), 19.43. 
 
1,2,3,4,6-Penta-O-benzoyl-,-D-galactopyranoside (195)  
To a solution of D-galactose (10.03 g; 55 mmol) in pyridine (120 mL) was added benzoyl chloride 
(40 mL; 330 mmol). The solution was stirred in an oil bath 60-65 C for 1 h. The resulting 
suspension was quenched with H2O (5 mL) and stirred for 10 min after which H2O (50 mL) was 
added. The mixture was poured into ice water (1 L) and stirred for 1 h. The white precipitate was filtered and 
recrystallized from MeOH/acetone to afford 195 as a white solid. Rf 0.56 (2:1 heptane/EtOAc). Yield: 18.5 g (48%).  
1
H NMR (400 MHz, CDCl3) δ 8.02-7.10 (m, 25H, Ar-H), 6.86 (d, 1H, J1,2 =4.8 Hz, H-1), 6.31 (t, 1H, J = 7.2 Hz), 
5.89-5.93 (m, 2H), 4.84-4.67 (m, 3H). 
13
C NMR (101 MHz, CDCl3) δ 166.13, 165.64, 165.16, 133.85, 133.80, 
133.66, 133.32, 133.29, 130.14-128.41(25C), 94.28, 79.71, 76.26, 73.95, 70.48, 63.25. 
 
2,3,4,6-Penta-O-benzoyl-,-D-galactopyranose (196)  
To a solution of 195 (10.04 g; 14.33 mmol) was dissolved in CH2Cl2 (25 mL) followed by addition 
of 30% HBr/AcOH (5 mL). The reaction mixture was stirred for one hour and then poured into ice 
water (200 mL). The aqueous phase was extracted with CH2Cl2 (2x50 mL). The combined organic 
phase was dried over MgSO4, filtered and concentrated. Without further purification the white solid was dissolved in 
acetone (45 mL) and H2O (2 mL). Ag2CO3 (2.0 g; 7.29 mmol) was added and the reaction mixture was stirred for 
1.5 h at 22 °C. The solution dispension was filtered through a plug of celite and concentrated to give the product in 
quantitative yield. Rf 0.3 (2:1 heptane/EtOAc) 
1
H NMR (400 MHz, CDCl3) δ 8.11-7.29 (m, 20H, Ar-H), 6.10-6.06 (m, 2H), 5.73-5.71 (m, 1H), 5.65 (d, 1H, J = 5.1 
Hz), 4.88-4.85 (m, 1H), 4.77-4.68 (m, 2H).  
 
 
 
 
 
 
 
 
 
 
Experimental 
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Benzyl 3,6-di-O-benzyl-4-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-
2-O-pivaloyl-β-D-galactopyranosyl-(14)-[2,3,5-tri-O-benzoyl--L-arabinofuranosyl-(15)-2,3-di-
O-benzoyl--L-arabinofuranosyl-(1→6)]-3-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-
di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-
galactopyranosyl-(14)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (197) 
To a 25 mL flame-dried flask was added acceptor 178 (600 mg, 
0.23 mmol) and the donor 187 (403 mg, 0.45 mmol). The 
mixture was dried azeotropically with toluene (2x10 mL) and 
subjected to vacuum overnight. It was then dissolved in dry 
CH2Cl2 (5 mL) and dry MeCN (5 mL), cooled to -40 °C, 
followed by addition of NIS (106 mg; 0.47 mmol) and TESOTf 
(12 mg; 0.045 mmol). The reaction mixture was stirred at -40 
°C until TLC revealed full conversion of the donor (2.5h). The 
solution was diluted with CH2Cl2 (100 mL) and washed with 
sat. aq. NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The 
organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash 
chromatography (19:1 Tol/EtOAc) to afford 197 as a white 
crystalline material. Rf 0.48 (9:1 Tol/EtOAc). Yield: 651 mg 
(83%) 
    
  = 3.0° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.97 – 7.76 (m, 10H, Ar-H
Bz
), 7.52 – 7.02 (m, 80H), 5.65 
(dd, J3,4 = 4.9, J2,3 = 1.2 Hz, 1H, H-3
ara
), 5.57 (d, J2,3 = 1.1 Hz, 1H, H-2
ara'
), 5.48 (d, J3,4 =4.9 Hz, J2,3 = 1.1 Hz, 1H, H-
3
ara'
), 5.46 (d, J1,2 = 1.2 Hz, 1H, H-2
ara
), 5.44 (d, J3,4 = 3.3 Hz, 1H, H-4
6
), 5.32 (s, 1H, H-1
ara
), 5.23 (s, 1H, H-1
ara
), 
5.05 – 4.89 (m, 5H, 5xH-2), 4.88 (d, J1,2 = 8.0 Hz, 1H, H-1), 4.82 (d, JCH2 = 12.1 Hz, 1H, 0.5xCH2
Bn
), 4.78 (d, JCH2 = 
10.8 Hz, 1H, 0.5xCH2
Bn
), 4.77 (d, J1,2 = 8.4 Hz, 1H, H-1), 4.73 (m, 2H, H-5
ara'
, H-1), 4.69 (m, 2H, 2xH-1), 4.67 – 
4.62 (m, 1H, H-4
ara'
), 4.62 – 4.20 (m, 30H, H-11, H-4ara, H-5ara, 3xH-4, 12xCH2
Bn
), 4.15 (dd, J6a,6b = 11.1, J5,6a = 3.1 
Hz, 1H, H-6
4
), 4.05 (d, J3,4 = 3.2 Hz, 1H, H-4), 4.02 (d, J3,4 = 3.0 Hz, 1H, H-4), 3.85 (d, JCH2 = 15.0 Hz, 1H, 
0.5xCH2
AcCl
), 3.82 – 3.73 (m, 2H, H-6b4, H-6a), 3.71 (d, JCH2 = 15.0 Hz, 1H, 0.5xCH2
AcCl
), 3.68 – 3.12 (m, 22H, H-
2
1
, 6xH-3, 6xH-5, 4.5xH-6), 1.17 (s, 9H, 3xCH3
Piv
), 1.12 (s, 9H, 3xCH3
Piv
), 1.10 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 
3xCH3
Piv
), 1.04 (s, 9H, 3xCH3
Piv
).  
13
C NMR (101 MHz, CDCl3) δ 177.46, 176.89, 176.77, 176.63, 176.62, 166.88, 
166.31, 165.81, 165.77, 165.46, 165.21, 139.06, 138.96, 138.95, 138.91, 138.66, 138.58, 138.49, 138.02, 137.96, 
137.88, 137.88, 137.48, 137.17, 133.51(3C), 133.34, 133.07, 130.03-127.03(90C), 106.93, 105.96, 102.61, 100.61, 
100.12, 99.97, 99.62, 99.21, 81.99, 81.93, 81.80, 81.34, 81.07, 80.85, 80.78, 80.47, 79.50, 78.03, 77.36, 76.90, 
75.12, 74.41, 74.15, 74.10, 73.74, 73.73, 73.67, 73.60, 73.22, 72.77, 72.43, 72.20, 71.97, 71.92, 71.75, 71.51, 71.37, 
71.27, 71.12, 70.76, 70.65, 70.45, 70.21, 70.03, 69.35, 69.30, 68.59, 68.32, 67.82, 67.44, 67.29, 65.72, 63.77, 40.83, 
38.92, 38.91, 38.91, 38.84, 38.81, 27.62, 27.60, 27.53, 27.49, 27.44. 
 
Benzyl 3,6-di-O-benzyl-4-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-
2-O-pivaloyl-β-D-galactopyranosyl-(14)-[4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-
galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)]-3-O-benzyl-2-
O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-
3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-2,3,6-tri-O-benzyl-β-D-galactopyranoside 
(198) 
To a 25 mL flame-dried flask was added acceptor 178 (600 
mg, 0.23 mmol) and the donor 186 (300 mg, 0.32 mmol). The 
mixture was dried azeotropically with toluene (2x10 mL) and 
subjected to vacuum overnight. It was then dissolved in dry 
CH2Cl2 (5 mL) and dry MeCN (5 mL), cooled to -40 °C, 
followed by addition of NIS (73 mg; 0.32 mmol) and TESOTf 
(6 mg; 0.02 mmol). The reaction mixture was stirred at -40 °C 
until TLC revealed full conversion of the donor (1h). The 
solution was diluted with CH2Cl2 (100 mL) and washed with 
sat. aq. NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The 
organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash 
chromatography (9:1 Tol/EtOAc) to afford 198 as a white 
Experimental 
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crystalline material. Rf 0.31 (9:1 Tol/EtOAc). Yield: 648 mg (82%) 
    
  = 5.0° (c 1.0, CDCl3). IR (neat, cm
-1
):3064.21, 3031.20, 2971.30, 2932.48, 2870.87, 1737.19, 1479.50, 
1454.68, 1365.99, 1277.98, 1137.43, 1070.12. 
1
H NMR (400 MHz, CDCl3) δ 7.42 – 6.92 (m, 75H, Ar-H), 5.49 (d, 
J3,4 = 3.4 Hz, 1H, H-4
6
), 5.32 (dd, J2,3 = 10.3, J1,2 = 8.0 Hz, 1H, H-2
digal
), 5.31 (dd, J2,3 = 10.4, J1,2 = 7.7 Hz, 1H, H-
2
digal
) 5.23 (s, 1H, H
benzylidene
), 5.11 – 4.79 (m, 9H, 2xH-1, 5xH-2, H-3digal, 0.5xCH2
Bn
), 4.79 – 4.75 (m, 2H, H-3digal, 
0.5xCH2
Bn
), 4.74 (d, J1,2 = 7.5 Hz, 1H, H-1), 4.70 (d, J1,2 = 8.0 Hz, 1H, H-1), 4.64 (d, J1,2 = 8.6 Hz, 1H, H-1), 4.62 – 
4.18 (m, 32H, H-1
1
, 2xH-1
digal
, 3xH-4, 13xCH2
Bn
), 4.13 – 4.01 (m, 3H, H-4, H-6), 3.99 (d, J3,4 = 3.9 Hz, 1H, H-4), 
3.92 (d, J3,4 = 3.0 Hz, 1H, H-4), 3.87 (d, JCH2 = 15.1 Hz, 1H, CH2
AcCl
), 3.82 (d, J3,4 = 3.1 Hz, 1H, H-4), 3.78 – 3.44 
(m, 14H, 2xH-3, 6xH-6) 3.71 (d, JCH2 = 15.1 Hz, 1H, CH2
AcCl
), 3.45 – 3.01 (m, 14H, 4xH-3, 8xH-5, H-6), 1.17 (s, 
9H, 3xCH3
Piv
), 1.16 (s, 9H, 3xCH3
Piv
), 1.09 (m, 27H, 9xCH3
Piv
), 1.07 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
), 1.05 
(s, 9H, 3xCH3
Piv
), 1.02 (s, 9H, 3xCH3
Piv
). 
13
C NMR (101 MHz, CDCl3) δ 178.11, 177.47, 177.27, 176.89, 176.82, 
176.82, 176.67, 176.66, 176.65, 167.01, 139.11, 139.03, 138.96, 138.96, 138.71, 138.58, 138.48, 138.20, 138.01, 
137.99, 137.91, 137.89, 137.77, 137.45, 137.17, 128.82-126.12(75C), 102.63, 100.93, 100.78, 100.72, 100.46, 
100.09, 99.94, 99.52, 99.23, 81.83, 81.20, 81.10, 80.97, 80.81, 79.52, 77.36, 77.32, 75.52, 75.16, 74.70, 74.40, 
74.33, 74.21, 73.74, 73.66, 73.47, 73.10, 73.03, 72.79, 72.47, 72.39, 72.35, 72.18, 71.96, 71.90, 71.43, 71.30, 71.05, 
70.82, 70.75, 70.49, 70.10, 69.75, 69.27, 68.82, 68.71, 68.44, 67.87, 67.47, 67.18, 66.37, 65.03, 40.81, 39.03, 38.98, 
38.96, 38.95, 38.89, 38.89, 38.84, 38.82, 38.73, 27.63, 27.61, 27.56, 27.51, 27.49, 27.36, 27.35, 27.33, 27.18. 
 
Benzyl 3,6-di-O-benzyl-4-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-
pivaloyl-β-D-galactopyranosyl-(14)-[3,6-di-O-benzyl-4-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-
(1→4) 3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→6)]-3-O-benzyl-2-O-pivaloyl-β-D-
galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-
pivaloyl-β-D-galactopyranosyl-(14)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (199) 
To a 25 mL flame-dried flask was added acceptor 178 (600 
mg, 0.23 mmol) and donor 170 (321 mg, 0.32 mmol). The 
mixture was dried azeotropically with toluene (2x10 mL) and 
subjected to vacuum overnight. It was then dissolved in dry 
CH2Cl2 (5 mL) and dry MeCN (5 mL), cooled to -40 °C, 
followed by addition of NIS (73 mg; 0.47 mmol) and TESOTf 
(12 mg; 0.045 mmol). The reaction mixture was stirred at -40 
°C until TLC revealed full conversion of the donor (2h). The 
solution was diluted with CH2Cl2 (100 mL) and washed with 
sat. aq. NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The 
organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash 
chromatography (12:1 Tol/EtOAc) to afford 199 as a white crystalline material. Rf 0.38 (9:1 Tol/EtOAc). Yield: 638 
mg (79%) 
    
  = 1.9° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.65 – 6.80 (m, 85H), 5.51 (d, J3,4 = 3.3 Hz, 1H, H-4), 
5.46 (d, J3,4 = 3.3 Hz, 1H, H-4), 5.10 – 4.88 (m, 7H, 7xH-2), 4.86 (d, J1,2 = 8.3 Hz, 1H, H-1), 4.85 (d, J1,2 = 8.2 Hz, 
1H, H-1), 4.82 (d, JCH2 = 12.1 Hz, 1H, 0.5xCH2
Bn
), 4.80 (d, J1,2 = 8.3 Hz, 1H, H-1), 4.78 (d, JCH2 = 10.7 Hz, 1H, 
0.5xCH2
Bn
), 4.72 (d, J1,2 = 7.8 Hz, 1H, H-1), 4.67 – 4.17 (m, 40H, 4xH-1, 4xH-4, 16xCH2
Bn
), 4.04 (d, J3,4 = 3.0 Hz, 
1H, H-4), 3.86 (d, J3,4 = 2.9 Hz, 1H, H-4), 3.78 (d, JCH2 = 15.1 Hz, 1H, 0.5xCH2
AcCl
), 3.76 (d,JCH2 = 15.1 Hz, 1H, 
0.5xCH2
AcCl
), 3.73 – 3.15 (m, 34H, CH2
AcCl
, H-2, 7xH-3, 8xH-5, 8xH-6), 3.06 (dd, J2,3 = 10.1, J3,4 = 3.0 Hz, 1H, H-
3), 1.15 (s, 9H, 3xCH3
Piv
), 1.12 (s, 18H, 6xCH3
Piv
), 1.05 (s, 18H, 6xCH3
Piv
), 1.02 (s, 9H, 3xCH3
Piv
), 1.01 (s, 9H, 
3xCH3
Piv
). 
13
C NMR (101 MHz, CDCl3) δ 177.29, 177.19, 176.78, 176.72, 176.71, 176.70, 176.35, 166.91, 166.90, 
139.42, 139.05, 139.05, 138.97, 138.80, 138.71, 138.68, 138.51, 138.07, 138.05, 138.03, 137.97, 137.94, 137.48, 
137.47, 137.17, 137.17, 128.67-127.08 (85C), 102.62, 101.96, 100.65, 100.24, 100.10, 100.03, 99.43, 99.35, 81.83, 
80.99, 80.85, 80.68, 80.52, 79.52, 77.36, 77.24, 75.15, 75.00, 74.35, 74.31, 74.20, 73.73, 73.67, 73.63, 73.56, 73.47, 
73.34, 73.18, 72.75, 72.61, 72.42, 72.09, 72.01, 71.83, 71.75, 71.56, 71.29, 71.22, 71.15, 70.93, 70.84, 70.74, 70.68, 
70.66, 70.49, 70.45, 70.32, 69.71, 69.21, 69.11, 69.06, 68.48, 68.44, 67.93, 67.24, 67.19, 66.77, 40.77, 40.75, 38.96, 
38.92, 38.89, 38.85, 38.84, 38.80, 38.71, 27.61(3C), 27.575(3C), 27.57(3C), 27.51(3C), 27.47(3C), 27.34(3C), 
27.31(3C). 
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Benzyl 3,6-di-O-benzyl-4-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-
2-O-pivaloyl-β-D-galactopyranosyl-(14)-[2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl-(1→6)]-3-
O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-
galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-2,3,6-tri-O-
benzyl-β-D-galactopyranoside (200) 
To a 25 mL flame-dried flask was added acceptor 178 (600 
mg, 0.23 mmol) and the donor 188 (338 mg, 0.45 mmol). The 
mixture was dried azeotropically with toluene (2x10 mL) and 
subjected to vacuum overnight. It was then dissolved in dry 
CH2Cl2 (10 mL), cooled to -40 °C, followed by addition of 
TMSOTf (5 mg; 0.023 mmol). The reaction mixture was 
stirred at -40 °C until TLC revealed full conversion of the 
donor (1h). The reaction mixture was quenched with Et3N (0.5 
mL) and concentrated. The product was purified by flash 
chroma-tography (14:1 Tol/EtOAc) to afford 200 as a white 
crystalline material. Rf 0.38 (9:1 Tol/EtOAc). Yield: 551 mg 
(75%) 
    
  = 11.5° (c 1.0, CDCl3). IR (neat, cm
-1
): 3063.82, 3031.21, 2971.29, 2870.44, 1730.96, 1453.03, 1397.21, 
1365.48, 1267.63, 1150.75, 1095.20, 1068.04, 1028.16. 
1
H NMR (400 MHz, CDCl3) δ 7.96 – 7.88 (m, 2H, Ar-H), 
7.89 – 7.82 (m, 2H Ar-H), 7.75 (m, 2H, Ar-H), 7.68 – 7.61 (m, 2H, Ar-H), 7.40 – 6.99 (m, 77H, Ar-H), 5.97 (d, J = 
2.9 Hz, 1H, H-4
gal
), 5.73 (dd, J2,3 = 10.3, J1,2 = 7.9, 1H, H-2
gal
), 5.51 (dt, J2,3 = 10.3, J3,4 = 2.9 Hz, 1H, H-3
gal
), 5.45 
(d, J3,4 = 3.5 Hz, 1H, H-4
6
), 5.07 – 4.73 (m, 9H, 2xH-1, 5xH-2, CH2
Bn
), 4.71 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.66 (m, 
J6a,6b = 6.7, J5,6a = 5.0, 1H, H-6a
gal
), 4.63 – 4.11 (m, 32H, 4xH-1, 3xH-4, H-6bgal, 12xCH2
Bn
), 4.02 (m, 2H, 2xH-4), 
3.96 (m, 2H, H-6), 3.83 (d, JCH2 = 15.1 Hz, 1H, 0.5xCH2
AcCl
), 3.74 – 3.23 (m, 18H, 0.5xCH2
AcCl
, 6xH-3, H-5, 5xH-
6), 3.21 (s, 1H, H-5), 3.18 (s, 1H, H-5), 3.11 (s, 1H, H-5), 3.09 (s, 1H, H-5), 2.99 (s, 1H, H-5), 2.97 (s, 1H, H-5), 
1.17 (s, 9H, 3xCH3
Piv
), 1.16 (d, 9H, 3xCH3
Piv
), 1.07 (s, 9H, 3xCH3
Piv
), 1.01 (s, 18H, 6xCH3
Piv
).
13
C NMR (101 MHz, 
CDCl3) δ 177.24, 176.75, 176.65, 176.64, 176.40, 167.09, 165.93, 165.59, 165.56, 165.11, 139.58, 139.04, 139.01, 
138.95, 138.71(2C), 138.63, 138.34, 138.02, 138.00, 137.88, 137.52, 137.09, 133.67, 133.47, 133.28, 133.20, 
130.01-126.62(85C), 102.64, 101.14, 100.73, 100.45, 99.63, 99.31, 99.22, 81.83, 81.55, 81.00, 80.74, 80.03, 79.54, 
77.36, 75.15, 74.39, 74.38, 74.09, 73.76, 73.69, 73.66, 73.57, 73.43, 73.31, 72.86, 72.44, 72.05, 71.97, 71.53, 71.45, 
71.38, 71.31, 71.17, 71.10, 70.99, 70.92, 70.90, 70.81, 70.70, 70.50, 70.18, 70.09, 69.28, 68.41, 68.20, 67.51, 67.16, 
40.83, 39.06, 38.93, 38.84, 38.83, 38.80, 27.70, 27.61, 27.58, 27.46, 27.45. 
 
Benzyl 3,6-di-O-benzyl-4-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-
2-O-pivaloyl-β-D-galactopyranosyl-(14)-[2,3,5-tri-O-benzoyl--L-arabinofuranosyl-(1→6)]-3-O-
benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-
galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-2,3,6-tri-O-
benzyl-β-D-galactopyranoside (201) 
To a 25 mL flame-dried flask was added acceptor 178 (600 
mg, 0.23 mmol) and the donor 189 (285 mg, 0.45 mmol). The 
mixture was dried azeotropically with toluene (2x10 mL) and 
subjected to vacuum overnight. It was then dissolved in dry 
CH2Cl2 (10 mL), cooled to -40 °C, followed by addition of 
TMSOTf (5 mg; 0.023 mmol). The reaction mixture was 
stirred at -40 °C until TLC revealed full conversion of the 
donor (1h). The reaction mixture was quenched with Et3N (0.5 
mL) and concentrated. The product was purified by flash 
chromatography (19:1 Tol/EtOAc) to afford 201 as a white 
crystalline material. Rf 0.42 (9:1 Tol/EtOAc). Yield: 567 mg 
(81%) 
    
  = 5.3° (c 1.0, CDCl3). IR (neat, cm
-1
):3063.86, 3030.69, 2971.83, 2930.37, 2870.36, 1737.69, 1453.53, 
1365.70, 1274.60, 1152.50, 1102.57, 1070.27, 1028.90. 
1
H NMR (400 MHz, CDCl3) δ 8.04 – 7.77 (m, 6H, Ar-H
Bz
), 
7.60 – 6.78 (m, 74H, Ar-H), 5.49 (dd, J = 5.2, 1.4 Hz, 1H, H-3ara), 5.45 (d, J = 3.4 Hz, 1H, H-46), 5.44 (d, J = 1.4 Hz, 
1H, H-2
ara
), 5.26 (s, 1H, H-1
ara
), 5.06 – 4.89 (m, 5H, H-22-H-26), 4.87 (d, J1,2 = 8.0 Hz, 1H, H-1), 4.82 (d, J6a,6b = 
12.1 Hz, 1H, 0.5xCH2
Bn
), 4.78 (d, J6a,6b = 11.1 Hz, 1H, 0.5xCH2
Bn
) 4.76 (d, J1,2 = 8.2 Hz, 1H, H-1), 4.74 (d, J1,2 = 7.8 
Hz, 1H, H-1), 4.70 (d, J1,2 = 8.1 Hz, 1H, H-1), 4.68 (d, J1,2 = 8.2 Hz, 1H), 4.65 – 4.60 (m, 2H, H-5
ara
), 4.60 – 4.20 
Experimental 
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(m, 29H, H-1
1
, H-4
ara
, 3xH-4, 12xCH2
Bn
), 4.05 (d, J3,4 = 3.6 Hz, 1H, H-4), 4.02 (d, J3,4 = 3.1 Hz, 1H, H-4), 3.86 (d, J 
= 15.0 Hz, 1H, CH2
AcCl
), 3.83 – 3.43 (m, 11H, H-3, 5xH-6), 3.72 (d, J = 15.0 Hz, 1H, CH2
AcCl
), 3.44 – 3.14 (m, 8H, 
H-2
1
, 5xH-3, H-6), 1.15 (s, 9H, 3xCH3
Piv
), 1.12 (s, 9H, 3xCH3
Piv
), 1.11 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
), 
1.05 (s, 9H, 3xCH3
Piv
). 
13
C NMR (101 MHz, CDCl3) δ 177.44, 176.88, 176.76, 176.64, 176.62, 166.93, 166.26, 
165.89, 165.53, 139.07, 138.97(3C), 138.96, 138.94, 138.68, 138.60, 138.40, 138.02, 138.01, 137.91, 137.50, 
137.19, 133.66, 133.54, 133.06, 130.00-125.42 (80C), 107.01, 102.63, 100.63, 100.17, 100.05, 99.63, 99.37, 82.40, 
81.81, 81.02, 80.83, 80.75, 80.69, 80.63, 79.52, 78.35, 77.36, 77.00, 75.15, 75.02, 74.42, 74.26, 74.12, 73.74, 73.72, 
73.68, 73.63, 73.27, 72.79, 72.49, 72.26, 72.02, 71.92, 71.83, 71.51, 71.36, 71.15, 70.76, 70.73, 70.48, 70.23, 70.07, 
69.50, 69.36, 68.58, 68.44, 68.07, 67.47, 67.32, 63.69, 40.85, 38.93, 38.93, 38.92, 38.87, 38.82, 27.61, 27.60, 27.53, 
27.51, 27.43. 
 
Benzyl 3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-
galactopyranosyl-(14)-3-O-benzyl-6-O-(2-naphthyl)methyl-2-O-pivaloyl-β-D-galactopyranosyl-
(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-
galactopyranosyl-(14)- 3,6-di-O-benzyl-2-O-
pivaloyl-β-D-galactopyranosyl-(14)-2,3,6-tri-O-
benzyl-β-D-galactopyranoside (202) 
To a solution of 179 (800 mg; 0.29 mmol) in THF (10 mL) at 
0 °C was added a 0.02M NaOMe solution in MeOH (30 mL). 
The reaction mixture was stirred at 0 °C for 1h, quenched with 
amberlite 120-H
+
 resin, filtered and concentrated. The residue 
was purified by flash chromatography (9:1 Tol/EtOAc) to 
afford 202 as a white crystalline material. Rf 0.4 (9:1 Tol/EtOAc). Yield: 720 mg (95%) 
 
Benzyl 2,3,5-tri-O-benzoyl--L-arabinofuranosyl-(1→4)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-
(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3-O-benzyl-6-O-(2-naphthyl)methyl-2-O-
pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)- 3,6-di-O-
benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (203) 
To a 25 mL flame-dried flask was added acceptor 202 
(600 mg, 0.23 mmol) and the donor 189 (279 mg, 0.45 
mmol). The mixture was dried azeotropically with 
toluene (2x10 mL) and subjected to vacuum overnight. It 
was then dissolved in dry CH2Cl2 (10 mL), cooled to -40 
°C, followed by addition of TMSOTf (5 mg; 0.023 
mmol). The reaction mixture was stirred at -40 °C until 
TLC revealed full conversion of the donor (1.5h). The 
reaction mixture was quenched with Et3N (0.5 mL) and 
concentrated. The product was purified by flash 
chromatography (20:1 Tol/EtOAc) to afford 203 as a 
white solid. Rf 0.50 (9:1 Tol/EtOAc). Yield: 518 mg (74%). 
    
  = 1.2° (c 1.0, CDCl3). IR (neat, cm
-1
): 3063.31, 3031.07, 2970.07, 2930.73, 2869.78, 1736.22, 1453.32, 
1365.04, 1274.28, 1153.05, 1097.62, 1069.80, 1049.66, 909.24. 
1
H NMR (400 MHz, CDCl3) δ 8.04 – 7.97 (m, 2H, 
Ar-H), 7.85 (m, 2H, Ar-H), 7.81 – 7.64 (m, 5H), 7.51 – 6.93 (m, 78H), 5.71 (s, 1H, H-1ara), 5.58 (s, 1H, H-2ara), 5.39 
(d, J3,4 = 4.5 Hz, 1H, H-3
ara
), 5.33 (dd, J2,3 = 10.0, J1,2 = 8.1 Hz, 1H, H-2), 5.03 (m, 4H, 4xH-2), 4.84 (d, J1,2 = 7.9 
Hz, 1H, H-1), 4.82 (d, JCH2 = 12.1 Hz, 1H, 0.5xCH2
Bn
), 4.78 (d, JCH2 = 11.0 Hz, 1H, 0.5xCH2
Bn
), 4.78 (d, J1,2 = 7.9 
Hz, 1H, H-1), 4.72 (d, J1,2 = 7.8 Hz, 1H, H-1), 4.69 (d, J1,2 = 7.4 Hz, 1H, H-1), 4.67 (d, J1,2 = 8.0 Hz, 1H, H-1), 4.65 
(d, JCH2 = 12.4 Hz, 1H, 0.5xCH2
Bn
), 4.61 – 3.90 (m, 34H, 12.5xCH2
Bn
, H-4
ara
, H-5
ara
, H-1
1
, 5xH-4, ), 3.73 – 3.48 (m, 
11H, H-2
1
, 5xH-6), 3.45 – 3.16 (m, 13H, 6xH-3, 6xH-5, H-6), 1.17 (s, 9H, 3xCH3
Piv
), 1.15 (s, 9H, 3xCH3
Piv
), 1.10 (s, 
9H, 3xCH3
Piv
), 1.09 (s, 9H, 3xCH3
Piv
), 1.05 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.19, 176.74, 
176.71, 176.69, 176.68, 166.28, 165.98, 165.25, 139.05, 139.04, 138.98, 138.97, 138.70, 138.56, 138.12, 138.07, 
138.06, 138.02, 137.99, 137.66, 137.51, 136.44, 133.54, 133.47, 133.35, 133.02, 130.20-125.76 (85C), 106.41, 
102.63, 100.68, 100.30, 100.25, 100.20, 99.59, 82.70, 82.28, 81.84, 80.98, 80.81, 80.66, 80.42, 80.25, 79.52, 78.29, 
77.36, 75.15, 74.52, 74.39, 74.19, 74.07, 73.66, 73.56, 73.48, 73.41, 73.11, 72.80, 72.64, 72.44, 72.19, 72.18, 71.43, 
71.38, 71.28, 71.20, 71.16, 71.09, 70.72, 70.48, 70.32, 70.01, 69.73, 69.52, 69.14, 68.89, 68.87, 68.38, 67.39, 63.79, 
38.98, 38.94, 38.88 (2C), 38.81, 27.66 (3C), 27.60 (3C), 27.56 (3C), 27.54 (3C), 27.50 (3C). 
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Phenyl 6-O-benzyl-4-O-chloroacetyl-3-O-(2-naphthyl)methyl-2-O-pivaloyl-1-thio-β-D-galactopyranoside (204) 
206 (4 g; 6.84 mmol) was dissolved in CH2Cl2 (68 mL) and cooled to 0 °C. (ClAc)2O (1.99 g; 
11.62 mmol), Et3N (1.91 mL; 13.68 mmol) and DMAP (17 mg; 0.14 mmol) was added and the 
reaction was stirred at 0 °C for 4 h. The reaction mixture was concentrated and purified by flash 
chromatography (19:1 Tol/EtOAc) to afford 204 as a yellowish crystalline powder. Rf 0.57 (9:1 
Tol/EtOAc). Yield 4.24 g (94%) 
    
  = 22.7° (c 1.0, CDCl3). IR (neat, cm
-1
): 3059.56, 3029.48, 2970.67, 2931.40, 2906.53, 2870.20, 1763.22, 
1738.34, 1478.56, 1367.36, 1277.26, 1145.22, 1098.10, 1064.55. 
1
H NMR (400 MHz, CDCl3) δ 7.78 – 7.58 (m, 4H, 
Ar-H), 7.45 – 7.13 (m, 13H, Ar-H), 5.68 (d, J3,4 = 3.0 Hz, 1H, H-4), 5.10 (t, J1,2 = J2,3 = 9.8 Hz, 1H, H-2), 4.79 (d, 
JCH2 = 11.6 Hz, 1H, 0.5xCH2
Bn
), 4.60 (d, J1,2 = 9.8 Hz, 1H, H-1), 4.49 (m, 2H, CH2
Bn
), 4.37 (d, JCH2 = 11.7 Hz, 1H, 
0.5xCH2
Bn
), 4.01 (d, JCH2 = 15.1 Hz, 1H, CH2
AcCl
), 3.90 (d, JCH2 = 15.1 Hz, 1H, CH2
AcCl
), 3.75 (dd, J5,6b =7.3, J5,6a = 
5.8 Hz, 1H, H-5), 3.62 (dd, J2,3 = 9.8, J2,3 = 3.0 Hz, 1H, H-3), 3.56 (dd, J6a,6b = 9.4, J5,6a = 5.8 Hz, 1H, H-6a), 3.46 
(dd, J6a,6b = 9.4, J5,6b = 7.3 Hz, 1H, H-6b), 1.14 (s, 9H, 3xCH3
Piv
). 
13
C NMR (101 MHz, CDCl3) δ 176.81, 166.97, 
137.38, 134.41, 133.22, 133.19, 133.10, 132.28 (2C), 129.07, 128.91 (2C), 128.56 (2C), 128.25, 128.21 (2C), 
128.06, 127.95, 127.93, 127.69, 126.97, 126.17, 126.05, 125.94, 87.29, 78.06, 75.72, 73.76, 71.90, 68.45, 68.40, 
67.51, 40.83, 38.78, 27.20 (3C). 
 
Phenyl 4,6-O-benzylidene-3-O-(2-naphthyl)methyl-2-O-pivaloyl-1-thio-β-D-galactopyranoside (205) 
56 (14 g; 27.97 mmol) was dissolved in CH2Cl2 (200 mL). Et3N (6.8 mL; 48.94 mmol), DMAP 
(1.71 g; 13.98 mmol) and pivaloyl chloride (5.2 mL; 41.95 mmol) was added to the solution and 
the reaction mixture was heated to 45 °C for 4 h. The reaction mixture was cooled to 0 °C, 
quenched with MeOH (10 mL), washed with water (2x100 mL), dried over MgSO4 and 
concentrated. The product was purified by flash chromatography (19:1 Tol/EtOAc) to give 
compound 205. Rf 0.5 (9:1 Tol/EtOAc). Yield 15.3 g (93%) 
    
  = 9.1° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.81 – 7.60 (m, 4H, H
napth
), 7.56 – 7.48 (m, 2H, Hnapth), 
7.44 – 7.33 (m, 5H, HSPh, Hnapth), 7.28 (dt, J = 5.0, 1.6 Hz, 3H, HSPh, Ar-H), 7.22 – 7.10 (m, 3H, HSPh, Ar-H), 5.34 (s, 
1H, -CH
benzylidene
), 5.31 (t, J1,2 = J2,3 = 9.8 Hz, 1H, H-2), 4.74 (d, JCH2 = 12.7 Hz, 1H, -CH2
NAP
), 4.68 (d, JCH2 = 12.7 
Hz, 1H, -CH2
NAP
), 4.62 (d, J1,2 = 9.8 Hz, 1H, H-1), 4.25 (dd, J6a,6b = 12.4, J5,6a = 1.6 Hz, 1H, H-6a), 4.08 (dd, J3,4 = 
3.4, J4,5 = 1.0 Hz, 1H, H-4), 3.87 (dd, J6a,6b =12.4, J5,6b 1.7 Hz, 1H, H-6b), 3.66 (dd, J2,3 = 9.8, J34 = 3.4 Hz, 1H, H-3), 
3.33 (m, 1H, H-5), 1.19 (s, 9H, 3x-CH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.49, 137.65, 135.50, 133.30 (2C), 
133.14, 133.00, 132.13, 129.02, 128.73 (2C), 128.13 (2C), 128.12, 127.85, 127.84, 127.71 (2C), 126.57 (2C), 
126.19, 125.98, 125.55, 101.15, 85.77, 78.82, 73.44, 71.54, 69.95, 69.29, 67.96, 38.80, 27.28 (3C). HRMS (ESI-
TOF) m/z: [M + NH4]+ Calcd for C35H40NO6S 602.2576 Found 602.2574. 
 
Phenyl 6-O-benzyl-3-O-(2-naphthyl)methyl-2-O-pivaloyl-1-thio-β-D-galactopyranoside (206) 
Trifluoroacetic acid (3.5 mL, 45.32 mmol) was added drop wise to a solution of 205 (5.3 g, 9.06 
mmol) and triethylsilane (7.2 mL, 45.32 mmol) in CH2Cl2 (100 mL) at 0 °C. When the addition 
was complete (10 min), the reaction was heated to 22 °C and stirred for 2h. The mixture was 
diluted with ethyl acetate and washed with sat. aq. NaHCO3 and brine. The organic phase was 
dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography (9:1 Tol/EtOAc) to 
afford 206. Rf 0.31 (9:1 Tol/EtOAc). Yield: 4.22 g (79%) 
    
  = 3.1° (c 1.0, CDCl3). IR (neat, cm
-1
): 3478.37, 3059.04, 2930.64, 1732.14, 1583.69, 1509.48, 1496.37 
,1478.63, 1455.17, 1367.17, 1277.64, 1152.50, 1123.46, 1098.39, 1065.56. 
1
H NMR (400 MHz, CDCl3) δ 7.91 – 
7.81 (m, 3H, Ar-H), 7.76 (s, 1H, Ar-H), 7.59 – 7.48 (m, 4H, Ar-H), 7.47 – 7.23 (m, 9H, Ar-H), 5.37 5.37 (t, J1,2 = 
J2,3 = 9.8 Hz, 1H, H-2), 4.85 (d, J = 12.0 Hz, 1H, CH2
Bn
), 4.78 (d, J = 12.0 Hz, 1H, CH2
Bn
), 4.69 (d, J = 9.8 Hz, 1H), 
4.60 (s, 2H, CH2
NAP
), 4.22 – 4.14 (m, 1H, H-4), 3.89 – 3.81 (m, 2H, H-6a, H-6b), 3.69 (m, 2H, H-3, H-5), 2.71 – 
2.50 (m, 1H, -OH), 1.29 (s, 9H, 3xCH3
Piv
).
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.89, 138.02, 134.71, 133.81, 133.18, 
133.09, 131.93 (2C), 128.87 (2C), 128.44 (2C), 127.90, 127.78 (2C), 127.75, 127.61, 126.48, 126.33, 126.16, 
125.46, 87.05, 80.08, 77.44, 73.73, 71.97, 69.37, 68.67, 66.66, 38.82, 27.25 (3C). HRMS (ESI-TOF) m/z: [M + 
Na]
+ 
Calcd for C35H38NaO6S: 609.2287; Found 609.2282. 
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Benzyl 6-O-benzyl-4-O-chloroacetyl-3-O-(2-naphthyl)methyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-
di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)- 3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-
(14)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (207) 
To a 50 mL flame-dried flask was added acceptor 172 (2.6 g, 1.87 mmol) 
and the donor 204 (1.7 g, 2.61 mmol). The mixture was dried azeotropically 
with toluene (2x50 mL) and subjected to vacuum overnight. It was then 
dissolved in dry CH2Cl2 (12.5 mL) and dry MeCN (12.5 mL), cooled to -40 
°C, followed by addition of NIS (603 mg; 2.69 mmol) and TESOTf (98 mg; 
0.37 mmol). The reaction mixture was stirred at -40 °C until TLC revealed 
full conversion of the donor (2.5h). The solution was diluted with CH2Cl2 
(100 mL) and washed with sat. aq. NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The organic phase was dried 
over MgSO4, filtered and concentrated. The product was purified by flash chromatography (15:1 Tol/EtOAc) to 
afford 207 as a white crystalline material. Rf 0.49 (9:1 Tol/EtOAc). Yield: 2.91 g (79%). 
    
  = 4.6° (c 1.0, CDCl3). IR (neat, cm
-1
): 3088.43, 3062.42, 3030.60, 2969.24, 2929.46, 2869.91, 1738.42, 
1496.71, 1479.37, 1454.23, 1365.97, 1277.68, 1154.68, 1100.72, 1072.51. 
1
H NMR (400 MHz, CDCl3) δ 7.77 – 
7.65 (m, 3H, Ar-H
NAP
), 7.60 (s, 1H, Ar-H
NAP
), 7.44 – 7.04 (m, 48H, Ar-H), 5.54 (s, 1H, H-44), 5.12 – 4.94 (m, 3H, 
H-2
2
-H-2
4
), 4.90 – 4.68 (m, 7H, H-12-H-14, 2xCH2
Bn
), 4.66 – 4.22 (m, 22H, H-11, H-41, 8xCH2
Bn
), 4.08 (s, 1H, H-
4
3/4
), 4.03 (s, 1H, H-4
3/4
), 3.89 (d, JCH2 = 14.8 Hz, 1H, 0.5xCH2
AcCl
), 3.80 (d, JCH2 = 14.8 Hz, 1H, 0.5xCH2
AcCl
), 3.73 
– 3.47 (m, 6H, H-21, 2.5xH-6), 3.46 – 3.19 (m, 11H, 1.5xH-6, H-51-H-54, H-31-H-34), 1.19 (s, 9H), 1.12 (s, 9H), 
1.06 (s, 9H). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.16, 176.65, 176.62, 166.86, 138.91, 138.86, 138.84, 138.60, 
138.55, 137.98, 137.93, 137.90, 137.44, 134.49, 133.20, 133.09, 129.07, 128.58-127.00 (44C), 126.09, 126.04, 
125.98, 102.60, 100.79, 100.16, 99.42, 81.72, 81.13, 80.43, 79.47, 77.26, 77.22, 75.06, 74.21, 73.74, 73.68, 73.56, 
73.48, 72.86, 72.72, 72.06, 71.67, 71.47, 71.43, 71.27, 71.18, 70.44, 69.89, 69.45, 69.37, 68.40, 67.31, 66.87, 40.82, 
38.88 (2C), 38.73, 27.56 (3C), 27.41 (3C), 27.40 (3C). 
 
Benzyl 6-O-benzyl-3-O-(2-naphthyl)methyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-
pivaloyl-β-D-galactopyranosyl-(14)- 3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-2,3,6-tri-O-
benzyl-β-D-galactopyranoside (208) 
To a solution of 207 (4.33 g; 2.22 mmol) in THF (25 mL) at 0 °C was added 
a 0.02M NaOMe solution in MeOH (75 mL). The reaction mixture was 
stirred at 0 °C for 2h, quenched with amberlite 120-H
+
 resin, filtered and 
concentrated. The residue was purified by flash chroma-tography (9:1 
Tol/EtOAc) to afford 208 as a white crystalline material. Rf 0.22 (9:1 
Tol/EtOAc) Yield: 4.00 g (96%) 
    
  = -1.9° (c 1.0, CDCl3). IR (neat, cm
-1
): 3062.57, 3030.57, 2970.81, 
2929.84, 2869.47, 1739.33, 1454.25, 1365.88, 1277.69, 1152.09, 1134.64, 1099.41, 1073.10. 
1
H NMR (400 MHz, 
CDCl3) δ 7.83 – 7.55 (m, 4H, Ar-H), 7.55 – 6.99 (m, 48H, Ar-H), 5.13 (dd, J2,3 = 9.8, 8.0 Hz, 1H, H-2
2/3/4
), 5.04 (m, 
2H, H-2
2/3/4
, H-2
2/3/4
), 4.90 – 4.22 (m, 25H, H-11-H-14, H-41/2/3/4,10xCH2
Bn
), 4.15 – 4.09 (m, 1H, H-41/2/3/4), 4.08 – 
4.00 (m, 1H, H-4
1/2/3/4
), 3.90 (dd, J3,4 = 3.3, J4,5 = 1.7 Hz, 1H, H-4
1/2/3/4
), 3.75 – 3.19 (m, 17H, H-21, H-31-H-34, H-51-
H-5
4
, H-6
1
-H-6
4
), 1.19 (s, 9H, 3xCH3
Piv
), 1.16 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, 
CDCl3) δ 177.42, 176.77, 176.75, 139.02, 138.96, 138.93, 138.74, 138.70, 138.13, 138.11, 138.03, 138.01, 134.84, 
133.29, 133.21, 128.55-125.66(52C), 102.69, 100.86, 99.99, 99.51, 81.83, 81.16, 80.48, 79.56, 79.22, 77.36, 75.17, 
74.35, 74.11, 73.79 (2C), 73.70 (2C), 73.62 (3C), 73.30, 72.94, 72.48, 72.15, 71.50, 71.43, 71.35, 71.30, 70.66, 
70.61, 70.54, 69.96, 69.69, 69.60, 68.99, 66.98, 66.41, 39.01, 38.98, 38.84, 27.68(3C), 27.58(3C), 27.51(3C). 
 
Benzyl 3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-
galactopyranosyl-(14)-6-O-benzyl-3-O-(2-naphthyl)methyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-
di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(14)-3,6-di-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-
(14)-2,3,6-tri-O-benzyl-β-D-galactopyranoside (209) 
To a 100 mL flame-dried flask was added acceptor 208 (3.5 g, 
1.87 mmol) and the donor 170 (2.7 g, 2.62 mmol). The 
mixture was dried azeotropically with toluene (2x50 mL) and 
subjected to vacuum overnight. It was then dissolved in dry 
CH2Cl2 (20 mL) and dry MeCN (20 mL), cooled to -40 °C, 
followed by addition of NIS (606 mg; 2.69 mmol) and 
TESOTf (99 mg; 0.37 mmol). The reaction mixture was 
stirred at -40 °C until TLC revealed full conversion of the 
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donor (2h). The solution was diluted with CH2Cl2 (200 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. 
NaHCO3 (100 mL). The organic phase was dried over MgSO4, filtered and concentrated. The product was purified 
by flash chromatography (12:1 Tol/EtOAc) to afford 209 as a white crystalline material. Rf 0.44 (9:1 Tol/EtOAc). 
Yield: 4.34 g (83%). 
    
  = -4.7° (c 1.0, CDCl3). IR (neat, cm
-1
): 3088.32, 3063.11, 3030.60, 2970.62, 2930.57, 2870.02, 1739.54, 
1496.77, 1479.43, 1397.40, 1366.02, 1277.67, 1152.19, 1101.13, 1074.37. 
1
H NMR (400 MHz, CDCl3) δ 7.79 – 
7.56 (m, 4H, Ar-H), 7.42 – 7.01 (m, 68H, Ar-H), 5.49 (d, J = 3.3 Hz, 1H, H-46), 5.09 – 4.89 (m, 5H, H-22-H-26), 
4.89 – 4.65 (m, 6H, H-12-H-16, CH2
Bn
), 4.64 – 4.21 (m, 29H, H-11, H-41/2/3/4/5, H-41/2/3/4/5,13xCH2
Bn
), 4.17 – 4.09 (m, 
1H, H-4
1/2/3/4/5
), 4.08 – 4.04 (m, 1H, H-41/2/3/4/5), 4.03 (m, 1H, H-41/2/3/4/5), 3.87 (d, JCH2 = 14.9 Hz, 1H, 0.5xCH2
AcCl
), 
3.77 (d, J = 14.8 Hz, 1H, 0.5xCH2
AcCl
), 3.70 – 3.15 (m, 25H, H-21, H-31-H-36, H-51-H-56, H-61-H-66), 1.17 (s, 9H, 
3xCH3
Piv
), 1.11 (s, 9H, 3xCH3
Piv
), 1.11 (s, 9H, 3xCH3
Piv
), 1.10 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 
(101 MHz, CDCl3) δ 177.20, 176.78, 176.70, 176.68, 176.65, 166.90, 139.04 (2C), 138.98, 138.97 (2C), 138.70, 
138.67, 138.10, 138.05, 138.02, 137.99, 137.50, 137.12, 135.56, 133.30, 132.99, 129.16-125.43 (72C), 102.64, 
100.68, 100.36, 100.07 (2C), 99.60, 81.85, 81.00, 80.76, 80.48, 79.53, 77.37, 75.16, 74.46, 74.39, 74.22, 73.90, 
73.75, 73.71, 73.69, 73.66, 73.53, 73.51, 72.81, 72.78, 72.32, 72.12, 72.07, 71.75, 71.48, 71.38, 71.33, 71.21, 71.04, 
70.72, 70.54, 70.50, 70.37, 70.33, 69.61, 69.41, 69.27, 68.43, 68.24, 67.44, 67.35, 40.88, 38.96, 38.93 (2C), 38.90, 
38.82, 27.67 (3C), 27.60 (3C), 27.58 (3C), 27.51 (3C), 27.48 (3C). 
 
β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-
(14)-β-D-galactopyranosyl-(14) -D-galactopyranose (210) 
179 (800 mg; 0.29 mmol) was dissolved in THF (20 mL) and a 
1M Et4NOH in MeOH solution (8.6 mL; 8.6 mmol) was added. 
The reaction mixture was stirred at 65 C for 24 h and then 
poured into sat. aq. NH4Cl (100 mL) and extracted with CH2Cl2 
(3x50 mL). The combined organic phases were dried over 
MgSO4, filtered and concentrated. The product was purified by 
flash chromatography (2:1 Tol/EtOAc) to yield colorless crystals. 
The product was dissolved in MeOH (20 mL), THF (5 mL). 20% 
Pd(OH)2/C (200 mg; 0.28 mmol) was added and an atmosphere 
of H2 (1 atm.) was installed. The reaction was stirred at 22 °C for 48h, filtered through celite, and concentrated to 
give a grey solid. Purified by reverse phase chromatography to afford 210 as a white solid. Yield: 203 mg (72% over 
two steps) 
1
H NMR (400 MHz, D2O) δ 5.18 (d, J1,2 = 3.7 Hz, 1H, H-1), 4.59 – 4.48 (m, 11H, H-1
2-H-16, H-11- H-17), 
4.14 (d, J3,4 = 3.1 Hz, 1H, H-4), 4.08 (m, 10H, 10xH-4), 4.04 (t, J = 6.5 Hz, 1H), 3.86 (dd, J = 10.3, 3.0 Hz, 1H), 
3.81 (d, J3,4 = 3.4 Hz, 1H), 3.79 – 3.45 (m, 58H). 
13
C NMR (101 MHz, D2O) δ 104.30, 104.25, 96.35, 92.27, 77.82, 
77.58, 77.55, 77.53, 77.07, 75.11, 74.46, 74.41, 74.28, 73.26, 73.19, 72.71, 72.19, 71.75, 71.32, 69.81, 69.66, 68.77, 
68.58, 60.95, 60.67, 60.50. Full characterization is currently being done in collaboration with the Carlsberg 
Laboratories. 
 
β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-[β-D-galactopyranosyl-(1→6)]-β-D-
galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14) -D-galactopyranose (211) 
200 (500 mg; 0.15 mmol) was dissolved in THF (20 mL) and a 
1M Et4NOH in MeOH solution (5.4 mL; 5.40 mmol) was added. 
The reaction mixture was stirred at 65 C for 24 h and then 
poured into sat. aq. NH4Cl (100 mL) and extracted with CH2Cl2 
(3x50 mL). The combined organic phases were dried over 
MgSO4, filtered and concentrated. The product was purified by 
flash chromatography (1:1 Tol/EtOAc) to yield colorless crystals. 
The product was dissolved in MeOH (16 mL), THF (4 mL). 20% 
Pd(OH)2/C (108 mg; 0.15 mmol) was added and an atmosphere 
of H2 (1 atm.) was installed. The reaction was stirred at 22 °C for 
48h, filtered through celite, and concentrated to give a grey solid. 
Purified by reverse phase chromatography to afford 211 as a white solid. Yield: 133 mg (75% over two steps) 
1
H NMR (400 MHz, D2O) δ 5.18 (d, J1,2 = 3.7 Hz, 1H, H-1), 4.61 – 4.46 (m, 11H, H-1
1-H-16, H-12-H-16), 
4.35 (d, J1,2 = 7.9 Hz, 2H, H-1
gal, H-1gal), 4.14 (d, J3,4 = 3.1 Hz, 1H, H-4), 4.11 (d, J3,4 = 3.3 Hz, 1H, H-4), 4.10 – 
3.98 (m, 12H, 12xH-4), 3.94 – 3.37 (m, 70H). 13C NMR (101 MHz, D2O) δ 104.34, 104.25, 104.18, 103.56, 96.36, 
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92.27, 81.68, 78.79, 77.82, 77.54, 77.02, 75.10, 75.07, 74.46, 74.33, 74.28, 73.70, 73.23, 73.20, 72.70, 72.66, 72.19, 
71.77, 71.61, 71.31, 70.69, 68.56, 60.96, 60.87, 60.67, 60.62, 60.40. 
 
β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-[β-D-galactopyranosyl-(1→6)-β-D-
galactopyranosyl-(1→6)]-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-
(14) -D-galactopyranose (212) 
198 (600 mg; 0.17 mmol) was dissolved in THF (20 mL) and a 
1M Et4NOH in MeOH solution (10.3 mL; 10.29 mmol) was 
added. The reaction mixture was stirred at 65 C for 24 h and 
then poured into sat. aq. NH4Cl (100 mL) and extracted with 
CH2Cl2 (3x50 mL). The combined organic phases were dried 
over MgSO4, filtered and concentrated. The product was purified 
by flash chromatography (1:2 Toluene/EtOAc) to yield colorless 
crystals. The product was dissolved in MeOH (20 mL), THF (5 
mL). 20% Pd(OH)2/C (120 mg; 0.17 mmol) was added and an 
atmosphere of H2 (1 atm.) was installed. The reaction was stirred 
at 22 °C for 48h, filtered through celite, and concentrated to give 
a grey solid. Purified by reverse phase chromatography to afford 
212 as a white solid. Yield: 157 mg (70% over two steps) 
1
H NMR (400 MHz, D2O) δ 5.18 (d, J1,2 = 3.7 Hz, 1H, H-1), 4.62 – 4.48 (m, 11H, H-1
1-H-16, H-12-H-16), 
4.37 (d, J1,2 = 7.9 Hz, 2H, H-1
6-branch, H-16-branch), 4.35 (d, J1,2 = 7.9 Hz, 2H, H-1'
6-branch, H-1'6-branch), 4.14 (d, J3,4 
= 3.1 Hz, 1H, H-4), 4.13 – 4.06 (m, 11H, 1xH-4), 4.04 (t, J = 6.5 Hz, 1H), 4.01 – 3.38 (m, 84H). 13C NMR (101 
MHz, D2O) δ 104.34, 104.25, 103.67, 103.44, 96.36, 92.27, 81.68, 78.79, 77.88, 77.81, 77.62, 77.56, 77.03, 75.11, 
74.48, 74.40, 74.28, 74.26, 73.56, 73.48, 73.21, 72.72, 72.69, 72.51, 72.19, 71.80, 71.64, 71.31, 70.69, 70.64, 70.41, 
68.97, 68.60, 68.54, 68.49, 60.97, 60.73, 60.67, 60.48, 60.46. 
 
β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-[β-D-galactopyranosyl-(1→4)-β-D-
galactopyranosyl-(1→6)]-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-
(14)-D-galactopyranose (213) 
199 (595 mg; 0.17 mmol) was dissolved in THF (20 mL) and a 
1M Et4NOH in MeOH solution (9.9 mL; 9.95 mmol) was added. 
The reaction mixture was stirred at 65 C for 24 h. The reaction 
mixture was poured into sat. aq. NH4Cl (100 mL) and extracted 
with CH2Cl2 (3x50 mL). The combined organic phases were 
dried over MgSO4, filtered and concentrated. The product was 
purified by flash chromatography (2:1 Tol/EtOAc) to yield 
colorless crystals. The product was dissolved in MeOH (20 mL), 
THF (5 mL). 20% Pd(OH)2/C (116 mg; 0.17 mmol) was added 
and an atmosphere of H2 (1 atm.) was installed. The reaction was 
stirred at 22 °C for 48h, filtered through celite, and concentrated 
to give a grey solid. Purified by reverse phase chromatography to 
afford 213 as a white solid. Yield: 159 mg (73% over two steps). 
1
H NMR (400 MHz, D2O) δ 5.18 (d, J1,2 = 3.7 Hz, 1H, H-1), 4.61 – 4.46 (m, 13H, 13xH-1), 4.38 (d, J = 7.9 Hz, 
1H, 2xH-1), 4.20 – 3.94 (m, 24H, 16xH-4), 3.94 – 3.43 (m, 96H, 80H). 13C NMR (101 MHz, D2O) δ 104.34, 
104.26, 104.19, 103.47, 96.35, 92.27, 81.68, 77.87, 77.81, 77.62, 77.54, 77.06, 76.96, 75.10, 75.04, 74.46, 74.35, 
74.31, 74.30, 74.28, 74.14, 73.72, 73.22, 73.19, 73.08, 72.70, 72.68, 72.18, 71.80, 71.77, 71.62, 71.36, 71.31, 71.19, 
70.21, 68.56, 60.96, 60.67, 60.37. 
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L-arabinofuranosyl-(1→4)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-
(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14) -D-galactopyranose (214) 
203 (489 mg; 0.15 mmol) was dissolved in THF (20 mL) 
and a 1M Et4NOH in MeOH solution (5.4 mL; 5.40 mmol) 
was added. The reaction mixture was stirred at 65 C for 24 
h and then poured into sat. aq. NH4Cl (100 mL) and 
extracted with CH2Cl2 (3x50 mL). The combined organic 
phases were dried over MgSO4, filtered and concentrated. 
The product was purified by flash chromatography (1:1 
Tol/EtOAc) to yield colorless crystals. The product was 
dissolved in MeOH (20 mL), THF (5 mL). 20% Pd(OH)2/C 
(108 mg; 0.15 mmol) was added and an atmosphere of H2 (1 
atm.) was installed. The reaction was stirred at 22 °C for 
48h, filtered through celite, and concentrated to give a grey 
solid. Purified by reverse phase chromatography to afford 214 as a white solid. Yield: 111 mg (65% over two steps) 
1
H NMR (400 MHz, D2O) δ 5.19 – 5.15 (m, 1H, H-1, H-1
ara, H-1ara), 4.61 – 4.48 (m, 11H, H-11-H-16, H-
1
2-H-16), 4.17 – 4.12 (m, 2H), 4.11 – 4.06 (m, 11H, 11xH-4), 4.06 – 3.96 (m, 4H), 3.92 (d, J3,4 = 3.3 Hz, 1H), 
3.87 – 3.53 (m, 65H), 3.47 (dd, J = 10.0, 7.9 Hz, 1H). 13C NMR (101 MHz, D2O) δ 109.15, 104.34, 104.29, 96.35, 
92.27, 84.17, 81.68, 81.03, 78.80, 77.82, 77.57, 77.45, 76.42, 75.03, 74.97, 74.46, 74.28, 73.29, 73.24, 73.07, 72.19, 
71.80, 71.76, 71.72, 71.33, 61.25, 61.21, 60.67. 
 
β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-[-L-arabinofuranosyl-(1→6)]- β-D-
galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-D-galactopyranosyl-(14) -D-galactopyranose (215) 
201 (485 g; 0.16 mmol) was dissolved in THF (20 mL) and a 1M 
Et4NOH in MeOH solution (5.5 mL; 5.47 mmol) was added. The 
reaction mixture was stirred at 65 C for 24 h and then poured 
into sat. aq. NH4Cl (100 mL) and extracted with CH2Cl2 (3x50 
mL). The combined organic phases were dried over MgSO4, 
filtered and concentrated. The product was purified by flash 
chromatography (1:1 Tol/EtOAc) to yield colorless crystals. The 
product was dissolved in MeOH (20 mL), THF (5 mL). 20% 
Pd(OH)2/C (109 mg; 0.16 mmol) was added and an atmosphere 
of H2 (1 atm.) was installed. The reaction was stirred at 22 °C for 
48h, filtered through celite, and concentrated to give a grey solid. Purified by reverse phase chromatography to 
afford 215 as a white solid. Yield: 120 mg (68% over two steps). 
1
H NMR (400 MHz, D2O) δ 5.18 (d, J1,2 = 3.7 Hz, 1H, H-1), 4.99 – 4.97 (m, 2H, H-1
ara, H-1ara), 4.59 – 4.46 (m, 
11H, H-1
1-H-16, H-12-H-16), 4.14 (d, J3,4 = 3.0 Hz, 1H, H-4), 4.10 – 4.06 (m, 11H, 11xH-4), 4.05 – 4.01 (m, 
1H), 3.99 (dd, J = 3.6, 1.8 Hz, 2H), 3.97 – 3.92 (m, 2H), 3.90 – 3.44 (m, 66H). 13C NMR (101 MHz, D2O) δ 107.96, 
104.36, 104.34, 104.24, 104.19, 96.35, 92.27, 83.71, 81.68, 80.97, 78.79, 77.82, 77.54, 77.02, 76.30, 75.11, 74.46, 
74.36, 74.28, 73.58, 73.24, 73.19, 72.70, 72.19, 71.80, 71.60, 71.31, 69.81, 69.66, 68.77, 68.59, 68.13, 61.10, 60.96, 
60.85, 60.67, 60.40. 
 
β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-[-L-arabinofuranosyl-(15)--L-
arabinofuranosyl-(1→6)]-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-(14)-β-D-galactopyranosyl-
(14)-β-D-galactopyranose (216) 
197 (600 mg; 0.17 mmol) was dissolved in THF (20 mL) and a 
1M Et4NOH in MeOH solution (8.7 mL; 8.71 mmol)  was 
added. The reaction mixture was stirred at 65 C for 24 h. The 
reaction mixture was poured into sat. aq. NH4Cl (100 mL) and 
extracted with CH2Cl2 (3x50 mL). The combined organic 
phases were dried over MgSO4, filtered and concentrated. The 
product was purified by flash chromatography (1:2 
Toluene/EtOAc) to yield colorless crystals. The product was 
dissolved in MeOH (20 mL), THF (5 mL). 20% Pd(OH)2/C 
(122 mg; 0.17 mmol) was added and an atmosphere of H2 (1 
atm.) was installed. The reaction was stirred at 22 °C for 48h, 
filtered through celite, and concentrated to give a grey solid. 
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Purified by reverse phase chromatography to afford 216 as a white solid. Yield: 147 mg (67% over two steps) 
1
H NMR (400 MHz, D2O) δ 5.18 (d, J1,2 = 3.7 Hz, 1H, H-1a), 5.02 – 4.96 (m, 4H, H-1
ara, H-1ara, H-1'ara, H-
1'
ara), 4.59 – 4.49 (m, 11H, H-11-H-16, H-12-H-16), 4.14 (d, J3,4 = 3.2 Hz, 1H, H-4
1), 4.13 – 3.96 (m, 11H, 
11xH-4), 3.92 (dd, J = 6.1, 3.5 Hz, 2H), 3.89 – 3.44 (m, 79H). 13C NMR (101 MHz, D2O) δ 108.11, 107.39, 104.36, 
104.24, 96.35, 92.27, 83.91, 82.11, 81.68, 80.87, 78.79, 77.83, 77.54, 76.96, 76.54, 76.47, 75.11, 74.46, 74.36, 
74.28, 74.28, 73.55, 73.20, 72.70, 72.19, 72.19, 71.80, 71.61, 71.31, 69.66, 68.78, 68.59, 68.23, 66.66, 61.13, 60.96, 
60.67, 60.36. 
 
Phenyl 3-O-acetyl-4,6-O-benzylidene-2-O-pivaloyl-1-thio-β-D-galactopyranoside (251) 
254 (30 g; 74.54 mmol) was dissolved in CH2Cl2 (500 mL). Et3N (20.9 mL; 149.1 mmol), DMAP 
(4.55 g; 37.3 mmol) and pivaloyl chloride (9.5 mL; 111.8 mmol) was added to the solution and the 
reaction mixture was heated to 45 °C for 4 h. The reaction mixture was cooled to 0 °C, quenched 
with MeOH (10 mL), washed with water (2x500 mL), dried over MgSO4 and concentrated. The 
product was purified by flash chromatography (Tol/EtOAc 15:1) to afford 251 as a white crystalline powder. Rf 0.44 
(9:1 Tol/EtOAc). Yield 32.0 g (88%) 
    
  = 3.1° (c 1.0, CDCl3). IR (neat, cm
-1
): 3061.41, 2975.48, 2872.21, 1746.23, 1479.26, 1458.20, 1440.23, 
1369.52, 1276.88, 1232.47, 1171.24, 1144.91, 1093.84, 1048.73, 1025.24. 
1
H NMR (400 MHz, CDCl3) δ 7.59 – 
7.43 (m, 2H, H
SPh
), 7.38 – 7.26 (m, 5H, HSPh, Ar-H), 7.25 – 7.14 (m, 3H, Ar-H), 5.40 (s, 1H, CHbenzylidene), 5.29 (t, 
J1,2 = J2,3 = 9.9 Hz, 1H, H-2), 5.01 (dd, J2,3 = 9.9, J3,4 = 3.4 Hz, 1H, H-3), 4.67 (d, J1,2 = 9.9 Hz, 1H, H-1), 4.30 (dd, 
J6a,6b = 12.5, J5,6a=1.6 Hz, 1H, H-6a), 4.27 (dd, J3,4 = 3.4, J4,5 = 0.9 Hz, 1H, H-4), 3.96 (dd, J6a,6b = 12.4, J5,6b = 1.7 
Hz, 1H, H-6b), 3.52 (m, 1H, H-5), 1.93 (s, 3H, -CH3
Ac
), 1.14 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 
176.29, 170.55, 137.48, 133.58 (2C), 131.56, 129.13, 128.77 (2C), 128.14 (2C), 128.09, 126.50 (2C), 101.02, 85.53, 
73.70, 72.97, 69.73, 69.13, 66.18, 38.74, 27.05, 20.80 (3C). HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for 
C26H30NaO7S 509.1610; Found 509.1595. 
 
Phenyl 3-O-acetyl-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)- 4,6-O-benzylidene-
2-O-pivaloyl-1-thio-β-D-galactopyranoside (252) 
To a 500 mL flame-dried flask was added 257 (7.0 g, 15.7 mmol) and the 256 (11.4 g, 20.5 
mmol). The mixture was co-evaporated with toluene (2x200 mL) and subjected to vacuum 
overnight. The mixture dissolved in DCM (200 mL) and cooled to -40 °C. TMSOTf (0.24 
mL; 1.6 mmol) was added and the reaction mixture was stirred at -40 °C (1h). Et3N (1 mL) 
was added and the reaction mixture was concentrated. The crude compound was purified by 
flash chromatography (9:1 Tol/EtOAc) affording 252. Rf 0.23 (9:1 Tol/EtOAc). Yield: 11.9 g (92%). 
    
  = 10.0° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.48 – 7.36 (m, 6H, Ar-H, H
SPh
), 7.27 (m, 6H, , Ar-H, 
H
SPh
), 7.20 – 7.06 (m, 3H, Ar-H, HSPh), 5.48 (s, 1H, -CHbenzylidene), 5.43 (s, 1H, -CHbenzylidene), 5.33 (dd, J2,3 = 10.6, 
J1,2 = 8.0 Hz, 1H, H-1
2
), 5.30 (t, J1,2 =J2,3 = 9.8 Hz, 1H, H-2
1
), 4.85 (d, J = 8.0 Hz, 1H, H-1
2
), 4.82 (dd, J2,3 = 10.6, 
J2,3 = 3.6 Hz, 1H, H-3
2
), 4.59 (d, J = 9.8 Hz, 1H, H-1
1
), 4.33 – 4.14 (m, 5H, H-31, H-41/2, H-41/2, H-6a1, H-6a2), 3.98 
(dd, J6a,6b = 12.5, J5,6b =1.8 Hz, 1H, H-6b
1
), 3.92 (dd, J6a,6b = 12.5, J5,6b =1.7 Hz, 1H, H-6b
2
), 3.40 – 3.36 (m, 1H, H-
5
1/2
), 3.36 (s, 1H, H-5
1/2
), 1.95 (s, 3H, CH3
Ac
), 1.22 (s, 9H, 3xCH3
Piv
), 1.00 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, 
CDCl3) δ 176.84, 176.14, 170.65, 137.88, 137.47, 133.46, 132.29 (2C), 129.11, 128.73 (2C), 128.59 (2C), 128.24 
(2C), 127.92 (2C), 127.56, 126.24 (2C), 126.21, 100.81, 100.14, 99.40, 86.83, 75.90, 73.58, 73.56, 71.82, 70.23, 
69.40, 68.93, 68.78, 68.18, 66.75, 38.78, 38.72, 27.36 (3C), 26.96 (3C), 20.80. HRMS (ESI-TOF) m/z:  [M + Na]+ 
Calcd for C44H52NaO13S: 843.3026; Found 843.3014. 
 
Benzyl 3-O-acetyl-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-
benzylidene-2-O-pivaloyl-β-D-galactopyranosyl- (1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-
(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside (253) 
To a 25 mL flame-dried flask was added 263 (1000 mg, 
0.7 mmol) and 252 (740 mg, 0.9 mmol). The mixture 
was dried azeotropically with toluene (2x6 mL) and 
subjected to vacuum overnight. It was then dissolved in 
dry CH2Cl2 (3 mL) and dry MeCN (3 mL), cooled to -30 
°C, followed by addition of NIS (206 mg; 0.9 mmol) and TESOTf (18 mg; 0.07 mmol). The reaction mixture was 
stirred at -30 °C until TLC revealed full conversion of the donor (2h). The solution was diluted with CH2Cl2 (50 
mL) and washed with sat. aq. NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The organic phase was dried over 
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MgSO4, filtered and concentrated. The product was purified by flash chromatography (6:1 Tol/EtOAc) to afford a 
white crystalline material. Rf 0.20 (6:1 Tol/EtOAc). Yield:  1.2 g (79%). 
1
H NMR (400 MHz, CDCl3) δ 7.43 (m, 12H, Ar-H), 7.33 – 7.14 (m, 23H, Ar-H), 5.52 – 5.22 (m, 12H, 
6xCH
benzylidene
, H-2
1
-H-2
6
), 4.86 (d, J1,2 = 8.0 Hz, 1H, H-1
1
), 4.82 (d, J = 11.7 Hz, 1H, 0.5xCH2
Bn
), 4.80 (dd, J2,3 = 
10.7, J3,4 = 3.3 Hz, 1H, H-3
6
), 4.71 – 4.60 (m, 4H, H-12-H-15), 4.44 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.36 (d, J = 
7.8 Hz, 1H, H-1
6
), 4.30 – 3.91 (m, 23H, H-31-H-35, H-41-H-46, H-61-H-66), 3.36 – 3.32 (m, 1H, H-51/2/3/4/5/6), 3.30 
(m, 1H, H-5
1/2/3/4/5/6
), 3.25 (m, 1H, , H-5
1/2/3/4/5/6
), 3.24 – 3.19 (m, 1H, H-51/2/3/4/5/6), 1.95 (m, 2H, H-51/2/3/4/5/6, H-
5
1/2/3/4/5/6
), 1.07 (s, 9H, 3xCH3
Piv
), 1.04 (s, 9H, 3xCH3
Piv
), 1.02 (s, 9H, 3xCH3
Piv
), 1.01 – 1.00 (m, 18H, 3xCH3
Piv
), 
1.00 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.95, 176.23, 176.11 (2C), 176.06, 176.03, 170.72, 
137.97, 137.87, 137.86, 137.84, 137.80, 137.55, 137.26, 129.19-125.40 (35C), 100.92, 100.45 (2C), 100.40, 100.35, 
100.22, 100.17, 100.05, 99.83, 99.78 (2C), 99.31, 77.36, 75.99, 75.89, 75.73, 73.59, 72.10, 72.02, 71.93 (2C), 71.61, 
71.57, 71.33, 71.25, 70.85, 70.06, 68.86, 68.76, 68.61, 68.34, 67.57, 67.50, 67.46, 67.02, 66.83, 38.81, 38.77, 38.73, 
38.70 (2C), 38.68, 27.31 (3C), 27.28 (3C), 27.26 (9C), 27.09 (3C), 20.88. 
 
Phenyl 3-O-acetyl-4,6-O-benzylidene-1-thio-β-D-galactopyranoside (254) 
Di-n-butyl tin oxide (36.3 g; 145.7 mmol) was added to a solution of compound 56 (50.0 g, 138.7 
mmol) in dry toluene (1000 mL) and stirred under refluxing temperature for 12 h. The reaction 
mixture was cooled to 0 °C, and freshly activated 4Å MS (50g) were added. After 30 min acetyl 
chloride (10.2 mL, 142.89 mmol) were added drop wise and stirring was maintained at this 
temperature for 1h. The reaction was quenched by addition of MeOH, filtered through a pad of 
celite and concentrated. The crude product was purified by flash chromatography (4:1 toluene/EtOAc) to give 254 
as white crystals. Rf 0.12 (9:1 Tol/EtOAc). Yield: 49.72 g (91%) 
    
  = 27.2° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.65 – 7.58 (m, 2H, H
SPh
), 7.37 – 7.15 (m, 8H, HSPh, 
H
Bn
), 5.39 (s, 1H, -CH
benzylidene
), 4.83 (dd, J2,3 = 9.8, J3,4 = 3.4 Hz, 1H, H-3), 4.51 (d, J1,2 = 9.8 Hz, 1H, H-1), 4.31 (m, 
1H, H-4), 4.29 (dd, J6a,6b = 12.5, J5,6a = 1.3 Hz, 1H, H-6a), 3.93 (dd, J6a,6b = 12.5, J5,6b = 1.7 Hz, 1H, H-6b), 3.89 (td, 
J1,2 = J2,3 =9.8, J2,OH =1.9 Hz, 1H, H-2), 3.52 (m, 1H, H-5), 2.01 (s, 3H, -CH3
Ac
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 
171.07, 137.81, 133.80 (2C), 130.40, 129.24, 129.13 (2C), 128.40, 128.26 (2C), 126.53 (2C), 101.07, 87.61, 74.98, 
73.71, 69.96, 69.27, 65.69, 21.20. HRMS (ESI-TOF) m/z: [M + NH4]+ Calcd for C21H26NO6S 420.1481 Found 
420.1478 
 
3-O-acetyl-4,6-O-benzylidene-2-O-pivaloyl-D-galactopyranose (255) 
251 (20.0 g; 41.1 mmol) was dissolved in MeCN (270 mL) and water (30 mL). NBS (29.3 g; 164.4 
mmol) and 2,6-lutidine (23.8 mL; 205.5 mmol) were added and the reaction was stirred at 50 °C 
until TLC showed full conversion (2h). The solution was diluted with CH2Cl2 (500 mL) and 
washed with sat. aq. NaS2O3 (200 mL) and sat. aq. NaHCO3 (200 mL). The organic phase was dried 
over MgSO4, filtered and concentrated. The product was purified by flash chromatography (6:1 
Tol/EtOAc) to afford 255 as α/ mixture. Rf 0.12 (9:1 Tol/EtOAc). Yield:  17.2 g (84%)  
    
  = 95.7° (c 1.0, CDCl3). IR (neat, cm
-1
): 3468.40, 2974.49, 2934.27, 2909.50, 2873.74, 1737.61, 1479.91, 
1457.72, 1369.67, 1240.78, 1115.19, 1093.82, 1025.30, 977.04. 
1
H NMR (400 MHz, CDCl3) δ 7.43 (m, 2H, Ar-H), 
7.30 (m, 3H, Ar-H), 6.31 (d, J1,2 = 3.6 Hz, 1H, H-1), 5.45 (s, 1H, H
benzylidene
), 5.08 (dd, J2,3 = 10.5, J3,4 = 3.4 Hz, 1H, 
H-3), 4.42 (dd, J3,4 = 3.4,  J4,5 = 1.2 Hz, 1H, H-4), 4.35 (dd, J2,3 = 10.5,  J1,2 = 3.6 Hz, 1H, H-2), 4.22 (dd, J6a,6b = 
12.6,  J5,6a = 1.6 Hz, 1H, H-6a), 3.97 (dd, J6a,6b = 12.6,  J5,6b = 1.8 Hz, 1H, H-6b), 3.75 (m, 1H, H-5), 2.09 (s, 3H, 
CH3
Ac
), 1.20 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.00, 171.69, 137.54, 129.24, 128.35, 126.27, 
100.92, 92.75, 73.80, 71.67, 69.10, 66.04, 64.66, 39.47, 27.25, 21.24. HRMS (ESI-TOF) m/z:  [M + Na]+ Calcd for 
C20H26NaO8: 417.1525; Found 417.1529. 
 
3-O-acetyl-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranose N-phenyl trifluoroacetimidate (256) 
255 (13 g; 33.0 mmol) was dissolved in CH2Cl2 (300 mL) and cooled to 0 °C. Cs2CO3 (21.5 g; 
65.9 mmol) was added followed by N-phenyl trifluoroacetimidoyl chloride (13.7 g; 65.9 mmol). 
The ice bath was removed and the reaction mixture was stirred until TLC showed full 
conversion (5 h). It was then filtered, concentrated and purified by flash chromatography (20:1 
Tol/EtOAc) to give a white crystalline product. Rf 0.66 (9:1 Tol/EtOAc) Yield:  14.7 g (79%)  
 
 
 
 
 
 
Experimental 
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Phenyl 4,6-O-benzylidene-2-O-pivaloyl-1-thio-β-D-galactopyranoside (257) 
251 (10 g; 20.6 mmol) was dissolved in dry DCM (200 mL) and cooled to 0 °C. A 1M L-selectride 
solution in THF (61.6 mL) was added and the reaction was stirred at 0 °C until complete 
consumption of the starting material (4h). The reaction mixture was poured into sat. aq. NH4Cl (400 
mL). The organic phase was dried over MgSO4, filtered and concentrated (avoid concentrating to 
dryness since the borane salts can be explosive). The crude product was purified by flash 
chromatography (9:1 Tol/EtOAc) to give a white crystalline product. Rf 0.23 (9:1 Tol/EtOAc) Yield: 8.6 g (94%) 
1
H NMR (400 MHz, CDCl3) δ 7.51 (m, 2H, Ar-H), 7.38 – 7.10 (m, 10H, Ar-H), 5.45 (s, 1H, CH
benzylidene
), 4.98 (t, 
J1,2 = J2,3 = 9.7 Hz, 1H, H-2), 4.60 (d, J1,2 = 9.7 Hz, 1H, H-1), 4.31 (dd, J6a,6b = 12.5, J5,6a =1.5 Hz, 1H, H-6a), 4.14 
(dd, J3,4 = 3.6, J4,5 =1.1 Hz, 1H, H-4), 3.96 (dd, J6a,6b = 12.5, J5,6b = 1.7 Hz, 1H, H-6b), 3.67 (dd, J2,3 = 9.7, J3,4 = 3.6 
Hz, 1H, H-3), 3.51 – 3.43 (m, 1H, H-5), 1.19 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.61, 137.39, 
133.58 (2C), 131.59, 129.35, 128.78 (2C), 128.24 (2C), 128.08, 126.52 (2C), 101.41, 85.06, 75.66, 72.92, 69.90, 
69.52, 69.17, 38.83, 27.16 (3C). HRMS (ESI-TOF) m/z:  [M + Na]+ Calcd for C24H28NaO6S: 467.1504; Found 
467.1511. 
 
Benzyl 3-O-acetyl-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranoside (260) 
252 (2.0 g; 2.4 mmol) was dried azeotropically with toluene (2x20 mL) and subjected to 
vacuum overnight. Benzyl alcohol (0.8 g; 7.3 mmol) was added. The mixture was dissolved 
in dry CH2Cl2 (50 mL) and cooled to -40 °C. NIS (602 mg; 2.7 mmol) and TESOTf (64 
mg; 0.24 mmol) was added and the reaction mixture was stirred at -40 °C until TLC 
revealed full conversion of the donor (2h). The solution was diluted with CH2Cl2 (100 mL) 
and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic phase was dried over 
MgSO4, filtered and concentrated. The product was purified by flash chromatography (9:1 toluene/EtOAc) to afford 
260 as a white crystalline material. Rf 0.10 (9:1 Tol/EtOAc)  
Yield: 1.5 g (75%) 
    
  = -0.8° (c 1.0, CDCl3). IR (neat, cm
-1
): 3524.57, 3065.71, 2973.85, 1733.56, 1497.34, 1479.42, 1454.83, 
1398.37, 1278.46, 1249.26, 1167.19, 1139.04, 1087.54, 1060.73. 
1
H NMR (400 MHz, CDCl3) δ 7.51 – 7.38 (m, 4H, 
H
SPh
), 7.35 – 7.13 (m, 11H, HSPh, Ar-H), 5.51 (s, 1H, -CHbenzylidene), 5.43 (s, 1H, -CHbenzylidene), 5.42 (dd, J2,3 = 10.4, 
J1,2 = 7.9 Hz, 1H, H-2), 5.35 (dd, J2,3 = 10.6, J1,2 = 8.1 Hz, 1H, H-2’), 4.93 (d, J1,2 = 8.1 Hz, 1H, H-1’), 4.87 – 4.79 
(m, 2H, H-3’, -CH2
Bn
), 4.47 (d, J = 11.9 Hz, 1H, -CH2
Bn
), 4.37 (d, J = 7.9 Hz, 1H, H-1), 4.34 – 4.23 (m, 4H, H-4’, 
H-4, H-6a’, H-6b’), 4.13 (dd, J2,3 = 10.4, J3,4 = 3.4 Hz, 1H, H-3), 3.99 (m, 2H, H-6a, H-6b), 3.42 – 3.26 (m, 2H, H-5, 
H-5’), 1.96 (s, 3H, -CH3
Ac
), 1.10 (s, 9H, 3xCH3
Piv
), 1.05 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.84, 
176.12, 170.68, 137.80, 137.50, 137.20, 129.08, 129.05, 128.59, 128.24, 128.22, 128.20, 127.96 (2C), 127.79 (2C), 
127.52, 126.27 (2C), 126.10 (2C), 100.84, 100.33, 100.21, 99.50, 75.94, 73.63, 72.76, 71.86, 70.81, 69.90, 68.83, 
68.77, 68.22, 66.90, 66.72, 38.76, 38.71, 27.22, 27.19, 27.19, 27.08 (3C), 27.02 (3C), 20.81. HRMS (ESI-TOF) 
m/z: [M + NH4]+ Calcd for C45H58NO14 836.3857 Found 836.3843 
 
Benzyl 4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranoside (261) 
260 (1.5 g; 1.8 mmol) was dissolved in dry CH Cl2 (30 mL) and cooled to 0 °C. A 1M L-
selectride solution in THF (5.5 mL) was added and the reaction was stirred at 0 °C until 
complete consumption of the starting material (5h). The reaction mixture was poured into 
sat. aq. NH4Cl (100 mL). The organic phase was dried over MgSO4, filtered and 
concentrated (avoid concentrating to dryness since the borane salts can be explosive). The 
crude product was purified by flash chromatography (6:1 Tol/EtOAc) yielding 261 as a white crystalline product. Rf 
0.46 (2:1 Tol/EtOAc). Yield: 1.28 g (90%) 
1
H NMR (400 MHz, CDCl3) δ 7.51 – 7.13 (m, 15H, Ar-H), 5.49 (s, 1H, CH
benzylidene
), 5.47 (s, 1H, 
CH
benzylidene
), 5.45 (dd, J2,3 = 10.1, J1,2 = 7.9 Hz, 1H, H-2
1
), 5.00 (dd, J2,3 = 10.1, J1,2 = 8.0 Hz, 1H, H-2
2
), 
4.84 (d, JCH2 = 11.8 Hz, 1H, CH2
Bn
), 4.84 (d, J1,2 = 8.0 Hz, 1H, H-1
2
), 4.48 (d, JCH2 = 11.9 Hz, 1H, CH2
Bn
), 
4.39 (d, J1,2 = 7.9 Hz, 1H, H-1
1
), 4.31 – 4.23 (m, 3H, H-41, H-6a2, H-6b2), 4.10 (d, J3,4 = 3.7 Hz, 1H, H-
4
2
), 4.08 (dd, J2,3 = 10.1, J3,4 = 3.2 Hz, 1H, H-3
1
), 4.02 – 3.95 (m, 2H, H-6a1, H-6b1), 3.52 (dd, J2,3 = 10.1, 
J3,4 = 3.7 Hz, 1H, H-3
2
), 3.34 (s, 1H, H-5
1
), 3.33 (s, 1H, H-5
2
), 1.10 (s, 9H, 3xCH3
Piv
), 1.10 (s, 9H, 
3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 178.95, 176.15, 137.90, 137.48, 137.30, 129.34, 129.14, 
128.76, 128.38, 128.34, 128.30 (2C), 128.04, 127.91 (2C), 127.63 (2C), 126.38 (2C), 126.29, 101.34, 
100.47, 100.39, 99.49, 76.11, 75.83, 73.18, 72.26, 72.16, 71.00, 69.99, 68.92, 66.97, 66.92, 38.99, 38.78, 
Experimental 
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27.31 (3C), 27.12 (3C). HRMS (ESI-TOF) m/z: [M + NH4]
+
 Calcd for C43H56NO13 794.3752 Found 
794.3756. 
 
Benzyl 4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranoside (261_2) 
285 (3.2 g; 3.8 mmol) was dissolved in dry CH2Cl2 (75 mL) and cooled to 0 °C. A 1M L-
selectride solution in THF (11.2 mL) was added and the reaction was stirred at 0 °C until 
complete consumption of the starting material (30 min). The reaction mixture was 
quenched with sat. aq. NH4Cl (100 mL). The organic phase was dried over MgSO4, filtered 
and concentrated (avoid concentrating to dryness since the borane salts can be explosive). 
The crude product was purified by flash chromatography (4:1 Tol/EtOAc) to give a white crystalline material. Rf 
0.48 (2:1 Tol/EtOAc) Yield: 2.7 g (92%) 
    
  = -78.1° (c 1.0, CDCl3). IR (neat, cm
-1
): 3509.54, 3065.12, 3034.81, 2974.26, 2932.39, 2906.51, 2872.12, 
1735.20, 1701.55, 1497.61, 1479.71, 1455.24, 1398.18, 1366.58, 1278.90, 1167.38, 1139.48, 1085.25, 1061.57, 
1044.79. 
1
H NMR (400 MHz, CDCl3) δ 7.51 – 7.13 (m, 15H, Ar-H), 5.49 (s, 1H, CH
benzylidene
), 5.47 (s, 1H, 
CH
benzylidene
), 5.45 (dd, J2,3 = 10.1, J1,2 = 7.9 Hz, 1H, H-2
1
), 5.00 (dd, J2,3 = 10.1, J1,2 = 8.0 Hz, 1H, H-2
2
), 4.84 (d, 
JCH2 = 11.8 Hz, 1H, CH2
Bn
), 4.84 (d, J1,2 = 8.0 Hz, 1H, H-1
2
), 4.48 (d, JCH2 = 11.9 Hz, 1H, CH2
Bn
), 4.39 (d, J1,2 = 7.9 
Hz, 1H, H-1
1
), 4.31 – 4.23 (m, 3H, H-41, H-6a2, H-6b2), 4.10 (d, J3,4 = 3.7 Hz, 1H, H-4
2
), 4.08 (dd, J2,3 = 10.1, J3,4 = 
3.2 Hz, 1H, H-3
1
), 4.02 – 3.95 (m, 2H, H-6a1, H-6b1), 3.52 (dd, J2,3 = 10.1, J3,4 = 3.7 Hz, 1H, H-3
2
), 3.34 (s, 1H, H-
5
1
), 3.33 (s, 1H, H-5
2
), 1.10 (s, 9H, 3xCH3
Piv
), 1.10 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 178.95, 
176.15, 137.90, 137.48, 137.30, 129.34, 129.14, 128.76, 128.38, 128.34, 128.30 (2C), 128.04, 127.91 (2C), 127.63 
(2C), 126.38 (2C), 126.29, 101.34, 100.47, 100.39, 99.49, 76.11, 75.83, 73.18, 72.26, 72.16, 71.00, 69.99, 68.92, 
66.97, 66.92, 38.99, 38.78, 27.31 (3C), 27.12 (3C). IR (neat, cm
-1
): 3065.11, 3034.05, 2973.45, 2933.97, 2906.79, 
2872.38, 1741.81, 1479.57, 1455.08, 1397.80, 1366.82, 1311.84, 1277.42, 1232.57, 1173.76, 1132.82, 1087.46, 1047.65, 
1026.57, 1001.49. HRMS (ESI-TOF) m/z: [M + NH4]
+
 Calcd for C42H54NO12S 796.3367 Found 796.3364 
 
Benzyl 3-O-acetyl-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-
benzylidene-2-O-pivaloyl-β-D-galactopyranoside (262) 
To a 25 mL flame-dried flask was added 261 (1.1 g, 1.4 mmol) and the 
252 (1.5 g, 1.8 mmol). The mixture was dried azeotropically with toluene 
(2x10 mL) and subjected to vacuum overnight. It was then dissolved in 
dry CH2Cl2 (5 mL) and dry MeCN (5 mL), cooled to -30 °C, followed by 
addition of NIS (420 mg; 1.9 mmol) and TESOTf ( 56 mg; 0.2 mmol). 
The reaction mixture was stirred at -30 °C until TLC revealed full conversion of the donor (2h). The solution was 
diluted with CH2Cl2 (100 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The 
organic phase was dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography 
(6:1 toluene/EtOAc) to afford a white crystalline material. Rf 0.58 (2:1 Tol/EtOAc). Yield: 1.9 g (88%) 
1
H NMR (400 MHz, CDCl3) δ 7.54 – 7.34 (m, 8H, Ar-H), 7.34 – 7.14 (m, 17H, Ar-H), 5.50 (s, 1H, CH
benzylidene
), 
5.49 (s, 1H, CH
benzylidene
), 5.46 (s, 1H, CH
benzylidene
), 5.43 (s, 1H, CH
benzylidene
), 5.42 – 5.26 (m, 4H, H-21-H-24), 4.86 
(d, J1,2 = 8.1 Hz, 1H, H-1
1
), 4.84 – 4.77 (m, 2H, H-34, 0.5xCH2
Bn
), 4.68 (d, J1,2 = 7.9 Hz, 1H, H-1
2/3
), 4.67 (d, J1,2 = 
8.0 Hz, 1H, H-1
2/3
), 4.45 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.36 (d, J1,2 = 7.9 Hz, 1H, H-1
4
), 4.31 – 4.17 (m, 8H, 
H-4
1
-H-4
4
, 2xH-6), 4.17 – 4.09 (m, 2H, H-31/2/3, H-31/2/3), 4.06 (dd, J2,3 = 10.5, J3,4 = 3.4 Hz, 1H, H-3
1/2/3
), 4.03 – 
3.92 (m, 4H, 2xH-6), 3.37 – 3.34 (m, 1H, H-51/2/3/4), 3.33 – 3.30 (m, 1H, H-51/2/3/4), 3.27 – 3.24 (m, 1H, H-51/2/3/4), 
3.24 – 3.23 (m, 1H, H-51/2/3/4), 1.95 (s, 3H, -CH3
Ac
), 1.08 (s, 9H, -CH3
Piv
), 1.04 (s, 9H, -CH3
Piv
), 1.03 (s, 9H, -CH3
Piv
), 
1.01 (s, 9H, -CH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.97, 176.28, 176.08 (2C), 170.73, 137.98, 137.85, 137.81, 
137.56, 137.29, 129.19-126.11 (25C), 100.93, 100.44, 100.42, 100.25, 100.21, 100.10, 99.75, 99.35, 77.36, 76.01 
(2C), 75.74, 73.60, 72.09, 71.98, 71.94 (2C), 71.55, 71.20, 70.86, 70.08, 68.87, 68.80, 68.75, 68.65, 68.36, 67.51, 
67.48, 67.04, 66.85, 38.83, 38.78, 38.73 (2C), 27.32, 27.29, 27.27, 27.10, 20.89. 
 
 
 
 
 
 
 
Experimental 
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Benzyl 4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranoside (263) 
262 (1.5 g; 1.8 mmol) was dissolved in dry DCM (30 mL) and cooled to 0 
°C. A 1M L-selectride solution in THF (5.5 mL) was added and the 
reaction was stirred at 0 °C until complete consumption of the starting 
material (5h). The reaction mixture was poured into sat. aq. NH4Cl (100 
mL). The organic phase was dried over MgSO4, filtered and concentrated 
(avoid concent-rating to dryness since the borane salts can be explosive). The crude product was purified by flash 
chromatography (4:1 Tol/EtOAc) to give a white crystalline product. Rf 0.46 (2:1 Tol/EtOAc). Yield: 1.28 g (90%). 
1
H NMR (400 MHz, CDCl3) δ 7.55 – 7.34 (m, 8H), 7.34 – 7.11 (m, 17H), 5.53 – 5.44 (m, 4H, 4xCH
benzylidene
), 5.39 
(dd, J2,3 = 9.8, J1,2 = 7.4 Hz, 1H, H-2
1/2/3/4
), 5.34 (m, 2H, H-2
1/2/3/4
, H-2
1/2/3/4
), 4.97 (dd, J2,3 = 10.0, J1,2 = 8.0 Hz, 1H, 
H-2
4
), 4.82 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.77 (d, J1,2 = 8.0 Hz, 1H, H-1
4
), 4.69 (d, J1,2 = 7.9 Hz, 1H, H-
1
1/2/3/4
), 4.68 (d, J1,2 = 8.0 Hz, 1H, H-1
1/2/3/4
), 4.44 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.36 (d, J1,2 = 7.8 Hz, 1H, H-
1
1/2/3/4
), 4.31 – 3.90 (m, 15H, H-31-H-33, H-41-H-44, H-61-H-64), 3.51 (td, J2,3 = 10.3, J3,4 = 3.6 Hz, 1H, H-3
4
), 3.37 – 
3.21 (m, 4H, H-5
1
-H-5
4
), 1.07 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
), 1.05 (s, 9H, 3xCH3
Piv
), 1.03 (s, 9H, 
3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 178.81, 176.09, 175.99, 175.97, 137.90, 137.76, 137.66, 137.34, 137.17, 
129.28-126.09 (25C), 101.25, 100.34 (2C), 100.30, 100.15, 99.99, 99.64, 99.20, 77.27, 76.00, 75.92, 75.64 (2C), 
72.37, 72.14, 71.98, 71.88, 71.49, 71.11, 70.87, 70.00, 68.76, 68.65, 68.55, 67.41, 67.37, 66.93, 66.89, 38.87, 38.68, 
38.64, 38.61, 27.23, 27.20, 27.16, 27.03 HRMS (ESI-TOF) m/z: [M + NH4]+ Calcd for C79H100NO25 1462.6584 
Found 1462.6579. 
 
Phenyl 3-O-acetyl-4-O-benzyl-2-O-pivaloyl-1-thio-β-D-galactopyranoside (266) 
A 1 M solution of BH3
.
THF complex in THF (61.6 mL) was added to a solution of 251 (6 g; 12.33 
mmol) in CH2Cl2 (50 mL) at 0 °C. The mixture was stirred for 10 min, and freshly dried Cu(OTf)2 
(669 mg, 1.85 mmol) was added to the solution. After stirring for a 5 h, the mixture was cooled to 0 
°C, and the reaction was quenched by addition of Et3N (1.7 mL, 12.33 mmol) and methanol (30 mL, 
caution: hydrogen gas was evolved). The resultant mixture was concentrated at reduced pressure followed by 
coevaporation with methanol. The residue was purified by flash chromatography (9:1 Tol/EtOAc). Rf 0.15 (9:1 
Tol/EtOAc). Yield: 4.79 g (80%) 
    
  = -5.5° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.45 – 7.35 (m, 2H, H
SPh
), 7.32 – 7.14 (m, 8H, HSPh,  
H
Bn
), 5.36 (dd, J1,2 = J2,3 =10.0 Hz, 1H, H-2), 5.00 (dd, J2,3 = 10.0, J3,4 = 3.0 Hz, 1H, H-3), 4.68 (d, JCH2= 11.7 Hz, 
1H, -CH2
Bn
), 4.65 (d, J1,2 = 10.0 Hz, 1H, H-1), 4.44 (d, JCH2 = 11.7 Hz, 1H, -CH2
Bn
), 3.86 (dd, J3,4 = 3.0, J4,5 =1.0 
Hz, 1H), 3.77 (ddd, J6a,6b = 11.0, J5,6a = 6.7, J6a,OH =3.9 Hz, 1H, H-6a), 3.59 – 3.50 (m, 1H, H-5), 3.48 (ddd, J6a,6b = 
11.1, J5,6b = 8.6, J6b,OH =5.2 Hz, 1H, H-6b), 1.92 (s, 3H, -CH3
Ac
), 1.14 (s, 9H, 3xCH3
Piv
). 
13
C NMR (101 MHz, 
CDCl3) δ 176.73, 170.17, 137.48, 133.18, 132.01 (2C), 128.93 (2C), 128.53 (2C), 128.29 (2C), 128.10, 127.81, 
86.91, 78.88, 74.96, 74.72, 73.76, 67.49, 61.79, 38.78, 27.03 (3C), 20.77. HRMS (ESI-TOF) m/z: [M+NH4]
+
 Calcd 
for C26H36NO7S 506.2213 Found 506.2228 
 
Phenyl 3-O-acetyl-4-O-benzyl-2-O-pivaloyl-6-O-triisopropylsilyl-1-thio-β-D-galactopyranoside (267) 
266 (1.3 g; 2.66 mmol) was dissolved in DMF (25 mL) and cooled to 0 °C. To the solution were 
added triisopropylsilyl chloride (0.85 mL; 3.99 mmol) and imidazole (0.36 g; 5.32 mmol). The 
reaction mixture was stirred at 0 °C for 1h and then at 22 °C for 18h. The mixture was diluted with 
Et2O (200 mL) and washed with water (3 x 200 mL). The organic phase was dried over MgSO4, filtered, 
concentrated and purified by flash chromatography (20:1 Tol/EtOAc) to give 267 as a white solid. Rf 0.63 (9:1 
Tol/EtOAc). 
Yield: 1.58 g (93%)  
    
  = -14.4° (c 1.0, CDCl3). IR (neat, cm
-1
): 3061.27, 3032.58, 2865.93, 1745.83, 1584.53, 1496.52, 1479.01, 
1461.73, 1366.26, 1276.30, 1231.32, 1147.24, 1113.13, 1077.71, 1047.98. 
1
H NMR (400 MHz, CDCl3) δ 7.46 – 
7.34 (m, 2H, Ar-H), 7.35 – 7.07 (m, 8H, Ar-H), 5.34 (t, J1,2 = J2,3 = 10.0 Hz, 1H, H-2), 5.04 (dd, J2,3 = 10.0, J3,4 = 
3.0 Hz, 1H, H-3), 4.67 (d, JCH2 = 11.6 Hz, 1H, 0.5xCH2
Bn
), 4.56 (d, J = 11.6 Hz, 1H, 0.5xCH2
Bn
), 3.97 (dd, J3,4 = 3.1, 
J4,5 = 1.0 Hz, 1H, H-4), 3.87 – 3.66 (m, 2H, H-6a, H-6b), 3.57 (ddd, J5,6a = 7.2, J5,6b =5.9, J4,5 =1.0 Hz, 1H, H-5), 
1.85 (s, 3H, CH3
Ac
), 1.12 (s, 9H, 3xCH3
Piv
), 0.98 (s, 6H, CH3
TIPS
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.78, 170.38, 
138.29, 133.63, 131.96 (2C), 128.90 (2C), 128.40 (2C), 128.02 (2C), 127.73, 127.67, 86.93, 79.26, 75.01, 74.20, 
67.78, 61.66, 38.87, 27.16 (3C), 20.87, 18.14 (2C), 18.12 (2C), 17.84, 12.42, 11.98 (2C).  HRMS (ESI-TOF) m/z: 
[M+Na]
+
 Calcd for C35H52NaO7SSi 667.3101Found 667.3098. 
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Benzyl 3-O-acetyl-4-O-benzyl-6-O-triisopropylsilyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-
benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranoside (268) 
To a 50 mL flame-dried flask was added 261 (0.92 g, 1.18 mmol) and 267 (1.14 g,  
1.78 mmol). The mixture was dried azeotropically with toluene (2x20 mL) and 
subjected to vacuum overnight. It was then dissolved in dry CH2Cl2 (10 mL) and 
dry MeCN (10 mL), cooled to -30 °C, followed by addition of NIS (413 mg; 1.84 
mmol) and TESOTf (63 mg; 0.24 mmol). The reaction mixture was stirred at -30 
°C until TLC revealed full conversion of the donor (1 h). The solution was diluted with CH2Cl2 (100 mL) and 
washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic phase was dried over MgSO4, 
filtered and concentrated. The product was purified by flash chromatography (12:1 toluene/EtOAc) to afford a white 
crystalline material. Yield: 590 mg (38%). Rf 0.46 (9:1 Tol/EtOAc). 
1
H NMR (400 MHz, CDCl3) δ 7.56 – 7.01 (m, 20H, Ar-H), 5.48 (s, 1H, CH
benzylidene
), 5.46 (s, 1H, CH
benzylidene
), 5.39 
(dd, J2,3 = 10.3, J1,2 = 7.8 Hz, 1H, H-2), 5.31 (dd, J2,3 = 10.1, J1,2 = 8.1 Hz, 1H, H-2), 5.27 (dd, J2,3 = 10.5, J1,2 = 8.0 
Hz, 2H), 4.84 (dd, J2,3 = 10.6, J3,4 = 3.1 Hz, 1H, H-3
3
), 4.82 (d, JCH2 = 11.9 Hz, 1H, CH2
Bn
), 4.71 (d, J1,2 = 8.1 Hz, 
1H, H-1), 4.70 (d, J1,2 = 8.0 Hz, 1H, H-1), 4.70 (d, JCH2 = 12.2 Hz, 1H, 0.5xCH2
Bn
), 4.65 (d, JCH2 = 11.9 Hz, 1H, 
0.5xCH2
Bn
), 4.55 (d, JCH2 = 11.3 Hz, 1H, 0.5xCH2
Bn
), 4.45 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.37 (d, J1,2 = 7.8 Hz, 
1H, H-1), 4.31 – 4.21 (m, 2H, H-6), 4.20 (d, J3,4 = 3.5 Hz, 1H, H-4), 4.15 (d, J3,4 = 3.4 Hz, 1H, H-4), 4.12 (d, J3,4 = 
3.4 Hz, 1H, H-4), 4.06 – 3.91 (m, 5H, 3xH-3, H-6), 3.81 (m, 1H, H-6a3), 3.71 (m, 1H, H-6b3), 3.47 (dd, J5,6a = 8.7, 
J5,6b = 5.5 Hz, 1H, H-5
3
), 3.31 (s, 1H, H-5), 3.27 (s, 1H, H-5), 1.83 (s, 3H, CH3
Ac
), 1.07 (s, 9H, 3xCH3
Piv
), 1.06 (s, 
9H, 3xCH3
Piv
), 1.03 – 0.96 (m, 27H, 3xCH3
Piv
, 6xCH3
TIPS
), 0.99 (m, 3H, 3xCH
TIPS
). 
13
C NMR (101 MHz, CDCl3) δ 
177.16, 176.07, 175.88, 170.27, 138.19, 137.85, 137.70, 137.27, 128.56-126.04 (20C), 100.21, 100.18, 100.12, 
99.95, 99.40, 78.86, 77.65, 77.25, 75.69, 75.61, 75.27, 75.25, 74.77, 74.11, 74.01, 73.74, 73.51, 71.74, 71.42, 69.87, 
69.31, 68.75, 68.72, 67.31, 66.98, 66.67, 60.93, 60.75, 38.71, 38.64, 38.58, 27.20(3C), 27.18(3C), 27.00(3C), 20.69, 
18.06(3C), 18.06(3C), 18.03(3C), 18.02(3C), 18.00(3C), 17.96(3C), 11.85, 11.85, 11.83. 
 
Benzyl 4-O-benzyl-6-O-triisopropylsilyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-
benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranoside (269) 
268 (350 mg; 0.27 mmol) was dissolved in dry CH2Cl2 (10 mL) and cooled to 0 °C. 
A 1M L-selectride solution in THF (1.1 mL) was added and the reaction was stirred 
at 0 °C until complete consumption of the starting material was observed by TLC (3 
h). The reaction mixture was poured into sat. aq. NH4Cl (100 mL) and extracted 
with CH2Cl2 (2x50 mL). The combined organic phases were dried over MgSO4, 
filtered and concentrated (avoid concentrating to dryness since the borane salts can be explosive). The crude product 
was purified by flash chromatography (9:1 Tol/EtOAc) to give a white crystalline product. Yield:  0.31 g (92%). Rf 
0.40 (9:1 Tol/EtOAc). 
1
H NMR (400 MHz, CDCl3) δ 7.54 – 7.31 (m, 4H, Ar-H), 7.35 – 7.05 (m, 16H, Ar-H), 5.49 (s, 1H, CH
benzylidene
), 
5.43 (s, 1H, CH
benzylidene
), 5.40 (dd, J2,3 = 10.1, J1,2 = 7.7 Hz, 1H, H-2), 5.35 (dd, J2,3 = 10.0, J1,2 = 7.8 Hz, 1H, H-2), 
4.84 (dd, J2,3 = 9.6, J1,2 = 7.4 Hz, 1H, H-2), 4.83 (d, JCH2 = 12.1 Hz, 1H, 0.5xCH2
Bn
), 4.73 – 4.71 (m, 2H, CH2
Bn
), 
4.69 (d, J1,2 = 7.7 Hz, 1H, H-1), 4.64 (d, J1,2 = 7.8 Hz, 1H, H-1), 4.45 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.37 (d, 
J1,2 = 7.9 Hz, 1H, H-1), 4.31 – 4.20 (m, 3H, H-4, H-6), 4.18 – 4.12 (m, 2H, H-3, H-4), 4.02 – 3.93 (m, 3H, H-3, H-
6), 3.88 (dd, J3,4 = 3.5, J4,5 = 1.0 Hz, 1H, H-4), 3.82 (dd, J6a,6b = 9.7, J5,6a = 8.6 Hz, 1H, H-6a), 3.75 (dd, J6a,6b = 9.7, 
J5,6b = 5.5 Hz, 1H, H-6b), 3.46 (dd, J2,3 = 9.7, J3,4 = 3.5 Hz, 1H, H-3), 3.37 (ddd, J5,6a = 8.6, J5,6b = 5.5, J4,5 =1.1 Hz, 
1H, H-5), 3.32 (d, J = 1.3 Hz, 1H, H-5), 3.29 (d, J = 1.4 Hz, 1H, H-5), 1.08 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 
3xCH3
Piv
), 1.04 (s, 9H, 3xCH3
Piv
), 1.00 (s, 18H, 6xCH3
TIPS
), 0.99 (m, 3H, 3xCH
TIPS
). 
13
C NMR (101 MHz, CDCl3) δ 
177.56, 176.10, 176.06, 137.91, 137.83, 137.32, 137.34, 127.63-125.05(20C), 99.28, 99.21, 99.14, 98.89, 98.32, 
75.20, 74.81, 74.66, 74.60, 74.30, 72.55, 72.46, 70.84, 70.74, 70.71, 69.98, 68.85, 67.72, 67.69, 66.25, 65.94, 
26.18(3C), 26.12(3C), 25.93(3C), 17.05(2C), 17.02(2C), 16.99(2C), 10.84(3C). 
 
Phenyl 3-O-acetyl-6-O-allyloxycarbonyl-4-O-benzyl-2-O-pivaloyl-1-thio-β-D-galactopyranoside (270) 
TMEDA (0.18 mL; 1.22 mmol) and allyl chloroformate (0.24 mL; 2.25 mmol) were added to a 
solution of  266 (1.0 g; 2.05 mmol) in anhydrous CH2Cl2 (25 mL) at 0 °C. After 1h the mixture was 
diluted with CH2Cl2 (75 mL), washed with water (100 mL), dried over MgSO4, filtered and 
concentrated. The product was purified by flash chromatography (15:1 Tol/EtOAc) to give compound 270. Rf 0.51 
(9:1 Tol/EtOAc). Yield: 8.3 g (91%). 
Experimental 
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  = -6.7° (c 1.0, CDCl3). IR (neat, cm
-1
): 3062.34, 2972.29, 2936.14, 2905.97, 1743.53, 1584.14, 
1496.611455.38, 1440.49, 1366.40, 1256.83, 1230.13, 1143.53, 1084.39. 
1
H NMR (400 MHz, CDCl3) δ 7.48 – 7.36 
(m, 2H, Ar-H), 7.34 – 7.09 (m, 8H, Ar-H), 5.85 (ddt, Jtrans = 17.2, Jcis = 10.4, JCH2 = 5.8 Hz, 1H, -CH=CH2), 5.34 (t, 
J1,2 = J2,3 = 10.1 Hz, 1H, H-2), 5.29 (dq, Jtrans = 17.2, JCH2 = 1.4 Hz, 1H, CH2=CH
trans
), 5.21 (dd, Jcis = 10.4, JCH2 = 
1.3 Hz, 1H, CH2=CH
trans
), 5.00 (dd, J2,3 = 10.0, J3,4 = 2.9 Hz, 1H, H-3), 4.68 (d, JCH2 = 11.6 Hz, 1H, CH2
Bn
), 4.62 (d, 
J1,2 = 10.0 Hz, 1H, H-1), 4.54 (dt, JCH=CH2 = 5.8, JCH2=CH = 1.4 Hz, 2H, CH2
allyl
), 4.47 (d, JCH2 = 11.6 Hz, 1H, CH2
Bn
), 
4.31 (dd, J6a,6b = 11.0, J5,6a = 6.4 Hz, 1H, H-6a), 4.05 (dd, J6a,6b = 11.0, J5,6b = 6.4 Hz, 1H, H-6b), 3.88 (dd, J3,4 = 3.0, 
J4,5 = 1.0 Hz, 1H, H-4), 3.74 (td, J5,6b = J5,6a = 6.4, J4,5 =1.1 Hz, 1H, H-5), 1.91 (s, 3H, CH3
Ac
), 1.14 (s, 9H, 
3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.77, 170.20, 154.63, 137.51, 133.11, 132.52 (2C), 131.42, 128.97 
(2C), 128.55 (2C), 128.24 (2C), 128.06, 128.02, 119.30, 87.07, 75.85, 75.02, 74.78, 73.88, 68.85, 67.39, 65.75, 
38.88, 27.13 (3C), 20.83. HRMS (ESI-TOF) m/z: [M+Na]
+
 Calcd for C30H36NaO9S 595.1978Found 595.1978. 
 
Benzyl 3-O-acetyl-4-O-benzyl-6-O-allyloxocarbonyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-
O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranoside (271) 
To a 25 mL flame-dried flask was added 261 (1.0 g, 1.29 mmol) and the 270 (0.96 
mg, 1.67 mmol). The mixture was dried azeotropically with toluene (2x10 mL) and 
subjected to vacuum overnight. It was then dissolved in dry CH2Cl2 (5 mL) and dry 
MeCN (5 mL), cooled to -30 °C, followed by addition of NIS (385 mg; 1.71 
mmol) and TESOTf (34 mg; 0.13 mmol). The reaction mixture was stirred at -30 
°C until TLC revealed full conversion of the donor (2 h). The solution was diluted with CH2Cl2 (100 mL) and 
washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic phase was dried over MgSO4, 
filtered and concentrated. The product was purified by flash chromatography (9:1 toluene/EtOAc) to afford 271 as a 
white crystalline material. Yield: 1.14 g (74%). 
1
H NMR (400 MHz, CDCl3) δ 7.43 (m, 4H, Ar-H), 7.39 – 7.05 (m, 16H, Ar-H), 5.86 (ddt, Jtrans = 17.2, Jcis = 10.3, 
JCH2 = 5.9 Hz, 1H, -CH=CH2), 5.48 (s, 2H, 2xCH
benzylidene
), 5.38 (dd, J2,3 = 10.1, J1,2 = 7.7 Hz, 1H, H-2), 5.33 (dd, 
J2,3 = 10.2, J1,2 = 7.8 Hz, 1H, H-2), 5.30 (dd, Jtrans = 17.2, JCH2 = 1.5 Hz, 1H, CH2=CH-), 5.28 (dd, J2,3 = 10.9, J1,2 = 
7.0 Hz, 1H, H-2), 5.23 (dq, Jcis = 10.4,  JCH2 = 1.2 Hz, 1H, CH2=CH-), 4.83 (dd, J2,3 = 10.9, J3,4 = 3.6 Hz, 1H, H-3), 
4.82 (d, JCH2 = 11.7 Hz, 1H), 4.72 (d, J1,2 = 7.7 Hz, 1H, H-1), 4.70 (d, J1,2 = 7.0 Hz, 1H, H-1), 4.67 (d, JCH2 = 11.5 
Hz, 1H, CH2
Bn
), 4.55 (m, 2H, CH2
Alloc
), 4.45 (d, JCH2 = 12.0 Hz, 1H, CH2
Bn
), 4.44 (d, JCH2 = 11.4 Hz, 1H, 
0.5xCH2
Bn
), 4.37 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.31 – 4.19 (m, 3H, 1.5xH-6), 4.24 (d, J3,4 = 3.5 Hz, 1H, H-4), 4.21 (dd, 
J3,4 = 3.8, J4,5 = 1.2 Hz, 1H, H-4), 4.14 (dd, J2,3 = 9.8, J3,4 = 3.0 Hz, 1H, H-3), 4.10 (dd, J6a,6b = 11.1, J5,6a = 5.9 Hz, 
1H, H-6a), 4.00 (m,  2H, H-6), 3.95 (dd, J2,3 = 10.5, J3,4 = 3.4 Hz, 1H, H-3), 3.86 (dd, J3,4 = 3.1, J4,5 = 1.5 Hz, 1H, H-
4), 3.67 (td, J5,6a = 5.9, J5,6a = 1.5 Hz, 1H, H-5), 3.34 – 3.27 (m, 2H, 2xH-5), 1.89 (s, 3H, CH3
Ac
), 1.09 (s, 8H, 
3xCH3
Piv
), 1.05 (s, 9H, 3xCH3
Piv
), 1.01 (s, 9H, 3xCH3
Piv
). 
13
C NMR (101 MHz, CDCl3) δ 177.06, 176.15, 176.13, 
170.26, 154.67, 137.96, 137.83, 137.38, 137.37, 131.41-126.13(20C), 119.52, 100.36, 100.28, 100.24, 100.02, 
99.94, 75.81, 75.76, 75.09, 73.82, 73.16, 72.81, 72.73, 71.92, 71.79, 70.85, 69.98, 68.88, 68.79, 67.39, 67.07, 65.96, 
38.85, 38.77, 38.73, 27.29(6C), 27.13(3C), 20.78. HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for C67H82NaO22: 
1261.5195; Found 1261.5197. 
 
Benzyl 3-O-acetyl-4-O-benzyl-2-O-pivaloyl-6-O-(tert-butyldiphenylsilyl)-β-D-galactopyranosyl-(1→3)-4,6-O-
benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside 
(273) 
To a 25 mL flame-dried flask was added 261 (800 mg, 1.03 mmol) and the 272 
(1050 mg, 1.45 mmol). The mixture was dried azeotropically with toluene (2x10 
mL) and subjected to vacuum overnight. It was then dissolved in dry CH2Cl2 (5 
mL) and dry MeCN (5 mL), cooled to -30 °C, followed by addition of NIS (333 
mg; 1.48 mmol) and TESOTf (54 mg; 0.21 mmol). The reaction mixture was 
stirred at -30 °C until TLC revealed full conversion of the donor (2h). The solution was diluted with CH2Cl2 (100 
mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic phase was dried over 
MgSO4, filtered and concentrated. The product was purified by flash chromatography (9:1 toluene/EtOAc) to afford 
a white crystalline material. Yield: 1020 mg (71%). 
1
H NMR (400 MHz, CDCl3) δ 7.55 (m, 4H, Ar-H), 7.51 – 7.04 (m, 32H, Ar-H), 5.47 (s, 1H, H
benzylidene
), 5.42 (s, 1H, 
H
benzylidene
), 5.34 (dd, J2,3 = 10.3, J1,2 = 7.9 Hz, 1H), 5.26 (dd, J2,3 = 10.7, J1,2 = 7.9 Hz, 1H, H-1), 5.25 (dd, J2,3 = 10.6, 
J1,2 = 7.9 Hz, 1H, H-1), 4.85 (dd, J2,3 = 10.6, J3,4 = 3.1 Hz, 1H, H-3), 4.81 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.68 
(d, JCH2 = 11.3 Hz, 1H, 0.5xCH2
Bn
), 4.64 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.59 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.54 (d, JCH2 = 
11.3 Hz, 1H, 0.5xCH2
Bn
), 4.44 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.35 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.28 – 4.18 (m, 
3H, H-4, H-6), 4.13 (d, J3,4 = 3.6 Hz, 1H, H-4), 4.10 (dd, J2,3 = 10.3, J3,4 = 3.4 Hz, 1H, H-3), 4.05 (d, J3,4 = 3.7 Hz, 
Experimental 
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1H, H-4), 3.95 (m, 1H, H-6), 3.90 (dd, J2,3 = 10.3, J3,4 = 3.4 Hz, 1H, H-3), 3.83 (t, J6a,6b = J5,6a = 9.8 Hz, 1H, H-6a), 
3.66 (dd, J6a,6b = 9.8, J5,6b = 5.4 Hz, 1H, H-6b), 3.53 – 3.44 (m, 1H, H-5), 3.29 (m, 1H, H-5), 3.19 (m, 1H, H-5), 1.86 
(s, 3H, CH3
Ac
), 1.00 (s, 9H, 3xCH3
Piv
), 1.00 (s, 12H, 3xCH3
Piv
), 0.98 (s, 9H, 3xCH3
Piv
), 0.91 (s, 9H, 3xCH3
TBDPS
). 
13
C 
NMR 
 
 (101 MHz, CDCl3) δ 177.26, 176.19, 176.06, 170.41, 138.28, 137.97, 137.83, 137.42, 135.62, 135.55, 
132.99-126.17(30C), 100.36, 100.24, 100.20, 100.01, 99.53, 77.36, 75.75, 75.72, 75.41, 74.84, 74.37, 73.87, 71.80, 
71.77, 71.65, 70.77, 69.95, 69.41, 68.88, 68.79, 67.37, 67.09, 61.39, 38.84, 38.70, 38.62, 27.28(3C), 27.21(3C), 
27.13(3C), 27.05(3C), 20.85, 19.33. HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for C79H96NaO20Si: 1415.6162; Found 
1415.6163. 
 
Benzyl 3-O-acetyl-4-O-benzyl-2-O-pivaloyl-6-O-(tert-butyldiphenylsilyl)-β-D-galactopyranosyl-(1→3)-4,6-O-
benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside 
(274) 
273 (1.0 g; 0.72 mmol) was dissolved in dry DCM (25 mL) and cooled to 0 °C. A 
1M L-selectride solution in THF (1.5 mL) was added and the reaction was stirred 
at 0 °C until complete consumption of the starting material (4h). The reaction 
mixture was poured into sat. aq. NH4Cl (100 mL). The organic phase was dried 
over MgSO4, filtered and concentrated (avoid concentrating to dryness since the 
borane salts can be explosive). The crude product was purified by flash chromatography to give a white crystalline 
product. Yield:  0.84 g (88%). 
1
H NMR (400 MHz, CDCl3) δ 7.57 (m, 4H, Ar-H), 7.49 – 7.07 (m, 32H, Ar-H), 5.48 (s, 1H, H
benzylidene
), 5.43 (dd, 
J2,3 = 10.4, J1,2 = 7.6 Hz, 1H) 5.40 (s, 1H, H
benzylidene
), 5.26 (dd, J2,3 = 10.2, J1,2 = 7.8 Hz, 1H, H-1), 4.83 (d, JCH2 = 
11.8 Hz, 1H, 0.5xCH2
Bn
), 4.80 – 4.72 (m, 1H, H-2), 4.75 (d, J1,2 = 7.6 Hz, 1H, H-1), 4.67 (d, JCH2 = 11.4 Hz, 1H, 
0.5xCH2
Bn
), 4.47 (d, JCH2 = 11.8 Hz, 1H, 0.5xCH2
Bn
), 4.38 (d, J1,2 = 8.0 Hz, 1H, H-1), 4.36 (d, JCH2 = 11.4 Hz, 1H, 
0.5xCH2
Bn
), 4.25 (d, J3,4 = 3.2 Hz, 1H, H-4), 4.21 (d, J6a,6b = 11.5 Hz, 1H, H-6a), 4.31 – 4.10 (m, 4H, H-1
1
, 2xH-4, 
H-6b), 3.98 (d, J6a,6b = 12.4 Hz, 1H, H-6a), 3.89 – 3.78 (m, 4H, H-3, H-5, H-6b), 3.72 (m, 1H, H-6a), 3.66 – 3.59 (m, 
1H, H-6b), 3.56 – 3.43 (m, 2H, 2xH-3), 3.30 (s, 1H, H-5), 3.18 (s, 1H, H-5), 1.15 (s, 9H, 3xCH3
Piv
), 1.09 (s, 9H, 
3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
), 0.97 (s, 9H, 3xCH3
TBDPS
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 178.39, 178.26, 
176.15, 138.07, 137.91, 137.79, 137.37, 135.68(2C), 135.60(2C), 133.35, 133.14, 130.02-126.36(26C), 105.71, 
100.91, 100.49, 100.32, 99.58, 78.43, 76.17, 75.90, 75.38, 75.15(2C), 74.52, 72.33, 71.26, 70.54, 69.94, 69.38, 
68.92, 68.76, 67.02(2C), 62.53, 39.18, 39.12, 38.80, 27.37(3C), 27.30(3C), 27.08(3C), 26.97(3C), 19.33. HRMS 
(ESI-TOF) m/z: [M + Na]
+ 
Calcd for C77H94NaO19Si: 1373.6056; Found 1373.6061. 
 
Phenyl 3-O-acetyl-6-O-allyl-4-O-benzyl-2-O-pivaloyl-1-thio-β-D-galactopyranoside (275) 
To a solution of Pd2(dba)3 (328 mg; 0.36 mmol) and 1,4-Bis(diphenyl-phosphino)butane (611 mg; 
1.43 mmol) in dry THF (20 mL) was added the alcohol 266 (1.75 g; 3.6 mmol) and allyl ethyl 
carbonate (1.86 g; 14.32 mmol) in dry THF (20 mL). The solution was stirred at 65 °C for 4 h, the 
solvent was evaporated and the crude product was purified by flash chromatographed (30:1 Tol/EtOAc) to give the 
pure O-allylated compound 275. Rf 0.60 (9:1 Tol/EtOAc). Yield: 1.56 g (83%) 
    
  = 3.8° (c 1.0, CDCl3). IR (neat, cm
-1
): 3061.43, 3031.49, 2973.33, 2933.85, 2907.2, 2871.32, 1744.39, 
1496.49, 1479.33, 1456.24, 1397.69, 1366.21, 1276.47, 1232.00, 1145.02, 1078.08 ,1047.78, 918.76 
1
H NMR (400 
MHz, CDCl3) δ 7.46 – 7.35 (m, 2H, Ar-H), 7.35 – 7.13 (m, 8H, Ar-H), 5.78 (ddt, Jtrans = 17.2, Jcis = 10.8, JCH2 = 5.6 
Hz, 1H, -CH=CH2), 5.34 (t, J1,2 = J2,3 =10.0 Hz, 1H, H-2), 5.17 (dd, Jtrans = 17.2, JCH2 = 1.7 Hz, 1H, CH2=CHtrans), 
5.10 (dt, Jcis = 10.4, JCH2 = 1.7 Hz, 1H, CH2=CHcis), 5.00 (dd, J2,3 = 10.0, J3,4 = 3.0 Hz, 1H, H-3), 4.65 (d, J = 11.6 
Hz, 1H, 0.5xCH2
Bn
), 4.63 (d, J1,2 = 10.0 Hz, 1H, H-1), 4.50 (d, JCH2 = 11.6 Hz, 1H, 0.5xCH2
Bn
), 3.93 (dd, J3,4 = 3.1, 
J4,5 = 0.9 Hz, 1H, H-4), 3.89 (ddt, JCH2a,CH2b= 12.8, JCH=CH2, CH2= 5.6, JCH2=CH, CH2 = 1.7 Hz, 0H), 3.82 (ddt, JCH2a,CH2b = 
12.7, JCH=CH2, CH2=5.6, JCH2=CH, CH2=1.7 Hz, 1H), 3.68 (ddd, J5,6a = 6.9, J5,6b = 5.8, J4,5 =1.0 Hz, 1H, H-5), 3.60 – 3.46 
(m, 1H, H-6a, H-6b), 1.87 (s, 3H, CH3
Ac
), 1.13 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.84, 170.28, 
138.09, 134.42, 133.56, 132.20 (2C), 128.96 (2C), 128.45 (2C), 128.16 (2C), 127.86, 127.81, 117.39, 87.11, 77.40, 
74.99, 74.88, 74.35, 72.45, 68.23, 67.66, 38.88, 27.15 (3C), 20.85. HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for 
C29H36NaO7S: 551.2079; Found 551.2082. 
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Benzyl 3-O-acetyl-6-O-allyl-4-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside (276) 
To a 25 mL flame-dried flask was added 261 (900 mg, 1.16 mmol) and 276 (918 
mg, 1.74 mmol). The mixture was dried azeotropically with toluene (2x10 mL) and 
subjected to vacuum overnight. It was then dissolved in dry CH2Cl2 (5 mL) and dry 
MeCN (5 mL), cooled to -30 °C, followed by addition of NIS (442 mg; 1.97 
mmol) and TESOTf (61 mg; 0.23 mmol). The reaction mixture was stirred at -30 
°C until TLC revealed full conversion of the donor (2h). The solution was diluted with CH2Cl2 (100 mL) and 
washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic phase was dried over MgSO4, 
filtered and concentrated. The product was purified by flash chromatography to afford as a slightly yellow solid. 
Yield: 707 mg (51%). Several impurities made it impossible to assign the spectrum 
 
Benzyl 6-O-allyl-4-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside (277) 
276 (200 mg; 0.17 mmol) was dissolved in dry CH2Cl2 (10 mL) and cooled to 0 °C. 
A 1M L-selectride solution in THF (0.7 mL) was added and the reaction was stirred 
at 0 °C until complete consumption of the starting material (3 h). The reaction 
mixture was poured into sat. aq. NH4Cl (100 mL). The organic phase was dried 
over MgSO4, filtered and concentrated (avoid concentrating to dryness since the 
borane salts can be explosive). The crude product was purified by flash chromatography to give a foamy white 
product. Yield:  191 mg (92%). Several impurities made it impossible to assign the spectrum 
 
Phenyl 4,6-O-benzylidene-3-O-chloroacetyl-1-thio-β-D-galactopyranoside (278)366 
Di-n-butyl tin oxide (21.8 g; 87.4 mmol) was added to a solution of compound 56 (30.0 g, 83.2 
mmol) in dry toluene (600 mL) and stirred under refluxing temperature for 12 h. The reaction 
mixture was cooled to 0 °C, and freshly activated 4Å MS (30 g) were added. After 30 min 
chloroacetyl chloride (6.7 mL, 85.7 mmol) were added drop wise and stirring was maintained for 1 
h at 0 °C. The reaction was quenched by addition of MeOH, filtered through a pad of celite and 
concentrated. The crude product was purified by flash chromatography (9:1 Tol/EtOAc) to give 278 as white 
crystals. Rf 0.16 (9:1 Tol/EtOAc). Yield: 33.1 g (91%) 
    
  = 44.7° (c 1.0, CDCl3). IR (neat, cm
-1
): 3481.62, 3090.41, 2951.69, 2870.27, 1756.92, 1479.38, 
1406.63, 1365.59, 1313.58, 1288.85, 1166.86, 1044.29, 1025.82. 
1
H NMR (400 MHz, CDCl3) δ 7.65 – 
7.57 (m, 2H, Ar-H), 7.34 – 7.26 (m, 8H, Ar-H), 5.40 (s, 1H, -CHbenzylidene), 4.90 (dd, J2,3 = 9.6, J3,4 = 3.4 
Hz, 1H, H-3), 4.51 (d, J1,2 = 9.6 Hz, 1H, H-1), 4.35 (dd, J3,4 = 3.4, J4,5 = 1.1 Hz, 1H, H-4), 4.32 (dd, J6a,6b 
= 12.5, J5,6a = 1.6 Hz, 1H, H-6a), 4.05 (d, JCH2 = 15.3 Hz, 1H, 0.5xCH2
AcCl
), 4.00 (d, J = 15.3 Hz, 1H, 
0.5xCH2
AcCl
), 3.96 (dd, J6a,6b = 12.5, J5,6b = 1.7 Hz, 1H, H-6b), 3.90 (td, J1,2 = J2,3 = 9.6, J2,OH = 2.5 Hz, 
1H, H-2), 3.55 (m, 1H, H-5), 2.34 (d, J2,OH = 2.5 Hz, 1H, OH). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 167.23, 
137.53, 133.72 (2C), 130.06, 129.21, 129.09 (2C), 128.43, 128.19 (2C), 126.38 (2C), 100.98, 87.46, 
76.45, 73.34, 69.78, 69.12, 65.50, 40.89. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C21H21ClNaO6S 
459.0645; Found 459.0639. 
 
Phenyl 4,6-O-benzylidene-3-O-chloroacetyl-2-O-pivaloyl-1-thio-β-D-galactopyranoside (279) 
278 (25 g; 57.2 mmol) was dissolved in CH2Cl2 (400 mL). Et3N (16.0 mL; 114.4 mmol), DMAP 
(3.5 g; 28.6 mmol) and pivaloyl chloride (7.3 mL; 85.8 mmol) was added to the solution and the 
reaction mixture was heated to 45 °C for 4 h. The reaction mixture was cooled to 0 °C, quenched 
with MeOH (10 mL), washed with water (2x400 mL), dried over MgSO4 and concentrated. The 
product was purified by flash chromatography (15:1 Tol/EtOAc) to afford 279 as a white 
crystalline powder. Rf 0.44 (9:1 Tol/EtOAc). Yield 26.2 g (88%). 
    
  = 16.5° (c 1.0, CDCl3). IR (neat, cm
-1
): 3061.25, 3036.54, 2974.08, 2935.25, 2905.99, 2871.97, 1764.64, 
1733.56, 1479.53, 1457.77, 1402.52, 1366.86, 1312.92, 1281.38, 1249.15, 1147.33, 1092.80, 1048.41, 1025.97, 997.24. 
1
H NMR (400 MHz, CDCl3) δ 7.56 – 7.47 (m, 2H, Ar-H), 7.35 – 7.25 (m, 8H, Ar-H), 5.40 (s, 1H, 
CH
benzylidene
), 5.28 (t, J1,2 = J2,3 = 9.9 Hz, 1H, H-2), 5.07 (dd, J2,3 = 9.9, J3,4 = 3.5 Hz, 1H, H-3), 4.67 (d, J1,2 
= 9.9 Hz, 1H, H-1), 4.31 (dd, J6a,6b = 11.5, J5,6a = 0.9 Hz, 1H, H-6a), 4.30 (d, J = 3.5 Hz, 1H, H-4), 3.96 
(dd, J6a,6b = 11.5, J5,6b = 1.8 Hz, 1H, H-6b), 3.95 (d, JCH2 = 15.2 Hz, 1H, CH2
AcCl
), 3.87 (d, JCH2 = 15.2 Hz, 
1H, CH2
AcCl
), 3.53 (s, 1H, H-5), 1.14 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.47, 167.13, 
137.42, 133.80 (2C), 131.35, 129.35, 128.93 (2C), 128.35, 128.30 (2C), 126.60 (2C), 101.18, 85.40, 
Experimental 
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74.77, 73.52, 69.70, 69.17, 66.21, 40.70, 38.90, 27.19 (3C). HRMS (ESI-TOF) m/z: [M + NH4]
+
 Calcd 
for C26H33ClNO7S 538.1666 Found 538.1671. 
 
4,6-O-benzylidene-3-O-chloroacetyl-2-O-pivaloyl-D-galactopyranose (280a) 
279 (20.0 g; 38.4 mmol) was dissolved in acetone (180 mL) and water (20 mL). NBS (27.3 g; 
153.5 mmol) and 2,4-lutidine (22.2 mL; 107.2 mmol) were added and the reaction was stirred at 50 
°C until TLC showed full conversion (3h). The solution was diluted with CH2Cl2 (500 mL) and 
washed with sat. aq. NaS2O3 (200 mL) and sat. aq. NaHCO3 (200 mL). The organic phase was 
dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography 
(6:1 toluene/EtOAc) to afford 280a as an α/β mixture. Rf 0.13 (9:1 toluene/EtOAc). Yield:  12.5 g (76%)  
    
  = 84.4° (c 1.0, CDCl3). IR (neat, cm
-1
):3063.99, 3030.86, 2972.24, 2931.14, 2870.06, 1738.21, 
1479.47, 1454.40, 1365.98, 1277.87, 1150.65, 1134.03, 1101.35, 1064.79. 
1
H NMR (400 MHz, CDCl3)  
δ 7.49 – 7.03 (m, 10H, Ar-H), 5.51 (d, J1,2 = 3.5 Hz, 1H, H-1), 5.45 (dd, J2,3 = 10.1, J3,4 = 2.9 Hz, 1H, H-
3), 5.43 (s, 1H, Hbenzylidene), 5.41 (s, 1H, Hbenzylidene), 5.18 (dd, J2,3 =10.1, J1,2 = 3.5 Hz, 1H, H-2), 5.13 
(dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-2), 5.02 (dd, J2,3 =10.4, J3,4 = 3.6 Hz, 1H, H-3), 4.60 (d, J1,2 = 7.9 
Hz, 1H, H-1), 4.32 (dd,  J3,4 = 2.9, J4,5 = 1.1 Hz, 1H, H-4), 4.29 – 4.22 (m, 1H, H-4b, H-6a,) 4.16 (dd, 
J6a,6b = 12.6,  J5,6a = 1.5 Hz, 1H, H-6a,), 4.01 (d, JCH2 = 15.0 Hz, 1H, 0.5xCH2
AcCl
), 3.94 (m, 3H, H-6b,; 
H-6b,; 0.5xCH2
AcCl
), 3.91 (m, 2H, H-5, H-5), 1.11 (m, 18H, 6xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) 
δ 177.66, 176.89, 165.94, 136.83, 136.36, 136.18, 128.21, 128.11, 128.00, 127.26, 127.22, 127.19, 
125.15, 125.07, 124.27, 99.70, 99.60, 94.77, 89.79, 72.85, 72.19, 71.90, 69.46, 69.02, 68.14, 67.89, 67.19, 
65.37, 60.89, 39.66, 39.51, 37.94, 37.79, 25.93. HRMS (ESI-TOF) m/z: [M + NH4]
+
 Calcd for 
C20H30ClNO8 447.1660 Found 447.1671 
 
4,6-O-benzylidene-3-O-chloroacetyl-2-O-pivaloyl-1-thio-β-D-galactopyranose N-phenyl trifluoroacetimidate 
(280) 
280a (10 g; 23.3 mmol) was dissolved in DCM (230 mL) and cooled to 0 °C. Cs2CO3 (15.2 g; 
46.6 mmol) was added followed by N-phenyl trifluoroacetimidoyl chloride (9.7 g; 46.6 mmol). 
The ice bath was removed and the reaction mixture was stirred until TLC showed full 
conversion (5 h). It was then filtered, concentrated and purified by flash chromatography to 
give a white crystalline product. Yield: 11.2 g (80%)  
 
Phenyl 4,6-O-benzylidene-2-O-pivaloyl-1-thio-β-D-galactopyranoside (281) 
279 (10 g; 19.2 mmol) was dissolved in dry CH2Cl2 (190 mL) and cooled to 0 °C. A 1M L-selectride 
solution in THF (57.6 mL) was added and the reaction was stirred at 0 °C until complete 
consumption of the starting material (1h). The reaction mixture was poured into sat. aq. NH4Cl (400 
mL). The organic phase was dried over MgSO4, filtered and concentrated (avoid concentrating to 
dryness since the borane salts can be explosive). The crude product was purified by flash 
chromatography to give 281 a white crystalline product. Yield: 8.2 g (96%) 
    
  = -20.0° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.51 (m, 2H, Ar-H), 7.38 – 7.10 (m, 10H, Ar-H), 5.45 
(s, 1H, CH
benzylidene
), 4.98 (t, J1,2 = J2,3 = 9.7 Hz, 1H, H-2), 4.60 (d, J1,2 = 9.7 Hz, 1H, H-1), 4.31 (dd, J6a,6b = 12.5, 
J5,6a =1.5 Hz, 1H, H-6a), 4.14 (dd, J3,4 = 3.6, J4,5 =1.1 Hz, 1H, H-4), 3.96 (dd, J6a,6b = 12.5, J5,6b = 1.7 Hz, 1H, H-6b), 
3.67 (dd, J2,3 = 9.7, J3,4 = 3.6 Hz, 1H, H-3), 3.51 – 3.43 (m, 1H, H-5), 1.19 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, 
CDCl3) δ 177.61, 137.39, 133.58 (2C), 131.59, 129.35, 128.78 (2C), 128.24 (2C), 128.08, 126.52 (2C), 101.41, 
85.06, 75.66, 72.92, 69.90, 69.52, 69.17, 38.83, 27.16 (3C). HRMS (ESI-TOF) m/z:  [M + Na]+ Calcd for 
C24H28NaO6S: 467.1504; Found 467.1511. 
 
Phenyl 4,6-O-benzylidene-3-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-1-thio-β-D-galactopyranoside (283) 
To a 250 mL flame-dried flask was added 281 (6.5 g, 14.6 mmol) and the 280 (11.4 g, 
19.0 mmol). The mixture was co-evaporated with toluene (2x150 mL) and subjected to 
vacuum overnight. The mixture dissolved in CH2Cl2 (150 mL) and cooled to -40 °C. 
TMSOTf (0.22 mL; 1.5 mmol) was added and the reaction mixture was stirred at -40 °C 
for 2h. Et3N (1 mL) was added and the reaction mixture was concentrated. The crude compound was purified by 
flash chromatography (9:1 Tol/EtOAc) affording 283. Rf 0.26 (9:1 Tol/EtOAc). Yield: 10.5 g (84%). 
    
  = 12.4° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.51 – 7.36 (m, 5H), 7.35 – 7.22 (m, 6H), 7.17 – 7.04 
(m, 3H), 5.49 (s, 1H, -CH
benzylidene
), 5.43 (s, 1H, -CH
benzylidene
), 5.33 (dd, J2,3 = 9.7 J1,2 = 8.1 Hz, 1H, H-2’), 5.30 (t, 
Experimental 
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J1,2 = J2,3 = 9.7 Hz, 1H, H-2), 4.87 (d, J = 8.1 Hz, 1H, H-1’), 4.86 (d, J = 3.8 Hz, 1H), 4.60 (d, J1,2 = 9.7 Hz, 1H, H-
1), 4.34 – 4.17 (m, 4H, H-3, H-4, H-4’, H-6a’), 4.00 (dd, J = 12.5, 1.5 Hz, 1H, H-6a), 3.99 (d, JCH2 = 15.3 Hz, 1H, 
CH2
AcCl
), 3.98 – 3.89 (dd, J6a,6b = 12.5 Hz, J5,6b =1.5, 1H, H-6b), 3.93 (dd, J6a,6b = 12.3 Hz, J5,6b =1.1, 1H, H-6b’), 
3.91 (d, JCH2 = 15.2 Hz, 1H, CH2
AcCl
), 3.38 (m, 2H, H-5, H-5’), 1.22 (s, 9H, -CH3
Piv
), 1.00 (s, 9H-CH3
Piv
). 
13
C NMR 
 
 
(101 MHz, CDCl3) δ 176.90, 176.12, 167.12, 137.82, 137.25, 133.37, 132.34 (2C), 129.21, 128.73 (2C), 128.63, 
128.27 (2C), 127.93 (2C), 127.58, 126.22 (2C), 126.19 (2C), 100.89, 100.18, 99.27, 86.79, 75.91, 73.65, 73.48, 
73.33, 70.21, 69.49, 68.93, 68.70, 68.18, 66.60, 40.60, 38.79, 38.76, 27.35 (3C), 26.95 (3C). HRMS (ESI-TOF) 
m/z: [M + NH4]+ Calcd for C44H55ClNO13S 872.3083 Found 872.3092 
 
Phenyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-1-
thio-β-D-galactopyranoside (284) 
283 (1.8 g; 2.1 mmol) was dissolved in dry CH2Cl2 (40 mL) and cooled to 0 °C. A 1M L-
selectride solution in THF (5.3 mL) was added and the reaction was stirred at 0 °C until 
complete consumption of the starting material was observed (30 min). The reaction 
mixture was quenched with sat. aq. NH4Cl (50 mL). The organic phase was dried over 
MgSO4, filtered and concentrated (avoid concentrating to dryness since the borane salts 
can be explosive). The residue was filtered through a plug of silica (9:1 Tol/EtOAc). The semi-crude alcohol (1.4 g; 
1.8 mmol) was dissolved in CH2Cl2 (20 mL). Et3N (0.5 mL; 3.6 mmol), DMAP (0.1 g; 0.9 mmol) and pivaloyl 
chloride (0.4 mL; 3.6 mmol) was added to the solution and the reaction mixture was heated to 45 °C for 4 h. The 
reaction mixture was cooled to 0 °C, quenched with MeOH (0.5 mL), washed with water (2x50 mL), dried over 
MgSO4 and concentrated. The product was purified by flash chromatography (Tol/EtOAc 9:1) to afford 284 as a 
white crystalline powder. Rf 0.26 (9:1 Tol/EtOAc) Yield 1.3 g (80% over two steps) 
    
  = 10.7° (c 1.0, CDCl3). IR (neat, cm
-1
): 3065.46, 2933.04, 1734.90, 1479.30, 1455.98, 1397.64, 
1366.82, 1279.26, 1173.33, 1140.59, 1091.22, 1048.23, 1026.27. 
1
H NMR (400 MHz, CDCl3) δ 7.49 – 
7.34 (m, 6H, Ar-H), 7.26 (m, 9H, Ar-H), 5.47 (s, 1H, -CH
benzylidene
), 5.45 (s, 1H, -CH
benzylidene
), 5.37 (dd, 
J2,3 = 10.5, J1,2 = 8.0 Hz, 1H, H-2’), 5.29 (t, J1,2 = J2,3 = 9.8 Hz, 1H, H-2), 4.81 (d, J1,2 = 8.0 Hz, 1H, H-1’), 
4.69 (dd, J2,3 = 10.5, J3,4 = 3.7 Hz, 1H, H-3’), 4.60 (d, J1,2 = 9.8 Hz, 1H, H-1), 4.38 – 4.17 (m, 5H, H-3, H-
4, H-4’, H-6a, H-6a’), 4.01 (dd, J6a,6b = 12.5, J5,6b =1.8 Hz, 1H, H-6b’), 3.93 (dd, J6a,6b = 12.4, J5,6b =1.6 
Hz, 1H, H-6b), 3.42 – 3.34 (m, 2H, H-5, H-5’), 1.22 (s, 9H, 3xCH3
Piv
), 1.07 (s, 9H, 3xCH3
Piv
), 0.98 (s, 9H, 
3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 178.20, 176.81, 176.10, 137.89, 137.47, 133.41, 132.27 (2C), 
128.90, 128.70 (2C), 128.52, 128.18 (2C), 127.86 (2C), 127.52, 126.19 (2C), 125.90 (2C), 100.43, 
100.13, 99.34, 86.66, 75.75, 73.13 (2C), 71.88, 70.24, 69.74, 68.90, 68.82, 68.18, 66.76, 38.92, 38.78, 
38.68, 27.39, 27.00, 26.98. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C47H58NaO13S 885.3496; Found 
885.3499. 
 
Benzyl 4,6-O-benzylidene-3-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranoside (285) 
283 (4.0 g; 4.7 mmol) was dried azeotropically with toluene (2x50 mL) and subjected to 
vacuum overnight. Benzyl alcohol (0.56 g; 5.17 mmol) was added. The mixture was 
dissolved in dry CH2Cl2 (50 mL) and cooled to -40 °C. NIS (1.2 g; 5.1 mmol) and 
TESOTf (124 mg; 0.47 mmol) was added and the reaction mixture was stirred at -40 °C 
until TLC revealed full conversion of the donor (3h). The solution was diluted with 
CH2Cl2 (100 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic phase was 
dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography (9:1 
toluene/EtOAc) to afford a white crystalline material. Rf 0.15 (9:1 Tol/EtOAc). Yield: 3.3 g (83%) 
IR (neat, cm
-1
): 3522.75, 3034.88, 2907.39, 1738.58, 1700.58, 1479.70, 1455.33, 1398.71, 1366.79, 
1310.93, 1277.82, 1173.90, 1135.07, 1087.56, 1047.93, 1026.20. 
1
H NMR (400 MHz, CDCl3) δ 7.51 – 
7.14 (m, 15H), 5.50 (s, 1H, CH
benzylidene
), 5.43 (s, 1H, CH
benzylidene
), 5.42 (dd, J2,3 = 10.6, J1,2 = 7.9 Hz, 1H, 
H-2
1
), 5.34 (dd, J2,3 = 10.5, J1,2 = 8.0 Hz, 1H, H-2
2
), 4.94 (d, J1,2 = 8.0 Hz, 1H, H-1
2
), 4.89 (dd, J2,3 = 10.5, 
J3,4 = 3.6 Hz, 1H, H-3
2
), 4.83 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.47 (d, JCH2 = 11.9 Hz, 1H, 
0.5xCH2
Bn
), 4.37 (d, J1,2 = 7.9 Hz, 1H, H-1
1
), 4.34 – 4.23 (m, 4H, H-41, H-42, H-6a2, H-6b2), 4.12 (dd, J2,3 
= 10.3, J3,4 = 3.4 Hz, 1H, H-3
1
), 4.04 – 3.96 (m, 2H, H-6a1, H-6b1), 3.98 (d, JCH2 = 15.2 Hz, 1H, CH2
AcCl
), 
3.91 (d, JCH2 = 15.2 Hz, 1H, CH2
AcCl
), 3.38 (s, 1H, H-5
2
), 3.33 (s, 1H, H-5
1
), 1.10 (s, 9H, 3xCH3
Piv
), 1.05 
(s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.02, 176.18, 167.22, 137.88, 137.42, 137.26, 
129.28, 129.15, 128.72, 128.35 (2C), 128.34, 128.31 (2C), 128.07 (2C), 127.89 (2C), 127.64, 126.36 
(2C), 126.19 (2C), 100.99, 100.41, 100.32, 99.48, 76.04, 73.60, 73.47, 72.96, 70.96, 70.03, 68.92, 68.78, 
Experimental 
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68.34, 66.98, 66.67, 40.71, 38.90, 38.80, 27.31 (3C), 27.12 (3C). HRMS (ESI-TOF) m/z: [M + NH4]
+
 
Calcd for C45H57ClNO14 870.3468 Found 870.3467 
 
Phenyl 6-O-acetyl-4-O-benzyl-3-O-chloroacetyl-2-O-pivaloyl-1-thio-β-D-galactopyranoside (286) 
A solution of 1M BH3 in THF (76.7 mL) was added to a 250 ml dry flask containing 279 (4.0 g; 
7.7 mmol) at 0 °C and the solution was stirred for 5 minutes. A solution of 1M Cu(OTf)2 in 
CH2CI2 (8.1 mL) was then added to the clear solution slowly. After 1.5 hours at 0 °C, TLC showed 
full consumption of starting material. Triethylamine (2 mL) was added followed by careful addition of methanol 
until the evolution of H2 had ceased. The reaction mixture was co-distilled with methanol three times and the crude 
was used in the next step. The crude material was dissolved in CH2Cl2 (50 mL). Et3N (1.1 mL; 7.7 mmol), DMAP 
(0.01 g; 0.1 mmol) and acetic anhydride (0.61 mL; 6.5 mmol) was added to the solution and the reaction mixture 
was stirred until TLC revealed full conversion (1 h). The reaction was quenched with MeOH (1 mL), diluted with 
DCM (50 mL), washed with water (2x100 mL), dried over MgSO4 and concentrated. The product was purified by 
flash chromatography (Tol/EtOAc 15:1) to afford 286 as a white crystalline powder Rf 0.42 (9:1 Tol/EtOAc). 
Yield: 2.8 g (68%) over two steps 
    
  = -5.2° (c 1.0, CDCl3). IR (neat, cm
-1
): 3061.37, 3031.47, 2972.29, 2906.59, 2872.68, 1739.50, 
1584.17, 1496.32, 1479.63, 1455.92, 1440.05, 1398.67, 1369.01, 1277.91, 1232.53, 1172.17, 1139.11, 
1088.80, 1043.02. 
1
H NMR (400 MHz, CDCl3) δ 7.47 – 7.37 (m, 2H), 7.33 – 7.15 (m, 8H), 5.34 (t, J1,2 = 
J2,3 = 9.9 Hz, 1H, H-2), 5.06 (dd, J2,3 = 9.9, J3,4 = 3.0 Hz, 1H, H-3), 4.62 (d, J1,2 = 9.9 Hz, 1H, H-1), 4.63 
(d, JCH2 = 11.9 Hz, 1H, CH2
Bn
), 4.53 (d, JCH2 = 11.9 Hz, 1H, CH2
Bn
), 4.26 (dd, J6a,6b = 11.2, J5,6a = 6.7 Hz, 
1H, H-6a), 4.04 (dd, J6a,6b = 11.2, J5,6b = 6.2 Hz, 1H, H-6b), 3.88 (dd, J3,4 = 3.0, J4,5 = 1.0 Hz, 1H, H-4), 
3.80 (d, J = 14.9 Hz, 1H, 0.5xCH2
AcCl
), 3.74 (d, J = 15.0 Hz, 1H, 0.5xCH2
AcCl
), 3.72 – 3.67 (m, 1H, H-5), 
1.95 (s, 3H, -CH3
Ac
), 1.13 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.80, 170.49, 166.80, 
137.41, 132.95, 132.61 (2C), 128.97 (2C), 128.62 (2C), 128.37 (2C), 128.20, 128.14, 86.90, 76.54, 76.00, 
75.13, 73.87, 67.41, 62.50, 40.42, 38.92, 27.16 (3C), 20.89. HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for 
C28H33ClNaO8S 587.1482; Found 587.1481. 
 
Benzyl 3-O-benzyl-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside 
To a 10 mL flame-dried flask was added 261 (500 mg, 0.64 mmol) and 167 (447 
mg, 0.84 mmol). The mixture was dried azeotropically with toluene (2x5 mL) and 
subjected to vacuum overnight. It was then dissolved in dry CH2Cl2 (2.5 mL) and 
dry MeCN (2.5 mL), cooled to -30 °C, followed by addition of NIS (192 mg; 0.86 
mmol) and TESOTf (17 mg; 0.06 mmol). The reaction mixture was stirred at -30 
°C until TLC revealed full conversion of the donor (2h). The solution was diluted with CH2Cl2 (50 mL) and washed 
with sat. aq. NaS2O3 (25 mL) and sat. aq. NaHCO3 (25 mL). The organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash chromatography (9:1 toluene/EtOAc) to afford a white crystalline 
material. Yield: 1.1 g (86%). 
    
  = 5.3° (c 1.0, CDCl3). IR(neat): 3514.99, 3064.69, 3035.30, 2872.12, 1739.17, 1699.76, 1497.26, 1455.35, 
1398.13, 1366.64, 1277.12, 1171.88, 1132.96, 1086.65, 1048.06, 1027.13.  
1
H NMR (400 MHz, CDCl3) δ 7.44 (m, 
6H, Ar-H), 7.35 – 7.11 (m, 19H), 5.48 (s, 2H, 2xCHbenzylidene), 5.40 (s, 1H, CHbenzylidene), 5.38 (dd, J2,3 = 9.8, J1,2 = 7.9 
Hz, 1H, H-2
1
), 5.36 (dd, J2,3 = 10.1, J1,2 = 8.0 Hz, 1H, H-2
2
), 5.29 (dd, J2,3 = 10.1, J1,2 = 8.1 Hz, 1H, H-2
3
), 4.82 (d, 
JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.75 (d, J1,2 = 8.1 Hz, 1H, H-1
3
), 4.69 (d, J1,2 = 8.0 Hz, 1H, H-1
2
), 4.55 (s, 2H, 
CH2
Bn
), 4.45 (d, JCH2 = 11.9 Hz, 1H, CH2
Bn
), 4.36 (d, J1,2 = 7.9 Hz, 1H, H-1
1
), 4.30 – 3.92 (m, 11H, H-31, H-32, H-
4
1
-H-4
3
, H-6
1
-H-6
3
), 3.40 (dd, J2,3 = 10.1, J3,4 = 3.5 Hz, 1H, H-3
3
), 3.30 (s, 1H, H-5
1/2/3
), 3.26 (s, 1H, H-5
1/2/3
), 3.19 
(s, 1H, H-5
1/2/3
), 1.05 (s, 9H, 3xCH3
Piv
), 1.03 (s, 9H, 3xCH3
Piv
), 1.02 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, 
CDCl3) δ 177.18, 176.18, 176.13, 138.00, 137.93, 137.88, 137.72, 137.34, 129.16, 129.07, 128.69, 128.58, 128.45, 
128.35, 128.30, 128.26, 128.04, 127.96, 127.92, 127.88, 127.69, 127.62, 126.40, 126.26, 101.03, 100.42, 100.29,  
100.07, 99.41, 76.00, 75.76, 73.48, 71.92, 71.88, 71.47, 71.37, 70.96, 70.05, 69.85, 69.00, 68.88, 68.80, 67.48, 
67.15, 67.06, 38.83, 38.75, 38.71, 27.31, 27.28, 27.22. 
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Benzyl 6-O-acetyl-4-O-benzyl-3-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-
2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside (287) 
To a 25 mL flame-dried flask was added 261 (3.0 g, 3.9 mmol) and the 286 (1.5 
g, 1.8 mmol). The mixture was dried azeotropically with toluene (2x10 mL) and 
subjected to vacuum overnight. It was then dissolved in dry CH2Cl2 (5 mL) and 
dry MeCN (5 mL), cooled to -30 °C, followed by addition of NIS (420 mg; 1.9 
mmol) and TESOTf ( 56 mg; 0.2 mmol). The reaction mixture was stirred at -30 
°C until TLC revealed full conversion of the donor (2h). The solution was diluted with CH2Cl2 (100 mL) and 
washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic phase was dried over MgSO4, 
filtered and concentrated. The product was purified by flash chromatography (6:1 Tol/EtOAc) to afford a white 
crystalline material. Rf 0.60 (2:1 Tol/EtOAc). Yield: 3.6 g (75%) 
1
H NMR (400 MHz, CDCl3) δ 7.49 – 7.15 (m, 20H, Ar-H), 5.48 (s, 1H, CH
benzylidene
), 5.47 (s, 1H, CH
benzylidene
), 5.37 
(dd, J2,3 = 10.2, J1,2 = 7.9 Hz, 1H, H-2
1
), 5.31 (dd, J2,3 = 10.3, J1,2 = 8.0 Hz, 1H, H-2
3
), 5.27 (dd, J2,3 = 10.2, J1,2 = 7.7 
Hz, 1H, H-2
2
), 4.88 (dd, J2,3 = 10.3, J3,4 = 3.0 Hz, 1H, H-3
3
), 4.82 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.73 (d, J1,2 = 
7.7 Hz, 1H, H-1
2
), 4.70 (d, J1,2 = 8.0 Hz, 1H, H-1
3
), 4.63 (d, JCH2 = 11.7 Hz, 1H, 0.5xCH2
Bn
), 4.51 (d, JCH2 = 11.7 
Hz, 1H, 0.5xCH2
Bn
), 4.45 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.36 (d, J1,2 = 7.9 Hz, 1H, H-1
1
), 4.32 – 3.94 (m, 12H, 
H-3
1
, H-3
2
, H-4
1
, H-4
2
, 3xH-6), 3.86 (d, J = 3.0 Hz, 1H, H-4
3
), 3.79 (d, JCH2 = 15.0 Hz, 1H, CH2
AcCl
), 3.72 (d, JCH2 = 
15.0 Hz, 1H, CH2
AcCl
), 3.60 (t, J5,6a = J5,6b = 6.6 Hz, 1H, H-5
3
), 3.31 (s, 1H, H-5
1/2
), 3.29 (s, 1H, H-5
1/2
), 1.95 (s, 3H, 
CH3
Ac
), 1.09 (s, 9H, CH3
Piv
), 1.05 (s, 9H, CH3
Piv
), 1.00 (s, 9H, CH3
Piv
).
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.15, 
176.11, 176.10, 170.27, 166.84, 137.95, 137.77, 137.32, 137.30, 128.76-126.12 (20C), 100.40, 100.27 (2C), 99.89, 
99.71, 75.83, 75.77, 75.21, 75.01, 73.59, 72.59 (2C), 71.89, 71.81, 71.06, 70.01, 69.01, 68.85, 68.77, 67.36, 67.04, 
62.01, 40.39, 38.87, 38.76, 38.72, 27.31 (3C), 27.25 (3C), 27.10 (3C), 20.92. HRMS (ESI-TOF) m/z: [M + NH4]+ 
Calcd for C64H81ClNO20S 1250.4761 Found 1250.4763 
 
Benzyl 6-O-acetyl-4-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside (288) 
287 (1.6 g; 1.3 mmol) was dissolved in 25 mL dry THF. Thiourea (382 mg; 5.0 
mmol), Bu4NI (93 mg; 0.25 mmol) and NaHCO3 (464 mg; 5.5 mmol) was added 
and the reaction mixture was heated to 55 °C for 12 h. The mixture was filtered, 
concentrated and purified by flash chromatography (4:1 Tol/EtOAc) to give 288 as 
a yellowish amorphous material. Rf 0.49 (2:1 Tol/EtOAc). Yield: 1.2 g (82%). 
    
  = -20.7° (c 1.0, CDCl3). IR (neat, cm
-1
):3521.34, 2973.04, 2932.85, 2907.14, 2872.47, 1737.38, 1479.63, 
1454.83, 1397.45, 1366.55, 1277.19, 1231.25, 1133.51, 1078.77, 1061.55, 1044.64. 
1
H NMR (400 MHz, CDCl3) δ 
7.50 – 7.14 (m, 20H), 5.49 (s, 1H, CHbenzylidene), 5.45 (s, 1H, CHbenzylidene), 5.39 (dd, J2,3 = 10.2, J1,2 = 7.9 Hz, 1H, H-
2
1
), 5.36 (dd, J2,3 = 10.4, J1,2 = 8.0 Hz, 1H, H-2
2
), 4.85 (dd, J2,3 = 10.0, J1,2 = 7.7 Hz, 1H, H-2
3
), 4.83 (d, JCH2 = 11.9 
Hz, 1H, 0.5xCH2
Bn
), 4.76 (d, JCH2 = 11.5 Hz, 1H, 0.5xCH2
Bn
), 4.70 (d, J1,2 = 8.0 Hz, 1H, H-1
2
), 4.65 (d, J1,2 = 7.7 
Hz, 1H, H-1
3
), 4.61 (d, JCH2 = 11.5 Hz, 1H, 0.5xCH2
Bn
), 4.45 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.37 (d, J1,2 = 7.9 
Hz, 1H, H-1
1
), 4.33 – 4.13 (m, 6H, H-31, 2xH-4, 1.5xH-6), 4.01 (m, 3H, 1.5xH-6), 3.93 (dd, J2,3 = 10.4, J3,4 = 3.4 
Hz, 1H, H-3
2
), 3.71 (d, J3,4 = 2.5 Hz, 1H, H-4
3
), 3.55 – 3.46 (m, 2H, H-33, H-53), 3.32 (s, 1H, H-5), 3.30 (s, 1H, H-
5), 1.94 (s, 3H, CH3
Ac
), 1.09 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
), 1.05 (s, 9H, 3xCH3
Piv
).
13
C NMR 
 
 (101 MHz, 
CDCl3) δ 180.36, 176.11, 176.05, 170.37, 137.99, 137.77, 137.74, 137.32, 129.87-126.13 (20C), 100.43 (2C), 
100.29, 99.91, 99.67, 76.15, 75.97, 75.86, 75.83, 75.79, 73.98, 73.66, 72.70, 72.60, 71.88, 71.84, 71.13, 70.03, 
68.87, 68.78, 67.38, 67.06, 62.54, 39.07, 38.78, 38.70, 27.32 (3C), 27.25 (3C), 27.05 (3C) 20.94. HRMS (ESI-TOF) 
m/z: [M + NH4]+ Calcd for C63H82NO20 1172.5430 Found 1172.5440. 
 
Benzyl 4,6-O-benzylidene-3-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene -2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-6-O-acetyl-4-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-
benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside 
(289) 
To a 25 mL flame-dried flask was added 289 (1.2 g, 1.0 
mmol) and the 283 (1.2 g, 1.4 mmol). The mixture was dried 
azeotropi-cally with toluene (2x10 mL) and subjected to 
vacuum overnight. It was then dissolved in dry CH2Cl2 (5 mL) 
and dry MeCN (5 mL), cooled to -30 °C, followed by addition of NIS (336 mg; 1.5 mmol) and TESOTf (27 mg; 0.1 
mmol). The reaction mixture was stirred at -30 °C until TLC revealed full conversion of the donor (2h). The solution 
was diluted with CH2Cl2 (100 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The 
organic phase was dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography 
(6:1 Tol/EtOAc) to afford 289 as a white crystalline material. Rf 0.62 (2:1 Tol/EtOAc). Yield: 1.6 g (80%) 
Experimental 
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  = 4.7° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.53 – 7.36 (m, 8H), 7.34 – 7.07 (m, 22H), 5.53 (s, 1H, 
CH
benzylidene
), 5.48 (s, 1H, CH
benzylidene
), 5.46 (s, 1H, CH
benzylidene
), 5.44 (s, 1H, CH
benzylidene
), 5.45 – 5.23 (m, 1H, H-21-
H-2
5
), 4.93 – 4.86 (m, 2H, H-11/2/3/4/5, H-35), 4.83 (m, 2H, CH2
Bn
), 4.66 (d, J1,2 = 8.0 Hz, 1H, H-1
1/2/3/4/5
), 4.63 (d, J1,2 
= 7.9 Hz, 1H, H-1
1/2/3/4/5
), 4.54 (d, J1,2 = 8.0 Hz, 1H, H-1
1/2/3/4/5
), 4.49 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2
Bn
), 4.44 (d, 
JCH2 = 12.3 Hz, 1H, 0.5xCH2
Bn
), 4.36 (d, J1,2 = 7.9 Hz, 1H, H-1
1/2/3/4/5
), 4.33 – 3.87 (m, 20H, H-31-H-34, H-4
1/2/4/5
, H-
4
1/2/4/5
, H-4
1/2/4/5
, H-4
1/2/4/5
, H-6
1
-H-6
5
, CH2
AcCl
), 3.83 – 3.77 (m, 1H, H-43), 3.43 – 3.38 (m, 2H, H-53, H-51/2/4/5), 3.34 
– 3.24 (m, 3H, H-51/2/4/5, H-51/2/4/5, H-51/2/4/5), 1.84 (s, 3H, CH3
Ac
), 1.10 (s, 9H, 3xCH3
Piv
), 1.07 (s, 9H, 3xCH3
Piv
), 
1.04 (s, 9H, 3xCH3
Piv
), 1.02 (s, 9H, 3xCH3
Piv
), 1.00 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.94, 
176.24, 176.03, 175.87, 175.83, 170.29, 167.08, 138.33, 137.92, 137.77, 137.71, 137.24, 137.15, 129.22-125.96 
(30C), 100.88, 100.26 (2C), 100.16, 100.13, 100.09, 100.03, 99.89, 99.07, 77.26, 75.79, 75.63, 74.72, 74.44, 74.29, 
73.46, 73.21, 72.99, 72.16, 71.81, 71.79, 71.76, 71.62, 71.44, 70.86, 69.95, 68.76, 68.65, 68.57, 68.21, 67.38, 66.94, 
66.67, 62.02, 40.57, 38.76, 38.73, 38.66, 38.61, 38.57, 27.30 (3C), 27.23 (3C), 27.19 (3C), 27.14 (3C), 26.97 (3C), 
20.80. 
 
Benzyl 4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene -2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-6-O-acetyl-4-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl- 
(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranoside  (290) 
289 (3.0 g; 1.6 mmol) was dissolved in 30 mL dry THF. Thiourea 
(481 mg; 6.3 mmol), Bu4NI (116 mg; 0.3 mmol) and NaHCO3 (584 
mg; 6.9 mmol) was added and the reaction mixture was heated to 
55 °C for 12 h. The mixture was filtered, concentrated and purified 
by flash chromatography (4:1 Tol/EtOAc) to give 290 as a 
colorless syrup. Rf 0.49 (2:1 Tol/EtOAc). Yield: 2.4 g (84%) 
    
  = -19.5° (c 1.0, CDCl3). IR (neat, cm
-1
): 3064.90, 2906.56, 2871.51, 1740.83, 1479.69, 1454.99, 1397.85, 
1366.58, 1276.77, 1229.22, 1172.47, 1134.96, 1087.71, 1047.90, 1027.22. 
1
H NMR (400 MHz, CDCl3) δ 7.54 – 
7.36 (m, 8H, Ar-H), 7.33 – 7.02 (m, 22H, Ar-H), 5.52 (s, 1H, CHbenzylidene), 5.49 (s, 1H, CHbenzylidene), 5.48 (s, 1H, 
CH
benzylidene
), 5.46 (s, 1H, CH
benzylidene
), 5.43 (dd, J2,3 = 10.3, J1,2 = 7.9 Hz, 1H, H-2
1/2/4/5
), 5.37 (dd, J2,3 = 10.2, J1,2 = 
7.9 Hz, 1H, , H-2
1/2/4/5
), 5.28 (dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 2H, H-2
1/2/4/5
, H-2
1/2/4/5
), 4.99 (dd, J = 10.1, 8.0 Hz, 1H, 
H-2
3
), 4.85 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.81 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.80 (d, J1,2 = 8.0 Hz, 1H, 
H-1
3
), 4.66 (d, J1,2 = 8.0 Hz, 1H, H-2
1/2/4/5
), 4.65 (d, J1,2 = 7.9 Hz, 1H, H-2
1/2/4/5
), 4.54 (d, J1,2 = 8.0 Hz, 1H, H-
2
1/2/4/5
), 4.51 (d, J = 12.0 Hz, 1H, 0.5xCH2
Bn
), 4.44 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.36 (d, J1,2 = 7.9 Hz, 1H, H-
2
1/2/4/5
), 4.31 – 3.88 (m, 18H, H-31/2/4/5, H-31/2/4/5, H-31/2/4/5, H-31/2/4/5, 4xH-4, H-61-H-65), 3.81 (dd, J3,4 = 2.9, J4,5 = 1.2 
Hz, 1H, H-4), 3.54 (dd, J2,3 = 10.1, J3,4 = 3.7 Hz, 1H, H-3
3
), 3.41 (dd, J5,6a = 7.4, J5,6b = 5.9 Hz, 1H, H-5
3
), 3.36 – 
3.32 (m, 1H, H-5
1/2/4/5
), 3.32 – 3.29 (m, 1H, H-51/2/4/5), 3.28 (m, 2H, H-51/2/4/5), 1.84 (s, 3H, CH3
Ac
), 1.10 (s, 9H, 
3xCH3
Piv
), 1.07 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
), 1.04 (s, 9H, 3xCH3
Piv
), 1.03 (s, 89H, 3xCH3
Piv
). 
13
C NMR 
 
 
(101 MHz, CDCl3) δ 178.88, 176.29, 176.13, 175.99, 175.94, 170.39, 138.41, 138.01, 137.88, 137.79, 137.41, 
137.25, 129.41-126.16 (30C), 101.35, 100.38, 100.36 (2C), 100.22 (2C), 100.13, 99.99, 99.26, 77.36, 75.99, 75.90, 
75.73 (2C), 74.79, 74.55, 74.42, 73.10, 72.29, 72.20 (2C), 72.03, 71.92, 71.86, 71.73, 71.54, 71.04, 70.05, 68.86, 
68.75, 68.67, 68.08, 67.48 (2C), 67.06, 67.03, 62.13, 38.96, 38.82, 38.76, 38.71, 38.69, 27.40 (3C), 27.34 (3C), 
27.29 (3C), 27.24 (3C), 27.10 (3C), 20.91. 
 
Benzyl 4,6-O-benzylidene-2,3-O-dipivaloyl-β-D-galactopyranosyl--(1→3)-4,6-O-benzylidene -2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl- (1→3)-4,6-O-benzylidene -2-
O-pivaloyl-β-D-galactopyranosyl-(1→3)-6-O-acetyl-4-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl- (1→3)-4,6-
O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranoside (291) 
To a 25 mL flame-dried flask was added 290 
(2.0 g, 1.1 mmol) and the 284 (1.2 g, 1.4 mmol). 
The mixture was dried azeotropically with 
toluene (2x15 mL) and subjected to vacuum 
overnight. It was then dissolved in dry CH2Cl2 
(7.5 mL) and dry MeCN (7.5 mL), cooled to -30 °C, followed by addition of NIS (329 mg; 1.5 mmol) and TESOTf 
(29 mg; 0.1 mmol). The reaction mixture was stirred at -30 °C until TLC revealed full conversion of the donor (2h). 
The solution was diluted with CH2Cl2 (150 mL) and washed with sat. aq. NaS2O3 (150 mL) and sat. aq. NaHCO3 
(150 mL). The organic phase was dried over MgSO4, filtered and concentrated. The product was purified by flash 
chromatography (9:1 Tol/EtOAc) to afford a white crystalline material. Rf 0.66 (2:1 Tol/EtOAc). Yield: 2.2 g (78%) 
Experimental 
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  = -2.3° (c 1.0, CDCl3), IR (neat, cm
-1
): 3539.46, 3064.70, 2972.47, 2932.93, 2906.87, 2872.21, 1739.43, 1700.74, 
1479.84, 1455.43, 1397.77, 1367.06, 1276.81, 1172.99, 1086.91, 1048.10, 1000.89. 
1
H NMR (400 MHz, CDCl3) δ 7.64 
– 7.44 (m, 12H, Ar-H), 7.44 – 7.13 (m, 28H, Ar-H), 5.61 (s, 1H, CHbenzylidene), 5.59 (s, 1H, CHbenzylidene), 5.57 (s, 2H, 
2xCH
benzylidene
), 5.56 (s, 1H, CH
benzylidene
), 5.54 (s, 1H, CH
benzylidene
), 5.52 – 5.34 (m, 7H, H-21-H-27), 4.96 – 4.87 (m, 
3H, CH2
Bn
, H-1), 4.80 – 4.72 (m, 4H, 3xH-1, H-37), 4.70 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.64 (d, J1,2 = 7.9 Hz, 1H, H-1), 
4.62 (d, JCH2 = 12.1 Hz, 1H, 0.5xCH2
Bn
), 4.55 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.46 (d, J1,2 = 7.9 Hz, 1H, H-1), 
4.40 – 4.01 (m, 25H, H-31-H-36, H-41, H-42, H-44, H-45, H-46, H-47, H-61, H-62, H-6a3, H-64, H-65, H-66, H-67), 4.00 
(dd, J6a,6b = 10.8, J5,6b = 6,6 Hz, 1H, H-6b
3
), 3.89 (d, J3,4 = 3.3 Hz, 1H, H-4
3
), 3.50 (t, J5,6a = J5,6b = 6.6 Hz, 1H, H-
5
3
), 3.45 (s, 1H, H-5
1/2/4/5/6/7
), 3.41 (s, 1H, H-5
1/2/4/5/6/7
), 3.38 (s, 1H, H-5
1/2/4/5/6/7
), 3.34 (s, 2H, H-5
1/2/4/5/6/7
, H-
5
1/2/4/5/6/7
), 3.31 (s, 1H, H-5
1/2/4/5/6/7
), 1.93 (s, 3H, CH3
Ac
), 1.19 (s, 9H, 3xCH3
Piv
), 1.17 (s, 18H, 3xCH3
Piv
), 1.13 (s, 9H, 
3xCH3
Piv
), 1.13 (s, 9H, 3xCH3
Piv
), 1.13 (s, 9H, 3xCH3
Piv
), 1.11 (s, 9H, 3xCH3
Piv
), 1.10 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
(101 MHz, CDCl3) δ 178.14, 176.80, 176.17, 176.06, 175.99, 175.95, 175.93, 175.83, 170.23, 137.92, 137.88, 
137.86, 137.78, 137.74, 137.49, 137.19, 136.43, 129.74-125.30(40C), 100.44-99.19(13C), 75.80-62.07(35C), 38.93, 
38.90, 38.72, 38.68, 38.65, 38.61, 38.60, 38.58, 27.29(3C), 27.22(3C), 27.19(3C), 27.19(3C), 27.16(3C), 27.14(3C), 
27.05(3C), 26.99(3C), 20.77. 
 
Benzyl 4,6-O-benzylidene-2,3-O-dipivaloyl-β-D-galactopyranosyl--(1→3)-4,6-O-benzylidene -2-O-pivaloyl-β-D-
galactopyranosyl-(1→3) 4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl- (1→3)-4,6-O-benzylidene -2-
O-pivaloyl-β-D-galactopyranosyl-(1→3)-4-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl- (1→3)-4,6-O-
benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside 
(292) 
291(2 g; 0.8 mmol) was dissolved in dry DCM 
(20 mL) and cooled to 0 °C. A 1M L-selectride 
solution in THF (3.1 mL) was added and the 
reaction was stirred at 0 °C until complete 
consumption of the starting material (1h). The 
reaction mixture was poured into sat. aq. NH4Cl (100 mL). The aqueous phase was extract with DCM (100 mL) and 
the combined organic phase was dried over MgSO4, filtered and concentrated (avoid concentrating to dryness since 
the borane salts can be explosive). The crude product was purified by flash chromatography to give a white 
crystalline product. 
Yield: 1.6 g (79%) 
    
  = -3.9° (c 1.0, CDCl3). IR (neat, cm
-1
): 3511.92, 2972.77, 2933.51, 2907.86, 2873.19, 1736.95, 1700.87, 
1479.95, 1397.88, 1366.87, 1276.67, 1168.85, 1135.17, 1080.83, 1046.25. 
1
H NMR (400 MHz, CDCl3) δ 7.51 – 
7.07 (m, 40H, Ar-H), 5.50 (s, 1H, CH
benzylidene
), 5.48 (s, 1H, CH
benzylidene
), 5.47 (s, 2H, 2xCH
benzylidene
), 5.45 (s, 1H, 
CH
benzylidene
), 5.43 (s, 1H, CH
benzylidene
), 5.42 – 5.04 (m, 7H, 7xH-2), 4.88 – 4.74 (m, 3H, H-1, CH2
Bn
), 4.73 – 4.53 (m, 
4H, 4xH-1, H-3
7
), 4.48 (d, J1,2 = 7.7 Hz, 1H, H-1), 4.44 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2Bn), 4.36 (d, J1,2 = 7.9 Hz, 
1H, H-1), 4.31 (d, J3,4 = 4.0 Hz, 1H, H-4), 4.29 – 3.80 (m,  23H, 6xH-3, 5xH-4, 6xH-6), 3.75 (d, J3,4 = 3.2 Hz, 1H, 
H-4), 3.52 (dd, J6a,6b = 11.3, J5,6a = 5.8 Hz, 1H, H-6a), 3.41 – 3.35 (m, 1H, H-6b), 3.35 (s, 2H, 2xH-5), 3.31 (s, 1H, 
H-5), 3.27 (s, 1H, H-5), 3.26 – 3.24 (m, 2H, 2xH-5), 3.22 (s, 1H, H-5), 1.97 (s, 1H, -OH), 1.11 (s, 9H, 3xCH3
Piv
), 
1.06 (s, 9H, 3xCH3
Piv
), 1.05 (s, 9H, 3xCH3
Piv
), 1.04 (s, 9H, 3xCH3
Piv
), 1.03 (s, 9H, 3xCH3
Piv
), 1.03 (s, 9H, 3xCH3
Piv
), 
1.00 (s, 9H, 3xCH3
Piv
), 0.98 (s, 9H, 3xCH3
Piv
).
13
C NMR (101 MHz, CDCl3) δ 178.28, 176.93, 176.31, 176.23, 
176.20, 176.08, 176.06, 176.04, 138.08, 138.00, 137.90, 137.87, 137.86, 137.61, 137.33, 136.57, 129.87-
125.43(40C), 100.58-99.31(13C), 75.94-66.90(35C), 39.04, 39.03, 38.87, 38.81, 38.79, 38.74, 38.73, 38.69, 
27.46(3C), 27.36(3C), 27.33(3C), 27.32(3C), 27.28(3C), 27.24(3C), 27.18(3C), 27.12(3C). 
 
Benzyl 4,6-O-benzylidene-3-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)- 3-O-4,6-
O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside (293) 
To a 50 mL flame-dried flask was added 261 (2.0 g, 2.57 mmol) and the 
283 (2.6 g, 3.09 mmol). The mixture was dried azeotropically with 
toluene (2x30 mL) and subjected to vacuum overnight. It was then 
dissolved in dry CH2Cl2 (15 mL) and dry MeCN (15 mL), cooled to -30 
°C, followed by addition of NIS (723 mg; 3.21 mmol) and TESOTf (68 
mg; 0.26 mmol). The reaction mixture was stirred at -30 °C until TLC revealed full conversion of the donor (1½h). 
The solution was diluted with CH2Cl2 (150 mL) and washed with sat. aq. NaS2O3 (150 mL) and sat. aq. NaHCO3 
(150 mL). The organic phase was dried over MgSO4, filtered and concentrated. The product was purified by flash 
chromatography (9:1 toluene/EtOAc) to afford a white crystalline material. Rf 0.13 (9:1 Tol/EtOAc). Yield: 3.1 g 
(88%). 
Experimental 
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  = 21.6° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.50 – 7.36 (m, 8H), 7.33 – 7.14 (m, 17H), 5.49 (s, 1H, 
CH
benzylidene
), 5.48 (s, 1H, CH
benzylidene
), 5.46 (s, 1H, CH
benzylidene
), 5.42 (s, 1H, CH
benzylidene
), 5.39 (dd, J2,3 = 10.3, J3,4 = 
7.9 Hz, 1H, H-2
1/2/3/4
), 5.36 – 5.27 (m, 3H, H-21/2/3/4, H-21/2/3/4, H-21/2/3/4 ), 4.88 (d, J1,2 = 8.0 Hz, 1H, H-1
1/2/3/4
), 4.86 
(dd, J2,3 = 10.5, J3,4 = 3.6 Hz, 1H, H-3
4
), 4.82 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.68 (d, J1,2 = 7.9 Hz, 1H, H-
1
1/2/3/4
), 4.67 (d, J = 7.9 Hz, 1H, H-1
1/2/3/4
), 4.44 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.35 (d, J1,2 = 7.9 Hz, 1H, H-
1
1/2/3/4
), 4.30 – 3.84 (m, 17H, H-31-H-33, H-41-H-44, H-61-H-64, CH2
AcCl
), 3.35 (m, 1H, H-5
1/2/3/4
), 3.30 (m, 1H, H-
5
1/2/3/4
), 3.25 (m, 1H, H-5
1/2/3/4
), 3.24 (m, 1H, H-5
1/2/3/4
), 1.08 (s, 9H, 3xCH3
Piv
), 1.05 (s, 9H, 3xCH3
Piv
), 1.03 (s, 9H, 
3xCH3
Piv
), 1.01 (s, 9H, 3xCH3
Piv
). 
13
C NMR
 
(101 MHz, CDCl3) δ 176.93, 176.13, 175.98, 175.96, 167.08, 137.90, 
137.75, 137.67, 137.28, 137.18, 129.20-125.31 (25C), 100.89, 100.33 (2C), 100.14 (2C), 99.99, 99.65, 99.14, 75.92 
(2C), 75.63, 73.48, 73.25, 72.12, 71.87, 71.48, 71.13, 70.80, 69.99, 68.77, 68.63, 68.53, 68.27, 67.41, 67.36, 66.94, 
66.60, 40.59, 38.77, 38.68, 38.63 (2C), 27.29-21.48 (12C). 
 
Benzyl 4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranoside (294) 
293 (2.5 g; 1.6 mmol) was dissolved in dry CH2Cl2 (30 mL) and cooled to 
0 °C. A 1M L-selectride solution in THF (4.9 mL) was added and the 
reaction was stirred at 0 °C until complete consumption of the starting 
material (0.5 h). The reaction mixture was poured into sat. aq. NH4Cl (100 
mL). The aqueous phase was extracted with CH2Cl2 (100 mL). The 
combined organic phase was dried over MgSO4, filtered and concentrated (avoid concentrating to dryness since the 
borane salts can be explosive). The crude product was purified by flash chromatography (4:1 Tol/EtOAc) to give a 
white crystalline product. Rf 0.46 (2:1 Tol/EtOAc). Yield:  2.2 g (94%) 
    
  = 4.7° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.55 – 7.34 (m, 8H), 7.34 – 7.11 (m, 17H), 5.53 – 5.44 
(m, 4H, 4xCH
benzylidene
), 5.39 (dd, J2,3 = 9.8, J1,2 = 7.4 Hz, 1H, H-2
1/2/3/4
), 5.34 (m, 2H, H-2
1/2/3/4
, H-2
1/2/3/4
), 4.97 (dd, 
J2,3 = 10.0, J1,2 = 8.0 Hz, 1H, H-2
4
), 4.82 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.77 (d, J1,2 = 8.0 Hz, 1H, H-1
4
), 4.69 
(d, J1,2 = 7.9 Hz, 1H, H-1
1/2/3/4
), 4.68 (d, J1,2 = 8.0 Hz, 1H, H-1
1/2/3/4
), 4.44 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.36 
(d, J1,2 = 7.8 Hz, 1H, H-1
1/2/3/4
), 4.31 – 3.90 (m, 15H, H-31-H-33, H-41-H-44, H-61-H-64), 3.51 (td, J2,3 = 10.3, J3,4 = 
3.6 Hz, 1H, H-3
4
), 3.37 – 3.21 (m, 4H, H-51-H-54), 1.07 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
), 1.05 (s, 9H, 
3xCH3
Piv
), 1.03 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 178.81, 176.09, 175.99, 175.97, 137.90, 137.76, 
137.66, 137.34, 137.17, 129.28-126.09 (25C), 101.25, 100.34 (2C), 100.30, 100.15, 99.99, 99.64, 99.20, 77.27, 
76.00, 75.92, 75.64 (2C), 72.37, 72.14, 71.98, 71.88, 71.49, 71.11, 70.87, 70.00, 68.76, 68.65, 68.55, 67.41, 67.37, 
66.93, 66.89, 38.87, 38.68, 38.64, 38.61, 27.23, 27.20, 27.16, 27.03. 
 
Benzyl 6-O-acetyl-4-O-benzyl-3-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-
2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-
benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside 
(295) 
To a 25 mL flame-dried flask was added 294 (2.8 g, 1.93 mmol) 
and the 286 (1.5 g, 2.7 mmol). The mixture was dried 
azeotropically with toluene (2x25 mL) and subjected to vacuum 
overnight. It was then dissolved in dry CH2Cl2 (12.5 mL) and 
dry MeCN (12.5 mL), cooled to -30 °C, followed by addition of 
NIS (651 mg;  2.90 mmol) and TESOTf (51 mg; 0.19 mmol). The reaction mixture was stirred at -30 °C until TLC 
revealed full conversion of the donor (3h). The solution was diluted with CH2Cl2 (150 mL) and washed with sat. aq. 
NaS2O3 (150 mL) and sat. aq. NaHCO3 (150 mL). The organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash chroma-tography (4:1 Tol/EtOAc) to afford 295 as a white 
crystalline material. Rf 0.64 (2:1 Tol/ EtOAc). Yield: 2.5 g (69%) 
    
  = 5.9° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.50 – 7.37 (m, 8H), 7.32 – 7.14 (m, 17H), 5.48 (s, 1H, 
CH
benzylidene
), 5.47 (s, 1H, CH
benzylidene
), 5.46 (s, 2H, 2xCH
benzylidene
), 5.39 (dd, J2,3 = 10.2, J1,2 = 7.9 Hz, 1H, H-
2
1/2/3/4/5
), 5.33 (dd, J2,3 = 10.5, J1,2 = 8.0 Hz, 1H, H-2
1/2/3/4/5
), 5.30 – 5.23 (m, 3H, H-21/2/3/4/5, H-21/2/3/4/5, H-21/2/3/4/5), 
4.87 (dd, J2,3 = 10.2, J2,3 = 3.1 Hz, 1H, H-3
5
), 4.82 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.71 (d, J1,2 = 7.7 Hz, 1H, H-
1
1/2/3/4/5
), 4.66 (m, 3H, H-1
1/2/3/4/5
, H-1
1/2/3/4/5
, H-1
1/2/3/4/5
), 4.62 (d, JCH2 = 12.5 Hz, 1H, 0.5xCH2
Bn
), 4.50 (d, JCH2 = 
11.6 Hz, 1H, 0.5xCH2
Bn
), 4.44 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.36 (d, J = 7.9 Hz, 1H, H-1
1/2/3/4/5
), 4.30 – 3.90 
(m, 18H, H-3
1
-H-3
4
, H-4
1
-H-4
4
, H-6
1
-H-6
5
), 3.84 (d, J3,4 = 2.8 Hz, 1H, H-4
5
), 3.79 (d, JCH2 = 15.0 Hz, 1H, 
0.5xCH2
AcCl
), 3.72 (d, JCH2 = 15.0 Hz, 1H, 0.5xCH2
AcCl
), 3.60 (t, J5,6a = J5,6b = 6.5 Hz, 1H, H-5
5
), 3.31 (s, 1H, H-
5
1/2/3/4
), 3.27 – 3.23 (m, 2H, H-51/2/3/4), 3.21 (s, 1H, H-51/2/3/4), 1.94 (s, 3H, CH3
Ac
), 1.07 (s, 9H, 3xCH3
Piv
), 1.04 (s, 
9H, 3xCH3
Piv
), 1.01 (s, 9H, 3xCH3
Piv
), 1.01 (s, 9H, 3xCH3
Piv
), 1.00 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) 
Experimental 
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δ 177.01, 176.04, 176.01, 175.97, 175.93, 170.18, 166.74, 137.89, 137.76, 137.73, 137.65, 137.19, 137.17, 129.04-
126.00 (30C), 100.36, 100.34, 100.26, 100.17, 100.13, 99.98, 99.69, 99.64, 99.54, 77.27, 75.89, 75.79, 75.63, 75.12, 
74.91, 73.55, 72.55, 71.93, 71.84, 71.54, 71.44, 71.16, 71.08, 71.00, 69.98, 68.92, 68.76, 68.65, 68.49, 67.49, 67.41, 
67.32, 66.93, 62.05, 40.30, 38.77, 38.67, 38.63, 38.59 (2C), 27.21 (3C), 27.19 (6C), 27.12 (3C), 27.01 (3C), 20.83. 
 
Benzyl 6-O-acetyl-4-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl- (1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside (296)  
295 (2.0 g; 1.05 mmol) was dissolved in 30 mL dry THF. Thiourea 
(481 mg; 6.3 mmol), Bu4NI (389 mg; 1.05 mmol) and NaHCO3 
(265 mg; 3.15 mmol) was added and the reaction mixture was 
heated to 55 °C for 12 h. The mixture was filtered, concentrated 
and purified by flash chromatography (19:1 Tol/EtOAc) to give 
296 as colorless syrup. Rf 0.48 (9:1 Tol/EtOAc). Yield: 1.6 g (83%) 
    
  = 0.0° (c 1.0, CDCl3). IR (neat, cm
-1
): 3524.49, 3089.87, 2972.59, 2931.86, 2906.24, 2871.90, 1741.17, 1497.18, 
1479.57, 1397.64, 1366.55, 1277.25, 1232.63, 1173.45, 1088.19, 1048.36, 1027.67. 
1
H NMR (400 MHz, CDCl3) δ 7.49 
– 7.35 (m, 12H), 7.32 – 7.13 (m, 18H), 5.48 (s, 1H, CHbenzylidene), 5.47 (s, 1H, CHbenzylidene), 5.46 (s, 1H, CHbenzylidene), 
5.45 (s, 1H, CH
benzylidene
), 5.39 (dd, J2,3 = 10.1, J1,2 = 8.1 Hz, 1H, H-2), 5.36 – 5.26 (m, 4H, 4xH-2), 4.85 (d, JCH2 = 
12.2 Hz, 1H, 0.5xCH2
Bn
), 4.83 (d, J2,3 = 10.1, J3,4 = 3.2 Hz, 1H, H-2
1
), 4.75 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2
Bn
), 4.69 
– 4.59 (m, 4H, H-12-H-15), 4.61 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.45 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.36 
(d, J1,2 = 7.9 Hz, 1H, H-1
1
), 4.29 – 3.93 (m, 18H, 4xH-3, H-41-H-44, 5xH-6), 3.89 (dd, J2,3 = 10.3, J3,4 = 3.2 Hz, 1H, 
H-3), 3.69 (d, J3,4 = 2.7 Hz, 1H, H-4
5
), 3.49 (t, J5,6a = J5,6b = 6.8 Hz, 1H, H-5
5
), 3.31 (s, 1H, H-5
1/2/3/4
), 3.26 (s, 2H, 
H-5
1/2/3/4
, H-5
1/2/3/4
), 3.22 (s, 1H, H-5
1/2/3/4
), 1.94 (s, 3H, CH3
Ac
), 1.07 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
), 1.04 
(s, 9H, 3xCH3
Piv
), 1.02 (s, 9H, 3xCH3
Piv
), 1.01 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 180.28, 176.14, 
176.08 (2C), 176.04, 170.39, 137.99, 137.87, 137.85, 137.73, 137.69, 137.26, 128.69-126.17 (30C), 100.46, 100.44 
(2C), 100.41, 100.39, 100.23, 100.07, 99.79, 99.72, 99.63, 77.36, 76.23, 75.99, 75.91, 75.82, 75.73, 73.94, 73.61, 
72.80, 72.68, 72.03, 71.94, 71.59, 71.27, 71.18, 71.12, 70.08, 68.86, 68.74, 68.63, 67.58, 67.51, 67.43, 67.02, 62.71, 
39.05, 38.76, 38.73, 38.69, 38.66, 27.31 (3C), 27.28 (6C), 27.21 (3C), 27.04 (3C), 20.94 (3C). 
 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-6-O-acetyl-4-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-
2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-
benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside 
(297) 
To a 25 mL flame-dried flask was added 296 (1.8 
g, 0.99 mmol) and 284 (1.1 g, 1.3 mmol). The 
mixture was dried azeotropically with toluene 
(2x10 mL) and subjected to vacuum overnight. It 
was then dissolved in dry CH2Cl2 (5 mL) and dry 
MeCN (5 mL), cooled to -30 °C, followed by addition of NIS (294 mg; 1.31 mmol) and TESOTf (26 mg; 0.1 
mmol). The reaction mixture was stirred at -30 °C until TLC revealed full conversion of the donor (3h). The solution 
was diluted with CH2Cl2 (100 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The 
organic phase was dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography 
(19:1 Tol/EtOAc) to afford a white crystalline material. Rf 0.58 (9:1 Tol/EtOAc). Yield: 1.95 g (77%) 
    
  = 7.1° (c 1.0, CDCl3). IR (neat, cm
-1
): 3065.85, 3035.79, 2972.47, 2871.63, 1738.98, 1479.57, 1454.98, 
1397.69, 1366.40, 1276.70, 1172.84, 1132.25, 1087.66, 1047.67, 1027.15. 
1
H NMR (400 MHz, CDCl3) δ 7.61 – 
6.91 (m, 40H, Ar-H), 5.51 (s, 1H, CH
benzylidene
), 5.48 (s, 1H, CH
benzylidene
), 5.46 (s, 2H, 2xCH
benzylidene
), 5.45 (s, 2H, 
2xCH
benzylidene
), 5.44 – 5.18 (m, 7H, 7xH-2), 4.83 (d, J = 8.1 Hz, 1H, H-1), 4.83 (d, JCH2 = 11.7 Hz, 1H, 0.5xCH2
Bn
), 
4.82 (d, JCH2 =11.9 Hz, 1H, 0.5xCH2
Bn
), 4.70 (dd, J2,3 = 10.5, J3,4 = 3.7 Hz, 1H, H-3
7
), 4.68 – 4.57 (m, 4H, 4xH-1), 
4.52 (d, J1,2 = 7.7 Hz, 1H, H-1), 4.49 (d, JCH2 = 11.7 Hz, 1H, 0.5xCH2
Bn
), 4.44 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 
4.35 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.33 (d, J3,4 = 3.8 Hz, 1H, H-4), 4.27 (d, J3,4 = 3.3 Hz, 1H, H-4), 4.26 – 3.93 (m, 
24H, 6xH-3, 5xH-4, 6.5xH-6), 3.90 (dd, J6a,6b = 11.0, J5,6b = 7.1 Hz, 1H, H-6b
5
), 3.78 (s, 1H, H-5), 3.41 (t, J5,6a = 
J5,6b = 6.6 Hz, 1H, H-5
5
), 3.38 (s, 1H, H-5), 3.29 (s, 1H, H-5), 3.23 (m, 2H, 2xH-5), 3.21 (s, 1H, H-5), 1.83 (s, 3H, 
CH3
Ac
), 1.10 (s, 9H, 3xCH3
Piv
), 1.07 (s, 18H, 6xCH3
Piv
), 1.04 (s, 9H, 3xCH3
Piv
), 1.02 (s, 9H, 3xCH3
Piv
), 1.00 (s, 18H, 
6xCH3
Piv
), 0.99 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 178.24, 176.98, 176.35, 176.15, 176.06, 176.02, 
176.00, 175.90, 170.39, 138.38, 137.96, 137.89, 137.86 (2C), 137.84, 137.56, 137.26, 129.13-125.97 (40C), 100.50, 
100.44 (2C), 100.33, 100.30, 100.21 (2C), 100.13, 100.09, 100.04, 99.71, 99.20, 77.36, 75.96, 75.87, 75.75, 75.72, 
75.71, 74.79, 74.49, 74.38, 73.11 (2C), 72.28, 71.99, 71.96, 71.93, 71.73, 71.62, 71.55, 71.52, 71.35, 71.27, 71.24, 
Experimental 
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71.14, 70.06, 68.84 (2C), 68.73, 68.60 (2C), 68.32, 67.56, 67.49 (2C), 67.01, 66.91, 62.29, 38.99, 38.81, 38.76 (2C), 
38.71, 38.66, 38.65 (2C), 27.40 (3C), 27.29 (6C), 27.26 (3C), 27.24 (3C), 27.19 (3C), 27.08 (6C), 20.89. 
 
Benzyl 4,6-O-benzylidene-2,3-O-dipivaloyl-β-D-galactopyranosyl--(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-6-O-acetyl-4-O-benzyl-3-O-chloroacetyl-2-O-pivaloyl-β-D-galactopyranosyl- (1→3)-
4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranoside (298) 
297(2 g; 0.8 mmol) was dissolved in dry DCM 
(20 mL) and cooled to 0 °C. A 1M L-selectride 
solution in THF (3.1 mL) was added and the 
reaction was stirred at 0 °C until complete 
consumption of the starting material (1h). The 
reaction mixture was poured into sat. aq. NH4Cl (100 mL). The aqueous phase was extract with DCM (100 mL) and 
the combined organic phase was dried over MgSO4, filtered and concentrated (avoid concentrating to dryness since 
the borane salts can be explosive). The crude product was purified by flash chromatography (9:1 Tol/EtOAc) to give 
298 as a colorless crystalline material. Yield: 1.6 g (79%) 
1
H NMR (400 MHz, CDCl3) δ 7.52 – 7.02 (m, 40H), 5.50 (s, 1H, CH
benzylidene
), 5.47 (s, 1H, CH
benzylidene
), 5.45 (m, 
4H, 4xCH
benzylidene
), 5.43 – 5.16 (m, 7H, 7xH-2), 4.84 (d, J1,2 = 7.7 Hz, 1H, H-1), 4.82 (d, JCH2 = 11.4 Hz, 1H, 
0.5xCH2
Bn
), 4.79 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2
Bn
), 4.70 (dd, J2,3 = 10.3, J3,4 = 3.7 Hz, 1H, H-3
7
), 4.67 (d, J1,2 = 
7.8 Hz, 1H, H-1), 4.64 (d, J1,2 = 7.5 Hz, 1H, H-1), 4.62 (d, J1,2 = 7.5 Hz, 1H, H-1), 4.61 (d, J1,2 = 7.7 Hz, 1H, H-1), 
4.57 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.56 (d, JCH2 = 12.1 Hz, 1H, 0.5xCH2
Bn
), 4.45 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2
Bn
), 
4.36 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.33 (d, J3,4 = 3.8 Hz, 1H, H-4), 4.29 – 3.88 (m, 23H, 6xH-3, 5xH-4, 6xH-6), 3.74 
(d, J3,4 = 3.1 Hz, 1H, H-4), 3.52 (dd, J6a,6b = 11.6, J5,6a = 5.9 Hz, 1H, H-6a
5
), 3.39 (s, 1H, H-5), 3.40 – 3.31 (m, 1H, 
H-6b
5
), 3.30 (s, 1H, H-5), 3.24 (s, 2H, 2xH-5), 3.23 (s, 1H, H-5), 3.21 – 3.19 (m, 2H, 2xH-5), 2.08 (s, 1H, -OH), 
1.12 (s, 9H, 3xCH3
Piv
), 1.07 (s, 18H,6xCH3
Piv
), 1.04 (s, 9H, 3xCH3
Piv
), 1.03 (s, 9H, 3xCH3
Piv
), 1.00 (s, 9H, 
3xCH3
Piv
), 0.98 (s, 9H, 3xCH3
Piv
), 0.97 (s, 9H, 3xCH3
Piv
). 
13
C NMR (101 MHz, CDCl3) δ 178.24, 176.96, 176.40, 
176.30, 176.09, 176.07, 175.97, 175.97, 138.26, 138.01, 137.99, 137.98, 137.91, 137.87, 137.61, 137.32, 129.85-
125.42(40C), 100.55-99.21(13C), 77.48, 76.17, 76.02, 75.94, 75.80, 75.78, 75.66, 74.96, 74.67, 74.20, 73.17, 72.47, 
72.01, 71.94, 71.66, 71.60, 71.50, 71.41, 71.33, 71.21, 70.06, 70.03, 68.88, 68.77, 68.66, 68.62, 68.35, 67.60, 67.53, 
67.52, 67.49, 67.07, 66.94, 39.02, 38.86, 38.79, 38.78, 38.77, 38.74, 38.73, 38.69, 27.48(3C), 27.36(3C), 27.32(3C), 
27.29(3C), 27.27(3C), 27.25(3C), 27.11(3C), 27.10(3C). 
 
Phenyl 2,3,5-tri-O-benzoyl-1-thio--L-arabinofuranoside (299) 
To a solution of 190 (7.8 g, 16.4 mmol) in   CH2Cl2 (200 mL) at 0 °C was added thiophenol (2.4 
mL, 22.4 mmol) dropwise. The reaction mixture was stirred at 0 °C for 15 min, then BF3
.
Et2O (13.6 
mL, 107.2 mmol) was added and the resulting mixture was warmed gradually to 22 °C. The reaction 
was stirred for 8 h at 22 °C. The reaction mixture was poured into sat. aq. NaHCO3 (100 mL). The 
water phase was extracted with CH2Cl2 (50 mL). The combined organic phases were dried over MgSO4, filtered and 
concentrated. The resulting residue was purified by column chromatography (20:1 Tol/EtOAc) to afford 299 as an 
amorphous solid. Rf 0.65 (9:1 Tol/EtOAc). Yield: 7.4 g (81%) 
    
  = 48.5° (c 1.0, CDCl3). IR (neat, cm
-1
): 3061.69, 1721.80, 1601.55, 1584.07, 1480.24, 1451.45, 1440.37, 
1315.28, 1266.25, 1177.61, 1107.62, 1095.64, 1069.33, 1026.52 
1
H NMR (400 MHz, CDCl3) δ 8.06 (m, 2H, Ar-H), 
8.03 – 7.91 (m, 4H, Ar-H), 7.62 – 7.14 (m, 14H, Ar-H), 5.77 (d, J = 3.7 Hz, 1H, H-1), 5.70 – 5.63 (m, 1H, H-2), 
5.60 (s, 1H, H-3), 4.91 – 4.60 (m, 2H, H-4, H-5a, H-5b). 13C NMR (101 MHz, CDCl3) δ 166.18, 165.60, 165.37, 
133.70-127.87 (24C), 91.45, 82.57, 81.17, 78.05, 63.52 HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C32H26NaO7S 
577.1297; Found 577.1299. 
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Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene -2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-[2,3,5-tri-O-benzoyl--L-arabinosyl-(1→6)]-4-O-benzyl-2-O-pivaloyl-β-
D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-
O-pivaloyl-β-D-galactopyranoside (300) 
To a 25 mL flame-dried flask was added 292 
(600 mg, 0.24 mmol) and the 193 (197 mg, 0.36 
mmol). The mixture was dried azeotropically 
with tol-uene (2x5 mL) and subject-ted to 
vacuum overnight. It was then dissolved in dry 
CH2Cl2 (2 mL) and dry MeCN (2 mL), cooled to 
-30 °C, followed by addition of NIS (82 mg; 
0.37 mmol) and TESOTf (13 mg; 0.05 mmol). 
The reaction mixture was stirred at -30 °C until TLC revealed full conversion of the donor (1h). The solution was 
diluted with CH2Cl2 (50 mL) and washed with sat. aq. NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The organic 
phase was dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography (19:1 
Tol/EtOAc) to afford a white crystalline material. Yield: 486 mg (69%) 
    
  = 2.4° (c 1.0, CDCl3). IR (neat, cm
-1
): 3090.00, 3065.36, 2972.21, 2933.47, 2907.23, 2872.02, 1722.44, 
1452.75, 1366.69, 1269.93, 1174.22, 1130.12, 1088.96, 1048.87, 1026.90 
1
H NMR (400 MHz, CDCl3) δ 8.04 (dd, J = 8.0, 1.0 Hz, 2H, Ar-H
Bz
), 8.00 (dd, J = 8.2, 1.3 Hz, 1H, Ar-H
Bz
), 7.96 
(dd, J = 8.1, 1.2 Hz, 2H, Ar-H
Bz
), 7.60 – 7.46 (m, 12H, Ar-H), 7.46 – 7.24 (m, 31H, Ar-H), 7.24 – 7.14 (m, 6H, Ar-
H), 5.65 (s, 1H, CH
benzylidene
), 5.59 – 5.56 (m, 4H, 4xCHbenzylidene), 5.55 (s, 1H, CHbenzylidene), 5.54 – 5.33 (m, 9H, H-
2
1
-H-2
7
, H-2’, H-3’), 5.25 (s, 1H, H-1’), 4.94 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.92 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 
4.81 (dd, J2,3 = 10.0, J3,4 = 3.1 Hz, 1H, H-3
7
), 4.79 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.78 – 4.72 (m, 4H, 4xH-1), 
4.69 (d, J1,2 = 8.0 Hz, 1H, H-1), 4.64 (dd, J5a,5b = 12.1, J4,5a = 3.4 Hz, 1H, H-5a’), 4.55 (d, JCH2 = 11.9 Hz, 1H, 
0.5xCH2
Bn
), 4.48 (dd J5a,5b = 12.1, J4,5a = 4.7 Hz, 1H, H-5b’), 4.45 – 4.02 (m, 27H, H-1, H-3
1
-H-3
6
, 6xH-4
1/2/4/5/6/7
, 
6xH-6
1/2/4/5/6/7
, H-4’, 0.5xCH2
Bn
), 3.94 (d, J3,4 = 3.7 Hz, 1H, H-4
3
), 3.92 (dd, J6a,6b = 9.6, J5,6a = 6.6 Hz, 1H, H-6a
3
), 
3.66 (t, J5,6a = J5,6b = 6.6 Hz, 1H, H-5
3
), 3.56 (dd, J6a,6b = 9.6, J5,6b = 6.6 Hz, 1H, H-6b
3
), 3.50 (s, 1H, H-4
1/2/4/5/6/7
), 
3.48 (s, 1H, H-4
1/2/4/5/6/7
), 3.41 (s, 1H, H-4
1/2/4/5/6/7
), 3.37 (s, 1H, H-4
1/2/4/5/6/7
), 3.35 (s, 1H, H-4
1/2/4/5/6/7
), 3.31 (s, 1H, H-
4
1/2/4/5/6/7
), 1.19 (s, 9H, 3xCH3
Piv
), 1.17 (s, 9H, 3xCH3
Piv
), 1.15 (s, 9H, 3xCH3
Piv
), 1.15 (s, 18H, 6xCH3
Piv
), 1.10 (s, 
18H, 6xCH3
Piv
), 1.05 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 178.26, 176.96, 176.21, 176.06 (2C), 
175.94, 175.92, 175.90, 166.26, 165.80, 165.54, 138.76, 137.98, 137.95 (2C), 137.89, 137.84, 137.56, 137.29, 
134.05, 133.72, 133.15, 130.16-125.42 (55C), 106.43, 100.56, 100.45 (2C), 100.38, 100.28, 100.24 (2C), 100.21 
(2C), 100.08, 99.84, 99.80, 99.42, 82.14, 81.50, 77.58, 77.36, 76.91, 76.12, 76.03, 75.99, 75.91, 75.86, 75.73, 74.48, 
74.42, 74.19, 73.14, 72.43, 72.01, 71.96, 71.89, 71.56, 71.46, 71.29, 71.03, 70.06, 68.86, 68.75, 68.63, 68.44, 67.75, 
67.59, 67.52, 67.41, 67.05, 66.95, 66.07, 63.57, 39.03, 38.83, 38.77, 38.73, 38.70 (2C), 38.68, 38.65, 27.41 (3C), 
27.35 (3C), 27.32 (6C), 27.26 (3C), 27.20 (6C), 27.12 (3C). 
 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene -2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-[2,3,5-tri-O-benzoyl--L-arabinosyl-(1→6)]-4-O-benzyl-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl- (1→3)-4,6-O-benzylidene-2-
O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-
benzylidene-2-O-pivaloyl-β-D-galactopyranoside (301) 
To a 25 mL flame-dried flask was added 298 
(400 mg, 0.13 mmol) and the 193 (111 mg, 0.20 
mmol). The mixture was dried azeotropically 
with toluene (2x5 mL) and subjected to vacuum 
overnight. It was then dissolved in dry CH2Cl2 (2 
mL) and dry MeCN (2 mL), cooled to -30 °C, 
followed by addition of NIS (51 mg; 0.31 mmol) 
and TESOTf (9 mg; 0.04 mmol). The reaction 
mixture was stirred at -30 °C until TLC revealed full conversion of the donor (1h). The solution was diluted with 
CH2Cl2 (50 mL) and washed with sat. aq. NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The organic phase was 
dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography (19:1 Tol/EtOAc) 
to afford a white crystalline material. Yield: 245 mg (72%) 
    
  = -4.7° (c 1.0, CDCl3). IR (neat,cm
-1
):3524.96, 2972.52, 2933.68, 2906.86, 2872.57, 1734.93, 1496.69, 
1456.03, 1397.62, 1366.61, 1277.07, 1170.07, 1082.44, 1046.46, 1001.32. 
1
H NMR (400 MHz, CDCl3) δ 8.11 – 
7.81 (m, 6H, Ar-H
Bz
), 7.58 – 6.99 (m, 49H, Ar-H), 5.53 (s, 1H, CHbenzylidene), 5.49 (s, 1H, CHbenzylidene), 5.47 (s, 1H, 
Experimental 
 193 
CH
benzylidene
), 5.47 (s, 1H, CH
benzylidene
), 5.45 (s, 1H, CH
benzylidene
), 5.44 (s, 1H, CH
benzylidene
), 5.43 – 5.42 (m, 1H, H-
2’/H-3’,), 5.40 – 5.25 (m, 8H, H-2’/H-3’, H-21-H-27), 5.14 (s, 1H, H-1’), 4.83 (d, J1,2 = 8.1 Hz, 1H, H-1), 4.79 (d, 
JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.75 – 4.59 (m, 8H, 5xH-1, H-37, H-5a’, 0.5xCH2
Bn
), 4.50 (dd, J5a,5b = 12.3, J4,5b = 
4.6 Hz, 1H, H-5b’), 4.43 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.34 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.33 – 3.90 (m, 26H, 
H-3
1
-H-3
6
, 6xH-4
1/2/3/4/6/7
, 6xH-6
1/2/3/4/6/7
, H-4’, 0.5xCH2
Bn
), 3.84 (d, J3,4 = 2.9 Hz, 1H, H-4
5
), 3.76 (dd, J6a,6b = 9.5, 
J5,6a = 6.0 Hz, 1H, H-6a
5
), 3.55 (t, J5,6a = J5,6b = 6.0 Hz, 1H, H-5
5
), 3.48 (dd, J6a,6b = 9.5, J5,6b = 6.0 Hz, 1H, H-6b
5
), 
3.43 (s, 1H, H-5
1/2/3/4/6/7
), 3.37 (s, 1H, H-5
1/2/3/4/6/7
), 3.30 (s, 1H, H-5
1/2/3/4/6/7
), 3.26 (s, 1H, H-5
1/2/3/4/6/7
), 3.23 (s, 1H, H-
5
1/2/3/4/6/7
), 3.22 (s, 1H, H-5
1/2/3/4/6/7
), 1.07 (s, 9H, 3xCH3
Piv
), 1.07 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
), 1.05 (s, 
18H, 6xCH3
Piv
), 1.00 (s, 9H, 3xCH3
Piv
), 0.99 (s, 9H, 3xCH3
Piv
), 0.99 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, 
CDCl3) δ 178.27, 176.94, 176.20, 176.18, 176.02, 175.98, 175.97, 175.84, 166.26, 166.24, 166.22, 138.73, 138.03, 
137.96, 137.92, 137.86, 137.83, 137.58, 137.31, 133.84, 133.72, 133.27, 130.15-125.41 (55C), 106.45, 101.11, 
100.56, 100.46, 100.39, 100.34, 100.29 (2C), 100.21 (2C), 100.06, 99.98, 99.75, 99.30, 82.64, 82.09, 81.52, 81.35, 
78.09, 77.62, 77.36, 76.91, 76.03, 75.95, 75.91, 75.74, 74.54, 74.46, 74.22, 73.15, 72.31, 72.03, 71.92, 71.74, 71.69, 
71.64, 71.52, 71.39, 71.25, 71.14, 69.96, 68.85, 68.62, 68.39, 67.77, 67.65, 67.53, 67.33, 67.06, 66.87, 64.02, 63.83, 
63.55, 39.01, 38.80, 38.73 (5C), 38.68, 27.39 (3C), 27.34 (6C), 27.32 (6C), 27.20 (3C), 27.16 (3C), 27.10 (3C). 
 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene -2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-[4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-
benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)]-4-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-
4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranoside (302) 
To a 25 mL flame-dried flask was added 292 
(600 mg, 0.24 mmol) and the 186 (337 mg, 0.36 
mmol). The mixture was dried azeotropically 
with tol-uene (2x5 mL) and subjected to vacuum 
overnight. It was then dissolved in dry CH2Cl2 (2 
mL) and dry MeCN (2 mL), cooled to -30 °C, 
followed by addition of NIS (82 mg; 0.37 mmol) 
and TESOTf (13 mg; 0.05 mmol). The reaction 
mixture was stirred at -30 °C until TLC revealed 
full conversion of the donor (2h). The solution 
was diluted with CH2Cl2 (50 mL) and washed 
with sat. aq. NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash chromatography (19:1 Tol/EtOAc) to afford a white crystalline 
material. Yield: 583 mg (73%) 
 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-[4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-
(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)]-4-O-benzyl-2-O-pivaloyl-β-D-
galactopyranosyl- (1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl- (1→3)-4,6-O-
benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside (303) 
To a 25 mL flame-dried flask was added 298 
(500 mg, 0.20 mmol) and the 186 (281 mg, 0.30 
mmol). The mixture was dried azeotropically 
with tol-uene (2x5 mL) and subjected to vacuum 
overnight. It was then dissolved in dry CH2Cl2 (2 
mL) and dry MeCN (2 mL), cooled to -30 °C, 
followed by addition of NIS (69 mg; 0.31 mmol) 
and TESOTf (10 mg; 0.04 mmol). The reaction 
mixture was stirred at -30 °C until TLC revealed 
full conversion of the donor (1h). The solution 
was diluted with CH2Cl2 (50 mL) and washed 
with sat. aq. NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash chromatography (19:1 Tol/EtOAc) to afford a white crystalline 
material. Yield: 505 mg (76%) 
Experimental 
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  = 4.2° (c 1.0, CDCl3). IR (neat, cm
-1
): 3524.96, 2972.52, 2933.68, 2906.86, 2872.57, 1734.93, 1496.69, 
1456.03, 1397.62, 1366.61 1277.07, 1170.07, 1082.44, 1046.46, 1001.32. 
1
H NMR (400 MHz, CDCl3) δ 7.41 (m, 
14H, Ar-H), 7.33 – 7.03 (m, 38H, Ar-H), 5.53 – 5.11 (m, 16H, 7xCHbenzylidene, H-21-H-27, H-21’, H-22’), 4.94 (dd, J2,3 
= 10.4, J3,4 = 3.1 Hz, 1H, H-3
7/1’/2’
), 4.84 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.89 – 4.74 (m, 3H, , H-3
7/1’/2’
,
 
CH2
Bn
), 4.73 – 
4.60 (m, 5H, 3xH-1, H-3
7/1’/2’
, 0.5xCH2
Bn
), 4.59 (d, J1,2 = 8.1 Hz, 1H, H-1), 4.55 (d, JCH2 = 11.2 Hz, 1H, 0.5xCH2
Bn
), 
4.47 (d, J1,2 = 7.7 Hz, 1H, H-1), 4.45 (d, JCH2 = 11.9 Hz, 1H, 0.5xCH2
Bn
), 4.41 (d, JCH2 = 12.2 Hz, 1H, 0.5xCH2
Bn
), 
4.36 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.32 (d, J = 3.8 Hz, 1H, H-4
1/2/3/4/6/7/2’
), 4.28 (d, J = 4.0 Hz, 1H, H-4
1/2/3/4/6/7/2’
), 4.25 
– 3.87 (m, 30H, H-31-H-36, H-41/2/3/4/6/7/2’, H-41/2/3/4/6/7/2’, H-41/2/3/4/6/7/2’, H-41/2/3/4/6/7/2’, H-41/2/3/4/6/7/2’, H-41/2/3/4/6/7/2’, H-
6
1
-H-6
7
, H-6
1’
, H-6
2’
), 3.79 (d, J3,4 = 3.4 Hz, 1H, H-4
5/1’
), 3.74 (d, J3,4 = 3.8 Hz, 1H, H-4
5/1’
), 3.52 (dd, J5,6a = 9.6, 
J5,6b = 6.4 Hz, 1H, H-5
5/1’
), 3.48 (dd, J5,6a = 7.9, J5,6b = 5.6 Hz, 1H, H-5
5/1’
), 3.39 (s, 1H, H-5
1/2/3/4/6/7/2’
), 3.35 (s, 1H, 
H-5
1/2/3/4/6/7/2’
), 3.33 (s, 1H, H-5
1/2/3/4/6/7/2’
), 3.31 (s, 1H, H-5
1/2/3/4/6/7/2’
), 3.29 (s, 1H, H-5
1/2/3/4/6/7/2’
), 3.26 (s, 1H, H-
5
1/2/3/4/6/7/2’
), 3.20 (s, 1H, H-5
1/2/3/4/6/7/2’
), 1.08 (s, 9H, 3xCH3
Piv
), 1.08 (s, 9H, 3xCH3
Piv
), 1.075 (s, 18H, 3xCH3
Piv
), 1.07 
(s, 9H, 3xCH3
Piv
), 1.04 (s, 18H, 3xCH3
Piv
), 1.02 (s, 9H, 3xCH3
Piv
), 1.02 (s, 9H, 3xCH3
Piv
), 0.99 (s, 9H, 3xCH3
Piv
), 
0.98 (s, 9H, 3xCH3
Piv
), 0.98 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 178.15, 178.10, 177.51, 176.84, 
176.44, 176.28, 176.20, 176.10, 175.97, 175.89, 175.87, 175.80, 139.11, 138.11, 137.88, 137.87, 137.85, 137.82, 
137.77, 137.63, 137.48, 137.18, 129.37-125.90 (38C), 101.66, 100.80, 100.53 (2C), 100.44, 100.34, 100.28, 100.19, 
100.16 (2C), 100.13, 100.07, 99.99, 99.71, 99.55, 99.10, 77.26, 75.93, 75.87, 75.78, 75.70, 75.66, 75.28, 74.46, 
74.31, 74.25, 73.22, 73.06, 72.29, 71.89, 71.83, 71.68, 71.50, 71.27, 71.19, 71.06, 70.88, 69.96, 69.76, 68.75, 68.69, 
68.57, 68.52, 68.28, 68.21, 67.44, 67.27, 66.94, 66.79, 66.44, 66.34, 38.91, 38.91, 38.87, 38.74, 38.71, 38.67 (2C), 
38.63, 38.61, 38.59, 38.58, 38.53, 27.29 (6C), 27.25 (3C), 27.23 (3C), 27.21 (3C), 27.19 (3C), 27.16 (3C), 27.14 
(3C), 27.11 (3C), 27.03 (6C), 26.99 (3C). 
 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene -2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-[4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-
O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→6)]-4-O-benzyl-2-O-pivaloyl-β-D-galactopyranosyl- 
(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranoside (304) 
To a 25 mL flame-dried flask was added 292 
(600 mg, 0.24 mmol) and the 284 (306 mg, 0.36 
mmol). The mixture was dried azeotropically 
with toluene (2x5 mL) and subjected to vacuum 
overnight. It was then dissolved in dry CH2Cl2 (2 
mL) and dry MeCN (2 mL), cooled to -30 °C, 
followed by addition of NIS (82 mg; 0.37 mmol) 
and TESOTf (13 mg; 0.05 mmol). The reaction 
mixture was stirred at -30 °C until TLC revealed 
full conversion of the donor (2h). The solution was diluted with CH2Cl2 (50 mL) and washed with sat. aq. NaS2O3 
(50 mL) and sat. aq. NaHCO3 (50 mL). The organic phase was dried over MgSO4, filtered and concentrated. The 
product was purified by flash chromatography (19:1 Tol/EtOAc) to afford a white crystalline material. Yield: 575 
mg (74%) 
    
  = 9.5° (c 1.0, CDCl3). IR (neat, cm
-1
): 3535.58, 2972.41, 2872.16, 1736.19, 1700.99, 1479.69, 1455.60, 
1397.63, 1366.51, 1276.86, 1171.43, 1132.66, 1084.76, 1046.59, 999.84. 
1
H NMR (400 MHz, CDCl3) δ 7.43 (m, 
16H, Ar-H), 7.34 – 7.14 (m, 34H, Ar-H), 5.49 (s, 1H, CHbenzylidene), 5.48 – 5.46 (m, 2H, 2xCHbenzylidene), 5.45 (s, 2H, 
2xCH
benzylidene
), 5.44 (s, 2H, 2xCH
benzylidene
), 5.42 (s, 1H, CH
benzylidene
), 5.40 – 5.25 (m, 7H, 7xH-2), 5.21 (dd, J2,3 = 
10.3, J1,2 = 7.9 Hz, 1H, H-2), 5.13 (dd, J2,3 = 10.3, J1,2 = 8.0 Hz, 1H, H-2), 4.85 – 4.76 (m, 4H, 2xH-1, CH2
Bn
), 4.74 
– 4.62 (m, 5H, 3xH-1, H-37, H-32’), 4.55 (d, J1,2 = 8.0 Hz, 1H, H-1), 4.50 (d, JCH2 = 12.5 Hz, 1H, 0.5xCH2
Bn
), 4.49 
(d, J1,2 = 7.6 Hz, 1H, H-1), 4.44 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2
Bn
), 4.34 (d, J = 8.0 Hz, 1H, H-1), 4.33 – 3.91 (m, 
29H, H-3
1
-H-3
6
, H-3
1’
, 8xH-4
1/2/4/5/6/7/1’/2’
, 7.5xH-6
1/2/4/5/6/7/1’/2’
), 3.89 (d, J1,2 = 7.8 Hz, 1H, H-1
1’
), 3.84 (d, J6a,6b = 11.9 
Hz, 1H, H-6
1/2/4/5/6/7/1’/2’
), 3.74 (d, J3,4 = 3.4 Hz, 1H, H-4
3
), 3.64 – 3.52 (m, 1H, H-63), 3.47 (t, J5,6a = J5,6b = 5.6 Hz, 
1H, H-5
3
), 3.38 (s, 1H, H-5
1/2/4/5/6/7/1’/2’
), 3.35 (s, 1H, H-5
1/2/4/5/6/7/1’/2’
), 3.30 (s, 1H, H-5
1/2/4/5/6/7/1’/2’
), 3.27 (s, 1H, H-
5
1/2/4/5/6/7/1’/2’
), 3.22 (s, 1H, H-5
1/2/4/5/6/7/1’/2’
), 3.20 (s, 2H, 2xH-5
1/2/4/5/6/7/1’/2’
), 3.04 (s, 1H, H-5
1/2/4/5/6/7/1’/2’
), 1.13 (s, 9H, 
3xCH3
Piv
), 1.08 (s, 9H, 3xCH3
Piv
), 1.06 (s, 9H, 3xCH3
Piv
), 1.04 (s, 9H, 3xCH3
Piv
), 1.03 (s, 18H, 6xCH3
Piv
), 1.01 (s, 
9H, 3xCH3
Piv
), 1.00 (s, 9H, 3xCH3
Piv
), 1.00 (s, 9H, 3xCH3
Piv
), 0.99 (s, 9H, 3xCH3
Piv
), 0.97 (s, 9H, 3xCH3
Piv
). 
13
C 
NMR 
 
 (101 MHz, CDCl3) δ 178.32, 178.26, 176.94, 176.82, 176.47, 176.19, 176.18, 176.13, 176.04 (2C), 175.65, 
138.91, 138.17, 138.03, 138.00, 137.98, 137.86, 137.82, 137.57 (2C), 137.37, 129.15-125.41 (50C), 102.58, 100.70, 
100.57, 100.54, 100.39, 100.29 (4C), 100.20 (3C), 100.04, 99.85, 99.73, 99.60, 99.29, 77.36, 76.03, 75.89, 75.81, 
75.72, 75.53, 75.18, 74.81, 74.40, 74.17, 73.23, 73.15, 73.03, 72.58, 72.34, 72.10, 72.00, 71.89, 71.68, 71.58, 71.53, 
Experimental 
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71.37, 71.25, 71.11, 69.89, 69.20, 68.96, 68.93, 68.88, 68.83, 68.60, 68.38, 68.03, 67.62, 67.51, 67.30, 67.04, 66.94, 
66.86, 66.83, 66.70, 65.19, 39.05, 39.03, 39.01, 38.83, 38.80, 38.79, 38.77, 38.71 (3C), 38.68, 38.67, 27.50 (3C), 
27.37 (6C), 27.29 (3C), 27.27 (3C), 27.25 (3C), 27.20 (3C), 27.15 (6C), 27.12 (3C), 27.10 (3C). 
 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl- (1→3)-4,6-O-benzylidene -2-O-
pivaloyl-β-D-galactopyranosyl-(1→3)-[4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-
(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→6)]-4-O-benzyl-2-O-pivaloyl-β-D-
galactopyranosyl- (1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranosyl- (1→3)-4,6-O-
benzylidene-2-O-pivaloyl-β-D-galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-
galactopyranosyl-(1→3)-4,6-O-benzylidene-2-O-pivaloyl-β-D-galactopyranoside (305) 
To a 25 mL flame-dried flask was added 298 
(500 mg, 0.20 mmol) and the 284 (255 mg, 0.30 
mmol). The mixture was dried azeotropically 
with tol-uene (2x5 mL) and subject-ted to 
vacuum over night. It was then dissolved in dry 
CH2Cl2 (2 mL) and dry MeCN (2 mL), cooled 
to -30 °C, followed by addition of NIS (69 mg; 
0.31 mmol) and TESOTf (10 mg; 0.04 mmol). 
The reaction mixture was stirred at -30 °C until 
TLC revealed full conversion of the donor (1h). The solution was diluted with CH2Cl2 (50 mL) and washed with sat. 
aq. NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash chromatography (19:1 Tol/EtOAc) to afford a white crystalline 
material. Yield: 460 mg (71%) 
    
  = 8.9° (c 1.0, CDCl3). IR (neat, cm
-1
): 2973.10, 2933.38, 2906.81, 2872.23, 1736.16, 1701.44, 1479.68, 
1455.34, 1397.62, 1366.36, 1276.86, 1171.55, 1132.07, 1085.98, 1046.35, 1026.49, 999.26. 
1
H NMR (400 MHz, 
CDCl3) δ 7.42 (m, 16H, Ar-H), 7.23 (m, 34H, Ar-H), 5.57 – 5.07 (m, 17H, H-2
1
-H-2
7
, H-2
1’
, H-2
2’
, 8xCH
benzylidene
), 
4.88 – 4.81 (m, 3H, 2xH-1, 0.5xCH2
Bn
), 4.79 (d, JCH2 = 11.5 Hz, 1H, 0.5xCH2
Bn
), 4.74 – 4.66 (m, 3H, H-37/2’, H-37/2’, 
H-1), 4.65 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.61 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.55 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.53 (d, JCH2 
= 11.7 Hz, 1H, 0.5xCH2
Bn
), 4.47 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.45 (d, JCH2 = 11.6 Hz, 1H, CH2
Bn
), 4.36 (d, J1,2 = 7.9 
Hz, 1H, H-1), 4.33 – 3.84 (m, 31H, H-31-H-36, H-31’, 8xH-41/2/3/4/6/7/1’/2’, 8xH-61/2/3/4/6/7/1’/2’), 3.89 (d, J1,2 = 7.8 Hz, 
1H, H-1
1’
), 3.82 (m, 1H, H-6a
5
), 3.78 (t, J3,4 = 3.4 Hz, 1H, H-4
5
), 3.69 – 3.53 (m, 1H, H-6b5), 3.47 (d, J5,6a = J5,6b = 
5.3 Hz, 1H, H-5
5
), 3.38 – 3.35 (m, 2H, 2xH-51/2/3/4/6/7/1’/2’), 3.30 (s, 1H, H-51/2/3/4/6/7/1’/2’), 3.24 (s, 1H, H-51/2/3/4/6/7/1’/2’), 
3.23 (s, 1H, H-5
1/2/3/4/6/7/1’/2’
), 3.21 (s, 1H, H-5
1/2/3/4/6/7/1’/2’
), 3.17 (s, 1H, H-5
1/2/3/4/6/7/1’/2’
), 3.00 (s, 1H, H-5
1/2/3/4/6/7/1’/2’
), 
1.11 (s, 9H, 3xCH3
Piv
), 1.08 (s, 9H, 3xCH3
Piv
), 1.07 (s, 27H, 9xCH3
Piv
), 1.04 (s, 9H, 3xCH3
Piv
), 1.02 (s, 9H, 
3xCH3
Piv
), 1.00 (s, 9H, 3xCH3
Piv
), 0.98 (s, 9H, 3xCH3
Piv
), 0.98 (s, 9H, 3xCH3
Piv
), 0.95 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 
(101 MHz, CDCl3) δ 178.30, 178.24, 176.96, 176.88, 176.34, 176.31, 176.10, 176.07, 176.01, 175.97, 175.69, 
138.93, 138.13, 138.03, 137.98 (2C), 137.89, 137.65, 137.59 (2C), 137.29, 129.14-125.40 (34C), 102.44, 100.69, 
100.54 (2C), 100.42, 100.32, 100.25 (3C), 100.16, 100.11 (2C), 99.80, 99.72, 99.59, 99.54, 99.21, 77.36, 76.02, 
75.91, 75.85, 75.71, 75.26, 75.21, 74.70, 74.39, 74.16, 73.23, 73.15, 73.02, 72.51, 72.41, 72.03, 71.99, 71.93, 71.50, 
71.23, 71.09, 70.97, 70.05, 69.18, 68.94, 68.81, 68.61, 68.37, 68.32, 68.03, 67.57, 67.53, 67.36, 67.04, 66.91, 66.87, 
66.82, 66.69, 39.02, 39.00, 38.79 (2C), 38.77 (3C), 38.71, 38.69, 38.66, 38.61, 27.40 (6C), 27.36 (3C), 27.30 (3C), 
27.29 (3C), 27.215 (3C), 27.21 (3C), 27.15 (3C), 27.12 (6C), 27.09 (3C). 
 
β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-D-
galactopyranosyl-(1→3)-D-galactopyranose (306) 
289 (350 mg; 0.18 mmol) was dissolved in THF (40 mL) and a 1M 
Et4NOH in MeOH solution (7.4 mL; 7.4 mmol) was added. The 
reaction mixture was stirred at 65 C for 24 h. The reaction mixture 
was poured into sat. aq. NH4Cl (100 mL) and extracted with CH2Cl2 (3x100 mL). The combined organic phases 
were dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography (9:1 
CH2Cl2/MeOH) to yield colorless crystals. The product was dissolved in MeOH (40 mL), THF (10 mL). 20% 
Pd(OH)2/C (129 mg; 0.18 mmol) was added and an atmosphere of H2 (1 atm.) was installed. The reaction was 
stirred at 22 °C for 48h, filtered through celite, and concentrated to give a grey solid. Purified by reverse phase 
chromatography to afford 306 as a white solid. Yield: 119 mg (78% over two steps). 
1
H NMR (400 MHz, D2O) δ 5.19 (d, J3,4 = 3.1 Hz, 1H, H-1), 4.62 – 4.49 (m, 9H, H-1
1-H-15, H-12-H-15), 
4.17 (d, J3,4 = 3.4 Hz, 1H, H-4), 4.11 (m, 9H, 9xH-4), 4.03 (t, J = 6.3 Hz, 1H), 3.90 (t, J = 3.0 Hz, 1H), 3.83 (d, J = 
3.3 Hz, 3H), 3.80 – 3.47 (m, 45H). 13C NMR (101 MHz, D2O) δ 104.24, 103.98, 103.92, 96.11, 92.11, 82.38, 81.98, 
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81.91, 81.68, 79.33, 75.02, 74.72, 74.64, 74.59, 72.46, 70.98, 70.89, 70.17, 70.06, 69.09, 68.51, 68.34, 68.28, 67.34, 
60.91, 60.88, 60.84, 58.55. 
 
β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-
(1→3)-β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-D-galactopyranose (307) 
291 (325 mg; 0.13 mmol) was dissolved in THF 
(40 mL) and a 1M Et4NOH in MeOH solution 
(7.6 mL; 7.6 mmol) was added. The reaction 
mixture was stirred at 65 C for 24 h. The reaction 
mixture was poured into sat. aq. NH4Cl (100 mL) and extracted with CH2Cl2 (3x100 mL). The combined organic 
phases were dried over MgSO4, filtered and concentrated. The product was purified by flash chromatography (9:1 
CH2Cl2/MeOH) to yield colorless crystals. The product was dissolved in MeOH (40 mL), THF (10 mL). 20% 
Pd(OH)2/C (88 mg; 0.13 mmol) was added and an atmosphere of H2 (1 atm.) was installed. The reaction was stirred 
at 22 °C for 48h, filtered through celite, and concentrated to give a grey solid. Purified by reverse phase 
chromatography to afford 307 as a white solid. Yield: 107 mg (74% over two steps). 
1
H NMR (400 MHz, D2O) δ 5.19 (d, J1,2 = 3.0 Hz, 1H, H-1), 4.63 – 4.48 (m, 13H,  H-1
1-H-17, H-12-H-17), 
4.16 (d, J3,4 = 3.2 Hz, 1H), 4.11 (m, 13H), 4.03 (t, J = 6.3 Hz, 1H), 3.90 (t, J = 3.0 Hz, 2H), 3.83 (d, J = 3.2 Hz, 2H), 
3.80 – 3.47 (m, 65H). 13C NMR (101 MHz, D2O) δ 104.24, 103.92, 96.11, 92.11, 82.38, 81.97, 81.91, 81.68, 75.02, 
74.64, 72.46, 70.98, 70.89, 70.17, 70.06, 69.09, 68.51, 68.34, 68.28, 67.34. 
 
β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-
(1→3)-[β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→6)]-β-D-galactopyranosyl- (1→3)-β-D-
galactopyranosyl-(1→3)-D-galactopyranose (308) 
304 (380 mg; 0.12 mmol) was dissolved in THF 
(30 mL) and a 1M Et4NOH in MeOH solution 
(9.24 mL; 9.24 mmol) was added. The reaction 
mixture was stirred at 65 C for 24 h. The reaction 
mixture was poured into sat. aq. NH4Cl (100 mL) 
and extracted with CH2Cl2 (3x100 mL). The 
combined organic phases were dried over MgSO4, filtered and concentrated. The product was purified by flash 
chromatography (9:1 CH2Cl2/MeOH) to yield colorless crystals. The product was dissolved in MeOH (40 mL), THF 
(10 mL). 20% Pd(OH)2/C (84 mg; 0.12 mmol) was added and an atmosphere of H2 (1 atm.) was installed. The 
reaction was stirred at 22 °C for 48h, filtered through celite, and concentrated to give a grey solid. Purified by 
reverse phase chromatography to afford 308 as a white solid. Yield: 112 mg (66% over two steps). 
1
H NMR (400 MHz, D2O) δ 5.29 (d, J1,2 = 3.1 Hz, 1H, H-1), 4.73 – 4.58 (m, 15H, H-1
1-H-17, H-12-H-17, H-
1'
6branch, H-1'6branch), 4.49 (d, J1,2 = 7.8 Hz, 2H, H-1
6branch, H-16branch), 4.26 (d, J3,4 = 3.3 Hz, 1H, H-4
1
a), 4.22 (m, 
17H, 17xH-4), 4.12 (t, J = 6.3 Hz, 1H), 4.08 – 3.55 (m, 89H). 13C NMR (101 MHz, D2O) δ 104.37, 104.25, 103.98, 
103.92, 103.78, 103.12, 96.11, 92.12, 82.47, 82.39, 81.97, 81.91, 81.86, 81.68, 79.35, 75.02, 74.70, 74.64, 73.33, 
72.46, 71.00, 70.98, 70.89, 70.17, 70.17, 70.11, 69.82, 68.51, 68.39, 68.34, 68.30, 68.28, 60.90, 60.85. 
 
β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→3)-β-D-
galactopyranosyl-(1→6)]-β-D-galactopyranosyl- (1→3)-β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-
(1→3)-β-D-galactopyranosyl-(1→3)-D-galactopyranose (309) 
305 (318 mg; 0.097 mmol) was dissolved in 
THF (30 mL) and a 1M Et4NOH in MeOH 
solution (7.7 mL; 7.7 mmol) was added. The 
reac-tion mixture was stirred at 65 C for 24 h. 
The reaction mixture was poured into sat. aq. 
NH4Cl (100 mL) and extracted with CH2Cl2 
(3x100 mL). The combined organic phases were dried over MgSO4, filtered and concentrated. The product was 
purified by flash chromatography (9:1 CH2Cl2/MeOH) to yield colorless crystals. The product was dissolved in 
MeOH (40 mL), THF (10 mL). 20% Pd(OH)2/C (68 mg; 0.097 mmol) was added and an atmosphere of H2 (1 atm.) 
was installed. The reaction was stirred at 22 °C for 48h, filtered through celite, and concentrated to give a grey solid. 
Purified by reverse phase chromatography to afford 309 as a white solid. Yield: 102 mg (72% over two steps). 
1
H NMR (400 MHz, D2O) δ 5.28 (d, J1,2 = 3.0 Hz, 1H, H-1), 4.73 – 4.58 (m, 15H,  H-1
1
b-H-1
7
b, H-1
2
a-H-1
7
a, H-
1'
branch, H-1'branch), 4.49 (d, J1,2 = 7.9 Hz, 3H, H-1
branch, H-1branch), 4.26 (d, J3,4 = 3.1 Hz, 1H, H-4), 4.22 (m, 
17H, 17xH-4), 4.12 (t, J = 6.2 Hz, 1H), 4.09 – 3.56 (m, 89H). 
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β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-
(1→3)-[-L-arabinosyl-(1→6)]-β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-D-galactopyranose 
(310) 
300 (320 mg; 0.11 mmol) was dissolved in THF 
(30 mL) and a 1M Et4NOH in MeOH solution 
(9.24 mL; 9.24 mmol) was added. The reaction 
mixture was stirred at 65 C for 24 h. The 
reaction mixture was poured into sat. aq. NH4Cl 
(100 mL) and extracted with CH2Cl2 (3x100 mL). 
The combined organic phases were dried over 
MgSO4, filtered and concentrated. The product was purified by flash chromatography (9:1 CH2Cl2/MeOH) to yield a 
colorless foam. The product was dissolved in MeOH (30 mL), THF (7.5 mL). 20% Pd(OH)2/C (75 mg; 0.11 mmol) 
was added and an atmosphere of H2 (1 atm.) was installed. The reaction was stirred at 22 °C for 48h, filtered through 
celite, and concentrated to give a grey solid. Purified by reverse phase chromatography to afford 310 as a white 
solid. Yield: 82 mg (60% over two steps). 
1
H NMR (400 MHz, D2O) δ 5.19 (d, J1,2 = 3.1 Hz, 1H, H-1), 4.97 (m, 2H, H-1
ara, H-1ara), 4.63 – 4.51 (m, 11H, 
H-1
1-H-17, H-12-H-17), 4.16 (d, J3,4 = 3.5 Hz, 1H, H-4),4.13 – 4.08 (m, 13H, 13xH-4), 4.03 (t, J = 6.2 Hz, 
1H), 4.00 – 3.92 (m, 4H), 3.90 (t, J = 2.9 Hz, 2H), 3.88 – 3.46 (m, 69H). 13C NMR (101 MHz, D2O) δ 107.84, 
104.24, 103.93, 103.74, 96.11, 83.87, 82.38, 82.38, 81.97, 81.91, 81.81, 81.00, 76.39, 75.02, 74.72, 74.63, 73.28, 
72.46, 70.98, 70.89, 70.16, 70.13, 70.07, 68.51, 68.48, 68.39, 68.38, 68.34, 68.27, 68.27, 67.29, 61.14, 60.94, 60.91, 
60.87, 60.84. 
 
β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-[-L-arabinosyl-(1→6)]-β-D-galactopyranosyl-
(1→3)-β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-D-
galactopyranose (311) 
301 (300 mg; 0.10 mmol) was dissolved in THF 
(30 mL) and a 1M Et4NOH in MeOH solution 
(8.1 mL; 8.1 mmol) was added. The reac-tion 
mixture was stirred at 65 C for 24 h. The 
reaction mixture was poured into sat. aq. NH4Cl 
(100 mL) and extracted with CH2Cl2 (3x100 mL). 
The combined organic phases were dried over 
MgSO4, filtered and concentrated. The product was purified by flash chromatography (9:1 CH2Cl2/MeOH) to yield 
colorless crystals. The product was dissolved in MeOH (40 mL), THF (10 mL). 20% Pd(OH)2/C (70 mg; 0.097 
mmol) was added and an atmosphere of H2 (1 atm.) was installed. The reaction was stirred at 22 °C for 48h, filtered 
through celite, and concentrated to give a grey solid. Purified by reverse phase chromatography to afford 311 as a 
white solid. Yield: 84 mg (65% over two steps). 
1
H NMR (400 MHz, D2O) δ 5.29 (d, J1,2 = 3.0 Hz, 1H, H-1), 5.08 – 5.04 (m, 2H, H-1
ara, H-1ara), 4.74 – 4.57 (m, 
13H, H-1
1-H-17, H-12-H-17), 4.26 (d, J3,4 = 3.1 Hz, 1H, H-4), 4.21 (m, 13H, 13xH-4), 4.12 (t, J = 6.2 Hz, 
1H), 4.10 – 3.36 (m, 79H). 13C NMR (101 MHz, D2O) δ 107.86, 104.25, 103.95, 96.12, 92.12, 83.88, 82.38, 82.04, 
81.98, 81.91, 81.81, 81.01, 76.40, 75.02, 74.73, 74.65, 73.30, 72.47, 70.98, 70.90, 70.18, 70.07, 68.52, 68.49, 68.40, 
68.34, 68.28, 67.29, 61.15, 60.91, 60.85. 
 
β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→6)-β-D-
galactopyranosyl-(1→6)]-β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl- (1→3)-β-D-galactopyranosyl-
(1→3)-β-D-galactopyranosyl-(1→3)-D-
galactopyranose (312) 
303 (328 mg; 0.097 mmol) was dissolved in THF 
(30 mL) and a 1M Et4NOH in MeOH solution 
(7.78 mL; 7.78 mmol) was added. The reaction 
mixture was stirred at 65 C for 24 h. The 
reaction mixture was poured into sat. aq. NH4Cl 
(100 mL) and extracted with CH2Cl2 (3x100 mL). 
The combined organic phases were dried over 
MgSO4, filtered and concentrated. The product was purified by flash chromatography (9:1 CH2Cl2/MeOH) to yield a 
colorless foam. The product was dissolved in MeOH (30 mL), THF (7.5 mL). 20% Pd(OH)2/C (68 mg; 0.097 mmol) 
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was added and an atmosphere of H2 (1 atm.) was installed. The reaction was stirred at 22 °C for 48h, filtered through 
celite, and concentrated to give a grey solid. Purified by reverse phase chromatography to afford 312 as a white 
solid. Yield: 99 mg (69% over two steps). 
1
H NMR (400 MHz, D2O) δ 5.19 (d, J1,2 = 3.1 Hz, 1H, H-1), 4.64 – 4.48 (m, 13H, H-1
1-H-17, H-12-H-17), 
4.36 (d, J1,2 = 7.8 Hz, 2H, H-1
6branch, H-16branch), 4.35 (d, J1,2 = 7.8 Hz, 2H, H-1'
6branch, H-1'6branch), 4.19 – 4.08 
(m, 18H, 18xH-4), 4.03 (t, J = 6.3 Hz, 1H), 3.98 – 3.38 (m, 89H). 
 
Phenyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-1-thio-β-D-galactopyranoside (351) 
56 (10 g; 27.74 mmol) was dissolved in CH2Cl2 (250 mL). Et3N (15.5 mL; 110.98 mmol), DMAP 
(1.70 g; 13.87 mmol) and pivaloyl chloride (9.4 mL; 110.98 mmol) was added to the solution and 
the reaction mixture was heated to 45 °C for 4 h. The reaction mixture was cooled to 0 °C, 
quenched with MeOH (20 mL), washed with water (2x200 mL), dried over MgSO4 and 
concentrated. The product was purified by flash chromatography (Tol/EtOAc 19:1) to afford 351 as a white 
crystalline powder. Rf 0.58 (9:1 Tol/EtOAc). Yield 13.79 g (94%) 
    
  = 18.6° (c 1.0, CDCl3). IR (neat, cm
-1
): 3062.19, 2972.17, 2933.64, 2906.05, 2872.25, 1732.66, 1584.21, 1479.49, 
1457.92, 1397.86, 1367.04, 1281.29, 1157.55, 1139.36, 1092.48, 1045.78, 1026.31. 
1
H NMR (400 MHz, CDCl3) δ 7.52 
– 7.47 (m, 2H, Ar-H), 7.31 (m, 8H, Ar-H), 5.42 (s, 1H, -CHbenzylidene), 5.36 (t, J1,2 = J2,3 = 9.9 Hz, 1H, H-2), 4.88 (dd, 
J2,3 = 9.9, J3,4 = 3.5 Hz, 1H, H-3), 4.66 (d, J1,2 = 9.9 Hz, 1H, H-1), 4.33 (d, J3,4 = 3.5 Hz, 1H, H-4), 4.31 (dd, J6a,6b = 
12.4, J5,6z = 1.1 Hz, 1H, H-6a), 3.95 (dd, J6a,6b = 12.4, J5,6b = 1.7 Hz, 1H, H-6b), 3.52 (m, 1H, H-5), 1.14 (s, 9H, 
3xCH3
Piv
), 1.04 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 178.22, 176.20, 137.72, 133.15 (2C), 131.98, 
129.00, 128.85 (2C), 128.18 (2C), 128.08, 126.23 (2C), 100.66, 85.77, 73.31, 73.16, 69.77, 69.21, 65.98, 39.00, 
38.80, 27.26 (3C), 27.09 (3C). HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C29H36NaO7S 551.2079; Found 
551.2071. 
 
4-O-benzyl-6-O-chloroacetyl-2,3-O-dipivaloyl-β-D-galactopyranose N-phenyl trifluoroacetimidate (352) 
351 (10.0 g; 18.91 mmol) was dissolved in MeCN (250 mL) and water (25 mL). NBS (13.5 g; 
75.66 mmol) was added and the reaction was stirred at 50 C for 4 h. The solution was diluted 
with EtOAc (500 mL) and washed with sat. aq. NaS2O3 (200 mL) and sat. aq. NaHCO3 (200 
mL). The organic phase was dried over MgSO4, filtered and concentrated. The residue was 
purified by flash chromatography (4:1 Tol/EtOAc) to afford the hemiacetal 352a. Rf 0.17 (4:1 
Tol/EtOAc). Hemiacetal 352a was dissolved in CH2Cl2 (200 mL) and cooled to 0 °C. Cs2CO3 (11.9 g; 36.65 mmol) 
was added followed by N-phenyl trifluoroacetimidoyl chloride (7.6 g; 36.65 mmol). The ice bath was removed and 
the reaction mixture was stirred for 12 h. It was then filtered, through a plug of celite, concentrated and purified by 
flash chromatography (9:1 Tol/EtOAc) to give 352 as white crystalline product. Yield: 6.9 g (62% over two steps)  
 
Phenyl 4-O-benzyl-2,3-di-O-pivaloyl-1-thio-β-D-galactopyranoside (353) 
A 1 M solution of BH3
.
THF complex in THF (189.2 mL) was added to a solution of 351 (20 g; 
37.8 mmol) in DCM (100 mL) at 0 °C. The mixture was stirred for 10 min, and freshly dried 
Cu(OTf)2 (2.1 g, 5.67 mmol) was added to the solution. After stirring for a 5 h, the mixture was 
cooled to 0 °C, and the reaction was quenched by addition of triethylamine (5.3 mL, 37.8 mmol) 
and methanol (69 mL, caution: hydrogen gas was evolved). The resultant mixture was concentrated at reduced 
pressure followed by coevaporation with methanol. The residue was purified by flash column chroma-tography (9:1 
Tol/EtOAc) to afford 353 as a slightly yellow crystalline material. Rf 0.21 (9:1 Tol/EtOAc). Yield: 18.1 g (90%) 
    
  = 2.2° (c 1.0, CDCl3). IR (neat, cm
-1
): 3522.91, 3062.40, 3032.17, 2970.89, 2934.65, 2906.13, 2872.39, 1733.22, 
1479.27, 1457.71, 1397.86, 1365.42, 1279.86, 1162.53, 1138.14, 1082.72, 1041.90 
1
H NMR (400 MHz, CDCl3) δ 7.42 – 7.35 (m, 2H, Ar-H), 7.32 – 7.14 (m, 8H, Ar-H), 5.42 (t, J1,2 = J2,3 = 9.9 Hz, 
1H, H-2), 5.01 (dd, J2,3 = 9.9, J3,4 = 2.9 Hz, 1H, H-3), 4.74 (d, JCH2 = 11.3 Hz, 1H, 0.5xCH2
Bn
), 4.64 (d, J1,2 = 9.9 Hz, 
1H, H-1), 4.39 (d, JCH2 = 11.3 Hz, 1H, 0.5xCH2
Bn
), 3.89 (d, J3,4 = 2.9 Hz, 1H, H-4), 3.76 (dd, J6a,6b = 11.2, J5,6a =6.9 
Hz, 1H, H-6a), 3.61 – 3.53 (dd, J5,6a =6.9, J5,6b =5.2 Hz, 1H), 3.47 (dd, J6a,6b =11.2, J5,6b =5.2 Hz, 1H, H-6b), 1.14 (s, 
9H, 3xCH3
Piv
), 1.11 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.74, 176.52, 137.57, 132.98, 131.96 
(2C), 128.90 (2C), 128.51 (2C), 128.00, 127.86 (2C), 127.77, 86.72, 78.84, 75.11, 74.83, 74.25, 67.42, 61.83, 38.96, 
38.77, 27.25 (3C), 27.21 (3C). HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C29H38NaO7S 553.2236; Found 
553.2231. 
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Phenyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-1-
thio.galactopyranoside (354)  
To a 250 mL flame-dried flask was added 353 (4.7 g, 8.76 mmol) and the 352 (6.4 g, 10.50 
mmol). The mixture was co-evaporated with toluene (2x100 mL) and subjected to vacuum 
overnight. The mixture dissolved in CH2Cl2 (100 mL) and cooled to -40 °C. TMSOTf (0.20 
mL; 0.88 mmol) was added and the reaction mixture was stirred at -40 °C for 1.5h. Et3N (1 
mL) was added and the reaction mixture was concentrated. The crude compound was 
purified by flash chromatography (19:1 Tol/EtOAc) to afford 354. Rf 0.52 (9:1 
Tol/EtOAc). Yield: 7.6 g (91%) 
    
  = 11.4° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.44 – 7.34 (m, 4H, H
SPh
), 7.29 – 7.13 (m, 11H, HSPh. 
Ar-H), 5.43 (s, 1H, -CH
benzylidene
), 5.38 (t, J1,2 = J2,3 =9.8 Hz, 1H, H-2), 5.33 (dd, J2,3 = 9.7, J1,2 =8.0 Hz, 1H, H-2’), 
5.02 (dd, J2,3 = 9.8, J3,4 = 2.9 Hz, 1H, H-3), 4.79 (dd, J2,3 = 9.7, J3,4 = 3.7 Hz, 1H, H-3’), 4.68 (d, JCH2 = 11.2 Hz, 1H, 
-CH2
Bn
), 4.59 (d, J = 9.8 Hz, 1H, H-1), 4.55 (d, JCH2 = 11.2 Hz, 1H, -CH2
Bn
), 4.45 (d, J = 8.0 Hz, 1H, H-1’), 4.33 – 
4.28 (m, 1H, H-4’), 4.22 – 4.15 (m, 1H, H-6a’), 3.95 (dd, J = 12.5, 1.9 Hz, 1H, H-6b’), 3.86 (m, 2H, H-4, H-6a), 
3.75 – 3.63 (m, 2H, H-6b, H-5), 3.39 – 3.35 (m, 1H, H-5’), 1.13 (s, 9H, 3xCH3
Piv
), 1.09 (s, 9H, 3xCH3
Piv
), 1.07 (s, 
9H, 3xCH3
Piv
), 1.07 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 178.13, 177.46, 176.53, 176.44, 138.12, 
137.59, 132.82, 132.11 (2C), 128.91 (2C), 128.80, 128.24 (2C), 128.08 (2C), 127.77, 127.59 (2C), 127.48, 125.98 
(2C), 100.73, 100.51, 86.43, 77.65, 74.93, 74.68, 74.56, 73.09, 71.86, 68.77, 68.14, 67.37, 66.95, 66.43, 38.92, 
38.89, 38.74, 27.22, 27.21 (3C), 27.16 (3C), 27.12 (3C), 27.04 (3C). HRMS (ESI-TOF) m/z: [M + Na]
+ 
Calcd for 
C52H58NaO14S: 971.4228; Found 971.4229. 
 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-
galactopyranoside (355) 
354 (2.0 g; 2.11 mmol) was dried azeotropically with toluene (2x30 mL) and left under 
vacuum over night. Freshly distilled benzyl alcohol (0.26 mL; 2.52 mmol) was added and the 
mixture was dissolved in dry CH2Cl2 (30 mL) and cooled to -40 °C. Then NIS (497 mg; 2.21 
mmol) and TESOTf (45 μL; 0.21 mmol) were added and the reaction mixture was stirred at -
40 °C until TLC revealed full conversion of the donor (4h min). The solution was diluted with 
CH2Cl2 (100 mL) and washed with sat. aq. Na2SO3 (50 mL) and sat. aq. NaHCO3 (50 mL), 
dried over MgSO4 and concentrated. The product was purified by flash chromatography (4:1 
Heptan/EtOAc) to yield a white crystalline solid. Rf 0.35 (9:1 Tol/EtOAc). Yield: 1.7 g (86 %) 
    
  = 24.6° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.41 (m, 2H, H
Bn
),  7.35 – 7.13 (m, 13H, HBn, Ar-H), 
5.45 (s, 1H, -CH
benzylidene
), 5.42 (dd, J2,3 = 10.6, J1,2 = 8.1 Hz, 1H, H-2), 5.37 (dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-2’), 
4.96 (dd, J2,3 = 10.6, J3,4 = 3.1 Hz, 1H, H-3), 4.82 (dd, J2,3 =  10.4, J3,4 = 3.8 Hz, 1H, H-3’), 4.77 (d, JCH2 = 12.0 Hz, 
1H, CH2
a
), 4.70 (d, JCH2 = 11.2 Hz, 1H, CH2
b
), 4.55 (d, JCH2 = 11.2 Hz, 1H, CH2
a
), 4.49 (d, JCH2 = 12.0 Hz, 1H, CH-
2
a
), 4.48 (d, J = 7.9 Hz, 1H, H-1’), 4.42 (d, J = 7.9 Hz, 1H, H-1), 4.32 (dd, J3,4 = 3.8, J4,5 = 1.0 Hz, 1H, H-4’), 4.20 
(dd, J6a,6b = 12.5, J5,6a = 1.6 Hz, 1H, H-6a’), 3.97 (dd, J6a,6b = 12.5, J5,6b 1.8 Hz, 1H, H-6b’), 3.89 (dd, J = 9.8, 5.9 Hz, 
1H, H-6a), 3.85 (d, J3,4 = 3.0 Hz, 1H, H-4), 3.73 – 3.62 (m, 1H, H-5, H-6b), 3.41 – 3.37 (m, 1H, H-5’), 1.11 (s, 9H, 
3x-CH3
Piv
), 1.09 (s, 18H, 6x-CH3
Piv
), 1.04 (s, 9H, 3x-CH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 178.15, 177.60, 
176.76, 176.51, 138.03, 137.58, 137.01, 128.81, 128.26 (4C), 128.08 (2C), 127.88 (2C), 127.73 (2C), 127.65, 
127.57, 125.98 (2C), 100.84, 100.53, 100.18, 77.22, 75.14, 74.71, 73.85, 73.51, 73.09, 71.90, 70.31, 69.34, 68.78, 
68.17, 66.99, 66.42, 38.92, 38.91, 38.77, 38.74, 27.24 (3C), 27.17 (3C), 27.14 (3C), 27.03 (3C). HRMS (ESI-TOF) 
m/z: [M + Na]
+
 Calcd for C53H70NaO15 969.4612; Found 969.4614. 
 
Benzyl 4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-
galactopyranoside (356) 
A solution of 1M BH3 in THF (10 mL) was added to a 50 ml dry flask containing l 
mmol of compound 355 at 0 °C and the solution was stirred for 5 minutes. A solution 
of of 1M Bu2BOTf in CH2Cl2 (1 mL) was then added to the clear solution slowly. 
After 1 hour at 0 °C, TLC showed that the starting material had disappeared. 
Triethylamine (0.5 mL) was added followed by careful addition of methanol until the 
evolution of H2 had ceased. The reaction mixture was co-distilled with methanol 
three times after which the product was purified by flash chromatography (9:1 Tol/EtOAc) to afford 356 
as a colorless crystalline material. Yield: 749 mg (79%) 
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Benzyl 4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-O-dipivaloyl-β-D-
galactopyranoside (356_2) 
362 (2.9 g; 2.83 mmol) was dissolved in dry THF (50 mL). Thiourea (645 mg; 8.48 mmol), 
Bu4NI (209 mg; 0.57 mmol) and NaHCO3 (784 mg; 9.33 mmol) were added and the reaction 
mixture was heated to 55 °C for 6h. The mixture was filtered, concentrated and purified by 
flash chromatography (9:1 Tol/EtOAc). Rf 0.22 (9:1 Tol/EtOAc). Yield: 2.39 g (89%) 
    
  = -8.0° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.44 – 7.00 (m, 15H, Ar-H), 5.40 
(dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-2), 5.34 (dd, J2,3 = 10.4, J1,2 = 7.8 Hz, 1H, H-2’), 4.93 (dd, J2,3 = 10.4, J3,4 = 2.8 
Hz, 1H, H-3), 4.93 (dd, J2,3 = 10.4, J3,4 = 2.8 Hz, 1H, H-3’), 4.80 – 4.74 (m, 2H, CH2
Bn
), 4.72 (d, JCH2 = 11.4 Hz, 1H, 
0.5xCH2
Bn
), 4.50 (d, J = 11.3 Hz, 1H, 0.5xCH2
Bn
), 4.49 (d, JCH2= 12.0 Hz, 1H, 0.5xCH2
Bn
), 4.41 (d, J1,2 = 7.9 Hz, 
1H, H-1), 4.37 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2
Bn
), 4.33 (d, J1,2 = 7.9 Hz, 1H, H-1’), 3.87 (d, J3,4 = 2.8 Hz, 1H, H-
4’), 3.85 (d, J3,4 = 2.8 Hz, 1H, H-4), 3.83 – 3.77 (m, 1H, H-6a), 3.67 – 3.56 (m, 3H, H-6b, H-6a’, H-5), 3.50 – 3.43 
(m, 1H, H-5’), 3.43 – 3.34 (m, 1H, H-6b’), 1.14 (s, 9H, 3xCH3
Piv
), 1.11 (s, 9H, 3xCH3
Piv
), 1.10 (s, 9H, 3xCH3
Piv
), 
1.03 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 176.76, 176.73, 175.70, 175.68, 137.00, 136.50, 135.88, 
127.53 (2C), 127.27 (2C), 127.23 (2C), 127.10 (2C), 126.80 (2C), 126.69 (2C), 126.65 (2C), 100.38, 98.97, 73.94, 
73.92, 73.43, 73.03, 72.82, 72.63, 72.58, 69.21, 68.39, 68.25, 66.46, 60.61, 37.94, 37.90, 37.78, 37.70, 26.23 (3C), 
26.21 (3C), 26.16 (3C), 26.11 (3C). HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C53H72NaO15 971.4769; Found 
971.4774. 
 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-
pivaloyl-β-D-galactopyranosyl-(1→6)-2,3,4-tri-O-benzyl-β-D-galactopyranoside 
To a 10 mL flame-dried flask was added 113 (300 mg, 0.55 mmol) and 186 (632 mg, 
0.67 mmol). The mixture was dried azeotropically with toluene (2x5 mL) and subjected 
to vacuum overnight. It was then dissolved in dry CH2Cl2 (2.5 mL) and dry MeCN (2.5 
mL), cooled to -30 °C, followed by addition of NIS (152 mg; 0.68 mmol) and TESOTf 
(15 mg; 0.06 mmol). The reaction mixture was stirred at -30 °C until TLC revealed full 
conversion of the donor (1h). The solution was diluted with CH2Cl2 (100 mL) and 
washed with sat. aq. NaS2O3 (50 mL) and sat. aq. NaHCO3 (50 mL). The organic phase 
was dried over MgSO4, filtered and concentrated. The product was purified by flash 
chromatography to afford a white crystalline material. Yield: 918 mg (85%). 
    
  = -4.4° (c 1.0, CDCl3). IR(neat, cm
-1
): 3501.69, 3033.79, 2905.82, 1736.89, 1700.15, 1497.26, 1479.42, 
1454.79, 1397.64, 1366.09, 1277.36, 1170.93, 1082.97, 1046.55, 1000.25.  
1
H NMR (400 MHz, CDCl3) δ 7.56 – 7.01 (m, 30H, Ar-H), 5.43 (s, 1H, CH
benzylidene
), 5.34 (dd, J2,3 = 10.3, J1,2 = 8.0 
Hz, 1H, H-2
3
), 5.31 (dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-2
2
), 4.99 (dd, J2,3 = 10.4, J3,4 = 3.0 Hz, 1H, H-3
2
), 4.86 (d, 
JCH2 = 11.7 Hz, 1H, CH2
Bn
), 4.84 – 4.79 (m, 3H, H-33, CH2
Bn
), 4.72 – 4.59 (m, 6H, 3xCH2
Bn
), 4.55 (d, J = 12.1 Hz, 
1H, 0.5xCH2
Bn
), 4.42 (d, J1,2 = 7.9 Hz, 1H, H-1
2
), 4.40 (d, J1,2 = 8.0 Hz, 1H, H-1
3
), 4.36 (d, J1,2 = 7.7 Hz, 1H, H-1
1
), 
4.31 (d, J3,4 = 3.8 Hz, 1H, H-4
3
), 4.15 (dd, J6a,6b = 12.6, J5,6a = 1.0 Hz, 1H, H-6a), 3.99 – 3.94 (m, 1H, H-6a), 3.94 
(dd, J6a,6b = 12.3, J5,6b = 1.4 Hz, 1H, H-6b), 3.86 (d, J3,4 = 2.7 Hz, 1H, H-4), 3.82 – 3.75 (m, 4H, 2xH-4, H-2
1
, H-6b), 
3.63 (dd, J6a,6b = 10.2, J5,6a = 6.1 Hz, 1H, H-6b), 3.58 (dd, J5,6a = 8.0, J5,6b = 5.5 Hz, 1H, H-5
2
), 3.47 (dd, J6a,6b = 9.5, 
J5,6b = 5.2 Hz, 1H, H-6b), 3.42 – 3.33 (m, 2H, H-3
1
, H-5
1
, H-5
3
), 1.11 (s, 8H), 1.09 (s, 17H), 1.07 (s, 9H). 
13
C NMR 
 
 
(101 MHz, CDCl3) δ 178.21, 177.58, 176.82, 176.64, 138.76, 138.76, 138.53, 138.44, 137.74, 137.71, 128.91-
126.11 (24C), 102.94, 101.32, 100.92, 100.66, 82.16, 79.49, 75.42, 75.38, 74.59, 74.47, 73.99, 73.36, 73.27, 73.18, 
73.13, 73.00, 71.99, 71.03, 69.91, 68.82, 68.33, 67.78, 66.54, 66.10, 39.03, 39.01, 38.89, 38.88, 27.35, 27.33, 27.29, 
27.23, 27.14. 
 
Benzyl 4,6-O-benzylidene-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-
galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl- β-D-galactopyranosyl- (1→6)-2,3,4-tri-O-benzyl-β-D-
galactopyranoside (357) 
To a 25 mL flame-dried flask was added 356 (500 mg, 0.53 mmol) and 354 (658 
mg, 2.05 mmol). The mixture was dried azeotropically with toluene (2x10 mL) 
and subjected to vacuum overnight. It was then dissolved in dry CH2Cl2 (5 mL) 
and dry MeCN (5 mL), cooled to -30 °C, followed by addition of NIS (157 mg; 
0.70 mmol) and TESOTf (14 mg; 0.05 mmol). The reaction mixture was stirred at 
-30 °C until TLC revealed full conversion of the donor (1.5h). The solution was 
diluted with CH2Cl2 (100 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. 
aq. NaHCO3 (100 mL). The organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash chromatography (9:1 Tol/EtOAc) 
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to afford 357 as a white crystalline material. Rf 0.45 (9:1 Tol/EtOAc).Yield: 792 mg (81%) 
1
H NMR (400 MHz, CDCl3) δ 7.52 – 7.01 (m, 35H), 5.44 (s, 1H, CH
benzylidene
), 5.42 (dd, J2,3 = 10.1, J1,2 = 8.7 Hz, 
1H, H-2), 5.37 (dd, J2,3 = 10.2, J1,2 = 8.0 Hz, 1H, H-2), 5.30 (dd, J2,3 = 10.4, J1,2 = 7.9 Hz, 1H, H-2), 5.29 (dd, J2,3 = 
10.7, J1,2 = 8.0 Hz, 1H, H-2), 4.99 (dd, J2,3 = 10.6, J3,4 = 2.8 Hz, 1H, H-3), 4.96 (dd, J2,3 = 10.3, J3,4 = 2.7 Hz, 1H, H-
3), 4.94 (dd, J2,3 = 10.3, J3,4 = 2.9 Hz, 1H, H-3), 4.82 (dd, J2,3 = 10.3, J3,4 = 3.7 Hz, 1H, H-3), 4.76 (d, JCH2 = 12.0 
Hz, 1H, 0.5xCH2
Bn
), 4.70 – 4.45 (m, 7H, 3.5xCH2
Bn
), 4.41 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.36 (d, J1,2 = 8.0 Hz, 1H, H-
1), 4.36 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.32 (d, J3,4 = 3.1 Hz, 1H), 4.29 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.14 (d, J = 11.8 Hz, 
1H, 0.5xH-6), 4.01 – 3.77 (m, 8H, 3xH-4, 2.5xH-6), 3.72 – 3.32 (m, 5H, 4xH-5, H-6), 1.11 – 1.02 (m, 72H, 
24xCH3
Piv
). 
13
C NMR (101 MHz, CDCl3) δ 178.22, 177.64, 177.56, 177.53, 176.88 (2C), 176.84, 176.64, 138.50, 
138.46, 138.22, 137.72, 137.03, 128.92-126.09 (35C), 101.20, 101.16, 100.96, 100.68, 100.09, 75.43, 75.26, 75.16, 
74.79, 74.52, 74.49, 73.95, 73.70, 73.62, 73.51, 73.15, 73.09, 72.00, 71.93, 70.42, 70.31, 69.77, 69.46, 68.88, 68.79, 
68.28, 67.08, 67.04, 66.57, 66.52, 66.11, 66.02, 39.02 (2C), 38.99 (2C), 38.88 (2C), 38.84 (2C), 27.34 (3C), 27.33 
(6C), 27.30 (3C), 27.28 (3C), 27.25 (6C), 27.13 (3C). 
 
Phenyl 4-O-benzyl-6-O-chloroacetyl-2,3-di-O-pivaloyl-1-thio-β-D-galactopyranoside (358) 
353 (30.0 g; 56.53 mmol) was dissolved in CH2Cl2 (560 mL) and cooled to 0 °C. (ClAc)2O (15.0 
g; 87.62 mmol), Et3N (12.7 mL; 90.45 mmol) and DMAP (138 mg; 1.13 mmol) was added and the 
reaction was stirred at 0 °C for 1 h. The reaction mixture was concentrated and purified by flash 
chromatography (20:1 Tol/EtOAc) to afford 358 as a yellowish crystalline powder. Rf 0.57 (9:1 
Toluene/EtOAc). Yield 30.2 g (88%) 
    
  = -6.7° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.45 – 7.33 (m, 2H, H
SPh
), 7.31 – 7.11 (m, 8H, HSPh, 
H
Bn
), 5.41 (t, J1,2 = J2,3 =9.9 Hz, 1H, H-2), 5.02 (dd, J2,3 = 9.9, J3,4 = 2.9 Hz, 1H, H-3), 4.78 (d, JCH2 = 11.4 Hz, 1H, -
CH2
Bn
), 4.62 (d, J1,2 = 9.9 Hz, 1H, H-1), 4.38 (d, JCH2 = 11.4 Hz, 1H, -CH2
Bn
), 4.29 (dd, J6a,6b = 11.2, J5,6a = 6.9 Hz, 
1H, H-6a), 4.04 (dd, J6a,6b = 11.2, J5,6b = 5.8 Hz, 1H, H-6b), 3.98 – 3.80 (m, 3H, -CH2
AcCl
, H-4), 3.73 (ddd, J5,6a = 
6.9, J5,6b = 5.8, J4,5 = 1.2 Hz, 1H, H-5), 1.15 (s, 9H, 3xCH3
Piv
), 1.13 (s, 9H, 3xCH3
Piv
). 
13
C NMR (101 MHz, CDCl3) 
δ 177.84, 176.60, 166.87, 137.40, 133.00, 132.45 (2C), 128.97 (2C), 128.63 (2C), 128.15, 128.08 (2C), 128.07, 
87.04, 75.68, 74.99, 74.97, 73.96, 67.35, 64.32, 40.65, 39.10, 38.90, 27.38 (3C), 27.33 (3C).  HRMS (ESI-TOF) 
m/z: [M + Na]
+
 Calcd for C31H40ClNaO8S 630.2030; Found  630.2030. 
 
4-O-benzyl-6-O-chloroacetyl-2,3-di-O-pivaloyl-β-D-galactopyranose (359) 
358 (20.0 g; 32.94 mmol) was dissolved in acetone (330 mL) and water (30 mL). NBS (14.8 g; 
65.88 mmol) was added and the reaction was stirred at 22 °C for 3 h. The solution was diluted with 
EtOAc (500 mL) and washed with sat. aq. NaS2O3 (200 mL) and sat. aq. NaHCO3 (200 mL). The 
organic phase was dried over MgSO4, filtered and concentrated. The residue was purified by flash chromatography 
(4:1 Tol/EtOAc) to afford 359. Rf 0.19 (4:1 Tol/EtOAc) Yield: 14.9 g (88%) 
 
4-O-benzyl-6-O-chloroacetyl-2,3-O-dipivaloyl-β-D-galactopyranose N-phenyl trifluoroacetimidate (360) 
Hemiacetal 359 (14.9 g; 28.88 mmol) was dissolved in CH2Cl2 (300 mL) and cooled to 0 °C. 
Cs2CO3 (18.8 g; 57.75 mmol) was added followed by N-phenyl trifluoroacetimidoyl chloride 
(12.0 g; 57.75 mmol). The ice bath was removed and the reaction mixture was stirred for 12 h. It 
was then filtered, through a plug of celite, concentrated and purified by flash chromatography 
(15:1 Tol/EtOAc) to give 360 as white crystalline product. Yield:  15.5 g (78%)  
 
Phenyl 4-O-benzyl-6-O-chloroacetyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-
pivaloyl-1-thio-β-D-galactopyranoside (361) 
To a 500 mL flame-dried flask was added 353 (7.2 g, 13.56 mmol) and 360 (11.2 g, 16.28 
mmol). The mixture was co-evaporated with toluene (2x200 mL) and subjected to vacuum 
overnight. The mixture dissolved in CH2Cl2 (200 mL) and cooled to -40 °C. TMSOTf (0.23 
mL; 1.35 mmol) was added and the reaction mixture was stirred at -40 °C for 2h. Et3N (1 mL) 
was added and the reaction mixture was concentrated. The crude compound was purified by 
flash chromatography (9:1 Tol/EtOAc) affording 361. Rf 0.5 (4:1 Tol/EtOAc). Yield: 12.5 g (90%).  
 
Benzyl 4-O-benzyl-6-O-chloroacetyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-
di-O-pivaloyl-β-D-galactopyranoside (362) 
361 (3.0 g; 2.92 mmol) was dried azeotropically with toluene (2x50 mL) and subjected to 
vacuum overnight. Benzyl alcohol (378 mg; 3.50 mmol) was added. The mixture was 
dissolved in dry CH2Cl2 (50 mL) and cooled to -40 °C. NIS (689 mg; 3.06 mmol) and 
TESOTf (77 mg; 0.29 mmol) was added and the reaction mixture was stirred at -40 °C until 
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TLC revealed full conversion of the donor (4h). The solution was diluted with CH2Cl2 (100 mL) and washed with 
sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 mL). The organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash chromatography (19:1 toluene/EtOAc) to afford 362 as a white 
crystalline material. Rf 0.49 (9:1 Tol/EtOAc). Yield: 2.60 g (87%) 
    
  = -14.3° (c 1.0, CDCl3). IR (neat, cm
-1
): 3064.94, 3031.76, 2971.70, 2935.70, 2906.97, 2872.91, 1734.87, 
1496.96, 1479.65, 1456.10, 1397.62, 1366.40, 1278.65, 1141.72, 1073.10, 1041.77, 910.10. 
1
H NMR (400 MHz, 
CDCl3) δ 7.48 – 6.88 (m, 15H, Ar-H), 5.40 (dd, J2,3 = 10.4, J1,2 =7.9 Hz, 1H, H-2), 5.35 (dd, J2,3 = 10.4, J1,2 = 7.8 
Hz, 1H, H-2’), 4.95 (dd, J2,3 = 10.4, J3,4 = 3.0 Hz, 1H, H-3’), 4.94 (dd, J2,3 = 10.4, J3,4 = 3.1 Hz, 1H, H-3), 4.80 (d, 
JCH2 = 11.8 Hz, 1H, 0.5xCH2
Bn
), 4.77 (d, JCH2 = 11.6 Hz, 1H, 0.5xCH2
Bn
), 4.70 (d, JCH2 = 11.8 Hz, 1H, 0.5xCH2
Bn
), 
4.48 (d, JCH2 = 11.6 Hz, 1H, 0.5xCH2
Bn
), 4.42 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.38 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2
Bn
), 
4.39 (d, J1,2 = 7.8 Hz, 1H, H-1’), 4.15 (dd, J6a,6b = 11.1, J5,6a = 6.4 Hz, 1H, H-6a’), 4.02 (dd, J6a,6b = 11.1, J5,6b = 6.5 
Hz, 1H, H-6b’), 3.88 – 3.78 (m, 5H, H-4, H-4’, H-6a, CH2
AcCl
), 3.68 – 3.54 (m, 3H, H-5, H-5’, H-6b), 1.15 (s, 9H, 
3xCH3
Piv
), 1.11 (s, 9H, 3xCH3
Piv
), 1.09 (s, 9H, 3xCH3
Piv
), 1.04 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 
177.90, 177.72, 176.84, 176.74, 166.83, 138.01, 137.38, 137.03, 128.66 (2C), 128.41 (2C), 128.37 (2C), 128.29 
(2C), 128.24, 127.91 (2C), 127.83 (2C), 127.80 (2C), 101.34, 100.14, 75.20, 75.10, 74.75, 73.81, 73.72 (2C), 73.59, 
71.94, 70.37, 69.39, 69.33, 67.58, 63.83, 40.61, 39.10, 39.02, 38.93, 38.84, 27.38 (3C), 27.35 (3C), 27.30 (3C), 
27.25 (3C). HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C55H73ClNaO16 1047.4485; Found 1047.4484. 
 
Benzyl 4-O-benzyl-6-O-chloroacetyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-
di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-
(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranoside (363) 
To a 100 mL flame-dried flask was added 356 (1.5 g, 1.58 mmol) and the 361 
(2.11 g, 2.05 mmol). The mixture was dried azeotropically with toluene (2x50 mL) 
and subjected to vacuum overnight. It was then dissolved in dry CH2Cl2 (25 mL) 
and dry MeCN (25 mL), cooled to -30 °C, followed by addition of NIS (472 mg; 
2.10 mmol) and TESOTf (42 mg; 0.16 mmol). The reaction mixture was stirred at -
30 °C until TLC revealed full conversion of the donor (1.5h). The solution was 
diluted with CH2Cl2 (150 mL) and washed with sat. aq. NaS2O3 (100 mL) and sat. 
aq. NaHCO3 (100 mL). The organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash chromatography (20:1 Tol/EtOAc) 
to afford a white crystalline material. Rf 0.43 (9:1 Tol/EtOAc). Yield: 2.6 g (88%) 
    
  = -18.8° (c 1.0, CDCl3) IR (neat, cm
-1
):2971.30, 2935.59, 2907.15, 2872.55, 1733.73, 1479.62, 1456.66, 
1397.50, 1365.79, 1278.22, 1132.71, 1070.76, 1042.84 
1
H NMR (400 MHz, CDCl3) δ 7.47 – 6.98 (m, 25H, Ar-H), 
5.39 (dd, J2,3= 10.4, J1,2 = 7.9 Hz, 1H, H-2), 5.33 (dd, J2,3 = 10.3, J1,2 = 7.7 Hz, 1H, H-2), 5.29 (dd, J2,3= 10.3, J1,2 = 
7.7 Hz, 1H, H-2), 5.28 (dd, J2,3= 10.4, J1,2 = 7.8 Hz, 1H, H-2), 5.01 – 4.90 (m, 4H, H-3
1
-H-3
4
), 4.79 (d, JCH2 = 11.4 
Hz, 1H, 0.5xCH2
Bn
), 4.76 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2
Bn
), 4.65 (m, 3H, 1.5xCH2
Bn
), 4.54 (d, JCH2 = 11.0 Hz, 1H, 
0.5xCH2
Bn
), 4.53 (d, JCH2 = 11.1 Hz, 1H, 0.5xCH2
Bn
), 4.49 (d, JCH2 = 11.3 Hz, 1H, 0.5xCH2
Bn
), 4.48 (d, JCH2 = 12.0 
Hz, 1H, 0.5xCH2
Bn
), 4.40 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.37 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2
Bn
), 4.36 (d, J1,2 = 7.8 Hz, 
1H, H-1), 4.29 (d, J1,2 = 7.8 Hz, 1H, H-1), 4.29 (d, J1,2 = 7.9 Hz, 1H, H-1), 4.09 (dd, J6a,6b = 11.0, J5,6a = 6.2 Hz, 1H, 
H-6a
4
), 4.00 (dd, J6a,6b = 11.0, J5,6b = 6.6 Hz, 1H, H-6b
4
), 3.95 – 3.76 (m, 7H, H-41-H-44, 1.5xH-6), 3.73 (d, J = 1.5 
Hz, 1H, H-5
4
), 3.67 – 3.48 (m, 4H, H-51-H-53, 0.5xH-6), 3.42 – 3.31 (m, 2H, H-6), 1.15 (s, 9H, 3xCH3
Piv
), 1.10 (s, 
9H, 3xCH3
Piv
), 1.09 (s, 9H, 3xCH3
Piv
), 1.09 (s, 9H, 3xCH3
Piv
), 1.08 (s, 9H, 3xCH3
Piv
), 1.08 (s, 18H, 6xCH3
Piv
), 1.03 
(s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.90, 177.65, 177.58, 177.55, 176.87, 176.85, 176.83, 176.81, 
166.82, 138.48, 138.33, 138.25, 137.41, 137.04, 128.67, 128.37, 128.35, 128.31, 128.25, 127.93, 127.83, 127.79, 
127.66, 127.62, 127.57, 127.47, 101.32, 101.20, 101.18, 100.09, 77.36, 75.35, 75.27, 75.17, 75.14, 74.81, 74.55, 
74.42, 73.76, 73.68, 73.51, 73.13, 73.08, 73.04, 71.99, 70.30, 69.76, 69.72, 69.46, 69.30, 67.02, 66.41, 66.24, 63.80, 
40.57, 39.11, 39.01, 38.99, 38.99, 38.92, 38.89, 38.88, 38.84, 27.37, 27.35, 27.33, 27.33, 27.30, 27.29, 27.28, 27.26. 
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Benzyl 4-O-benzyl-2,3-O-dipivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-O-dipivaloyl-β-D-
galactopyranosyl-(1→6)-4-O-benzyl-2,3-O-dipivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-O-
dipivaloyl-β-D-galactopyranoside (364) 
363 (3.1 g; 1.66 mmol) was dissolved in dry THF (50 mL). Thiourea (380 mg; 
4.98 mmol), Bu4NI (123 mg; 0.33 mmol) and NaHCO3 (460 mg; 5.48 mmol) was 
added and the reaction mixture was heated to 55 °C for 8h. The mixture was 
filtered, concentrated and purified by flash chromatography (9:1 Tol/EtOAc) to 
give 364. Rf 0.17 (9:1 Tol/EtOAc). Yield: 2.59 g (87%) 
    
  = -14.8° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) δ 7.40 – 7.00 (m, 
25H), 5.47 – 5.20 (m, 4H, H-21-H-24), 5.03 – 4.86 (m, 4H, H-31-H-34), 4.81 – 4.44 
(m, 9H, 4.5xCH2
Bn
), 4.40 (d, J1,2 = 7.9 Hz, 1H, H-1
1/2/3/4
), 4.35 (d, J1,2 = 7.8 Hz, 
1H, H-1
1/2/3/4
), 4.28 (d, J1,2 = 7.8 Hz, 1H, H-1
1/2/3/4
), 4.24 (d, J1,2 = 7.9 Hz, 1H, H-
1
1/2/3/4
), 3.94 – 3.74 (m, 8H, H-41-H-44, 2xH-6), 3.64 – 3.25 (m, 8H, H-51-H-54, 
2xH-6), 1.13 (s, 9H, 3xCH3
Piv
), 1.12 – 1.06 (m, 54H, 18xCH3
Piv
), 1.03 (s, 9H, 3xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.78, 177.62, 177.53, 177.45, 176.77, 176.73 (2C), 176.70, 138.37, 138.30, 
138.11, 137.58, 136.92, 128.56, 128.25, 128.19, 128.15, 128.12, 128.07, 127.82, 127.72, 127.66, 127.57, 127.54, 
127.51, 127.47, 127.41, 101.40, 101.09, 101.06, 99.96, 77.24, 75.14, 75.07, 75.06, 75.04, 74.97, 74.66, 74.14, 73.81, 
73.58, 73.40, 73.17, 73.08, 73.05, 73.00, 70.18, 69.64, 69.55, 69.41, 69.36, 66.95, 66.46, 66.20, 61.66, 38.97, 38.92, 
38.88 (2C), 38.80, 38.77 (2C), 38.73, 27.25-27.15 (24C). 
 
Benzyl 4-O-benzyl-6-O-chloroacetyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-
di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-
(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-O-dipivaloyl-β-D-
galactopyranosyl-(1→6)-4-O-benzyl-2,3-O-dipivaloyl-β-D-galactopyranoside (365) 
To a 100 mL flame-dried flask was added 364 (2.15 g, 1.20 mmol) and 
the 361 (1.60 g, 1.56 mmol). The mixture was dried azeotropically with 
toluene (2x50 mL) and subjected to vacuum overnight. It was then 
dissolved in dry CH2Cl2 (20 mL) and dry MeCN (20 mL), cooled to -30 
°C, followed by addition of NIS (359 mg; 1.60 mmol) and TESOTf (32 
mg; 0.12 mmol). The reaction mixture was stirred at -30 °C until TLC 
revealed full conversion of the donor (1h). The solution was diluted 
with CH2Cl2 (200 mL) and washed with sat. aq. NaS2O3 (100 mL) and 
sat. aq. NaHCO3 (100 mL). The organic phase was dried over MgSO4, 
filtered and concentrated. The product was purified by flash 
chromatography (20:1 Tol/EtOAc) to afford 365 as a white crystalline 
material. Rf 0.45 (9:1 Tol/EtOAc). Yield: 2.95 g (91%) 
    
  = -11.6° (c 1.0, CDCl3). IR(neat, cm
-1
): 3065.46, 3031.60, 
2971.56, 2935.77, 2906.25, 2872.58, 1733.63, 1479.50, 1457.02, 
1397.49, 1365.53, 1278.11, 1132.52, 1070.03, 910.36. 
1
H NMR (400 MHz, CDCl3) δ 7.40 – 7.00 (m, 35H), 5.48 – 
5.14 (m, 6H, H-2
1
-H-2
6
), 5.05 – 4.88 (m, 6H, H-31-H-36), 4.79 (d, JCH2 = 11.3 Hz, 1H, 0.5xCH2
Bn
), 4.76 (d, JCH2 = 
12.0 Hz, 1H, 0.5xCH2
Bn
), 4.69 – 4.44 (m, 11H, 5.5xCH2
Bn
), 4.40 (d, J1,2 = 7.9 Hz, 1H, H-1
1/2/3/4/5/6
), 4.375 (d, J1,2 = 
7.9 Hz, 1H, H-1
1/2/3/4/5/6
), 4.37 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2
Bn
), 4.35 (d, J1,2 = 7.8 Hz, 1H, H-1
1/2/3/4/5/6
), 4.30 – 
4.21 (m, 3H, H-1
1/2/3/4/5/6
, H-1
1/2/3/4/5/6
, H-1
1/2/3/4/5/6
), 4.07 (dd, J6a,6b = 11.1, J5,6a = 6.2 Hz, 1H, H-6a
6
), 3.99 (dd, J6a,6b =  
11.1, J5,6b = 6.6 Hz, 1H, H-6b
6
), 3.94 – 3.75 (m, 11H, H-41-H-46, 2.5xH-6), 3.71 (d, JCH2 = 2.1 Hz, 2H, -CH2
AcCl
), 
3.68 – 3.44 (m, 8H, H-51-H-56, H-6), 3.36 (dd, J6a,6b = 9.3, J5,6a = 5.3 Hz, 1H, 0.5xH-6), 3.27 (m, 2H, H-6), 1.15 (s, 
9H, 3xCH3
Piv
), 1.11 – 1.05 (m, 90H, 30xCH3
Piv
), 1.03 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 177.78, 177.53, 
177.46, 177.39 (2C), 177.35, 176.75 (2C), 176.71 (2C), 176.67, 166.69, 138.50 (2C), 138.38, 138.28, 138.12, 
137.29, 136.91, 128.55-127.19 (35C), 101.21, 101.10 (2C), 99.98, 77.24, 75.24, 75.13, 75.04, 74.69, 74.44, 74.22, 
73.67, 73.57, 73.40, 73.04, 72.93, 72.81, 71.89, 70.19, 69.69, 69.64, 69.34, 69.17, 66.96, 65.83, 63.69, 40.44-38.73 
(12C), 27.26-27.15 (36C). 
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Benzyl 4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)- 4-O-benzyl-2,3-di-O-pivaloyl-β-
D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-
2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-
(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranoside (366) 
365 (2.15 g; 0.79 mmol) was dissolved in dry THF (50 mL). Thiourea 
(241 mg; 3.18 mmol), Bu4NI (59 mg; 0.16 mmol) and NaHCO3 (293 
mg; 3.49 mmol) was added and the reaction mixture was heated to 55 °C 
for 8h. The mixture was filtered, concentrated and purified by flash 
chromatography (9:1 Tol/EtOAc) to afford 366 as a slightly yellow 
crystalline material. Rf 0.22 (9:1 Tol/EtOAc). Yield: 1.75 g (84%) 
    
  = -22.5° (c 1.0, CDCl3) IR (neat, cm
-1
):2971.76, 2935.69, 2872.84, 
1734.05, 1496.96, 1479.64, 1278.40, 1133.95, 1070.54, 1045.28. 
1
H 
NMR (400 MHz, CDCl3) δ 7.36 – 7.08 (m, 35H), 5.39 (dd, J2,3 = 10.4, 
J1,2 = 7.9 Hz, 1H, H-2), 5.29 (m, 5H, 5xH-2), 5.04 – 4.89 (m, 6H, 6xH-
3), 4.76 (d, JCH2 = 11.8 Hz, 1H, 0.5xCH2
Bn
), 4.72 – 4.45 (m, 12H, 
6xCH2
Bn
), 4.43 – 4.19 (m, 7H, 0.5xCH2
Bn
, 6xH-1), 3.96 – 3.77 (m, 11H, 
6xH-4, 2.5xH-6), 3.64 – 3.18 (m, 13H, 6xH-5, 3.5xH-6), 1.15 – 1.02 (m, 
108H, 36xCH3
Piv
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.91-176.84 
(12C), 138.60-137.04 (7C), 128.68-127.41 (35C), 101.51-100.10 (6C), 75.25, 75.17, 75.09, 74.81, 74.56, 74.43, 
74.27, 73.91, 73.70, 73.52, 73.15, 73.05, 70.31, 69.78, 69.53, 69.46, 67.22, 67.07, 66.33, 61.75, 39.08-38.85 (12C), 
27.33-27.26 (36C). 
 
Benzyl 4-O-benzyl-6-O-chloroacetyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)- 4-O-benzyl-2,3-di-O-
pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-
2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-
benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranosyl-
(1→6)-4-O-benzyl-2,3-di-O-pivaloyl-β-D-galactopyranoside (367) 
To a 50 mL flame-dried flask was added 366 (1.2 g, 0.46 
mmol) and the 361 (609 mg, 0.59 mmol). The mixture was 
dried azeotropically with toluene (2x25 mL) and subjected 
to vacuum overnight. It was then dissolved in dry CH2Cl2 
(20 mL) and dry MeCN (20 mL), cooled to -30 °C, followed 
by addition of NIS (136 mg; 0.61 mmol) and TESOTf (12 
mg; 0.05 mmol). The reaction mixture was stirred at -30 °C 
until TLC revealed full conversion of the donor (1h). The 
solution was diluted with CH2Cl2 (200 mL) and washed 
with sat. aq. NaS2O3 (100 mL) and sat. aq. NaHCO3 (100 
mL). The organic phase was dried over MgSO4, filtered and 
concentrated. The product was purified by flash 
chromatography (15:1 Tol/EtOAc) to afford 367 as a white 
crystalline material. Rf 0.37 (9:1 Tol/EtOAc). Yield: 1.4 g 
(87%) 
    
  = -15.7° (c 1.0, CDCl3). 
1
H NMR (400 MHz, CDCl3) 
δ 7.39 – 6.97 (m, 45H), 5.42 – 5.20 (m, 8H, H-21-H-28), 
5.02 – 4.90 (m, 8H, H-31-H-38), 4.79 (d, JCH2 = 11.4 Hz, 1H, 
0.5xCH2
Bn
), 4.76 (d, JCH2 = 12.1 Hz, 1H, 0.5xCH2
Bn
), 4.72 – 
4.44 (m, 15H, 7.5xCH2
Bn
), 4.40 (d, J = 7.9 Hz, 1H, H-1
1/2/3/4/5/6
), 4.37 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2
Bn
), 4.35 (d, J 
= 7.8 Hz, 1H, H-1
1/2/3/4/5/6
), 4.30 – 4.19 (m, 6H, 6xH-1), 4.06 (dd, J6a,6b = 11.1, J5,6a = 6.2 Hz, 1H, H-6a
8
), 3.99 (dd, 
J6a,6b =  11.0, J5,6a = 6.6 Hz, 1H, H-6b
8
), 3.95 – 3.73 (m, 17H, H-41-H-48, 4.5xH-6), 3.70 (d, JCH2 = 2.3 Hz, 2H, 
CH2
AcCl
), 3.67 – 3.44 (m, 10H, H-51-H-58, H-6), 3.36 (dd, J = 9.3, 5.2 Hz, 1H, 0.5xH-6), 3.32 – 3.14 (m, 4H, 2xH-
6), 1.15 (s, 9H, 3xCH3
Bn
), 1.08 (dd, 126H, 42xCH3), 1.03 (s, 9H, 3xCH3
Bn
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 
177.78-176.66 (16C), 166.69, 138.59, 138.56, 138.53, 138.50, 138.38, 138.29, 138.12, 137.29, 136.92, 128.55-
127.13 (45C), 101.21-101.10 (7C), 99.98, 77.25, 75.24, 75.11, 75.04, 74.69, 74.31, 74.21, 73.67, 73.58, 73.55, 
73.40, 73.03, 72.93, 72.84, 72.82, 72.76, 72.72, 71.89, 70.19, 69.70, 69.64, 69.33, 69.17, 40.43, 39.00-38.73 (16C), 
27.26-27.06 (48C). 
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Preparative scale isolation of tunicamycins (368) 
50 mL of TYD media (Trypton (2 g/L), Yeast extract (2 g/L), MgCl2.6H2O 
(0.3 g/L) and glucose (6 g/L)) in a 250 mL spring coiled flask was inoculated 
with dense S. chartreusis spore suspension (10 μL) and incubated at 28 °C and 
200 rpm. After 24 h, aliquots of this culture (12 × 1 mL) were used to inoculate 
12 × 1 L of TYD media in unbaffled 2 L conical flasks, which were 
subsequently incubated at 28 °C and 200 rpm for 6-8 days. After this time the 
cultures adopted a characteristic red color which was used as a qualitative 
indicator of tunicamycin production. Most of the supernatant was decanted off and the cells were collected by 
centrifugation (8000 × g, 10 min). 
Extraction from cell culture supernatant:  
Amberlite XAD-16 was preconditioned by washing with MeOH (× 3), then distilled water (× 2). This 
preconditioned resin (15 g/L) was added to the cell culture supernatant and stirred for 2 h. The magnetic stirrer was 
then turned off and the XAD-16 resin allowed to settle to the bottom of the flask, after which the majority of the 
supernatant was decanted along with any remaining cell debris. The remaining supernatant was removed by 
filtration through cotton wool. The combined resin was next stirred in water (300 mL, 10 min) and the water was 
decanted off. This process was repeated with water (2 × 300 mL), MeOH (2 × 300 mL) and 
i
PrOH (2 × 300 mL) 
with a final wash in MeOH (200 mL, 60 min). TLC analysis (H2O/
i
PrOH/EtOAc 1:2:4) identified tunicamycin 
containing fractions (Rf = 0.4), which were combined and concentrated. The residue was washed with 1 M aq. HCl 
(2 × 50 mL) and the collected by centrifugation (3500 × g, 5 min). 
Extraction from cell pellet 
The cell pellet was stirred in 1M aq. HCl (800 mL, 20 min) and the cells collected by centrifugation (8000 × g, 10 
min). This process was repeated, after which the cell pellet was stirred in MeOH (800 mL, 2 h). The cells were 
collected by centrifugation (3500 × g, 5 min) and the supernatant decanted. The cells were then re-suspended in 
MeOH (800 mL) and vortexed for 5 min, prior to centrifugation (3500 × g, 5 min) and collection of the supernatant. 
The resulting MeOH fractions were combined and concentrated. 
The combined tunicamycin extracts were precipitated from acetone (400 mL) at 0 °C over 24 h. Rf = 0.3 
(water/isopropanol/ethyl acetate (W.IP.E) 1:3:6) 
1
H NMR (500 MHz, MeOD) 7.93 (d, J6,5 = 8.2 Hz, 1H, H-6
uracil
), 6.84 (dt, JHC=CH trans = 15.4 Hz, J = 6.9 Hz, 1H, -
CH2HC=), 5.96 (d, 3JHC=CH trans = 15.4 Hz, 1H, =CHC(O)-), 5.95 (d, J1´,2´ = 5.7 Hz, 1 H, H-1´), 5.77 (d, J5,6 = 8.2 Hz, 
1H, H-5
uracil
), 4.95 (d, J = 3.2 Hz, 1H, H-1´´), 4.59 - 4.63 (m, H-11´), 4.21 (t, J2´,1´ = 5.7 Hz, J = 5.7 Hz, 1H, H-2´), 
4.10 (t, J = 9.3 Hz, 1H, H-10´), 3.35 -4.05 (m, -CH2
sugar
, -CH
sugar
), 1.95 (s, 3H, -CH3 
NHAc
),1.16 - 1.61 (m, n × CH2 
fatty acid
), 0.89, 0.90 (2 × s, 2 × 3H, -CH(CH3)2) 
The presence of at least 9 homologues prevented full assignment, resulting in broad multiplets in the 3 - 4 (sugar 
C-H) and 1.1 - 1.6 (fatty acid CH2) regions. 
 
Analytical Scale Analysis of Purity 
HPLC Column: Waters Symmetry C18 3.5μM 4.6x150mm 
Flow rate: 1 mL/min. 
Solvent: 50% Acetonitrile with 0.1% formic acid in H2O, degassed.  
UV: 260 nm 
Sample injection volume: 20μL 
Run time: 15 minutes 
Solvent:  A. 5% Acetonitrile with 0.1% formic acid in H2O, 
 B. 99.9% Acetonitrile with 0.1% formic acid 
Gradient 
100%A from 0-1min.  
0%A-100%B from 1-28 min. 
100%B from 28-32 min. 
100%A from 32-35min.  
 
Heptaacetyl-tunicaminyl-uracil (371) 
Tunicamycin (1.5 g (40% purity), 1.22 mmol) was suspended in 3M aq. HCl (30 mL) 
and refluxed. After 3 h the reaction mixture was concentrated, and the residue 
dissolved in dry pyridine (15 mL) and acetic anhydride (15 mL). After 24 h at 22 °C, 
TLC (MeOH/EtOAc 1:19) showed three products at Rf 0.3 (product), Rf 0.50 
(pentaacetyl-D-glucosamine) and Rf 0.7 (non-degraded acetylated tunicamycin). After 
Experimental 
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removal of solvent in vacuo, flash chromatography (MeOH/EtOAc 1:19), afforded heptaacetyltunicaminyl-uracil 
371 as a white foam. Yield: 311 mg (36%) / ratio 56:44.  
IR (neat, cm
-1
): 3500-3700, 1747, 1717, 1698, 1684, 1653, 1636, 1558, 1540, 1521, 1374, 1224.  
1
H NMR (500 
MHz, CDCl3) δ ppm 8.82 (d, J = 1.9 Hz, 1H, N-H
uracil, β
), 8.70 (d, J = 2.0 Hz, 1H, N-H
uracil, α
), 7.22 (d, J6,5 = 8.2 Hz, 
1H, H-6
uracil, α
),7.19 (d, J6,5 = 8.2 Hz, 1H, H-6
uracil, β
), 6.14 (d, J11´,10´ = 3.8 Hz, 1H, H-11
´α
), 5.91 (d, J1´,2´= 5.7 Hz, 1H, 
H-1
´α
), 5.82 (d, J1´,2´ = 5.0 Hz, 1H, H-1
´β
), 5.81 (m, J = 2.0 Hz, J5,6 = 8.2 Hz, 1H, H-5
uracil, α
), 5.78 (dd, J = 1.9 Hz, J5,6 
= 8.2 Hz, 1H, H-5
uracil, β
), 5.71 (d, JN-H,10´ = 9.8 Hz, 1H, N-H
Ac, β
), 5.64 (d, J11´,10´ = 8.8 Hz, 1H, H-11
´β
), 5.50 (d, JN-H, 
10´ = 9.5 Hz, 1H, NH
Ac, α
), 5.43 (dd, J3´,4´ = 4.9 Hz, J3´,2´ = 6.1 Hz, 1H, H-3
´β
), 5.37 (dd, J3´,4´ = 4.7 Hz, J3´,2´ = 5.8 Hz, 
1H, H-3
´α
), 5.34 (app t, J2´,1´ = 5.7 Hz, J2´,3´ = 5.8 Hz, 1H, H-2
´α
), 5.30 (app t, J2´,1´ = 5.0, J2´,3´ = 6.1 Hz, 1H, H-2
´β
), 
5.24 (dd, J9´,8´ = 2.8 Hz, J9´,10´ = 11.5 Hz, 1H, H-9
´α
), 5.22 (dd, J8´,7´ = 1.0 Hz, J8´,9´ = 3.2 Hz, 1H, H-8
´β
), 5.20 (m, 1H, 
H-5
´β
), 5.19 (dd, J8´,7´ = 1.0 Hz, J8´,9´ = 2.8 Hz, 1H, H-8
´α
), 5.11 (ddd, J = 2.8 Hz, J5´,4´ = 4.7 Hz, J5´,6b´ = 8.3 Hz, 1H, 
H-5
´α
), 5.08 (dd, J9´,8´ = 3.2 Hz, J9´,10´ = 11.0 Hz, 1H, H-9
´β
), 4.71 (ddd, J10´,11´ = 3.8 Hz, J10´,N-H = 9.5 Hz, J10´,9´ = 11.5 
Hz, 1H, H-10
´α
), 4.42 (ddd, J10´,9´ = 8.8 Hz, J10´,N-H´ = 9.8 Hz, J10´,9´ = 11.0 Hz, 1H, H-10
´β
), 4.13 (app t, J4´,5´ = J4´,3´ = 
4.9 Hz, 1H, H-4
´β
), 4.08 (app t, J4´,5´ = J4´,3´ = 4.7 Hz, 1H, H-4
´α
), 4.07 (m, 1H, H-7
´α
), 3.92 (ddd, J7´,8´ = 1.0 Hz, J7´,6b´ 
= 3.2 Hz, J = 9.6 Hz, 1H, H-7
´β
), 2.20 (s, 3 H, -CH3
Ac, α
), 2.20 (s, 3 H, -CH3
Ac, β
), 2.18, 2.13 (2 × s, 2 × 3 H, 2 × -
CH3
Ac, α
), 2.12, 2.12 (2 × s, 2 × 3 H, 2 × -CH3
Ac, β
), 2.11 (s, 6H, 2 × - CH3
Ac, β
), 2.09 (s, 6H, 2 × -CH3
Ac, α
), 2.03 (s, 
3H, -CH3
Ac, α
), 2.01 (s, 3H, -CH3 
Ac, β
), 2.00 - 2.02 (m, 1H, H-6a
´β
), 1.97 - 1.99 (m, 1H, H-6a
´α
), 1.96 (s, 3H, -
CH3
NHAc, α
), 1.94 (s, 3H, -CH3
NHAc, β
), 1.75 (ddd, J6b´,7´ = 3.2 Hz, J = 8.2 Hz, 
2
J6b´,6a´ = 14.8 Hz, 1H, H-6b
´β
), 1.57 
(ddd, J = 1.7 Hz, J6b´,5´ = 8.3 Hz, 
2
J6b´,6a´ = 14.9 Hz, 1H, H-6b
´α
);  
13
C NMR 
 
 (126 MHz, MeOD-d4) δ ppm 171.2, 
170.7, 170.6, 170.6, 170.4, 170.2, 170.1, 170.0, 169.7, 169.6, 169.5, 169.3, 169.3, 169.1 (14 × s, 14 × C, C=O
NHAc, α
, 
C=O
NHAc, β
, 6 × C=O
Ac, α
, 6 × C=O
Ac, β
), 162.5 (C-4 C=O
β
), 162.5 (C-4 C=O
α
), 149.9 (C-2 C=O
α
), 149.9 (C-2 
C=O
β
),140.2 (C-6
uracil, β
), 139.8 (C-6
uracil, α
), 103.4 (C-5
uracil, α
), 103.3 (C-5
uracil, β
), 93.0 (C-11
´β
), 91.1 (C-11
´α
), 88.7 
(C-1
´β
), 88.1 (C-1
´α
), 82.5 (C-4
´β
), 82.4 (C-4
´α
), 72.4 (C-2
´α
), 72.4 (C- 2
´β
), 70.9 (C-7
´β
), 70.5 (C-9
´β
), 69.6, 69.6, 69.3, 
68.7, 68.1 (5 × s, 7 × C, C-3
´α
, C-3
´β
, C- 5
´α
, C-5
´β
, C-8
´α
, C-8
´β
, C-9
´α
)67.6 (C-7
´α
), 49.5 (C-10
´β
), 46.7 (C-10
´α
), 32.5 
(C-6
´α
), 31.6 (C-6
´β
), 23.3 (-CH3
NHAc, β
), 23.2 (-CH3
NHAc, α
), 20.4 – 21.0 (12 × C, 6 × -CH3
Ac, α
, 6 × - CH3
Ac, β
); HRMS 
m/z (ESI
+
) : calc. for C29H37N3NaO17 (M + Na)
+
 722.2015. Found 722.2019. 
 
2-acetamido-2-deoxy-1,3,4,6-tetra-O-acetyl-D-glucopyranoside (372)  
To a solution of N-acetyl glucosamine (12.1 g; 54.6 mmol) in anhydrous CH2Cl2 (50 mL) was 
added pyridine (22 mL), DMAP (0.33 g; 2.7 mmol) and Ac2O (26 mL; 273 mmol) at 0 °C. The 
reaction mixture was stirred at 0 °C for 15 min and then 12 h at 22 °C. The reaction was cooled to 
0 °C, poured into H2O (200 mL) and the aqueous layer was extracted with EtOAc (3x100 mL). The combined 
organic phase was washed with sat. aq. NaCl (200 mL), dried and concentrated in vacuo. Recrystallization from 
EtOAc/hexane resulted in 372 as a white crystalline material. Yield: 19.3 g (91%). 
1
H NMR (400 MHz, CDCl3) δ 6.16 (d, J = 3.6 Hz, 1H), 5.62 (d, J1,2 = 9.0 Hz, 1H, H-1), 5.29 – 5.17 (m, 2H, H-3, 
H-5), 4.58 – 4.43 (m, 1H, H-2), 4.24 (dd, J = 12.5, 4.0 Hz, 1H, H-6a), 4.06 (dd, J = 12.5, 2.3 Hz, 1H, H-6b), 4.02 – 
3.96 (m, 1H, H-4), 2.19 (s, 3H, -CH3), 2.08 (s, 3H, -CH3), 2.05 (s, 3H, -CH3), 2.04 (s, 3H, -CH3), 1.93 (s, 3H, -CH3). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 171.72, 170.70, 169.96, 169.09, 168.64, 90.66, 70.64, 69.68, 67.42, 61.49, 51.02, 
23.04, 20.94, 20.72, 20.69, 20.56. MS m/z (ESI
+
): 412.3 [(M+ Na)
+
] 
 
2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-D-glucopyranose (373) 
A mixture of 372 (5g; 12.8 mmol) and freshly activated, powdered 4Å MS (5 g) in dry MeOH (100 
mL) was stirred at 22 °C for 2 h. The mixture was filtered through a celite plug, concentrated and 
purified by flash chromatography (MeOH:CH2Cl2 1:19) to give 373 as white crystals. Rf 0.3 (1:19 
MeOH:CH2Cl2).Yield 3.65 g (82%). 
1
H-NMR (400 MHz, CDCl3) δ  6.02 (d, JNHAc,2 = 9.3 Hz, 1 H, NHAc), 5.30 (t, J2,3 = 10.6 Hz, J3,4 = 9.6 Hz, 1 H, H-
3), 5.25 (d, J1,2 = 3.3 Hz, 1 H, H-1), 5.13 (t, J4,5 = J3,4 = 9.6 Hz, 1 H, H-4), 4.29 (dt, J2,3 = JNHAc,2 = 10.6 Hz, J1.2 = 3.5 
Hz), 4.21 (m, 2 H, H-5, H-6a), 4.13 (m, 1 H, H-6b), 2.09, 2.03, 2.02, 1.97 (4 x s, 4 x 3 H, 4 x AcMe).
13
C NMR (101 
MHz, CDCl3) δ 171.46, 171.07, 170.79, 169.52, 91.42, 70.97, 68.28, 67.36, 62.12, 52.32, 23.06, 20.77, 20.74, 20.63. 
MS m/z (ESI
+
): 554.3 [(M+ Na)
+
] 
 
Hexaacetyl-tunicaminyl-uracil (374) 
Glacial acetic acid in dry THF (36.1 mg; 0.60 mmol) was added to a solution of 
ethylenediamine (30.9 mg; 0.51) in THF (20 mL). After 10 min heptaacetyl 
tunicaminyl uridine 371 (300 mg; 0.43 mmol) was added and the mixture was stirred at 
22 °C for 24h. At this point the reaction showed app. 50% conversion. The reaction 
mixture was poured into sat. aq. NaHCO3 (10 mL) and extracted with CH2Cl2 (3x50 
mL). The combined organic phases were dried over MgSO4, filtered and concentrated. The crude was purified by 
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flash chromatography (40:1 EtOAc/MeOH) to give starting material 371 and product 374. Rf 0.15 (19:1 
EtOAc/MeOH). Yield: 110 mg (39%). 
1
H NMR (500 MHz, CDCl3) δ 8.77 (s, 1H, N-H
uracil
), 7.21 (d, J5,6 = 8.1 Hz, 1H, H-6
uracil
), 5.83 (d, J1,2 = 5.4 Hz, 1H, 
H-1’), 5.79 (d, J5,6 = 8.1 Hz, 1H, H-6
uracil
), 5.43 (dd, J2,3 = 5.4, J3,4 = 4.9 Hz, 1H, H-3’), 5.37 (t, J1,2 = J2,3 = 5.4 Hz, 
1H, H-2’), 5.32 (ddd, J5,6b = 9.5, J4,5 = 4.9, J5,6a = 3.0 Hz, 1H, H-5’), 5.28 (t, J10,11 = 3.0 Hz, 1H, H-11’), 5.24 – 5.18 
(m, 2H, H-8’, H-9’), 4.58 – 4.50 (m, 1H, H-10’), 4.30 – 4.24 (m, 1H, C-11’-OH), 4.16 (dd, J6a,7 = 9.2, J6b,7 = 2.2 Hz, 
1H, H-7’), 4.11 (t, J3,4 = J4,5 = 4.9 Hz, 1H, H-4’), 2.19 (s, 3H, CH3
Ac
), 2.14 (s, 3H, CH3
Ac
), 2.13 (s, 3H, CH3
Ac
), 2.10 
(s, 3H, CH3
Ac
), 2.01 (s, 3H, CH3
Ac
), 1.98 (s, 3H, CH3
Ac
), 1.97 – 1.90 (m, 1H, H-6a’), 1.60 (ddd, J6a,6b = 14.7, J5,6b = 
9.5, J6b,7 = 2.2 Hz, 1H, H-6b’). 
13
C NMR 
  
 (126 MHz, CDCl3) δ 171.02, 171.00, 170.73, 170.30, 169.73, 169.34, 
162.52, 149.89, 140.19, 103.39, 91.93, 88.62, 82.56, 77.19, 72.33, 70.12, 69.57, 68.48, 64.55, 47.86, 32.19, 29.68, 
23.32, 21.05, 20.80, 20.79, 20.47, 20.41. HRMS: calc. [M+Na]
+
: 680.19150 found [M+Na]
+
: 680.1951 
 
Phenyl 4,6-O-dibenzyl-3-O-(benzyl (S)-lactate)-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside (375) 
A solution of 384 (600 mg; 1.06 mmol) and KI (530 mg; 3.19 mmol)  in DMF (12 mL) was 
cooled to 0 °C. BnBr (1.01 mL; 8.51 mmol) and Ag2O (2.0 g; 8.62 mmol) was added and the 
reaction was stirred at 3 °C for 12h. The reaction mixture was filtered through a celite plug, 
diluted with CH2Cl2 (150 mL) and washed with sat. aq. Na2S2O3 (3x50 mL) and H2O (2x50 mL). 
The organic phase was dried over MgSO4 and concentrated. The product was purified by flash 
chromatography (9:1 Tol/EtOAc). Rf 0.58 (5:1 Tol/EtOAc)Yield: 510 mg (41%).  
MS m/z (ESI
+
): 767 [(M+ Na)
+
] 
 
Phenyl 4,6-O-diacetyl-3-O-(benzyl (S)-lactate)-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside (376) 
To a solution of 384 (3 g; 5.32 mmol) in CH2Cl2 (50 mL) at 0 °C was added Et3N (2.23 mL; 15.97 
mmol), Ac2O (1.26 mL; 13.31 mmol) and DMAP (13 mg; 0.11 mmol). The reaction mixture was 
stirred at 0 °C until TLC showed full conversion (2h). The solution was diluted with DCM (100 
mL) and washed with H2O (100 mL). The organic phase was dried over MgSO4 and concentrated. 
The product was purified by flash chromatography (8:1 Tol/EtOAc) to give 376 as a white 
crystalline material. Rf 0.4 (5:1 Tol/EtOAc). Yield: 3.2 g (96%). 
1
H NMR (400 MHz, CDCl3) δ 7.99 – 7.79 (m, 2H), 7.74 (dd, J = 5.5, 2.7 Hz, 2H), 7.42 (dd, J = 6.3, 2.8 Hz, 2H), 
7.35 – 7.23 (m, 6H), 7.11 (dd, J = 6.4, 2.9 Hz, 2H), 5.58 (d, J1,2 = 10.1 Hz, 1H, H-1), 5.15 (dd, J4,5 = 9.8, J3,4=8.8 
Hz, 1H, H-4), 4.68 (dd, J = 31.0, 12.2 Hz, 2H, CH2-Ph), 4.43 (dd, J2,3 = 10.2, J3,4=8.8 Hz, 1H, H-3), 4.37 (t, J1,2=J2,3 
= 10.2 Hz, 1H, H-2), 4.23 (dd, J = 12.2, 5.4 Hz, 1H, H-6a), 4.16 (dd, J = 12.2, 2.3 Hz, 1H, H-6b), 4.09 (q, J = 6.8 
Hz, 1H, CH-CH3), 3.77 (ddd, J6a,6b = 9.9, J5,6a=5.3, J5,6b=2.4 Hz, 1H, H-5), 2.10 (s, 3H), 2.09 (s, 3H), 1.21 (d, J = 6.8 
Hz, 3H, CH3-CH). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 171.98, 170.75, 168.71(1C), 167.67, 169.28, 135.25, 133.91, 
132.82 (2C), 131.71, 128.83 (2C), 128.50 (2C), 128.33, 128.11 (2C), 123.70, 122.92, 83.59, 78.01, 75.98, 75.91, 
71.94, 66.34, 62.41, 54.21, 20.89, 20.81, 18.92. HRMS: calc. [M+H]
+
: 502.1661 found [M+ H]
+
: 502.1667 
 
1,3,4,6-Tetra-O-acetyl-2-phthalimido-2-deoxy-β-D-glucopyranoside (380) 
A 1 M NaOMe solution was prepared by adding Na metal (5.33 g, 0.232 mol) in small pieces to 
MeOH (232 mL) at –5 °C in a 500 mL round-bottomed flask equipped with a reflux condenser, 
which was swirled until the metal had been completely consumed. This was slowly added at 0 °C to 
a 1 L round-bottomed flask containing glucosamine hydrochloride (50 g, 0.232 mol). The reactionmixture was 
mechanically agitated for 2 h at r.t., then treated with finely ground phthalic anhydride (19 g, 0.128 mol) and stirred 
for another 45 min. The mixture was charged with a second portion of phthalic anhydride (19 g, 0.128 mol), Et3N 
(35.5 mL, 0.255 mol), and MeOH (230 mL) and vigorously stirred for another 24 h, during which it slowly changed 
from a milky white solution to a thick yellow paste. The intermediate phthalamate (and salts) were precipitated as a 
white solid by cooling the mixture to – 20 °C for 4 h. These were filtered and washed with cold MeOH, then dried 
overnight under reduced pressure. The solid was re-dispersed in pyridine (500 mL) and cooled to –5 °C, followed by 
treatment with Ac2O (330 mL). The mixture was stirred at r.t. for 48 h, during which it slowly changed from a 
translucent white to an opaque yellow solution. Cold EtOH (100 mL) was slowly added to quench the excess Ac2O, 
which was then reduced by rotary evaporation. This was re-dispersed in toluene (3x100 mL) and concentrated 
several times for the azeotropic removal of pyridine. The remaining slurry was re-dissolved in CHCl3 (1 L) and 
washed with distilled H2O (4x250 mL) and brine (250 mL), then dried (Na2SO4) and concentrated The crude 
product was dissolved in minimal amount of hot EtOAc (100 mL), then diluted with hexanes (400 mL) and left to 
cool at –5 °C. The recrystallized product was collected by filtration, washed with cold hexanes, and dried to yield 
the desired tetraacetate 380 as an 8:1 mixture of anomers  
Yield: 85.3 g (77%). 
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1
H NMR (400 MHz, CDCl3) δ 7.85 (dd, J = 5.5, 3.1 Hz, 1H), 7.74 (dd, J = 5.5, 3.1 Hz, 1H), 6.49 (d, J1,2 = 8.9 Hz, 
1H, H-1), 5.87 (dd, J2,3= 10.6, J3,4=9.1 Hz, 1H, H-3), 5.20 (dd, J 4,5= 10.1, J3,4=9.1 Hz, 1H, H-4), 4.45 (dd, J2,3= 10.6, 
J1,2=8.9 Hz, 1H, H-2), 4.35 (dd, J6a,6b = 12.5, J5,6a=4.4 Hz, 1H, H-6a), 4.20 – 4.06 (m, 1H, H-6b), 4.01 (ddd, J4,5 = 
10.2, J5,6a=4.4, J5,6b=2.1 Hz, 1H, H-5). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 170.76, 170.12, 169.57, 168.73, 134.60 
(2C), 131.32 (2C), 123.90 (2C), 89.86, 72.73, 70.60, 68.39, 61.63, 53.60, 20.87, 20.84, 20.71, 20.50. MS m/z (ESI
+
) 
: 500.4 [(M+ Na)
+
] 
 
Phenyl 3,4,6-Tri-O-acetyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside (381) 
An oven-dried 1 L round-bottomed flask was charged with 380 (43.25 g, 90.9 mmol), thiophenol 
(28 mL, 272.8 mmol), and anhyd. CH2Cl2 (430 mL). The mixture was treated with TMSOTf (20 
mL, 109.2 mmol) at rt and stirred for 7 h. The mixture was then quenched with a sat. aq. solution of 
NaHCO3 (400 mL). The aqueous layer was extracted with additional CH2Cl2 (2 x 100 mL); the 
combined organic phases were then washed with brine (250 mL), dried (Na2SO4), and concentrated. The crude 
product was dissolved in a minimum amount of hot EtOAc (65 mL), then diluted with hexanes (200 mL) and cooled 
to 0 °C. The recrystallized product was collected by filtration, washed with cold 10% EtOAc in hexanes, and dried 
to yield the desired thiophenyl glycoside 381. Yield: 36.5 g (76%). 
1
H NMR (400 MHz, CDCl3) δ 7.84 (dd, J = 5.4, 3.0 Hz, 2H, ArH), 7.73 (dd, J = 5.5, 3.0 Hz, 2H, ArH), 7.39 (dd, J 
= 7.7, 1.8 Hz, 2H, ArH), 7.31 – 7.19 (m, 3H, ArH), 5.77 (dd, J2,3 = 10.6, J3,4=9.3 Hz, 1H, H-3), 5.69 (d, J1,2 = 10.6 
Hz, 1H, H-1), 5.12 (dd, J4,5=10.0, J3,4=9.3 Hz, 1H, H-4), 4.33 (t, J1,2 =J2,3=10.6 Hz, 1H, H-2), 4.27 (dd, J6a,6b  = 12.3, 
J5,6b=5.1 Hz, 1H, H-6a), 4.18 (dd, J6a,6b = 12.2, J5,6b=2.3 Hz, 1H, H-6b), 3.88 (ddd, J4,5 = 10.0, J5,6a5.0, J5,6b2.3 Hz, 
1H, H-5), 2.08 (s, 3H), 2.00 (s, 3H), 1.81 (s, 3H). 
13
C NMR 
 
 (101 MHz,CDCl3): δ 170.70, 170.08, 169.55, 168.71, 
167.44, 134.57, 131.26, 123.87, 89.82, 72.67, 70.56, 68.32, 61.58, 53.55, 20.82, 20.68, 20.48. 
MS m/z (ESI
+
) : 550.5 [(M+ Na)
+
] 
 
Phenyl 4,6-O-(p-Methoxybenzylidene)-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside (382) 
To a 100 mL round-bottomed flask was added the triacetate 381 (15.0 g, 28.43 mmol) and a 3:2 
mixture of MeOH–CH2Cl2 (130 mL). The mixture was cooled to -20 °C, treated with a 0.3 M 
NaOMe solution in MeOH (37.7 mL, 11.3 mmol) and stirred for 10 min, then warmed to -10 °C 
and stirred for 2 h. The reaction mixture was warmed to 0 ºC, quenched with Amberlite 120-H
+
 
resin, filtered and concentrated. The crude was concentrated with toluene three times and left on under vacuum 
overnight. The crude (11.42 g; 28.45 mmol) was suspended in MeCN (175 ml). (4-OMe)Ph(OMe)2 (6.54 mL; 38.41 
mmol) and CSA (0.66 g; 2.84 mmol) was added and the reaction was heated to reflux. 1/3 of the volume was 
distilled off over 1h after which the mixture was heated to reflux until TLC showed full conversion (2 h). The 
reaction was quenched by addition of Et3N (2 mL) and concentrated.  The product 382 was purified by flash 
chromatography (6:1 Tol/EtOAc). Rf 0.5 (4:1 Tol/EtOAc). Yield: 13.0 g (88%). 
1
H NMR (400 MHz, CDCl3) δ 7.79 (m, 1H, -Ar-H
PhTh
), 7.77 – 7.72 (m, 1H, -HPhTh), 7.69 – 7.56 (m, 2H), 7.38 – 
7.25 (m, 4H), 7.25 – 7.14 (m, 3H), 6.78 (d, J = 8.8 Hz, 2H, HMP), 5.59 (d, J1,2 = 10.6 Hz, 1H, H-1), 5.42 (s, 1H, CH-
MP), 4.51 (ddd, J2,3=10.6, J3,4= 9.1, J3,OH=1.0 Hz, 1H, H-3), 4.27 (dd, J6a,6b = 10.5, J5,6a=4.9 Hz, 1H, H-6a), 4.22 (t, 
J1,2 =J2,3=10.6 Hz, 1H, H-2), 3.71 (s, 3H, -OCH3), 3.70 (m, 1H, H-6b), 3.56 (td, J4,5b = 9.1, J5,6a=4.9 Hz, 1H, H-5), 
3.46 (t, J3,4=J4,5=9.1 Hz, 1H, H-4), 2.71 (d, J = 2.6 Hz, 1H, -OH). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 168.35, 167.64, 
160.40, 134.33, 132.68 (2C), 131.94, 129.48, 129.07 (2C), 128.19, 127.77 (2C), 123.95, 123.47, 113.84 (2C), 
101.97, 84.38, 81.92, 70.40, 69.77, 68.62, 55.64, 55.42. MS m/z (ESI
+
): 542.5 [(M+ Na)
+
] 
 
Phenyl 3-O-(benzyl (S)-lactate)-4,6-O-(p-Methoxybenzylidene)-2-deoxy-2-phthalimido-1-thio-β-D-
glucopyranoside (383) 
382 (1.0 g; 1.92 mmol) was dissolved in dry DMF (15 mL). The solution was cooled to 0 °C and 
treated with NaH (60%)(0.101 g; 2.52 mmol) and stirred for 10 min. Then a solution of 385 (2.34 
g; 9.62 mmol) in DMF was added and the solution was stirred at 0 °C until TLC showed full 
conversion of the starting material (12 h). The solution was diluted with EtOAc (150 mL) and 
washed with 1N HCl (50 mL) and H2O (50 mL). The organic layer was dried over MgSO4 and concentrated. The 
compound was purified by flash chromatography (40:1 Tol/EtOAc) to give 383 as white crystals. Rf 0.75 (5:1 
Tol/EtOAc). Yield: 0.44 g (35%). 
1
H NMR (400 MHz, CDCl3) δ 7.86 -6.79 (m, 36H, Ar-H), 5.64 (d, J = 10.5 Hz, 1H, H-1a), 5.55 (d, J = 10.1 Hz, 1H, 
H-1b), 5.46 (s, 1H), 4.76 (d, J = 3.4 Hz, 2H, CH2
Bn,b
), 4.69 (d, JCH2 = 12.4 Hz, 1H, 0.5xCH2
Bn,a
), 4.59 (d, JCH2 = 12.4 
Hz, 1H, 0.5xCH2
Bn,a
), 4.44 – 4.17 (m, 5H, H-2a, H-2b, H-3a, H-3b, CH-CH3
a
, CH-CH3
b
), 3.81 (s, 3H, -OMe
b
), 3.79 – 
3.72 (m, 2H, H-4
a
, H-4
b
), 3.71 (s, 3H, -OMe
a
), 3.69 – 3.56 (m, 2H, H-5a, H-5b), 1.19 (d, J = 5.5 Hz, 3H, CH3-CH
b
), 
1.18 (d, J = 6.9 Hz, 3H, CH3-CH
a
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 190.97, 173.70, 172.72, 168.87, 167.64, 
164.74, 160.19, 135.66, 135.40, 134.15, 133.94, 132.97, 132.56, 132.46, 132.13, 131.97, 131.76, 130.08, 129.66, 
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129.09, 129.05, 128.69, 128.65, 128.53, 128.45, 128.23, 128.20, 128.10, 128.02, 127.78, 127.35, 127.11, 123.75, 
123.28, 123.07, 114.44, 113.79, 101.40, 84.26, 83.88, 82.99, 79.90, 79.26, 77.36, 76.64, 75.59, 73.80, 71.66, 70.22, 
68.72, 66.71, 66.20, 65.48, 62.82, 55.72, 55.40, 54.52, 53.54, 19.33, 19.03. HRMS: calc. [M+H]
+
: 558.1688 found 
[M+ H]
+
: 558.1688 
 
Phenyl 3-O-(benzyl (S)-lactate)-4,6-O-(p-Methoxybenzylidene)-2-deoxy-2-phthalimido-1-thio-β-D-
glucopyranoside (383_2) 
A solution of 382 (10g; 19.25 mmol) in dry THF (180 mL) was treated with NaH (60%) (1.39g; 
57.74 mmol) at 22 °C for 15 min. The solution was cooled to 0 °C and a solution of 386 (13.22 
g; 42.34 mmol) in dry THF (20 mL) was added slowly. The reaction mixture was stirred at 0 °C 
until TLC showed full conversion (app. 4h). The reaction mixture was diluted with CH2Cl2 (500 
mL) and washed with sat. aq. NH4Cl (200mL). The organic phase was dried over MgSO4 and concentrated. The 
product was purified by flash chromatography (40:1 Tol/EtOAc) to give 383 as a white crystalline material. Rf 0.75 
(5:1 Tol/EtOAc). Yield: 11.9 g (88%). 
1
H NMR (400 MHz, CDCl3) δ 7.86 -6.79 (m, 36H, Ar-H), 5.64 (d, J = 10.5 Hz, 1H, H-1a), 5.55 (d, J = 10.1 Hz, 1H, 
H-1b), 5.46 (s, 1H), 4.76 (d, J = 3.4 Hz, 2H, CH2
Bn,b
), 4.69 (d, JCH2 = 12.4 Hz, 1H, 0.5xCH2
Bn,a
), 4.59 (d, JCH2 = 12.4 
Hz, 1H, 0.5xCH2
Bn,a
), 4.44 – 4.17 (m, 5H, H-2a, H-2b, H-3a, H-3b, CH-CH3
a
, CH-CH3
b
), 3.81 (s, 3H, -OMe
b
), 3.79 – 
3.72 (m, 2H, H-4
a
, H-4
b
), 3.71 (s, 3H, -OMe
a
), 3.69 – 3.56 (m, 2H, H-5a, H-5b), 1.19 (d, J = 5.5 Hz, 3H, CH3-CH
b
), 
1.18 (d, J = 6.9 Hz, 3H, CH3-CH
a
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 190.97, 173.70, 172.72, 168.87, 167.64, 
164.74, 160.19, 135.66, 135.40, 134.15, 133.94, 132.97, 132.56, 132.46, 132.13, 131.97, 131.76, 130.08, 129.66, 
129.09, 129.05, 128.69, 128.65, 128.53, 128.45, 128.23, 128.20, 128.10, 128.02, 127.78, 127.35, 127.11, 123.75, 
123.28, 123.07, 114.44, 113.79, 101.40, 84.26, 83.88, 82.99, 79.90, 79.26, 77.36, 76.64, 75.59, 73.80, 71.66, 70.22, 
68.72, 66.71, 66.20, 65.48, 62.82, 55.72, 55.40, 54.52, 53.54, 19.33, 19.03. HRMS: calc. [M+H]
+
: 558.1688 found 
[M+ H]
+
: 558.1688 
 
Phenyl 3-O-(benzyl (S)-lactate)-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside (384) 
383 (6 g; 8.8 mmol) was dissolved in a mixture of MeOH and CH2Cl2 (80 mL:20 mL). To the 
solution was added CSA (204 mg; 0.88 mmol) and the reaction mixture was stirred at 45 °C for 
1½h. The reaction mixture was neutralized with Et3N (0.5 mL) and concentrated. The crude 
mixture was purified by flash chromatography (2:1 Tol/EtOAc) to afford 384 as a white 
crystalline material. Rf 0.15 (2:1 Tol/EtOAc). Yield 4.5 g (92%). 
1
H NMR (400 MHz, CDCl3) δ 7.95 – 7.87 (m, 1H), 7.86 – 7.80 (m, 1H), 7.77 – 7.68 (m, 2H), 7.42 – 7.33 (m, 2H), 
7.34 – 7.28 (m, 6H), 7.28 – 7.22 (m, 2H), 7.18 – 7.11 (m, 2H), 5.65 (d, J1,2 = 9.9 Hz, 1H, H-1), 4.81 (m, 2H, CH2-
Ph), 4.48 (d, J = 6.8 Hz, 1H, CH-CH3), 4.34 (m, 1H, H-5), 4.33(t, J1,2=J2,3=9.9, 1H, H-2), 4.11 – 3.81 (m, 2H, H-6a, 
H-6b), 3.74 (s, 2H, H-3, -OH), 3.57 (m, 1H, H-4), 2.53 (s, 1H, HO-), 1.28 (d, J = 6.8 Hz, 3H, CH3-CH). 
13
C NMR 
 
 
(101 MHz, CDCl3) δ 173.51, 168.71(1C), 167.67, 135.32, 134.02, 132.30 (2C), 132.05, 129.00 (2C), 128.51 (2C), 
128.29, 128.04 (2C), 127.97, 123.67, 123.13, 83.73, 79.77, 79.29, 77.39, 77.07, 76.75, 74.29, 71.60, 66.47, 62.43, 
53.70, 19.17. HRMS: calc. [M+H]
+
: 564.1692 found [M+ H]
+
: 564.1698 
 
 (S)-benzyl 2-bromopropanoate (385) 
α-bromopropionic acid (5 g; 32.68 mmol), BnOH (3.54 g; 32.75 mmol) and p-TSA (0.053 g; 0.28 
mmol) was dissolved in toluene (15 mL) and refluxed for 18 h with a Dean-Stark apparatus for removal 
of water. The reaction mixture was diluted with Et2O (50 mL), washed with 5% NaOH (3x), dried over 
MgSO4, filtered and concentrated. The product 385 was purified by flash chromatography (4% 
EtOAc/petroleum ether). Rf 0.33 (4% EtOAc/petroleum ether. Yield: 9.87 g (97%). 
1
H NMR (400 MHz, CDCl3) δ 7.45 – 7.30 (m, 5H, Ar-H), 5.21 (s, 2H, -CH2Ph), 4.42 (q, J = 6.9 Hz, 1H, -CH-CH3), 
1.85 (d, J = 6.9 Hz, 3H, -CH3-CH). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 170.08, 135.19, 128.66 (2C), 128.51, 128.21 
(2C), 67.61, 40.02, 21.66. 
 
(S)-benzyl 2-(((trifluoromethyl)sulfonyl)oxy)propanoate (386) 
Tf2O (19.7 mL; 116.54 mmol) was dissolved in dry CH2Cl2 (300 mL) and the solution was cooled to -10 
°C. Pyridine (13.44 mL; 123.20 mmol) was added and after 5 min a white precipitate was observed. 387 
(20 g; 110.99 mmol) was dissolved in CH2Cl2 (120 mL) and added slowly to the reaction mixture. The 
reaction mixture was warmed to 22 °C and stirred for another 10 min. The solid was removed by 
filtration and washed with CH2Cl2. The sample was concentrated at low temperature and purified on a silica plug 
(10x5cm 4:1 DCM/hexane. The solvent was quickly removed and the clear liquid 386 was stored at -20 °C. Yield: 
30.1 g (87%). 
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1
H NMR (400 MHz, CDCl3) δ 7.59 – 7.31 (m, 5H, ArH), 5.69 – 5.13 (m, 3H, CH2Ph, CH-CH3), 1.71 (d, J = 7.0 Hz, 
3H, CH3-CH). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 167.25, 134.35, 128.85, 128.74 (2C), 128.43 (2C), 79.95, 68.31, 
53.44, 18.05. 
 
(S)-benzyl 2-hydroxypropanoate (387) 
In a 2L flask was placed Fe(acac)3 (4.48 g; 12.7 mmol), benzyl alcohol (31.57 mL; 304.75 mmol) and 
Na2CO3 (1.35 g; 12.70 mmol) in heptane (800 mL). A solution of 385 (30 g; 253.96 mmol) in heptane 
(200 mL) was added and the resulting mixture was heated to reflux with azeotropic removal of ethanol. 
After TLC showed full conversion (3 h) the reaction was cooled to 22 °C and quenched with sat. aq. 
NH4Cl (500 mL) and extracted with EtOAc (500 mL). The product 387 was purified by flash chromatography (7:1 
hexane/EtOAc). Rf 0.33 (7:1 hexane/EtOAc). Yield 40.1 g (88%). 
1
H NMR (400 MHz, CDCl3) δ 7.36 – 7.23 (m, 5H, ArH), 5.12 (s, 2H, -CH2Ph), 4.23 (q, J = 6.9 Hz, 1H, -CH-CH3), 
2.89 (s, 1H, -OH), 1.35 (d, J = 6.9 Hz, 3H, CH3-CH). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 175.57, 135.25, 128.69, 
128.57, 128.26, 127.63, 127.00, 67.31, 66.87, 20.38. 
 
Phenyl 3-O-allyl-4,6-O-(p-Methoxybenzylidene)-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside (388) 
A solution of 382 (11.3 g; 21.75 mmol) and allyl bromide (3.75 mL; 43.49 mmol) in THF (150 
mL) was cooled to 0 °C and added drop wise to a flask containing NaH (60% oil dispersion; 
1.734 g; 43.49 mmol). The mixture was stirred at 0 °Cfor 2h then Ac2O (8 mL) was added and 
the mixture was stirred for another 2 h. The reaction was quenched by addition of MeOH (10 mL) and diluted with 
Et2O (250 mL). The organic phase was washed with H2O(2x100 mL), dried over MgSO4 and concentrated. The 
product 388 was purified by flash chromatography (9:1 Tol/EtOAc). Rf 0.65 (5:1 Tol/EtOAc). Yield: 9.57 g (79%). 
1
H NMR (400 MHz, CDCl3) δ 7.90 – 7.80 (m, 1H, H
PhTh
), 7.80 – 7.73 (m, 1H, HPhTh), 7.73 – 7.65 (m, 2H), 7.38 – 
7.26 (m, 4H), 7.24 – 7.15 (m, 3H), 6.82 (d, J = 8.8 Hz, 2H, HMP), 5.60 (d, J1,2 = 10.3 Hz, 1H, H-1), 5.46 (s, 1H, CH-
MP), 5.50 – 5.38 (m, 1H, -CH=CH2), 4.92 (ddd, Jtrans = 17.2, Jgem=3.1, JCH2=1.6 Hz, 1H, transCH2=CH), 4.76 (dd, J 
= 10.4, 1.5 Hz, 1H, cisCH2=CH), 4.36 – 4.29 (m, 2H, H-3, H-6a), 4.25 (t, J1,2 = J2,3=10.3 Hz, 1H, H-2), 4.17 (ddt, 
Jgem = 13.1, JCH=CH2= 5.1, JCH2=CH=1.3 Hz, 1H, CH2a
allyl
)), 3.86 (dd, Jgem= 13.1, JCH=CH2=6.3 Hz, 1H, CH2a
allyl
), 3.75 
(t, J = 10.2 Hz, 1H, H-6b), 3.72 (s, 3H, CH3O-), 3.69 – 3.60 (m, 2H, H-4, H-5). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 
168.35, 167.31, 160.08, 136.78, 134.26, 132.69 (2C), 131.78, 129.75, 128.96 (2C), 128.10, 127.37 (2C), 123.83, 
123.34, 117.17, 113.62 (2C), 101.25, 84.29, 82.42, 76.22, 73.27, 70.55, 68.60, 55.31, 54.91. MS m/z (ESI
+
): 560.1 
[(M+ H)
+
] 
 
Phenyl 3-O-allyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside (389) 
388 (8.1 g; 14.5 mmol) was dissolved in a mixture of MeOH and CH2Cl2 (80 mL:20 mL). To the 
solution was added CSA (336 mg; 1.45 mmol) and the reaction mixture was stirred at 45 °C for 
2½h. The reaction mixture was neutralized with Et3N (1.5 mL) and concentrated. The crude mixture 
was purified by flash chromatography (3:2 Tol/EtOAc) to afford 389 as a white crystalline material. Rf 0.23 (2:1 
Tol/EtOAc). Yield 6.01 g (94%) 
1
H NMR (400 MHz, CDCl3) δ 7.92 (m, 1H), 7.91 – 7.82 (m, 1H), 7.77 (dd, J = 5.6, 3.0 Hz, 2H), 7.49 – 7.32 (m, 
2H), 7.32 – 7.21 (m, 3H), 5.63 (d, J1,2 = 10.0 Hz, 1H, H-1), 5.72 – 5.49 (m, 1H, -CH=CH2), 5.04 (dd, J = 17.2, 1.5 
Hz, 1H, -transCH2=CH), 4.88 (d, J = 10.3 Hz, 1H, -cisCH2=CH), 4.22 (t, J1,2=J2,3=10.0 Hz, 1H, H-2), 4.20 (dd, 
J2,3=10.0, J3,4= 9.4 Hz, H-3), 4.17 (m, 1H, -CH2
allyl
) 3.98 (m, 1H, -CH2
allyl
), 3.97 (m, 1H, H-6a), 3.89 (m, 1H, H-6b), 
3.76 (td, J3,4 = 9.4, J4,5=4.1 Hz, 1H, H-4), 3.68 – 3.52 (m, 1H, H-5), 3.37 – 3.16 (m, 1H, -OH), 2.52 (d, J = 6.7 Hz, 
1H, -OH). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 168.59, 167.53, 134.44, 134.39, 132.33 (2C), 132.20, 131.68, 129.09 
(2C), 128.33, 128.05, 123.93, 123.49, 117.61, 83.80, 80.35, 79.59, 73.53, 71.44, 62.51, 54.77. HRMS: calc. 
[M+H]
+
: 442.1324 found [M+ H]
+
: 442.1328 
 
Phenyl 3-O-allyl-4,6-O-dibenzyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside (390) 
389 (5.85 g; 13.25 mmol) was dissolved in dry THF (120 mL) and cooled to 0 °C. NaH (60%; 
2.12 g; 53.0 mmol) was added and the reaction mixture was stirred at 0 °C for 10 min. BnBr 
(6.30 mL; 53.0 mmol) and TBAI (0.98 g; 2.65 mmol) was then added and the reaction mixture 
was stirred at 22 °C until TLC showed full conversion (7 h). The reaction mixture was diluted with CH2Cl2 (500 
mL) and washed with NH4Cl (400 mL), dried over MgSO4 and concentrated. The product was purified by flash 
chromatography (19:1 Tol/EtOAc) to give 390 as slightly yellow viscous oil. Rf 0.35 (19:1 Tol/EtOAc). Yield: 8.05 
g (97%) 
1
H NMR (400 MHz, CDCl3) δ 7.82 (s, 1H), 7.75 (s, 1H), 7.71 – 7.63 (m, 2H), 7.39 – 7.31 (m, 2H), 7.31 – 7.05 (m, 
13H), 5.50 (d, J = 10.3 Hz, 1H, H-1), 5.58 – 5.35 (m, 1H, -CH=CH2), 4.90 (ddd, Jtrans = 17.2, 2.9, 1.4 Hz, 1H, 
transCH2=CH), 4.72 (d, J = 10.9 Hz, 1H, -CH2Ph), 4.71 (dd, Jcis= 10.3, 1.4 Hz, 1H, , -cisCH2=CH), 4.60 – 4.40 (m, 
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3H, -CH2Ph), 4.24 – 4.19 (m, 2H, H-2, H-4), 4.13 (ddt, Jgem = 12.7, J CH=CH2=5.3, JCH2=CH=1.2 Hz, 1H, -CH2
allyl
), 3.81 
(dd, Jgem = 12.7, JCH=CH2=6.4 Hz, 1H, -CH2
allyl
), 3.77 – 3.57 (m, 4H, H-3, H-5, H-6a, H-6b). 13C NMR   (101 MHz, 
CDCl3) δ 168.46, 167.39, 138.30, 138.03, 134.22 (2C), 132.53 (2C), 132.29, 131.73, 128.83 (2C), 128.45 (2C), 
128.38 (2C), 127.94 (2C), 127.84, 127.79, 127.72 (2C), 127.59, 123.77, 123.29, 117.34, 83.38, 80.46, 79.43, 78.89, 
74.94, 73.89, 73.46, 68.93, 55.16. HRMS: calc. [M+Na]
+
: 644.2083 found [M+ Na]
+
: 644.2078 
 
Phenyl 3-O-allyl-4,6-O-dibenzyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside (391) 
A solution of {Ir(COD)[PCH3(C6H5)2]}PF6 (286 mg; 0.34 mmol) in dry THF (100 mL) was 
degassed and then H2 was bubbled through the solution until it had changed colour from red to 
pale yellow. It was then purged with N2 and a solution of 390 (3.5 g; 5.63 mmol) in THF (20 mL) 
was added. After stirring for 2h the solution was diluted with EtOAc (100 mL) and concentrated. 
The slurry was re-dissolved in MeOH (120 mL) and amberlite 120-H
+
 resin (30 mL) was added. The solution was 
stirred at 70 °C until full conversion was observed (36h). The reaction mixture was filtered and concentrated. The 
product was purified by flash chromatography (19:1 Tol/EtOAc) to give 391 as off-white crystals. Rf 0.10 (19:1 
Tol/EtOAc). Yield: 2.91 g (88%)  
1
H NMR (400 MHz, CDCl3) δ 7.86 (s, 1H, ArH), 7.81 (s, 1H, ArH), 7.78 – 7.65 (m, 2H, ArH), 7.49 – 7.05 (m, 15H, 
ArH), 5.60 (d, J1,2 = 10.4 Hz, 1H, H-1), 4.71 (s, 2H, CH2Ph), 4.64 (dd, J = 36.2, 12.0 Hz, 2H, CH2Ph), 4.48 (ddd, J 
2,3= 10.4, J3,4 = 8.4, J3,OH=4.7 Hz, 1H, H-3), 4.26 (t, J 1,2=J2,3=10.4 Hz, 1H, H-2), 3.94 – 3.77 (m, 2H, H-6a, H-6b), 
3.70 (ddd, J4,5 = 9.7, J5,6a=3.6, J5,6b=2.1 Hz, 1H, H-5), 3.67 – 3.56 (m, 1H, H-4), 2.36 (dd, J = 8.0, 3.7 Hz, 1H, OH). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 138.21, 138.10, 134.18, 132.51, 132.28, 129.06, 128.85, 128.61, 128.40, 128.25, 
128.01, 127.91, 127.79, 127.65, 83.41, 79.25, 79.11, 74.77, 73.49, 72.88, 68.90, 55.68. 
HRMS: calc. [M+Na]
+
: 604.1770 found [M+ Na]
+
: 604.1772 
 
Phenyl 4,6-O-benzylidene-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside (392) 
To a 100 mL round-bottomed flask was added the triacetate 381 (15.0 g, 28.43 mmol) and a 3:2 
mixture of MeOH–CH2Cl2 (130 mL). The mixture was cooled to –20 °C, treated with a 0.3 M 
NaOMe solution in MeOH (37.7 mL, 11.3 mmol) and stirred for 10 min, then warmed to –10 °C 
and stirred for 2 h. The reaction mixture was warmed to 0 ºC, quenched with Amberlite 120-H
+
 resin, filtered and 
concentrated. The crude was concentrated with toluene three times and left on under vacuum overnight. To a 
solution of benzaldehyde dimethyl acetal (7.4 mL; 49.29 mmol) and CSA (0.88 g; 3.79 mmol) in MeCN (250 mL) 
was added the crude triol (15.2 g; 37.91 mmol). The reaction mixture was heated to reflux for 2h during which app. 
1/3 of the solvent was distilled off. The flask was fitted with a condenser and the reaction was refluxed until TLC 
showed full conversion (2h). The reaction was quenched by addition of Et3N (2 mL) and concentrated. The product 
was purified by flash chromatography (16:1  9:1 toluene/EtOAc) to give 392 as a white solid. Yield: 17.5 (95%) 
1
H NMR (400 MHz, CDCl3) δ 7.89 – 7.71 (m, 2H), 7.71 – 7.60 (m, 2H), 7.45 – 7.33 (m, 2H), 7.36 – 7.23 (m, 4H), 
7.23 – 7.16 (m, 4H), 5.61 (d, J1,2 = 10.3 Hz, 1H, H-1), 5.48 (s, 1H, , -CH
benzylidene
), 4.58 (t, J2,3=J3,4 = 10.3 Hz,  1H, 
H-3), 4.31 (dd, J6a,6b= 10.3, J5,6a=4.8 Hz, 1H, H-6b), 4.25 (t, J1,2=J2,3 = 10.3 Hz, 1H, H-2), 3.74 (t, J5,6b=J6a,6b= 10.3 
Hz, 1H, 6b), 3.60 (td, J4,5=J5,6b=10.3, J5,6a=4.8 Hz, 1H, H-5), 3.51 (t, J3,4=J4,5= 10.3 Hz, 1H, H-4). 
13
C NMR 
 
 (101 
MHz, CDCl3) δ 168.28, 167.57, 136.91 (2C), 134.29, 132.69, 131.78, 129.43, 129.07, 129.00 (2C), 128.43 (2C), 
128.26, 128.16, 126.35 (2C), 125.33, 123.91, 123.43, 102.00, 84.31, 81.90, 70.32, 69.73, 68.60, 55.54. HRMS: calc. 
[M+Na]
+
: 512.1143 found [M+ Na]
+
: 512.1143 
 
Phenyl 2-Amino-4,6-O-benzylidene-2-deoxy-1-thio--D-glucopyranoside (393) 
392 (5 g; 10.21 mmol) was dissolved in ethylendiamine (50 mL) and n-BuOH (250 mL) and was 
heated to 90 °C. The reaction mixture was stirred at 90 °C
 
for 12h and then concentrated. The oily 
residue was purified by flash chromatography (9:1 CH2Cl2/MeOH) to give 393 as a white 
crystalline material. Yield: 3.19 g (86%) 
1
H NMR (400 MHz, DMSO-d6) δ 7.73 – 7.08 (m, 10H, Ar-H), 5.61 (s, 1H, -CHbenzylidene), 5.51 – 5.38 (m, 1H, -OH), 
4.79 (d, J = 9.8 Hz, 1H, H-1), 4.21 (dd, J6a,6b = 10.1, J5,6a = 4.9 Hz, 1H, H-6a), 3.71 (t, J6a,6b = J5,6b =10.1 Hz, 1H, H-
6b), 3.54 (dd, J5,6b = 10.1, J5,6a = 4.9 Hz, 1H, H-5), 3.48 – 3.37 (m, 2H, H-3, H-4), 2.57 (dd, J1,2 = 9.8, J2,3 = 8.5 Hz, 
1H, H-2), 1.73 (s, 2H, -NH2). 
13
C NMR 
 
 (101 MHz, DMSO) δ 138.22, 133.62, 131.19 (2C), 129.50 (2C), 129.30, 
128.48 (2C), 127.60, 126.80 (2C), 101.17, 88.82, 81.14, 74.44, 70.51, 68.24, 57.77. HRMS: calc. [M+H]
+
: 
360.1270 found [M+H]
+
: 360.1275 
 
 
 
 
Phenyl 2-Azido-4,6-O-benzylidene-2-deoxy-1-thio--D-glucopyranoside (394) 
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To a solution of NaN3 (7.96 g; 122.4 mmol) in H2O (20 mL) was added CH2Cl2 (25 mL). The 
mixture was cooled to 0 °C and Tf2O (4.11 mL; 24.48 mmol) was added drop wise over 15 min. 
The two-phase mixture was stirred for 2 h at 0 °C after which the phases were separated and the 
aqueous phase was extracted with CH2Cl2 (2x15mL). The combined organic phases were washed with sat. aq. 
NaHCO3 (40 mL) and H2O (45 mL), dried over MgSO4 and filtered. The resulting solution was added drop wise to a 
slurry of 393 (4.4 g; 12.24 mmol) and DMAP (4.55 g; 37.21 mmol) in CH2Cl2 (45 mL). The reaction mixture was 
stirred for 12 h at 22 °C, concentrated and the product 394 was purified by flash chromatography (9:1 
toluene/EtOAc). Yield: 4.3 g (91%). 
1
H NMR (400 MHz, CDCl3) δ 7.54 – 7.44 (m, 2H), 7.44 – 7.35 (m, 2H), 7.36 – 7.23 (m, 6H), 5.46 (s, 1H, -
CH
benzylidene
), 4.47 (d, J1,2 = 10.2 Hz, 1H, H-1), 4.35 – 4.27 (dd, J = 10.6, 4.6 Hz, 1H, H-4), 3.76 – 3.62 (m, 2H, H-3, 
H-6a), 3.40 (m, 2H, H-5, H-6b), 3.28 (dd, J1,2 =  10.2, J2,3 =9.1 Hz, 1H, H-2). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 
136.82, 133.80 (2C), 130.93, 129.59, 129.28 (2C), 128.84, 128.55 (2C), 126.38 (2C), 102.06, 86.91, 80.31, 74.16, 
70.36, 68.52, 65.23. HRMS: calc. [M+Na]
+
: 408.0994 found [M+ Na]
+
: 408.0991 
 
Phenyl 2-Azido-4,6-O-benzylidene-3-O-(R)-1-carboxyethyl-2-deoxy-1-thio--D-glucopyranoside (395) 
394 (1.5 g; 3.89 mmol) was dissolved in THF (125 mL) and cooled to 0 °C. NaH (60% oil 
dispersion; 1.55 g; 38.9 mmol) was added and the mixture was stirred at 0 °C for 30 min. (S)-
(−)-2-Bromopropionic acid (2.23 mL; 15.56 mmol) was added and the reaction mixture was 
stirred at 22 °C for 12 h. The reaction was poured into 1M HCl (100 mL) and the aqueous phase 
was washed with CH2Cl2 (3x100 mL). The combined organic phases were washed sat. aq. NaHCO3 (100 mL), dried 
over MgSO4 and concentrated. The crude was purified by flash chromatography (4:1:0.01 toluene/EtOAc/AcOH) to 
give 395. Yield: 1.33 g (75%) 
1
H NMR (400 MHz, CDCl3) δ 7.55 – 7.46 (m, 2H), 7.41 – 7.24 (m, 8H), 5.48 (s, 1H), 4.49 (d, J1,2 = 10.1 Hz, 1H, 
H-1), 4.44 (q, J = 6.9 Hz, 1H, CH-CH3), 4.32 (dd, J6a,6b = 10.3, J5,6a=5.0 Hz, 1H, H6-a), 3.71 (t, J6a,6b = J5,6b = 10.3 
Hz, 1H, H6-b), 3.57 – 3.49 (m, 2H, H-3, H-4), 3.42 – 3.31 (m, 2H, H-2, H-5), 1.38 (d, J = 6.9 Hz, 3H, CH3-CH). 
13
C 
NMR 
 
 (101 MHz, CDCl3) δ 176.95, 136.75, 133.89 (2C), 130.55, 129.23 (3C), 128.85, 128.41 (2C), 125.86 (2C), 
101.37, 86.97, 80.95, 80.78, 76.02, 70.31, 68.42, 64.31, 18.96. HRMS: calc. [M+Na]
+
: 480.1205 found [M+ Na]
+
: 
480.1211 
 
Phenyl 2-Azido-4,6-O-benzylidene-3-O-[(R)-1’-allyloxycarbonylethyl]-2-deoxy-1-thio--D-glucopyranoside 
(396) 
To a solution of 395 (1.52 g; 3.32 mmol) in DMF (20 mL) was added allyl bromide (320 L; 
3.65 mmol) and DBU (520 L; 3.49 mmol). The reaction mixture was stirred at 22 °C for 16 h, 
diluted by EtOAc (200 mL) and poured into H2O (200 mL). The aqueous phase was extracted 
with EtOAc (3x100 mL), dried over MgSO4 and concentrated. The crude was purified by flash 
chromatography (6:3.5:0.5 Pet. et./toluene/EtOAc) to give 396. Yield: 1.52 g (92%).   
1
H NMR (400 MHz, CDCl3) δ 7.54 – 7.46 (m, 2H), 7.40 – 7.34 (m, 2H), 7.33 – 7.25 (m, 6H), 5.85 (ddt, J = 16.3, 
10.4, 5.9 Hz, 1H, -CH=CH2), 5.47 (s, 1H, -CH
benzylidene
), 5.25 (ddd, J = 17.2, 2.9, 1.4 Hz, 1H, -CH2=CH
trans
), 5.17 
(dd, J = 10.4, 1.2 Hz, 1H, -CH2=CH
cis
), 4.57 (dt, J = 5.9, 1.2 Hz, 2H, -CH2
allyl
), 4.44 (q, J = 6.8 Hz, 1H, CH-CH3), 
4.41 (d, J1,2 = 10.2 Hz, 1H, H-1), 4.30 (dd, J6a,6b= 10.5, J5,6a=5.0 Hz, 1H, H-6a), 3.70 (t, J5,6b=J6a,6b= 10.5 Hz, 1H, H-
6b), 3.64 (t, J2,3=J3,4= 9.2 Hz, 1H, H-3), 3.52 (t, J3,4=J4,5= 9.2 Hz, 1H, H-4), 3.35 (td, J5,6b= 9.7, J5,6a=4.9 Hz, 1H, H-
5), 3.29 (dd, J1,2 = 10.2, J2,3 =9.2 Hz, 1H, H-2), 1.35 (d, J = 6.8 Hz, 3H). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 172.19, 
136.91, 133.95 (2C), 131.78, 130.67, 129.17 (2C), 129.14, 128.76, 128.36, 125.88 (2C), 118.82, 101.26, 86.68, 
80.98, 76.16, 70.28, 68.47, 65.67, 64.50, 19.05. HRMS: calc. [M+Na]
+
: 520.1518 found [M+ Na]
+
: 520.1521 
 
Phenyl 2-Azido-3-O-allyl-4,6-O-benzylidene-2-deoxy-1-thio--D-glucopyranoside (397) 
To a solution of NaN3 (2.03 g; 31.2 mmol) in H2O (5 mL) was added CH2Cl2 (6.25 mL). The 
mixture was cooled to 0 °C and Tf2O (1.05 mL; 6.26 mmol) was added drop wise over 15 min. 
The two-phase mixture was stirred for 2 h at 0 °C after which the the phases were separated and 
the aqueous phase was extracted with CH2Cl2 (2x3mL). The combined organic phases were washed with sat. aq. 
NaHCO3 (10 mL) and H2O (10 mL), dried over MgSO4 and filtered. The resulting solution was added drop wise to a 
solution of 394 (1.25 g; 3.12 mmol) and DMAP (1.16 g; 9.51 mmol) in CH2Cl2 (12.5 mL). The reaction mixture was 
stirred for 12 h at 22 °C. The mixture was concentrated and the crude product was purified by flash chromatography 
(6:3:1 heptane/toluene/EtOAc). Yield: 1.22 g (92%). 
1
H NMR (400 MHz, CDCl3) δ 7.55 – 7.45 (m, 2H), 7.44 – 7.34 (m, 2H), 7.33 – 7.21 (m, 6H), 5.87 (ddt, J = 16.3, 
10.4, 5.9 Hz, 1H, -CH=CH2), 5.47 (s, 1H, -CH
benzylidene
), 5.21 (dq, J = 17.2, 1.5 Hz, 1H, -CH2=CH
trans
), 5.12 (ddd, J 
= 10.4, 2.7, 1.1 Hz, 1H, -CH2=CH
cis
), 4.41 (d, J = 10.2 Hz, 1H, H-1), 4.37 – 4.31 (m, 1H, CH2
allyl
), 4.30 (dd, J = 
10.5, 4.9 Hz, 1H, H-6a), 4.16 (ddt, J = 12.4, 6.0, 1.3 Hz, 1H, CH2
allyl
), 3.70 (t, J = 10.3 Hz, 1H, H-6b), 3.54 – 3.44 
Experimental 
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(m, 2H, H-3, H-4), 3.35 (m, 1H, H-5), 3.31 – 3.21 (m, 1H, H-2). 13C NMR   (101 MHz, CDCl3) δ 137.07, 134.30, 
133.90 (2C), 130.70, 129.16 (2C), 129.10, 128.75, 128.31 (2C), 125.96 (2C), 117.81, 101.24, 86.58, 81.18, 80.99, 
74.12, 70.48, 68.48, 64.57. HRMS: calc. [M+Na]
+
: 448.1307 found [M+ Na]
+
: 448.1311 
 
Phenyl 2-Azido-3-O-allyl-2-deoxy-1-thio--D-glucopyranoside (398) 
Compound 397 (0.5 g; 1.18 mmol) was dissolved in CH2Cl2 (10 mL) at 22 °C. p-TSA (0.045 g; 
0.24 mmol) was added followed by addition of ethanethiol (0.6 mL; 8.22mmol). The reaction 
mixture was stirred for 30 min. The mixture was concentrated and the crude product was purified 
by flash chromatography (2:1 toluene/EtOAc) to give 398. Rf 0.19 (2:1 Tol/EtOAc). Yield: 0.36 g (90%). 
 
Phenyl 2-Azido-3-O-allyl-4,6-di-O-benzyl-2-deoxy-1-thio--D-glucopyranoside (398) 
Compound 398 (0.4 g; 4.74 mmol) was dissolved in DMF (10 mL) and cooled to 0 °C. NaH (190 
mg; 4.74 mmol) was added and the mixture was stirred for 10 min. Then BnBr (0.71 mL; 5.93 
mmol) was added and the reaction was allowed to reach 22 °C and stirred overnight. The reaction 
was quenched by addition of MeOH and poured into sat. aq. NaHCO3 (100 mL). The aqueous phase was extracted 
with EtOAc (2x50 mL). The combined organic phases were dried over MgSO4, filtered and concentrated. The 
product was purified by flash chromatography (9:1 Heptane/EtoAc). Rf 0.78 (19:1 Tol/EtOAc). Yield: 0.54 g (89%). 
 
Phenyl 3-allyl-4,6-O-benzylidene-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside (400) 
A solution of 392 (15.4 g; 31.49 mmol) and allyl bromide (5.5 mL; 62.97 mmol) in THF (200 
mL) was cooled to 0 °C and added drop wise to a flask containing NaH (60%) (2.5 g; 62.97 
mmol). The mixture was stirred at 0 °Cfor 2h then Ac2O (8 mL) was added and the mixture was 
stirred for another 2 h. The reaction was quenched by addition of MeOH (10 mL) and diluted 
with Et2O (350 mL). The organic phase was washed with H2O (2x200 mL), dried over MgSO4 and concentrated. 
The crude was purified by flash chromatography (9:1 Tol/EtOAc), Rf 0.55 (5:1 Tol/EtOAc) to afford 400. Yield: 
13.8 g; (83%) 
1
H NMR (400 MHz, CDCl3) δ 7.94 – 7.75 (m, 2H, Ar-H), 7.71 – 7.63 (m, 2H, Ar-H), 7.48 – 6.96 (m, 10H, Ar-H), 
5.60 (d, J1,2 = 10.3 Hz, 1H, H-1), 5.51 (s, 1H, CH
benzylidene
), 5.45 (ddd, Jtrans = 16.9, Jcis =10.3, JCH2 =6.3, 1H, 
CH=CH2), 4.93 (dd, Jtrans = 17.2, JCH2 =1.6 Hz, 1H, CH2=CH
trans
), 4.76 (dd, Jcis = 10.4, JCH2 =1.5 Hz, 1H, 
CH2=CH
trans
), 4.39 – 4.30 (m, 2H, H-6a, H-3), 4.26 (t, J1,2 = J2,3 =10.2 Hz, 1H, H-2), 4.18 (ddt, JCH2 = 13.1, JCH=CH2 
= 5.1, JCH2=CH =1.6 Hz, 1H, 0.5xCH2
allyl
), 3.87 (ddt, JCH2 = 13.1, JCH=CH2 = 6.3, JCH2=CH =1.6 Hz, 1H, 0.5xCH2
allyl
), 
3.76 (t, J6a,6b = J5,6b = 10.0 Hz, 1H, H-6b), 3.71 – 3.56 (m, 2H, H-4, H-5), 2.27 (s, 1H, -OH). 
13
C NMR 
 
 (101 MHz, 
CDCl3) δ 168.33, 167.29, 137.24, 134.27, 134.22, 132.71 (2C), 131.74, 129.05, 129.02, 128.95 (2C), 128.26 (2C), 
128.24, 128.11, 126.04 (2C), 125.31, 123.83, 123.32, 117.20, 101.25, 84.29, 82.47, 76.20, 73.28, 70.51, 68.65, 
54.90. HRMS: calc. [M+Na]
+
: 552.1457 found [M+ Na]
+
: 552.1457 
 
Phenyl 2-Amino-4,6-O-dibenzyl-2-deoxy-1-thio--D-glucopyranoside (401) 
391 (3.4 g; 5.85 mmol) was dissolved in 213thylenediamine (22.5 mL) and n-BuOH (105 mL) and 
was heated to 90 °C. The reaction mixture was stirred at 90 °C for 14h and then concentrated. The 
oily residue was purified by flash chro-matography (9:1 CH2Cl2/MeOH) to give 401 as a white 
crystalline material. Yield: 2.19 g (83%) 
1
H NMR (400 MHz, CDCl3) δ 7.57 – 7.41 (m, 2H, Ar-H), 7.35 – 7.09 (m, 13H, Ar-H), 4.68 (d, JCH2 = 11.3 Hz, 1H, 
0.5xCH2
Bn
), 4.58 – 4.52 (m, 2H, CH2
Bn
), 4.48 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2
Bn
), 4.33 (d, J1,2 = 9.9 Hz, 1H, H-1), 
3.79 – 3.62 (m, 2H, H-6), 3.47 – 3.29 (m, 3H, H-3, H-4, H-5), 2.60 (dd J1,2 =9.8 Hz, J2,3 = 9.2 Hz, 1H, H-2). 
13
C 
NMR 
 
 (101 MHz, CDCl3) δ 138.38 (2C), 132.72, 132.42 (2C), 129.02 (2C), 128.63 (2C), 128.45 (2C), 128.07 (2C), 
128.00, 127.87, 127.79 (2C), 127.68, 89.48, 79.15, 78.40, 77.89, 74.64, 73.54, 69.33, 56.30. HRMS: calc. [M+H]
+
: 
452.1896 found [M+ H]
+
: 452.1899 
 
Phenyl 2-Azido-4,6-O-dibenzyl-2-deoxy-1-thio--D-glucopyranoside (402) 
To a solution of NaN3 (2.3 g; 35.4 mmol) in H2O (6 mL) was added CH2Cl2 (7.5 mL). The 
mixture was cooled to 0 °C and Tf2O (1.2 mL; 7.08 mmol) was added drop wise over 15 min. The 
two-phase mixture was stirred for 2 h at 0 °C after which the phases were separated and the 
aqueous phase was extracted with CH2Cl2 (2x5mL). The combined organic phases were washed 
with sat. aq. NaHCO3 (10 mL) and H2O (10 mL), dried over MgSO4 and filtered. The resulting solution was added 
drop wise to a solution of 401 (1.6 g; 3.54 mmol) and DMAP (1.32 g; 10.77 mmol) in CH2Cl2 (15 mL). The reaction 
mixture was stirred for 12 h at 22 °C. The mixture was concentrated and the product was purified by flash 
chromatography (20:1 toluene/EtOAc). Yield: 1.34 g (79%). 
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1
H NMR (400 MHz, CDCl3) δ 7.65 – 7.41 (m, 2H), 7.37 – 7.08 (m, 13H), 4.61 (d, J = 9.8 Hz, 2H, -CH2
Bn1
), 4.54 (d, 
J = 11.4 Hz, 2H, -CH2
Bn2
), 4.37 (d, J1,2 = 10.1 Hz, 1H, H-1), 3.74 (dd, J6a,6b = 11.0, J5,6a = 2.0 Hz, 1H, H-6a), 3.69 
(dd, J6a,6b=11.0, J5,6b = 3.8 Hz, 1H, H-6b), 3.51 (t, J2,3=J3,4= 9.0 Hz, 1H, H-3), 3.44 (t, J3,4=J4,5= 9.0 Hz, 1H, H-4), 
3.38 (ddd, J4,5=9.5,  J5,6b=3.8, J5,6a = 2.0 Hz, 1H, H-5), 3.22 (dd, J1,2 = 10.0, J2,3=9.0 Hz, 1H, H-2). 
13
C NMR 
 
 (101 
MHz, CDCl3) δ 138.14, 137.97, 133.39 (2C), 131.48, 129.03 (2C), 128.69 (2C), 128.44 (2C), 128.33, 128.15, 
128.03 (2C), 127.73 (3C), 86.08, 79.07, 77.30, 77.20, 74.82, 73.52, 68.79, 64.98. HRMS: calc. [M+Na]
+
: 500.1620 
found [M+ Na]
+
: 500.1645 
 
Phenyl 2-Azido-4,6-O-dibenzyl-3-O-(R)-1-carboxyethyl-2-deoxy-1-thio--D-glucopyranoside (403) 
A solution of 402 (4.50 g; 9.43 mmol) in dry THF (300 mL) was treated with NaH (60% oil 
dispersion; 3.77 g; 94.31 mmol) at 0 °C for 15 min. Then (S)-(−)-2-Bromopropionic acid (9.17 g; 
37.72 mmol) was added and the reaction was stirred at 22 °C for 12h. The reaction mixture was 
poured into 1M HCl and extracted with CH2Cl2 (3x200 mL). The combined organic phases were 
dried over MgSO4, filtered and concentrated. The residue was purified by flash chromatography (4:1:0.01 
toluene/EtOAc/AcOH) to give 403 as a white crystalline solid. Yield: 4.1 (78%)  
1
H NMR (400 MHz, CDCl3) δ 7.54 (m, 2H), 7.33 – 7.11 (m, 13H), 4.68 (d, JCH2 = 10.9 Hz, 1H, -CH2
Bn1
), 4.55 (d, 
JCH2 = 11.9 Hz, 1H, -CH2
Bn2
), 4.52 (d, JCH2 = 10.9 Hz, 1H, -CH2
Bn1
), 4.47 (d, J -CH2= 11.9 Hz, 1H, -CH2
Bn2
), 4.42 (q, 
J = 7.0 Hz, 1H, CH-CH3), 4.37 (d, J1,2 = 9.8 Hz, 1H, H-1), 3.69 (m, 2H, H-6a, H-6b), 3.57 (dd, J2,3= 9.8 Hz, J3,4= 
9.1, 1H, H-3), 3.36 (m, 1H, H-5), 3.35 (t, J1,2=J2,3 = 9.8 Hz, 1H, H-2), 3.28 (t, J3,4 = 9.1 Hz, 1H, H-4), 1.36 (d, J = 
7.0 Hz, CH3-CH, 3H). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 177.70, 138.19, 137.71, 133.67 (2C), 131.12 (2C), 129.17 
(2C), 128.64 (2C), 128.52 (2C), 128.09, 127.88 (2C), 127.79 (2C), 127.72 (2C), 86.67, 85.09, 79.25, 76.99, 76.86, 
75.27, 73.55, 68.72, 64.92, 19.30. HRMS: calc. [M+Na]
+
: 572.1831 found [M+Na]
+
: 572.1842 
 
Phenyl 2-Azido-4,6-O-benzylidene-3-O-[(R)-1’-((2-trimethylsilyl)-ethyloxycarbonyl)ethyl]-2-deoxy-1-thio--D-
glucopyranoside (404) 
To a solution of 403 (2.28 g; 4.14 mmol) in CH2Cl2 (50 mL) was added 2-(trimethylsilyl)ethanol 
(980 mg; 8.28 mmol), DMAP (76 mg; 0.62 mmol) and EDCl (836 mg; 5.39 mmol). The reaction 
mixture was stirred at 22 °C until TLC showed full conversion (4h). The reaction mixture was 
diluted with CH2Cl2 (100 mL) and washed with H2O (100 mL). The organic phase was dried over 
MgSO4, filtered and concentrated. The crude residue was purified by flash chromatography (6:3.5:0.5 Pet. et. 
/toluene/EtOAc). Yield: 2.44 (91%) 
1
H NMR (400 MHz, CDCl3) δ 7.63 – 7.49 (m, 2H), 7.38 – 7.10 (m, 13H), 4.75 (d, J = 10.9 Hz, 1H, -CH2
Bn1
), 4.57 
(d, J = 11.9 Hz, 1H, -CH2
Bn2
), 4.53 (d, J = 10.9 Hz, 1H, -CH2
Bn1
), 4.49 (d, J = 11.9 Hz, 1H, -CH2
Bn2
), 4.42 – 4.31 (m, 
2H, H-1, CH-CH3), 4.28 – 4.13 (m, 2H, CH2-CH2-TMS), 3.76 – 3.65 (m, 2H, H-6a, H-6b), 3.57 (m, 1H, H-3), 3.43 
– 3.33 (m, 3H, H-2, H-4, H-5), 1.35 (d, J = 6.8 Hz, 3H, CH-CH3), 0.97 (t, J = 8.7 Hz, 2H, CH2-CH2-TMS), 0.00 (s, 
9H, 3xCH3
TMS
). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 174.37, 139.67, 139.27, 135.05 (2C), 132.64, 130.54, 130.50, 
129.98, 129.89 (2C), 129.83 (2C), 129.73, 129.39, 129.28 (2C), 129.12, 129.06 (3C), 87.87, 86.42, 80.68, 78.77, 
78.37, 76.60, 74.92, 70.20, 66.39, 64.91, 20.65, 18.79, 0.00 (3C). HRMS: calc. [M+Na]
+
: 672.2540 found [M+ 
Na]
+
: 672.2521 
 
2-Azido-4,6-O-benzylidene-3-O-[(R)-1’-((2-trimethylsilyl)-ethyloxycarbonyl)ethyl]-2-deoxy--D-glucopyranose 
(405) 
404 (2.3 g; 3.54 mmol) was dissolved in acetone/H2O (50 mL). NBS (2.84 g; 15.94 mmol) was 
added and the solution was stirred at 22 °C until TLC showed full conversion (1h). The reaction 
mixture was poured into 10% NaS2O3 (200 mL), extracted with CH2Cl2 (2x100 mL), dried over 
MgSO4, filtered and concentrated. The product 405 was purified by flash chromatography (9:1 
toluene/EtOAc). Yield: 1.92 (97%). 
1
H NMR (400 MHz, CDCl3) δ 7.48 – 6.95 (m, 20H, Ar-H), 5.28 (d, J1,2 = 3.5 Hz, 1H, H-1), 4.78 (d, JCH2 = 10.9 
Hz, 1H, 0.5xCH2
Bn
), 4.76 (d, JCH2 = 10.9 Hz, 1H, 0.5xCH2
Bn
), 4.62 – 4.37 (m, 8H, 3xCH2
Bn
, H-1, CHlactate/), 4.35 
– 4.15 (m, 5H, -OCH2
TMSE, -OCH2
TMSE, CHlactate/), 3.99 (ddd, J4,5 = 10.1, J5,6a = 4.4, J5,6a = 2.1 Hz, 1H, H-5), 
3.87 (dd, J2,3 = 10.0, J3,4 = 8.8 Hz, 1H, H-3), 3.68 – 3.24 (m, 8H, H-2, H-2, H-3, H-4, H-4, H-5, H-6, H-
6,), 1.37 (m, 4H, 2xCH2
lactate
), 1.00 (m, 4H, 2xCH2
TMSE
), 0.01 (m, 18H, 2xTMS). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 
173.25, 173.06, 137.83, 137.74, 137.71, 128.57, 128.34, 128.13, 128.04, 128.00, 127.96, 127.85, 96.48, 92.07, 
83.31, 79.48, 78.24, 77.21, 76.60, 75.28, 75.12, 74.80, 73.60, 70.50, 68.74, 68.64, 67.34, 64.05, 63.51, 63.46, 19.30, 
19.27, 17.50, 17.38, -1.38. 
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2-Azido-4,6-O-benzylidene-3-O-[(R)-1’-((2-trimethylsilyl)-ethyloxycarbonyl)ethyl]-2-deoxy--D-glucopyranose 
N-phenyl trifluoroacetimidate (406) 
To a solution of 405 (600 mg; 1.08 mmol) in CH2Cl2 (15 mL) was added PTFAICl (447 mg; 
2.15 mmol) and Cs2CO3 (701 mg; 2.15 mmol) at 0 °C. The reaction was stirred at 0 °C until 
TLC showed full conversion (2.5h). The reaction was filtered, concentrated and the crude was 
purified by flash chromatography (19:1 Pet. et./EtOAc) to give 406 as a viscous oil. Yield: 637 
mg (82%). 
1
H NMR (400 MHz, CDCl3) δ 7.33 – 7.09 (m, 12H, 2xBn, N-Ph), 7.04 (t, J = 7.5 Hz, 1H, N-Ph), 6.76 (d, J = 7.6 
Hz, 2H, N-Ph), 4.76 (d, J = 11.0 Hz, 1H, -CH2
Bn1
), 4.57 (d, J = 12.0 Hz, 1H, -CH2
Bn2
), 4.49 (d, J = 11.0 Hz, 2H, -
CH2
Bn1
), 4.46 (d, J = 12.0 Hz, 1H, -CH2
Bn2
), 4.31 (dt, J = 9.7, 4.8 Hz, 1H, CH-CH3), 4.27 – 4.18 (m, 2H, CH2-CH2-
TMS), 4.27 – 4.17 (m, 2H, ), 3.70 (t, J = 9.3 Hz, 1H), 3.63 (s, 3H), 1.36 (d, J = 6.9 Hz, 3H, CH-CH3), 0.99 (t, J = 
8.7 Hz, 2H, CH2-CH2-TMS), 0.00 (s, J = 3.3 Hz, 9H, 3xCH3
TMS
).  
 
2,3,4,6-tetra-O-benzyl-D-galactopyranose (407) 
33 (8 g; 12.64 mmol) was dissolved in acetone/H2O (9:1) (200 mL). NBS (2.77 g; 15.55 mmol) was 
added and the reaction mixture was stirred at 22 °C for 4h. The reaction mixture was then diluted 
with H2O (200 mL) and extracted with Et2O (3x100 mL). The combined organic phases where 
washed with sat. aq. NaHCO3 (150 mL), dried over MgSO4, filtered and concentrated. The crude product was 
purified by flash chromatography (9:1 Tol/EtOAc) to give 407 as white crystals. Rf 0.1 (20:1 Tol/EtOAc). Yield: 
6.82 g (98%). 
1
H NMR (400 MHz, CDCl3) δ = 7.40-7.25 (m, 33H, Ph), 5.29 (d, J1,2=3.5 Hz, 1H, H-1α), 4.95 (d, J=11.4 Hz, 
0.65H, CH2Phβ), 4.94 (d, J=11.7 Hz, 1H, CH2Phα), 4.92 (d, J=10.5 Hz, 0.65H, CH2Phβ), 4.71-4.56 (m, 5.95H, 
4xCH2Phα, 3xCH2Phβ), 4.66 (d, J1,2=7.4 Hz, 0.65H, H-1β), 4.61 (d, J=11.4 Hz, 0.65H,  CH2Phβ), 4.58 (d, J=11.7 
Hz, 1H, CH2Phα), 4.48 (d, J=11.7Hz, 1.65H, CH2Phα, CH2Phβ), 4.41 (d, J=11.7 Hz, 1H,  CH2Phα), 4.41 (d, J=11.7 
Hz, 0.65H, CH2Phβ), 4.16 (dd, J=6.8, 6.2 Hz, 1H,  H-5α), 4.04 (dd, J=9.9, 3.5 Hz, 1H,  H-2α), 3.97 (d, J=2.8 Hz, 
1H, H-4α), 3.91(dd, J=9.9, 2.8 Hz, 1H, H-3α), 3.89 (d, J=1.7 Hz, 0.65H, H-4β), 3.77 (dd, J=9.6, 7.5 Hz, 0.65H, H-
2β), 3.61-3.52 (m, 3.6H, 2xH-6β, H-5β, H-3β, H-6α), 3.52-3.48 (dd, J=9.4, 6.8 Hz, 1H,H-6α), 3.31 (d, J=6.5 Hz, 
0.65H, OHβ), 2.99 (s, 1H, OHα). 13C NMR   (101 MHz, CDCl3) δ 138.72 (1.65C), 138.64, 138.57 (0.65C), 138.49 
(0.65C), 138.34(1C), 137.93(1C), 137.83 (0.65C) 128.53-127.61 (33C), 97.88 (0.65C), 91.97, 82.28 (0.65C), 80.81 
(0.65C), 78.83, 76.67, 75.18 (0.65C), 74.83 (0.65C), 74.75, 74.65 (0.65C), 73.70 (0.65C), 73.64 (0.65C), 73.56, 
73.04, 69.57, 69.16, 69.02 (0.65C). HRMS: calc. [M+ Na]
+
: 563.6358 found [M+ Na]
+
: 563.6355  
 
2,3,4,6-tetra-O-benzyl-β-D-galactopyranose N-phenyl trifluoroacetimidate (408) 
To a solution of 407 (400 mg; 0.74 mmol) in CH2Cl2 (7.5 mL) was added PTFAICl (383 mg; 
1.85 mmol) and Cs2CO3 (602 mg; 1.85 mmol) at 0 °C. The reaction was stirred at 0 °C until 
TLC showed full conversion (2.5h). The reaction was filtered, concentrated and the crude was 
purified by flash chromatography (19:1 Pet. et./EtOAc) to give 408 as a viscous oil. Yield: 460 
mg (88%). 
1
H NMR (400 MHz, CDCl3) δ 7.40 – 7.10 (m, 22H, N-Ph), 6.99 (t, J = 7.4 Hz, 1H, N-Ph), 6.69 (d, J = 7.7 Hz, 2H, 
N-Ph), 5.77 – 5.40 (m, 1H), 4.88 (d, J = 11.5 Hz, 1H, -CH2
Bn
), 4.80 – 4.71 (m, 2H, -CH2
Bn
), 4.66 (s, 2H, -CH2
Bn
), 
4.55 (d, J = 11.5 Hz, 1H, -CH2
Bn
), 4.36 (q, J = 11.7 Hz, 2H, -CH2
Bn
), 3.99 (t, J = 8.6 Hz, 1H), 3.87 (s, 1H), 3.54 (d, J 
= 6.6 Hz, 4H). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 143.56, 138.41, 138.16, 138.03, 137.77, 128.66, 128.49, 128.45 
(2C), 128.32, 128.27 (2C), 127.97, 127.89, 127.86, 127.78, 127.73, 127.58, 124.15, 119.33, 97.37, 82.10, 78.16, 
75.59, 74.78, 74.42, 73.53, 73.23, 73.02, 68.16. 
 
3,4,6-Tri-O-acetyl-1,2-O-(exo-ethoxyethylidene)-α-D-galactopyranose (409) 
Galactose pentaacetate (20 g; 51.2 mmol) was dissolved in CH2Cl2 under N2-atmosphere. A 30% 
solution of HBr in AcOH (40 mL) was added and the reaction mixture was stirred at 22 °C 
overnight. The reaction mixture was diluted with CH2Cl2 (150 mL) and poured over ice. The organic 
layer was separated and washed with H2O (2x75 mL) and cold sat. aq. NaHCO3 (2x120 mL). The 
organic phase was dried over Na2SO4, filtered and concentrated to give the glycosyl bromide. The crude product was 
used directly in the next step without further purification. To a solution of crude product in s-collidine (70 mL) was 
added dry ethanol (5 mL) and TBAB (5.0 g; 15.5 mmol) and the mixture was stirred at 50 °C for 12 h. During this 
period the reaction mixture went from a solution to almost solid due to precipitated s-collidinium bromide salts. The 
reaction mixture was diluted with chloroform (150 mL) and washed with 2N HCl (70 mL), sat. aq. NaHCO3 (70 
mL) and H2O (70 mL). The organic phase was dried over MgSO4, filtered and concentrated. 
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1,2-O-diacetyl-3,4,6-tri-O-benzyl-D-galactopyranose (411) 
The syrupy ortho ester 409 (20 g; 51.81 mmol) was dissolved in MeOH (330 mL) and a freshly 
prepared 0.1M solution if NaOMe in MeOH (55 mL) was added. The reaction mixture was stirred 
at 22 °C for 2 h after followed by removal of MeOH in vacuo and co-distillation with toluene 
(2x100 mL). Rf 0.6 (9:1 CH2Cl2/ MeOH). To the oily residue was added DMF (200 mL), NaH (60%; 5.49 g; 228.7 
mmol) and benzyl bromide (27.06 mL; 126.94 mmol). After stirring for 10 h at 22 °C the reaction mixture was 
diluted with EtOAc (750 mL) and washed with sat. aq. NaHCO3 and water (500 mL). The organic phase was dried 
over MgSO4, filtered and concentrated. Rf 0.2 (9:1 Pet. Ether/EtOAc) 
The crude orthoester 410 (26.1 g; 51.81 mmol) was dissolved in 60% AcOH (500 mL) and was stirred at 22 °C for 
16 h. The reaction mixture was co-evaporated with toluene (2x200 mL) and left under high vacuum.The crude was 
purified by flash chromatography (4:1 Tol/EtOAc) to give a viscous oil. Rf 0.3 (4:1 Tol/EtOAc). The oil (22.6 g; 
45.88 mmol) and DMAP (0.56 g; 4.59 mmol) was dissolved in dry pyridine (150 mL) and cooled to 0 °C. Ac2O 
(8.67 mL; 91.77 mmol) was added and the reaction was allowed to reach 22 °C. After 3h the reaction was quenched 
with MeOH (15 mL), diluted with ether (300 mL) and washed with 1M HCl (300 mL) and sat. aq. NaHCO3 (300 
mL). The organic phase was dried over MgSO4, filtered and concentrated. The crude product was purified by flash 
chromatography (19:1 Tol/EtOAc) to give 411 as white crystals. Rf 0.45 (9:1 Tol/EtOAc). Yield: 23.30 g (9:1α/β 
mixture) (82% over four steps). 
1
H NMR (400 MHz, CDCl3) δ 7.54 – 7.10 (m, 18H), 6.35 (d, J 1,2= 3.7 Hz, 1H, H-1), 5.53 (dd, J2,3= 10.5, J1,2=3.7 
Hz, 1H, H-2), 4.96 (d, J = 11.4 Hz, 1H, -CH2Ph), 4.70 (dd, J = 12.1 Hz, 2H, -CH2Ph), 4.59 (d, J = 11.4 Hz, 1H, -
CH2Ph), 4.46 (dd, J = 11.7 Hz, 2H, -CH2Ph), 4.08 (m, 2H, H-4, H-5), 3.93 (dd, J2,3 = 10.5, J3,4=2.7 Hz, 1H, H-3), 
3.59 (ddd, J6a,6b = 14.6, J5,6a=9.1, J5,6b=6.6 Hz, 2H, H6a, ), 2.11 (s, 3H), 2.03 (s, 3H). 
13
C NMR 
 
 (101 MHz, CDCl3) 
δ 169.95, 169.25, 138.26, 138.11, 137.69, 128.47 (2C), 128.44 (2C), 128.30 (2C), 128.15 (2C), 128.00 (2C), 127.90, 
127.74, 127.69, 127.30 (2C), 90.49, 76.50, 74.88, 73.92, 73.62, 72.55, 72.03, 69.37, 68.25, 21.04, 20.78. 
MS m/z (ESI
+
): 535.2 [(M+ H)
+
] 
 
Phenyl 2-O-Acetyl-3,4,6-tri-O-benzyl-1-thio-β-D-galactopyranoside (412) 
411 (7 g; 13.09 mmol) was dissolved in CH2Cl2 (150 mL) under N2-atmosphere. Thiophenol (2.02 
mL; 19.64 mmol) was added and the reaction mixture was cooled to 0 °C. BF3
.
OEt2 (1.93 mL; 
15.71 mmol) was added drop wise. The mixture was allowed to warm to 22 °C and the reaction 
was monitored by TLC. After 4h the reaction was diluted with CH2Cl2 (200 mL) and washed with sat. aq. NaHCO3 
(200 mL), dried over MgSO4 and concentrated. The product was purified by flash chromatography (9:1 Pet. 
Ether/EtOAc) to give 412 as a white powder. Rf 0.75 (9:1 Tol/EtOAc). Yield: 5.43 g (71%). 
1
H NMR (400 MHz, CDCl3) δ 7.56 – 7.48 (m, 2H, Ar-H), 7.43 – 7.19 (m, 18H, Ar-H), 5.46 (dd J1,2=J2,3= 9.8 Hz, 
1H, H-2), 4.97 (d, J = 11.6 Hz, 1H, CH2
 Bn
), 4.77 – 4.53 (m, 4H, H-1, CH2
Bn
, CH2
Bn
), 4.47 (dd, JCH2 = 11.6 Hz, 2H, -
CH2
Bn
), 4.02 (d, J3,4 = 2.7 Hz, 1H, H-4), 3.76 – 3.63 (m, 3H, H-5, H-6
a,b
), 3.59 (dd, J2,3= 9.6, J3,4=2.7 Hz, 1H, H-3). 
13
C NMR 
 
 (101 MHz, CDCl3) δ 169.52, 138.47, 137.88, 137.84, 133.72-127.37 (17C), 86.69, 81.47, 77.61, 74.38, 
73.62, 72.79, 72.00, 69.71, 68.80, 21.10. MS m/z (ESI
+
): 585.2 [(M+ H)
+
] 
 
2-O-Acetyl-3,4,6-tri-O-benzyl-D-galactopyranose (413) 
A solution of 411 (5.0 g; 9.35 mmol) in Et2O (125 mL) and benzyl amine (20 mL) was stirred at 22 
°C for 5 h and then concentrated. The residue was dissolved in CH2Cl2 (200 mL) and washed with 
1M HCl (100 mL), sat. aq. NH4Cl (100 mL) and H2O, dried over MgSO4 and concentrated. The 
product 413 was purified by column chromatography (4:1 Tol/EtOAc). Rf 0.4 (4:1 Tol/EtOAc). 
Yield: 3.0 g (66%). 
1
H NMR (400 MHz, CDCl3) δ 7.37 – 7.14 (m, 6H), 6.20 (d, J = 3.9 Hz, 1H), 5.37 (t, J = 3.3 Hz, 1H), 5.31 – 5.22 
(m, 1H), 5.16 – 5.07 (m, 1H), 4.85 (dd, J = 11.5, 2.4 Hz, 1H), 4.77 – 4.25 (m, 2H), 4.25 (dt, J = 10.0, 4.0 Hz, 1H), 
4.08 (t, J = 6.3 Hz, 1H), 4.02 (d, J = 1.6 Hz, 1H), 3.88 (td, J = 10.2, 2.3 Hz, 1H), 3.69 (dd, J = 10.1, 2.7 Hz, 1H), 
3.64 – 3.52 (m, 1H), 3.51 – 3.43 (m, 1H), 3.37 (dd, J = 9.5, 6.0 Hz, 1H), 3.14 (t, J = 10.4 Hz, 1H), 2.00 (s, 1H). 13C 
NMR 
 
 (101 MHz, CDCl3) δ 170.41, 169.75, 138.32, 138.24, 137.89, 137.75, 137.70, 129.07, 128.61, 128.48, 
128.45, 128.31, 128.29, 128.02, 127.92, 127.87, 127.86, 127.72, 127.69, 127.51, 127.41, 96.33, 90.90, 79.66, 77.38, 
77.06, 76.74, 76.45, 74.85, 74.77, 74.64, 74.60, 74.25, 73.73, 73.61, 73.56, 73.00, 72.82, 72.38, 71.26, 69.48, 69.29, 
68.34, 21.07. MS m/z (ESI
+
) : 493.2 [(M+ H)
+
] 
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2-O-Acetyl-3,4,6-tri-O-benzyl-D-galactopyranose N-phenyltrifluoroacetimidate(414) 
Hemiacetal 413 (300 mg; 0.61 mmol) was dissolved in CH2Cl2 (10 mL) and cooled to 0 °C. 
PTAICl (253 mg; 1.22 mmol) and CsCO3 (397 mg; 1.22 mmol) were added and the reaction 
was stirred at 0 °C for 4 h. The reaction mixture was then filtered and concentrated. The crude 
product was purified by flash chromatography (7:2:1 heptane/toluene/EtOAc) to give 414. 
Yield: 310 mg (76%). 
 
2-acetamido-2-deoxy-3,4,6-tri-O-acetyl--D-glucopyranosyl-(11)-2,3,4,6-O-tetrabenzyl--D-
galactopyranosyl (415) 
373 (52 mg; 0.15 mmol) and 408 (160 mg; 0.22 mmol) were mixed and dried azeotropically 
with toluene (2x5 mL) and dried under high vacuum overnight. The mixture was dissolved in 
CH2Cl2 (3 mL), freshly dried 4Å MS were added, and the mixture was cooled to 0 °C. 
TMSOTf (3 mg; 0.015 mmol) was added and the reaction was stirred at 0 °C until TLC showed 
full conversion (0.5h). The reaction was quenched with Et3N (100 L), concentrated and 
purified by flash chromatography (4:1 toluene/EtOAc) to give 415 as a colorless crystalline 
material. Yield: 79 mg (61%). 
1
H NMR (400 MHz, CDCl3) δ 7.40 – 7.08 (m, 20H, Ar-H), 5.73 (d, J2,NH = 8.8 Hz, 1H, NH
Ac
), 5.17 (dd, J3,4 = 9.8, 
J2,3 =9.5 Hz, 1H, H-3’), 5.095 (d, J1,2 = 3.9 Hz, 1H, H-1), 5.09 (d, J1,2 = 3.7 Hz, 1H, H-1’), 5.05 (t, J3,4 = J4,5 = 9.8 
Hz, 1H, H-4’), 4.85 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2
Bn
), 4.79 (d, JCH2 = 11.7 Hz, 1H, 0.5xCH2
Bn
), 4.75 (m, 2H, 
CH2
Bn
), 4.56 (d, JCH2 = 11.6 Hz, 1H, 0.5xCH2
Bn
), 4.48 (d, JCH2 = 11.4 Hz, 1H, 0.5xCH2
Bn
), 4.34 (d, JCH2 = 11.7 Hz, 
1H, 0.5xCH2
Bn
), 4.27 (d, JCH2 = 11.7 Hz, 1H, 0.5xCH2
Bn
), 4.24 (ddd, J2,3 = 9.5 J2,NH = 8.8, J1,2 = 3.1 Hz, 1H, H-2’), 
4.15 (ddd, J4,5 = 10.2, J5,6a =3.5, J5,6b =2.3 Hz, 1H, H-5’), 4.05 (dd, J2,3 = 10.1, J1,2 = 3.9 Hz, 1H, H-2), 3.98 (dd, J3,4 
= 2.7, J4,5 = 1.2 Hz, 1H, H-4), 3.91 (dd, J2,3 = 10.2, J3,4 = 2.7 Hz, 1H, H-3), 3.88 – 3.79 (m, 2H, H-6a’, H-5), 3.64 
(dd, J6a,6b = 12.6, J5,6b = 2.3 Hz, 1H, H-6b’), 3.45 (dd, J6a,6b = 9.1, J5,6a = 7.3 Hz, 1H, H-6a), 3.37 (dd, J6a,6b =  9.1, 
J5,6a = 5.5 Hz, 1H, H-6b), 1.96 (s, 3H, CH3
Ac
), 1.96 (s, 3H, CH3
Ac
), 1.93 (s, 3H, CH3
Ac
), 1.76 (s, 3H, CH3
Ac
). 
13
C 
NMR 
 
 (101 MHz, CDCl3) δ 171.96, 170.76, 170.23, 169.31, 138.40 (2C), 138.24, 137.59, 128.55-127.62 (20C), 
94.93, 94.31, 78.95, 75.58, 74.92, 74.23, 74.02, 73.70, 72.69, 71.15, 70.97, 68.59, 67.84, 67.75, 61.46, 52.31, 22.87, 
20.92, 20.80, 20.72. HRMS: calc. [M+ Na]
+
: 892.3520 found [M+ Na]
+
: 892.3524  
 
2,3,4,6-O-tetrabenzyl--D-galactopyranosyl-(1N-3)-hexaacetyl-tunicaminyl-uracil (416) 
374 (90 mg; 0.14 mmol) and 408 (195 mg; 0.27 mmol) was dried 
azeotropically with toluene (2x5 mL) and dried under high vacuum overnight. 
The mixture was dissolved in dry CH2Cl2 (4 mL) and freshly dried 4Å MS 
(200 mg) was added. The reaction mixture was stirred for 20 min at -20 °C 
after which TMSOTf (3 mg; 0.014 mmol) was added. After 30 min at -20 °C 
another round of TMSOTf (3 mg; 0.014 mmol) was added. The reaction was 
allowed to reach 0 °C and stirred until TLC showed full conversion (1.5h). The reaction was quenched with Et3N 
(100 L) and concentrated. The product 416 was purified by flash chromatography (40:1 EtOAc/MeOH). Yield: 103 
mg (65%). 
1
H NMR (500 MHz, CDCl3) δ 7.39 – 7.19 (m, 20H, Ar-H), 7.12 (d, J5,6 = 8.1 Hz, 1H, H-6
uracil
), 6.96 (d, J1,2 = 8.3 
Hz, 1H, H-1’’), 5.94 (d, J1,2 = 5.5 Hz, 1H, H-1’), 5.75 (d, J5,6 = 8.1 Hz, 1H, H-5
uracil
), 5.44 (dd, J2,3 = 5.5, J3,4 = 2.0 
Hz, 1H, H-3’), 5.38 – 5.31 (m, 1H, H-5’), 5.26 – 5.13 (m, 4H, H-2’, H’8, H-9’, H-11’), 4.96 (d, JCH2 = 11.4 Hz, 1H, 
0.5xCH2
Bn
), 4.83 (d, JCH2 = 11.7 Hz, 1H, 0.5xCH2
Bn
), 4.75 (d, JCH2 = 11.7 Hz, 1H, 0.5xCH2
Bn
), 4.69 – 4.35 (m, 7H, 
H-2’’, H-3’’, H-5’’, H-10’, 1.5xCH2
Bn
), 4.39 (d, JCH2 = 12.0 Hz, 1H, 0.5xCH2
Bn
) 4.17 – 4.11 (m, 1H, H-7’), 4.11 – 
4.01 (m, 2H, H-4’, H-4’’), 3.51 (m, 2H, H-6’’), 2.17 (s, 3H, CH3
Ac
), 2.14 (s, 3H, CH3
Ac
), 2.11 (s, 3H, CH3
Ac
), 2.11 
(s, 3H, CH3
Ac
), 2.00 (s, 3H, CH3
Ac
), 1.96 (s, 3H, CH3
Ac
), 1.94 – 1.88 (m, 1H, H-6a’), 1.58 (ddd, J6a,6b = 14.7, J5,6b = 
9.5, J7,6b = 2.2 Hz, 1H, H-6b’). 
13
C NMR 
 
 (126 MHz, CDCl3) δ 171.11, 170.91, 170.84, 170.33, 169.62, 169.36, 
163.07, 139.24, 138.87, 138.11, 138.01, 137.75, 128.45, 128.37, 128.34, 128.29, 128.16, 127.96, 127.79, 127.66, 
127.59, 127.58, 127.48, 127.40, 92.02, 88.55, 82.72, 81.24, 77.36, 75.88, 75.82, 74.78, 74.56, 74.15, 73.54, 73.14, 
70.22, 69.92, 69.69, 69.57, 68.67, 64.68, 47.99, 31.05, 23.45, 21.19, 20.92, 20.88, 20.62, 20.39. HRMS: calc. [M+ 
Na]
+
: 1202.4321 found [M+ Na]
+
: 1202.4322 
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4,6-O-diacetyl-3-O-(benzyl (S)-lactate)-2-deoxy-2-phthalimido-β-D-glucopyranosyl-(1N-3)-hexaacetyl-
tunicaminyl-uracil (417) 
374 (120 mg; 0.18 mmol) and 376 (331 mg; 0.46 mmol) was dried 
azeotropically with toluene (2x5 mL) and left under high vacuum 
overnight. The mixture was dissolved in CH2Cl2 (5 mL) and freshly 
dried 4Å MS were added. The mixture was stirred at -20 °C for 15 min. 
TMSOTf (4 mg; 0.018 mmol) was added and the reaction was stirred at 
0 °C until TLC showed full conversion of the acceptor (5h). The reaction 
was quenched with Et3N, filtered and concentrated. The residue was 
purified by flash chromatography (40:1 EtOAc/MeOH) to afford 417 as colorless crystals. Yield: 97 mg (45%). 
1
H NMR (500 MHz, CDCl3) δ 7.81 (dd, JAr-H = 5.4, JAr-H = 3.0 Hz, 2H, H
Phth
), 7.69 (dd, JAr-H =  5.4, JAr-H = 3.0 Hz, 
2H, H
Phth
), 7.39 (d, J5,6 = 7.4 Hz, 1H, H-6
uracil
), 7.33 – 7.24 (m, 3H, Ar-H), 7.10 (m, 2H, Ar-H), 6.73 (d, J1,2= 8.8 Hz, 
1H, H-1’’), 5.90 (d, J1,2 = 5.2 Hz, 1H, H-1’), 5.87 (d, J5,6 = 7.4 Hz, 1H, H-5
uracil
), 5.48 (d, J10,NH = 9.3 Hz, 1H, NH
Ac
), 
5.37 (t, J2,3 = J3,4 = 5.6 Hz, 1H, H-3’), 5.26 – 5.22 (m, 1H, H-4’’), 5.20 (dd, J2,3 = 5.6 Hz, J1,2 = 5.2 Hz, 1H, H-2’), 
5.18 – 5.13 (m, 3H, H-9’, H-11’, H-8’), 5.09 (dt, J5,6b = 7.8 Hz, J4,5 = J5,6a = 4.0 Hz, 1H, H-5’), 4.71 (d, JCH2 = 12.2 
Hz, 1H, CH2
Bn
), 4.64 (d, JCH2 = 12.2 Hz, 1H, CH2
Bn
), 4.59 – 4.53 (m, 2H, H-2’’, H-3’’), 4.44 (td, J9,10 = J10,NH = 
10.5, J10,11 = 3.5, 1H, H-10’), 4.30 (dd, J6a,6b = 12.5 Hz, J5,6a = 4.3 Hz, 1H, H-6a’’), 4.15 (dd, J3,4 = 5.6, J4,5 = 4.0 Hz, 
1H, H-4’), 4.13 – 4.04 (m, 3H, CH-CH3
lactate
, H-6b’’, H-7’), 3.96 (ddd, J4,5 =10.0 Hz, J5,6a = 4.3 Hz, J5,6b = 2.3 Hz, 
1H, H-5’’), 2.16 (s, 3H, CH3
Ac
), 2.09 (s, 6H, 2xCH3
Ac
), 2.08 (s, 3H, CH3
Ac
), 2.06 (s, 3H, CH3
Ac
), 2.05 (s, 3H, CH3
Ac
), 
1.99 (s, 3H, CH3
Ac
), 1.94 (s, 3H, CH3
Ac
), 1.92 – 1.85 (m, 1H, H-6a’), 1.58 (ddd, J6a,6b = 14.8, J5,6b = 7.9, J6b,7 = 2.5 
Hz, 1H, H-6b’), 1.21 (d, JCH,CH3 = 6.9 Hz, 3H, CH3-CH
lactate
). 
13
C NMR 
 
 (126 MHz, CDCl3) δ 172.00, 171.19, 
170.83, 170.67, 169.96, 169.92, 169.78, 169.49, 169.24, 169.11, 154.55, 143.53, 135.18, 133.89, 133.87, 128.47, 
128.30, 128.11, 123.35, 96.46, 92.11, 91.48, 88.98, 82.54, 77.23, 75.99, 73.20, 72.33, 71.20, 70.02, 69.88, 69.48, 
68.11, 66.36 (2C), 65.54, 61.40, 54.20, 48.78, 31.97, 23.27, 21.01, 20.86, 20.80, 20.76, 20.72, 20.46, 20.42, 18.92. 
HRMS: calc. [M+ Na]
+
: 1071.3308 found [M+ Na]
+
: 1071.3312 
  
2-Azido-4,6-O-dibenzyl-3-O-[(R)-1’-((2-trimethylsilyl)-ethyloxycarbonyl)ethyl]-2-deoxy--D-glucopyranosyl-
(1N-3)-hexaacetyl-tunicaminyl-uracil (418) 
374 (110 mg; 0.17 mmol) and 406 (365 mg; 0.50 mmol) was dried 
azeotropically with toluene (2x5 mL) and left under high vacuum overnight. 
The mixture was dissolved in CH2Cl2 (5 mL) and freshly dried 4Å MS were 
added. The mixture was stirred at -20 °C for 15 min. TMSOTf (4 mg; 0.017 
mmol) was added and the reaction was stirred at 0 °C until TLC showed full 
conversion of the acceptor (5h). The reaction was quenched with Et3N, filtered 
and concentrated. The residue was purified by flash chromatography (40:1 
EtOAc/MeOH) to afford 418 as colorless crystals. Yield: 120 mg (59%). 
1
H NMR (400 MHz, CDCl3) δ 7.54 (d, J = 7.4 Hz, 1H, H-6
uracil
 ), 7.48 (d, J5,6 = 7.4 Hz, 1H, H-6
uracil), 7.38 – 7.05 
(m, 15H, Ar-H), 6.74 (d, J1,2 = 8.6 Hz, 1H, H-1’’), 6.71 (d, J1,2 = 3.6 Hz, 1H, H-1’’), 6.00 (d, J5,6 = 7.4 Hz, 1H, H-
5
uracil), 5.99 (d, J = 4.9 Hz, 1H, H-1’), 5.98 (d, J1,2 = 5.3 Hz, 1H, H-1’), 5.91 (d, J5,6 = 7.4 Hz, 1H, H-5
uracil), 
5.82 (d, J10,NH = 9.6 Hz, 1H, NH
Ac
), 5.40 (td, J2,3 = 6.0, J3,4 = 3.7 Hz, 2H, H-3’, H-3’), 5.36 – 5.06 (m, 10H, H-
2’, H-2’, H-5’, H-5’, H-11’, H-11’, H-8’, H-8’, H-9’, H-9’), 4.77 (d, JCH2 = 10.9 Hz, 1H, 0.5xCH2
Bn) 
4.76 (d, J = 10.9 Hz, 1H, 0.5xCH2), 4.63 – 4.31 (m, 14H, H-3’’, H-3’’, H-7’, , H-7’, H-10’, H-10’, 
3xCH2
Bn
, O-CH-CH3, O-CH-CH3), 4.30 – 4.05 (m, 8H, H-2’’, H-4’, O-CH2-CH2
TMS, 
O-CH2-CH2
TMS
), 3.94 – 
3.84 (m, 2H, H-5’’, H-5’’), 3.83 – 3.49 (m, 4H, H-2’’, H-4’’, H-6a’’, H-6b’’), 2.13 (s, 6H, 2xCH3
Ac
), 2.08 (s, 
3H, 2xCH3
Ac
), 2.07 (s, 6H, 2xCH3
Ac
), 2.04 (s, 6H, 2xCH3
Ac
), 1.95 (s, 6H, 2xCH3
Ac
), 1.93 (s, 6H, 2xCH3
Ac
), 1.90 – 
1.86 (m, 2H, H-6a’, H-6a’), 1.56 (ddd, J6a,6b = 14.5, J5,6b = 8.5, J7,6b =2.1 Hz, 1H, H-6b’, H-6b’), 1.39 (d, J = 
6.9 Hz, 3H, CH3-CH-), 1.37 (d, J = 6.9 Hz, 3H, CH3-CH-), 1.05 – 0.93 (m, 4H, TMS-CH2-CH2-O, TMS-CH2-
CH2-O), 0.03 (s, 9H, TMS). 0.00 (s, 9H, TMS) 
13
C NMR 
 
 (101 MHz, CDCl3) δ 174.43, 174.21, 172.47, 172.45, 
172.38, 172.36, 172.22, 171.80, 171.55, 171.50, 171.23, 171.15, 170.87, 156.46, 145.27, 139.25, 139.23, 139.12, 
130.02, 129.98, 129.96, 129.90, 129.86, 129.83, 129.44, 129.40, 129.35, 129.32, 129.30, 129.26, 129.24, 129.21,  
129.13, 98.21, 98.11, 95.92, 94.13, 93.43, 90.46, 84.33, 84.28, 84.12, 81.08, 78.99, 78.75, 78.47, 78.38, 78.01, 
77.97, 76.82, 76.58, 76.53, 75.07, 75.02, 74.97, 74.78, 74.73, 74.69, 71.68, 71.65, 71.58, 71.47, 71.34, 71.14, 70.04, 
69.35, 69.31, 66.74, 66.21, 66.10, 64.85, 64.71, 64.36, 49.42, 33.82, 31.17, 24.81, 24.69, 22.59, 22.57, 22.55, 22.48, 
22.38, 22.30, 22.29, 22.26, 22.21, 22.02, 21.98, 21.96, 21.84, 20.75, 20.64, 20.62, 18.84, 18.78, 18.76, 2.51, -0.00. 
HRMS: calc. [M+ Na]
+
:  1219.4367 found [M+ Na]
+
: 1219.4361 
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3-N-benzyl-heptaacetyl-tunicaminyl uracil (419) 
 371 (110 mg; 0.15 mmol) was dissolved in DMF (4 mL). BnBr (40 mg; 0.24 mmol) 
and Cs2CO3 (54 mg; 0.17 mmol) was added and the reaction was stirred at 50 °C for 
1h. The mixture was poured into water (50 mL) and extracted with EtOAc (3x100 
mL). The combined organic phases were concentrated and the crude was purified by 
flash chromatography to give 419 as an off-white solid (40:1 EtOAc/MeOH). Yield: 
109 mg (88%). 
1
H NMR (500 MHz, CDCl3) δ 7.44 – 7.40 (m, 2H, Ar-H), 7.34 – 7.23 (m, 3H, Ar-H), 7.21 – 7.15 (m, 1H, H-6
uracil
), 
6.14 (d, J10,11 = 3.7 Hz, 1H, H-11’), 6.00 (d, J1,2 = 5.8 Hz, 1H, H-1’), 5.88 (d, J5,6 = 8.1 Hz, 1H, H-5
uracil
), 5.48 (d, 
J10,NH = 9.4 Hz, 1H, NH
Ac
), 5.35 (dd, J2,3 = 5.9 Hz, J3,4 = 4.3 Hz, 1H, H-3’), 5.30 – 5.17 (m, 3H, H-2’, H-8’, H-9’), 
5.12 (m, 1H, H-5’), 5.10 – 5.07 (m, 2H, CH2
Bn
), 4.71 (ddd, J9,10 = 10.8, J10,NH = 9.4, J10,11 = 3.7 Hz, 1H, H-10’), 4.08 
– 4.02 (m, 2H, H-4’, H-7’).18 (s, 3H, CH3
Ac
), 2.17 (s, 3H, CH3
Ac
), 2.11 (s, 3H, CH3
Ac
), 2.06 (s, 3H, CH3
Ac
), 2.03 (s, 
3H, CH3
Ac
), 2.02 (s, 3H, CH3
Ac
), 1.96 (s, 3H, CH3
Ac
), 1.94 – 1.84 (m, 1H, H-6a’), 1.56 (ddd, J6a,6b = 15.0, J5,6b = 8.3, 
J6b,7 = 2.1 Hz, 1H, H-6b’). 
13
C NMR 
 
 (126 MHz, CDCl3) δ 171.32, 170.68, 170.18, 170.13, 169.66, 169.40, 169.21, 
162.24, 151.08, 137.98, 137.38, 136.55, 129.15, 128.96, 128.94, 128.53, 128.34, 127.74, 125.41, 103.26, 91.16, 
87.99, 82.47, 77.36, 72.60, 69.67, 69.64, 69.50, 68.27, 67.72, 46.85, 44.46, 32.90, 29.82, 23.34, 21.58, 21.04, 21.01, 
20.89, 20.83, 20.64, 20.47. HRMS: calc. [M+ Na]
+
:  812.2490 found [M+ Na]
+
: 812.2499 
 
3-N-benzyl-hexaacetyl-tunicamine uracil (420) 
419 (200 mg; 0.25 mmol) was dissolved in THF (3 mL). A solution of ethylene 
diamine (18.3 mg; 0.30 mmol) and AcOH (21.3 mg; 0.35 mmol) in THF was added 
and the reaction was stirred for 18h at 22 °C. The reaction mixture was poured into 
0.5M HCl (50 mL) and extracted with EtOAc (3x50 mL). The combined organic 
phases were dried over MgSO4, and concentrated. The crude was purified by flash 
chro-matography (50:1 EtOAc/MeOH) to afford 420 as colorless crystals. Yield: 56 mg (30 %). 
1
H NMR (500 MHz, CDCl3) δ 7.45 – 7.39 (m, 2H, Ar-H), 7.34 – 7.22 (m, 3H, Ar-H), 7.16 (d, J5,6 = 8.1 Hz, 1H, H-
6
uracil
), 5.95 (d, J = 5.7 Hz, 1H, H-1’), 5.85 (d, J = 8.1 Hz, 1H, H-5uracil), 5.77 (d, J N-H, 10 = 9.7 Hz, 1H, N-H
Ac
), 5.40 
(dd, J2,3 = 6.1, J3,4 = 4.6 Hz, 1H, H-3’), 5.34 – 5.24 (m, 2H, H-2
’
, H-5
’
) 5.26 (d, J10,11 = 3.6 Hz, 1H, H-11’), 5.23 – 
5.16 (m, 2H, H-9’, H-8’), 5.12 – 5.02 (m, 2H, CH2
Bn
), 4.53 (ddd, J9,10 = 10.5, JNH,10 = 9.7, J10,11 = 3.5, 1H, H-10’), 
4.14 (dd, J6b,7 = 10.0 Hz,  J6a,7 = 3.1 Hz 1H, H-7
’
), 4.09 (t, J3,4 = J4,5 = 4.6 Hz, 1H, H-4
’
), 2.17 (s, 3H, CH3
Ac
), 2.11 (s, 
3H, CH3
Ac
), 2.08 (s, 3H, CH3
Ac
), 2.03 (s, 3H, CH3
Ac
), 2.00 (s, 3H, CH3
Ac
), 1.97 (s, 3H, CH3
Ac
), 1.90 (ddd, J6a,6b = 
14.3 Hz, J5,6a = 11.0 Hz, J6a,7 = 3.1 Hz, 2H, H-6a
´
), 1.58 (ddd, J6a,6b = 14.6 Hz, J6b,7 =  9.4 Hz, J5,6b =  2.2 Hz, 1H, H-
6b
´
). 
13
C NMR 
 
 (126 MHz, CDCl3) δ 171.13, 171.05, 170.79, 170.38, 169.80, 169.48, 162.24, 150.95, 137.57, 
136.49, 129.15, 128.97 (2C), 128.55 (2C), 128.34, 127.80, 103.24, 92.08, 88.32, 82.52, 77.36, 72.51, 70.22, 69.69, 
69.50, 68.60, 64.72, 48.05, 44.50, 32.37, 29.82, 23.46, 21.16, 20.93 (2C), 20.62, 20.49. HRMS: calc. [M+ Na]
+
: 
770.2385 found [M+ Na]
+
: 770.2387.
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